data_2jzj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jzj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 52.78 71.17 0.5 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.375 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CD1' HG12 ' A' ' 92' ' ' VAL . 2.7 p90 -54.02 -36.76 63.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.264 0.554 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.14 -21.61 33.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -62.74 -27.78 69.52 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.459 ' HB2' HD21 ' A' ' 94' ' ' ASN . 26.7 m -134.62 16.7 3.63 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.049 0.452 . . . . 0.0 110.774 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.5 m -117.48 133.04 56.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.129 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -130.84 152.71 49.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.717 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.22 61.65 6.15 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.095 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 m -95.08 131.3 42.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.393 0.616 . . . . 0.0 111.898 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -124.59 157.44 35.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.099 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.586 HD22 HD23 ' A' ' 64' ' ' LEU . 14.2 tp -139.82 121.66 15.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.501 . . . . 0.0 111.295 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.42 102.17 6.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.98 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.7 -60.67 3.71 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.965 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -170.81 26.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 122.875 0.47 . . . . 0.0 110.38 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 15.2 mt -119.23 113.61 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.08 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -99.2 114.24 26.93 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -124.22 142.78 50.96 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.486 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.42 -179.27 41.19 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.401 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -103.59 107.69 18.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 79.8 m -107.62 132.77 52.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.013 0.435 . . . . 0.0 110.025 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.1 mt -72.78 137.21 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.575 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -102.41 -169.09 1.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.028 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -62.83 -26.31 68.68 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 111.598 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.21 -23.26 64.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.296 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.45 5.92 58.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.351 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -110.43 142.16 25.47 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.678 0.275 . . . . 0.0 110.624 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.51 122.15 8.9 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.819 2.346 . . . . 0.0 111.979 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -111.71 131.03 55.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.75 120.85 17.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.157 0.503 . . . . 0.0 111.104 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 t -136.69 152.75 50.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.122 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.7 p -131.22 148.22 52.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.472 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.04 145.53 34.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.463 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -101.95 98.75 8.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.163 0.506 . . . . 0.0 110.121 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.5 mm? -60.38 -26.81 66.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.64 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.02 -24.91 57.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.756 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -106.83 7.22 30.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 60.0 m-85 -128.68 -16.37 4.26 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.08 144.24 27.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.669 0.271 . . . . 0.0 110.974 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.565 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -117.79 179.26 17.18 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.138 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 19.1 p-10 -131.76 102.22 5.79 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.809 0.814 . . . . 0.0 110.618 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -105.27 121.85 44.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.068 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.806 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 53.6 t30 60.13 32.38 20.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.207 0.527 . . . . 0.0 110.171 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.01 21.31 79.97 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.043 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -121.84 157.52 30.93 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 86' ' ' MET . 33.4 mt -82.11 115.69 21.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.203 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HG2' ' C ' ' A' ' 42' ' ' GLY . 10.2 pt-20 -103.24 143.42 32.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.5 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -46.38 -74.06 0.08 OUTLIER Pre-proline 0 CA--C 1.431 -3.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.835 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 50' ' ' TYR . 13.1 Cg_endo -110.24 124.28 0.03 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.393 0 C-N-CA 113.794 -3.671 . . . . 0.0 113.122 -177.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.565 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -150.32 -160.88 9.56 Favored Glycine 0 C--N 1.278 -2.648 0 CA-C-N 113.429 -1.714 . . . . 0.0 113.284 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.486 ' C ' ' HG ' ' A' ' 54' ' ' SER . 33.2 mt-10 -149.6 139.85 22.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.411 -0.395 . . . . 0.0 110.728 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.486 ' HG ' ' C ' ' A' ' 53' ' ' GLU . 45.6 p 48.3 52.23 13.77 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.296 1.038 . . . . 0.0 113.569 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -75.69 -39.55 57.28 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -18.71 53.49 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.576 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.3 m -68.65 -22.72 64.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.291 -0.454 . . . . 0.0 110.728 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.2 m -135.02 22.42 3.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.7 m -131.92 145.38 51.47 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.63 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 m -134.13 169.98 20.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.107 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 66.43 37.09 4.83 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.404 0.44 . . . . 0.0 110.834 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.7 117.36 8.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.54 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.09 161.32 42.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.255 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -112.13 124.0 51.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.869 0.366 . . . . 0.0 110.813 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.424 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 2.7 t30 -95.53 127.28 41.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.833 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 52.41 24.27 2.88 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.972 0.795 . . . . 0.0 112.249 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.33 38.5 79.05 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.859 -0.61 . . . . 0.0 114.1 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.424 ' HD2' ' O ' ' A' ' 65' ' ' ASN . 1.3 p80 -153.46 -27.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.52 0.66 . . . . 0.0 111.798 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.4 m -115.74 130.3 56.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.697 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.603 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.2 tp -90.65 138.95 31.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.9 132.95 52.05 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.68 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.422 ' HB3' HD22 ' A' ' 48' ' ' LEU . . . -164.58 159.89 19.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.128 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 t -107.53 122.94 47.67 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 30.8 m -124.75 154.91 40.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -97.5 146.25 25.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.428 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.94 -31.18 0.74 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.919 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.806 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -52.91 -42.53 65.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -174.39 55.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.75 11.23 59.96 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.446 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -130.51 161.24 31.91 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 50.5 p90 -96.1 168.58 10.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.401 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.08 136.41 9.9 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.2 126.93 31.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.951 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -140.81 171.82 13.55 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.124 0.487 . . . . 0.0 111.072 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.78 158.22 44.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.419 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.872 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.7 OUTLIER -141.83 122.92 14.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.679 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.75 105.66 5.15 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HA ' HG22 ' A' ' 91' ' ' VAL . 21.0 mt -75.55 -8.97 58.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.025 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -47.55 -29.75 3.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.166 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -118.37 21.32 12.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.977 0.418 . . . . 0.0 111.18 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -129.43 -9.63 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.752 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.88 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 14.5 p -152.58 143.73 15.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.41 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.77 169.69 27.87 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.135 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.459 HD21 ' HB2' ' A' ' 8' ' ' SER . 28.2 t30 -100.15 131.06 46.32 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.9 m -138.59 95.04 2.92 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.572 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 62.9 44.88 5.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.441 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.0 23.21 56.79 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.38 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -123.12 140.11 53.36 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -56.17 112.09 1.13 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.85 0.719 . . . . 0.0 111.336 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -137.68 77.62 38.86 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.104 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.88 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 58.1 Cg_endo -74.42 93.96 0.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.428 2.085 . . . . 0.0 112.228 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.097 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 41.49 73.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.573 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.7 p90 -54.76 -39.76 68.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.981 0.419 . . . . 0.0 111.33 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.91 -22.94 41.29 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.53 -20.73 61.29 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.438 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 m -129.97 11.54 5.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.911 0.386 . . . . 0.0 110.928 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.2 m -120.14 132.9 55.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -127.07 160.23 31.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.65 45.34 90.62 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.741 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -87.09 123.94 40.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.449 0.642 . . . . 0.0 111.594 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 47.3 mt-10 -121.61 142.43 50.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.534 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.771 HD21 HD21 ' A' ' 64' ' ' LEU . 17.2 tp -117.83 112.31 20.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.952 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -133.83 104.92 6.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.077 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.36 51.54 21.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.771 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD1' HG22 ' A' ' 62' ' ' THR . 7.7 m-85 63.81 16.18 9.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.214 0.605 . . . . 0.0 111.57 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 20.9 mt -116.38 116.3 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 120.659 0.266 . . . . 0.0 110.534 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.498 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 mt -103.13 114.43 28.71 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -121.07 145.05 48.2 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.79 -175.23 40.54 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.284 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -109.07 110.41 21.66 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.894 0.378 . . . . 0.0 110.263 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.9 m -107.4 132.56 53.04 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.88 134.75 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.227 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.69 -174.24 2.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 96' ' ' TYR . 7.4 tp10 -49.43 -40.04 35.16 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.489 0.493 . . . . 0.0 111.52 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -57.96 -26.14 61.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.303 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.44 -0.44 58.35 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.712 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -106.77 146.08 32.37 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.886 0.374 . . . . 0.0 110.889 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.62 122.16 9.11 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.136 2.557 . . . . 0.0 112.266 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -109.89 127.37 54.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.594 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.65 125.36 25.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.169 0.509 . . . . 0.0 111.475 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 t -143.56 158.85 43.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.342 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 p -139.63 147.0 40.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.857 0.36 . . . . 0.0 111.254 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 mp -130.9 143.44 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.29 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -104.31 95.3 5.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -59.11 -19.81 47.91 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.806 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.572 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 21.7 t-20 -54.84 -32.57 60.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.928 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -106.42 16.44 24.71 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.489 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -127.91 -23.45 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.72 144.0 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.625 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -116.53 171.76 13.92 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.881 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -107.28 112.9 25.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.959 0.409 . . . . 0.0 111.222 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -110.61 105.09 13.88 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 2.7 p-10 42.19 44.82 3.36 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.822 1.249 . . . . 0.0 112.806 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.401 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 87.11 7.72 76.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.405 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.85 160.85 20.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.987 0.422 . . . . 0.0 110.83 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 72' ' ' ALA . 31.2 mt -84.05 115.76 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.114 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -103.13 126.06 50.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.586 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.588 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -35.25 -71.28 0.11 Allowed Pre-proline 0 CA--C 1.429 -3.702 0 O-C-N 124.49 1.119 . . . . 0.0 113.736 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -110.75 120.96 0.02 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.436 0 C-N-CA 113.776 -3.682 . . . . 0.0 113.097 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.625 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -152.45 -161.73 10.42 Favored Glycine 0 C--N 1.274 -2.871 0 CA-C-N 113.541 -1.663 . . . . 0.0 113.211 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.69 141.94 17.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.996 0.468 . . . . 0.0 110.458 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.2 m 58.66 36.69 25.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.801 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.572 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 5.3 p90 -69.18 -33.48 73.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.23 -18.78 58.57 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.396 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.5 m -67.19 -14.05 62.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.83 0.347 . . . . 0.0 110.774 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.9 p -146.26 20.53 1.38 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.1 m -133.15 139.19 46.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.773 0.321 . . . . 0.0 111.194 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 m -134.16 177.63 6.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.167 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.9 mptt 59.84 44.08 14.28 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.406 0.441 . . . . 0.0 111.136 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.474 HG22 ' CD1' ' A' ' 17' ' ' TYR . 30.6 p -75.75 125.78 29.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 111.358 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.65 162.57 39.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.574 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.771 HD21 HD21 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -118.59 116.99 27.77 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.626 0.251 . . . . 0.0 111.039 -179.06 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -93.19 127.47 38.77 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.639 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 t70 54.0 23.31 3.92 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.914 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.48 28.66 67.8 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.22 -18.09 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 117.899 0.85 . . . . 0.0 112.334 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.0 m -116.38 127.42 54.63 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.749 0.309 . . . . 0.0 111.245 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.527 ' HA ' HD23 ' A' ' 64' ' ' LEU . 14.3 tp -90.03 136.85 32.79 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.56 130.4 50.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.162 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.447 ' HB3' HD22 ' A' ' 48' ' ' LEU . . . -161.44 167.14 26.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.105 0.478 . . . . 0.0 110.713 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 t -116.75 122.02 43.27 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.401 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.4 m -121.51 149.64 42.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 0.0 112.108 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -99.88 146.73 26.31 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.05 -22.79 0.78 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.558 -1.306 . . . . 0.0 113.473 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . -60.89 -40.64 93.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.716 0.293 . . . . 0.0 111.208 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -176.61 57.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.392 0.615 . . . . 0.0 110.08 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.84 0.14 40.13 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.811 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -122.53 163.6 19.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 40.9 p90 -112.45 167.19 10.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.844 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.53 152.76 27.71 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.78 129.45 37.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.231 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.1 t -142.06 166.53 24.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.516 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.86 163.17 32.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.885 ' HE1' ' HA ' ' A' ' 86' ' ' MET . 1.3 tpt -144.73 121.49 11.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.674 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -75.31 105.55 6.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.558 ' HA ' HG23 ' A' ' 91' ' ' VAL . 18.0 mt -74.76 -8.64 57.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.522 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -46.86 -30.1 2.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.222 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -120.83 23.6 10.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 111.348 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.4 m -127.08 -9.28 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.081 0.467 . . . . 0.0 110.472 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.842 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.7 p -156.28 138.34 6.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.858 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.76 177.44 19.07 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.065 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -109.83 123.42 49.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.626 0.25 . . . . 0.0 110.559 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 t -127.57 101.15 6.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 26' ' ' GLU . 98.0 m-85 57.98 47.62 14.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.5 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 58.9 25.22 59.0 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.034 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -129.82 148.93 51.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.813 0.34 . . . . 0.0 110.088 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -58.69 118.94 6.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.66 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -143.9 77.9 14.43 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.958 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.842 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 57.6 Cg_endo -74.69 93.85 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.542 2.161 . . . . 0.0 112.675 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.182 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 53.15 68.39 0.85 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.503 ' CD1' ' HB ' ' A' ' 92' ' ' VAL . 10.9 p90 -55.02 -45.99 75.18 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.163 0.506 . . . . 0.0 111.123 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.21 -22.08 62.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.87 -20.48 66.25 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.612 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 m -135.69 25.26 3.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.915 0.388 . . . . 0.0 110.946 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.0 m -134.1 132.95 40.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.051 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 p -134.46 165.11 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.611 0.243 . . . . 0.0 110.867 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.12 98.37 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.185 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.429 ' HB ' ' CD1' ' A' ' 19' ' ' LEU . 35.8 m -83.17 139.81 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.304 0.574 . . . . 0.0 111.848 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.09 148.46 52.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.545 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.507 HD23 HD21 ' A' ' 64' ' ' LEU . 14.5 tp -132.21 117.38 18.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.023 0.439 . . . . 0.0 111.155 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.41 109.99 12.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.462 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.04 -68.91 2.78 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.366 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 17.5 p90 -170.45 28.94 0.02 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.326 0.584 . . . . 0.0 110.387 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 mt -121.2 115.64 47.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.643 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -96.99 113.7 25.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -124.44 139.38 53.95 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.129 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.45 -170.9 33.71 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.269 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -108.25 111.01 22.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.931 0.396 . . . . 0.0 110.278 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.4 m -107.52 132.09 53.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.01 141.82 16.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.678 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -108.92 -171.46 1.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.78 -33.82 64.71 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -64.46 -24.69 67.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.909 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.0 6.98 57.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.623 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -111.55 144.78 31.26 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.44 133.64 28.67 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.864 2.376 . . . . 0.0 112.166 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -118.07 133.24 56.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.378 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.75 122.89 19.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.005 0.431 . . . . 0.0 111.282 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 t -142.17 159.08 42.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.021 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.7 p -140.39 146.02 37.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.83 146.08 33.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.329 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -102.2 96.29 6.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.009 0.433 . . . . 0.0 110.07 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 19' ' ' LEU . 1.1 mm? -59.32 -26.54 65.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.311 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 25.9 t-20 -55.0 -28.95 55.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.054 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -103.34 6.04 37.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -125.25 -19.84 5.0 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.264 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 mt -117.3 143.59 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.801 0.334 . . . . 0.0 110.805 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -119.47 176.29 16.07 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.219 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -127.27 112.76 15.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.735 0.779 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -110.6 115.0 28.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.342 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.801 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 56.3 t30 59.4 38.36 22.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.286 0.565 . . . . 0.0 110.476 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.12 12.09 84.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.195 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -118.45 151.43 37.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.872 0.368 . . . . 0.0 110.797 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -76.96 129.39 36.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.599 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -121.87 132.92 54.83 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.231 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.559 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -37.94 -66.4 0.3 Allowed Pre-proline 0 CA--C 1.423 -3.924 0 O-C-N 124.216 0.948 . . . . 0.0 113.186 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -109.94 129.29 0.04 OUTLIER 'Trans proline' 1 N--CA 1.34 -7.509 0 C-N-CA 113.742 -3.706 . . . . 0.0 113.064 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -163.44 -162.85 14.95 Favored Glycine 0 C--N 1.283 -2.38 0 CA-C-N 114.012 -1.449 . . . . 0.0 113.403 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -150.58 142.94 24.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.935 0.398 . . . . 0.0 110.743 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.8 p 50.83 49.25 21.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.552 1.141 . . . . 0.0 113.585 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.439 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 11.1 p90 -73.91 -43.97 56.71 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.66 -19.01 47.39 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.893 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 m -66.5 -16.02 63.81 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.041 0.448 . . . . 0.0 110.889 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 m -146.55 28.74 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.466 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 55' ' ' PHE . 62.9 m -133.66 149.58 51.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.595 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.69 173.13 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.812 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.22 39.31 9.81 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.062 0.545 . . . . 0.0 111.524 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.442 ' HB ' HD22 ' A' ' 14' ' ' LEU . 22.3 p -66.29 120.6 13.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.335 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.67 156.49 40.48 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.555 HD23 ' HA ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -113.79 112.0 22.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.889 0.376 . . . . 0.0 111.766 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.48 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 6.2 m-20 -73.75 117.48 15.58 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.44 23.58 7.6 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.733 0.646 . . . . 0.0 110.701 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.85 28.46 65.9 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.024 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -139.58 -28.02 0.77 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.707 0.754 . . . . 0.0 111.544 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 22.2 m -110.72 126.16 54.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.707 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.675 ' HB2' HD11 ' A' ' 88' ' ' LEU . 19.3 tp -90.3 127.92 36.29 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.743 -0.383 . . . . 0.0 109.99 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.26 129.62 56.03 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.981 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.57 154.33 18.31 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.678 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 28.0 t -102.41 123.01 45.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 59.8 m -120.2 153.02 36.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.0 111.9 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 10.5 tmtt? -98.77 142.31 30.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.449 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.49 -32.74 0.53 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.278 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.801 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -54.33 -39.68 67.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -169.29 48.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.351 0.596 . . . . 0.0 109.524 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.31 6.48 47.91 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.296 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 28.5 pt20 -128.17 168.11 15.87 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 41.5 p90 -88.26 167.76 13.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.344 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.2 OUTLIER -155.29 129.55 8.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.531 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -70.6 114.7 8.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.674 0.273 . . . . 0.0 110.753 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.7 t -129.49 160.62 32.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.076 0.465 . . . . 0.0 111.238 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.87 165.04 21.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.051 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.957 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 1.7 tpt -152.85 124.83 7.95 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.869 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -76.43 107.05 8.42 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 70' ' ' LEU . 15.6 mt -78.42 -8.17 58.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.649 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -49.78 -28.62 6.5 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.276 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -116.37 21.31 13.66 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.242 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -129.18 -11.21 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.1 t -134.7 145.51 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.15 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.95 166.44 25.4 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -130.85 132.64 45.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 111.319 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.412 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 3.6 m -140.39 113.14 8.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.515 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 59.99 42.67 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.477 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.25 22.03 62.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.449 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -123.55 137.6 54.73 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 127.05 31.57 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.574 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -145.57 68.68 13.39 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 121.75 0.786 . . . . 0.0 109.415 177.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 13.1 Cg_endo -54.68 115.12 2.19 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.539 2.826 . . . . 0.0 113.19 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.705 179.011 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 59.7 m . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 p30 33.04 78.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 2.8 p90 -60.14 -31.86 70.48 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.932 0.396 . . . . 0.0 111.76 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.73 -23.14 66.68 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -70.33 -7.46 42.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.285 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.4 m -145.15 27.01 1.3 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.071 0.462 . . . . 0.0 110.412 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -133.36 147.7 51.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.47 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -140.06 148.18 41.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.654 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.81 59.24 10.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.234 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' HB ' ' CD1' ' A' ' 19' ' ' LEU . 18.2 m -95.24 133.22 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.106 0.479 . . . . 0.0 110.618 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -128.36 142.4 51.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.501 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.634 HD21 HD21 ' A' ' 64' ' ' LEU . 12.7 tp -107.45 112.86 25.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.097 0.475 . . . . 0.0 110.759 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.458 ' O ' HG12 ' A' ' 18' ' ' ILE . 54.8 m-85 -105.17 97.81 7.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.803 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.78 -64.18 0.47 Allowed Glycine 0 CA--C 1.523 0.594 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.549 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.604 ' HD1' HD22 ' A' ' 36' ' ' ASN . 7.9 p90 -158.23 16.67 0.22 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.779 0.432 . . . . 0.0 111.38 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.0 pt -122.63 132.26 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 0.0 110.305 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.532 ' HB2' HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -104.18 114.4 28.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.816 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -117.75 136.82 53.12 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.51 -179.24 38.51 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.385 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -101.71 104.88 15.72 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -105.36 132.13 51.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.998 0.427 . . . . 0.0 110.106 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.6 mt -75.25 132.75 32.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.192 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -101.6 -171.65 2.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.929 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -55.85 -29.93 60.66 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.7 -22.56 66.97 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.053 0.454 . . . . 0.0 111.696 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.58 6.92 65.46 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.459 -0.876 . . . . 0.0 111.293 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -112.86 142.89 28.02 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.542 -0.329 . . . . 0.0 110.354 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.94 121.9 8.54 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.819 2.346 . . . . 0.0 112.131 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -111.92 127.48 55.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.5 124.44 22.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.166 0.508 . . . . 0.0 111.326 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -136.96 159.51 41.67 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.419 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 p -140.05 140.74 36.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.49 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.1 146.87 30.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.414 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.604 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -101.86 94.62 5.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -59.86 -26.62 66.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.631 0.253 . . . . 0.0 111.461 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 27.9 t30 -60.37 -16.48 35.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -109.68 6.82 24.05 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.135 -0.353 . . . . 0.0 110.849 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -127.56 -23.95 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.56 142.45 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.535 ' N ' ' HA3' ' A' ' 52' ' ' GLY . . . -117.16 173.9 14.95 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.005 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -110.14 103.23 11.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.829 0.347 . . . . 0.0 110.51 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -112.42 107.86 16.8 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.371 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.832 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 58.0 t30 59.73 39.05 21.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.243 0.544 . . . . 0.0 110.412 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.497 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 72.57 21.66 79.41 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.71 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -125.94 150.35 48.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.506 0.194 . . . . 0.0 111.358 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.77 114.69 11.18 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.566 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 39.4 tt0 -108.54 123.75 49.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.512 0.672 . . . . 0.0 110.305 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.548 ' HD1' ' SD ' ' A' ' 86' ' ' MET 0.251 0.2 OUTLIER -36.66 -57.73 1.15 Allowed Pre-proline 0 CA--C 1.423 -3.912 0 CA-C-N 113.503 -1.68 . . . . 0.0 115.164 -178.691 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.566 ' HD2' ' HG2' ' A' ' 49' ' ' GLU . 17.2 Cg_endo -117.08 109.23 0.01 OUTLIER 'Trans proline' 1 N--CA 1.348 -7.083 0 C-N-CA 113.471 -3.886 . . . . 0.0 113.12 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.535 ' HA3' ' N ' ' A' ' 42' ' ' GLY . . . -148.43 -164.63 11.55 Favored Glycine 0 C--N 1.271 -3.066 0 CA-C-N 112.988 -1.915 . . . . 0.0 113.851 -176.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -151.79 142.2 22.52 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.629 0.372 . . . . 0.0 110.309 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.4 m 53.67 54.39 10.01 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 19.4 p90 -78.95 -32.99 45.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.63 -19.23 54.13 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.935 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.2 m -65.08 -18.93 65.72 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.98 0.512 . . . . 0.0 111.432 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.3 m -144.83 14.32 1.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.816 0.341 . . . . 0.0 111.193 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.4 m -121.45 139.4 53.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.33 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.72 175.85 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.063 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER 58.42 43.8 19.16 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.604 0.565 . . . . 0.0 111.135 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 p -66.17 132.72 49.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.774 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.61 163.33 40.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.817 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.634 HD21 HD21 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -121.11 113.39 19.96 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.099 0.476 . . . . 0.0 110.518 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.65 120.15 25.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.612 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 54.04 30.75 12.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.901 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 51.33 36.64 37.7 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.442 -0.799 . . . . 0.0 114.644 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -150.76 -29.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.768 0.784 . . . . 0.0 111.415 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 m -113.02 130.73 56.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.27 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.582 ' HB2' HD12 ' A' ' 88' ' ' LEU . 13.2 tp -89.98 128.34 36.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.89 129.24 55.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.576 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.21 170.11 21.85 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.775 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 t -113.81 116.92 30.11 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.497 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.7 m -116.71 148.5 41.02 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.12 0.486 . . . . 0.0 111.859 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.8 tmtt? -100.2 142.62 31.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.232 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.07 -31.03 0.54 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.329 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.832 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.09 -41.28 64.78 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -172.13 52.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.525 0.679 . . . . 0.0 110.182 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.16 -0.28 32.13 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.852 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -119.7 162.92 18.2 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 24.2 p90 -91.03 165.98 13.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.07 127.58 7.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.644 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -67.19 123.03 19.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.787 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 p -142.88 176.07 9.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.349 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.28 160.49 40.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.121 0.486 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.899 ' HE1' ' HA ' ' A' ' 86' ' ' MET . 1.5 tpt -143.91 124.84 14.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.009 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -78.29 106.77 10.43 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.542 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 70' ' ' LEU . 16.1 mt -77.36 -8.93 58.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.987 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -49.37 -27.75 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.334 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -118.62 20.02 13.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.508 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 88' ' ' LEU . 2.0 m -125.22 -13.03 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.958 0.409 . . . . 0.0 110.651 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.879 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 6.9 p -147.26 136.37 16.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.789 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.17 173.89 20.85 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.47 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -111.93 124.57 52.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.4 m -133.07 103.4 6.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.75 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 63.84 41.42 6.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.24 28.28 66.61 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.883 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -125.55 147.19 49.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.897 0.38 . . . . 0.0 110.858 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.5 ptm -64.2 103.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.887 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -132.83 80.32 61.34 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.177 0.513 . . . . 0.0 110.48 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.879 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 65.6 Cg_endo -74.3 125.28 9.59 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.696 2.264 . . . . 0.0 112.148 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 121.372 0.606 . . . . 0.0 111.52 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.7 m . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 43.04 70.2 0.32 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.945 0.778 . . . . 0.0 113.071 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 11.7 p90 -53.25 -34.16 56.02 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.331 0.586 . . . . 0.0 110.402 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.86 -23.29 67.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.349 -0.842 . . . . 0.0 113.002 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -62.06 -27.48 68.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.7 m -129.88 15.91 5.78 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.525 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -117.53 139.89 50.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.371 0.605 . . . . 0.0 111.651 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -137.82 154.48 49.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.199 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.79 60.51 7.99 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.358 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 31.6 m -94.14 139.91 17.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.075 0.464 . . . . 0.0 111.532 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -131.32 148.74 52.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.13 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.689 HD22 HD21 ' A' ' 64' ' ' LEU . 14.9 tp -133.41 119.19 19.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.992 0.425 . . . . 0.0 110.974 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.473 ' O ' HG12 ' A' ' 18' ' ' ILE . 67.6 t80 -127.09 101.32 6.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.202 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.23 -63.08 3.65 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.625 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.642 ' HD1' HD22 ' A' ' 36' ' ' ASN . 8.3 p90 -167.82 20.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.585 0.231 . . . . 0.0 111.602 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 15' ' ' TYR . 35.8 pt -116.25 126.08 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.523 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -111.3 114.74 28.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.263 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 17.8 ttm180 -116.98 138.43 51.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.53 168.12 35.93 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.778 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 9.7 m-20 -101.66 109.56 21.37 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -106.91 133.41 51.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.933 0.396 . . . . 0.0 110.426 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.5 mt -67.85 139.57 20.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.378 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -112.49 -168.1 1.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.567 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -56.18 -33.94 65.74 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.689 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.88 -28.62 67.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.597 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.14 -3.77 58.48 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.596 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -107.3 144.67 29.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.9 128.27 20.45 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.387 2.725 . . . . 0.0 112.795 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -114.75 131.5 56.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.095 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.02 127.29 30.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.271 0.558 . . . . 0.0 111.75 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 t -142.34 159.31 42.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.479 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.6 p -139.69 150.55 45.0 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.351 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -134.63 143.11 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.979 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.642 HD22 ' HD1' ' A' ' 17' ' ' TYR . 1.8 t-20 -100.82 97.03 7.7 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.5 mm? -59.42 -22.55 61.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.383 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -55.11 -28.76 54.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.125 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -108.18 11.54 27.37 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.909 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.409 ' C ' HD12 ' A' ' 41' ' ' ILE . 43.9 m-85 -129.09 -6.91 4.89 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 2.5 mp -129.06 133.74 65.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.64 176.42 18.22 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.391 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -115.38 101.63 9.09 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.983 0.42 . . . . 0.0 109.982 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.78 107.18 16.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.331 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.512 ' CG ' ' HA ' ' A' ' 77' ' ' ALA . 13.7 t-20 56.53 45.2 22.8 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.553 0.692 . . . . 0.0 110.471 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.95 19.8 75.64 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.828 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 149.01 47.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.982 0.42 . . . . 0.0 111.359 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.516 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 8.5 mp -72.45 122.47 21.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.714 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.617 ' HG2' ' CD ' ' A' ' 51' ' ' PRO . 24.7 tt0 -111.57 124.27 51.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 110.68 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.509 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 34.2 p90 -46.55 -28.2 0.68 Allowed Pre-proline 0 CA--C 1.452 -2.817 0 N-CA-C 119.107 3.003 . . . . 0.0 119.107 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.617 ' CD ' ' HG2' ' A' ' 49' ' ' GLU . 6.8 Cg_endo -127.04 5.97 0.01 OUTLIER 'Trans proline' 1 N--CA 1.391 -4.545 1 C-N-CA 112.76 -4.36 . . . . 0.0 116.392 178.82 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -56.24 -175.11 0.21 Allowed Glycine 0 C--N 1.265 -3.386 0 CA-C-N 111.099 -2.773 . . . . 0.0 115.903 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -147.81 144.09 27.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.942 0.401 . . . . 0.0 111.302 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.2 t 65.76 43.53 3.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.561 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.5 -37.51 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.771 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.98 -18.97 20.72 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.567 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 t -63.05 -22.38 66.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.786 0.327 . . . . 0.0 110.92 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 m -143.48 19.12 1.87 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.608 0.242 . . . . 0.0 111.136 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.6 m -124.54 140.58 52.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 0.0 111.091 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.38 176.02 7.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.143 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 60.89 46.57 8.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 123.752 0.658 . . . . 0.0 111.028 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.487 ' HB ' HD21 ' A' ' 14' ' ' LEU . 36.5 p -73.07 126.98 31.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.262 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.4 153.99 34.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.689 HD21 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -109.95 113.21 25.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.816 0.341 . . . . 0.0 111.083 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.2 117.39 20.17 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.298 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 t70 51.53 35.51 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.489 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.422 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 52.28 35.59 43.29 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.106 -0.952 . . . . 0.0 115.373 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.0 -25.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.024 0.912 . . . . 0.0 112.33 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.6 m -117.34 129.94 56.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.702 0.287 . . . . 0.0 111.433 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.577 ' HB2' HD13 ' A' ' 88' ' ' LEU . 20.1 tp -90.62 132.88 35.49 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.02 129.83 51.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.655 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.468 ' HB2' HD12 ' A' ' 48' ' ' LEU . . . -161.3 169.43 22.11 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.539 0.524 . . . . 0.0 110.849 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.9 t -114.63 125.26 53.55 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 35.4 m -125.17 151.86 45.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -98.78 140.34 33.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.615 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.63 -32.01 0.48 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.5 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.512 ' HA ' ' CG ' ' A' ' 45' ' ' ASN . . . -50.83 -42.61 58.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -169.84 53.23 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.247 0.546 . . . . 0.0 110.015 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.9 1.79 49.09 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.423 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -125.27 165.53 18.16 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 40.3 p90 -95.19 161.04 14.27 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 123.618 0.574 . . . . 0.0 110.616 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -155.43 140.48 17.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -72.74 135.63 45.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.466 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.9 p -150.54 174.68 12.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.137 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.14 164.18 30.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.886 0.374 . . . . 0.0 110.373 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.791 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 3.2 tpt -147.01 122.1 10.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.225 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.68 106.4 4.07 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.577 HD13 ' HB2' ' A' ' 70' ' ' LEU . 21.4 mt -78.56 -8.35 58.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.135 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -47.12 -32.12 3.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.999 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -117.7 21.91 12.66 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.198 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -124.35 -14.96 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.279 0.561 . . . . 0.0 110.605 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.7 t -132.41 127.79 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -124.77 153.76 17.91 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.956 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.403 HD21 ' HB2' ' A' ' 8' ' ' SER . 32.1 t30 -103.96 117.44 34.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.806 0.336 . . . . 0.0 110.564 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.9 m -112.45 84.7 2.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.099 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 60.74 61.44 1.68 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.418 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.13 28.56 58.69 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.84 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -134.01 144.95 49.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.116 0.484 . . . . 0.0 110.917 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 tmm? -67.09 115.82 7.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.363 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -144.27 73.59 15.97 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.711 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 18.7 Cg_endo -57.09 156.73 23.33 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.261 2.641 . . . . 0.0 112.313 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.702 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 24.3 p . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.67 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.4 m . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 56.11 77.48 0.24 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 10.1 p90 -61.1 -44.44 97.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.011 0.434 . . . . 0.0 110.595 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.25 -21.11 61.47 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -54.46 -35.69 63.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.58 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 94' ' ' ASN . 52.4 m -134.03 21.62 3.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.65 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.4 m -118.06 132.99 56.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.611 0.243 . . . . 0.0 110.358 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.0 p -132.65 155.26 49.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.541 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.5 67.81 1.99 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.915 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 11.3 m -107.32 129.64 60.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.274 0.559 . . . . 0.0 112.373 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 67.5 mm-40 -115.98 145.76 42.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.314 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.925 HD23 HD23 ' A' ' 64' ' ' LEU . 53.6 tp -133.0 122.26 23.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.0 111.089 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.466 ' O ' HG12 ' A' ' 18' ' ' ILE . 76.8 t80 -134.2 100.07 4.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.967 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' O ' HG22 ' A' ' 62' ' ' THR . . . 81.39 -64.01 4.25 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.645 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -166.49 19.83 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.735 0.302 . . . . 0.0 111.365 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.506 HG23 ' ND2' ' A' ' 36' ' ' ASN . 33.6 pt -116.4 119.08 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.753 0.311 . . . . 0.0 110.942 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 1.2 mt -111.91 114.5 27.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.4 ttt85 -120.68 138.75 53.79 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.117 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 179.37 38.83 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.268 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -105.68 109.53 21.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.73 0.3 . . . . 0.0 110.318 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.3 m -108.19 133.38 52.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.133 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 55.0 mt -67.8 138.29 22.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.616 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -106.75 -170.83 1.78 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.118 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -57.67 -29.43 64.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.938 0.399 . . . . 0.0 111.691 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -64.71 -22.97 67.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.539 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.08 -1.4 62.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.929 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -108.32 148.02 36.78 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 55.0 Cg_endo -70.96 128.59 15.13 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.9 2.4 . . . . 0.0 112.732 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -116.49 127.64 54.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.061 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.86 126.69 28.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.963 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.0 t -144.67 160.54 41.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.317 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 p -140.47 142.51 35.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.096 0.474 . . . . 0.0 111.184 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.408 ' CG1' ' HB2' ' A' ' 99' ' ' MET . 2.6 mp -123.69 143.8 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.691 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.506 ' ND2' HG23 ' A' ' 18' ' ' ILE . 9.2 m120 -104.14 92.65 4.46 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -56.35 -23.45 37.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.299 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -54.9 -32.69 61.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.955 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -100.78 11.29 39.86 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.771 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -128.55 -26.91 2.68 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.66 142.08 24.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.72 0.295 . . . . 0.0 110.825 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.679 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -121.21 166.12 14.18 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.13 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -113.16 111.79 22.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.422 0.629 . . . . 0.0 110.23 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -110.59 113.27 25.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.411 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.694 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 14.7 t30 57.12 36.18 27.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.04 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.97 13.84 82.63 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.798 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -118.93 145.69 45.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.582 0.23 . . . . 0.0 110.767 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 8.4 mp -73.84 113.8 11.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.739 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -104.91 133.35 49.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.376 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.502 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.87 -68.93 0.2 Allowed Pre-proline 0 CA--C 1.425 -3.836 0 O-C-N 124.352 1.033 . . . . 0.0 113.152 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -109.6 129.43 0.04 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.441 0 C-N-CA 113.763 -3.691 . . . . 0.0 113.31 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.679 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -161.02 -160.35 10.65 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 113.998 -1.456 . . . . 0.0 113.46 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -154.73 140.6 18.2 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.962 0.448 . . . . 0.0 110.468 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m 52.39 46.78 26.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -72.19 -38.92 68.96 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.98 -18.73 48.52 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.533 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.5 m -64.92 -20.43 66.45 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 122.74 0.416 . . . . 0.0 111.12 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.0 m -143.69 28.15 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.078 0.466 . . . . 0.0 110.74 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.5 m -131.44 145.79 51.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.563 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.3 173.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.615 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mptt 61.65 41.8 11.72 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.689 0.618 . . . . 0.0 111.265 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 16' ' ' GLY . 7.5 p -68.75 123.88 22.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.605 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.88 156.7 38.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.155 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.925 HD23 HD23 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -113.61 112.88 24.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.717 0.294 . . . . 0.0 110.981 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -76.9 117.52 18.58 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.203 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 61.63 5.48 1.27 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.837 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.47 35.7 41.0 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.969 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 7.0 p80 -148.91 -26.34 0.3 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 111.274 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 m -115.71 129.93 56.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.911 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.571 ' HA ' HD22 ' A' ' 64' ' ' LEU . 17.9 tp -90.36 136.78 32.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.51 129.55 46.2 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -163.25 166.51 23.09 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.404 0.44 . . . . 0.0 110.725 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 t -116.06 127.33 54.79 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 18.5 m -127.65 156.43 42.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.214 0.53 . . . . 0.0 112.065 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -99.72 152.29 20.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.425 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.45 -26.4 1.22 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.103 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.694 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -54.28 -42.14 69.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.843 0.354 . . . . 0.0 111.481 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -178.68 58.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.391 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.06 -2.92 32.22 Favored Glycine 0 CA--C 1.518 0.225 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.135 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -118.75 165.23 14.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.805 0.336 . . . . 0.0 110.421 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 49.1 p90 -104.41 166.36 10.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.679 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -151.14 152.07 32.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.691 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.47 129.4 34.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.23 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.9 p -148.25 170.54 17.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 0.0 111.462 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.53 165.69 25.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.874 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.584 ' HE3' ' N ' ' A' ' 87' ' ' ASP . 9.3 tpt -143.54 113.27 7.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.491 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.584 ' N ' ' HE3' ' A' ' 86' ' ' MET . 21.8 t70 -72.31 104.01 3.58 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.592 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 14.8 mt -76.36 -8.54 57.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.322 -177.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.539 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 8.0 m120 -49.88 -28.56 6.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.575 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -117.53 21.5 12.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.187 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -129.11 -14.79 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.606 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.2 t -133.58 147.0 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.78 149.73 21.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.167 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.413 HD21 ' HB2' ' A' ' 8' ' ' SER . 23.7 t30 -89.37 116.63 27.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -116.94 84.37 2.13 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.365 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 61.44 53.99 3.25 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.485 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.48 28.05 64.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.943 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -130.35 142.27 50.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.467 ' O ' ' HG2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -74.61 106.66 6.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.566 0.698 . . . . 0.0 112.507 -178.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -137.5 78.83 37.08 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.418 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 39.7 Cg_endo -65.71 104.97 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 123.296 2.664 . . . . 0.0 112.853 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.231 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.7 m . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 51.97 73.66 0.31 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.4 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.546 ' CD1' HG11 ' A' ' 92' ' ' VAL . 1.9 p90 -58.31 -36.89 74.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 111.164 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.19 -22.21 60.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.83 -20.47 65.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.695 0.283 . . . . 0.0 111.404 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 m -135.33 16.65 3.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 97.7 m -124.58 136.9 54.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.78 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -132.95 147.77 52.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.293 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.19 43.3 80.92 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.748 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -81.99 119.48 31.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.436 0.636 . . . . 0.0 111.507 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.89 133.38 56.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.766 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.794 HD23 HD22 ' A' ' 64' ' ' LEU . 42.7 tp -108.14 121.08 44.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.45 ' O ' HG12 ' A' ' 18' ' ' ILE . 85.7 m-85 -124.74 105.18 9.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.689 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 62' ' ' THR . . . 75.35 -66.95 2.23 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.512 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' HD1' HD22 ' A' ' 36' ' ' ASN . 6.4 p90 -164.59 18.64 0.05 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.695 0.398 . . . . 0.0 111.24 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 15' ' ' TYR . 30.7 pt -122.26 133.96 66.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.128 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.477 ' HB2' HD22 ' A' ' 37' ' ' LEU . 1.3 mt -114.12 114.63 26.32 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.274 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -118.01 140.9 49.08 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.95 -174.37 37.47 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.277 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -109.21 108.69 19.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.576 0.227 . . . . 0.0 110.54 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 74.9 m -106.81 132.37 52.86 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 53.6 mt -68.26 140.72 18.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -108.96 -174.99 2.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.986 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -50.53 -36.67 35.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.66 0.384 . . . . 0.0 111.993 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -59.39 -25.31 64.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.806 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.64 4.91 59.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.367 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -112.84 146.95 36.13 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.345 -0.428 . . . . 0.0 110.137 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 56.5 Cg_endo -72.02 133.75 22.09 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.907 2.405 . . . . 0.0 112.903 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -121.82 130.51 53.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.619 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.82 129.67 40.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.041 0.448 . . . . 0.0 111.337 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.0 t -144.07 160.16 41.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.745 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.9 p -140.02 140.02 36.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.61 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -124.61 144.87 33.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 123.225 0.328 . . . . 0.0 110.401 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.503 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -102.98 91.48 4.14 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.477 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -58.3 -26.14 62.68 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.081 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 42.3 t30 -59.19 -20.38 53.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -105.62 8.13 33.04 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.432 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -129.13 -25.54 2.73 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -107.85 140.52 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.665 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.31 164.6 12.12 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.239 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -113.61 108.29 16.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.125 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -110.76 108.95 18.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.328 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 43.9 m-20 53.96 39.18 30.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.187 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 80.27 19.0 70.28 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.042 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.27 154.99 39.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.045 0.45 . . . . 0.0 111.096 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.488 HD13 ' HG ' ' A' ' 70' ' ' LEU . 51.6 mt -88.1 113.78 24.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.363 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -109.09 138.21 45.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.477 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.529 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -38.9 -71.74 0.12 Allowed Pre-proline 0 CA--C 1.426 -3.79 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -107.92 129.29 0.05 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.234 0 C-N-CA 113.876 -3.616 . . . . 0.0 113.209 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.665 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -165.2 -162.97 17.47 Favored Glycine 0 C--N 1.284 -2.324 0 CA-C-N 113.976 -1.466 . . . . 0.0 113.408 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -156.28 144.73 19.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.445 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.0 t 59.59 41.75 18.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.725 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 17.1 p90 -72.26 -37.57 69.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.45 -18.69 44.79 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.322 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 t -61.87 -20.67 63.97 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 110.63 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 m -144.46 24.34 1.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 111.02 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.2 m -124.95 139.83 53.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.262 0.554 . . . . 0.0 111.467 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.91 177.12 6.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.041 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 61.75 39.78 13.72 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.284 0.365 . . . . 0.0 111.431 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 16' ' ' GLY . 5.7 p -70.43 126.47 29.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.956 0.408 . . . . 0.0 111.92 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.56 150.34 29.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.866 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.794 HD22 HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -105.62 113.52 27.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.95 0.405 . . . . 0.0 111.218 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.453 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 4.7 t30 -84.21 123.64 30.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.645 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 61.0 8.24 1.83 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.768 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.55 30.83 68.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.993 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.453 ' HD2' ' O ' ' A' ' 65' ' ' ASN . 0.5 OUTLIER -150.7 -20.43 0.22 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.883 0.342 . . . . 0.0 111.453 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.45 ' O ' HD13 ' A' ' 64' ' ' LEU . 40.7 m -116.03 135.65 53.75 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.493 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.488 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.0 tp -97.6 129.78 44.69 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.66 129.85 53.07 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.62 173.11 17.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.067 0.46 . . . . 0.0 110.788 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.7 t -119.95 119.27 32.98 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.46 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.6 m -122.52 146.79 47.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.8 tmtt? -100.54 146.38 27.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.01 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.0 -24.75 0.41 Allowed Glycine 0 C--O 1.227 -0.328 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.477 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -68.97 -34.34 75.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.623 0.712 . . . . 0.0 111.828 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -169.64 54.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.187 0.517 . . . . 0.0 110.542 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.53 -1.77 8.91 Favored Glycine 0 CA--C 1.518 0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.143 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.56 160.55 22.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.808 0.337 . . . . 0.0 110.825 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 49.3 p90 -97.63 168.63 10.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.395 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -155.72 148.67 24.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.823 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.19 132.87 45.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.121 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -152.35 161.1 43.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.558 0.694 . . . . 0.0 112.131 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.47 159.74 41.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.919 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.529 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 7.8 tpt -146.29 116.96 7.6 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.615 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.443 ' O ' ' HE2' ' A' ' 86' ' ' MET . 32.9 t0 -77.02 104.39 7.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.409 0.623 . . . . 0.0 110.342 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.589 ' HA ' HG22 ' A' ' 91' ' ' VAL . 12.5 mt -73.81 -8.32 55.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.403 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -47.19 -31.73 3.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.794 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -118.79 24.35 10.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.79 0.329 . . . . 0.0 111.602 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.589 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -130.39 -4.32 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.044 0.45 . . . . 0.0 110.996 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 9.1 p -153.03 144.29 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.341 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.18 -171.78 12.34 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.282 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -132.5 137.92 47.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.828 0.347 . . . . 0.0 110.849 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.0 t -144.57 116.72 8.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 60.2 41.45 16.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.499 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 58.37 31.32 66.12 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.899 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -136.51 149.27 48.06 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -55.44 127.11 28.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.442 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -142.12 77.78 17.77 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.296 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 43.0 Cg_endo -68.82 93.5 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.561 2.174 . . . . 0.0 113.103 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.315 -0.894 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.28 179.275 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 94.3 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 111.277 0.103 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 62.56 83.9 0.15 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CD1' HG12 ' A' ' 92' ' ' VAL . 3.3 p90 -64.46 -36.97 85.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.078 0.466 . . . . 0.0 111.167 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -63.12 -20.43 65.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.331 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -52.47 -32.83 41.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.122 0.487 . . . . 0.0 111.417 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 m -138.73 35.76 2.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.263 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -128.77 135.27 48.94 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.093 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.3 p -132.56 162.53 31.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.361 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.17 54.98 32.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.353 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 32.9 m -95.81 138.88 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.413 . . . . 0.0 111.263 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -134.99 140.67 45.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.888 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.754 HD21 HD22 ' A' ' 64' ' ' LEU . 20.1 tp -120.97 116.84 25.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.011 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.511 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.3 t80 -125.14 104.04 8.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.869 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.98 -68.45 2.83 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.553 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -163.81 19.54 0.07 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 122.445 0.298 . . . . 0.0 111.21 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.572 HG21 ' ND2' ' A' ' 36' ' ' ASN . 38.8 pt -114.4 126.69 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.712 0.291 . . . . 0.0 110.729 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.531 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.15 113.95 26.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.0 ttm180 -119.08 139.18 52.19 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.388 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' HA3' HG13 ' A' ' 12' ' ' VAL . . . -160.96 168.99 36.48 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.632 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 9.2 m-20 -97.3 105.79 18.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -104.16 131.73 51.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.8 mt -74.61 135.86 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.097 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -95.1 -179.96 5.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.632 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -50.4 -39.93 48.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.63 -24.42 65.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.64 1.38 46.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.41 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -101.99 139.67 20.51 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 57.8 Cg_endo -72.12 135.14 24.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.886 2.39 . . . . 0.0 112.188 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -125.21 126.11 44.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.154 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.13 122.74 18.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.987 0.423 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 t -136.94 158.86 43.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.809 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 p -138.95 143.01 38.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.623 0.249 . . . . 0.0 110.909 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.32 146.74 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.572 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.572 ' ND2' HG21 ' A' ' 18' ' ' ILE . 7.1 m120 -100.5 96.86 7.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.073 0.463 . . . . 0.0 110.244 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -60.43 -26.69 66.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.207 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -53.93 -34.01 58.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.09 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -102.72 11.46 37.61 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.0 m-85 -127.37 -21.8 3.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -112.73 139.95 35.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.663 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.3 165.55 12.07 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.177 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -110.71 106.22 15.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.613 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -112.17 107.37 16.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.751 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.812 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 39.7 t30 60.8 39.43 17.16 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.93 17.74 79.46 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.559 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.47 144.4 50.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.834 0.35 . . . . 0.0 111.045 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.507 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 9.2 mp -72.69 123.76 23.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.883 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -113.95 139.33 49.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.621 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -41.79 -69.42 0.22 Allowed Pre-proline 0 CA--C 1.426 -3.799 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.867 -179.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 3.5 Cg_endo -110.3 131.36 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.323 0 C-N-CA 113.81 -3.66 . . . . 0.0 113.2 -177.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.663 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -162.45 -159.29 10.2 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 114.108 -1.406 . . . . 0.0 113.604 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -155.17 144.94 21.45 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 124.026 0.486 . . . . 0.0 110.869 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 m 51.41 43.92 29.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -73.03 -38.8 66.41 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.23 -18.6 49.75 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.515 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.3 m -64.71 -24.79 67.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.846 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 m -136.86 20.27 3.05 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.9 m -126.56 140.42 52.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.495 HG22 ' HE2' ' A' ' 61' ' ' LYS . 27.8 m -131.27 176.45 8.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.146 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.495 ' HE2' HG22 ' A' ' 60' ' ' VAL . 2.4 mppt? 58.75 44.85 16.51 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.451 0.47 . . . . 0.0 111.248 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 p -71.41 123.19 21.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.611 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.3 163.09 38.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.305 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.754 HD22 HD21 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -121.24 112.65 18.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 0.0 111.524 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.07 119.27 20.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.294 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 51.99 26.51 3.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 124.087 0.867 . . . . 0.0 110.956 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 6' ' ' ALA . . . 58.35 32.63 68.48 Favored Glycine 0 C--O 1.224 -0.472 0 CA-C-N 115.663 -0.698 . . . . 0.0 113.722 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -141.35 -29.82 0.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.708 0.754 . . . . 0.0 111.661 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 m -116.28 131.06 57.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.802 0.334 . . . . 0.0 111.359 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' HD21 ' A' ' 64' ' ' LEU . 16.1 tp -90.74 131.93 36.13 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.38 130.43 53.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.783 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 48' ' ' LEU . . . -160.58 165.37 30.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 t -111.63 120.58 42.54 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 34.8 m -119.29 152.43 36.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 9.0 tmtt? -99.85 144.66 28.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.689 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.79 -27.85 0.66 Allowed Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.629 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.812 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.6 -40.3 75.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -174.33 54.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.349 0.595 . . . . 0.0 109.93 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.81 6.51 44.42 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.112 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 28.8 pt20 -126.01 169.91 12.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 45.7 p90 -98.78 171.55 8.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.822 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -160.21 145.2 14.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -76.41 132.87 39.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.21 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.9 p -152.1 166.22 32.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 111.369 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.81 162.66 34.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.426 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.621 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 16.9 tpp -147.92 117.87 7.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.5 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.401 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 37.8 t0 -74.44 107.65 6.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.202 0.525 . . . . 0.0 109.677 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.572 ' HA ' HG21 ' A' ' 91' ' ' VAL . 16.8 mt -76.04 -9.52 58.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.523 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.401 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 1.8 m120 -48.41 -29.43 4.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.602 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -119.23 21.67 12.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.698 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.572 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -127.7 -10.46 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.037 0.446 . . . . 0.0 110.693 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.753 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.1 p -150.78 141.62 16.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.356 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.86 -168.51 11.84 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.063 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -132.54 127.68 35.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.281 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.5 m -139.1 112.2 8.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.76 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 57.49 40.45 27.13 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.512 0.507 . . . . 0.0 111.185 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.44 20.05 58.42 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.743 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -116.74 147.13 42.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.721 0.296 . . . . 0.0 110.279 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -61.48 117.31 5.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.367 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -135.03 79.33 51.22 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.735 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 53.7 Cg_endo -71.33 82.98 1.04 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.799 2.332 . . . . 0.0 112.392 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.306 -1.313 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.433 -179.763 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.4 m . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 111.417 0.154 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 54.79 75.68 0.29 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 15.0 p90 -60.18 -36.83 78.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.181 0.515 . . . . 0.0 110.94 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.72 63.91 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -60.06 -25.43 65.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.931 0.396 . . . . 0.0 111.319 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 m -132.04 29.97 4.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.664 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -131.23 140.11 49.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -133.32 150.53 51.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.29 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.97 73.65 0.46 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.531 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.533 HG11 ' HA3' ' A' ' 21' ' ' GLY . 33.3 m -112.0 144.39 19.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.837 0.351 . . . . 0.0 111.249 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -128.45 155.67 44.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.215 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.692 HD23 HD22 ' A' ' 64' ' ' LEU . 23.1 tp -132.18 109.38 9.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.026 0.441 . . . . 0.0 110.59 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.461 ' O ' HG12 ' A' ' 18' ' ' ILE . 80.4 m-85 -114.37 100.43 8.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 62' ' ' THR . . . 77.56 -63.64 3.36 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.919 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.677 ' HD1' HD22 ' A' ' 36' ' ' ASN . 8.7 p90 -166.04 23.45 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.618 0.247 . . . . 0.0 111.633 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 15' ' ' TYR . 42.2 pt -121.73 133.53 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.53 HD22 HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -112.65 120.16 40.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.863 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -127.96 139.71 52.42 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.876 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.533 ' HA3' HG11 ' A' ' 12' ' ' VAL . . . -167.35 -175.51 37.38 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.335 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.84 107.66 18.79 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 m -105.19 131.84 52.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 72.0 mt -72.46 137.43 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -100.82 -175.18 2.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.123 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.3 -27.5 62.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 112.048 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.62 -26.36 68.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.64 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.44 2.78 55.55 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.926 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -112.18 142.11 26.27 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.722 0.296 . . . . 0.0 110.374 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 42.1 Cg_endo -68.7 136.64 36.5 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.981 2.454 . . . . 0.0 112.596 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -123.87 134.27 53.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.132 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.83 126.06 28.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.431 . . . . 0.0 111.241 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 t -141.09 160.31 40.36 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.579 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -139.45 145.45 38.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.978 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.58 145.29 35.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.81 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.677 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -102.66 95.44 6.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.53 HD22 HD22 ' A' ' 19' ' ' LEU . 1.3 mm? -57.99 -26.7 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.691 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.0 t-20 -55.25 -27.91 49.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.281 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -104.7 7.94 34.95 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 30.9 m-85 -128.22 -21.94 3.5 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 mp -113.59 141.2 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.497 0.189 . . . . 0.0 110.722 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.641 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -118.61 170.07 13.66 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.371 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -109.56 110.89 22.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.963 0.411 . . . . 0.0 110.928 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -110.78 106.91 16.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.577 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 12.0 t30 52.12 41.55 30.08 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.909 0.484 . . . . 0.0 111.508 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.96 16.18 77.48 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.21 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.23 153.64 41.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.06 0.457 . . . . 0.0 110.92 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.572 HD13 ' HG ' ' A' ' 70' ' ' LEU . 37.1 mt -81.4 114.07 19.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.305 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.58 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.1 tt0 -107.31 132.75 52.78 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.474 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -32.49 -69.94 0.12 Allowed Pre-proline 0 CA--C 1.425 -3.837 0 O-C-N 124.762 1.289 . . . . 0.0 114.047 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.58 ' HD2' ' HG2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -108.77 133.59 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.321 0 C-N-CA 113.939 -3.574 . . . . 0.0 112.655 -177.636 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.641 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -168.61 -162.94 21.73 Favored Glycine 0 C--N 1.283 -2.389 0 C-N-CA 119.559 -1.305 . . . . 0.0 113.65 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -154.29 146.3 23.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.352 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.1 m 53.43 41.9 32.05 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -71.93 -35.51 69.65 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.14 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.09 -18.64 57.96 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.259 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -63.32 -24.29 67.79 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.494 -0.353 . . . . 0.0 111.136 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -136.46 22.08 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.095 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.4 m -126.89 148.37 50.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.128 0.489 . . . . 0.0 111.476 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.5 m -138.11 173.75 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.532 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.83 40.38 22.93 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.452 0.47 . . . . 0.0 111.648 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 16' ' ' GLY . 6.4 p -65.97 118.46 9.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.085 0.469 . . . . 0.0 111.822 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.91 149.56 31.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.095 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.692 HD22 HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -109.0 115.02 29.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.772 0.32 . . . . 0.0 110.761 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -88.8 124.77 34.48 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.751 0.31 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 58.1 19.74 6.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.603 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.431 ' HA2' HD11 ' A' ' 64' ' ' LEU . . . 58.43 31.31 66.31 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.929 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -139.36 -32.41 0.65 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.561 0.68 . . . . 0.0 111.142 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -116.01 131.9 56.81 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.268 0.556 . . . . 0.0 111.747 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.608 ' HA ' HD21 ' A' ' 64' ' ' LEU . 9.1 tp -90.1 130.84 36.22 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.613 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 129.22 53.88 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.0 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -160.85 164.36 31.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.999 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -111.76 124.37 52.2 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 21.9 m -126.47 150.09 48.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.325 0.583 . . . . 0.0 112.042 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.4 tmtt? -99.36 146.74 25.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.419 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.87 -30.69 0.66 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.209 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.577 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.09 -42.32 76.56 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -169.9 54.86 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.422 0.63 . . . . 0.0 110.293 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.54 3.43 26.49 Favored Glycine 0 C--N 1.328 0.108 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.7 160.78 25.15 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 12.2 p90 -101.98 169.88 8.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.851 0.358 . . . . 0.0 110.643 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -157.86 138.73 13.16 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.78 121.2 25.08 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.518 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.2 p -133.08 -179.81 5.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.148 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.48 164.51 28.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.044 0.449 . . . . 0.0 110.658 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.474 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 9.2 tpt -145.86 113.72 6.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.96 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.65 105.84 5.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.555 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.589 ' HA ' HG23 ' A' ' 91' ' ' VAL . 14.4 mt -75.78 -9.0 58.23 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.697 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -50.88 -26.04 5.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.591 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -119.41 22.21 11.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.325 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 88' ' ' LEU . 2.2 m -127.62 -14.99 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.849 0.357 . . . . 0.0 110.569 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -139.22 145.42 27.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.924 177.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -134.18 179.96 17.01 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.89 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -131.85 127.79 37.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.684 0.278 . . . . 0.0 110.921 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.2 m -135.14 107.36 7.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.234 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 60.93 42.58 12.73 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.751 0.657 . . . . 0.0 110.622 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.26 22.47 63.16 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.692 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -118.24 147.18 43.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.484 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -60.82 121.08 11.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.043 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -137.02 80.45 35.51 Favored Pre-proline 0 CA--C 1.516 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.346 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 44.5 Cg_endo -68.81 89.02 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.672 2.248 . . . . 0.0 112.962 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.215 179.784 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.567 0.222 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 60.67 71.06 0.58 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.625 ' CD1' HG12 ' A' ' 92' ' ' VAL . 5.1 p90 -66.24 -37.5 85.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.025 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.56 -20.0 65.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.204 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -51.57 -39.11 57.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.026 0.441 . . . . 0.0 110.769 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -132.01 27.71 4.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -118.53 139.99 50.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.012 0.434 . . . . 0.0 111.051 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -137.01 152.26 49.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.647 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.05 57.23 14.41 Favored Glycine 0 N--CA 1.455 -0.082 0 O-C-N 123.527 0.517 . . . . 0.0 112.764 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.505 HG11 ' HA3' ' A' ' 21' ' ' GLY . 15.9 m -101.17 134.03 42.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.065 0.459 . . . . 0.0 111.852 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -127.72 153.14 46.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.263 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.733 HD22 HD21 ' A' ' 64' ' ' LEU . 23.7 tp -128.33 120.55 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.97 0.414 . . . . 0.0 111.991 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.43 ' O ' HG12 ' A' ' 18' ' ' ILE . 73.0 t80 -126.66 108.55 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 62' ' ' THR . . . 78.5 -73.35 2.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.3 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -164.0 23.38 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.821 0.343 . . . . 0.0 111.377 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 15' ' ' TYR . 24.7 pt -121.13 127.84 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.702 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.533 HD21 ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -109.29 114.59 28.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.176 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -119.06 139.74 51.22 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.014 178.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.505 ' HA3' HG11 ' A' ' 12' ' ' VAL . . . -165.93 -175.39 36.32 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.139 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 3.5 m-20 -107.89 108.05 19.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.572 0.225 . . . . 0.0 110.577 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -105.72 131.36 53.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.1 mt -69.65 140.78 18.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.982 0.42 . . . . 0.0 111.904 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -108.05 -172.8 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.331 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.533 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 7.2 tp10 -49.85 -41.79 45.96 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.469 0.48 . . . . 0.0 112.153 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.87 -22.97 63.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.408 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.78 5.03 60.14 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.346 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -109.47 145.39 31.8 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.483 -0.359 . . . . 0.0 110.573 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.74 131.53 26.12 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.98 2.453 . . . . 0.0 112.52 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -115.24 130.64 56.97 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.503 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.65 120.16 12.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.715 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -140.94 159.52 42.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.386 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 p -140.16 148.02 41.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.029 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.94 147.61 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.373 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.53 85.9 2.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -54.39 -25.29 23.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.046 0.451 . . . . 0.0 111.383 -178.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.449 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 23.1 t-20 -53.47 -24.81 13.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.391 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -113.5 10.36 18.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -126.79 -8.2 6.13 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 111.309 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.58 HD11 HD21 ' A' ' 88' ' ' LEU . 3.0 mp -127.41 134.55 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -117.04 -177.33 17.78 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 23.9 p-10 -127.96 101.66 6.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.648 0.737 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.92 113.81 27.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.957 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.433 ' CG ' ' HA ' ' A' ' 77' ' ' ALA . 8.4 t-20 58.84 36.69 24.81 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.645 0.736 . . . . 0.0 110.129 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.6 19.75 78.95 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.992 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -122.45 146.1 47.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.654 0.264 . . . . 0.0 110.432 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.476 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 9.5 mp -72.04 120.78 18.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.401 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -108.16 138.73 43.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.426 0.632 . . . . 0.0 110.254 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.453 ' HB2' HG13 ' A' ' 91' ' ' VAL . 12.4 p90 -58.8 -24.15 1.44 Allowed Pre-proline 0 CA--C 1.447 -2.991 0 N-CA-C 118.125 2.639 . . . . 0.0 118.125 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -129.5 12.16 0.0 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.771 1 C-N-CA 112.787 -4.342 . . . . 0.0 116.353 179.253 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -62.13 -176.23 2.52 Favored Glycine 0 C--N 1.259 -3.707 0 CA-C-N 111.266 -2.697 . . . . 0.0 115.547 -176.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -146.95 147.98 31.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m 58.48 45.41 16.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.046 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.449 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 9.5 p90 -74.11 -38.26 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.01 -23.74 47.65 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.444 -0.408 . . . . 0.0 112.317 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -62.02 -18.1 59.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.293 -0.453 . . . . 0.0 111.365 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 m -148.93 27.54 0.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.614 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.3 m -132.24 145.09 51.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.985 0.422 . . . . 0.0 111.052 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 m -136.39 176.85 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.253 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? 61.9 40.65 12.31 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.241 0.338 . . . . 0.0 111.659 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 16' ' ' GLY . 2.4 p -69.13 123.03 19.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.094 0.473 . . . . 0.0 112.05 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.41 161.97 41.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.718 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.733 HD21 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -123.17 113.79 19.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.872 0.368 . . . . 0.0 111.34 -178.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.32 122.09 28.0 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.009 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 52.5 25.24 3.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.776 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.488 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 56.62 39.62 86.02 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.624 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -149.24 -30.88 0.24 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 117.249 0.524 . . . . 0.0 111.078 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.428 ' O ' HD13 ' A' ' 64' ' ' LEU . 5.7 m -116.02 130.6 56.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.801 0.334 . . . . 0.0 111.282 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.665 ' HB2' HD12 ' A' ' 88' ' ' LEU . 14.0 tp -93.26 131.22 38.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.975 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.59 129.81 56.0 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.069 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 48' ' ' LEU . . . -162.36 162.93 28.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 110.528 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 t -111.36 125.29 53.7 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 34.8 m -125.06 156.06 38.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -98.45 148.89 23.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.685 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.67 -28.37 0.84 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.269 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.433 ' HA ' ' CG ' ' A' ' 45' ' ' ASN . . . -55.53 -42.64 74.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.841 0.353 . . . . 0.0 111.564 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -172.98 56.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.765 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.92 2.39 38.02 Favored Glycine 0 C--O 1.229 -0.213 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.45 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -122.87 162.45 22.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 48.2 p90 -91.45 160.85 15.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.713 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -146.98 147.17 30.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.53 135.5 35.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 p -155.7 173.19 17.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.744 0.307 . . . . 0.0 111.259 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.84 164.28 30.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.843 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.766 ' HE1' ' HA ' ' A' ' 86' ' ' MET . 3.3 tpt -149.99 119.64 7.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.553 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -73.28 108.9 6.42 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 70' ' ' LEU . 15.0 mt -81.59 -9.12 59.75 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.327 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -47.88 -29.48 3.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.648 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -117.11 15.82 15.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.557 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.56 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -120.24 -3.58 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.654 0.74 . . . . 0.0 110.294 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.988 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.3 p -155.46 131.18 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.017 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.12 179.67 16.16 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.128 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -118.62 126.17 51.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.441 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.7 m -130.27 97.3 4.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.533 ' CD2' ' HB2' ' A' ' 26' ' ' GLU . 71.8 m-85 61.7 52.38 3.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.262 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.36 16.79 60.98 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.814 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -119.87 143.13 48.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.31 120.99 18.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.218 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -127.71 75.57 77.79 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.47 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.988 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.7 Cg_endo -72.4 103.89 1.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.964 2.443 . . . . 0.0 112.391 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.724 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.713 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 55.6 m . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 46.25 73.31 0.18 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CD1' HG12 ' A' ' 92' ' ' VAL . 2.3 p90 -59.24 -42.45 91.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.566 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.99 -21.38 44.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.67 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.0 -28.68 69.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.502 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB2' HD21 ' A' ' 94' ' ' ASN . 50.4 m -139.44 23.9 2.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.871 0.367 . . . . 0.0 111.388 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.5 m -122.21 132.88 54.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.519 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -133.67 160.8 36.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.929 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.76 51.82 56.8 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.366 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.531 HG11 ' HA3' ' A' ' 21' ' ' GLY . 29.8 m -97.59 139.47 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.832 0.349 . . . . 0.0 111.231 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -136.02 151.8 50.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.564 HD21 HD22 ' A' ' 64' ' ' LEU . 13.1 tp -119.35 110.1 16.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.098 0.475 . . . . 0.0 111.661 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.428 ' O ' HG12 ' A' ' 18' ' ' ILE . 36.2 m-85 -106.1 98.58 8.24 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 62' ' ' THR . . . 71.27 -65.13 0.99 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.16 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.751 ' HD1' HD22 ' A' ' 36' ' ' ASN . 4.3 p90 -156.34 12.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.782 -0.246 . . . . 0.0 111.645 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 15' ' ' TYR . 44.9 pt -114.45 133.54 60.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 110.896 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.533 HD23 HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.29 113.97 26.48 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.118 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.3 ttm105 -120.28 138.38 53.71 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.531 ' HA3' HG11 ' A' ' 12' ' ' VAL . . . -158.85 -177.44 31.94 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.825 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -108.51 103.5 12.64 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.2 m -107.13 131.98 53.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.845 0.355 . . . . 0.0 110.288 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.8 mt -70.14 139.18 20.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.1 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -112.01 -168.62 1.34 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.509 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.29 -28.11 64.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.726 0.298 . . . . 0.0 111.788 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.96 -28.51 69.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.01 0.433 . . . . 0.0 111.345 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.8 -9.29 60.12 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.424 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -101.39 142.84 25.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -64.16 121.74 9.5 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.791 2.327 . . . . 0.0 112.317 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -104.39 134.99 46.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.504 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.26 124.95 25.68 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.497 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.3 t -143.95 159.79 41.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.81 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 p -139.45 154.78 47.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.67 145.5 25.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.751 HD22 ' HD1' ' A' ' 17' ' ' TYR . 2.9 t-20 -100.87 104.6 15.82 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.533 HD22 HD23 ' A' ' 19' ' ' LEU . 1.6 mm? -64.61 -22.16 66.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 25.4 t30 -63.97 -13.23 44.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -108.03 -1.3 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.364 -0.21 . . . . 0.0 110.977 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -127.67 -9.43 5.6 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.41 HD11 HD23 ' A' ' 88' ' ' LEU . 2.6 mp -124.45 134.14 67.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -113.86 178.16 18.21 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.558 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -113.92 102.57 10.32 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.06 0.457 . . . . 0.0 110.452 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -102.42 103.92 14.36 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 47.48 45.42 17.32 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.535 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.3 14.69 76.0 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.769 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.13 147.39 47.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.041 0.42 . . . . 0.0 111.114 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.595 HD12 ' HG ' ' A' ' 70' ' ' LEU . 25.6 mt -72.35 121.64 19.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.014 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -110.99 127.23 55.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.267 0.556 . . . . 0.0 110.792 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -49.29 -29.13 1.72 Allowed Pre-proline 0 CA--C 1.453 -2.784 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -129.57 17.63 0.0 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.764 1 C-N-CA 113.032 -4.179 . . . . 0.0 115.931 179.073 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -68.36 -174.86 9.13 Favored Glycine 1 C--N 1.254 -4.013 0 CA-C-N 111.16 -2.745 . . . . 0.0 115.508 -176.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -143.45 148.14 35.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.407 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m 57.83 60.47 2.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.915 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 12.5 p90 -90.1 -35.33 15.5 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.791 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.99 -19.03 43.03 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.607 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 m -62.19 -25.22 67.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.323 -0.439 . . . . 0.0 111.353 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.1 m -141.84 27.24 1.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.154 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.9 m -129.02 151.25 49.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.215 0.531 . . . . 0.0 111.732 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.491 HG21 ' HE2' ' A' ' 61' ' ' LYS . 15.7 m -146.81 175.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.25 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HE2' HG21 ' A' ' 60' ' ' VAL . 2.0 mppt? 63.14 41.94 7.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.873 0.368 . . . . 0.0 110.777 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 16' ' ' GLY . 12.5 p -72.1 125.21 26.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.987 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.79 156.68 40.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.802 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.564 HD22 HD21 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -117.11 112.01 20.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.899 0.38 . . . . 0.0 110.738 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.533 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 11.6 m120 -73.08 117.28 14.62 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.342 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.2 t70 51.95 21.17 1.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.017 0.823 . . . . 0.0 111.056 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.38 37.61 95.1 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.441 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -144.96 -29.99 0.45 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 117.506 0.653 . . . . 0.0 111.296 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 16.9 m -116.6 135.15 54.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.639 0.257 . . . . 0.0 111.072 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HG ' HD12 ' A' ' 48' ' ' LEU . 14.3 tp -95.91 131.72 41.96 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.62 132.29 54.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.171 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.431 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -164.05 163.5 23.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.375 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.6 t -110.96 125.07 53.32 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.8 m -125.46 148.02 49.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.306 0.574 . . . . 0.0 112.063 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.9 tmtt? -99.61 144.93 28.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.683 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.32 -21.64 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.834 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.17 89.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.878 0.339 . . . . 0.0 111.385 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -173.8 55.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.353 0.597 . . . . 0.0 109.759 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.14 -3.74 20.92 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.603 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -115.44 163.48 15.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.63 0.252 . . . . 0.0 110.604 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 29.4 p90 -103.69 166.99 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.194 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.07 127.49 5.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.419 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.01 123.1 18.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.498 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.2 p -136.79 175.91 9.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.198 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.07 162.27 35.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.902 0.382 . . . . 0.0 110.778 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 21.3 tpp -148.83 123.69 9.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.481 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -78.37 106.75 10.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.384 0.612 . . . . 0.0 109.762 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.559 ' HA ' HG21 ' A' ' 91' ' ' VAL . 13.6 mt -76.23 -9.52 58.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.733 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -51.64 -26.72 9.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.041 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -116.86 19.25 14.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.782 0.325 . . . . 0.0 111.375 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -126.59 -9.25 4.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.108 0.48 . . . . 0.0 110.583 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.867 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 5.5 p -153.82 139.96 11.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.476 ' HA2' ' N ' ' A' ' 5' ' ' PHE . . . -134.09 176.73 19.62 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.197 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.441 HD21 ' HB2' ' A' ' 8' ' ' SER . 28.7 t30 -118.57 123.44 45.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.012 0.434 . . . . 0.0 110.276 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.3 m -124.7 99.9 6.38 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.474 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.85 51.02 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.173 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 56.69 27.8 55.8 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.958 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -130.76 141.34 50.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.93 0.395 . . . . 0.0 110.469 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.6 ptm -55.21 116.68 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.349 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -141.43 75.63 22.32 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.111 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.867 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 61.2 Cg_endo -75.66 112.54 3.54 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.741 2.294 . . . . 0.0 112.156 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.417 -179.572 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.4 m . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 111.164 0.061 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 51.64 75.45 0.21 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.843 0.457 . . . . 0.0 111.896 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.502 ' CD1' HG11 ' A' ' 92' ' ' VAL . 3.1 p90 -56.94 -39.8 75.21 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.89 -22.57 38.27 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -68.4 -21.65 64.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.69 0.281 . . . . 0.0 111.569 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.9 m -134.29 19.09 3.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.929 0.395 . . . . 0.0 110.903 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 81.4 m -124.8 132.98 53.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.244 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.6 p -126.77 155.14 43.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.262 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.79 63.78 4.79 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.381 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.38 133.93 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.252 0.549 . . . . 0.0 111.473 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.62 136.28 48.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.624 HD23 HD21 ' A' ' 64' ' ' LEU . 23.0 tp -121.64 124.84 45.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.086 0.469 . . . . 0.0 111.07 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -133.35 114.93 14.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.683 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.13 -71.46 1.98 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.007 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -167.81 24.07 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.314 0.646 . . . . 0.0 109.573 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.4 HG12 ' ND2' ' A' ' 36' ' ' ASN . 7.5 mt -120.08 113.27 40.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.549 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.506 ' HB2' HD22 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -99.81 114.82 28.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.994 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -116.94 140.03 49.95 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.21 176.6 40.14 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.265 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -105.87 107.95 19.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 82.5 m -105.81 131.69 52.83 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.084 0.469 . . . . 0.0 110.043 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mt -70.02 138.96 20.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.516 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.409 HD22 ' CD2' ' A' ' 29' ' ' HIS . 4.7 p30 -105.61 -169.46 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.331 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.96 -29.03 66.85 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.76 -26.26 65.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.15 0.5 . . . . 0.0 111.751 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.34 57.29 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.132 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.409 ' CD2' HD22 ' A' ' 25' ' ' ASN . 0.0 OUTLIER -107.78 138.95 20.17 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -63.65 127.19 19.13 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.113 2.542 . . . . 0.0 112.808 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -109.79 133.17 53.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.184 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.39 118.73 16.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.903 0.383 . . . . 0.0 111.508 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.3 t -135.4 157.39 47.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.006 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.8 p -139.83 138.29 35.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.499 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.58 145.9 33.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.955 0.407 . . . . 0.0 111.258 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.403 ' HA ' HD21 ' A' ' 36' ' ' ASN . 3.4 m120 -103.57 99.16 8.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.049 0.452 . . . . 0.0 110.1 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -62.29 -23.67 66.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.895 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.98 -30.94 62.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.939 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -103.95 13.54 32.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -130.87 -25.85 2.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.08 141.95 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.647 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -111.94 -174.93 19.78 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.843 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -129.24 105.06 7.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.07 0.462 . . . . 0.0 111.292 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -103.27 111.17 23.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.531 ' HB2' ' HA ' ' A' ' 77' ' ' ALA . 5.4 p-10 42.18 47.08 3.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.675 1.19 . . . . 0.0 113.298 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.91 14.93 74.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.596 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.15 143.23 50.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.823 0.344 . . . . 0.0 111.23 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.542 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 8.9 mp -71.49 119.34 15.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.814 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -109.9 139.13 45.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.519 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -41.14 -68.97 0.23 Allowed Pre-proline 0 CA--C 1.428 -3.746 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -111.46 122.97 0.03 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.361 0 C-N-CA 113.943 -3.571 . . . . 0.0 113.544 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.647 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -158.67 -160.82 10.58 Favored Glycine 0 C--N 1.277 -2.703 0 CA-C-N 113.758 -1.565 . . . . 0.0 113.282 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -156.31 144.39 19.67 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.942 0.436 . . . . 0.0 110.818 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 m 57.14 41.24 27.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.15 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -72.09 -40.2 68.39 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.049 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.01 -18.99 49.62 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.733 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.2 m -65.14 -24.34 67.38 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.514 0.326 . . . . 0.0 110.955 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.1 m -138.32 24.76 2.71 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.916 0.389 . . . . 0.0 110.635 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.0 m -131.29 141.48 49.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.314 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 m -133.92 172.81 15.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.376 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.8 mptt 64.1 43.3 5.13 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.715 0.635 . . . . 0.0 110.873 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 p -68.83 124.4 23.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.386 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.2 156.07 37.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.86 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.624 HD21 HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -110.48 120.39 42.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.541 0.21 . . . . 0.0 110.61 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.518 ' C ' ' H ' ' A' ' 67' ' ' GLY . 19.3 t-20 -87.46 121.18 29.57 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.9 t70 68.33 -25.76 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.437 1.085 . . . . 0.0 112.356 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 65' ' ' ASN . . . 110.19 22.02 6.71 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -142.84 -20.47 0.66 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.445 ' O ' HD11 ' A' ' 64' ' ' LEU . 43.3 m -116.95 127.36 54.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.251 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.542 ' HG ' ' CD2' ' A' ' 48' ' ' LEU . 16.6 tp -90.61 129.28 36.75 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.79 130.29 54.86 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.487 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HB2' HD11 ' A' ' 48' ' ' LEU . . . -162.55 165.32 26.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.833 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -110.08 125.55 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.426 ' SG ' HD12 ' A' ' 48' ' ' LEU . 60.9 m -123.23 147.73 46.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.351 0.596 . . . . 0.0 112.582 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.9 tmtt? -99.69 145.3 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.923 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.73 -16.27 0.94 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.822 -1.18 . . . . 0.0 113.332 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' A' ' 45' ' ' ASN . . . -59.67 -39.46 84.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.875 0.369 . . . . 0.0 110.759 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 t70 178.91 60.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.843 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.79 4.48 54.11 Favored Glycine 0 C--O 1.228 -0.223 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.544 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -124.92 165.34 18.26 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.6 p90 -112.53 166.27 11.47 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.282 0.364 . . . . 0.0 111.488 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -158.55 144.61 16.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -76.29 142.36 41.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.786 0.327 . . . . 0.0 110.158 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.9 p -153.6 174.58 14.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.82 156.54 46.12 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.082 0.468 . . . . 0.0 110.586 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.519 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 12.3 tpp -140.78 123.18 15.92 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.644 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -76.06 106.24 7.55 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.556 ' HA ' HG21 ' A' ' 91' ' ' VAL . 16.3 mt -73.34 -9.09 58.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.747 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -47.58 -31.15 4.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.79 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -119.74 23.58 11.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.411 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -128.49 -7.85 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.02 0.438 . . . . 0.0 110.52 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.752 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.8 p -156.82 141.79 8.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.023 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -134.91 -174.96 13.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.229 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -130.0 133.26 46.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.938 0.399 . . . . 0.0 110.991 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.417 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 3.3 m -142.35 112.25 6.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.398 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 60.17 40.51 18.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.397 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.67 24.6 66.44 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -128.17 138.86 52.66 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.5 ptt? -64.46 129.17 38.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.347 0.594 . . . . 0.0 112.5 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG2' ' HB2' ' A' ' 95' ' ' SER . 0.9 OUTLIER -140.09 77.35 25.77 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 33.3 Cg_endo -61.79 93.25 0.12 Allowed 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.422 2.748 . . . . 0.0 112.951 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.315 -0.923 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.406 179.733 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 63.54 71.28 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.298 0.374 . . . . 0.0 110.891 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 9.8 p90 -54.43 -37.51 65.21 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 111.361 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.86 -22.15 64.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.78 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -69.79 -16.1 63.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.68 0.276 . . . . 0.0 111.301 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -127.03 4.44 6.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.2 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 0.8 OUTLIER -118.49 137.53 53.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.162 0.506 . . . . 0.0 112.079 -178.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 p -128.59 153.07 47.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.096 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.65 64.9 3.95 Favored Glycine 0 N--CA 1.453 -0.22 0 O-C-N 123.518 0.511 . . . . 0.0 112.442 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.548 HG13 ' HA3' ' A' ' 21' ' ' GLY . 32.4 m -100.64 147.04 8.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 111.278 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -138.18 148.91 45.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.127 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.615 HD22 HD21 ' A' ' 64' ' ' LEU . 8.5 tp -122.19 105.36 10.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.023 0.439 . . . . 0.0 110.72 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -134.62 112.4 10.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.34 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.24 38.33 39.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.282 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' HA ' HD11 ' A' ' 14' ' ' LEU . 10.2 m-85 64.55 24.06 12.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.15 0.58 . . . . 0.0 110.675 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.2 mt -117.77 122.23 69.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.253 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.531 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -102.6 113.64 27.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.351 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 20.4 ttm180 -118.84 134.3 55.25 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.426 -0.509 . . . . 0.0 109.835 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.548 ' HA3' HG13 ' A' ' 12' ' ' VAL . . . -157.63 175.3 34.98 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.898 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 26.6 m-20 -101.15 107.29 18.66 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -106.02 131.8 52.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.5 mt -70.09 135.25 28.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -103.64 -175.12 2.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -54.09 -31.33 51.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.06 -27.5 69.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.451 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.34 -0.04 53.83 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.121 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -108.66 144.54 29.76 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 120.802 0.334 . . . . 0.0 110.385 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.91 121.27 8.45 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.057 2.505 . . . . 0.0 112.655 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -107.09 129.24 54.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.306 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.53 119.19 13.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.011 0.434 . . . . 0.0 110.871 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -132.19 159.48 38.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.808 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 99' ' ' MET . 78.4 p -138.5 147.97 43.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.847 0.356 . . . . 0.0 111.502 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.74 142.55 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.9 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -101.96 92.71 4.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.69 -23.72 53.05 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.322 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.447 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 21.1 t-20 -54.8 -30.9 58.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.98 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -108.57 16.31 23.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.534 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -126.97 -25.05 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.52 140.62 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.672 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -115.35 161.66 12.74 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.395 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -100.63 104.75 16.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.691 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -111.94 106.55 15.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.922 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.803 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 56.2 t30 58.41 36.98 25.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.121 0.486 . . . . 0.0 110.817 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.66 17.07 80.22 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.403 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.07 154.88 39.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.834 0.349 . . . . 0.0 110.825 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.402 HD23 ' HB2' ' A' ' 72' ' ' ALA . 31.5 mt -79.92 114.48 18.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.239 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -105.52 135.18 47.4 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.439 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -39.84 -72.45 0.11 Allowed Pre-proline 0 CA--C 1.426 -3.792 0 O-C-N 124.254 0.971 . . . . 0.0 113.333 -178.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -108.36 126.14 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.319 0 C-N-CA 113.623 -3.784 . . . . 0.0 113.252 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.672 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.65 -164.2 13.21 Favored Glycine 0 C--N 1.283 -2.398 0 CA-C-N 113.582 -1.645 . . . . 0.0 113.029 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -153.39 142.86 21.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.857 0.36 . . . . 0.0 111.013 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 m 53.4 42.37 32.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.226 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 10.5 p90 -68.47 -36.7 79.35 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.48 -18.12 28.69 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.377 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.7 t -64.54 -21.08 66.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.723 0.297 . . . . 0.0 110.487 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.5 m -140.8 23.38 2.26 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.099 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.5 m -128.97 142.61 50.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.954 0.407 . . . . 0.0 111.311 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -134.37 172.93 15.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.249 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? 63.25 37.74 10.91 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.501 0.5 . . . . 0.0 111.766 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.8 p -66.67 122.66 18.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.117 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.69 163.57 39.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.877 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.615 HD21 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -119.54 113.44 20.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.908 0.385 . . . . 0.0 111.471 -179.32 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.452 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 16.1 m120 -76.13 117.18 17.57 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.322 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t70 58.9 9.53 1.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.907 0.755 . . . . 0.0 111.567 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.22 30.75 58.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.777 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -144.56 -26.06 0.51 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 117.547 0.674 . . . . 0.0 111.394 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 21.9 m -115.82 130.39 56.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.316 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.561 ' HA ' HD23 ' A' ' 64' ' ' LEU . 23.1 tp -91.02 130.67 36.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.71 129.82 55.48 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.402 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -162.59 159.84 25.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.231 0.538 . . . . 0.0 111.039 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.7 t -109.59 123.31 49.23 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 56.9 m -122.25 149.67 43.37 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.369 0.604 . . . . 0.0 112.534 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.7 tmtt? -99.74 139.56 35.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.024 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.91 -32.52 0.38 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.947 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.803 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -47.49 -43.33 24.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -171.69 49.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.85 5.56 65.05 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.608 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.83 165.72 16.17 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 33.4 p90 -101.2 162.55 12.82 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 123.292 0.37 . . . . 0.0 110.155 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.14 134.22 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -72.22 125.48 27.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.225 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.1 p -142.29 170.71 15.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.969 0.414 . . . . 0.0 110.719 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.37 164.95 26.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.887 ' HE1' ' HA ' ' A' ' 86' ' ' MET . 1.4 tpt -145.74 120.02 9.57 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.067 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.27 105.01 5.25 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.563 ' HA ' HG21 ' A' ' 91' ' ' VAL . 17.5 mt -75.98 -8.44 56.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.528 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -47.15 -32.08 4.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.917 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -117.16 23.75 11.64 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.087 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.563 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -130.76 -5.71 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.989 0.423 . . . . 0.0 110.843 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 1.022 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.6 t -141.16 146.33 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.45 176.82 22.66 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.989 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -131.7 132.95 44.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 5.6 m -141.75 109.22 5.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.286 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 62.31 43.93 7.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.905 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.58 26.28 66.41 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.159 -0.543 . . . . 0.0 111.874 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -127.53 142.15 51.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 34' ' ' SER . 4.4 ppp? -67.68 134.14 50.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.115 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 95' ' ' SER . 0.0 OUTLIER -153.07 71.09 7.07 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.039 178.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 1.022 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 12.3 Cg_endo -54.45 103.52 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.408 2.739 . . . . 0.0 112.432 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.828 179.425 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.436 ' CB ' ' HA3' ' A' ' 93' ' ' GLY . 1.1 m . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 120.376 0.132 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.422 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 62.4 m-80 53.8 85.31 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.681 0.613 . . . . 0.0 112.56 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.577 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 6.0 p90 -62.51 -37.6 86.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.182 0.515 . . . . 0.0 110.165 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.91 -20.25 66.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.092 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.422 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 11.2 t-20 -52.11 -29.05 20.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.378 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.9 m -145.16 28.87 1.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.759 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -119.27 141.65 48.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.898 0.38 . . . . 0.0 110.97 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.9 p -137.97 157.44 46.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.065 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.5 34.3 89.53 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.211 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 21.3 m -69.76 138.95 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.003 0.43 . . . . 0.0 111.762 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -132.56 133.18 43.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.348 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.759 HD23 HD21 ' A' ' 64' ' ' LEU . 46.5 tp -119.8 123.33 43.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.934 0.397 . . . . 0.0 111.168 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.53 101.97 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.703 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 62' ' ' THR . . . 75.83 -60.8 2.96 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.944 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 1.6 p90 -166.91 18.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 26.3 pt -119.95 127.15 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.548 ' HB2' HD23 ' A' ' 37' ' ' LEU . 1.1 mt -116.05 114.92 25.21 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.197 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 27.2 ttm180 -111.83 139.03 47.65 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.88 165.15 33.03 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.2 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 1.7 m-20 -99.37 105.72 17.72 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.8 m -104.57 132.21 51.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.261 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.6 mt -69.86 139.57 20.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.318 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -108.9 -171.54 1.87 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.837 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -55.21 -31.35 61.38 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.35 -20.92 66.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.712 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.33 4.09 66.63 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.74 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.34 148.5 39.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.787 0.327 . . . . 0.0 110.29 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.7 132.46 21.87 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.019 2.479 . . . . 0.0 113.027 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -118.39 132.45 56.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.269 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.94 127.29 31.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.169 0.509 . . . . 0.0 111.65 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -141.93 154.94 45.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.041 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 p -139.9 142.73 36.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.64 0.257 . . . . 0.0 111.155 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.55 143.8 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.485 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.51 90.49 3.88 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.548 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.35 -23.66 50.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.592 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.7 t-20 -52.74 -31.44 38.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.105 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -108.36 16.7 22.9 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.52 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -129.69 -22.93 2.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -113.93 142.17 27.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.648 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -116.11 164.22 12.29 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.547 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -102.04 105.49 16.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.247 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -110.59 104.92 13.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.505 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.716 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 36.7 t30 52.96 43.64 31.43 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.199 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.13 16.55 80.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.948 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -123.68 157.48 33.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.862 0.363 . . . . 0.0 110.768 -179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.482 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 38.9 mt -83.97 113.4 20.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.472 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -103.11 130.43 50.27 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.46 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.35 -71.79 0.11 Allowed Pre-proline 0 CA--C 1.424 -3.877 0 O-C-N 124.47 1.106 . . . . 0.0 113.063 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -107.44 133.3 0.05 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.42 0 C-N-CA 113.704 -3.731 . . . . 0.0 112.179 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.648 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -164.74 -163.64 18.3 Favored Glycine 0 C--N 1.285 -2.261 0 CA-C-N 114.379 -1.282 . . . . 0.0 113.665 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -151.37 143.59 24.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.283 -0.459 . . . . 0.0 110.921 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.4 m 52.07 45.0 29.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -74.27 -36.03 63.8 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.91 -19.37 50.07 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.281 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -62.27 -26.87 68.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.943 0.401 . . . . 0.0 110.816 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 m -134.16 15.15 3.84 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.268 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.1 m -121.64 140.33 52.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.448 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 m -136.82 174.52 11.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.886 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 62.48 41.49 9.73 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 110.725 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 16' ' ' GLY . 21.5 p -71.83 126.78 30.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.93 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.81 162.68 40.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.766 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.759 HD21 HD23 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -118.01 113.54 21.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.806 0.336 . . . . 0.0 111.566 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.443 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 3.9 m120 -73.51 116.13 13.71 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.403 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.95 5.21 0.49 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.114 0.884 . . . . 0.0 111.742 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.1 27.89 35.79 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.717 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -145.21 -23.06 0.49 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.504 0.652 . . . . 0.0 112.23 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 30.6 m -114.68 130.73 56.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.744 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 64' ' ' LEU . 15.2 tp -91.88 127.79 37.47 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 129.69 55.46 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.84 171.11 20.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.805 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.3 t -118.58 121.21 39.67 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 32.8 m -121.4 149.84 42.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.181 0.515 . . . . 0.0 111.835 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.3 tmtt? -99.89 145.37 27.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.932 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.85 -28.1 0.74 Allowed Glycine 0 C--O 1.228 -0.256 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.251 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.716 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.14 -38.81 71.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.314 0.486 . . . . 0.0 112.314 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -172.02 50.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.385 0.612 . . . . 0.0 109.899 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.75 2.08 42.57 Favored Glycine 0 C--O 1.229 -0.174 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.112 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -125.25 167.29 15.08 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 42.8 p90 -104.99 169.64 8.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.459 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -161.78 147.01 13.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.95 130.24 42.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.139 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -144.66 161.13 39.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.225 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.03 160.25 37.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.482 ' HB2' ' CB ' ' A' ' 48' ' ' LEU . 9.7 tpt -144.25 112.83 6.58 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.156 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.469 ' N ' ' HE3' ' A' ' 86' ' ' MET . 55.9 m-20 -72.08 105.11 3.81 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.574 ' HA ' HG21 ' A' ' 91' ' ' VAL . 15.4 mt -73.37 -9.18 58.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.534 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -48.82 -28.17 3.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.691 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -122.41 25.76 8.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.686 0.279 . . . . 0.0 111.441 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -129.78 -13.67 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.025 0.44 . . . . 0.0 110.708 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 1.05 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.7 p -155.36 136.56 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.539 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.493 ' HA2' ' N ' ' A' ' 5' ' ' PHE . . . -131.85 -173.54 13.37 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.469 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -123.81 133.31 53.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.428 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.6 m -137.42 104.72 5.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.208 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 60.34 45.86 10.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.912 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.94 20.27 70.51 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.276 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -127.4 145.18 50.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.055 0.427 . . . . 0.0 109.866 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -64.11 130.71 45.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.977 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -140.77 77.93 21.24 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.613 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 1.05 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 38.7 Cg_endo -68.77 97.15 0.54 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.665 2.244 . . . . 0.0 112.714 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.0 p . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.458 179.218 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.5 m . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 120.516 0.198 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 52.44 73.16 0.36 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.989 0.516 . . . . 0.0 112.054 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.524 ' HE1' ' HB2' ' A' ' 88' ' ' LEU . 9.3 p90 -57.43 -33.6 68.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.063 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.97 64.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -68.94 -20.36 64.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.1 m -119.93 9.84 11.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -123.26 146.37 47.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.006 0.432 . . . . 0.0 111.432 -179.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -134.4 147.42 50.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.638 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.16 56.79 21.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.492 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.519 HG11 ' HA3' ' A' ' 21' ' ' GLY . 7.1 m -99.23 130.5 48.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.113 0.482 . . . . 0.0 111.433 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.98 152.81 47.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.601 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.631 HD23 HD23 ' A' ' 64' ' ' LEU . 11.5 tp -113.22 113.58 25.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.817 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.479 ' O ' HG12 ' A' ' 18' ' ' ILE . 26.3 m-85 -108.22 98.79 8.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.992 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.5 -65.5 1.36 Allowed Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.084 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 2.8 p90 -161.39 18.64 0.11 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.748 0.419 . . . . 0.0 111.128 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 15' ' ' TYR . 30.6 pt -122.16 133.1 69.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 110.271 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -108.69 116.9 32.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.724 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.8 tmm_? -121.9 142.29 50.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.1 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' HA3' HG11 ' A' ' 12' ' ' VAL . . . -168.4 -174.71 37.4 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.414 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -108.49 109.19 20.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -105.73 131.98 52.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.03 0.443 . . . . 0.0 110.005 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 58.2 mt -70.16 138.17 22.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.421 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -102.36 -174.31 2.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.89 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.71 -37.81 63.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.191 0.519 . . . . 0.0 111.946 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.64 -25.11 66.07 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.086 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.89 50.33 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.575 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -105.35 140.52 21.22 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-O 120.854 0.359 . . . . 0.0 110.388 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 39.4 Cg_endo -67.84 134.36 32.1 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 123.082 2.521 . . . . 0.0 112.955 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -119.91 133.65 55.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.596 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.75 126.09 27.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.281 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -143.13 156.03 44.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 p -136.72 151.3 49.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.937 0.399 . . . . 0.0 111.156 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -134.07 143.67 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.221 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.97 93.62 5.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.83 -29.25 64.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.317 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.2 t-20 -52.78 -29.13 25.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.935 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -108.53 12.76 25.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.6 m-85 -128.9 -20.14 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -113.57 142.11 27.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.665 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -113.72 166.07 12.11 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.256 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -109.92 111.13 22.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.141 -0.53 . . . . 0.0 110.82 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -110.78 105.46 14.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.669 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.711 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 29.9 t30 53.09 42.21 32.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.046 0.451 . . . . 0.0 111.401 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 78.11 17.63 77.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.121 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.62 154.71 40.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.966 0.412 . . . . 0.0 110.827 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD11 ' HG ' ' A' ' 70' ' ' LEU . 35.7 mt -82.1 122.99 28.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.051 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -112.71 138.49 49.44 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.532 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -40.88 -75.14 0.05 OUTLIER Pre-proline 0 CA--C 1.433 -3.556 0 CA-C-O 118.11 -0.947 . . . . 0.0 113.186 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.2 Cg_endo -111.32 129.0 0.03 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.425 0 C-N-CA 114.009 -3.527 . . . . 0.0 113.042 -177.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.665 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.08 -158.02 8.6 Favored Glycine 0 C--N 1.28 -2.572 0 CA-C-N 113.529 -1.669 . . . . 0.0 113.143 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -155.2 138.45 15.71 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.897 0.41 . . . . 0.0 110.646 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.3 m 58.27 45.05 17.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -75.07 -37.61 61.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -19.04 54.47 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.705 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -64.67 -22.49 66.99 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 120.83 0.348 . . . . 0.0 110.911 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.2 m -135.87 18.37 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.841 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 81.9 m -125.23 145.55 49.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.174 0.511 . . . . 0.0 111.44 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.0 m -138.07 176.91 6.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.16 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 61.85 35.0 16.75 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.145 0.278 . . . . 0.0 111.474 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 p -64.16 123.82 20.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 111.187 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.95 148.87 27.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.836 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.631 HD23 HD23 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -107.18 113.45 26.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.453 0.168 . . . . 0.0 110.749 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.574 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 40.6 t-20 -79.63 126.1 30.47 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.56 18.61 1.47 Allowed 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.354 1.034 . . . . 0.0 112.045 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.0 33.53 87.49 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.935 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.574 ' HD2' ' O ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -148.0 -25.55 0.35 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.525 0.663 . . . . 0.0 111.609 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.424 ' O ' HD11 ' A' ' 64' ' ' LEU . 44.4 m -116.71 131.13 57.03 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.207 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.536 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -90.97 134.21 34.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.787 0.327 . . . . 0.0 110.466 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.19 131.45 53.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.967 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.417 ' HB2' HD22 ' A' ' 48' ' ' LEU . . . -160.63 163.69 32.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.164 0.507 . . . . 0.0 111.544 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -110.8 118.21 35.53 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.443 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 37.4 m -119.17 147.48 44.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.4 tmtt? -100.1 142.92 30.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.473 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.72 -27.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.021 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.711 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -49.85 -41.07 44.42 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -179.34 51.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.22 -3.76 57.19 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.234 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -113.23 161.01 17.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.975 -0.612 . . . . 0.0 109.781 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 41.0 p90 -103.71 168.37 9.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.522 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -158.03 137.93 12.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.354 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.13 127.27 32.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.8 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.7 p -142.62 177.81 8.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.597 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.414 ' HA ' HD13 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -138.78 162.22 35.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.979 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.532 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 11.8 tpp -145.67 120.99 10.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.113 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -77.63 106.09 9.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.33 0.586 . . . . 0.0 109.439 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HA ' HG23 ' A' ' 91' ' ' VAL . 16.0 mt -73.1 -8.98 58.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.124 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -48.72 -33.04 9.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.815 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -116.15 24.49 11.38 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.062 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -128.69 -12.09 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.536 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.814 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 1.8 t -138.52 144.29 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.28 171.5 23.92 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.731 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -121.96 141.19 51.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.045 0.45 . . . . 0.0 110.855 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.2 m -146.93 109.31 4.52 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 58.58 42.05 21.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.633 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.9 13.11 63.51 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.473 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -116.29 141.72 47.79 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.94 129.78 40.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.401 0.619 . . . . 0.0 111.645 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -139.02 78.81 28.45 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.179 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.814 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 32.1 Cg_endo -65.36 96.55 0.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.779 2.319 . . . . 0.0 112.442 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.317 -0.847 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.952 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.5 m . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.143 0.053 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.433 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 12.5 m-20 55.46 78.77 0.18 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.919 0.488 . . . . 0.0 111.889 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.581 ' CD1' HG12 ' A' ' 92' ' ' VAL . 4.8 p90 -62.48 -46.18 89.64 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.719 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.46 -22.28 54.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.186 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.433 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 6.4 t-20 -57.91 -30.5 65.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.856 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 94' ' ' ASN . 49.7 m -137.67 23.47 2.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.822 0.344 . . . . 0.0 111.353 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 92.3 m -120.96 132.83 55.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.985 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 p -132.19 152.99 51.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.531 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.78 42.88 94.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.622 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.519 HG11 ' HA3' ' A' ' 21' ' ' GLY . 26.8 m -89.33 141.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.794 0.331 . . . . 0.0 111.342 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.67 159.18 42.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.143 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.731 HD23 HD23 ' A' ' 64' ' ' LEU . 20.8 tp -127.08 126.89 43.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 111.588 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.544 ' O ' HG12 ' A' ' 18' ' ' ILE . 68.4 t80 -130.83 104.79 7.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.808 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 62' ' ' THR . . . 75.92 -71.27 1.95 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.738 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.8 OUTLIER -163.01 23.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.605 0.362 . . . . 0.0 111.337 179.141 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 15' ' ' TYR . 34.0 pt -117.24 131.11 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 110.544 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.511 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -112.41 114.66 27.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.688 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 13.2 ttm180 -121.56 140.44 52.22 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' HA3' HG11 ' A' ' 12' ' ' VAL . . . -164.69 179.31 39.47 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.449 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -104.44 105.42 15.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 69.3 m -106.16 132.18 52.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.213 0.53 . . . . 0.0 110.29 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.68 141.4 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -105.83 -172.26 2.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.305 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -56.23 -30.52 62.46 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.76 -26.82 66.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.0 111.371 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.82 1.67 55.15 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.506 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.58 139.31 19.98 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 121.158 0.504 . . . . 0.0 111.037 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.38 127.96 20.3 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 124.117 3.211 . . . . 0.0 112.674 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -116.86 138.09 51.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.615 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.46 121.71 23.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.937 0.398 . . . . 0.0 111.171 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.4 t -140.54 156.6 46.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.928 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 p -140.4 138.92 35.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 mp -124.54 147.86 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.491 HD21 HG23 ' A' ' 18' ' ' ILE . 13.4 t-20 -103.75 107.55 18.47 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -66.1 -22.67 66.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.683 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.453 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 32.2 t30 -66.72 -12.93 60.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.017 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -110.57 0.89 17.81 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.325 -0.234 . . . . 0.0 110.981 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 50.8 m-85 -128.31 -20.47 3.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.418 HD11 HD21 ' A' ' 88' ' ' LEU . 2.0 mp -112.7 138.79 40.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.676 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -116.33 165.51 12.28 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.529 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -108.82 106.05 15.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.89 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -110.92 107.19 16.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.586 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 13.4 t30 56.78 40.42 29.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.173 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.63 16.18 80.96 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.81 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.14 152.61 42.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.434 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 10.1 mp -80.52 123.49 28.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.895 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -114.56 132.67 56.25 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.2 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CB ' HG11 ' A' ' 91' ' ' VAL 0.251 0.1 OUTLIER -41.54 -63.11 0.89 Allowed Pre-proline 0 CA--C 1.423 -3.921 0 CA-C-O 117.87 -1.062 . . . . 0.0 113.522 -179.075 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 9.0 Cg_endo -112.28 123.36 0.02 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.471 0 C-N-CA 113.766 -3.689 . . . . 0.0 112.978 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.676 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.52 -165.89 18.24 Favored Glycine 0 C--N 1.281 -2.519 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.26 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -153.34 146.52 24.69 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 m 59.96 45.69 11.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 10.8 p90 -79.35 -37.81 36.59 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.83 55.03 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.538 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 m -63.22 -29.16 70.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.223 -0.489 . . . . 0.0 110.943 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.8 m -133.49 19.58 3.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.304 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 55' ' ' PHE . 84.1 m -123.04 149.07 44.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.283 0.563 . . . . 0.0 111.724 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.459 HG22 ' HG2' ' A' ' 61' ' ' LYS . 23.4 m -141.58 176.8 3.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.943 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' A' ' 60' ' ' VAL . 74.1 mmtt 62.81 37.3 12.44 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.246 0.342 . . . . 0.0 111.001 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -69.82 122.43 19.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.178 0.513 . . . . 0.0 111.75 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.73 149.23 28.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.438 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.731 HD23 HD23 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -106.34 113.29 26.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.741 0.305 . . . . 0.0 111.08 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -75.49 117.19 17.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.202 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.0 t70 55.05 23.32 5.09 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.084 0.865 . . . . 0.0 111.491 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.29 36.73 92.9 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.988 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -147.16 -29.94 0.35 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.692 0.746 . . . . 0.0 111.49 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 m -115.62 132.34 56.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.51 0.195 . . . . 0.0 111.115 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.527 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -92.8 130.06 38.52 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.97 129.75 53.55 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.093 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.426 ' HB1' HD13 ' A' ' 48' ' ' LEU . . . -159.03 163.32 36.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.09 0.472 . . . . 0.0 111.116 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 16.4 t -110.51 120.17 41.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.3 m -121.75 148.75 44.24 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.6 tmtt? -100.35 145.58 28.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.542 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.03 -30.9 0.49 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.852 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.582 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.46 -41.58 66.31 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -172.93 52.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.225 0.536 . . . . 0.0 109.892 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.11 44.95 Favored Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.335 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -119.12 158.53 25.72 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 21.0 p90 -100.6 171.12 7.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.467 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -163.3 151.15 13.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.9 132.34 41.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.1 t -148.35 158.51 44.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.851 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.1 159.99 39.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.287 0.565 . . . . 0.0 110.93 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.9 tpp -147.3 118.67 7.86 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.589 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -75.93 106.89 7.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.408 0.623 . . . . 0.0 109.773 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.568 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.9 mt -73.55 -9.58 58.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.709 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -50.9 -27.33 7.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.197 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -117.82 19.28 13.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 111.583 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.568 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.4 m -126.18 -7.35 5.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.121 0.486 . . . . 0.0 110.603 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.5 p -157.69 145.08 9.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.321 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.438 ' HA2' ' N ' ' A' ' 5' ' ' PHE . . . -135.82 -174.3 13.33 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.799 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.409 HD21 ' HB2' ' A' ' 8' ' ' SER . 23.4 t30 -126.01 131.24 52.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.93 0.395 . . . . 0.0 110.946 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.8 m -135.95 111.08 8.94 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.678 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 59.66 42.92 16.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.938 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.85 24.31 64.44 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.198 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -127.0 147.58 50.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 110.165 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -60.02 128.85 38.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.145 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -140.38 78.16 22.92 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.004 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 44.0 Cg_endo -72.52 92.13 0.77 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.351 2.034 . . . . 0.0 111.859 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.313 -0.979 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.589 -179.54 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 56.14 73.96 0.41 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.467 ' CD1' ' HB ' ' A' ' 92' ' ' VAL . 12.5 p90 -57.93 -34.5 69.93 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.138 0.494 . . . . 0.0 111.366 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.94 -22.08 63.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -62.43 -26.52 68.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 46.6 m -124.64 13.4 8.67 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.2 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -119.15 135.56 54.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.051 0.453 . . . . 0.0 111.212 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -132.46 154.36 49.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.26 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.07 53.0 48.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.064 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 m -92.07 137.81 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.728 0.299 . . . . 0.0 110.874 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -135.21 149.85 49.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.178 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.544 HD21 HD23 ' A' ' 64' ' ' LEU . 11.9 tp -114.41 118.01 32.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.163 0.506 . . . . 0.0 111.485 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.49 ' O ' HG12 ' A' ' 18' ' ' ILE . 91.9 m-85 -115.51 99.75 7.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.82 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.82 -73.3 1.47 Allowed Glycine 0 C--O 1.224 -0.499 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.484 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HD1' HD22 ' A' ' 36' ' ' ASN . 3.9 p90 -157.49 21.14 0.29 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.671 0.388 . . . . 0.0 110.848 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 15' ' ' TYR . 39.0 pt -121.4 132.77 69.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.054 0.454 . . . . 0.0 110.251 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -109.38 117.56 34.37 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.119 -179.136 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tmm_? -121.72 139.57 53.41 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.89 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -161.8 179.35 37.23 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.303 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 10.7 m-20 -100.98 106.14 17.43 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.0 OUTLIER -106.05 131.83 52.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.954 0.406 . . . . 0.0 109.944 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -69.15 138.12 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.692 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -108.26 -170.28 1.65 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.29 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.48 -28.58 60.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.81 -26.69 66.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.55 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.64 -2.89 57.4 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.159 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -104.86 143.53 26.89 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.932 0.396 . . . . 0.0 110.3 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.84 121.97 9.65 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.937 2.425 . . . . 0.0 113.015 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -108.32 130.72 55.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.171 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.84 119.65 15.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.057 0.456 . . . . 0.0 111.716 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.9 t -135.54 160.05 39.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.501 ' O ' ' HG2' ' A' ' 99' ' ' MET . 13.2 p -136.7 152.72 50.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.184 0.516 . . . . 0.0 111.551 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.22 145.78 33.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.799 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.464 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -104.58 94.56 5.38 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.9 -30.24 63.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.587 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -54.53 -29.15 49.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -103.68 10.93 36.57 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.656 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 52.8 m-85 -129.67 -22.9 2.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -112.24 141.49 27.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.602 0.239 . . . . 0.0 110.83 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.561 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.54 -173.77 18.16 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.918 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -128.65 109.5 11.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.844 0.354 . . . . 0.0 111.128 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -113.11 109.62 19.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.66 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.633 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 22.1 t-20 56.08 45.48 23.48 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.72 0.772 . . . . 0.0 110.943 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.54 18.12 73.41 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.709 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.07 147.49 47.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.863 0.363 . . . . 0.0 110.364 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.448 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 8.4 mp -71.42 127.94 34.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.189 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -114.5 129.51 56.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.15 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.578 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.7 -70.53 0.14 Allowed Pre-proline 0 CA--C 1.425 -3.852 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.868 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 14.2 Cg_endo -110.36 124.36 0.03 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.444 0 C-N-CA 113.509 -3.861 . . . . 0.0 113.146 -178.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.561 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -159.08 -161.04 10.8 Favored Glycine 0 C--N 1.281 -2.527 0 CA-C-N 113.4 -1.727 . . . . 0.0 113.197 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.419 ' C ' ' HG ' ' A' ' 54' ' ' SER . 51.4 mt-10 -153.93 150.04 27.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 0.0 110.341 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.419 ' HG ' ' C ' ' A' ' 53' ' ' GLU . 59.2 p 47.79 44.97 18.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -69.84 -40.93 75.54 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.33 -26.9 38.41 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.675 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -56.93 -25.99 58.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.221 0.208 . . . . 0.0 111.286 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.2 m -137.17 28.0 2.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 0.0 110.705 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.1 m -131.61 145.92 51.94 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.346 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.4 m -136.62 174.82 11.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.811 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.41 37.86 16.47 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.322 0.649 . . . . 0.0 112.265 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 p -63.11 123.0 17.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.895 0.379 . . . . 0.0 111.044 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.12 155.57 37.02 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.587 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -110.86 120.15 41.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.829 0.347 . . . . 0.0 110.838 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.57 119.1 23.82 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 68.75 -59.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 124.623 1.202 . . . . 0.0 111.113 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.88 34.64 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.342 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.471 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 1.2 p-80 -155.81 -19.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m -116.55 128.0 55.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.618 0.247 . . . . 0.0 111.587 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.587 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.8 tp -91.09 130.74 36.95 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.16 129.87 54.33 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.724 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.426 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -160.28 164.12 32.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.148 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.6 t -110.95 123.98 51.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 39.2 m -125.45 153.74 43.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.92 0.391 . . . . 0.0 111.809 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.9 tmtt? -99.26 144.51 28.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.693 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.1 -26.82 0.62 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.0 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.633 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . . . -52.25 -42.5 63.69 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.551 0.341 . . . . 0.0 111.715 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -175.83 55.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.017 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.42 20.84 73.93 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.464 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -142.67 159.34 42.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 46.7 p90 -101.26 166.72 10.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.248 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -159.53 145.53 16.1 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -78.6 131.6 36.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.002 0.43 . . . . 0.0 110.772 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 p -143.51 176.03 9.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.271 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.85 164.9 28.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.226 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 1.003 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -145.87 121.72 10.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.533 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.6 105.11 6.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.558 ' HA ' HG22 ' A' ' 91' ' ' VAL . 19.8 mt -77.34 -8.26 57.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.659 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.471 ' OD1' ' HB2' ' A' ' 68' ' ' HIS . 11.5 m120 -47.15 -32.82 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.72 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -116.45 22.76 12.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.427 . . . . 0.0 111.324 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -127.94 -13.5 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.818 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.89 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -132.17 147.97 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.286 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.99 174.61 22.63 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.204 -0.522 . . . . 0.0 111.799 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -135.31 133.54 38.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.684 0.278 . . . . 0.0 111.124 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.457 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 8.2 m -142.89 115.65 8.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.264 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 58.93 41.13 21.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.389 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.09 12.36 57.51 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.721 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -114.63 139.81 49.33 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 34' ' ' SER . 4.6 ppp? -66.01 133.54 51.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.032 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -152.87 69.31 7.0 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.759 178.13 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.89 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 15.7 Cg_endo -56.08 102.82 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.312 2.675 . . . . 0.0 112.548 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 121.637 0.732 . . . . 0.0 110.983 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 42.77 79.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.573 ' CD1' HG11 ' A' ' 92' ' ' VAL . 3.1 p90 -59.23 -34.54 72.31 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.226 0.536 . . . . 0.0 110.618 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.66 -21.76 66.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.529 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.73 -18.79 65.34 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.595 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 50.2 m -142.65 18.39 2.01 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.525 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -118.17 136.07 53.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 110.822 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -133.8 154.19 51.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.572 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.26 61.8 6.9 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.291 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 35.6 m -93.3 144.59 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.293 0.568 . . . . 0.0 111.608 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -135.88 136.7 40.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.84 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.804 HD21 HD22 ' A' ' 64' ' ' LEU . 37.3 tp -122.63 119.77 31.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.976 0.417 . . . . 0.0 110.762 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.56 ' O ' HG12 ' A' ' 18' ' ' ILE . 28.8 t80 -127.93 109.39 11.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.019 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 62' ' ' THR . . . 72.98 -67.16 1.41 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.791 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.9 p90 -164.56 19.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.795 0.438 . . . . 0.0 110.653 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.583 HG22 ' ND2' ' A' ' 36' ' ' ASN . 43.5 pt -117.47 122.61 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.02 0.438 . . . . 0.0 110.569 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.474 ' HB2' HD22 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -109.21 114.67 28.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.788 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.2 ttt85 -115.71 140.92 48.75 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.82 176.74 41.81 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.142 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 2.7 m-20 -104.88 109.06 20.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.621 0.248 . . . . 0.0 110.417 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -107.61 132.86 52.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.942 0.401 . . . . 0.0 110.403 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 57.9 mt -67.38 136.15 27.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.452 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -103.68 -174.03 2.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.197 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -54.62 -29.67 52.6 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.01 -25.82 68.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.819 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.52 -4.4 56.68 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.787 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -106.76 145.11 30.41 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 37.2 Cg_endo -66.37 134.02 34.59 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.904 2.403 . . . . 0.0 112.764 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -122.58 123.76 41.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.311 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.07 130.19 44.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.293 0.568 . . . . 0.0 111.761 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 t -144.05 164.96 29.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.478 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.3 p -140.47 138.33 34.57 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.65 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.02 145.48 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 120.838 0.351 . . . . 0.0 110.723 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 18' ' ' ILE . 9.5 m120 -104.07 91.58 4.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 110.015 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -57.75 -25.42 60.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.171 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.0 t-20 -55.29 -30.47 60.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.692 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -103.21 11.03 37.42 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.47 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -126.71 -26.96 3.15 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 mp -110.64 140.89 27.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.64 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -112.6 171.5 14.04 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.481 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -113.86 108.25 16.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.608 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -111.92 105.94 14.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.635 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.808 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 52.6 t30 57.34 41.01 27.18 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.177 0.513 . . . . 0.0 110.78 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.62 15.75 81.3 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.132 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.03 145.74 48.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.832 0.349 . . . . 0.0 111.054 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 HD13 ' SG ' ' A' ' 59' ' ' CYS . 9.7 mp -75.09 119.31 19.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.268 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 49.0 tt0 -109.93 136.42 49.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.783 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.549 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -39.65 -68.01 0.26 Allowed Pre-proline 0 CA--C 1.426 -3.82 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.347 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.504 ' HD2' ' HG2' ' A' ' 49' ' ' GLU . 2.4 Cg_endo -109.74 126.62 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.32 0 C-N-CA 113.69 -3.74 . . . . 0.0 113.328 -178.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.64 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -164.49 -161.53 13.71 Favored Glycine 0 C--N 1.283 -2.408 0 CA-C-N 113.693 -1.594 . . . . 0.0 113.372 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -153.24 147.76 26.07 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.777 0.339 . . . . 0.0 110.586 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m 56.86 37.34 28.73 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 8.4 p90 -71.24 -35.7 71.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.4 0.619 . . . . 0.0 109.466 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.93 -18.38 70.59 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.165 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 m -72.47 -7.59 50.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.173 0.511 . . . . 0.0 110.894 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 56.3 m -146.3 23.01 1.33 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.16 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -128.25 154.79 45.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 111.893 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.494 HG21 ' HD2' ' A' ' 61' ' ' LYS . 25.3 m -141.39 174.38 7.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.73 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HD2' HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER 63.17 29.61 16.06 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.238 0.215 . . . . 0.0 111.245 -179.199 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 16' ' ' GLY . 4.0 p -60.98 117.72 5.82 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.201 0.524 . . . . 0.0 111.193 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.35 161.39 42.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.93 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.804 HD22 HD21 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -120.04 113.32 20.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.022 -178.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.581 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 2.6 t-20 -84.9 128.52 34.66 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 t70 52.59 20.09 1.41 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.414 1.071 . . . . 0.0 112.014 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.99 35.11 86.15 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.324 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.581 ' HD2' ' O ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -148.49 -23.55 0.33 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.152 0.476 . . . . 0.0 111.549 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.41 ' O ' HD11 ' A' ' 64' ' ' LEU . 55.5 m -116.67 129.66 56.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.173 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.56 ' HB2' HD13 ' A' ' 88' ' ' LEU . 13.8 tp -96.14 128.08 42.73 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.1 130.17 56.68 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.863 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.47 155.4 22.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.378 0.608 . . . . 0.0 111.303 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 59' ' ' CYS . 7.9 t -105.93 108.28 19.71 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.801 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.0 m -105.1 149.27 26.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.448 0.642 . . . . 0.0 111.765 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 11.3 tmtt? -100.43 141.31 33.46 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.572 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.33 -30.9 0.48 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.485 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.808 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -49.34 -41.24 38.22 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -172.67 49.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.215 0.531 . . . . 0.0 110.144 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.52 1.9 62.43 Favored Glycine 0 C--O 1.23 -0.132 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.249 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -122.0 162.34 21.31 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 36.3 p90 -104.73 170.31 7.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.91 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.3 OUTLIER -157.17 133.76 9.95 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 112.42 7.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.009 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.6 p -125.82 175.04 7.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.978 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.99 163.83 29.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.9 0.381 . . . . 0.0 110.819 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.773 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 3.4 tpt -151.88 120.9 6.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 50.4 m-20 -74.89 106.78 6.58 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HA ' HG23 ' A' ' 91' ' ' VAL . 15.4 mt -75.28 -9.43 58.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -47.99 -31.18 5.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.399 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 87' ' ' ASP . 4.0 p90 -117.3 21.35 13.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.61 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -126.69 -11.64 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.064 0.459 . . . . 0.0 110.484 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.881 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.4 p -153.07 138.36 10.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.832 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.481 ' HA2' ' N ' ' A' ' 5' ' ' PHE . . . -134.86 -169.45 11.93 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.013 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -125.85 139.67 53.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.613 0.244 . . . . 0.0 110.451 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.14 109.64 4.01 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 62.54 43.27 7.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.49 25.02 62.47 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.529 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.17 148.72 52.04 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 120.919 0.39 . . . . 0.0 110.693 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.9 ptt? -57.44 118.49 5.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.925 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -132.36 76.77 71.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.563 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.881 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.7 Cg_endo -71.86 87.88 0.82 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.785 2.323 . . . . 0.0 112.681 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.019 179.614 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.378 0.132 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 55.08 79.39 0.15 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.956 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.481 ' HE1' ' HB2' ' A' ' 88' ' ' LEU . 14.5 p90 -56.76 -38.18 72.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.523 . . . . 0.0 111.158 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.03 -26.61 67.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.677 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -71.38 -6.51 40.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.673 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.3 m -137.67 8.04 2.8 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.765 0.316 . . . . 0.0 110.661 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -120.96 149.99 41.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.843 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.3 p -137.93 147.53 44.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.362 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.67 57.51 17.42 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.567 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 15.3 m -98.57 130.35 47.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.139 0.495 . . . . 0.0 111.817 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -127.4 137.5 52.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.511 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.61 HD21 HD23 ' A' ' 64' ' ' LEU . 18.3 tp -111.09 105.39 14.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -135.79 117.11 14.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.59 34.66 38.93 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.886 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.568 ' HD1' HG22 ' A' ' 62' ' ' THR . 19.8 m-85 65.27 23.07 12.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.053 0.541 . . . . 0.0 110.701 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 9.2 mt -122.05 125.49 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.003 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.514 ' HB2' HD22 ' A' ' 37' ' ' LEU . 1.4 mt -108.07 114.22 27.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.007 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 4.6 ttm180 -116.86 140.23 49.69 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.989 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.483 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.08 177.99 41.48 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.265 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -104.69 110.86 23.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.591 0.234 . . . . 0.0 110.565 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.9 OUTLIER -107.09 132.52 52.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.6 mt -69.9 134.31 30.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.027 0.441 . . . . 0.0 111.497 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -103.14 -173.11 2.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.842 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.93 -26.12 64.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.813 0.339 . . . . 0.0 111.909 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.75 -23.43 67.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.69 2.07 63.36 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.811 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -113.02 146.11 34.47 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.828 0.347 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.26 125.76 14.55 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.236 2.624 . . . . 0.0 112.705 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -109.59 127.46 54.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.255 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.81 126.63 30.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.973 0.416 . . . . 0.0 111.209 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -143.09 162.51 35.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.445 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.2 p -139.59 133.58 30.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.457 0.17 . . . . 0.0 110.709 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.23 143.01 25.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.253 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.08 92.82 5.17 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -58.56 -25.61 62.69 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.722 -178.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.551 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 22.8 t-20 -54.18 -31.7 53.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.376 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -107.61 16.4 23.77 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.0 m-85 -129.5 -22.32 3.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -112.66 141.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.626 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.0 174.26 15.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.363 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -112.82 108.32 17.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.9 0.381 . . . . 0.0 110.71 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -111.59 105.24 13.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.679 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.691 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 41.5 t30 56.75 42.59 26.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.146 0.498 . . . . 0.0 110.696 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.44 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 73.7 18.03 79.37 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.733 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.98 146.91 49.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 111.229 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.543 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 7.5 mp -72.38 114.32 10.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.616 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -108.79 132.04 54.37 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.424 ' HD1' ' CE ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -31.21 -74.12 0.05 OUTLIER Pre-proline 0 CA--C 1.432 -3.568 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.184 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 10.7 Cg_endo -108.89 129.43 0.04 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.242 0 C-N-CA 113.852 -3.632 . . . . 0.0 112.913 -177.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.626 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -161.44 -163.28 14.08 Favored Glycine 0 C--N 1.278 -2.683 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.016 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -153.38 143.22 22.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.013 0.435 . . . . 0.0 110.892 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.5 m 57.15 35.1 25.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.169 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 7.2 p90 -64.81 -34.16 77.7 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.03 -17.61 37.56 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.165 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 t -68.26 -30.82 69.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.739 0.304 . . . . 0.0 110.625 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 m -125.29 6.32 7.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.192 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -120.48 141.38 50.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.684 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.8 m -137.5 171.84 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? 63.61 43.35 5.8 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.774 0.671 . . . . 0.0 111.457 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.568 HG22 ' HD1' ' A' ' 17' ' ' TYR . 4.2 p -69.28 133.6 48.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.072 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.71 163.97 38.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.698 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.61 HD23 HD21 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -120.62 112.87 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.666 0.27 . . . . 0.0 111.647 -179.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.584 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 16.9 m120 -72.18 116.93 13.19 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.224 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.7 t70 54.08 15.17 0.83 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.955 0.784 . . . . 0.0 111.929 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.31 34.41 57.79 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.836 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -147.83 -26.1 0.36 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.7 0.75 . . . . 0.0 112.001 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 18.5 m -116.08 134.59 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.495 0.188 . . . . 0.0 111.058 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.543 ' HG ' ' CD2' ' A' ' 48' ' ' LEU . 24.3 tp -94.64 133.5 38.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.582 0.23 . . . . 0.0 110.613 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.71 130.57 52.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.855 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.485 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -163.19 163.31 25.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.8 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -109.68 126.82 54.08 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.44 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 17.5 m -124.85 150.36 46.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.22 0.533 . . . . 0.0 112.153 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.0 tmtt? -100.27 140.55 34.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.721 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.45 -30.49 0.52 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.145 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.691 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.19 -40.31 64.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -171.21 51.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.416 0.627 . . . . 0.0 110.053 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.71 5.21 56.11 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.782 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -129.34 162.14 28.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 47.9 p90 -90.14 160.11 16.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.309 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -153.87 133.04 12.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.48 124.75 24.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.702 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.8 p -138.45 171.0 15.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.766 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.17 159.41 41.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.965 0.412 . . . . 0.0 110.521 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.435 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 12.0 tpp -143.28 123.76 13.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.505 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.458 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 10.8 m-20 -73.1 105.74 4.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.247 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.1 mt -76.18 -8.61 57.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.909 0.385 . . . . 0.0 110.426 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.11 -28.73 7.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.943 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 87' ' ' ASP . 44.1 p90 -120.16 22.77 11.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.982 0.42 . . . . 0.0 110.973 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -128.72 -9.93 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.594 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.988 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -138.93 140.6 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.235 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.01 176.47 20.91 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.305 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -121.66 123.31 41.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.632 0.253 . . . . 0.0 110.972 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.9 m -127.82 94.34 3.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.601 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 64.67 47.07 2.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.49 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.62 20.97 66.57 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.366 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -124.17 139.0 54.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -57.52 122.38 12.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.99 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -142.93 78.34 15.54 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.788 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.988 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.0 Cg_endo -71.78 96.38 0.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.884 2.389 . . . . 0.0 113.215 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.0 p . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.66 179.664 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 88.7 m . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 110.94 -0.022 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.482 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 58.4 m-80 52.17 82.73 0.06 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 14.4 p90 -60.77 -34.83 75.05 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.289 0.566 . . . . 0.0 110.507 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.85 -19.16 60.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.235 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.482 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 7.4 t-20 -51.22 -33.42 27.74 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.438 0.461 . . . . 0.0 111.532 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 m -136.5 27.14 3.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.941 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -120.41 132.81 55.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.088 0.471 . . . . 0.0 111.161 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 p -131.87 155.74 47.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.988 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.76 30.43 74.55 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.318 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.526 HG13 ' HA3' ' A' ' 21' ' ' GLY . 17.5 m -77.45 134.34 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.029 0.443 . . . . 0.0 111.669 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.73 151.88 49.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.697 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.658 HD23 HD21 ' A' ' 64' ' ' LEU . 8.8 tp -121.92 106.33 11.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.006 0.431 . . . . 0.0 111.176 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -134.21 114.73 13.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.789 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.45 49.97 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.738 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CD1' HG21 ' A' ' 62' ' ' THR . 18.1 m-85 64.2 25.6 13.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.199 0.6 . . . . 0.0 110.886 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.56 124.81 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.133 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.54 HD23 HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -102.74 113.76 27.44 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 20' ' ' ARG . 15.2 ttm180 -123.04 133.74 54.32 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.7 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.526 ' HA3' HG13 ' A' ' 12' ' ' VAL . . . -162.79 -173.38 31.43 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.13 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -106.55 109.53 21.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.626 0.25 . . . . 0.0 110.662 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -104.82 132.08 51.5 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.74 142.19 15.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -109.5 -171.12 1.78 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.399 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -54.91 -31.22 59.89 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.88 -9.68 58.8 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.16 5.23 85.87 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.845 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.4 133.94 20.4 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.869 0.366 . . . . 0.0 110.168 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.48 138.53 81.04 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 123.246 2.63 . . . . 0.0 112.741 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -123.41 135.87 54.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.32 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 112.39 5.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.214 0.53 . . . . 0.0 110.828 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -131.1 156.75 44.71 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.601 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 99' ' ' MET . 19.9 p -139.57 147.0 40.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.102 0.477 . . . . 0.0 111.603 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -129.74 143.96 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.563 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.06 89.77 3.38 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.54 HD21 HD23 ' A' ' 19' ' ' LEU . 1.2 mm? -54.29 -30.44 50.82 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.61 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.533 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.3 t-20 -54.33 -28.34 41.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.468 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -108.76 14.67 24.18 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.643 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -128.05 -24.2 3.21 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.4 143.03 22.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.638 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -112.61 170.58 13.54 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.56 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -113.84 111.35 21.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.294 -0.453 . . . . 0.0 111.35 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -110.63 104.35 13.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.76 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.523 HD21 ' HA ' ' A' ' 77' ' ' ALA . 9.4 m120 48.08 47.04 19.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.126 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.51 12.51 84.19 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.673 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.39 143.97 47.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.832 0.349 . . . . 0.0 110.667 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 mp -76.94 114.29 15.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.516 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -103.39 136.97 42.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.089 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.563 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -39.23 -76.19 0.05 OUTLIER Pre-proline 0 CA--C 1.436 -3.416 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' CD ' ' HB2' ' A' ' 50' ' ' TYR . 20.5 Cg_endo -109.95 125.64 0.04 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.324 0 C-N-CA 113.751 -3.699 . . . . 0.0 113.165 -177.342 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.638 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -155.67 -157.55 8.33 Favored Glycine 0 C--N 1.284 -2.36 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.664 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -151.56 143.31 23.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 111.052 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 m 49.82 44.9 25.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.533 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 11.5 p90 -68.97 -31.08 69.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 59' ' ' CYS . . . -62.22 -18.21 57.47 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.196 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -53.9 -30.66 47.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.315 0.246 . . . . 0.0 110.904 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 25.1 m -135.48 17.75 3.36 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.429 ' HB2' ' HA2' ' A' ' 56' ' ' GLY . 7.5 m -108.08 147.73 30.79 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.45 0.643 . . . . 0.0 112.238 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.74 173.3 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.995 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 59.94 35.91 21.68 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.427 0.291 . . . . 0.0 111.432 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.443 HG21 ' CD1' ' A' ' 17' ' ' TYR . 16.7 p -68.31 120.09 13.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.992 0.425 . . . . 0.0 111.488 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.85 152.49 30.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.728 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.658 HD21 HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -108.34 112.75 25.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.525 0.202 . . . . 0.0 110.59 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -76.08 117.49 17.84 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.8 t70 58.48 18.04 5.36 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.081 0.863 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.06 32.52 84.38 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.413 -0.812 . . . . 0.0 114.082 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -141.9 -27.26 0.65 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 117.811 0.805 . . . . 0.0 111.249 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.9 m -116.01 126.24 53.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.223 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' A' ' 64' ' ' LEU . 16.8 tp -89.97 126.58 35.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.162 0.506 . . . . 0.0 109.783 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.67 130.47 56.37 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.305 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.31 166.47 27.49 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.661 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 t -118.26 117.57 29.48 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -114.32 154.21 28.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.544 0.688 . . . . 0.0 111.828 -179.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 7.8 tmtt? -100.36 149.27 23.8 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.826 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.31 -15.53 1.87 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.829 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.523 ' HA ' HD21 ' A' ' 45' ' ' ASN . . . -58.78 -40.77 84.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.687 0.28 . . . . 0.0 110.744 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 178.24 58.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.698 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.13 19.68 74.17 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -143.82 161.34 38.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 51.4 p90 -101.82 165.5 11.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.318 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.96 152.84 40.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.408 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.86 131.09 37.45 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.8 p -149.58 172.68 14.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.95 0.405 . . . . 0.0 111.286 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.85 163.29 31.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.99 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.639 ' HE1' ' HA ' ' A' ' 86' ' ' MET . 4.6 tpt -146.67 113.05 5.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.472 ' H ' ' HE1' ' A' ' 86' ' ' MET . 0.9 OUTLIER -72.4 106.49 4.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.009 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.581 ' HB2' ' HE1' ' A' ' 5' ' ' PHE . 14.4 mt -74.47 -7.62 53.6 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.762 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -46.83 -30.76 2.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.874 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -118.63 19.14 13.33 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.628 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -125.14 -10.01 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.313 0.578 . . . . 0.0 110.154 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.852 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.1 t -141.79 139.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.525 178.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.92 176.42 18.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.519 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -129.48 133.54 47.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.61 0.243 . . . . 0.0 110.454 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.4 t -142.38 111.49 6.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.88 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 57.65 43.55 22.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.401 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.56 7.56 65.01 Favored Glycine 0 C--N 1.33 0.218 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.455 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.9 145.16 41.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -68.91 131.22 44.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.224 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -136.67 76.03 48.79 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.693 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.852 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 35.2 Cg_endo -66.27 119.36 6.38 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.438 2.092 . . . . 0.0 111.322 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.826 -178.994 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 82.0 m . . . . . 0 C--O 1.232 0.17 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.456 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 24.4 m-80 51.76 69.09 0.7 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.651 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 17.5 p90 -58.1 -41.66 83.98 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.25 0.547 . . . . 0.0 110.21 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.94 -21.62 65.09 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.821 -178.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.456 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 28.2 t-20 -54.71 -33.72 61.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.333 0.587 . . . . 0.0 110.802 -179.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 m -134.69 28.4 3.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.076 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.651 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -120.0 134.88 55.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.943 0.401 . . . . 0.0 110.584 179.267 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 p -128.25 152.19 48.39 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.985 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.84 57.91 12.68 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.756 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.531 HG12 ' HA3' ' A' ' 21' ' ' GLY . 15.5 m -104.83 132.12 52.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.962 0.41 . . . . 0.0 110.824 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -133.27 156.69 47.11 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.739 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.651 HD22 HD21 ' A' ' 64' ' ' LEU . 21.9 tp -121.33 127.73 51.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.542 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.431 ' O ' HG12 ' A' ' 18' ' ' ILE . 42.7 t80 -131.23 98.92 4.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.836 179.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 62' ' ' THR . . . 78.41 -63.77 3.61 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.709 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' HD1' HD22 ' A' ' 36' ' ' ASN . 6.4 p90 -169.15 23.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.724 0.297 . . . . 0.0 111.47 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.7 pt -121.57 133.91 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.798 0.332 . . . . 0.0 110.659 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.526 HD22 HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -115.72 114.28 24.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.828 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.46 140.55 51.23 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.531 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.22 -177.71 39.03 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.96 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 7.1 m-20 -109.63 108.3 18.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.439 0.162 . . . . 0.0 110.609 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.9 m -104.54 132.38 50.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.5 mt -69.58 133.43 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.56 -178.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -94.68 -176.59 3.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.917 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -54.72 -37.71 66.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.727 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.81 -30.02 67.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.938 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.03 -2.01 31.53 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.322 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -104.49 139.69 20.35 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.372 . . . . 0.0 110.944 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 42.8 Cg_endo -69.91 125.99 12.7 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.921 2.414 . . . . 0.0 111.67 179.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -112.02 136.88 50.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.048 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.3 123.77 21.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.453 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -140.01 158.36 44.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.602 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.0 p -140.1 141.86 36.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.743 0.306 . . . . 0.0 111.192 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -124.86 145.4 32.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.588 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.458 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -103.74 95.82 6.29 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.75 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.526 HD21 HD22 ' A' ' 19' ' ' LEU . 1.3 mm? -58.54 -26.9 64.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.742 0.306 . . . . 0.0 111.337 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -55.41 -24.12 28.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.863 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -112.86 12.37 19.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.58 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -129.02 -12.03 4.7 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.62 133.9 68.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -108.67 170.92 15.13 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.577 -179.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -110.88 102.49 10.99 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.299 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -110.57 105.64 14.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.889 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 14.3 t-20 52.6 47.37 24.83 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.708 0.766 . . . . 0.0 111.094 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.69 75.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.933 179.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -120.27 151.79 38.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.797 0.332 . . . . 0.0 110.672 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.491 HD23 ' HG ' ' A' ' 70' ' ' LEU . 10.8 mp -85.5 117.01 24.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.892 -179.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -110.57 126.8 54.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.183 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.609 ' HB2' ' CG1' ' A' ' 91' ' ' VAL 0.252 53.5 p90 -61.13 -12.06 0.2 Allowed Pre-proline 0 CA--C 1.452 -2.811 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 -174.804 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -128.62 9.22 0.0 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.601 1 C-N-CA 112.461 -4.56 . . . . 0.0 114.972 175.693 . . . . . . . . 3 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -66.94 -167.72 3.05 Favored Glycine 0 C--N 1.27 -3.106 0 CA-C-N 110.849 -2.887 . . . . 0.0 115.69 -177.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -145.59 154.56 42.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.721 0.296 . . . . 0.0 110.928 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.8 m 55.76 45.28 24.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 10.4 p90 -79.61 -36.7 37.63 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.845 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.54 -18.38 69.83 Favored Glycine 0 CA--C 1.505 -0.533 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.83 -178.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 m -66.7 -13.21 61.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.049 -0.576 . . . . 0.0 110.779 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.4 m -149.02 26.84 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.617 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -124.55 155.36 39.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.162 0.506 . . . . 0.0 111.123 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.6 m -141.62 171.1 12.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.816 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 62.46 31.77 16.98 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.523 0.514 . . . . 0.0 111.345 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 16' ' ' GLY . 2.6 p -59.66 123.16 16.02 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.926 0.393 . . . . 0.0 111.489 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.45 162.88 40.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.315 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.651 HD21 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -121.98 112.62 18.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -85.33 124.8 32.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 110.959 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 t70 56.36 21.36 5.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.048 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.94 36.06 92.28 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.33 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -154.48 -23.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.571 0.686 . . . . 0.0 112.393 179.008 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 m -116.35 128.48 55.57 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.22 -0.3 . . . . 0.0 111.143 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.545 ' HA ' HD23 ' A' ' 64' ' ' LEU . 11.8 tp -91.3 129.73 37.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.297 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.84 129.75 53.67 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.657 178.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.91 165.56 24.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.133 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -117.01 111.78 20.04 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 56.7 m -103.38 146.14 28.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.414 0.626 . . . . 0.0 110.742 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.2 tmtt? -100.59 140.49 34.78 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.883 177.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.73 -24.46 0.3 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.909 -1.139 . . . . 0.0 112.992 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . . . -47.97 -45.85 31.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.0 111.135 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.2 t70 178.72 58.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.917 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.57 -0.16 65.71 Favored Glycine 0 C--O 1.229 -0.189 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.695 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -118.23 163.95 15.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.172 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 50.5 p90 -111.77 169.54 8.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.071 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -155.95 135.19 12.21 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -72.05 114.65 10.38 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.291 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.8 t -130.55 167.53 18.54 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.977 0.418 . . . . 0.0 110.418 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.03 160.93 38.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.163 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.892 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 0.6 OUTLIER -146.04 126.25 13.86 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.327 -179.611 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -78.28 108.78 11.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.144 0.497 . . . . 0.0 109.874 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.56 ' HA ' HG21 ' A' ' 91' ' ' VAL . 13.1 mt -82.26 -9.25 59.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.586 -179.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -52.21 -26.27 11.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.489 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -116.54 17.76 15.27 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.066 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 102' ' ' CYS . 2.5 m -123.7 -10.57 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 121.188 0.518 . . . . 0.0 110.476 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -133.73 124.16 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -114.98 159.03 13.95 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.44 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -107.81 121.94 45.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.4 m -137.12 107.16 6.31 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.809 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 61.01 40.74 14.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.326 178.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.73 18.31 68.11 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.606 -0.725 . . . . 0.0 113.164 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -124.75 147.97 48.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -66.01 127.77 33.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.867 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -133.61 75.07 69.47 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.289 178.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 31.6 Cg_endo -62.19 135.48 54.71 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.734 2.289 . . . . 0.0 112.218 -179.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 5.7 p . . . . . 0 C--N 1.318 -0.791 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.578 -179.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.9 m . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 41.82 76.04 0.08 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 3.4 p90 -62.19 -32.68 73.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.006 0.431 . . . . 0.0 111.035 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.6 -22.31 65.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -63.05 -27.18 69.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.0 m -129.87 28.7 5.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.733 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -129.75 144.81 51.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.927 0.394 . . . . 0.0 111.104 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.1 p -140.39 147.39 39.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.061 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.13 48.14 55.01 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.893 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 ' HA3' ' A' ' 21' ' ' GLY . 18.1 m -93.5 132.75 36.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.202 0.525 . . . . 0.0 111.083 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -126.6 154.86 43.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.672 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.711 HD23 HD23 ' A' ' 64' ' ' LEU . 16.2 tp -123.8 119.44 29.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.872 0.368 . . . . 0.0 111.41 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.535 ' O ' HG12 ' A' ' 18' ' ' ILE . 29.2 m-85 -118.01 99.21 6.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.158 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 62' ' ' THR . . . 73.44 -61.92 1.89 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.975 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 28.1 p90 -165.39 21.15 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.868 0.366 . . . . 0.0 111.211 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.569 HG22 ' ND2' ' A' ' 36' ' ' ASN . 35.4 pt -118.82 127.54 75.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.922 0.391 . . . . 0.0 110.552 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.519 HD22 ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -108.82 117.64 34.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.695 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 20' ' ' ARG . 6.1 tmm_? -128.85 138.22 51.92 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.737 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.507 ' HA3' HG13 ' A' ' 12' ' ' VAL . . . -166.78 -168.54 29.12 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.937 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -112.34 110.66 21.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.737 0.303 . . . . 0.0 111.078 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 m -106.38 132.98 51.78 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.7 mt -67.41 136.34 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.83 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.34 -174.46 2.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.355 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -52.79 -33.41 48.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.481 0.488 . . . . 0.0 112.098 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.68 -28.18 69.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.786 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.06 -4.04 48.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.514 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -104.87 146.08 31.95 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.808 0.337 . . . . 0.0 110.524 179.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 37.1 Cg_endo -67.52 130.6 22.6 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.805 2.337 . . . . 0.0 112.137 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -118.96 132.38 56.07 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.743 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.82 126.25 27.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.41 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 t -143.03 158.7 43.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.649 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 p -138.98 151.17 46.64 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.542 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -136.25 147.24 28.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.316 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.569 ' ND2' HG22 ' A' ' 18' ' ' ILE . 8.6 m120 -104.38 96.05 6.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.897 0.379 . . . . 0.0 110.785 179.299 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.515 HD22 HD21 ' A' ' 19' ' ' LEU . 1.2 mm? -60.39 -28.5 68.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.008 -179.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.461 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 24.4 t-20 -55.81 -26.56 46.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.2 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.05 11.93 22.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.484 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.9 m-85 -128.71 -20.28 3.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.69 141.32 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.597 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.32 176.54 17.05 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.105 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -116.71 106.62 13.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.889 0.376 . . . . 0.0 110.695 -178.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -111.87 107.27 16.25 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.376 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.842 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 55.1 t30 56.02 40.79 30.27 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.037 0.446 . . . . 0.0 110.533 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.41 19.6 79.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.509 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -123.89 157.06 35.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.848 0.356 . . . . 0.0 110.568 -179.584 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.05 116.63 21.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.234 -178.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.18 128.77 51.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.596 179.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.559 ' HD2' ' HE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -36.83 -76.22 0.04 OUTLIER Pre-proline 0 CA--C 1.43 -3.639 0 CA-C-O 117.697 -1.144 . . . . 0.0 112.819 -179.825 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 6.0 Cg_endo -108.68 123.98 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.273 1 C-N-CA 113.199 -4.067 . . . . 0.0 113.083 -178.661 . . . . . . . . 4 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.597 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -152.35 -160.75 9.77 Favored Glycine 0 C--N 1.281 -2.509 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.939 -177.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -154.87 142.76 20.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.693 0.282 . . . . 0.0 110.583 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.1 m 56.48 42.49 27.34 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.184 178.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 14.9 p90 -71.75 -35.61 70.17 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.07 -18.69 48.98 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.321 -178.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 m -64.4 -16.55 62.55 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.06 0.544 . . . . 0.0 111.01 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 m -148.22 23.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.884 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.7 m -129.99 138.67 50.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.26 0.552 . . . . 0.0 111.093 -179.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 m -133.06 178.09 6.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.295 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 62.81 37.09 12.6 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.415 0.447 . . . . 0.0 111.329 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 16' ' ' GLY . 12.6 p -67.84 123.2 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.86 149.73 27.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.92 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.711 HD23 HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -106.34 115.01 29.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.853 0.359 . . . . 0.0 110.724 -179.639 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -85.94 120.37 27.27 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.195 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.69 23.36 10.98 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.924 0.765 . . . . 0.0 111.925 179.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.93 32.19 59.1 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 114.361 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -148.09 -25.15 0.35 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.376 0.588 . . . . 0.0 111.436 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.6 m -114.81 126.39 54.77 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.777 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.493 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.0 tp -89.83 132.72 35.11 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.45 129.56 52.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.748 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.19 166.93 28.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 110.521 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 t -114.79 122.66 47.05 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 57.2 m -122.44 149.68 43.52 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.4 tmtt? -99.96 140.45 34.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.824 178.148 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.61 -32.07 0.3 Allowed Glycine 0 C--O 1.227 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.18 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.842 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -52.95 -41.16 64.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -173.55 52.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.618 0.723 . . . . 0.0 109.811 -179.094 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.21 10.01 61.65 Favored Glycine 0 C--O 1.225 -0.418 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.096 -179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -131.78 158.67 40.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 17.4 p90 -100.72 166.3 10.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -158.53 149.12 20.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -69.59 139.33 53.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.931 0.396 . . . . 0.0 110.636 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.3 t -152.01 162.99 40.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.038 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.58 164.55 27.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.908 0.385 . . . . 0.0 110.021 179.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.855 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 2.6 tpt -148.7 121.38 8.63 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.689 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.413 ' HB2' ' HH ' ' A' ' 90' ' ' TYR . 19.2 m-20 -73.94 106.5 5.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.559 ' HA ' HG23 ' A' ' 91' ' ' VAL . 18.3 mt -75.76 -9.11 58.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.523 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.38 -31.33 3.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.079 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.559 ' HE1' ' HD2' ' A' ' 50' ' ' TYR . 3.2 p90 -119.57 23.59 11.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 111.564 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -127.53 -14.35 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.102 0.477 . . . . 0.0 110.505 178.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 1.011 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.5 p -150.79 133.81 6.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.691 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.03 -179.82 16.08 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.523 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -126.01 135.85 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 t -147.66 120.61 8.77 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 57.99 41.49 24.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.58 28.98 68.59 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.764 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -136.29 151.44 49.64 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.835 0.35 . . . . 0.0 110.139 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -61.9 127.89 33.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.071 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -140.45 71.48 32.02 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.246 178.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 1.011 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 51.7 Cg_endo -70.91 100.73 0.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.77 2.314 . . . . 0.0 112.871 -179.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.031 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.3 m . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.418 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 44.2 m-80 62.51 80.5 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 178.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 6.2 p90 -65.01 -35.87 82.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.066 178.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.9 64.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.871 -178.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.418 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 7.3 t-20 -52.18 -31.27 30.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.51 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.0 m -144.12 30.77 1.27 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.893 0.378 . . . . 0.0 110.721 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -119.48 142.17 48.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.024 179.156 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -141.44 157.53 45.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.395 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.79 61.03 7.66 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.723 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.547 HG12 ' HA3' ' A' ' 21' ' ' GLY . 30.9 m -100.71 139.02 23.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.91 0.386 . . . . 0.0 110.991 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 11.3 pt-20 -130.32 139.72 50.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.393 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 64' ' ' LEU . 51.9 tp -124.62 123.74 40.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.469 ' O ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-85 -133.67 103.65 5.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.412 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.433 ' O ' HG22 ' A' ' 62' ' ' THR . . . 79.37 -65.2 3.67 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.161 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.6 p90 -167.6 21.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.813 0.339 . . . . 0.0 111.313 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 45.6 pt -117.02 129.05 74.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.47 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.552 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -119.79 114.45 22.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.609 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 21.2 ttm180 -114.0 136.0 53.38 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.547 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -154.93 168.32 32.89 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.399 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -100.66 105.15 16.49 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -104.97 131.79 52.02 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -70.71 136.2 26.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.646 -178.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -99.73 -176.5 3.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.404 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.37 -32.79 57.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.89 -29.04 69.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.022 0.439 . . . . 0.0 111.66 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.12 0.8 41.5 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.096 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -107.56 141.52 23.2 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.791 0.329 . . . . 0.0 110.656 179.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.62 130.23 21.69 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 122.966 2.444 . . . . 0.0 112.532 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -114.72 132.61 56.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.95 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.38 124.27 23.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.171 0.51 . . . . 0.0 111.638 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 t -143.22 152.94 42.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.413 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.7 p -135.7 145.5 46.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.506 0.193 . . . . 0.0 111.117 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.84 151.81 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.788 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.481 ' ND2' HG21 ' A' ' 18' ' ' ILE . 5.4 m120 -103.07 93.61 5.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.171 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -60.18 -24.48 64.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.797 -178.911 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.5 t-20 -55.09 -30.9 60.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.969 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -105.7 15.17 27.27 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.537 -178.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.1 m-85 -130.38 -24.62 2.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 mp -112.71 141.78 27.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.652 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.35 169.7 12.99 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.547 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -119.33 114.2 21.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.973 0.416 . . . . 0.0 110.933 -179.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -111.02 108.12 17.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.241 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 51.87 42.56 30.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.077 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 74' ' ' CYS . . . 80.07 18.05 73.03 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.539 179.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.67 150.17 46.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.047 0.451 . . . . 0.0 111.2 -179.83 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.463 HD11 ' HG ' ' A' ' 70' ' ' LEU . 43.4 mt -82.43 116.19 21.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.14 -179.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -112.49 132.04 55.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.567 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -33.17 -73.67 0.06 OUTLIER Pre-proline 0 CA--C 1.427 -3.765 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.598 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 4.9 Cg_endo -107.85 130.48 0.05 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.327 0 C-N-CA 113.563 -3.824 . . . . 0.0 113.212 -176.669 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.652 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -163.89 -160.46 11.8 Favored Glycine 0 C--N 1.286 -2.204 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.322 -177.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -151.53 145.53 25.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 111.401 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m 51.57 41.79 28.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.774 178.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -69.33 -39.37 78.23 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.523 178.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.03 -18.08 46.54 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.24 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 t -68.82 -20.44 64.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.002 0.43 . . . . 0.0 110.166 179.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -134.49 17.25 3.66 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.402 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.7 m -125.8 143.13 51.19 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.97 0.414 . . . . 0.0 111.17 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.31 172.81 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.454 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 62.0 37.54 14.85 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.597 0.56 . . . . 0.0 111.359 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 16' ' ' GLY . 18.0 p -63.94 127.43 31.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.972 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.55 160.28 43.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.231 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -118.54 112.92 20.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.805 0.336 . . . . 0.0 110.967 -179.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.566 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 15.9 m120 -70.28 114.61 8.58 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.316 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.7 t70 55.2 3.32 0.06 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.145 0.903 . . . . 0.0 112.766 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 65' ' ' ASN . . . 86.84 47.78 4.66 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.475 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 2.2 p-80 -162.04 -30.06 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 111.684 178.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.566 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 23.9 m -115.89 134.15 55.28 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.692 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.592 ' HB2' HD13 ' A' ' 88' ' ' LEU . 12.3 tp -94.92 131.24 41.06 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.541 0.21 . . . . 0.0 110.482 179.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 128.99 53.81 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.77 162.57 37.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.165 0.507 . . . . 0.0 111.149 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -110.76 120.95 44.09 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.441 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 21.3 m -121.36 148.21 44.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.277 0.56 . . . . 0.0 112.303 -177.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 8.2 tmtt? -99.41 147.48 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.226 178.046 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.68 -18.55 0.87 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.005 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.72 81.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.823 0.311 . . . . 0.0 110.815 179.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.7 t70 179.13 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.205 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.52 -3.75 16.22 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.635 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -116.19 161.51 18.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 44.3 p90 -106.11 166.58 10.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.299 -179.473 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -154.97 143.16 20.28 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.4 127.55 32.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.78 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 p -141.4 174.72 10.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.13 162.49 34.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 0.0 110.791 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.95 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 1.2 tpt -148.66 117.18 6.55 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.575 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 26.4 t70 -76.68 106.75 8.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 70' ' ' LEU . 12.5 mt -78.85 -10.05 59.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.387 -177.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -58.44 -16.72 16.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.06 -179.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -119.45 19.43 12.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.174 0.512 . . . . 0.0 110.823 177.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.565 HG21 ' HA ' ' A' ' 88' ' ' LEU . 2.6 m -125.52 -6.63 5.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.479 0.657 . . . . 0.0 109.84 177.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 101' ' ' PRO . 9.9 p -153.06 147.02 14.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.937 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -134.71 -177.09 14.71 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.793 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -122.71 127.01 48.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.716 0.293 . . . . 0.0 110.65 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.2 m -127.68 92.9 3.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.77 178.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 60.99 54.29 3.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.996 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.25 27.37 62.8 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.965 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.88 142.83 51.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.898 0.38 . . . . 0.0 110.52 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -62.22 121.21 12.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.547 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -138.43 80.93 25.94 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.199 178.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.539 ' HA ' HG22 ' A' ' 92' ' ' VAL . 42.3 Cg_endo -68.67 102.06 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.909 2.406 . . . . 0.0 112.064 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.043 179.66 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.411 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 2.1 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 56.73 70.38 0.66 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.162 0.289 . . . . 0.0 110.863 179.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 6.8 p90 -58.35 -38.35 77.03 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.071 0.462 . . . . 0.0 111.582 -178.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.91 -22.6 65.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -69.37 -19.48 63.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.784 0.326 . . . . 0.0 111.312 -178.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.2 m -128.94 10.01 5.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.154 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -118.29 138.55 52.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.218 0.532 . . . . 0.0 111.475 -179.615 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.7 p -132.48 151.42 51.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.921 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.03 49.22 80.88 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.947 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.498 ' HB ' HD23 ' A' ' 19' ' ' LEU . 15.7 m -83.39 127.53 39.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.275 0.56 . . . . 0.0 111.493 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -116.29 137.35 52.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.31 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.862 HD23 HD22 ' A' ' 64' ' ' LEU . 59.4 tp -119.08 129.05 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 111.763 -178.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.488 ' O ' HG12 ' A' ' 18' ' ' ILE . 52.5 m-85 -133.91 103.49 5.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.624 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 62' ' ' THR . . . 75.34 -66.82 2.24 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.655 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.653 ' HD1' HD22 ' A' ' 36' ' ' ASN . 5.8 p90 -164.18 21.02 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.993 0.425 . . . . 0.0 111.089 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.2 pt -121.42 127.28 75.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.176 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.5 mt -113.18 114.12 26.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.346 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -116.49 132.39 56.69 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.577 178.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.42 -173.56 26.0 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.052 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -109.04 109.65 20.72 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.719 0.295 . . . . 0.0 110.384 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -106.79 132.54 52.64 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.267 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.9 mt -72.97 138.4 21.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.558 -178.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -102.94 -166.77 1.31 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.762 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.36 -28.41 69.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.907 0.384 . . . . 0.0 111.623 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.58 -26.89 68.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.649 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.83 -2.9 55.74 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.217 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -104.42 142.53 24.81 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.888 0.375 . . . . 0.0 110.707 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.41 133.46 30.29 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.817 2.345 . . . . 0.0 112.158 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -115.74 139.0 50.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.528 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.24 119.83 16.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.012 0.435 . . . . 0.0 111.291 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -142.19 153.04 43.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.035 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 p -138.2 136.25 36.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.664 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.75 144.17 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.829 -179.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.653 HD22 ' HD1' ' A' ' 17' ' ' TYR . 1.8 t-20 -103.62 87.51 2.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -57.78 -18.16 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.034 -178.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 54' ' ' SER . 0.2 OUTLIER -52.95 -32.33 45.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.69 -178.489 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -107.1 18.58 21.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.7 0.286 . . . . 0.0 111.307 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -125.66 -30.1 3.09 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 mp -111.08 143.13 21.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.69 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -116.88 166.92 12.46 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.645 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -109.78 110.07 20.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.442 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -110.15 105.19 14.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.468 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 22.2 t30 54.48 41.53 31.9 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.897 178.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.43 4.77 89.17 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.083 179.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.84 151.63 33.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.025 0.441 . . . . 0.0 111.131 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.03 127.94 34.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.753 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 7.9 tp10 -120.18 138.89 53.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.536 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.707 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -40.47 -69.31 0.21 Allowed Pre-proline 0 CA--C 1.429 -3.692 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.197 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -109.73 124.9 0.03 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.46 0 C-N-CA 114.054 -3.498 . . . . 0.0 113.551 -177.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.69 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.4 -161.79 11.8 Favored Glycine 0 C--N 1.281 -2.505 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.006 -177.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -153.04 143.75 22.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.758 0.328 . . . . 0.0 110.643 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.447 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 8.2 t 60.22 45.2 11.77 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.824 177.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.471 ' CE2' HD22 ' A' ' 70' ' ' LEU . 9.2 p90 -80.88 -37.43 29.8 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.732 -0.605 . . . . 0.0 110.069 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.74 -18.42 68.27 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.33 -178.085 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.3 m -68.9 -25.59 64.68 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.85 0.357 . . . . 0.0 110.929 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.7 p -123.76 0.6 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.375 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.5 m -107.77 151.78 25.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.058 0.456 . . . . 0.0 111.14 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.09 168.53 13.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.406 178.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mptt 64.4 36.4 9.0 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.542 0.526 . . . . 0.0 110.751 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 16' ' ' GLY . 1.4 p -63.97 132.03 49.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.087 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.17 162.17 41.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.801 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.862 HD22 HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -123.04 112.91 18.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.773 0.321 . . . . 0.0 111.335 -179.401 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -82.35 123.27 28.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.266 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 57.59 17.47 4.0 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.01 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.68 29.9 76.14 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.401 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -143.39 -30.41 0.5 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 117.458 0.629 . . . . 0.0 111.391 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.8 m -105.43 125.37 50.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.099 0.476 . . . . 0.0 111.615 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.667 ' HB2' HD11 ' A' ' 88' ' ' LEU . 14.0 tp -90.54 129.29 36.71 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.65 129.01 51.37 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.87 169.38 21.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.27 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.423 ' OG ' ' HD1' ' A' ' 81' ' ' TYR . 14.6 t -119.25 121.02 38.72 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.72 155.86 26.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.657 0.741 . . . . 0.0 111.856 -179.537 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -101.04 148.25 25.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.371 178.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.33 -32.66 0.54 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.433 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.729 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -55.0 -43.42 73.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -173.5 56.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 110.661 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.55 -1.03 31.12 Favored Glycine 0 CA--C 1.516 0.147 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.783 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -119.01 168.54 10.71 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.423 ' HD1' ' OG ' ' A' ' 73' ' ' SER . 42.8 p90 -110.27 161.38 15.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.119 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -153.01 135.17 14.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -61.87 134.4 56.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.966 -179.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 t -147.65 157.78 43.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.057 -179.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.63 162.13 31.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.363 . . . . 0.0 110.338 179.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.707 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 17.9 tpp -150.37 127.69 11.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.548 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -80.77 111.22 17.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 70' ' ' LEU . 11.4 mt -81.33 -8.71 59.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.43 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -52.6 -26.09 12.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.888 179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -116.66 19.05 14.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.772 0.32 . . . . 0.0 111.093 179.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -129.55 -12.41 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.232 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.7 t -131.26 147.12 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.458 ' H ' ' HA ' ' A' ' 101' ' ' PRO . . . -138.47 172.89 22.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.907 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -130.31 123.58 30.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.439 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.6 m -124.82 98.63 5.79 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.219 179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 62.59 48.36 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.352 179.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.01 21.55 65.85 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.176 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -121.81 139.24 53.86 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.607 0.241 . . . . 0.0 110.379 -179.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -59.28 117.27 4.6 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.589 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -142.76 71.83 19.74 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.059 0.457 . . . . 0.0 110.654 179.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 51.8 Cg_endo -69.26 114.16 3.53 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.908 2.405 . . . . 0.0 112.772 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.999 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.1 m . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.424 0.154 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 55.72 69.88 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 10.7 p90 -57.58 -39.51 76.93 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.324 0.583 . . . . 0.0 110.496 179.067 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.75 -22.34 61.95 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -177.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -72.01 -6.17 40.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.5 m -146.85 18.19 1.27 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.971 0.415 . . . . 0.0 110.399 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.5 m -127.31 133.39 50.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.786 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.9 p -136.13 154.59 50.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.11 57.38 10.76 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.649 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 31.5 m -93.24 138.2 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.297 0.57 . . . . 0.0 112.3 -178.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 43.2 mt-10 -126.67 144.26 50.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.825 179.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.725 HD22 HD22 ' A' ' 64' ' ' LEU . 12.2 tp -127.97 110.59 12.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.388 179.099 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.437 ' O ' HG12 ' A' ' 18' ' ' ILE . 83.2 t80 -116.95 101.61 8.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.055 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.31 -65.7 2.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.97 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.426 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 6.2 p90 -162.57 18.99 0.09 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.2 pt -118.79 131.52 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.342 . . . . 0.0 110.614 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.525 ' HB2' HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.45 113.81 26.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.087 -179.522 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 7.8 ttm180 -113.67 139.38 49.1 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.158 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.21 165.0 34.15 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.449 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.07 102.56 14.37 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 60.0 m -105.95 132.78 51.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mt -69.55 132.18 33.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.018 0.437 . . . . 0.0 111.184 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -103.57 -170.9 1.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.955 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.63 -28.92 61.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 111.712 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.24 -25.54 68.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.869 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.61 -1.02 63.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.629 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -110.03 142.88 26.83 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.36 122.3 10.42 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.062 2.508 . . . . 0.0 112.326 179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -107.63 132.53 53.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.24 117.25 15.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.142 0.496 . . . . 0.0 111.469 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -133.52 160.85 36.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.286 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.5 p -136.43 147.49 47.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.22 142.7 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.94 88.5 3.56 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.525 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -54.36 -29.37 48.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.705 -178.342 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 24.5 t-20 -52.87 -35.8 58.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.82 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -100.9 12.47 37.56 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.792 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.7 m-85 -126.02 -23.55 3.91 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.26 141.56 30.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.634 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.5 169.14 12.76 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.153 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -117.42 110.49 18.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 111.305 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.57 108.82 18.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.725 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 47.75 48.34 17.48 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.256 1.022 . . . . 0.0 112.791 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.16 15.04 81.61 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.711 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.64 149.65 46.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.042 0.448 . . . . 0.0 111.591 -179.362 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mp -81.1 123.44 28.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.984 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -114.99 131.97 56.75 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.635 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.35 -70.62 0.13 Allowed Pre-proline 0 CA--C 1.426 -3.816 0 CA-C-O 118.142 -0.932 . . . . 0.0 113.48 -179.213 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 10.2 Cg_endo -109.43 127.04 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.284 0 C-N-CA 113.724 -3.717 . . . . 0.0 113.399 -177.855 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.634 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -158.93 -160.64 10.5 Favored Glycine 0 C--N 1.281 -2.485 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.78 -177.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -153.42 138.82 17.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.831 0.371 . . . . 0.0 111.041 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 m 59.44 42.7 17.42 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 178.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -72.43 -36.18 68.51 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.56 -17.89 54.76 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.031 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -71.6 -12.94 61.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.295 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 p -144.73 13.59 1.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 111.149 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.4 m -125.87 149.51 48.62 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.019 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m -140.79 174.3 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.176 179.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.7 mptt 64.31 39.72 7.06 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.402 0.439 . . . . 0.0 111.32 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -68.32 120.81 15.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.391 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.43 162.33 39.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.725 HD22 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -118.68 112.86 20.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.681 -178.893 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.572 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 13.4 m120 -76.7 118.33 19.22 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.989 179.208 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 t70 54.66 19.64 2.57 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.869 0.731 . . . . 0.0 111.632 179.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.87 30.69 78.66 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.531 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -142.09 -26.04 0.66 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 117.538 0.669 . . . . 0.0 111.803 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 22.2 m -116.5 128.4 55.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.642 0.258 . . . . 0.0 111.489 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.506 ' HA ' HD21 ' A' ' 64' ' ' LEU . 14.7 tp -93.26 129.58 39.27 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.01 130.23 54.63 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.764 0.316 . . . . 0.0 110.512 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.58 156.75 30.68 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.515 178.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.5 t -106.34 125.55 51.14 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 22.9 m -122.7 150.99 41.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.231 0.539 . . . . 0.0 112.408 -178.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -100.14 148.92 24.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.138 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.47 -14.01 1.82 Allowed Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.098 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.12 -38.05 78.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.576 0.227 . . . . 0.0 110.986 179.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -175.81 54.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.255 0.55 . . . . 0.0 110.336 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.63 -7.38 13.68 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.402 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -117.84 168.99 9.98 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -111.03 162.34 14.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -148.89 149.32 31.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.08 141.98 47.57 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -151.08 157.07 42.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.013 0.435 . . . . 0.0 110.235 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.22 164.18 26.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.842 179.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.968 ' HE1' ' HA ' ' A' ' 86' ' ' MET . 1.6 tpt -150.02 121.45 7.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.862 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -75.75 106.11 7.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.367 0.603 . . . . 0.0 109.405 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.553 ' HA ' HG22 ' A' ' 91' ' ' VAL . 19.6 mt -72.74 -8.36 55.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.01 -179.253 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.89 -31.39 5.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.549 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -116.85 23.31 12.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.738 0.304 . . . . 0.0 111.23 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -130.48 -12.22 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.143 178.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.2 t -136.83 142.83 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -137.88 162.64 25.58 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -108.31 113.66 26.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.059 0.457 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.9 m -116.74 82.88 1.87 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.417 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 62.99 55.99 1.89 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.171 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.36 27.28 57.85 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.77 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.1 141.01 51.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.025 0.44 . . . . 0.0 110.674 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 18.3 ptm -61.04 97.29 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.472 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -129.06 78.17 76.67 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.136 0.493 . . . . 0.0 111.007 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.834 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 61.0 Cg_endo -75.22 96.02 1.01 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.47 2.113 . . . . 0.0 112.26 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.316 -0.891 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.927 179.833 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.1 m . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 53.26 66.56 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.539 0.524 . . . . 0.0 112.071 177.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 11.3 p90 -61.79 -39.3 91.24 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 111.053 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.66 -22.61 61.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.505 -178.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -71.68 -7.07 45.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.969 0.414 . . . . 0.0 111.32 -178.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 31.2 m -138.49 15.44 2.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.178 179.249 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -127.2 140.65 52.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.147 -179.625 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 p -136.27 148.53 48.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.571 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.69 47.82 46.49 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.383 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.514 HG12 ' HA3' ' A' ' 21' ' ' GLY . 24.4 m -89.69 143.63 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.996 0.427 . . . . 0.0 111.252 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 6.3 tp10 -141.61 146.16 35.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.097 179.308 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.74 HD22 HD22 ' A' ' 64' ' ' LEU . 49.9 tp -126.76 123.32 37.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 111.403 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.435 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.0 t80 -132.82 112.74 12.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.714 178.394 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.88 -68.24 2.27 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.677 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.0 p90 -166.0 18.7 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 122.594 0.357 . . . . 0.0 111.114 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.569 HG23 ' ND2' ' A' ' 36' ' ' ASN . 41.6 pt -119.65 125.12 74.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.051 0.453 . . . . 0.0 110.891 -178.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.518 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -111.06 115.15 28.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.704 179.627 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.6 ttm180 -116.24 136.47 52.98 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.514 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -161.46 169.73 37.04 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.92 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.39 110.86 22.94 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.3 m -105.72 132.78 51.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 57.9 mt -68.65 136.53 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.438 -178.743 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -102.28 -175.18 2.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -55.42 -27.8 50.19 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.33 -23.44 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 0.0 111.768 -179.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.79 5.21 57.67 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.357 -179.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -111.65 142.52 26.76 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.286 -0.457 . . . . 0.0 109.87 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 56.1 Cg_endo -71.94 133.77 22.28 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.833 2.355 . . . . 0.0 112.536 179.547 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -119.97 131.55 55.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.695 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.82 126.35 28.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.145 0.498 . . . . 0.0 111.643 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 t -140.43 156.59 46.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.645 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -130.54 148.75 52.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.47 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.81 146.75 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.818 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.569 ' ND2' HG23 ' A' ' 18' ' ' ILE . 8.3 m120 -105.43 96.17 6.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.23 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -63.07 -25.96 68.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.048 -178.216 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.53 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.0 t-20 -56.31 -27.51 55.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.03 -179.096 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -107.56 11.63 28.48 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.646 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -128.02 -23.21 3.36 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.52 140.81 29.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.674 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -111.83 163.34 12.22 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.268 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -112.43 106.62 15.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.183 -0.508 . . . . 0.0 110.176 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -111.51 107.17 16.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.373 -179.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 m120 57.86 42.13 23.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.306 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 74.47 17.49 79.83 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.849 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.76 143.04 51.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.036 0.446 . . . . 0.0 111.385 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.559 HD11 ' HG ' ' A' ' 70' ' ' LEU . 33.6 mt -73.16 124.02 24.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.618 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -117.21 137.15 52.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.634 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.1 -71.46 0.11 Allowed Pre-proline 0 CA--C 1.429 -3.687 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -111.45 126.78 0.03 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.366 0 C-N-CA 114.09 -3.473 . . . . 0.0 113.12 -177.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.674 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -159.89 -162.07 11.92 Favored Glycine 0 C--N 1.28 -2.547 0 CA-C-N 113.833 -1.531 . . . . 0.0 113.345 -177.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -152.76 142.16 21.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.531 -0.334 . . . . 0.0 111.015 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 m 55.32 43.16 29.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 17.7 p90 -70.24 -34.82 73.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.732 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.13 -18.38 27.29 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.545 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.1 t -52.7 -47.29 67.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.791 0.329 . . . . 0.0 110.544 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 42.8 m -119.7 12.39 12.2 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.0 m -111.14 137.47 48.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 111.903 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.8 m -136.67 175.56 9.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.393 178.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 60.82 43.19 12.31 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.915 0.388 . . . . 0.0 111.038 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 p -67.77 130.09 41.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.208 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.65 163.33 39.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.434 179.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.74 HD22 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -122.56 113.02 18.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.948 0.404 . . . . 0.0 111.642 -179.55 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -83.68 122.08 28.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.618 179.195 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.2 t70 58.01 16.95 4.06 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.93 0.769 . . . . 0.0 111.347 179.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.62 29.32 74.89 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.464 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 5.9 p80 -143.51 -28.22 0.54 Allowed 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 117.243 0.521 . . . . 0.0 111.471 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -110.51 129.65 55.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.802 0.334 . . . . 0.0 111.769 -179.077 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.559 ' HG ' HD11 ' A' ' 48' ' ' LEU . 14.4 tp -90.04 129.53 36.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.041 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.16 130.38 53.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.538 179.102 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.35 168.02 27.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.825 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -113.95 123.39 49.63 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.451 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 14.2 m -126.13 147.61 49.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -177.563 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.0 tmtt? -99.96 144.65 28.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.471 177.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.95 -26.31 0.63 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.684 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.75 80.31 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -171.58 52.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.83 2.2 50.41 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.431 -179.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -122.34 158.11 30.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.8 p90 -98.82 162.79 12.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.434 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -158.45 144.47 16.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -73.65 142.38 46.46 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.52 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.46 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 31.5 p -152.36 172.97 15.65 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.927 179.27 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -143.78 156.05 44.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.137 0.494 . . . . 0.0 111.016 -179.924 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.634 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 13.3 tpp -142.17 121.35 13.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.742 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -74.66 106.27 6.15 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.568 ' HA ' HG23 ' A' ' 91' ' ' VAL . 13.8 mt -78.82 -9.11 59.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.549 -178.808 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -52.26 -26.57 12.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.07 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -115.9 17.79 15.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.176 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -125.31 -11.69 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.985 0.422 . . . . 0.0 110.49 178.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.94 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.6 t -134.04 144.57 35.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.203 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.05 174.66 21.79 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.071 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -122.98 134.54 54.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.834 0.35 . . . . 0.0 110.478 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.4 t -145.35 104.59 3.94 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 61.69 44.27 9.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.085 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.26 34.53 67.66 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.542 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -131.43 142.95 50.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 ptt? -59.34 114.9 2.89 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.764 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -135.23 73.14 65.0 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.197 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.94 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 46.4 Cg_endo -70.38 96.06 0.63 Allowed 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.471 2.114 . . . . 0.0 112.56 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.316 -0.875 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.055 179.692 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 59.5 m . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 59.73 67.15 0.91 Allowed 'General case' 0 N--CA 1.462 0.148 0 O-C-N 123.145 0.278 . . . . 0.0 111.738 177.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 12.0 p90 -59.57 -42.75 93.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.296 0.569 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.74 -21.18 63.48 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.377 -178.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -60.33 -24.06 64.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.366 -178.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.0 m -136.92 25.5 3.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.459 179.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -125.64 134.88 51.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.823 179.634 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.1 p -131.41 158.71 40.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.739 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.89 61.37 7.26 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.588 179.054 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 27.8 m -95.65 149.96 4.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.081 0.467 . . . . 0.0 111.328 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -138.67 140.16 38.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.031 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.9 HD21 HD23 ' A' ' 64' ' ' LEU . 40.2 tp -126.41 122.68 36.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 110.993 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.534 ' O ' HG12 ' A' ' 18' ' ' ILE . 92.2 m-85 -130.09 106.3 8.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.334 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.451 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.74 -66.98 2.35 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.495 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.556 ' HD1' HD22 ' A' ' 36' ' ' ASN . 2.2 p90 -165.58 22.65 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.621 0.369 . . . . 0.0 111.209 179.794 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 15' ' ' TYR . 34.0 pt -119.86 127.48 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 110.263 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HB2' HD23 ' A' ' 37' ' ' LEU . 1.3 mt -112.78 119.87 39.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.415 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 1.4 ttt180 -120.32 138.01 53.94 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.36 175.16 40.45 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.517 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 23.4 m-20 -101.61 107.07 18.22 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 m -105.28 132.63 51.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mt -67.45 134.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.019 0.438 . . . . 0.0 111.511 -178.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -103.26 -171.44 1.94 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.45 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -51.32 -41.34 60.48 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.469 0.481 . . . . 0.0 111.846 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -59.79 -27.53 66.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.496 -179.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.75 -0.3 52.38 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.444 -178.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -105.51 138.44 19.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.554 0.693 . . . . 0.0 110.948 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.76 121.25 9.41 Favored 'Trans proline' 0 C--N 1.329 -0.475 0 C-N-CA 124.207 3.271 . . . . 0.0 112.027 178.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -111.92 126.79 55.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.941 -179.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.32 126.94 29.77 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.008 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 t -142.93 160.16 40.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.373 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.1 p -133.35 148.17 51.85 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.765 0.316 . . . . 0.0 110.601 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -133.69 143.95 37.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.556 HD22 ' HD1' ' A' ' 17' ' ' TYR . 2.1 t-20 -103.2 96.29 6.68 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.347 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.507 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -59.5 -22.17 61.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.919 -178.567 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -55.08 -31.53 61.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.768 -179.31 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -102.92 8.92 39.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.736 -179.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 43.8 m-85 -126.37 -22.63 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.1 139.13 41.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.623 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -112.32 170.06 13.36 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.718 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -115.33 107.44 15.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.901 0.381 . . . . 0.0 110.619 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -106.99 106.22 16.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.071 179.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 50.65 42.22 26.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.196 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.47 15.13 74.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.512 178.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.93 145.79 48.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.226 0.536 . . . . 0.0 111.011 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.515 HD12 ' HG ' ' A' ' 70' ' ' LEU . 23.7 mt -74.98 116.32 15.59 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.47 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.435 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.8 tt0 -107.53 132.31 53.39 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -39.0 -66.22 0.34 Allowed Pre-proline 0 CA--C 1.431 -3.634 0 CA-C-O 117.385 -1.293 . . . . 0.0 114.408 -179.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HD2' ' HG2' ' A' ' 49' ' ' GLU . 5.6 Cg_endo -112.67 119.47 0.02 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.219 0 C-N-CA 113.552 -3.832 . . . . 0.0 113.361 -178.296 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.623 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -154.75 -163.9 12.44 Favored Glycine 0 C--N 1.275 -2.82 0 CA-C-N 113.754 -1.566 . . . . 0.0 113.745 -177.402 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -153.14 142.02 21.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.6 45.53 16.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.586 177.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -75.66 -38.96 58.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.916 0.389 . . . . 0.0 110.408 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.04 -18.55 41.41 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.747 -178.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.0 m -59.74 -19.57 50.98 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.814 0.446 . . . . 0.0 111.602 179.378 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.0 m -144.49 26.04 1.47 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.668 179.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.6 m -127.69 144.65 51.06 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.23 0.538 . . . . 0.0 111.624 -179.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -136.82 172.8 14.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.474 179.038 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mptt 62.83 37.88 11.95 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.377 0.423 . . . . 0.0 111.192 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.2 p -68.81 122.26 18.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.152 0.501 . . . . 0.0 111.278 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.12 154.64 35.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.866 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.9 HD23 HD21 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -109.65 116.84 32.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.918 -179.344 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 67' ' ' GLY . 5.0 m-80 -84.05 118.86 24.34 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.2 t70 65.61 -1.92 0.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 124.199 0.937 . . . . 0.0 111.729 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 65' ' ' ASN . . . 83.21 29.22 34.32 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.029 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -143.32 -29.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.056 0.428 . . . . 0.0 110.889 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.423 ' O ' HD11 ' A' ' 64' ' ' LEU . 15.9 m -113.39 130.28 56.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.354 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.526 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.9 tp -91.14 130.4 37.04 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.22 129.82 53.38 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.876 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.95 162.91 32.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.092 0.473 . . . . 0.0 110.868 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.7 t -111.02 122.57 48.23 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.7 m -122.77 149.0 44.7 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.532 0.682 . . . . 0.0 112.469 -177.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.2 tmtt? -99.17 142.34 30.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.229 178.152 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.13 -24.46 0.39 Allowed Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.661 179.4 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.59 88.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.872 0.368 . . . . 0.0 111.83 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -173.59 55.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.289 0.566 . . . . 0.0 109.5 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.32 -1.42 12.82 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.0 -179.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 24.9 pt20 -113.72 166.11 11.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.381 -178.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.4 p90 -106.2 168.84 8.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.239 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.88 133.19 5.28 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.51 123.17 23.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.93 0.395 . . . . 0.0 110.346 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 p -135.25 173.82 11.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.172 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.28 155.29 46.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.405 0.621 . . . . 0.0 111.241 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.5 tpp -141.22 115.39 9.3 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.472 179.056 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -72.2 108.05 5.16 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.497 0.665 . . . . 0.0 109.449 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.593 ' HA ' HG21 ' A' ' 91' ' ' VAL . 13.1 mt -77.64 -8.83 58.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.957 -178.19 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -51.14 -26.48 6.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.083 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -116.72 13.83 15.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.18 179.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.593 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -122.37 -8.76 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.201 0.524 . . . . 0.0 111.109 179.175 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.4 t -133.53 137.45 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.59 161.61 20.87 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.281 178.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -114.49 129.64 56.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.876 0.37 . . . . 0.0 110.432 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.2 m -143.83 113.11 6.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.939 178.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 56.32 36.89 28.25 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 123.39 0.431 . . . . 0.0 111.196 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.75 22.06 63.78 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.791 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -118.85 145.98 45.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.804 0.335 . . . . 0.0 110.323 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 16.0 ptm -58.59 110.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.794 179.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -135.15 74.79 61.52 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.042 0.448 . . . . 0.0 110.654 178.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.2 Cg_endo -70.95 150.44 60.95 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.729 2.286 . . . . 0.0 112.592 -179.632 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 27.3 p . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.83 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.429 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 2.2 m-20 52.64 76.17 0.2 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.569 0.543 . . . . 0.0 111.525 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.485 ' CZ ' ' HA ' ' A' ' 68' ' ' HIS . 13.1 p90 -57.98 -44.28 87.05 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.149 0.499 . . . . 0.0 110.17 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.22 -21.34 65.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.587 -179.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.429 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 18.8 t-20 -57.72 -29.54 64.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.494 -178.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.421 ' HB2' HD21 ' A' ' 94' ' ' ASN . 13.5 m -132.94 17.46 4.18 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.62 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 80.9 m -117.96 133.49 55.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.777 0.322 . . . . 0.0 110.577 -179.255 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -130.59 149.28 52.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.749 -179.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.88 45.3 92.92 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.607 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.502 HG12 ' HA3' ' A' ' 21' ' ' GLY . 17.4 m -88.22 135.31 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.093 0.473 . . . . 0.0 111.353 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -129.45 156.41 44.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.169 -179.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 19.4 tp -130.03 125.01 34.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.976 0.417 . . . . 0.0 112.108 -178.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -126.32 99.18 5.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.12 178.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 62' ' ' THR . . . 77.45 -62.43 3.46 Favored Glycine 0 C--O 1.226 -0.368 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.857 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.46 25.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.29 0.566 . . . . 0.0 110.141 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 12.8 mt -119.52 115.55 47.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.708 -179.169 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -103.8 113.62 27.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.201 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 4.5 ttm180 -122.73 142.83 50.27 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.732 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -170.19 179.54 42.35 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.165 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.71 108.31 19.51 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 62.1 m -106.23 131.8 53.04 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.7 mt -75.37 136.29 25.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.33 0.586 . . . . 0.0 111.694 -177.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -102.97 -173.47 2.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.389 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -54.77 -36.55 64.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.932 0.396 . . . . 0.0 111.662 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -59.21 -27.56 65.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.73 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.04 1.33 57.13 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.845 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.19 140.1 20.94 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 121.302 0.572 . . . . 0.0 111.086 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.09 122.08 9.96 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 123.557 2.838 . . . . 0.0 112.454 179.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -105.3 130.02 53.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.51 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.65 115.69 12.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 t -136.73 156.88 47.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.063 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.3 p -140.06 142.75 36.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.732 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.12 144.91 35.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.864 0.364 . . . . 0.0 110.578 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -100.7 99.73 10.32 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -62.89 -22.23 66.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.76 -178.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.87 -32.81 64.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.09 -178.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -103.99 13.76 32.01 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.641 -178.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.7 m-85 -131.13 -17.27 3.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.6 142.05 35.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.564 0.221 . . . . 0.0 110.555 -179.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.676 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -120.06 165.04 13.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.319 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -117.69 112.01 19.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.57 0.7 . . . . 0.0 110.634 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -110.9 114.61 28.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.264 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.792 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 44.0 t30 59.52 33.82 22.29 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.148 0.499 . . . . 0.0 110.976 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.82 9.58 86.15 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.013 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -115.42 154.88 28.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.66 0.267 . . . . 0.0 110.707 179.951 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 30.9 mt -82.59 122.41 28.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.244 -179.303 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -111.31 137.35 49.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.217 179.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.454 ' N ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -39.87 -70.15 0.18 Allowed Pre-proline 0 CA--C 1.424 -3.889 0 CA-C-O 118.441 -0.79 . . . . 0.0 113.027 -179.272 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 5.6 Cg_endo -110.45 131.21 0.04 OUTLIER 'Trans proline' 1 N--CA 1.34 -7.519 0 C-N-CA 113.911 -3.593 . . . . 0.0 112.973 -177.619 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.676 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.48 -159.16 9.25 Favored Glycine 0 C--N 1.283 -2.385 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.87 -177.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -152.43 137.16 16.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.261 -0.469 . . . . 0.0 111.311 -178.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 t 48.58 45.01 21.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.037 177.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -65.75 -36.54 83.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.161 0.505 . . . . 0.0 109.671 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.76 -18.8 33.41 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.281 -179.143 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 t -62.68 -28.65 70.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.0 110.34 179.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.2 m -136.32 28.83 3.06 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.868 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.2 m -133.73 139.69 46.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 m -135.17 175.07 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.36 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 63.43 40.09 8.67 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.435 0.459 . . . . 0.0 111.648 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 16' ' ' GLY . 17.1 p -66.65 126.45 28.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.995 179.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.99 162.64 40.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.922 179.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -120.94 113.65 20.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.867 0.365 . . . . 0.0 111.06 -179.616 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -75.51 116.53 16.32 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.654 179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 55.29 15.35 1.32 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.901 0.75 . . . . 0.0 111.475 178.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.99 37.98 74.1 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.515 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.485 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 9.8 p80 -147.01 -30.73 0.34 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 117.396 0.598 . . . . 0.0 111.479 178.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 m -116.23 133.21 56.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.631 0.253 . . . . 0.0 111.403 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.562 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.7 tp -91.31 131.42 36.82 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.612 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.42 130.39 55.94 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.95 163.73 31.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.113 0.483 . . . . 0.0 110.817 179.277 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 t -112.94 123.67 50.85 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.1 m -123.51 154.94 38.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.15 0.5 . . . . 0.0 112.031 -178.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -99.81 150.08 22.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.072 178.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.13 -29.95 0.89 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.98 178.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.792 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.02 -38.56 70.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -175.22 52.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.252 0.549 . . . . 0.0 109.983 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.92 6.36 51.71 Favored Glycine 0 C--N 1.329 0.146 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.65 -179.108 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -123.97 170.52 10.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -110.84 164.74 12.47 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 123.448 0.467 . . . . 0.0 110.815 -179.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -155.34 150.03 26.37 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -81.02 141.23 34.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.849 0.357 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.3 p -153.01 167.52 28.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.963 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.17 162.83 30.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.962 0.41 . . . . 0.0 110.445 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.824 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 3.4 tpt -145.99 112.98 6.09 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.97 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -71.78 106.86 4.3 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 91' ' ' VAL . 15.1 mt -77.81 -8.62 58.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.265 -178.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -49.45 -29.62 6.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.244 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -116.68 20.26 14.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.49 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -125.94 -12.88 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.234 0.54 . . . . 0.0 110.031 177.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.811 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -134.5 147.39 29.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.157 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.23 171.9 23.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.005 -0.616 . . . . 0.0 111.678 179.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.421 HD21 ' HB2' ' A' ' 8' ' ' SER . 37.0 t30 -117.1 129.42 55.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.84 0.352 . . . . 0.0 110.849 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.7 m -134.42 100.31 4.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.436 178.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 61.0 44.46 10.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.558 179.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.57 29.73 70.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.167 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -128.9 148.21 50.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.693 0.282 . . . . 0.0 110.302 -179.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -62.63 119.61 9.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.167 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -143.46 79.06 14.2 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.541 178.207 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 42.9 Cg_endo -69.95 93.34 0.54 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.766 2.31 . . . . 0.0 113.174 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.501 178.988 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.8 m . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 53.68 78.18 0.16 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.554 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 4.4 p90 -56.91 -36.63 70.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.987 0.422 . . . . 0.0 111.506 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.01 -21.77 66.41 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.292 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -61.6 -18.35 59.01 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 69.7 m -145.21 29.55 1.17 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.696 0.284 . . . . 0.0 110.699 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -128.78 133.01 47.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.023 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -129.51 158.21 39.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.373 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.81 58.48 14.35 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.747 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.538 HG11 ' HA3' ' A' ' 21' ' ' GLY . 19.7 m -101.07 139.61 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.992 0.425 . . . . 0.0 111.546 -179.317 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -137.03 155.64 49.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.263 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.604 HD23 HD22 ' A' ' 64' ' ' LEU . 27.0 tp -127.78 123.66 35.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.428 . . . . 0.0 111.706 -179.29 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-85 -124.64 99.49 6.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.579 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 62' ' ' THR . . . 75.46 -63.18 2.63 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.167 -0.54 . . . . 0.0 113.077 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.443 ' HD1' HD22 ' A' ' 36' ' ' ASN . 3.9 p90 -165.27 21.93 0.05 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.0 pt -121.76 126.94 75.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.569 179.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.53 ' HB2' HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -107.82 114.64 28.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.652 -179.922 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.2 ttt180 -118.13 141.24 48.7 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.641 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.538 ' HA3' HG11 ' A' ' 12' ' ' VAL . . . -167.99 177.6 42.14 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.796 179.405 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 16.1 m-20 -101.62 107.98 19.4 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -106.09 132.84 51.68 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.7 mt -69.15 139.89 19.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.472 -178.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 96' ' ' TYR . 6.0 p30 -110.14 -173.1 2.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.632 179.534 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.85 -27.98 54.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.92 -20.35 65.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.497 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.77 4.5 69.7 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.913 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -112.72 144.62 31.35 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.791 0.329 . . . . 0.0 110.175 179.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.21 123.68 10.86 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.021 2.48 . . . . 0.0 113.002 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -115.27 132.16 56.7 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.7 127.2 31.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.39 0.614 . . . . 0.0 112.142 -178.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 t -136.05 155.2 50.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.612 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 78.0 p -138.45 132.08 30.77 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.527 -179.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.85 143.96 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 O-C-N 123.517 0.511 . . . . 0.0 110.328 -179.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.443 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -99.37 92.19 5.29 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.933 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.53 -27.09 56.65 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.63 -178.376 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.2 t-20 -53.98 -30.66 48.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.967 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -103.15 10.39 37.89 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.613 -178.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.1 m-85 -129.35 -21.09 3.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -113.84 141.34 30.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.629 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -113.58 170.91 13.54 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.629 -179.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -114.76 104.42 11.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.027 -0.587 . . . . 0.0 109.753 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -111.24 106.16 15.06 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.786 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.71 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 24.6 t30 59.2 40.06 22.07 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.121 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.82 17.09 80.25 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.559 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.58 149.82 46.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 -179.511 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.417 HD11 ' HG ' ' A' ' 70' ' ' LEU . 28.9 mt -74.99 124.24 26.6 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.352 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -112.01 139.22 47.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.598 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -43.52 -75.51 0.05 OUTLIER Pre-proline 0 CA--C 1.433 -3.536 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.497 179.949 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 2.5 Cg_endo -108.45 127.89 0.04 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.242 1 C-N-CA 113.196 -4.069 . . . . 0.0 112.779 -178.662 . . . . . . . . 4 3 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.629 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -155.16 -159.42 9.29 Favored Glycine 0 C--N 1.281 -2.514 0 CA-C-N 113.74 -1.573 . . . . 0.0 113.417 -177.629 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -151.23 147.32 26.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.917 0.389 . . . . 0.0 111.068 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.6 p 46.42 44.95 13.42 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 177.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -71.79 -38.8 70.22 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.7 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.21 -18.52 55.36 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.288 -178.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -65.26 -19.28 65.89 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.736 0.414 . . . . 0.0 110.896 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.4 m -142.16 20.76 2.09 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.006 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.5 m -126.75 144.09 51.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.601 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.457 HG23 ' HD2' ' A' ' 61' ' ' LYS . 23.2 m -136.78 173.62 13.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.734 179.315 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HD2' HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER 63.68 41.15 7.29 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.486 0.491 . . . . 0.0 110.829 179.405 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 16' ' ' GLY . 11.5 p -69.22 130.49 42.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.612 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.65 162.85 40.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.807 179.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.604 HD22 HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -121.61 112.55 18.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.596 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -85.47 122.04 29.04 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.216 -179.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.09 24.04 10.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.686 178.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.81 39.8 69.28 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.524 -0.762 . . . . 0.0 114.074 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.471 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 4.7 p80 -153.26 -28.53 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.272 0.536 . . . . 0.0 111.537 179.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 m -115.93 131.43 56.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.797 0.332 . . . . 0.0 111.461 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.586 ' HA ' HD21 ' A' ' 64' ' ' LEU . 12.7 tp -90.2 134.53 34.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 178.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.65 130.76 53.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.614 178.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.05 160.85 22.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.098 0.475 . . . . 0.0 111.464 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 13.1 t -106.62 125.06 50.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.891 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 48.5 m -125.5 149.16 48.52 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -99.25 143.3 29.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.585 178.139 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.58 -31.09 0.52 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.621 178.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.71 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -47.51 -45.42 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 179.128 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -171.89 49.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.466 0.65 . . . . 0.0 109.606 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.32 2.4 79.11 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.009 -179.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -121.91 160.35 24.97 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 51.3 p90 -101.02 160.43 14.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 -179.192 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -153.79 141.25 19.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 36.4 t70 -82.1 132.98 35.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.89 0.376 . . . . 0.0 110.693 -179.056 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.408 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 26.0 p -143.34 179.51 7.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.432 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.28 161.43 37.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.814 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.598 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 14.2 tpp -145.02 125.39 13.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.557 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 28.2 t70 -79.35 106.59 11.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.567 ' HA ' HG21 ' A' ' 91' ' ' VAL . 17.0 mt -76.61 -10.02 59.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.323 -177.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.557 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 5.9 m120 -48.51 -33.83 10.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.99 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -113.74 20.97 15.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.897 0.379 . . . . 0.0 111.326 -179.166 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.567 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -126.58 -8.66 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.549 178.575 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 1.029 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 8.9 p -153.22 138.35 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.097 0.475 . . . . 0.0 111.409 179.298 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.16 172.22 20.78 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.877 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.402 HD21 ' HB2' ' A' ' 8' ' ' SER . 18.4 t30 -113.74 116.76 29.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.33 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 58.7 m -111.65 78.53 1.13 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.829 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 25' ' ' ASN . 43.1 m-85 66.28 60.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.581 178.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.78 23.0 60.54 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.774 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -126.98 132.02 50.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.907 0.384 . . . . 0.0 110.593 -178.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -64.28 117.36 7.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.742 179.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -142.26 81.59 13.89 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 121.314 0.578 . . . . 0.0 109.889 177.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 1.029 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 58.4 Cg_endo -71.47 125.83 11.62 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.864 2.376 . . . . 0.0 112.023 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 32.0 p . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.767 -179.18 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 119.964 -0.065 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 52.32 76.96 0.17 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.839 0.352 . . . . 0.0 111.747 179.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 15.4 p90 -60.31 -41.96 94.55 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.019 0.438 . . . . 0.0 110.873 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.94 -23.91 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.99 -178.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -60.46 -29.73 69.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.168 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 8.3 m -123.36 16.4 9.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 -179.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -124.33 146.28 48.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.368 0.604 . . . . 0.0 112.029 -179.301 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.7 p -140.33 152.77 46.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.005 179.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.86 33.15 70.38 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.574 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 18.2 m -79.89 133.38 29.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.012 0.434 . . . . 0.0 111.655 -179.471 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' HD21 ' A' ' 19' ' ' LEU . 10.7 pt-20 -132.19 150.16 52.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.007 179.021 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.797 HD21 HD22 ' A' ' 64' ' ' LEU . 32.7 tp -122.01 120.71 35.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.2 0.524 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -125.1 101.02 6.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.956 179.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.01 -68.44 3.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.811 179.248 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.708 ' HD1' HD22 ' A' ' 36' ' ' ASN . 24.3 p90 -162.26 17.79 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.654 0.264 . . . . 0.0 111.294 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -121.6 131.29 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.966 0.412 . . . . 0.0 110.51 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.481 ' HB2' HD23 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -113.78 114.72 26.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.115 -179.632 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.2 ttt180 -118.12 141.68 48.23 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.734 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.28 -176.44 38.12 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.878 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -108.8 111.11 22.67 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.673 0.273 . . . . 0.0 110.907 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.3 m -106.28 133.18 51.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.8 mt -68.83 134.3 30.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.828 0.347 . . . . 0.0 110.704 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -105.5 -172.68 2.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.02 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -57.24 -25.31 58.92 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.16 -20.65 65.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.068 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.43 1.69 74.46 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.88 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -112.19 144.48 30.88 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.0 123.77 12.09 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.744 2.296 . . . . 0.0 112.445 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -109.17 130.19 55.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.671 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.24 122.89 21.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.972 0.415 . . . . 0.0 111.613 -179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.6 t -142.57 164.03 31.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 p -138.69 149.67 45.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.024 0.44 . . . . 0.0 111.288 -179.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.87 142.65 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.723 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.708 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -103.37 92.0 4.3 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.641 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.95 -29.41 63.15 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.669 -178.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -52.21 -33.88 43.12 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.875 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -102.05 16.32 26.39 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.839 -178.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -130.86 -26.47 2.19 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.52 141.55 27.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.622 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -111.9 171.53 14.26 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.312 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -113.37 109.05 18.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.996 -179.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.05 105.89 15.18 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 0.0 OUTLIER 49.32 39.12 15.32 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 122.662 1.22 . . . . 0.0 111.867 179.652 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.65 3.66 77.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.415 178.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -110.06 154.4 23.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.988 0.423 . . . . 0.0 110.888 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.5 mt -85.47 117.22 24.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.074 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.53 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.3 tt0 -106.04 128.61 53.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.018 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.654 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.55 -66.8 0.25 Allowed Pre-proline 1 CA--C 1.42 -4.05 0 O-C-N 124.117 0.885 . . . . 0.0 112.754 -179.493 . . . . . . . . 4 4 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.53 ' HD2' ' HG2' ' A' ' 49' ' ' GLU . 3.0 Cg_endo -109.6 126.4 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.313 0 C-N-CA 113.821 -3.652 . . . . 0.0 113.413 -177.708 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.622 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -165.05 -161.83 14.84 Favored Glycine 0 C--N 1.285 -2.257 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.684 -177.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.48 146.45 25.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.381 -0.41 . . . . 0.0 110.665 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.6 m 54.5 40.65 31.97 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.427 ' HD2' ' SG ' ' A' ' 59' ' ' CYS . 13.2 p90 -72.2 -34.16 68.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.49 -18.26 67.55 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.998 -179.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 m -68.89 -9.34 51.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.153 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.8 m -145.62 8.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.726 179.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' A' ' 55' ' ' PHE . 6.4 m -109.33 153.28 24.14 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.101 0.477 . . . . 0.0 111.462 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.9 m -142.22 167.41 15.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.906 178.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 63.39 33.06 14.14 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.618 0.574 . . . . 0.0 111.293 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -59.68 122.09 13.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.324 179.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.94 161.39 42.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.869 -179.513 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.797 HD22 HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -114.4 113.78 24.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.815 0.341 . . . . 0.0 111.803 -179.003 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.548 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 90.0 m-20 -73.09 116.35 13.52 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.47 20.01 2.6 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.104 0.878 . . . . 0.0 111.558 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.85 29.24 73.54 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.072 -0.513 . . . . 0.0 114.375 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -142.57 -24.48 0.65 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.913 0.856 . . . . 0.0 112.036 179.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 20.3 m -116.24 132.53 56.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.475 ' HB2' HD13 ' A' ' 88' ' ' LEU . 16.0 tp -90.77 129.63 36.83 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.2 129.29 54.03 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.312 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -163.86 163.94 23.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.067 0.46 . . . . 0.0 110.776 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.6 t -114.5 119.48 36.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.474 -0.784 . . . . 0.0 108.98 179.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -116.17 156.36 26.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.329 0.585 . . . . 0.0 111.831 -179.172 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.9 tmtt? -99.5 143.34 29.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.304 178.471 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.72 -17.81 0.66 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.445 -1.359 . . . . 0.0 114.098 178.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -63.37 -38.06 89.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.426 0.613 . . . . 0.0 110.484 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -177.25 59.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.754 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.84 16.72 66.47 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.086 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -139.31 163.36 32.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 40.8 p90 -97.6 171.62 8.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.143 -179.075 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.13 136.63 11.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.69 128.64 37.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.162 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -146.02 169.0 19.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.264 -179.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.7 164.47 30.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.905 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.5 OUTLIER -149.21 125.95 11.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.492 -179.235 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.46 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 9.0 m-20 -75.25 106.31 6.71 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.458 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.573 ' HA ' HG23 ' A' ' 91' ' ' VAL . 14.8 mt -79.11 -8.63 59.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.163 0.506 . . . . 0.0 109.687 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -49.61 -28.43 5.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.731 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.46 ' CE2' ' HB2' ' A' ' 87' ' ' ASP . 10.4 p90 -119.11 21.52 12.29 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 179.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -127.2 -16.25 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.943 0.402 . . . . 0.0 110.563 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.1 t -132.94 148.74 31.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -147.72 164.26 28.81 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.89 179.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -107.93 135.06 49.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.899 0.38 . . . . 0.0 110.638 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.0 m -140.14 96.51 3.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.713 178.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 62.03 45.96 6.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.675 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 56.51 29.76 57.9 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.773 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -127.08 147.11 50.17 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.844 0.354 . . . . 0.0 110.665 -178.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.0 103.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.475 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -137.96 67.1 48.63 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.426 179.008 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 28.3 Cg_endo -62.72 114.41 2.39 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 123.32 2.68 . . . . 0.0 112.838 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.042 179.197 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 ttm . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 58.12 -159.23 0.27 Allowed 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.325 0.391 . . . . 0.0 110.398 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.5 m -108.53 -64.09 1.26 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 52.78 71.17 0.5 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.375 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CD1' HG12 ' A' ' 92' ' ' VAL . 2.7 p90 -54.02 -36.76 63.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.264 0.554 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.14 -21.61 33.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -62.74 -27.78 69.52 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.459 ' HB2' HD21 ' A' ' 94' ' ' ASN . 26.7 m -134.62 16.7 3.63 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.049 0.452 . . . . 0.0 110.774 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.5 m -117.48 133.04 56.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.129 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -130.84 152.71 49.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.717 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.22 61.65 6.15 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.095 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 m -95.08 131.3 42.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.393 0.616 . . . . 0.0 111.898 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -124.59 157.44 35.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.099 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.586 HD22 HD23 ' A' ' 64' ' ' LEU . 14.2 tp -139.82 121.66 15.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.501 . . . . 0.0 111.295 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.42 102.17 6.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.98 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.7 -60.67 3.71 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.965 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -170.81 26.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 122.875 0.47 . . . . 0.0 110.38 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 15.2 mt -119.23 113.61 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.08 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -99.2 114.24 26.93 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -124.22 142.78 50.96 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.486 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.42 -179.27 41.19 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.401 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -103.59 107.69 18.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 79.8 m -107.62 132.77 52.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.013 0.435 . . . . 0.0 110.025 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.1 mt -72.78 137.21 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.575 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -102.41 -169.09 1.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.028 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -62.83 -26.31 68.68 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 111.598 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.21 -23.26 64.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.296 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.45 5.92 58.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.351 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -110.43 142.16 25.47 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.678 0.275 . . . . 0.0 110.624 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -69.51 122.15 8.9 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.819 2.346 . . . . 0.0 111.979 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -111.71 131.03 55.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.75 120.85 17.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.157 0.503 . . . . 0.0 111.104 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 t -136.69 152.75 50.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.122 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.7 p -131.22 148.22 52.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.472 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.04 145.53 34.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.463 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -101.95 98.75 8.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.163 0.506 . . . . 0.0 110.121 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.5 mm? -60.38 -26.81 66.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.64 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.02 -24.91 57.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.756 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -106.83 7.22 30.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 60.0 m-85 -128.68 -16.37 4.26 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.08 144.24 27.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.669 0.271 . . . . 0.0 110.974 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.565 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -117.79 179.26 17.18 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.138 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.526 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 19.1 p-10 -131.76 102.22 5.79 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.809 0.814 . . . . 0.0 110.618 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -105.27 121.85 44.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.068 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.806 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 53.6 t30 60.13 32.38 20.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.207 0.527 . . . . 0.0 110.171 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.01 21.31 79.97 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.043 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -121.84 157.52 30.93 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 86' ' ' MET . 33.4 mt -82.11 115.69 21.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.203 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HG2' ' C ' ' A' ' 42' ' ' GLY . 10.2 pt-20 -103.24 143.42 32.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.5 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -46.38 -74.06 0.08 OUTLIER Pre-proline 0 CA--C 1.431 -3.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.835 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 50' ' ' TYR . 13.1 Cg_endo -110.24 124.28 0.03 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.393 0 C-N-CA 113.794 -3.671 . . . . 0.0 113.122 -177.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.565 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -150.32 -160.88 9.56 Favored Glycine 0 C--N 1.278 -2.648 0 CA-C-N 113.429 -1.714 . . . . 0.0 113.284 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.486 ' C ' ' HG ' ' A' ' 54' ' ' SER . 33.2 mt-10 -149.6 139.85 22.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.411 -0.395 . . . . 0.0 110.728 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.486 ' HG ' ' C ' ' A' ' 53' ' ' GLU . 45.6 p 48.3 52.23 13.77 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.296 1.038 . . . . 0.0 113.569 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -75.69 -39.55 57.28 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -18.71 53.49 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.576 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.3 m -68.65 -22.72 64.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.291 -0.454 . . . . 0.0 110.728 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.2 m -135.02 22.42 3.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.7 m -131.92 145.38 51.47 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.63 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 m -134.13 169.98 20.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.107 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 66.43 37.09 4.83 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.404 0.44 . . . . 0.0 110.834 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.7 117.36 8.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.54 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.09 161.32 42.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.255 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -112.13 124.0 51.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.869 0.366 . . . . 0.0 110.813 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.424 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 2.7 t30 -95.53 127.28 41.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.833 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 52.41 24.27 2.88 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.972 0.795 . . . . 0.0 112.249 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.33 38.5 79.05 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.859 -0.61 . . . . 0.0 114.1 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.424 ' HD2' ' O ' ' A' ' 65' ' ' ASN . 1.3 p80 -153.46 -27.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.52 0.66 . . . . 0.0 111.798 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.4 m -115.74 130.3 56.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.697 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.603 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.2 tp -90.65 138.95 31.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.9 132.95 52.05 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.68 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.422 ' HB3' HD22 ' A' ' 48' ' ' LEU . . . -164.58 159.89 19.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.128 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 t -107.53 122.94 47.67 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 30.8 m -124.75 154.91 40.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -97.5 146.25 25.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.428 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.94 -31.18 0.74 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.919 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.806 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -52.91 -42.53 65.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -174.39 55.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.75 11.23 59.96 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.446 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -130.51 161.24 31.91 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 50.5 p90 -96.1 168.58 10.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.401 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.08 136.41 9.9 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.2 126.93 31.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.951 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -140.81 171.82 13.55 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.124 0.487 . . . . 0.0 111.072 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.78 158.22 44.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.419 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.872 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.7 OUTLIER -141.83 122.92 14.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.679 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.75 105.66 5.15 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HA ' HG22 ' A' ' 91' ' ' VAL . 21.0 mt -75.55 -8.97 58.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.025 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -47.55 -29.75 3.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.166 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -118.37 21.32 12.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.977 0.418 . . . . 0.0 111.18 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 1.1 m -129.43 -9.63 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.752 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.88 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 14.5 p -152.58 143.73 15.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.41 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.77 169.69 27.87 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.135 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.459 HD21 ' HB2' ' A' ' 8' ' ' SER . 28.2 t30 -100.15 131.06 46.32 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.9 m -138.59 95.04 2.92 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.572 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 62.9 44.88 5.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.441 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.0 23.21 56.79 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.38 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -123.12 140.11 53.36 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -56.17 112.09 1.13 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.85 0.719 . . . . 0.0 111.336 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -137.68 77.62 38.86 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.104 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.88 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 58.1 Cg_endo -74.42 93.96 0.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.428 2.085 . . . . 0.0 112.228 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.84 111.51 23.22 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.097 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -88.76 149.77 23.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.914 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.67 56.04 0.63 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.013 0.435 . . . . 0.0 110.511 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.2 t -177.38 -117.72 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.352 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.413 HD21 ' HA ' ' A' ' 106' ' ' ASN . 1.6 t-20 54.23 57.43 5.9 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.706 0.802 . . . . 0.0 111.155 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.8 -171.84 3.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.923 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 109' ' ' HIS . 4.8 p-10 37.35 -102.51 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.127 0.971 . . . . 0.0 112.568 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.447 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 4.4 t60 -160.54 -67.49 0.07 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.4 m -104.12 75.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 122.035 0.921 . . . . 0.0 110.824 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.675 ' H ' HD22 ' A' ' 111' ' ' LEU . 2.5 pt? -77.08 -0.78 26.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.842 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 80.4 tttt -88.16 13.53 11.14 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.274 1.035 . . . . 0.0 110.134 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.5 t 50.3 51.83 15.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.635 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.0 m -118.18 102.48 9.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.911 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.7 t -67.43 -35.95 80.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.35 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.403 -179.189 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 67.0 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 110.781 -0.081 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.4 mp0 71.76 137.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.596 0.712 . . . . 0.0 111.071 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.5 m -86.33 -74.92 0.4 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.178 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 41.49 73.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.573 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.7 p90 -54.76 -39.76 68.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.981 0.419 . . . . 0.0 111.33 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.91 -22.94 41.29 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.53 -20.73 61.29 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.438 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 m -129.97 11.54 5.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.911 0.386 . . . . 0.0 110.928 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.2 m -120.14 132.9 55.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -127.07 160.23 31.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.65 45.34 90.62 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.741 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -87.09 123.94 40.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.449 0.642 . . . . 0.0 111.594 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 47.3 mt-10 -121.61 142.43 50.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.534 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.771 HD21 HD21 ' A' ' 64' ' ' LEU . 17.2 tp -117.83 112.31 20.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.952 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -133.83 104.92 6.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.077 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.36 51.54 21.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.771 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD1' HG22 ' A' ' 62' ' ' THR . 7.7 m-85 63.81 16.18 9.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.214 0.605 . . . . 0.0 111.57 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 20.9 mt -116.38 116.3 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 120.659 0.266 . . . . 0.0 110.534 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.498 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 mt -103.13 114.43 28.71 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -121.07 145.05 48.2 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.79 -175.23 40.54 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.284 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -109.07 110.41 21.66 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.894 0.378 . . . . 0.0 110.263 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.9 m -107.4 132.56 53.04 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.88 134.75 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.227 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.69 -174.24 2.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 96' ' ' TYR . 7.4 tp10 -49.43 -40.04 35.16 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.489 0.493 . . . . 0.0 111.52 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -57.96 -26.14 61.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.303 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.44 -0.44 58.35 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.712 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -106.77 146.08 32.37 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.886 0.374 . . . . 0.0 110.889 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.62 122.16 9.11 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.136 2.557 . . . . 0.0 112.266 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -109.89 127.37 54.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.594 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.65 125.36 25.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.169 0.509 . . . . 0.0 111.475 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 t -143.56 158.85 43.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.342 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 p -139.63 147.0 40.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.857 0.36 . . . . 0.0 111.254 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 mp -130.9 143.44 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.29 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -104.31 95.3 5.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -59.11 -19.81 47.91 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.806 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.572 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 21.7 t-20 -54.84 -32.57 60.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.928 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -106.42 16.44 24.71 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.489 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -127.91 -23.45 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.72 144.0 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.625 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -116.53 171.76 13.92 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.881 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -107.28 112.9 25.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.959 0.409 . . . . 0.0 111.222 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -110.61 105.09 13.88 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.469 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 2.7 p-10 42.19 44.82 3.36 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.822 1.249 . . . . 0.0 112.806 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.401 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 87.11 7.72 76.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.405 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.85 160.85 20.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.987 0.422 . . . . 0.0 110.83 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 72' ' ' ALA . 31.2 mt -84.05 115.76 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.114 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -103.13 126.06 50.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.586 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.588 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -35.25 -71.28 0.11 Allowed Pre-proline 0 CA--C 1.429 -3.702 0 O-C-N 124.49 1.119 . . . . 0.0 113.736 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.511 ' HB2' HD21 ' A' ' 106' ' ' ASN . 10.1 Cg_endo -110.75 120.96 0.02 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.436 0 C-N-CA 113.776 -3.682 . . . . 0.0 113.097 -178.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.625 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -152.45 -161.73 10.42 Favored Glycine 0 C--N 1.274 -2.871 0 CA-C-N 113.541 -1.663 . . . . 0.0 113.211 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.69 141.94 17.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.996 0.468 . . . . 0.0 110.458 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.2 m 58.66 36.69 25.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.801 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.572 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 5.3 p90 -69.18 -33.48 73.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.23 -18.78 58.57 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.396 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.5 m -67.19 -14.05 62.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.83 0.347 . . . . 0.0 110.774 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.9 p -146.26 20.53 1.38 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.1 m -133.15 139.19 46.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.773 0.321 . . . . 0.0 111.194 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 m -134.16 177.63 6.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.167 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.9 mptt 59.84 44.08 14.28 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.406 0.441 . . . . 0.0 111.136 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.474 HG22 ' CD1' ' A' ' 17' ' ' TYR . 30.6 p -75.75 125.78 29.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 111.358 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.65 162.57 39.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.574 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.771 HD21 HD21 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -118.59 116.99 27.77 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.626 0.251 . . . . 0.0 111.039 -179.06 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -93.19 127.47 38.77 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.639 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 t70 54.0 23.31 3.92 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.914 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.48 28.66 67.8 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.22 -18.09 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 117.899 0.85 . . . . 0.0 112.334 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.0 m -116.38 127.42 54.63 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.749 0.309 . . . . 0.0 111.245 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.527 ' HA ' HD23 ' A' ' 64' ' ' LEU . 14.3 tp -90.03 136.85 32.79 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.56 130.4 50.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.162 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.447 ' HB3' HD22 ' A' ' 48' ' ' LEU . . . -161.44 167.14 26.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.105 0.478 . . . . 0.0 110.713 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 t -116.75 122.02 43.27 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.401 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.4 m -121.51 149.64 42.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 0.0 112.108 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -99.88 146.73 26.31 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.05 -22.79 0.78 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.558 -1.306 . . . . 0.0 113.473 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 45' ' ' ASN . . . -60.89 -40.64 93.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.716 0.293 . . . . 0.0 111.208 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -176.61 57.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.392 0.615 . . . . 0.0 110.08 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.84 0.14 40.13 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.811 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -122.53 163.6 19.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 40.9 p90 -112.45 167.19 10.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.844 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.53 152.76 27.71 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.78 129.45 37.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.231 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.1 t -142.06 166.53 24.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.516 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.86 163.17 32.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.885 ' HE1' ' HA ' ' A' ' 86' ' ' MET . 1.3 tpt -144.73 121.49 11.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.674 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -75.31 105.55 6.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.558 ' HA ' HG23 ' A' ' 91' ' ' VAL . 18.0 mt -74.76 -8.64 57.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.522 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -46.86 -30.1 2.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.222 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -120.83 23.6 10.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 111.348 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.4 m -127.08 -9.28 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.081 0.467 . . . . 0.0 110.472 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.842 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.7 p -156.28 138.34 6.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.858 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.76 177.44 19.07 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.065 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -109.83 123.42 49.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.626 0.25 . . . . 0.0 110.559 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 t -127.57 101.15 6.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 26' ' ' GLU . 98.0 m-85 57.98 47.62 14.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.5 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 58.9 25.22 59.0 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.034 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -129.82 148.93 51.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.813 0.34 . . . . 0.0 110.088 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -58.69 118.94 6.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.66 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -143.9 77.9 14.43 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.958 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.842 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 57.6 Cg_endo -74.69 93.85 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.542 2.161 . . . . 0.0 112.675 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.78 112.32 24.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.182 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -86.88 144.94 26.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.126 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.42 42.15 1.17 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.215 0.531 . . . . 0.0 110.41 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.4 t -166.32 -121.12 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.578 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.511 HD21 ' HB2' ' A' ' 51' ' ' PRO . 9.3 t-20 70.27 19.98 6.36 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.864 0.866 . . . . 0.0 110.001 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.37 115.51 14.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.765 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.22 -163.2 1.73 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -69.87 -59.17 3.1 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.9 p -104.82 52.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 122.862 1.315 . . . . 0.0 109.404 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.3 tp -156.2 90.85 1.22 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.584 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -106.48 128.98 54.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.241 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -72.04 57.17 0.33 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.471 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.8 m -152.67 124.89 8.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.76 0.315 . . . . 0.0 110.304 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.0 m -80.54 -23.73 39.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.459 0.647 . . . . 0.0 109.895 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.373 -179.33 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 62.99 -172.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.419 0.688 . . . . 0.0 111.42 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 62.1 m -127.64 -66.59 0.87 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.055 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 53.15 68.39 0.85 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.503 ' CD1' ' HB ' ' A' ' 92' ' ' VAL . 10.9 p90 -55.02 -45.99 75.18 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.163 0.506 . . . . 0.0 111.123 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.21 -22.08 62.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.87 -20.48 66.25 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.612 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 m -135.69 25.26 3.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.915 0.388 . . . . 0.0 110.946 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.0 m -134.1 132.95 40.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.051 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 p -134.46 165.11 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.611 0.243 . . . . 0.0 110.867 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.12 98.37 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.185 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.429 ' HB ' ' CD1' ' A' ' 19' ' ' LEU . 35.8 m -83.17 139.81 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.304 0.574 . . . . 0.0 111.848 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.09 148.46 52.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.545 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.507 HD23 HD21 ' A' ' 64' ' ' LEU . 14.5 tp -132.21 117.38 18.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.023 0.439 . . . . 0.0 111.155 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.41 109.99 12.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.462 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.04 -68.91 2.78 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.366 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 17.5 p90 -170.45 28.94 0.02 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.326 0.584 . . . . 0.0 110.387 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 mt -121.2 115.64 47.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.643 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -96.99 113.7 25.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.265 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -124.44 139.38 53.95 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.129 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.45 -170.9 33.71 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.269 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -108.25 111.01 22.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.931 0.396 . . . . 0.0 110.278 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.4 m -107.52 132.09 53.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.01 141.82 16.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.678 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -108.92 -171.46 1.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.78 -33.82 64.71 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -64.46 -24.69 67.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.909 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.0 6.98 57.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.623 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -111.55 144.78 31.26 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.44 133.64 28.67 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.864 2.376 . . . . 0.0 112.166 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -118.07 133.24 56.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.378 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.75 122.89 19.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.005 0.431 . . . . 0.0 111.282 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 t -142.17 159.08 42.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.021 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.7 p -140.39 146.02 37.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.83 146.08 33.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.329 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -102.2 96.29 6.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.009 0.433 . . . . 0.0 110.07 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.506 HD21 HD21 ' A' ' 19' ' ' LEU . 1.1 mm? -59.32 -26.54 65.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.311 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 25.9 t-20 -55.0 -28.95 55.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.054 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -103.34 6.04 37.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -125.25 -19.84 5.0 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.264 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 mt -117.3 143.59 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.801 0.334 . . . . 0.0 110.805 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -119.47 176.29 16.07 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.219 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -127.27 112.76 15.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.735 0.779 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -110.6 115.0 28.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.342 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.801 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 56.3 t30 59.4 38.36 22.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.286 0.565 . . . . 0.0 110.476 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.12 12.09 84.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.195 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -118.45 151.43 37.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.872 0.368 . . . . 0.0 110.797 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.8 mp -76.96 129.39 36.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.599 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -121.87 132.92 54.83 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.231 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.559 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -37.94 -66.4 0.3 Allowed Pre-proline 0 CA--C 1.423 -3.924 0 O-C-N 124.216 0.948 . . . . 0.0 113.186 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -109.94 129.29 0.04 OUTLIER 'Trans proline' 1 N--CA 1.34 -7.509 0 C-N-CA 113.742 -3.706 . . . . 0.0 113.064 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -163.44 -162.85 14.95 Favored Glycine 0 C--N 1.283 -2.38 0 CA-C-N 114.012 -1.449 . . . . 0.0 113.403 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -150.58 142.94 24.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.935 0.398 . . . . 0.0 110.743 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.8 p 50.83 49.25 21.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.552 1.141 . . . . 0.0 113.585 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.439 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 11.1 p90 -73.91 -43.97 56.71 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.66 -19.01 47.39 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.893 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 m -66.5 -16.02 63.81 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.041 0.448 . . . . 0.0 110.889 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 m -146.55 28.74 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.466 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 55' ' ' PHE . 62.9 m -133.66 149.58 51.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.595 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.69 173.13 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.812 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.22 39.31 9.81 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.062 0.545 . . . . 0.0 111.524 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.442 ' HB ' HD22 ' A' ' 14' ' ' LEU . 22.3 p -66.29 120.6 13.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.335 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.67 156.49 40.48 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.555 HD23 ' HA ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -113.79 112.0 22.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.889 0.376 . . . . 0.0 111.766 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.48 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 6.2 m-20 -73.75 117.48 15.58 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.44 23.58 7.6 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.733 0.646 . . . . 0.0 110.701 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.85 28.46 65.9 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.024 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -139.58 -28.02 0.77 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.707 0.754 . . . . 0.0 111.544 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 22.2 m -110.72 126.16 54.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.707 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.675 ' HB2' HD11 ' A' ' 88' ' ' LEU . 19.3 tp -90.3 127.92 36.29 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.743 -0.383 . . . . 0.0 109.99 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.26 129.62 56.03 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.981 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.57 154.33 18.31 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.678 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 28.0 t -102.41 123.01 45.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 59.8 m -120.2 153.02 36.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.0 111.9 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 10.5 tmtt? -98.77 142.31 30.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.449 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.49 -32.74 0.53 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.278 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.801 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -54.33 -39.68 67.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -169.29 48.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.351 0.596 . . . . 0.0 109.524 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.31 6.48 47.91 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.296 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 28.5 pt20 -128.17 168.11 15.87 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 41.5 p90 -88.26 167.76 13.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.344 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.2 OUTLIER -155.29 129.55 8.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.531 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -70.6 114.7 8.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.674 0.273 . . . . 0.0 110.753 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.7 t -129.49 160.62 32.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.076 0.465 . . . . 0.0 111.238 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.87 165.04 21.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.051 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.957 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 1.7 tpt -152.85 124.83 7.95 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.869 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -76.43 107.05 8.42 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 70' ' ' LEU . 15.6 mt -78.42 -8.17 58.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.649 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -49.78 -28.62 6.5 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.276 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 45.1 p90 -116.37 21.31 13.66 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.242 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -129.18 -11.21 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.1 t -134.7 145.51 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.15 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.95 166.44 25.4 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -130.85 132.64 45.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 111.319 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.412 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 3.6 m -140.39 113.14 8.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.515 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 59.99 42.67 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.477 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.25 22.03 62.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.449 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -123.55 137.6 54.73 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 127.05 31.57 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.574 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -145.57 68.68 13.39 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 121.75 0.786 . . . . 0.0 109.415 177.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 13.1 Cg_endo -54.68 115.12 2.19 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.539 2.826 . . . . 0.0 113.19 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p -122.35 128.68 51.3 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.705 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -111.51 150.14 30.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.426 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.47 50.2 0.86 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.124 0.488 . . . . 0.0 110.58 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.1 t -165.29 -151.64 0.15 Allowed 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 63.3 23.1 13.64 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.063 0.945 . . . . 0.0 110.184 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -173.41 -49.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.936 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.32 163.24 13.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.306 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 22.6 t60 69.03 162.35 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.619 0.768 . . . . 0.0 110.822 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.4 t -107.62 95.5 3.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.996 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mp -83.22 68.61 9.69 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 0.0 109.443 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 15.9 tttm -144.08 33.71 1.23 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.013 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.8 t 57.53 27.21 13.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.359 0.6 . . . . 0.0 109.947 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 t -144.36 143.16 30.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.815 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.3 m -80.08 -31.15 39.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.041 0.448 . . . . 0.0 110.166 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.494 179.598 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 pm0 -83.87 130.01 34.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 59.7 m -123.66 -63.25 1.24 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.558 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 p30 33.04 78.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 2.8 p90 -60.14 -31.86 70.48 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.932 0.396 . . . . 0.0 111.76 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.73 -23.14 66.68 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -70.33 -7.46 42.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.285 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.4 m -145.15 27.01 1.3 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.071 0.462 . . . . 0.0 110.412 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -133.36 147.7 51.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.47 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -140.06 148.18 41.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.654 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.81 59.24 10.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.234 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' HB ' ' CD1' ' A' ' 19' ' ' LEU . 18.2 m -95.24 133.22 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.106 0.479 . . . . 0.0 110.618 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -128.36 142.4 51.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.501 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.634 HD21 HD21 ' A' ' 64' ' ' LEU . 12.7 tp -107.45 112.86 25.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.097 0.475 . . . . 0.0 110.759 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.458 ' O ' HG12 ' A' ' 18' ' ' ILE . 54.8 m-85 -105.17 97.81 7.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.803 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.78 -64.18 0.47 Allowed Glycine 0 CA--C 1.523 0.594 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.549 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.604 ' HD1' HD22 ' A' ' 36' ' ' ASN . 7.9 p90 -158.23 16.67 0.22 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.779 0.432 . . . . 0.0 111.38 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.0 pt -122.63 132.26 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 0.0 110.305 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.532 ' HB2' HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -104.18 114.4 28.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.816 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -117.75 136.82 53.12 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.51 -179.24 38.51 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.385 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -101.71 104.88 15.72 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -105.36 132.13 51.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.998 0.427 . . . . 0.0 110.106 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.6 mt -75.25 132.75 32.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.192 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -101.6 -171.65 2.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.929 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -55.85 -29.93 60.66 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.7 -22.56 66.97 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.053 0.454 . . . . 0.0 111.696 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.58 6.92 65.46 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.459 -0.876 . . . . 0.0 111.293 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -112.86 142.89 28.02 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.542 -0.329 . . . . 0.0 110.354 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.94 121.9 8.54 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.819 2.346 . . . . 0.0 112.131 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -111.92 127.48 55.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.5 124.44 22.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.166 0.508 . . . . 0.0 111.326 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -136.96 159.51 41.67 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.419 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 p -140.05 140.74 36.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.49 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.1 146.87 30.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.414 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.604 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -101.86 94.62 5.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -59.86 -26.62 66.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.631 0.253 . . . . 0.0 111.461 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.516 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 27.9 t30 -60.37 -16.48 35.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -109.68 6.82 24.05 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.135 -0.353 . . . . 0.0 110.849 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -127.56 -23.95 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 mp -113.56 142.45 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.535 ' N ' ' HA3' ' A' ' 52' ' ' GLY . . . -117.16 173.9 14.95 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.005 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -110.14 103.23 11.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.829 0.347 . . . . 0.0 110.51 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -112.42 107.86 16.8 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.371 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.832 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 58.0 t30 59.73 39.05 21.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.243 0.544 . . . . 0.0 110.412 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.497 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 72.57 21.66 79.41 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.71 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -125.94 150.35 48.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.506 0.194 . . . . 0.0 111.358 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.77 114.69 11.18 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.566 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 39.4 tt0 -108.54 123.75 49.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.512 0.672 . . . . 0.0 110.305 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.548 ' HD1' ' SD ' ' A' ' 86' ' ' MET 0.251 0.2 OUTLIER -36.66 -57.73 1.15 Allowed Pre-proline 0 CA--C 1.423 -3.912 0 CA-C-N 113.503 -1.68 . . . . 0.0 115.164 -178.691 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.566 ' HD2' ' HG2' ' A' ' 49' ' ' GLU . 17.2 Cg_endo -117.08 109.23 0.01 OUTLIER 'Trans proline' 1 N--CA 1.348 -7.083 0 C-N-CA 113.471 -3.886 . . . . 0.0 113.12 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.535 ' HA3' ' N ' ' A' ' 42' ' ' GLY . . . -148.43 -164.63 11.55 Favored Glycine 0 C--N 1.271 -3.066 0 CA-C-N 112.988 -1.915 . . . . 0.0 113.851 -176.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -151.79 142.2 22.52 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.629 0.372 . . . . 0.0 110.309 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.4 m 53.67 54.39 10.01 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 19.4 p90 -78.95 -32.99 45.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.63 -19.23 54.13 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.935 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.2 m -65.08 -18.93 65.72 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.98 0.512 . . . . 0.0 111.432 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.3 m -144.83 14.32 1.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.816 0.341 . . . . 0.0 111.193 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.4 m -121.45 139.4 53.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.33 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.72 175.85 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.063 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.5 OUTLIER 58.42 43.8 19.16 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.604 0.565 . . . . 0.0 111.135 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 p -66.17 132.72 49.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.774 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.61 163.33 40.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.817 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.634 HD21 HD21 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -121.11 113.39 19.96 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.099 0.476 . . . . 0.0 110.518 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.65 120.15 25.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.612 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 54.04 30.75 12.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.901 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 51.33 36.64 37.7 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.442 -0.799 . . . . 0.0 114.644 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -150.76 -29.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.768 0.784 . . . . 0.0 111.415 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 m -113.02 130.73 56.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.27 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.582 ' HB2' HD12 ' A' ' 88' ' ' LEU . 13.2 tp -89.98 128.34 36.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.89 129.24 55.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.576 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.21 170.11 21.85 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.775 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 t -113.81 116.92 30.11 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.497 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.7 m -116.71 148.5 41.02 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.12 0.486 . . . . 0.0 111.859 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.8 tmtt? -100.2 142.62 31.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.232 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.07 -31.03 0.54 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.329 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.832 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.09 -41.28 64.78 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -172.13 52.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.525 0.679 . . . . 0.0 110.182 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.16 -0.28 32.13 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.852 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -119.7 162.92 18.2 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 24.2 p90 -91.03 165.98 13.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.07 127.58 7.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.644 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -67.19 123.03 19.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.787 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 p -142.88 176.07 9.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.349 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.28 160.49 40.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.121 0.486 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.899 ' HE1' ' HA ' ' A' ' 86' ' ' MET . 1.5 tpt -143.91 124.84 14.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.009 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -78.29 106.77 10.43 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.542 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 70' ' ' LEU . 16.1 mt -77.36 -8.93 58.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.987 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -49.37 -27.75 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.334 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -118.62 20.02 13.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.508 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 88' ' ' LEU . 2.0 m -125.22 -13.03 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.958 0.409 . . . . 0.0 110.651 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.879 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 6.9 p -147.26 136.37 16.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.789 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.17 173.89 20.85 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.47 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -111.93 124.57 52.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.4 m -133.07 103.4 6.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.75 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 63.84 41.42 6.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.24 28.28 66.61 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.883 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -125.55 147.19 49.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.897 0.38 . . . . 0.0 110.858 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.5 ptm -64.2 103.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.887 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -132.83 80.32 61.34 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.177 0.513 . . . . 0.0 110.48 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.879 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 65.6 Cg_endo -74.3 125.28 9.59 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.696 2.264 . . . . 0.0 112.148 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.37 125.35 25.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.372 0.606 . . . . 0.0 111.52 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.49 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -113.53 150.43 32.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.859 179.31 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.85 50.88 0.84 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.094 0.474 . . . . 0.0 110.483 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.2 t -160.64 -142.41 0.08 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 17.6 t-20 59.05 79.09 0.23 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.777 0.831 . . . . 0.0 111.022 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.56 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . . . -140.51 175.72 9.37 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.621 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.63 -57.45 10.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.925 0.393 . . . . 0.0 111.301 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -111.82 -18.74 12.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.44 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 107' ' ' ALA . 19.3 t -86.36 66.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.858 0.837 . . . . 0.0 109.605 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 53.3 tp -135.36 95.92 3.37 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.069 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -64.89 110.44 2.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.454 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.2 p -68.65 106.48 2.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.544 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -137.3 52.6 1.9 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.11 0.481 . . . . 0.0 111.646 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -67.21 -48.9 66.49 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 C--O 1.248 1.015 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.62 178.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 2' ' ' GLN . 15.9 mm-40 66.83 114.7 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.749 0.785 . . . . 0.0 111.593 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 99.7 m -87.78 -63.63 1.27 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.282 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 43.04 70.2 0.32 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.945 0.778 . . . . 0.0 113.071 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 11.7 p90 -53.25 -34.16 56.02 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.331 0.586 . . . . 0.0 110.402 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.86 -23.29 67.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.349 -0.842 . . . . 0.0 113.002 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -62.06 -27.48 68.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.632 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.7 m -129.88 15.91 5.78 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.525 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -117.53 139.89 50.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.371 0.605 . . . . 0.0 111.651 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -137.82 154.48 49.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.199 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.79 60.51 7.99 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.358 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 31.6 m -94.14 139.91 17.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.075 0.464 . . . . 0.0 111.532 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -131.32 148.74 52.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.13 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.689 HD22 HD21 ' A' ' 64' ' ' LEU . 14.9 tp -133.41 119.19 19.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.992 0.425 . . . . 0.0 110.974 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.473 ' O ' HG12 ' A' ' 18' ' ' ILE . 67.6 t80 -127.09 101.32 6.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.202 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.23 -63.08 3.65 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.625 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.642 ' HD1' HD22 ' A' ' 36' ' ' ASN . 8.3 p90 -167.82 20.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.585 0.231 . . . . 0.0 111.602 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 15' ' ' TYR . 35.8 pt -116.25 126.08 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.523 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -111.3 114.74 28.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.263 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 17.8 ttm180 -116.98 138.43 51.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.53 168.12 35.93 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.778 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 9.7 m-20 -101.66 109.56 21.37 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -106.91 133.41 51.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.933 0.396 . . . . 0.0 110.426 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.5 mt -67.85 139.57 20.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.378 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -112.49 -168.1 1.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.567 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -56.18 -33.94 65.74 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.689 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.88 -28.62 67.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.597 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.14 -3.77 58.48 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.596 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -107.3 144.67 29.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.9 128.27 20.45 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.387 2.725 . . . . 0.0 112.795 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -114.75 131.5 56.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.095 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.02 127.29 30.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.271 0.558 . . . . 0.0 111.75 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 t -142.34 159.31 42.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.479 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.6 p -139.69 150.55 45.0 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.351 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -134.63 143.11 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.979 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.642 HD22 ' HD1' ' A' ' 17' ' ' TYR . 1.8 t-20 -100.82 97.03 7.7 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.5 mm? -59.42 -22.55 61.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.383 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -55.11 -28.76 54.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.125 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -108.18 11.54 27.37 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.909 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.409 ' C ' HD12 ' A' ' 41' ' ' ILE . 43.9 m-85 -129.09 -6.91 4.89 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 2.5 mp -129.06 133.74 65.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.64 176.42 18.22 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.391 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -115.38 101.63 9.09 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.983 0.42 . . . . 0.0 109.982 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.78 107.18 16.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.331 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.512 ' CG ' ' HA ' ' A' ' 77' ' ' ALA . 13.7 t-20 56.53 45.2 22.8 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.553 0.692 . . . . 0.0 110.471 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.95 19.8 75.64 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.828 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 149.01 47.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.982 0.42 . . . . 0.0 111.359 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.516 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 8.5 mp -72.45 122.47 21.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.714 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.617 ' HG2' ' CD ' ' A' ' 51' ' ' PRO . 24.7 tt0 -111.57 124.27 51.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 110.68 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.559 ' HH ' HD12 ' A' ' 111' ' ' LEU . 34.2 p90 -46.55 -28.2 0.68 Allowed Pre-proline 0 CA--C 1.452 -2.817 0 N-CA-C 119.107 3.003 . . . . 0.0 119.107 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.617 ' CD ' ' HG2' ' A' ' 49' ' ' GLU . 6.8 Cg_endo -127.04 5.97 0.01 OUTLIER 'Trans proline' 1 N--CA 1.391 -4.545 1 C-N-CA 112.76 -4.36 . . . . 0.0 116.392 178.82 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.534 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -56.24 -175.11 0.21 Allowed Glycine 0 C--N 1.265 -3.386 0 CA-C-N 111.099 -2.773 . . . . 0.0 115.903 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -147.81 144.09 27.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.942 0.401 . . . . 0.0 111.302 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.2 t 65.76 43.53 3.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.561 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -74.5 -37.51 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.771 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.98 -18.97 20.72 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.567 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 t -63.05 -22.38 66.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.786 0.327 . . . . 0.0 110.92 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 m -143.48 19.12 1.87 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.608 0.242 . . . . 0.0 111.136 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.6 m -124.54 140.58 52.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 0.0 111.091 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.38 176.02 7.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.143 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 60.89 46.57 8.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 123.752 0.658 . . . . 0.0 111.028 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.487 ' HB ' HD21 ' A' ' 14' ' ' LEU . 36.5 p -73.07 126.98 31.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.262 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.4 153.99 34.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.689 HD21 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -109.95 113.21 25.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.816 0.341 . . . . 0.0 111.083 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.2 117.39 20.17 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.298 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 t70 51.53 35.51 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.489 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.422 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 52.28 35.59 43.29 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.106 -0.952 . . . . 0.0 115.373 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.0 -25.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.024 0.912 . . . . 0.0 112.33 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.6 m -117.34 129.94 56.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.702 0.287 . . . . 0.0 111.433 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.577 ' HB2' HD13 ' A' ' 88' ' ' LEU . 20.1 tp -90.62 132.88 35.49 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.02 129.83 51.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.655 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.468 ' HB2' HD12 ' A' ' 48' ' ' LEU . . . -161.3 169.43 22.11 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.539 0.524 . . . . 0.0 110.849 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.9 t -114.63 125.26 53.55 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 35.4 m -125.17 151.86 45.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -98.78 140.34 33.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.615 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.63 -32.01 0.48 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.5 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.512 ' HA ' ' CG ' ' A' ' 45' ' ' ASN . . . -50.83 -42.61 58.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -169.84 53.23 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.247 0.546 . . . . 0.0 110.015 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.9 1.79 49.09 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.423 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -125.27 165.53 18.16 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 40.3 p90 -95.19 161.04 14.27 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 123.618 0.574 . . . . 0.0 110.616 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -155.43 140.48 17.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -72.74 135.63 45.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.466 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.9 p -150.54 174.68 12.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.137 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.14 164.18 30.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.886 0.374 . . . . 0.0 110.373 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.791 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 3.2 tpt -147.01 122.1 10.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.225 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.68 106.4 4.07 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.577 HD13 ' HB2' ' A' ' 70' ' ' LEU . 21.4 mt -78.56 -8.35 58.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.135 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -47.12 -32.12 3.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.999 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -117.7 21.91 12.66 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.198 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -124.35 -14.96 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.279 0.561 . . . . 0.0 110.605 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.7 t -132.41 127.79 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -124.77 153.76 17.91 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.956 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.403 HD21 ' HB2' ' A' ' 8' ' ' SER . 32.1 t30 -103.96 117.44 34.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.806 0.336 . . . . 0.0 110.564 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.9 m -112.45 84.7 2.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.099 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 60.74 61.44 1.68 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.418 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.13 28.56 58.69 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.84 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -134.01 144.95 49.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.116 0.484 . . . . 0.0 110.917 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 6.2 tmm? -67.09 115.82 7.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.363 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -144.27 73.59 15.97 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.711 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 18.7 Cg_endo -57.09 156.73 23.33 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.261 2.641 . . . . 0.0 112.313 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.702 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 24.3 p -140.46 142.02 35.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.67 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.85 147.34 35.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.63 15.47 19.85 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.54 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.8 p -176.62 -93.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.333 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 19.7 t-20 53.03 36.75 22.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.788 -1.097 . . . . 0.0 110.108 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 109' ' ' HIS . . . -151.68 142.38 22.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.273 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -75.6 63.06 1.5 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.5 ' CE1' HG21 ' A' ' 110' ' ' VAL . 5.0 p80 -132.27 -51.45 0.95 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.5 HG21 ' CE1' ' A' ' 109' ' ' HIS . 26.9 m -128.93 47.17 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.882 0.849 . . . . 0.0 109.88 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.559 HD12 ' HH ' ' A' ' 50' ' ' TYR . 62.6 tp -155.87 83.57 1.02 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.49 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -133.63 101.43 5.12 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.522 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.3 m -77.25 51.61 0.86 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.6 0.714 . . . . 0.0 110.122 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.3 m -131.4 105.51 7.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.801 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.3 m -68.55 -53.4 23.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.155 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.496 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.8 ttm . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 74.63 149.7 0.1 Allowed 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.357 0.663 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.4 m -65.15 -67.61 0.43 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.52 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 56.11 77.48 0.24 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 10.1 p90 -61.1 -44.44 97.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.011 0.434 . . . . 0.0 110.595 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.25 -21.11 61.47 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -54.46 -35.69 63.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.58 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 94' ' ' ASN . 52.4 m -134.03 21.62 3.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.65 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.4 m -118.06 132.99 56.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.611 0.243 . . . . 0.0 110.358 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.0 p -132.65 155.26 49.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.541 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.5 67.81 1.99 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.915 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 11.3 m -107.32 129.64 60.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.274 0.559 . . . . 0.0 112.373 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 67.5 mm-40 -115.98 145.76 42.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.314 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.925 HD23 HD23 ' A' ' 64' ' ' LEU . 53.6 tp -133.0 122.26 23.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.0 111.089 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.466 ' O ' HG12 ' A' ' 18' ' ' ILE . 76.8 t80 -134.2 100.07 4.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.967 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' O ' HG22 ' A' ' 62' ' ' THR . . . 81.39 -64.01 4.25 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.645 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -166.49 19.83 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.735 0.302 . . . . 0.0 111.365 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.506 HG23 ' ND2' ' A' ' 36' ' ' ASN . 33.6 pt -116.4 119.08 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.753 0.311 . . . . 0.0 110.942 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 1.2 mt -111.91 114.5 27.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.4 ttt85 -120.68 138.75 53.79 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.117 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 179.37 38.83 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.268 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -105.68 109.53 21.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.73 0.3 . . . . 0.0 110.318 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 61.3 m -108.19 133.38 52.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.133 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 55.0 mt -67.8 138.29 22.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.616 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -106.75 -170.83 1.78 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.118 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -57.67 -29.43 64.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.938 0.399 . . . . 0.0 111.691 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -64.71 -22.97 67.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.539 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.08 -1.4 62.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.929 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -108.32 148.02 36.78 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 55.0 Cg_endo -70.96 128.59 15.13 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.9 2.4 . . . . 0.0 112.732 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -116.49 127.64 54.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.061 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.86 126.69 28.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.963 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.0 t -144.67 160.54 41.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.317 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 p -140.47 142.51 35.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.096 0.474 . . . . 0.0 111.184 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.408 ' CG1' ' HB2' ' A' ' 99' ' ' MET . 2.6 mp -123.69 143.8 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.691 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.506 ' ND2' HG23 ' A' ' 18' ' ' ILE . 9.2 m120 -104.14 92.65 4.46 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -56.35 -23.45 37.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.299 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -54.9 -32.69 61.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.955 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -100.78 11.29 39.86 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.771 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -128.55 -26.91 2.68 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.66 142.08 24.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.72 0.295 . . . . 0.0 110.825 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.679 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -121.21 166.12 14.18 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.13 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -113.16 111.79 22.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.422 0.629 . . . . 0.0 110.23 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -110.59 113.27 25.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.411 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.694 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 14.7 t30 57.12 36.18 27.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.04 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.97 13.84 82.63 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.798 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -118.93 145.69 45.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.582 0.23 . . . . 0.0 110.767 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 8.4 mp -73.84 113.8 11.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.739 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -104.91 133.35 49.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.376 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.502 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.87 -68.93 0.2 Allowed Pre-proline 0 CA--C 1.425 -3.836 0 O-C-N 124.352 1.033 . . . . 0.0 113.152 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -109.6 129.43 0.04 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.441 0 C-N-CA 113.763 -3.691 . . . . 0.0 113.31 -177.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.679 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -161.02 -160.35 10.65 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 113.998 -1.456 . . . . 0.0 113.46 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -154.73 140.6 18.2 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.962 0.448 . . . . 0.0 110.468 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m 52.39 46.78 26.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -72.19 -38.92 68.96 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.98 -18.73 48.52 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.533 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.5 m -64.92 -20.43 66.45 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 122.74 0.416 . . . . 0.0 111.12 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.0 m -143.69 28.15 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.078 0.466 . . . . 0.0 110.74 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.5 m -131.44 145.79 51.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.563 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.3 173.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.615 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mptt 61.65 41.8 11.72 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.689 0.618 . . . . 0.0 111.265 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 16' ' ' GLY . 7.5 p -68.75 123.88 22.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.605 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.88 156.7 38.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.155 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.925 HD23 HD23 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -113.61 112.88 24.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.717 0.294 . . . . 0.0 110.981 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -76.9 117.52 18.58 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.203 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 61.63 5.48 1.27 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.837 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.47 35.7 41.0 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.969 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 7.0 p80 -148.91 -26.34 0.3 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 111.274 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 m -115.71 129.93 56.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.911 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.571 ' HA ' HD22 ' A' ' 64' ' ' LEU . 17.9 tp -90.36 136.78 32.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.51 129.55 46.2 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -163.25 166.51 23.09 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.404 0.44 . . . . 0.0 110.725 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 t -116.06 127.33 54.79 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 18.5 m -127.65 156.43 42.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.214 0.53 . . . . 0.0 112.065 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -99.72 152.29 20.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.425 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.45 -26.4 1.22 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.103 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.694 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -54.28 -42.14 69.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.843 0.354 . . . . 0.0 111.481 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -178.68 58.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.391 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.06 -2.92 32.22 Favored Glycine 0 CA--C 1.518 0.225 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.135 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -118.75 165.23 14.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.805 0.336 . . . . 0.0 110.421 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 49.1 p90 -104.41 166.36 10.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.679 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -151.14 152.07 32.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.691 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.47 129.4 34.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.23 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.9 p -148.25 170.54 17.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 0.0 111.462 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.53 165.69 25.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.874 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.584 ' HE3' ' N ' ' A' ' 87' ' ' ASP . 9.3 tpt -143.54 113.27 7.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.491 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.584 ' N ' ' HE3' ' A' ' 86' ' ' MET . 21.8 t70 -72.31 104.01 3.58 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.592 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 14.8 mt -76.36 -8.54 57.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.322 -177.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.539 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 8.0 m120 -49.88 -28.56 6.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.575 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -117.53 21.5 12.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.187 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -129.11 -14.79 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.606 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.2 t -133.58 147.0 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.78 149.73 21.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.167 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.413 HD21 ' HB2' ' A' ' 8' ' ' SER . 23.7 t30 -89.37 116.63 27.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -116.94 84.37 2.13 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.365 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 61.44 53.99 3.25 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.485 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.48 28.05 64.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.943 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -130.35 142.27 50.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.467 ' O ' ' HG2' ' A' ' 99' ' ' MET . 0.0 OUTLIER -74.61 106.66 6.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.566 0.698 . . . . 0.0 112.507 -178.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -137.5 78.83 37.08 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.418 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 39.7 Cg_endo -65.71 104.97 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 123.296 2.664 . . . . 0.0 112.853 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -102.7 120.16 40.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.231 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -84.32 147.0 27.43 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.9 19.11 15.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.004 0.43 . . . . 0.0 111.64 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.43 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 48.7 m -152.66 -129.03 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.797 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 69.5 3.14 4.05 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.788 0.835 . . . . 0.0 111.55 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 66.89 -60.48 0.35 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.696 0.798 . . . . 0.0 111.749 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -161.02 -64.48 0.06 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.134 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -156.13 -52.04 0.08 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.543 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.3 t -101.31 87.08 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.511 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 111' ' ' LEU . 2.6 pt? -86.12 1.12 51.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.798 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -76.26 118.74 19.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.41 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.2 p -76.25 77.67 3.04 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.577 0.703 . . . . 0.0 109.484 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 t -155.21 142.92 19.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.097 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.7 m -70.2 -30.01 67.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.071 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 . . . . . 0 C--O 1.245 0.837 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.404 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -134.56 131.56 38.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.783 0.325 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 91.7 m -90.07 -51.74 5.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.813 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 51.97 73.66 0.31 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.4 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.546 ' CD1' HG11 ' A' ' 92' ' ' VAL . 1.9 p90 -58.31 -36.89 74.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 111.164 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.19 -22.21 60.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.83 -20.47 65.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.695 0.283 . . . . 0.0 111.404 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 m -135.33 16.65 3.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 97.7 m -124.58 136.9 54.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.78 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -132.95 147.77 52.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.293 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.19 43.3 80.92 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.748 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -81.99 119.48 31.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.436 0.636 . . . . 0.0 111.507 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.89 133.38 56.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.766 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.794 HD23 HD22 ' A' ' 64' ' ' LEU . 42.7 tp -108.14 121.08 44.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.45 ' O ' HG12 ' A' ' 18' ' ' ILE . 85.7 m-85 -124.74 105.18 9.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.689 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 62' ' ' THR . . . 75.35 -66.95 2.23 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.512 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' HD1' HD22 ' A' ' 36' ' ' ASN . 6.4 p90 -164.59 18.64 0.05 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.695 0.398 . . . . 0.0 111.24 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 15' ' ' TYR . 30.7 pt -122.26 133.96 66.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.128 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.477 ' HB2' HD22 ' A' ' 37' ' ' LEU . 1.3 mt -114.12 114.63 26.32 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.274 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -118.01 140.9 49.08 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.95 -174.37 37.47 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.277 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -109.21 108.69 19.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.576 0.227 . . . . 0.0 110.54 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 74.9 m -106.81 132.37 52.86 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 53.6 mt -68.26 140.72 18.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -108.96 -174.99 2.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.986 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -50.53 -36.67 35.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.66 0.384 . . . . 0.0 111.993 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -59.39 -25.31 64.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.806 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.64 4.91 59.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.367 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -112.84 146.95 36.13 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.345 -0.428 . . . . 0.0 110.137 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 56.5 Cg_endo -72.02 133.75 22.09 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.907 2.405 . . . . 0.0 112.903 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -121.82 130.51 53.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.619 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.82 129.67 40.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.041 0.448 . . . . 0.0 111.337 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.0 t -144.07 160.16 41.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.745 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.9 p -140.02 140.02 36.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.61 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -124.61 144.87 33.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 123.225 0.328 . . . . 0.0 110.401 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.503 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -102.98 91.48 4.14 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.477 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -58.3 -26.14 62.68 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.081 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 42.3 t30 -59.19 -20.38 53.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -105.62 8.13 33.04 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.432 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -129.13 -25.54 2.73 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -107.85 140.52 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.665 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.31 164.6 12.12 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.239 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -113.61 108.29 16.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.125 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -110.76 108.95 18.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.328 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 43.9 m-20 53.96 39.18 30.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.187 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 80.27 19.0 70.28 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.042 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.27 154.99 39.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.045 0.45 . . . . 0.0 111.096 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.488 HD13 ' HG ' ' A' ' 70' ' ' LEU . 51.6 mt -88.1 113.78 24.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.363 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -109.09 138.21 45.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.477 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.529 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -38.9 -71.74 0.12 Allowed Pre-proline 0 CA--C 1.426 -3.79 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -107.92 129.29 0.05 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.234 0 C-N-CA 113.876 -3.616 . . . . 0.0 113.209 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.665 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -165.2 -162.97 17.47 Favored Glycine 0 C--N 1.284 -2.324 0 CA-C-N 113.976 -1.466 . . . . 0.0 113.408 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -156.28 144.73 19.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.445 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.0 t 59.59 41.75 18.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.725 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.513 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 17.1 p90 -72.26 -37.57 69.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.45 -18.69 44.79 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.322 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 t -61.87 -20.67 63.97 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 110.63 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 m -144.46 24.34 1.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 111.02 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.2 m -124.95 139.83 53.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.262 0.554 . . . . 0.0 111.467 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.91 177.12 6.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.041 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 61.75 39.78 13.72 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.284 0.365 . . . . 0.0 111.431 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 16' ' ' GLY . 5.7 p -70.43 126.47 29.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.956 0.408 . . . . 0.0 111.92 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.56 150.34 29.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.866 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.794 HD22 HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -105.62 113.52 27.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.95 0.405 . . . . 0.0 111.218 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.453 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 4.7 t30 -84.21 123.64 30.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.645 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 61.0 8.24 1.83 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.768 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.55 30.83 68.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.993 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.453 ' HD2' ' O ' ' A' ' 65' ' ' ASN . 0.5 OUTLIER -150.7 -20.43 0.22 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.883 0.342 . . . . 0.0 111.453 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.45 ' O ' HD13 ' A' ' 64' ' ' LEU . 40.7 m -116.03 135.65 53.75 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.493 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.488 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.0 tp -97.6 129.78 44.69 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.66 129.85 53.07 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.62 173.11 17.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.067 0.46 . . . . 0.0 110.788 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.7 t -119.95 119.27 32.98 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.46 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.6 m -122.52 146.79 47.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.8 tmtt? -100.54 146.38 27.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.01 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.0 -24.75 0.41 Allowed Glycine 0 C--O 1.227 -0.328 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.477 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -68.97 -34.34 75.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.623 0.712 . . . . 0.0 111.828 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -169.64 54.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.187 0.517 . . . . 0.0 110.542 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.53 -1.77 8.91 Favored Glycine 0 CA--C 1.518 0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.143 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.56 160.55 22.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.808 0.337 . . . . 0.0 110.825 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 49.3 p90 -97.63 168.63 10.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.395 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -155.72 148.67 24.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.823 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.19 132.87 45.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.121 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -152.35 161.1 43.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.558 0.694 . . . . 0.0 112.131 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.47 159.74 41.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.919 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.529 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 7.8 tpt -146.29 116.96 7.6 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.615 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.443 ' O ' ' HE2' ' A' ' 86' ' ' MET . 32.9 t0 -77.02 104.39 7.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.409 0.623 . . . . 0.0 110.342 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.589 ' HA ' HG22 ' A' ' 91' ' ' VAL . 12.5 mt -73.81 -8.32 55.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.403 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -47.19 -31.73 3.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.794 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -118.79 24.35 10.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.79 0.329 . . . . 0.0 111.602 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 1.6 m -130.39 -4.32 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.044 0.45 . . . . 0.0 110.996 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 9.1 p -153.03 144.29 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.341 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.18 -171.78 12.34 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.282 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -132.5 137.92 47.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.828 0.347 . . . . 0.0 110.849 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.0 t -144.57 116.72 8.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 60.2 41.45 16.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.499 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 58.37 31.32 66.12 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.899 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -136.51 149.27 48.06 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -55.44 127.11 28.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.442 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -142.12 77.78 17.77 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.296 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 43.0 Cg_endo -68.82 93.5 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.561 2.174 . . . . 0.0 113.103 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.7 p -111.23 116.53 31.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.28 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.704 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -91.34 147.07 23.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.769 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.23 34.93 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.37 0.605 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.8 m -154.95 -132.79 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 63.93 19.87 11.94 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.822 0.82 . . . . 0.0 110.466 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.08 156.67 38.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.129 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.43 93.82 4.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.276 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -162.31 176.57 10.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.27 83.05 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.529 0.68 . . . . 0.0 110.265 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 111' ' ' LEU . 2.4 pt? -90.99 73.21 6.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.698 0.761 . . . . 0.0 110.366 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -78.08 42.26 0.39 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.869 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.8 t 54.19 28.14 8.69 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.289 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.1 t -166.24 147.06 6.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.343 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.9 m -77.82 -16.73 58.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.386 0.612 . . . . 0.0 109.39 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--O 1.248 1.013 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.492 179.091 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 tpt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -83.05 151.56 25.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.856 0.36 . . . . 0.0 110.968 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 94.3 m -122.15 -76.03 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.277 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 62.56 83.9 0.15 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CD1' HG12 ' A' ' 92' ' ' VAL . 3.3 p90 -64.46 -36.97 85.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.078 0.466 . . . . 0.0 111.167 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -63.12 -20.43 65.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.331 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -52.47 -32.83 41.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.122 0.487 . . . . 0.0 111.417 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 m -138.73 35.76 2.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.263 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -128.77 135.27 48.94 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.093 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.3 p -132.56 162.53 31.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.361 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.17 54.98 32.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.353 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 32.9 m -95.81 138.88 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.413 . . . . 0.0 111.263 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -134.99 140.67 45.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.888 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.754 HD21 HD22 ' A' ' 64' ' ' LEU . 20.1 tp -120.97 116.84 25.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.011 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.511 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.3 t80 -125.14 104.04 8.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.869 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.98 -68.45 2.83 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.553 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -163.81 19.54 0.07 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 122.445 0.298 . . . . 0.0 111.21 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.572 HG21 ' ND2' ' A' ' 36' ' ' ASN . 38.8 pt -114.4 126.69 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.712 0.291 . . . . 0.0 110.729 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.531 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.15 113.95 26.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.0 ttm180 -119.08 139.18 52.19 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.388 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' HA3' HG13 ' A' ' 12' ' ' VAL . . . -160.96 168.99 36.48 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.632 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 9.2 m-20 -97.3 105.79 18.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -104.16 131.73 51.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.8 mt -74.61 135.86 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.097 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -95.1 -179.96 5.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.632 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -50.4 -39.93 48.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.63 -24.42 65.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.64 1.38 46.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.41 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -101.99 139.67 20.51 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 57.8 Cg_endo -72.12 135.14 24.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.886 2.39 . . . . 0.0 112.188 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -125.21 126.11 44.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.154 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.13 122.74 18.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.987 0.423 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 t -136.94 158.86 43.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.809 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 p -138.95 143.01 38.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.623 0.249 . . . . 0.0 110.909 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.32 146.74 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.572 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.572 ' ND2' HG21 ' A' ' 18' ' ' ILE . 7.1 m120 -100.5 96.86 7.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.073 0.463 . . . . 0.0 110.244 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -60.43 -26.69 66.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.207 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -53.93 -34.01 58.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.09 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -102.72 11.46 37.61 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.0 m-85 -127.37 -21.8 3.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -112.73 139.95 35.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.663 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.3 165.55 12.07 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.177 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -110.71 106.22 15.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.613 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -112.17 107.37 16.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.751 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.812 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 39.7 t30 60.8 39.43 17.16 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.93 17.74 79.46 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.559 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.47 144.4 50.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.834 0.35 . . . . 0.0 111.045 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.507 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 9.2 mp -72.69 123.76 23.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.883 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -113.95 139.33 49.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.621 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -41.79 -69.42 0.22 Allowed Pre-proline 0 CA--C 1.426 -3.799 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.867 -179.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 3.5 Cg_endo -110.3 131.36 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.323 0 C-N-CA 113.81 -3.66 . . . . 0.0 113.2 -177.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.663 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -162.45 -159.29 10.2 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 114.108 -1.406 . . . . 0.0 113.604 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -155.17 144.94 21.45 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 124.026 0.486 . . . . 0.0 110.869 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 m 51.41 43.92 29.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -73.03 -38.8 66.41 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.23 -18.6 49.75 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.515 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.3 m -64.71 -24.79 67.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.846 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 m -136.86 20.27 3.05 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.9 m -126.56 140.42 52.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.495 HG22 ' HE2' ' A' ' 61' ' ' LYS . 27.8 m -131.27 176.45 8.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.146 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.495 ' HE2' HG22 ' A' ' 60' ' ' VAL . 2.4 mppt? 58.75 44.85 16.51 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.451 0.47 . . . . 0.0 111.248 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 p -71.41 123.19 21.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.611 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.3 163.09 38.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.305 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.754 HD22 HD21 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -121.24 112.65 18.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 0.0 111.524 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.07 119.27 20.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.294 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 51.99 26.51 3.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 124.087 0.867 . . . . 0.0 110.956 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 6' ' ' ALA . . . 58.35 32.63 68.48 Favored Glycine 0 C--O 1.224 -0.472 0 CA-C-N 115.663 -0.698 . . . . 0.0 113.722 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -141.35 -29.82 0.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.708 0.754 . . . . 0.0 111.661 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 m -116.28 131.06 57.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.802 0.334 . . . . 0.0 111.359 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' HD21 ' A' ' 64' ' ' LEU . 16.1 tp -90.74 131.93 36.13 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.38 130.43 53.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.783 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 48' ' ' LEU . . . -160.58 165.37 30.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 t -111.63 120.58 42.54 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 34.8 m -119.29 152.43 36.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 9.0 tmtt? -99.85 144.66 28.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.689 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.79 -27.85 0.66 Allowed Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.629 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.812 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.6 -40.3 75.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -174.33 54.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.349 0.595 . . . . 0.0 109.93 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.81 6.51 44.42 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.112 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 28.8 pt20 -126.01 169.91 12.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 45.7 p90 -98.78 171.55 8.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.822 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -160.21 145.2 14.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -76.41 132.87 39.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.21 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.9 p -152.1 166.22 32.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 111.369 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.81 162.66 34.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.426 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.621 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 16.9 tpp -147.92 117.87 7.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.5 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.401 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 37.8 t0 -74.44 107.65 6.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.202 0.525 . . . . 0.0 109.677 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.572 ' HA ' HG21 ' A' ' 91' ' ' VAL . 16.8 mt -76.04 -9.52 58.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.523 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.401 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 1.8 m120 -48.41 -29.43 4.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.602 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 47.2 p90 -119.23 21.67 12.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.698 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.572 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -127.7 -10.46 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.037 0.446 . . . . 0.0 110.693 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.753 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.1 p -150.78 141.62 16.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.356 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.86 -168.51 11.84 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.063 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -132.54 127.68 35.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.281 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.5 m -139.1 112.2 8.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.76 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 57.49 40.45 27.13 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.512 0.507 . . . . 0.0 111.185 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.44 20.05 58.42 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.743 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -116.74 147.13 42.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.721 0.296 . . . . 0.0 110.279 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -61.48 117.31 5.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.367 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -135.03 79.33 51.22 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.735 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 53.7 Cg_endo -71.33 82.98 1.04 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.799 2.332 . . . . 0.0 112.392 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 p -104.28 127.26 51.9 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.433 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -111.71 149.96 30.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.191 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.38 39.92 1.36 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.136 0.493 . . . . 0.0 111.008 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 58.2 m -159.09 -127.07 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 70.23 -68.35 0.21 Allowed 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 123.706 0.802 . . . . 0.0 110.902 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.48 -25.2 23.83 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.474 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -90.78 47.76 1.45 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.749 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -166.09 157.53 13.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.165 0.507 . . . . 0.0 110.168 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 m -79.3 77.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.616 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.1 tp -112.58 33.02 5.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.908 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -80.44 117.71 21.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.689 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 p -79.14 62.3 3.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.198 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.2 m -147.22 115.6 6.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.109 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 p -64.59 -44.73 89.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.552 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.834 179.877 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.795 0.331 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -89.81 149.3 22.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.4 m -74.97 -76.18 0.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.417 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 54.79 75.68 0.29 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 15.0 p90 -60.18 -36.83 78.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.181 0.515 . . . . 0.0 110.94 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.16 -22.72 63.91 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -60.06 -25.43 65.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.931 0.396 . . . . 0.0 111.319 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.3 m -132.04 29.97 4.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.664 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -131.23 140.11 49.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -133.32 150.53 51.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.29 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.97 73.65 0.46 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.531 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.533 HG11 ' HA3' ' A' ' 21' ' ' GLY . 33.3 m -112.0 144.39 19.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.837 0.351 . . . . 0.0 111.249 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -128.45 155.67 44.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.215 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.692 HD23 HD22 ' A' ' 64' ' ' LEU . 23.1 tp -132.18 109.38 9.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.026 0.441 . . . . 0.0 110.59 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.461 ' O ' HG12 ' A' ' 18' ' ' ILE . 80.4 m-85 -114.37 100.43 8.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 62' ' ' THR . . . 77.56 -63.64 3.36 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.919 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.677 ' HD1' HD22 ' A' ' 36' ' ' ASN . 8.7 p90 -166.04 23.45 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.618 0.247 . . . . 0.0 111.633 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 15' ' ' TYR . 42.2 pt -121.73 133.53 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.53 HD22 HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -112.65 120.16 40.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.863 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -127.96 139.71 52.42 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.876 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.533 ' HA3' HG11 ' A' ' 12' ' ' VAL . . . -167.35 -175.51 37.38 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.335 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -106.84 107.66 18.79 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 m -105.19 131.84 52.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 72.0 mt -72.46 137.43 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -100.82 -175.18 2.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.123 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.3 -27.5 62.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 112.048 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.62 -26.36 68.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.64 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.44 2.78 55.55 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.926 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -112.18 142.11 26.27 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.722 0.296 . . . . 0.0 110.374 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 42.1 Cg_endo -68.7 136.64 36.5 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.981 2.454 . . . . 0.0 112.596 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -123.87 134.27 53.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.132 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.83 126.06 28.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.431 . . . . 0.0 111.241 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 t -141.09 160.31 40.36 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.579 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -139.45 145.45 38.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.978 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.58 145.29 35.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.81 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.677 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -102.66 95.44 6.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.53 HD22 HD22 ' A' ' 19' ' ' LEU . 1.3 mm? -57.99 -26.7 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.691 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.0 t-20 -55.25 -27.91 49.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.281 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -104.7 7.94 34.95 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 30.9 m-85 -128.22 -21.94 3.5 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 mp -113.59 141.2 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.497 0.189 . . . . 0.0 110.722 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.641 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -118.61 170.07 13.66 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.371 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -109.56 110.89 22.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.963 0.411 . . . . 0.0 110.928 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -110.78 106.91 16.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.577 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 12.0 t30 52.12 41.55 30.08 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.909 0.484 . . . . 0.0 111.508 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.96 16.18 77.48 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.21 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.23 153.64 41.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.06 0.457 . . . . 0.0 110.92 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.572 HD13 ' HG ' ' A' ' 70' ' ' LEU . 37.1 mt -81.4 114.07 19.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.305 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.58 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.1 tt0 -107.31 132.75 52.78 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.474 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -32.49 -69.94 0.12 Allowed Pre-proline 0 CA--C 1.425 -3.837 0 O-C-N 124.762 1.289 . . . . 0.0 114.047 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.58 ' HD2' ' HG2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -108.77 133.59 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.321 0 C-N-CA 113.939 -3.574 . . . . 0.0 112.655 -177.636 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.641 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -168.61 -162.94 21.73 Favored Glycine 0 C--N 1.283 -2.389 0 C-N-CA 119.559 -1.305 . . . . 0.0 113.65 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -154.29 146.3 23.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.352 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.1 m 53.43 41.9 32.05 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -71.93 -35.51 69.65 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.14 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.09 -18.64 57.96 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.259 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -63.32 -24.29 67.79 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.494 -0.353 . . . . 0.0 111.136 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -136.46 22.08 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.095 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.4 m -126.89 148.37 50.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.128 0.489 . . . . 0.0 111.476 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.5 m -138.11 173.75 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.532 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.83 40.38 22.93 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.452 0.47 . . . . 0.0 111.648 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 16' ' ' GLY . 6.4 p -65.97 118.46 9.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.085 0.469 . . . . 0.0 111.822 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.91 149.56 31.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.095 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.692 HD22 HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -109.0 115.02 29.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.772 0.32 . . . . 0.0 110.761 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -88.8 124.77 34.48 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.751 0.31 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 58.1 19.74 6.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.603 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.431 ' HA2' HD11 ' A' ' 64' ' ' LEU . . . 58.43 31.31 66.31 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.929 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -139.36 -32.41 0.65 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.561 0.68 . . . . 0.0 111.142 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -116.01 131.9 56.81 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.268 0.556 . . . . 0.0 111.747 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.608 ' HA ' HD21 ' A' ' 64' ' ' LEU . 9.1 tp -90.1 130.84 36.22 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.613 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 129.22 53.88 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.0 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -160.85 164.36 31.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.999 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -111.76 124.37 52.2 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 21.9 m -126.47 150.09 48.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.325 0.583 . . . . 0.0 112.042 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.4 tmtt? -99.36 146.74 25.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.419 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.87 -30.69 0.66 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.209 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.577 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.09 -42.32 76.56 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -169.9 54.86 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.422 0.63 . . . . 0.0 110.293 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.54 3.43 26.49 Favored Glycine 0 C--N 1.328 0.108 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.454 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.7 160.78 25.15 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 12.2 p90 -101.98 169.88 8.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.851 0.358 . . . . 0.0 110.643 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -157.86 138.73 13.16 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.78 121.2 25.08 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.518 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.2 p -133.08 -179.81 5.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.148 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.48 164.51 28.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.044 0.449 . . . . 0.0 110.658 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.474 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 9.2 tpt -145.86 113.72 6.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.96 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.65 105.84 5.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.555 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.589 ' HA ' HG23 ' A' ' 91' ' ' VAL . 14.4 mt -75.78 -9.0 58.23 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.697 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -50.88 -26.04 5.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.591 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 51.4 p90 -119.41 22.21 11.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.325 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 88' ' ' LEU . 2.2 m -127.62 -14.99 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.849 0.357 . . . . 0.0 110.569 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -139.22 145.42 27.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.924 177.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -134.18 179.96 17.01 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.89 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -131.85 127.79 37.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.684 0.278 . . . . 0.0 110.921 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 64.2 m -135.14 107.36 7.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.234 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 60.93 42.58 12.73 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.751 0.657 . . . . 0.0 110.622 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.26 22.47 63.16 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.692 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -118.24 147.18 43.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.484 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -60.82 121.08 11.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.043 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -137.02 80.45 35.51 Favored Pre-proline 0 CA--C 1.516 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.346 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 44.5 Cg_endo -68.81 89.02 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.672 2.248 . . . . 0.0 112.962 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.7 p -114.66 123.55 49.58 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.215 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -99.94 149.81 23.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.386 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -100.33 23.51 10.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.939 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.9 m -145.67 -141.11 0.12 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 64.05 104.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.592 0.757 . . . . 0.0 111.584 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.96 -28.19 19.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.389 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -133.12 133.16 42.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -78.15 -28.39 48.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.15 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.64 73.19 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 122.57 1.176 . . . . 0.0 110.339 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 111' ' ' LEU . 2.7 pt? -104.57 23.57 13.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.159 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -80.52 100.61 8.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.088 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.6 t -80.84 79.85 7.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.227 0.537 . . . . 0.0 109.663 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.9 m -155.31 -173.49 4.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.229 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.9 m -84.08 -53.14 5.74 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.623 -179.654 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 65.45 -171.83 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.98 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.0 m -122.85 -74.44 0.62 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.608 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 60.67 71.06 0.58 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.625 ' CD1' HG12 ' A' ' 92' ' ' VAL . 5.1 p90 -66.24 -37.5 85.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.025 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.56 -20.0 65.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.204 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -51.57 -39.11 57.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.026 0.441 . . . . 0.0 110.769 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -132.01 27.71 4.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.566 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -118.53 139.99 50.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.012 0.434 . . . . 0.0 111.051 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -137.01 152.26 49.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.647 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.05 57.23 14.41 Favored Glycine 0 N--CA 1.455 -0.082 0 O-C-N 123.527 0.517 . . . . 0.0 112.764 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.505 HG11 ' HA3' ' A' ' 21' ' ' GLY . 15.9 m -101.17 134.03 42.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.065 0.459 . . . . 0.0 111.852 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -127.72 153.14 46.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.263 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.733 HD22 HD21 ' A' ' 64' ' ' LEU . 23.7 tp -128.33 120.55 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.97 0.414 . . . . 0.0 111.991 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.43 ' O ' HG12 ' A' ' 18' ' ' ILE . 73.0 t80 -126.66 108.55 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 62' ' ' THR . . . 78.5 -73.35 2.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.3 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -164.0 23.38 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.821 0.343 . . . . 0.0 111.377 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 15' ' ' TYR . 24.7 pt -121.13 127.84 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.702 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.533 HD21 ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -109.29 114.59 28.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.176 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -119.06 139.74 51.22 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.014 178.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.505 ' HA3' HG11 ' A' ' 12' ' ' VAL . . . -165.93 -175.39 36.32 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.139 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 3.5 m-20 -107.89 108.05 19.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.572 0.225 . . . . 0.0 110.577 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -105.72 131.36 53.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.1 mt -69.65 140.78 18.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.982 0.42 . . . . 0.0 111.904 -178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -108.05 -172.8 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.331 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.533 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 7.2 tp10 -49.85 -41.79 45.96 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.469 0.48 . . . . 0.0 112.153 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.87 -22.97 63.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.408 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.78 5.03 60.14 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.346 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -109.47 145.39 31.8 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.483 -0.359 . . . . 0.0 110.573 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.74 131.53 26.12 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.98 2.453 . . . . 0.0 112.52 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -115.24 130.64 56.97 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.503 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.65 120.16 12.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.715 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -140.94 159.52 42.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.386 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 p -140.16 148.02 41.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.029 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mp -126.94 147.61 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.373 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -105.53 85.9 2.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -54.39 -25.29 23.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.046 0.451 . . . . 0.0 111.383 -178.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.449 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 23.1 t-20 -53.47 -24.81 13.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.391 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -113.5 10.36 18.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -126.79 -8.2 6.13 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 111.309 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.58 HD11 HD21 ' A' ' 88' ' ' LEU . 3.0 mp -127.41 134.55 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -117.04 -177.33 17.78 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 23.9 p-10 -127.96 101.66 6.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.648 0.737 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.92 113.81 27.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.957 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.433 ' CG ' ' HA ' ' A' ' 77' ' ' ALA . 8.4 t-20 58.84 36.69 24.81 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.645 0.736 . . . . 0.0 110.129 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.6 19.75 78.95 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.992 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -122.45 146.1 47.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.654 0.264 . . . . 0.0 110.432 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 9.5 mp -72.04 120.78 18.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.401 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -108.16 138.73 43.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.426 0.632 . . . . 0.0 110.254 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.453 ' HB2' HG13 ' A' ' 91' ' ' VAL . 12.4 p90 -58.8 -24.15 1.44 Allowed Pre-proline 0 CA--C 1.447 -2.991 0 N-CA-C 118.125 2.639 . . . . 0.0 118.125 -178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 4.4 Cg_endo -129.5 12.16 0.0 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.771 1 C-N-CA 112.787 -4.342 . . . . 0.0 116.353 179.253 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.522 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -62.13 -176.23 2.52 Favored Glycine 0 C--N 1.259 -3.707 0 CA-C-N 111.266 -2.697 . . . . 0.0 115.547 -176.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -146.95 147.98 31.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m 58.48 45.41 16.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.046 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.449 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 9.5 p90 -74.11 -38.26 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.01 -23.74 47.65 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.444 -0.408 . . . . 0.0 112.317 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -62.02 -18.1 59.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.293 -0.453 . . . . 0.0 111.365 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 m -148.93 27.54 0.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.614 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.3 m -132.24 145.09 51.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.985 0.422 . . . . 0.0 111.052 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 m -136.39 176.85 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.253 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mptm? 61.9 40.65 12.31 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.241 0.338 . . . . 0.0 111.659 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 16' ' ' GLY . 2.4 p -69.13 123.03 19.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.094 0.473 . . . . 0.0 112.05 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.41 161.97 41.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.718 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.733 HD21 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -123.17 113.79 19.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.872 0.368 . . . . 0.0 111.34 -178.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.32 122.09 28.0 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.009 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 52.5 25.24 3.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.776 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.488 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 56.62 39.62 86.02 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.624 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -149.24 -30.88 0.24 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 117.249 0.524 . . . . 0.0 111.078 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.428 ' O ' HD13 ' A' ' 64' ' ' LEU . 5.7 m -116.02 130.6 56.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.801 0.334 . . . . 0.0 111.282 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.665 ' HB2' HD12 ' A' ' 88' ' ' LEU . 14.0 tp -93.26 131.22 38.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.975 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.59 129.81 56.0 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.069 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 48' ' ' LEU . . . -162.36 162.93 28.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 110.528 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 t -111.36 125.29 53.7 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 34.8 m -125.06 156.06 38.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -98.45 148.89 23.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.685 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.67 -28.37 0.84 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.269 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.433 ' HA ' ' CG ' ' A' ' 45' ' ' ASN . . . -55.53 -42.64 74.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.841 0.353 . . . . 0.0 111.564 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -172.98 56.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.765 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.92 2.39 38.02 Favored Glycine 0 C--O 1.229 -0.213 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.45 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -122.87 162.45 22.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 48.2 p90 -91.45 160.85 15.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.713 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -146.98 147.17 30.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.53 135.5 35.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 p -155.7 173.19 17.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.744 0.307 . . . . 0.0 111.259 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.84 164.28 30.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.843 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.766 ' HE1' ' HA ' ' A' ' 86' ' ' MET . 3.3 tpt -149.99 119.64 7.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.553 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -73.28 108.9 6.42 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 70' ' ' LEU . 15.0 mt -81.59 -9.12 59.75 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.327 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -47.88 -29.48 3.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.648 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -117.11 15.82 15.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.557 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.56 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -120.24 -3.58 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.654 0.74 . . . . 0.0 110.294 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.988 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.3 p -155.46 131.18 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.017 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.12 179.67 16.16 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.128 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -118.62 126.17 51.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.441 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.7 m -130.27 97.3 4.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.533 ' CD2' ' HB2' ' A' ' 26' ' ' GLU . 71.8 m-85 61.7 52.38 3.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.262 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.36 16.79 60.98 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.814 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -119.87 143.13 48.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.31 120.99 18.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.218 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -127.71 75.57 77.79 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.47 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.988 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.7 Cg_endo -72.4 103.89 1.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.964 2.443 . . . . 0.0 112.391 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.23 110.35 22.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.713 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.38 150.52 38.35 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.45 99.25 10.92 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.2 m 74.96 -66.12 0.31 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.155 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 17.0 t-20 60.48 100.06 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.274 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -154.87 132.39 11.26 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.336 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -78.68 -22.75 46.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.361 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -124.5 -60.44 1.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.816 0.341 . . . . 0.0 111.55 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.1 m -85.09 55.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.726 0.774 . . . . 0.0 112.165 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.1 tp -82.05 71.06 9.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.557 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -120.22 108.18 13.9 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.796 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 t -60.93 92.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.445 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.8 p -169.75 60.96 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.982 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.5 m -61.39 -43.08 99.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.698 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.793 -179.495 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 ttp . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.569 0.223 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -74.58 125.43 28.62 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 55.6 m -65.43 -67.96 0.4 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.292 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 46.25 73.31 0.18 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CD1' HG12 ' A' ' 92' ' ' VAL . 2.3 p90 -59.24 -42.45 91.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.566 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.99 -21.38 44.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.67 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -61.0 -28.68 69.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.502 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB2' HD21 ' A' ' 94' ' ' ASN . 50.4 m -139.44 23.9 2.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.871 0.367 . . . . 0.0 111.388 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.5 m -122.21 132.88 54.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.519 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -133.67 160.8 36.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.929 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.76 51.82 56.8 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.366 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.531 HG11 ' HA3' ' A' ' 21' ' ' GLY . 29.8 m -97.59 139.47 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.832 0.349 . . . . 0.0 111.231 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -136.02 151.8 50.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.564 HD21 HD22 ' A' ' 64' ' ' LEU . 13.1 tp -119.35 110.1 16.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.098 0.475 . . . . 0.0 111.661 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.428 ' O ' HG12 ' A' ' 18' ' ' ILE . 36.2 m-85 -106.1 98.58 8.24 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 62' ' ' THR . . . 71.27 -65.13 0.99 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.16 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.751 ' HD1' HD22 ' A' ' 36' ' ' ASN . 4.3 p90 -156.34 12.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.782 -0.246 . . . . 0.0 111.645 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 15' ' ' TYR . 44.9 pt -114.45 133.54 60.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 110.896 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.533 HD23 HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.29 113.97 26.48 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.118 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.3 ttm105 -120.28 138.38 53.71 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.531 ' HA3' HG11 ' A' ' 12' ' ' VAL . . . -158.85 -177.44 31.94 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.825 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -108.51 103.5 12.64 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.2 m -107.13 131.98 53.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.845 0.355 . . . . 0.0 110.288 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.8 mt -70.14 139.18 20.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.1 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -112.01 -168.62 1.34 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.509 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.29 -28.11 64.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.726 0.298 . . . . 0.0 111.788 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.96 -28.51 69.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.01 0.433 . . . . 0.0 111.345 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.8 -9.29 60.12 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.424 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -101.39 142.84 25.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -64.16 121.74 9.5 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.791 2.327 . . . . 0.0 112.317 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -104.39 134.99 46.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.504 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.26 124.95 25.68 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.497 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.3 t -143.95 159.79 41.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.81 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 p -139.45 154.78 47.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.67 145.5 25.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.751 HD22 ' HD1' ' A' ' 17' ' ' TYR . 2.9 t-20 -100.87 104.6 15.82 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.533 HD22 HD23 ' A' ' 19' ' ' LEU . 1.6 mm? -64.61 -22.16 66.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 25.4 t30 -63.97 -13.23 44.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -108.03 -1.3 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.364 -0.21 . . . . 0.0 110.977 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.413 ' HD1' ' NH2' ' A' ' 103' ' ' ARG . 52.3 m-85 -127.67 -9.43 5.6 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.41 HD11 HD23 ' A' ' 88' ' ' LEU . 2.6 mp -124.45 134.14 67.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -113.86 178.16 18.21 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.558 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -113.92 102.57 10.32 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.06 0.457 . . . . 0.0 110.452 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -102.42 103.92 14.36 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 47.48 45.42 17.32 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.535 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.3 14.69 76.0 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.769 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.13 147.39 47.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.041 0.42 . . . . 0.0 111.114 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.595 HD12 ' HG ' ' A' ' 70' ' ' LEU . 25.6 mt -72.35 121.64 19.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.014 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -110.99 127.23 55.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.267 0.556 . . . . 0.0 110.792 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -49.29 -29.13 1.72 Allowed Pre-proline 0 CA--C 1.453 -2.784 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.498 ' HB2' HD21 ' A' ' 106' ' ' ASN . 3.3 Cg_endo -129.57 17.63 0.0 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.764 1 C-N-CA 113.032 -4.179 . . . . 0.0 115.931 179.073 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.561 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -68.36 -174.86 9.13 Favored Glycine 1 C--N 1.254 -4.013 0 CA-C-N 111.16 -2.745 . . . . 0.0 115.508 -176.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -143.45 148.14 35.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.407 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m 57.83 60.47 2.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.915 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 12.5 p90 -90.1 -35.33 15.5 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.791 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.99 -19.03 43.03 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.607 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 m -62.19 -25.22 67.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.323 -0.439 . . . . 0.0 111.353 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.1 m -141.84 27.24 1.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.154 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.9 m -129.02 151.25 49.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.215 0.531 . . . . 0.0 111.732 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG21 ' HE2' ' A' ' 61' ' ' LYS . 15.7 m -146.81 175.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.25 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HE2' HG21 ' A' ' 60' ' ' VAL . 2.0 mppt? 63.14 41.94 7.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.873 0.368 . . . . 0.0 110.777 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 16' ' ' GLY . 12.5 p -72.1 125.21 26.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.987 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.79 156.68 40.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.802 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.564 HD22 HD21 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -117.11 112.01 20.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.899 0.38 . . . . 0.0 110.738 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.533 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 11.6 m120 -73.08 117.28 14.62 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.342 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.2 t70 51.95 21.17 1.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.017 0.823 . . . . 0.0 111.056 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.38 37.61 95.1 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.441 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -144.96 -29.99 0.45 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 117.506 0.653 . . . . 0.0 111.296 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 16.9 m -116.6 135.15 54.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.639 0.257 . . . . 0.0 111.072 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.595 ' HG ' HD12 ' A' ' 48' ' ' LEU . 14.3 tp -95.91 131.72 41.96 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.62 132.29 54.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.171 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.431 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -164.05 163.5 23.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.375 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.6 t -110.96 125.07 53.32 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.8 m -125.46 148.02 49.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.306 0.574 . . . . 0.0 112.063 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.9 tmtt? -99.61 144.93 28.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.683 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.32 -21.64 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.834 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.17 89.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.878 0.339 . . . . 0.0 111.385 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -173.8 55.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.353 0.597 . . . . 0.0 109.759 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.14 -3.74 20.92 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.603 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -115.44 163.48 15.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.63 0.252 . . . . 0.0 110.604 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 29.4 p90 -103.69 166.99 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.194 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.07 127.49 5.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.419 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.01 123.1 18.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.498 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.2 p -136.79 175.91 9.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.198 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.07 162.27 35.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.902 0.382 . . . . 0.0 110.778 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 21.3 tpp -148.83 123.69 9.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.481 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -78.37 106.75 10.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.384 0.612 . . . . 0.0 109.762 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.559 ' HA ' HG21 ' A' ' 91' ' ' VAL . 13.6 mt -76.23 -9.52 58.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.733 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -51.64 -26.72 9.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.041 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -116.86 19.25 14.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.782 0.325 . . . . 0.0 111.375 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -126.59 -9.25 4.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.108 0.48 . . . . 0.0 110.583 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.867 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 5.5 p -153.82 139.96 11.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.476 ' HA2' ' N ' ' A' ' 5' ' ' PHE . . . -134.09 176.73 19.62 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.197 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.441 HD21 ' HB2' ' A' ' 8' ' ' SER . 28.7 t30 -118.57 123.44 45.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.012 0.434 . . . . 0.0 110.276 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.3 m -124.7 99.9 6.38 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.474 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.85 51.02 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.173 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 56.69 27.8 55.8 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.958 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -130.76 141.34 50.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.93 0.395 . . . . 0.0 110.469 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.6 ptm -55.21 116.68 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.349 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -141.43 75.63 22.32 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.111 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.867 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 61.2 Cg_endo -75.66 112.54 3.54 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.741 2.294 . . . . 0.0 112.156 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p -128.41 130.0 47.0 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.417 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -113.36 149.68 33.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.546 179.082 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.84 49.96 0.8 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.261 0.553 . . . . 0.0 110.737 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 22.3 p -165.95 -122.83 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.498 HD21 ' HB2' ' A' ' 51' ' ' PRO . 25.8 t-20 67.77 -53.02 0.51 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.096 0.958 . . . . 0.0 113.526 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -113.67 -27.86 7.68 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.992 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 109' ' ' HIS . 24.0 t70 -144.13 -172.34 3.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.486 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 77.6 t60 72.91 -67.41 0.27 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.65 0.78 . . . . 0.0 110.958 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.445 HG13 ' HD2' ' A' ' 109' ' ' HIS . 5.7 p -146.85 94.96 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.989 0.899 . . . . 0.0 110.498 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.7 tp -135.88 73.03 1.45 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.664 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -120.38 101.8 8.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.742 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.3 m -70.56 115.98 10.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.893 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.5 p -115.71 82.48 1.77 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.131 0.491 . . . . 0.0 110.987 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.2 m -67.7 -53.88 23.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.747 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.933 179.589 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.711 0.291 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -88.91 117.21 27.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.91 0.386 . . . . 0.0 110.049 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.4 m -83.99 -74.02 0.39 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.164 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 51.64 75.45 0.21 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.843 0.457 . . . . 0.0 111.896 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.502 ' CD1' HG11 ' A' ' 92' ' ' VAL . 3.1 p90 -56.94 -39.8 75.21 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.89 -22.57 38.27 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -68.4 -21.65 64.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.69 0.281 . . . . 0.0 111.569 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.9 m -134.29 19.09 3.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.929 0.395 . . . . 0.0 110.903 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 81.4 m -124.8 132.98 53.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.244 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.6 p -126.77 155.14 43.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.262 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.79 63.78 4.79 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.381 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.38 133.93 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.252 0.549 . . . . 0.0 111.473 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.62 136.28 48.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.624 HD23 HD21 ' A' ' 64' ' ' LEU . 23.0 tp -121.64 124.84 45.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.086 0.469 . . . . 0.0 111.07 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -133.35 114.93 14.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.683 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.13 -71.46 1.98 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.007 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -167.81 24.07 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.314 0.646 . . . . 0.0 109.573 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.4 HG12 ' ND2' ' A' ' 36' ' ' ASN . 7.5 mt -120.08 113.27 40.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.549 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.506 ' HB2' HD22 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -99.81 114.82 28.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.994 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -116.94 140.03 49.95 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.21 176.6 40.14 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.265 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -105.87 107.95 19.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 82.5 m -105.81 131.69 52.83 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.084 0.469 . . . . 0.0 110.043 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mt -70.02 138.96 20.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.516 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.409 HD22 ' CD2' ' A' ' 29' ' ' HIS . 4.7 p30 -105.61 -169.46 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.331 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.96 -29.03 66.85 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.76 -26.26 65.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.15 0.5 . . . . 0.0 111.751 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.34 57.29 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.132 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.409 ' CD2' HD22 ' A' ' 25' ' ' ASN . 0.0 OUTLIER -107.78 138.95 20.17 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -63.65 127.19 19.13 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.113 2.542 . . . . 0.0 112.808 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -109.79 133.17 53.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.184 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.39 118.73 16.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.903 0.383 . . . . 0.0 111.508 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.3 t -135.4 157.39 47.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.006 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.8 p -139.83 138.29 35.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.499 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.58 145.9 33.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.955 0.407 . . . . 0.0 111.258 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.403 ' HA ' HD21 ' A' ' 36' ' ' ASN . 3.4 m120 -103.57 99.16 8.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.049 0.452 . . . . 0.0 110.1 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.506 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -62.29 -23.67 66.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.895 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.98 -30.94 62.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.939 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -103.95 13.54 32.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -130.87 -25.85 2.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.08 141.95 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.647 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -111.94 -174.93 19.78 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.843 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -129.24 105.06 7.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.07 0.462 . . . . 0.0 111.292 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -103.27 111.17 23.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.531 ' HB2' ' HA ' ' A' ' 77' ' ' ALA . 5.4 p-10 42.18 47.08 3.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.675 1.19 . . . . 0.0 113.298 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.91 14.93 74.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.596 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.15 143.23 50.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.823 0.344 . . . . 0.0 111.23 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.542 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 8.9 mp -71.49 119.34 15.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.814 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -109.9 139.13 45.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.519 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -41.14 -68.97 0.23 Allowed Pre-proline 0 CA--C 1.428 -3.746 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' CB ' ' HB2' ' A' ' 106' ' ' ASN . 7.8 Cg_endo -111.46 122.97 0.03 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.361 0 C-N-CA 113.943 -3.571 . . . . 0.0 113.544 -177.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.647 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -158.67 -160.82 10.58 Favored Glycine 0 C--N 1.277 -2.703 0 CA-C-N 113.758 -1.565 . . . . 0.0 113.282 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -156.31 144.39 19.67 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.942 0.436 . . . . 0.0 110.818 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 m 57.14 41.24 27.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.15 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -72.09 -40.2 68.39 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.049 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.01 -18.99 49.62 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.733 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.2 m -65.14 -24.34 67.38 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.514 0.326 . . . . 0.0 110.955 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.1 m -138.32 24.76 2.71 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.916 0.389 . . . . 0.0 110.635 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.0 m -131.29 141.48 49.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.314 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 m -133.92 172.81 15.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.376 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.8 mptt 64.1 43.3 5.13 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.715 0.635 . . . . 0.0 110.873 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 p -68.83 124.4 23.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.386 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.2 156.07 37.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.86 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.624 HD21 HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -110.48 120.39 42.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.541 0.21 . . . . 0.0 110.61 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.518 ' C ' ' H ' ' A' ' 67' ' ' GLY . 19.3 t-20 -87.46 121.18 29.57 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.9 t70 68.33 -25.76 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.437 1.085 . . . . 0.0 112.356 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 65' ' ' ASN . . . 110.19 22.02 6.71 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -142.84 -20.47 0.66 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.445 ' O ' HD11 ' A' ' 64' ' ' LEU . 43.3 m -116.95 127.36 54.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.251 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.542 ' HG ' ' CD2' ' A' ' 48' ' ' LEU . 16.6 tp -90.61 129.28 36.75 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.79 130.29 54.86 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.487 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HB2' HD11 ' A' ' 48' ' ' LEU . . . -162.55 165.32 26.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.833 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -110.08 125.55 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.426 ' SG ' HD12 ' A' ' 48' ' ' LEU . 60.9 m -123.23 147.73 46.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.351 0.596 . . . . 0.0 112.582 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.9 tmtt? -99.69 145.3 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.923 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.73 -16.27 0.94 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.822 -1.18 . . . . 0.0 113.332 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' A' ' 45' ' ' ASN . . . -59.67 -39.46 84.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.875 0.369 . . . . 0.0 110.759 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 t70 178.91 60.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.843 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.79 4.48 54.11 Favored Glycine 0 C--O 1.228 -0.223 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.544 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -124.92 165.34 18.26 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.6 p90 -112.53 166.27 11.47 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.282 0.364 . . . . 0.0 111.488 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -158.55 144.61 16.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -76.29 142.36 41.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.786 0.327 . . . . 0.0 110.158 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.9 p -153.6 174.58 14.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.82 156.54 46.12 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.082 0.468 . . . . 0.0 110.586 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.519 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 12.3 tpp -140.78 123.18 15.92 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.644 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -76.06 106.24 7.55 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.556 ' HA ' HG21 ' A' ' 91' ' ' VAL . 16.3 mt -73.34 -9.09 58.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.747 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -47.58 -31.15 4.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.79 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 26.7 p90 -119.74 23.58 11.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.411 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -128.49 -7.85 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.02 0.438 . . . . 0.0 110.52 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.752 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.8 p -156.82 141.79 8.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.023 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -134.91 -174.96 13.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.229 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -130.0 133.26 46.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.938 0.399 . . . . 0.0 110.991 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.417 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 3.3 m -142.35 112.25 6.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.398 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 60.17 40.51 18.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.397 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.67 24.6 66.44 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -128.17 138.86 52.66 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.5 ptt? -64.46 129.17 38.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.347 0.594 . . . . 0.0 112.5 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG2' ' HB2' ' A' ' 95' ' ' SER . 0.9 OUTLIER -140.09 77.35 25.77 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 33.3 Cg_endo -61.79 93.25 0.12 Allowed 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.422 2.748 . . . . 0.0 112.951 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 p -106.88 119.47 39.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.406 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -102.78 149.52 24.39 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.032 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -99.51 35.83 1.89 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.18 0.514 . . . . 0.0 111.237 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.401 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 21.6 t -161.49 -132.89 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' A' ' 108' ' ' ASP . 20.0 t-20 62.83 96.74 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.607 0.763 . . . . 0.0 110.432 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 73.29 -13.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.737 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 106' ' ' ASN . 12.3 m-20 -129.61 168.12 16.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.662 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 63.4 t60 74.3 154.46 0.15 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.813 0.816 . . . . 0.0 110.856 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.09 91.67 2.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 122.242 1.02 . . . . 0.0 110.71 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.765 HD21 ' H ' ' A' ' 111' ' ' LEU . 1.8 pt? -97.82 69.39 2.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.949 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.79 118.2 30.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.817 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.2 t -93.35 75.46 4.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.7 m -100.26 86.18 3.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.331 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -54.04 48.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.187 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.607 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 tpp . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.987 0.423 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -120.44 101.85 8.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.5 m -75.55 -57.85 3.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.33 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 63.54 71.28 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.298 0.374 . . . . 0.0 110.891 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 9.8 p90 -54.43 -37.51 65.21 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 111.361 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.86 -22.15 64.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.78 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -69.79 -16.1 63.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.68 0.276 . . . . 0.0 111.301 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -127.03 4.44 6.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.2 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 0.8 OUTLIER -118.49 137.53 53.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.162 0.506 . . . . 0.0 112.079 -178.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 p -128.59 153.07 47.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.096 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.65 64.9 3.95 Favored Glycine 0 N--CA 1.453 -0.22 0 O-C-N 123.518 0.511 . . . . 0.0 112.442 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.548 HG13 ' HA3' ' A' ' 21' ' ' GLY . 32.4 m -100.64 147.04 8.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 111.278 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -138.18 148.91 45.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.127 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.615 HD22 HD21 ' A' ' 64' ' ' LEU . 8.5 tp -122.19 105.36 10.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.023 0.439 . . . . 0.0 110.72 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -134.62 112.4 10.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.34 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.24 38.33 39.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.282 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' HA ' HD11 ' A' ' 14' ' ' LEU . 10.2 m-85 64.55 24.06 12.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.15 0.58 . . . . 0.0 110.675 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.2 mt -117.77 122.23 69.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.253 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.531 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -102.6 113.64 27.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.351 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 20.4 ttm180 -118.84 134.3 55.25 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.426 -0.509 . . . . 0.0 109.835 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.548 ' HA3' HG13 ' A' ' 12' ' ' VAL . . . -157.63 175.3 34.98 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.898 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 26.6 m-20 -101.15 107.29 18.66 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -106.02 131.8 52.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.5 mt -70.09 135.25 28.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -103.64 -175.12 2.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.125 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -54.09 -31.33 51.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.06 -27.5 69.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.451 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.34 -0.04 53.83 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.121 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -108.66 144.54 29.76 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 120.802 0.334 . . . . 0.0 110.385 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -66.91 121.27 8.45 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.057 2.505 . . . . 0.0 112.655 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -107.09 129.24 54.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.306 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.53 119.19 13.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.011 0.434 . . . . 0.0 110.871 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -132.19 159.48 38.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.808 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 99' ' ' MET . 78.4 p -138.5 147.97 43.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.847 0.356 . . . . 0.0 111.502 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.74 142.55 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.9 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -101.96 92.71 4.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.69 -23.72 53.05 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.322 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.447 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 21.1 t-20 -54.8 -30.9 58.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.98 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -108.57 16.31 23.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.534 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -126.97 -25.05 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -110.52 140.62 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.672 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -115.35 161.66 12.74 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.395 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -100.63 104.75 16.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.691 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -111.94 106.55 15.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.922 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.803 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 56.2 t30 58.41 36.98 25.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.121 0.486 . . . . 0.0 110.817 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.66 17.07 80.22 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.403 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.07 154.88 39.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.834 0.349 . . . . 0.0 110.825 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.402 HD23 ' HB2' ' A' ' 72' ' ' ALA . 31.5 mt -79.92 114.48 18.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.239 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -105.52 135.18 47.4 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.439 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -39.84 -72.45 0.11 Allowed Pre-proline 0 CA--C 1.426 -3.792 0 O-C-N 124.254 0.971 . . . . 0.0 113.333 -178.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -108.36 126.14 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.319 0 C-N-CA 113.623 -3.784 . . . . 0.0 113.252 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.672 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.65 -164.2 13.21 Favored Glycine 0 C--N 1.283 -2.398 0 CA-C-N 113.582 -1.645 . . . . 0.0 113.029 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -153.39 142.86 21.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.857 0.36 . . . . 0.0 111.013 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 m 53.4 42.37 32.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.226 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 10.5 p90 -68.47 -36.7 79.35 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.48 -18.12 28.69 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.377 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.7 t -64.54 -21.08 66.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.723 0.297 . . . . 0.0 110.487 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.5 m -140.8 23.38 2.26 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.099 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.5 m -128.97 142.61 50.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.954 0.407 . . . . 0.0 111.311 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -134.37 172.93 15.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.249 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? 63.25 37.74 10.91 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.501 0.5 . . . . 0.0 111.766 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.8 p -66.67 122.66 18.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.117 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.69 163.57 39.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.877 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.615 HD21 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -119.54 113.44 20.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.908 0.385 . . . . 0.0 111.471 -179.32 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.452 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 16.1 m120 -76.13 117.18 17.57 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.322 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t70 58.9 9.53 1.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.907 0.755 . . . . 0.0 111.567 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.22 30.75 58.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.777 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -144.56 -26.06 0.51 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 117.547 0.674 . . . . 0.0 111.394 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 21.9 m -115.82 130.39 56.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.316 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.561 ' HA ' HD23 ' A' ' 64' ' ' LEU . 23.1 tp -91.02 130.67 36.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.71 129.82 55.48 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.402 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -162.59 159.84 25.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.231 0.538 . . . . 0.0 111.039 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.7 t -109.59 123.31 49.23 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 56.9 m -122.25 149.67 43.37 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.369 0.604 . . . . 0.0 112.534 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.7 tmtt? -99.74 139.56 35.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.024 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.91 -32.52 0.38 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.947 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.803 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -47.49 -43.33 24.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -171.69 49.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.85 5.56 65.05 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.608 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.83 165.72 16.17 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 33.4 p90 -101.2 162.55 12.82 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 123.292 0.37 . . . . 0.0 110.155 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.14 134.22 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -72.22 125.48 27.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.225 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.1 p -142.29 170.71 15.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.969 0.414 . . . . 0.0 110.719 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.37 164.95 26.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.887 ' HE1' ' HA ' ' A' ' 86' ' ' MET . 1.4 tpt -145.74 120.02 9.57 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.067 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.27 105.01 5.25 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.563 ' HA ' HG21 ' A' ' 91' ' ' VAL . 17.5 mt -75.98 -8.44 56.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.528 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -47.15 -32.08 4.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.917 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.575 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 36.7 p90 -117.16 23.75 11.64 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.087 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.563 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -130.76 -5.71 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.989 0.423 . . . . 0.0 110.843 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 1.022 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.6 t -141.16 146.33 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.45 176.82 22.66 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.989 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -131.7 132.95 44.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 5.6 m -141.75 109.22 5.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.286 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 62.31 43.93 7.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.905 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.58 26.28 66.41 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.159 -0.543 . . . . 0.0 111.874 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -127.53 142.15 51.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 34' ' ' SER . 4.4 ppp? -67.68 134.14 50.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.115 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 95' ' ' SER . 0.0 OUTLIER -153.07 71.09 7.07 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.039 178.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 1.022 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 12.3 Cg_endo -54.45 103.52 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.408 2.739 . . . . 0.0 112.432 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 p -108.17 136.77 47.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.828 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -112.16 149.22 32.51 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.42 58.15 0.64 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.023 0.44 . . . . 0.0 111.06 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.1 t -176.48 -107.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.947 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 64.08 102.09 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.771 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.37 133.33 20.24 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.088 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.84 127.55 35.34 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.928 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 71.16 -52.05 0.69 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.642 0.777 . . . . 0.0 111.984 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.9 m -88.12 60.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 111.713 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.3 tp -128.48 43.66 3.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.017 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.411 ' C ' ' HG ' ' A' ' 113' ' ' SER . 19.8 pttt -124.74 27.32 6.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.991 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 112' ' ' LYS . 86.8 p 46.62 -121.92 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.186 0.594 . . . . 0.0 110.786 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.6 t 74.03 102.66 0.07 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.522 0.677 . . . . 0.0 109.652 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.1 m -63.02 -43.15 99.53 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.649 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.016 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 tpp . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.846 0.355 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.66 132.51 36.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.098 0.475 . . . . 0.0 109.85 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.436 ' CB ' ' HA3' ' A' ' 93' ' ' GLY . 1.1 m -108.93 -72.55 0.72 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.823 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.422 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 62.4 m-80 53.8 85.31 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.681 0.613 . . . . 0.0 112.56 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.577 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 6.0 p90 -62.51 -37.6 86.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.182 0.515 . . . . 0.0 110.165 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.91 -20.25 66.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.092 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.422 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 11.2 t-20 -52.11 -29.05 20.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.378 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.9 m -145.16 28.87 1.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.759 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -119.27 141.65 48.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.898 0.38 . . . . 0.0 110.97 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.9 p -137.97 157.44 46.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.065 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.5 34.3 89.53 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.211 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 21.3 m -69.76 138.95 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.003 0.43 . . . . 0.0 111.762 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -132.56 133.18 43.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.348 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.759 HD23 HD21 ' A' ' 64' ' ' LEU . 46.5 tp -119.8 123.33 43.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.934 0.397 . . . . 0.0 111.168 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.53 101.97 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.703 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' HG22 ' A' ' 62' ' ' THR . . . 75.83 -60.8 2.96 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.944 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 1.6 p90 -166.91 18.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 26.3 pt -119.95 127.15 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.548 ' HB2' HD23 ' A' ' 37' ' ' LEU . 1.1 mt -116.05 114.92 25.21 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.197 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 27.2 ttm180 -111.83 139.03 47.65 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.88 165.15 33.03 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.2 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 1.7 m-20 -99.37 105.72 17.72 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.8 m -104.57 132.21 51.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.261 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.6 mt -69.86 139.57 20.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.318 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -108.9 -171.54 1.87 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.837 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -55.21 -31.35 61.38 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.35 -20.92 66.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.712 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.33 4.09 66.63 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.74 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.34 148.5 39.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.787 0.327 . . . . 0.0 110.29 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.7 132.46 21.87 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.019 2.479 . . . . 0.0 113.027 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -118.39 132.45 56.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.269 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.94 127.29 31.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.169 0.509 . . . . 0.0 111.65 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -141.93 154.94 45.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.041 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 p -139.9 142.73 36.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.64 0.257 . . . . 0.0 111.155 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.55 143.8 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.485 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.51 90.49 3.88 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.548 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.35 -23.66 50.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.592 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.7 t-20 -52.74 -31.44 38.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.105 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -108.36 16.7 22.9 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.52 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -129.69 -22.93 2.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -113.93 142.17 27.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.648 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -116.11 164.22 12.29 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.547 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -102.04 105.49 16.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.247 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -110.59 104.92 13.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.505 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.716 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 36.7 t30 52.96 43.64 31.43 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.199 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.13 16.55 80.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.948 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -123.68 157.48 33.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.862 0.363 . . . . 0.0 110.768 -179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.482 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 38.9 mt -83.97 113.4 20.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.472 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -103.11 130.43 50.27 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.46 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.35 -71.79 0.11 Allowed Pre-proline 0 CA--C 1.424 -3.877 0 O-C-N 124.47 1.106 . . . . 0.0 113.063 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -107.44 133.3 0.05 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.42 0 C-N-CA 113.704 -3.731 . . . . 0.0 112.179 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.648 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -164.74 -163.64 18.3 Favored Glycine 0 C--N 1.285 -2.261 0 CA-C-N 114.379 -1.282 . . . . 0.0 113.665 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -151.37 143.59 24.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.283 -0.459 . . . . 0.0 110.921 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.4 m 52.07 45.0 29.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -74.27 -36.03 63.8 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.91 -19.37 50.07 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.281 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -62.27 -26.87 68.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.943 0.401 . . . . 0.0 110.816 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 m -134.16 15.15 3.84 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.268 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.1 m -121.64 140.33 52.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.448 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 m -136.82 174.52 11.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.886 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 62.48 41.49 9.73 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 110.725 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 16' ' ' GLY . 21.5 p -71.83 126.78 30.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.93 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.81 162.68 40.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.766 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.759 HD21 HD23 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -118.01 113.54 21.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.806 0.336 . . . . 0.0 111.566 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.443 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 3.9 m120 -73.51 116.13 13.71 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.403 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.95 5.21 0.49 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.114 0.884 . . . . 0.0 111.742 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.1 27.89 35.79 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.717 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -145.21 -23.06 0.49 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.504 0.652 . . . . 0.0 112.23 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 30.6 m -114.68 130.73 56.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.744 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 64' ' ' LEU . 15.2 tp -91.88 127.79 37.47 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 129.69 55.46 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.84 171.11 20.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.805 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.3 t -118.58 121.21 39.67 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 32.8 m -121.4 149.84 42.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.181 0.515 . . . . 0.0 111.835 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.3 tmtt? -99.89 145.37 27.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.932 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.85 -28.1 0.74 Allowed Glycine 0 C--O 1.228 -0.256 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.251 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.716 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.14 -38.81 71.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.314 0.486 . . . . 0.0 112.314 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -172.02 50.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.385 0.612 . . . . 0.0 109.899 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.75 2.08 42.57 Favored Glycine 0 C--O 1.229 -0.174 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.112 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -125.25 167.29 15.08 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 42.8 p90 -104.99 169.64 8.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.459 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -161.78 147.01 13.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.95 130.24 42.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.139 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.0 t -144.66 161.13 39.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.225 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.03 160.25 37.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.482 ' HB2' ' CB ' ' A' ' 48' ' ' LEU . 9.7 tpt -144.25 112.83 6.58 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.156 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.469 ' N ' ' HE3' ' A' ' 86' ' ' MET . 55.9 m-20 -72.08 105.11 3.81 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.574 ' HA ' HG21 ' A' ' 91' ' ' VAL . 15.4 mt -73.37 -9.18 58.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.534 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -48.82 -28.17 3.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.691 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 36.2 p90 -122.41 25.76 8.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.686 0.279 . . . . 0.0 111.441 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -129.78 -13.67 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.025 0.44 . . . . 0.0 110.708 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 1.05 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.7 p -155.36 136.56 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.539 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.493 ' HA2' ' N ' ' A' ' 5' ' ' PHE . . . -131.85 -173.54 13.37 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.469 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -123.81 133.31 53.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.428 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.6 m -137.42 104.72 5.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.208 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 60.34 45.86 10.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.912 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.94 20.27 70.51 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.276 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -127.4 145.18 50.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.055 0.427 . . . . 0.0 109.866 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -64.11 130.71 45.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.977 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -140.77 77.93 21.24 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.613 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 1.05 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 38.7 Cg_endo -68.77 97.15 0.54 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.665 2.244 . . . . 0.0 112.714 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.0 p -116.68 133.48 55.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.458 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -90.99 138.0 31.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.448 ' HB3' ' HB2' ' A' ' 90' ' ' TYR . . . -109.4 28.18 8.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.181 0.515 . . . . 0.0 110.714 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.3 m -152.99 -76.07 0.12 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.639 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 64.08 97.54 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.777 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.46 -58.44 3.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.835 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.06 130.29 41.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.79 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -78.34 -51.81 9.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.752 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.5 t -92.7 63.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.881 0.848 . . . . 0.0 110.257 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 35.2 tp -107.01 78.47 1.23 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.609 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -147.13 86.56 1.64 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -79.26 41.1 0.44 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.237 0.541 . . . . 0.0 110.675 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.6 m -113.03 71.31 0.74 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.777 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.5 m -78.09 -46.78 19.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.266 0.555 . . . . 0.0 109.647 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.683 179.513 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -79.07 133.0 36.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.836 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.5 m -73.83 -54.96 6.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.903 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 52.44 73.16 0.36 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.989 0.516 . . . . 0.0 112.054 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.524 ' HE1' ' HB2' ' A' ' 88' ' ' LEU . 9.3 p90 -57.43 -33.6 68.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.063 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.97 64.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -68.94 -20.36 64.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.1 m -119.93 9.84 11.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -123.26 146.37 47.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.006 0.432 . . . . 0.0 111.432 -179.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -134.4 147.42 50.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.638 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.16 56.79 21.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.492 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.519 HG11 ' HA3' ' A' ' 21' ' ' GLY . 7.1 m -99.23 130.5 48.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.113 0.482 . . . . 0.0 111.433 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.98 152.81 47.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.601 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.631 HD23 HD23 ' A' ' 64' ' ' LEU . 11.5 tp -113.22 113.58 25.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.817 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.479 ' O ' HG12 ' A' ' 18' ' ' ILE . 26.3 m-85 -108.22 98.79 8.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.992 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.5 -65.5 1.36 Allowed Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.084 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 2.8 p90 -161.39 18.64 0.11 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.748 0.419 . . . . 0.0 111.128 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 15' ' ' TYR . 30.6 pt -122.16 133.1 69.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 110.271 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -108.69 116.9 32.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.724 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.8 tmm_? -121.9 142.29 50.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.1 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' HA3' HG11 ' A' ' 12' ' ' VAL . . . -168.4 -174.71 37.4 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.414 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -108.49 109.19 20.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -105.73 131.98 52.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.03 0.443 . . . . 0.0 110.005 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 58.2 mt -70.16 138.17 22.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.421 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -102.36 -174.31 2.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.89 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.71 -37.81 63.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.191 0.519 . . . . 0.0 111.946 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.64 -25.11 66.07 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.086 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.89 50.33 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.575 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -105.35 140.52 21.22 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-O 120.854 0.359 . . . . 0.0 110.388 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 39.4 Cg_endo -67.84 134.36 32.1 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 123.082 2.521 . . . . 0.0 112.955 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -119.91 133.65 55.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.596 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.75 126.09 27.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.281 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -143.13 156.03 44.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 p -136.72 151.3 49.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.937 0.399 . . . . 0.0 111.156 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -134.07 143.67 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.221 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.97 93.62 5.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.83 -29.25 64.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.317 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.2 t-20 -52.78 -29.13 25.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.935 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -108.53 12.76 25.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.6 m-85 -128.9 -20.14 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -113.57 142.11 27.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.665 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -113.72 166.07 12.11 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.256 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -109.92 111.13 22.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.141 -0.53 . . . . 0.0 110.82 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -110.78 105.46 14.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.669 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.711 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 29.9 t30 53.09 42.21 32.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.046 0.451 . . . . 0.0 111.401 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 78.11 17.63 77.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.121 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.62 154.71 40.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.966 0.412 . . . . 0.0 110.827 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD11 ' HG ' ' A' ' 70' ' ' LEU . 35.7 mt -82.1 122.99 28.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.051 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -112.71 138.49 49.44 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.532 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -40.88 -75.14 0.05 OUTLIER Pre-proline 0 CA--C 1.433 -3.556 0 CA-C-O 118.11 -0.947 . . . . 0.0 113.186 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 23.2 Cg_endo -111.32 129.0 0.03 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.425 0 C-N-CA 114.009 -3.527 . . . . 0.0 113.042 -177.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.665 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.08 -158.02 8.6 Favored Glycine 0 C--N 1.28 -2.572 0 CA-C-N 113.529 -1.669 . . . . 0.0 113.143 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -155.2 138.45 15.71 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.897 0.41 . . . . 0.0 110.646 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.3 m 58.27 45.05 17.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -75.07 -37.61 61.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -19.04 54.47 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.705 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -64.67 -22.49 66.99 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 120.83 0.348 . . . . 0.0 110.911 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.2 m -135.87 18.37 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.841 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 81.9 m -125.23 145.55 49.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.174 0.511 . . . . 0.0 111.44 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.0 m -138.07 176.91 6.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.16 178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 61.85 35.0 16.75 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.145 0.278 . . . . 0.0 111.474 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 p -64.16 123.82 20.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 111.187 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.95 148.87 27.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.836 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.631 HD23 HD23 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -107.18 113.45 26.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.453 0.168 . . . . 0.0 110.749 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.574 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 40.6 t-20 -79.63 126.1 30.47 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.56 18.61 1.47 Allowed 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.354 1.034 . . . . 0.0 112.045 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.0 33.53 87.49 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.935 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.574 ' HD2' ' O ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -148.0 -25.55 0.35 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.525 0.663 . . . . 0.0 111.609 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.424 ' O ' HD11 ' A' ' 64' ' ' LEU . 44.4 m -116.71 131.13 57.03 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.207 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.536 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -90.97 134.21 34.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.787 0.327 . . . . 0.0 110.466 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.19 131.45 53.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.967 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.417 ' HB2' HD22 ' A' ' 48' ' ' LEU . . . -160.63 163.69 32.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.164 0.507 . . . . 0.0 111.544 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -110.8 118.21 35.53 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.443 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 37.4 m -119.17 147.48 44.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.4 tmtt? -100.1 142.92 30.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.473 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.72 -27.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.021 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.711 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -49.85 -41.07 44.42 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -179.34 51.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.22 -3.76 57.19 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.234 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -113.23 161.01 17.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.975 -0.612 . . . . 0.0 109.781 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 41.0 p90 -103.71 168.37 9.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.522 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -158.03 137.93 12.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.354 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.13 127.27 32.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.8 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.7 p -142.62 177.81 8.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.597 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.414 ' HA ' HD13 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -138.78 162.22 35.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.979 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.532 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 11.8 tpp -145.67 120.99 10.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.113 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -77.63 106.09 9.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.33 0.586 . . . . 0.0 109.439 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HA ' HG23 ' A' ' 91' ' ' VAL . 16.0 mt -73.1 -8.98 58.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.124 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -48.72 -33.04 9.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.815 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -116.15 24.49 11.38 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.062 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -128.69 -12.09 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.536 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.814 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 1.8 t -138.52 144.29 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.28 171.5 23.92 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.731 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -121.96 141.19 51.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.045 0.45 . . . . 0.0 110.855 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.2 m -146.93 109.31 4.52 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 58.58 42.05 21.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.633 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.9 13.11 63.51 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.473 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -116.29 141.72 47.79 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.94 129.78 40.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.401 0.619 . . . . 0.0 111.645 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -139.02 78.81 28.45 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.179 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.814 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 32.1 Cg_endo -65.36 96.55 0.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.779 2.319 . . . . 0.0 112.442 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -102.67 131.82 49.2 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.952 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.413 ' HG2' ' H ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -102.31 146.43 28.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.916 0.388 . . . . 0.0 110.517 -179.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -99.5 19.24 16.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.04 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.413 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 68.8 m -156.01 -120.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.987 ' HA ' HD21 ' A' ' 111' ' ' LEU . 13.3 t-20 64.34 43.96 4.48 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.049 0.939 . . . . 0.0 110.402 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 54.93 -153.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.898 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.97 -32.89 57.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.231 0.538 . . . . 0.0 110.099 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -136.69 -75.86 0.42 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.234 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.2 t -136.94 111.27 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.787 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.987 HD21 ' HA ' ' A' ' 106' ' ' ASN . 4.2 pp -72.45 -11.02 60.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.281 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.83 76.27 4.36 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.88 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.9 m -62.94 118.27 7.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.375 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.4 t -165.45 136.88 3.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.326 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.7 m -72.76 -24.32 60.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 N--CA 1.441 -0.901 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.246 179.767 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -92.2 117.57 30.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.5 m -98.24 -72.29 0.66 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.143 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.433 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 12.5 m-20 55.46 78.77 0.18 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.919 0.488 . . . . 0.0 111.889 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.581 ' CD1' HG12 ' A' ' 92' ' ' VAL . 4.8 p90 -62.48 -46.18 89.64 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.719 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.46 -22.28 54.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.186 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.433 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 6.4 t-20 -57.91 -30.5 65.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.856 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.409 ' HB2' HD21 ' A' ' 94' ' ' ASN . 49.7 m -137.67 23.47 2.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.822 0.344 . . . . 0.0 111.353 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 92.3 m -120.96 132.83 55.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.985 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 p -132.19 152.99 51.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.531 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.78 42.88 94.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.622 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.519 HG11 ' HA3' ' A' ' 21' ' ' GLY . 26.8 m -89.33 141.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.794 0.331 . . . . 0.0 111.342 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.67 159.18 42.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.143 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.731 HD23 HD23 ' A' ' 64' ' ' LEU . 20.8 tp -127.08 126.89 43.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 111.588 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.544 ' O ' HG12 ' A' ' 18' ' ' ILE . 68.4 t80 -130.83 104.79 7.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.808 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 62' ' ' THR . . . 75.92 -71.27 1.95 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.738 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.8 OUTLIER -163.01 23.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.605 0.362 . . . . 0.0 111.337 179.141 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 15' ' ' TYR . 34.0 pt -117.24 131.11 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 110.544 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.511 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -112.41 114.66 27.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.688 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 13.2 ttm180 -121.56 140.44 52.22 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' HA3' HG11 ' A' ' 12' ' ' VAL . . . -164.69 179.31 39.47 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.449 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -104.44 105.42 15.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 69.3 m -106.16 132.18 52.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.213 0.53 . . . . 0.0 110.29 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.68 141.4 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -105.83 -172.26 2.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.305 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -56.23 -30.52 62.46 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.76 -26.82 66.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.0 111.371 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.82 1.67 55.15 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.506 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.58 139.31 19.98 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 121.158 0.504 . . . . 0.0 111.037 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.38 127.96 20.3 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 124.117 3.211 . . . . 0.0 112.674 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -116.86 138.09 51.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.615 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.46 121.71 23.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.937 0.398 . . . . 0.0 111.171 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.4 t -140.54 156.6 46.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.928 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 p -140.4 138.92 35.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 mp -124.54 147.86 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.491 HD21 HG23 ' A' ' 18' ' ' ILE . 13.4 t-20 -103.75 107.55 18.47 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -66.1 -22.67 66.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.683 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.453 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 32.2 t30 -66.72 -12.93 60.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.017 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -110.57 0.89 17.81 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.325 -0.234 . . . . 0.0 110.981 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 50.8 m-85 -128.31 -20.47 3.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.418 HD11 HD21 ' A' ' 88' ' ' LEU . 2.0 mp -112.7 138.79 40.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.676 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -116.33 165.51 12.28 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.529 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -108.82 106.05 15.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.89 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -110.92 107.19 16.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.586 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 13.4 t30 56.78 40.42 29.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.173 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.63 16.18 80.96 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.81 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.14 152.61 42.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 10.1 mp -80.52 123.49 28.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.895 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -114.56 132.67 56.25 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.2 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CB ' HG11 ' A' ' 91' ' ' VAL 0.251 0.1 OUTLIER -41.54 -63.11 0.89 Allowed Pre-proline 0 CA--C 1.423 -3.921 0 CA-C-O 117.87 -1.062 . . . . 0.0 113.522 -179.075 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.609 ' HB2' HD21 ' A' ' 106' ' ' ASN . 9.0 Cg_endo -112.28 123.36 0.02 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.471 0 C-N-CA 113.766 -3.689 . . . . 0.0 112.978 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.676 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.52 -165.89 18.24 Favored Glycine 0 C--N 1.281 -2.519 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.26 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -153.34 146.52 24.69 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 m 59.96 45.69 11.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 10.8 p90 -79.35 -37.81 36.59 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.83 55.03 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.538 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 m -63.22 -29.16 70.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.223 -0.489 . . . . 0.0 110.943 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.8 m -133.49 19.58 3.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.304 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 55' ' ' PHE . 84.1 m -123.04 149.07 44.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.283 0.563 . . . . 0.0 111.724 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.459 HG22 ' HG2' ' A' ' 61' ' ' LYS . 23.4 m -141.58 176.8 3.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.943 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' A' ' 60' ' ' VAL . 74.1 mmtt 62.81 37.3 12.44 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.246 0.342 . . . . 0.0 111.001 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -69.82 122.43 19.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.178 0.513 . . . . 0.0 111.75 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.73 149.23 28.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.438 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.731 HD23 HD23 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -106.34 113.29 26.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.741 0.305 . . . . 0.0 111.08 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -75.49 117.19 17.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.202 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.0 t70 55.05 23.32 5.09 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.084 0.865 . . . . 0.0 111.491 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.29 36.73 92.9 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.988 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -147.16 -29.94 0.35 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.692 0.746 . . . . 0.0 111.49 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 m -115.62 132.34 56.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.51 0.195 . . . . 0.0 111.115 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.527 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -92.8 130.06 38.52 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.97 129.75 53.55 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.093 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.426 ' HB1' HD13 ' A' ' 48' ' ' LEU . . . -159.03 163.32 36.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.09 0.472 . . . . 0.0 111.116 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 16.4 t -110.51 120.17 41.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.3 m -121.75 148.75 44.24 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.6 tmtt? -100.35 145.58 28.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.542 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.03 -30.9 0.49 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.852 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.582 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.46 -41.58 66.31 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -172.93 52.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.225 0.536 . . . . 0.0 109.892 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.4 -1.11 44.95 Favored Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.335 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -119.12 158.53 25.72 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 21.0 p90 -100.6 171.12 7.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.467 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -163.3 151.15 13.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.9 132.34 41.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.1 t -148.35 158.51 44.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.851 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.1 159.99 39.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.287 0.565 . . . . 0.0 110.93 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 20.9 tpp -147.3 118.67 7.86 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.589 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -75.93 106.89 7.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.408 0.623 . . . . 0.0 109.773 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.568 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.9 mt -73.55 -9.58 58.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.709 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -50.9 -27.33 7.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.197 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -117.82 19.28 13.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 111.583 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.568 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.4 m -126.18 -7.35 5.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.121 0.486 . . . . 0.0 110.603 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.5 p -157.69 145.08 9.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.321 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.438 ' HA2' ' N ' ' A' ' 5' ' ' PHE . . . -135.82 -174.3 13.33 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.799 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.409 HD21 ' HB2' ' A' ' 8' ' ' SER . 23.4 t30 -126.01 131.24 52.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.93 0.395 . . . . 0.0 110.946 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.8 m -135.95 111.08 8.94 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.678 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 59.66 42.92 16.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.938 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.85 24.31 64.44 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.198 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -127.0 147.58 50.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 110.165 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -60.02 128.85 38.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.145 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -140.38 78.16 22.92 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.004 178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 44.0 Cg_endo -72.52 92.13 0.77 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.351 2.034 . . . . 0.0 111.859 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p -114.38 121.58 44.03 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.589 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.504 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -113.52 149.02 34.98 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.056 178.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -99.91 48.56 0.93 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.158 0.504 . . . . 0.0 110.368 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.401 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 25.8 t -169.7 -133.82 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.609 HD21 ' HB2' ' A' ' 51' ' ' PRO . 28.6 t-20 72.71 107.65 0.07 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.343 1.057 . . . . 0.0 112.028 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 111' ' ' LEU . . . -164.39 163.54 22.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.507 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -70.01 -70.33 0.3 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.178 0.513 . . . . 0.0 110.516 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -121.62 -41.39 2.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.732 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.6 p -82.31 78.79 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 122.266 1.031 . . . . 0.0 109.683 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 13.5 tp -71.25 82.62 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.553 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -90.92 109.37 20.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.335 0.588 . . . . 0.0 111.36 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 37.7 m -88.77 64.46 7.29 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.3 m -149.85 137.98 20.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.405 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -72.36 -33.23 67.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.715 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.297 179.502 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.691 0.281 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -142.14 146.91 35.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.7 m -130.99 -63.46 0.86 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.284 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 56.14 73.96 0.41 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.467 ' CD1' ' HB ' ' A' ' 92' ' ' VAL . 12.5 p90 -57.93 -34.5 69.93 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.138 0.494 . . . . 0.0 111.366 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.94 -22.08 63.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -62.43 -26.52 68.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 46.6 m -124.64 13.4 8.67 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.2 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -119.15 135.56 54.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.051 0.453 . . . . 0.0 111.212 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -132.46 154.36 49.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.26 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.07 53.0 48.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.064 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 m -92.07 137.81 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.728 0.299 . . . . 0.0 110.874 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -135.21 149.85 49.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.178 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.544 HD21 HD23 ' A' ' 64' ' ' LEU . 11.9 tp -114.41 118.01 32.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.163 0.506 . . . . 0.0 111.485 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.49 ' O ' HG12 ' A' ' 18' ' ' ILE . 91.9 m-85 -115.51 99.75 7.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.82 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.82 -73.3 1.47 Allowed Glycine 0 C--O 1.224 -0.499 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.484 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HD1' HD22 ' A' ' 36' ' ' ASN . 3.9 p90 -157.49 21.14 0.29 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.671 0.388 . . . . 0.0 110.848 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 15' ' ' TYR . 39.0 pt -121.4 132.77 69.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.054 0.454 . . . . 0.0 110.251 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -109.38 117.56 34.37 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.119 -179.136 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tmm_? -121.72 139.57 53.41 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.89 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -161.8 179.35 37.23 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.303 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 10.7 m-20 -100.98 106.14 17.43 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.0 OUTLIER -106.05 131.83 52.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.954 0.406 . . . . 0.0 109.944 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -69.15 138.12 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.692 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -108.26 -170.28 1.65 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.29 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.48 -28.58 60.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.81 -26.69 66.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.55 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.64 -2.89 57.4 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.159 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -104.86 143.53 26.89 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.932 0.396 . . . . 0.0 110.3 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.84 121.97 9.65 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.937 2.425 . . . . 0.0 113.015 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -108.32 130.72 55.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.171 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.84 119.65 15.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.057 0.456 . . . . 0.0 111.716 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.9 t -135.54 160.05 39.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.501 ' O ' ' HG2' ' A' ' 99' ' ' MET . 13.2 p -136.7 152.72 50.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.184 0.516 . . . . 0.0 111.551 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.22 145.78 33.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.799 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.464 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -104.58 94.56 5.38 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.9 -30.24 63.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.587 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -54.53 -29.15 49.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -103.68 10.93 36.57 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.656 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 52.8 m-85 -129.67 -22.9 2.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -112.24 141.49 27.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.602 0.239 . . . . 0.0 110.83 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.561 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.54 -173.77 18.16 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.918 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -128.65 109.5 11.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.844 0.354 . . . . 0.0 111.128 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -113.11 109.62 19.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.66 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.633 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 22.1 t-20 56.08 45.48 23.48 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.72 0.772 . . . . 0.0 110.943 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.54 18.12 73.41 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.709 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.07 147.49 47.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.863 0.363 . . . . 0.0 110.364 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.448 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 8.4 mp -71.42 127.94 34.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.189 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -114.5 129.51 56.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.15 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.578 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.7 -70.53 0.14 Allowed Pre-proline 0 CA--C 1.425 -3.852 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.868 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 14.2 Cg_endo -110.36 124.36 0.03 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.444 0 C-N-CA 113.509 -3.861 . . . . 0.0 113.146 -178.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.561 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -159.08 -161.04 10.8 Favored Glycine 0 C--N 1.281 -2.527 0 CA-C-N 113.4 -1.727 . . . . 0.0 113.197 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.419 ' C ' ' HG ' ' A' ' 54' ' ' SER . 51.4 mt-10 -153.93 150.04 27.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 0.0 110.341 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.419 ' HG ' ' C ' ' A' ' 53' ' ' GLU . 59.2 p 47.79 44.97 18.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -69.84 -40.93 75.54 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.33 -26.9 38.41 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.675 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -56.93 -25.99 58.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.221 0.208 . . . . 0.0 111.286 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.2 m -137.17 28.0 2.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 0.0 110.705 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.1 m -131.61 145.92 51.94 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.346 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.4 m -136.62 174.82 11.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.811 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.41 37.86 16.47 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.322 0.649 . . . . 0.0 112.265 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 p -63.11 123.0 17.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.895 0.379 . . . . 0.0 111.044 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.12 155.57 37.02 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.587 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -110.86 120.15 41.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.829 0.347 . . . . 0.0 110.838 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.57 119.1 23.82 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 68.75 -59.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 124.623 1.202 . . . . 0.0 111.113 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.88 34.64 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.342 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.471 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 1.2 p-80 -155.81 -19.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m -116.55 128.0 55.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.618 0.247 . . . . 0.0 111.587 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.587 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.8 tp -91.09 130.74 36.95 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.16 129.87 54.33 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.724 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.426 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -160.28 164.12 32.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.148 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.6 t -110.95 123.98 51.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 39.2 m -125.45 153.74 43.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.92 0.391 . . . . 0.0 111.809 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.9 tmtt? -99.26 144.51 28.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.693 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.1 -26.82 0.62 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.0 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.633 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . . . -52.25 -42.5 63.69 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.551 0.341 . . . . 0.0 111.715 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -175.83 55.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.017 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.42 20.84 73.93 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.464 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -142.67 159.34 42.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 46.7 p90 -101.26 166.72 10.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.248 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -159.53 145.53 16.1 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -78.6 131.6 36.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.002 0.43 . . . . 0.0 110.772 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 p -143.51 176.03 9.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.271 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -138.85 164.9 28.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.226 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 1.003 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -145.87 121.72 10.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.533 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.6 105.11 6.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.558 ' HA ' HG22 ' A' ' 91' ' ' VAL . 19.8 mt -77.34 -8.26 57.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.659 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.471 ' OD1' ' HB2' ' A' ' 68' ' ' HIS . 11.5 m120 -47.15 -32.82 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.72 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -116.45 22.76 12.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.427 . . . . 0.0 111.324 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -127.94 -13.5 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.818 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.89 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -132.17 147.97 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.286 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.99 174.61 22.63 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.204 -0.522 . . . . 0.0 111.799 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -135.31 133.54 38.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.684 0.278 . . . . 0.0 111.124 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.457 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 8.2 m -142.89 115.65 8.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.264 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 58.93 41.13 21.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.389 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.09 12.36 57.51 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.721 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -114.63 139.81 49.33 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 34' ' ' SER . 4.6 ppp? -66.01 133.54 51.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.032 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -152.87 69.31 7.0 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.759 178.13 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.89 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 15.7 Cg_endo -56.08 102.82 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.312 2.675 . . . . 0.0 112.548 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.83 110.09 21.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.637 0.732 . . . . 0.0 110.983 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.444 ' O ' HD22 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -114.83 149.99 36.19 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.068 178.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -129.11 65.49 1.45 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.501 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.4 t -160.96 14.69 0.11 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.974 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.723 ' H ' HD21 ' A' ' 111' ' ' LEU . 2.9 t-20 -103.21 16.86 25.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.462 0.648 . . . . 0.0 110.386 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -161.83 141.45 10.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.034 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -85.94 -23.34 26.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.356 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -89.4 -79.77 0.32 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.728 0.299 . . . . 0.0 110.498 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.45 111.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.608 0.718 . . . . 0.0 110.847 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.723 HD21 ' H ' ' A' ' 106' ' ' ASN . 31.1 tp -92.18 62.04 4.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.468 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 114' ' ' SER . 86.9 tttt -94.32 122.94 37.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.3 m -76.12 35.27 0.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.308 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.448 ' H ' ' C ' ' A' ' 112' ' ' LYS . 11.4 t -159.79 83.01 0.73 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.6 m -59.13 -31.23 68.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.249 0.547 . . . . 0.0 110.493 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.272 179.278 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.834 0.35 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -73.96 140.74 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.336 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.2 m -75.98 -66.4 0.79 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.489 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 42.77 79.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.573 ' CD1' HG11 ' A' ' 92' ' ' VAL . 3.1 p90 -59.23 -34.54 72.31 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.226 0.536 . . . . 0.0 110.618 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.66 -21.76 66.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.529 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.73 -18.79 65.34 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.595 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 50.2 m -142.65 18.39 2.01 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.525 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -118.17 136.07 53.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 110.822 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -133.8 154.19 51.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.572 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.26 61.8 6.9 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.291 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 35.6 m -93.3 144.59 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.293 0.568 . . . . 0.0 111.608 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -135.88 136.7 40.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.84 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.804 HD21 HD22 ' A' ' 64' ' ' LEU . 37.3 tp -122.63 119.77 31.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.976 0.417 . . . . 0.0 110.762 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.56 ' O ' HG12 ' A' ' 18' ' ' ILE . 28.8 t80 -127.93 109.39 11.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.019 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 62' ' ' THR . . . 72.98 -67.16 1.41 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.791 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.9 p90 -164.56 19.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.795 0.438 . . . . 0.0 110.653 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.583 HG22 ' ND2' ' A' ' 36' ' ' ASN . 43.5 pt -117.47 122.61 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.02 0.438 . . . . 0.0 110.569 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.474 ' HB2' HD22 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -109.21 114.67 28.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.788 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.2 ttt85 -115.71 140.92 48.75 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.82 176.74 41.81 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.142 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 2.7 m-20 -104.88 109.06 20.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.621 0.248 . . . . 0.0 110.417 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -107.61 132.86 52.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.942 0.401 . . . . 0.0 110.403 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 57.9 mt -67.38 136.15 27.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.452 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -103.68 -174.03 2.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.197 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -54.62 -29.67 52.6 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.01 -25.82 68.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.819 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.52 -4.4 56.68 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.787 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -106.76 145.11 30.41 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 37.2 Cg_endo -66.37 134.02 34.59 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.904 2.403 . . . . 0.0 112.764 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -122.58 123.76 41.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.311 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.07 130.19 44.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.293 0.568 . . . . 0.0 111.761 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 t -144.05 164.96 29.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.478 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.3 p -140.47 138.33 34.57 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.65 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.02 145.48 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 120.838 0.351 . . . . 0.0 110.723 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 18' ' ' ILE . 9.5 m120 -104.07 91.58 4.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 110.015 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -57.75 -25.42 60.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.171 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.0 t-20 -55.29 -30.47 60.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.692 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -103.21 11.03 37.42 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.47 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -126.71 -26.96 3.15 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 mp -110.64 140.89 27.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.64 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -112.6 171.5 14.04 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.481 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -113.86 108.25 16.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.608 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -111.92 105.94 14.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.635 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.808 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 52.6 t30 57.34 41.01 27.18 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.177 0.513 . . . . 0.0 110.78 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.62 15.75 81.3 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.132 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.03 145.74 48.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.832 0.349 . . . . 0.0 111.054 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 HD13 ' SG ' ' A' ' 59' ' ' CYS . 9.7 mp -75.09 119.31 19.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.268 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 49.0 tt0 -109.93 136.42 49.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.783 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.549 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -39.65 -68.01 0.26 Allowed Pre-proline 0 CA--C 1.426 -3.82 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.347 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.504 ' HD2' ' HG2' ' A' ' 49' ' ' GLU . 2.4 Cg_endo -109.74 126.62 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.32 0 C-N-CA 113.69 -3.74 . . . . 0.0 113.328 -178.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.64 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -164.49 -161.53 13.71 Favored Glycine 0 C--N 1.283 -2.408 0 CA-C-N 113.693 -1.594 . . . . 0.0 113.372 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -153.24 147.76 26.07 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.777 0.339 . . . . 0.0 110.586 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m 56.86 37.34 28.73 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 8.4 p90 -71.24 -35.7 71.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.4 0.619 . . . . 0.0 109.466 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.93 -18.38 70.59 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.165 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 m -72.47 -7.59 50.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.173 0.511 . . . . 0.0 110.894 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 56.3 m -146.3 23.01 1.33 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.16 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -128.25 154.79 45.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 111.893 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.494 HG21 ' HD2' ' A' ' 61' ' ' LYS . 25.3 m -141.39 174.38 7.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.73 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HD2' HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER 63.17 29.61 16.06 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.238 0.215 . . . . 0.0 111.245 -179.199 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 16' ' ' GLY . 4.0 p -60.98 117.72 5.82 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.201 0.524 . . . . 0.0 111.193 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.35 161.39 42.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.93 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.804 HD22 HD21 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -120.04 113.32 20.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.022 -178.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.581 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 2.6 t-20 -84.9 128.52 34.66 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 t70 52.59 20.09 1.41 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.414 1.071 . . . . 0.0 112.014 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.99 35.11 86.15 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.324 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.581 ' HD2' ' O ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -148.49 -23.55 0.33 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.152 0.476 . . . . 0.0 111.549 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.41 ' O ' HD11 ' A' ' 64' ' ' LEU . 55.5 m -116.67 129.66 56.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.173 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.56 ' HB2' HD13 ' A' ' 88' ' ' LEU . 13.8 tp -96.14 128.08 42.73 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.1 130.17 56.68 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.863 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.47 155.4 22.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.378 0.608 . . . . 0.0 111.303 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 59' ' ' CYS . 7.9 t -105.93 108.28 19.71 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.801 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.0 m -105.1 149.27 26.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.448 0.642 . . . . 0.0 111.765 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 11.3 tmtt? -100.43 141.31 33.46 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.572 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.33 -30.9 0.48 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.485 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.808 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -49.34 -41.24 38.22 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -172.67 49.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.215 0.531 . . . . 0.0 110.144 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.52 1.9 62.43 Favored Glycine 0 C--O 1.23 -0.132 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.249 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -122.0 162.34 21.31 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 36.3 p90 -104.73 170.31 7.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.91 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.3 OUTLIER -157.17 133.76 9.95 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 112.42 7.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.009 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.6 p -125.82 175.04 7.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.978 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.99 163.83 29.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.9 0.381 . . . . 0.0 110.819 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.773 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 3.4 tpt -151.88 120.9 6.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 50.4 m-20 -74.89 106.78 6.58 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HA ' HG23 ' A' ' 91' ' ' VAL . 15.4 mt -75.28 -9.43 58.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -47.99 -31.18 5.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.399 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 87' ' ' ASP . 4.0 p90 -117.3 21.35 13.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.61 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -126.69 -11.64 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.064 0.459 . . . . 0.0 110.484 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.881 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.4 p -153.07 138.36 10.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.832 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.481 ' HA2' ' N ' ' A' ' 5' ' ' PHE . . . -134.86 -169.45 11.93 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.013 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -125.85 139.67 53.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.613 0.244 . . . . 0.0 110.451 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.14 109.64 4.01 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 62.54 43.27 7.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.49 25.02 62.47 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.529 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.17 148.72 52.04 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 120.919 0.39 . . . . 0.0 110.693 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 15.9 ptt? -57.44 118.49 5.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.925 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -132.36 76.77 71.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.563 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.881 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.7 Cg_endo -71.86 87.88 0.82 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.785 2.323 . . . . 0.0 112.681 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.8 p -110.79 130.87 55.46 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.019 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -112.44 149.63 32.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.454 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.31 61.12 0.62 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.025 0.441 . . . . 0.0 110.19 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.9 t -175.39 -113.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.495 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 66.3 105.16 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.849 0.718 . . . . 0.0 111.161 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 64.85 109.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.901 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -138.21 156.51 47.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.861 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.414 ' CD2' HG11 ' A' ' 110' ' ' VAL . 86.2 t60 -52.4 -45.55 65.93 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.66 0.6 . . . . 0.0 111.134 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.414 HG11 ' CD2' ' A' ' 109' ' ' HIS . 6.5 m -128.51 57.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.698 0.761 . . . . 0.0 111.677 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.38 73.93 4.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.972 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -132.88 28.1 4.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.076 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.9 t 56.27 41.05 29.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.627 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.4 m -144.38 94.9 2.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.633 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.0 t -70.99 -29.3 65.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.354 -179.361 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.786 0.327 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -106.48 142.42 36.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.654 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.5 m -118.83 -55.32 2.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.74 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 55.08 79.39 0.15 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.956 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.481 ' HE1' ' HB2' ' A' ' 88' ' ' LEU . 14.5 p90 -56.76 -38.18 72.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.523 . . . . 0.0 111.158 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.03 -26.61 67.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.677 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -71.38 -6.51 40.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.673 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.3 m -137.67 8.04 2.8 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.765 0.316 . . . . 0.0 110.661 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -120.96 149.99 41.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.843 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.3 p -137.93 147.53 44.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.362 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.67 57.51 17.42 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.567 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 15.3 m -98.57 130.35 47.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.139 0.495 . . . . 0.0 111.817 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -127.4 137.5 52.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.511 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.61 HD21 HD23 ' A' ' 64' ' ' LEU . 18.3 tp -111.09 105.39 14.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -135.79 117.11 14.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.59 34.66 38.93 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.886 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.568 ' HD1' HG22 ' A' ' 62' ' ' THR . 19.8 m-85 65.27 23.07 12.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.053 0.541 . . . . 0.0 110.701 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 9.2 mt -122.05 125.49 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.003 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.514 ' HB2' HD22 ' A' ' 37' ' ' LEU . 1.4 mt -108.07 114.22 27.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.007 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 4.6 ttm180 -116.86 140.23 49.69 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.989 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.483 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.08 177.99 41.48 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.265 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -104.69 110.86 23.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.591 0.234 . . . . 0.0 110.565 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.9 OUTLIER -107.09 132.52 52.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.6 mt -69.9 134.31 30.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.027 0.441 . . . . 0.0 111.497 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -103.14 -173.11 2.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.842 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.93 -26.12 64.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.813 0.339 . . . . 0.0 111.909 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.75 -23.43 67.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.69 2.07 63.36 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.811 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -113.02 146.11 34.47 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.828 0.347 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -66.26 125.76 14.55 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.236 2.624 . . . . 0.0 112.705 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -109.59 127.46 54.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.255 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.81 126.63 30.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.973 0.416 . . . . 0.0 111.209 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -143.09 162.51 35.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.445 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.2 p -139.59 133.58 30.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.457 0.17 . . . . 0.0 110.709 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.23 143.01 25.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.253 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.08 92.82 5.17 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -58.56 -25.61 62.69 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.722 -178.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.551 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 22.8 t-20 -54.18 -31.7 53.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.376 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -107.61 16.4 23.77 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.0 m-85 -129.5 -22.32 3.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -112.66 141.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.626 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.0 174.26 15.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.363 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -112.82 108.32 17.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.9 0.381 . . . . 0.0 110.71 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -111.59 105.24 13.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.679 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.691 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 41.5 t30 56.75 42.59 26.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.146 0.498 . . . . 0.0 110.696 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.44 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 73.7 18.03 79.37 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.733 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.98 146.91 49.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 111.229 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.543 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 7.5 mp -72.38 114.32 10.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.616 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -108.79 132.04 54.37 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.424 ' HD1' ' CE ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -31.21 -74.12 0.05 OUTLIER Pre-proline 0 CA--C 1.432 -3.568 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.184 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.452 ' O ' HD22 ' A' ' 111' ' ' LEU . 10.7 Cg_endo -108.89 129.43 0.04 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.242 0 C-N-CA 113.852 -3.632 . . . . 0.0 112.913 -177.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.626 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -161.44 -163.28 14.08 Favored Glycine 0 C--N 1.278 -2.683 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.016 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -153.38 143.22 22.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.013 0.435 . . . . 0.0 110.892 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.5 m 57.15 35.1 25.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.169 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 7.2 p90 -64.81 -34.16 77.7 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.03 -17.61 37.56 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.165 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 t -68.26 -30.82 69.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.739 0.304 . . . . 0.0 110.625 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 m -125.29 6.32 7.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.192 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -120.48 141.38 50.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.684 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.8 m -137.5 171.84 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? 63.61 43.35 5.8 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.774 0.671 . . . . 0.0 111.457 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.568 HG22 ' HD1' ' A' ' 17' ' ' TYR . 4.2 p -69.28 133.6 48.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.072 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.71 163.97 38.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.698 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.61 HD23 HD21 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -120.62 112.87 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.666 0.27 . . . . 0.0 111.647 -179.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.584 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 16.9 m120 -72.18 116.93 13.19 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.224 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.7 t70 54.08 15.17 0.83 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.955 0.784 . . . . 0.0 111.929 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.31 34.41 57.79 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.836 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -147.83 -26.1 0.36 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.7 0.75 . . . . 0.0 112.001 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 18.5 m -116.08 134.59 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.495 0.188 . . . . 0.0 111.058 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.543 ' HG ' ' CD2' ' A' ' 48' ' ' LEU . 24.3 tp -94.64 133.5 38.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.582 0.23 . . . . 0.0 110.613 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.71 130.57 52.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.855 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.485 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -163.19 163.31 25.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.8 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 t -109.68 126.82 54.08 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.44 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 17.5 m -124.85 150.36 46.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.22 0.533 . . . . 0.0 112.153 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.0 tmtt? -100.27 140.55 34.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.721 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.45 -30.49 0.52 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.145 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.691 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.19 -40.31 64.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -171.21 51.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.416 0.627 . . . . 0.0 110.053 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.71 5.21 56.11 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.782 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -129.34 162.14 28.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 47.9 p90 -90.14 160.11 16.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.309 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -153.87 133.04 12.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.48 124.75 24.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.702 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.8 p -138.45 171.0 15.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.766 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.17 159.41 41.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.965 0.412 . . . . 0.0 110.521 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.435 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 12.0 tpp -143.28 123.76 13.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.505 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.458 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 10.8 m-20 -73.1 105.74 4.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.247 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.1 mt -76.18 -8.61 57.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.909 0.385 . . . . 0.0 110.426 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.11 -28.73 7.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.943 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' A' ' 87' ' ' ASP . 44.1 p90 -120.16 22.77 11.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.982 0.42 . . . . 0.0 110.973 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -128.72 -9.93 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.594 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.988 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -138.93 140.6 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.235 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.01 176.47 20.91 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.305 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -121.66 123.31 41.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.632 0.253 . . . . 0.0 110.972 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 57.9 m -127.82 94.34 3.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.601 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 64.67 47.07 2.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.49 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.62 20.97 66.57 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.366 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -124.17 139.0 54.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -57.52 122.38 12.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.99 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -142.93 78.34 15.54 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.788 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.988 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.0 Cg_endo -71.78 96.38 0.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.884 2.389 . . . . 0.0 113.215 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.0 p -90.76 133.0 35.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.66 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.38 147.2 39.54 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -103.72 45.2 0.97 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.292 0.568 . . . . 0.0 110.489 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.5 t -165.89 -125.89 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.309 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.71 ' HA ' HD21 ' A' ' 111' ' ' LEU . 6.8 t-20 63.16 33.72 14.18 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.922 0.889 . . . . 0.0 110.583 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -154.4 -171.07 3.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.132 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 66.99 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.733 0.813 . . . . 0.0 111.547 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -67.31 157.44 33.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.846 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.9 m -70.65 60.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.762 0.792 . . . . 0.0 112.689 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 106' ' ' ASN . 39.7 tp -82.27 3.81 26.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.179 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 84.5 tttt -109.16 13.44 24.45 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.556 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.0 t 54.32 39.61 31.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.084 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -97.84 74.18 2.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.023 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.5 m -65.26 -46.03 82.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.696 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.197 179.815 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.643 0.258 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -131.73 -167.53 1.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 88.7 m -119.59 -72.45 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.94 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.482 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 58.4 m-80 52.17 82.73 0.06 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 14.4 p90 -60.77 -34.83 75.05 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.289 0.566 . . . . 0.0 110.507 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.85 -19.16 60.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.235 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.482 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 7.4 t-20 -51.22 -33.42 27.74 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.438 0.461 . . . . 0.0 111.532 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 m -136.5 27.14 3.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.941 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.591 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -120.41 132.81 55.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.088 0.471 . . . . 0.0 111.161 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 p -131.87 155.74 47.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.988 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.76 30.43 74.55 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.318 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.526 HG13 ' HA3' ' A' ' 21' ' ' GLY . 17.5 m -77.45 134.34 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.029 0.443 . . . . 0.0 111.669 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.73 151.88 49.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.697 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.658 HD23 HD21 ' A' ' 64' ' ' LEU . 8.8 tp -121.92 106.33 11.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.006 0.431 . . . . 0.0 111.176 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -134.21 114.73 13.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.789 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.76 38.45 49.97 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.738 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CD1' HG21 ' A' ' 62' ' ' THR . 18.1 m-85 64.2 25.6 13.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.199 0.6 . . . . 0.0 110.886 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.56 124.81 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.133 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.54 HD23 HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -102.74 113.76 27.44 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 20' ' ' ARG . 15.2 ttm180 -123.04 133.74 54.32 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.7 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.526 ' HA3' HG13 ' A' ' 12' ' ' VAL . . . -162.79 -173.38 31.43 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.13 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -106.55 109.53 21.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.626 0.25 . . . . 0.0 110.662 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -104.82 132.08 51.5 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.1 mt -71.74 142.19 15.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -109.5 -171.12 1.78 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.399 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -54.91 -31.22 59.89 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.88 -9.68 58.8 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.16 5.23 85.87 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.845 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.4 133.94 20.4 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.869 0.366 . . . . 0.0 110.168 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.48 138.53 81.04 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 123.246 2.63 . . . . 0.0 112.741 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -123.41 135.87 54.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.32 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 112.39 5.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.214 0.53 . . . . 0.0 110.828 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -131.1 156.75 44.71 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.601 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 99' ' ' MET . 19.9 p -139.57 147.0 40.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.102 0.477 . . . . 0.0 111.603 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -129.74 143.96 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.563 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.06 89.77 3.38 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.54 HD21 HD23 ' A' ' 19' ' ' LEU . 1.2 mm? -54.29 -30.44 50.82 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.61 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.533 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.3 t-20 -54.33 -28.34 41.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.468 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -108.76 14.67 24.18 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.643 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -128.05 -24.2 3.21 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.4 143.03 22.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.638 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -112.61 170.58 13.54 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.56 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -113.84 111.35 21.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.294 -0.453 . . . . 0.0 111.35 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -110.63 104.35 13.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.76 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.523 HD21 ' HA ' ' A' ' 77' ' ' ALA . 9.4 m120 48.08 47.04 19.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.126 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.51 12.51 84.19 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.673 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.39 143.97 47.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.832 0.349 . . . . 0.0 110.667 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 mp -76.94 114.29 15.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.516 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -103.39 136.97 42.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.089 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.563 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -39.23 -76.19 0.05 OUTLIER Pre-proline 0 CA--C 1.436 -3.416 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.594 ' HG2' ' HB2' ' A' ' 106' ' ' ASN . 20.5 Cg_endo -109.95 125.64 0.04 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.324 0 C-N-CA 113.751 -3.699 . . . . 0.0 113.165 -177.342 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.638 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -155.67 -157.55 8.33 Favored Glycine 0 C--N 1.284 -2.36 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.664 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -151.56 143.31 23.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 111.052 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 m 49.82 44.9 25.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.533 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 11.5 p90 -68.97 -31.08 69.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 59' ' ' CYS . . . -62.22 -18.21 57.47 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.196 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -53.9 -30.66 47.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.315 0.246 . . . . 0.0 110.904 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 25.1 m -135.48 17.75 3.36 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.429 ' HB2' ' HA2' ' A' ' 56' ' ' GLY . 7.5 m -108.08 147.73 30.79 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.45 0.643 . . . . 0.0 112.238 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.74 173.3 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.995 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 59.94 35.91 21.68 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.427 0.291 . . . . 0.0 111.432 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.443 HG21 ' CD1' ' A' ' 17' ' ' TYR . 16.7 p -68.31 120.09 13.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.992 0.425 . . . . 0.0 111.488 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.85 152.49 30.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.728 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.658 HD21 HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -108.34 112.75 25.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.525 0.202 . . . . 0.0 110.59 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -76.08 117.49 17.84 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.8 t70 58.48 18.04 5.36 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.081 0.863 . . . . 0.0 111.044 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.06 32.52 84.38 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.413 -0.812 . . . . 0.0 114.082 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -141.9 -27.26 0.65 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 117.811 0.805 . . . . 0.0 111.249 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.9 m -116.01 126.24 53.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.223 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' A' ' 64' ' ' LEU . 16.8 tp -89.97 126.58 35.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.162 0.506 . . . . 0.0 109.783 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.67 130.47 56.37 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.305 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.31 166.47 27.49 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.661 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 t -118.26 117.57 29.48 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -114.32 154.21 28.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.544 0.688 . . . . 0.0 111.828 -179.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 7.8 tmtt? -100.36 149.27 23.8 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.826 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.31 -15.53 1.87 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.829 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.523 ' HA ' HD21 ' A' ' 45' ' ' ASN . . . -58.78 -40.77 84.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.687 0.28 . . . . 0.0 110.744 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 178.24 58.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.698 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.13 19.68 74.17 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -143.82 161.34 38.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 51.4 p90 -101.82 165.5 11.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.318 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.96 152.84 40.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.408 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.86 131.09 37.45 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.8 p -149.58 172.68 14.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.95 0.405 . . . . 0.0 111.286 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.85 163.29 31.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.99 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.639 ' HE1' ' HA ' ' A' ' 86' ' ' MET . 4.6 tpt -146.67 113.05 5.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.472 ' H ' ' HE1' ' A' ' 86' ' ' MET . 0.9 OUTLIER -72.4 106.49 4.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.009 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.581 ' HB2' ' HE1' ' A' ' 5' ' ' PHE . 14.4 mt -74.47 -7.62 53.6 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.762 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -46.83 -30.76 2.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.874 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -118.63 19.14 13.33 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.628 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -125.14 -10.01 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.313 0.578 . . . . 0.0 110.154 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.852 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.1 t -141.79 139.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.525 178.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.92 176.42 18.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.519 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -129.48 133.54 47.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.61 0.243 . . . . 0.0 110.454 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.4 t -142.38 111.49 6.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.88 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 57.65 43.55 22.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.401 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.56 7.56 65.01 Favored Glycine 0 C--N 1.33 0.218 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.455 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.9 145.16 41.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -68.91 131.22 44.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.224 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -136.67 76.03 48.79 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.693 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.852 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 35.2 Cg_endo -66.27 119.36 6.38 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.438 2.092 . . . . 0.0 111.322 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 p -109.3 144.63 37.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.826 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.37 129.9 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.69 15.6 17.57 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.971 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.0 m -157.16 9.78 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.594 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 14.9 t-20 -111.13 74.79 0.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.589 0.709 . . . . 0.0 109.832 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.5 -47.01 0.07 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.93 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.37 177.27 7.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.833 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -115.71 -21.12 9.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.688 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.9 64.54 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.72 0.771 . . . . 0.0 110.369 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 tt -92.95 78.27 4.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.335 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -128.75 96.21 4.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.908 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.6 t -56.61 112.31 1.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.458 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 41.3 t -144.44 125.57 14.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.049 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.0 m -75.19 -43.13 53.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.066 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.359 179.445 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -82.27 137.94 34.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.601 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 82.0 m -75.81 -81.49 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.821 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.456 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 24.4 m-80 51.76 69.09 0.7 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.651 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 17.5 p90 -58.1 -41.66 83.98 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.25 0.547 . . . . 0.0 110.21 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.94 -21.62 65.09 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.821 -178.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.456 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 28.2 t-20 -54.71 -33.72 61.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.333 0.587 . . . . 0.0 110.802 -179.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.1 m -134.69 28.4 3.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.076 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.651 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -120.0 134.88 55.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.943 0.401 . . . . 0.0 110.584 179.267 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 p -128.25 152.19 48.39 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.985 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.84 57.91 12.68 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.756 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.531 HG12 ' HA3' ' A' ' 21' ' ' GLY . 15.5 m -104.83 132.12 52.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.962 0.41 . . . . 0.0 110.824 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -133.27 156.69 47.11 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.739 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.651 HD22 HD21 ' A' ' 64' ' ' LEU . 21.9 tp -121.33 127.73 51.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.542 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.431 ' O ' HG12 ' A' ' 18' ' ' ILE . 42.7 t80 -131.23 98.92 4.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.836 179.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 62' ' ' THR . . . 78.41 -63.77 3.61 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.709 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' HD1' HD22 ' A' ' 36' ' ' ASN . 6.4 p90 -169.15 23.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.724 0.297 . . . . 0.0 111.47 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.7 pt -121.57 133.91 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.798 0.332 . . . . 0.0 110.659 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.526 HD22 HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -115.72 114.28 24.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.828 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.46 140.55 51.23 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.531 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.22 -177.71 39.03 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.96 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 7.1 m-20 -109.63 108.3 18.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.439 0.162 . . . . 0.0 110.609 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.9 m -104.54 132.38 50.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.5 mt -69.58 133.43 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.56 -178.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -94.68 -176.59 3.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.917 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -54.72 -37.71 66.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.727 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.81 -30.02 67.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.938 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.03 -2.01 31.53 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.322 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -104.49 139.69 20.35 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.372 . . . . 0.0 110.944 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 42.8 Cg_endo -69.91 125.99 12.7 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.921 2.414 . . . . 0.0 111.67 179.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -112.02 136.88 50.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.048 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.3 123.77 21.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.453 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -140.01 158.36 44.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.602 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.0 p -140.1 141.86 36.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.743 0.306 . . . . 0.0 111.192 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -124.86 145.4 32.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.588 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.458 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -103.74 95.82 6.29 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.75 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.526 HD21 HD22 ' A' ' 19' ' ' LEU . 1.3 mm? -58.54 -26.9 64.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.742 0.306 . . . . 0.0 111.337 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -55.41 -24.12 28.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.863 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -112.86 12.37 19.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.58 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -129.02 -12.03 4.7 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.62 133.9 68.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -108.67 170.92 15.13 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.577 -179.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -110.88 102.49 10.99 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.299 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -110.57 105.64 14.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.889 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 14.3 t-20 52.6 47.37 24.83 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.708 0.766 . . . . 0.0 111.094 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.69 75.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.933 179.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -120.27 151.79 38.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.797 0.332 . . . . 0.0 110.672 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.491 HD23 ' HG ' ' A' ' 70' ' ' LEU . 10.8 mp -85.5 117.01 24.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.892 -179.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -110.57 126.8 54.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.183 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.609 ' HB2' ' CG1' ' A' ' 91' ' ' VAL 0.252 53.5 p90 -61.13 -12.06 0.2 Allowed Pre-proline 0 CA--C 1.452 -2.811 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 -174.804 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.774 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 8.3 Cg_endo -128.62 9.22 0.0 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.601 1 C-N-CA 112.461 -4.56 . . . . 0.0 114.972 175.693 . . . . . . . . 4 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -66.94 -167.72 3.05 Favored Glycine 0 C--N 1.27 -3.106 0 CA-C-N 110.849 -2.887 . . . . 0.0 115.69 -177.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -145.59 154.56 42.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.721 0.296 . . . . 0.0 110.928 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.8 m 55.76 45.28 24.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 10.4 p90 -79.61 -36.7 37.63 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.845 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.54 -18.38 69.83 Favored Glycine 0 CA--C 1.505 -0.533 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.83 -178.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 m -66.7 -13.21 61.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.049 -0.576 . . . . 0.0 110.779 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.4 m -149.02 26.84 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.617 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -124.55 155.36 39.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.162 0.506 . . . . 0.0 111.123 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.6 m -141.62 171.1 12.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.816 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 62.46 31.77 16.98 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.523 0.514 . . . . 0.0 111.345 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 16' ' ' GLY . 2.6 p -59.66 123.16 16.02 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.926 0.393 . . . . 0.0 111.489 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.45 162.88 40.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.315 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.651 HD21 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -121.98 112.62 18.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -85.33 124.8 32.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 110.959 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 t70 56.36 21.36 5.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.048 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.94 36.06 92.28 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.33 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -154.48 -23.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.571 0.686 . . . . 0.0 112.393 179.008 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 m -116.35 128.48 55.57 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.22 -0.3 . . . . 0.0 111.143 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.545 ' HA ' HD23 ' A' ' 64' ' ' LEU . 11.8 tp -91.3 129.73 37.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.297 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.84 129.75 53.67 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.657 178.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.91 165.56 24.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.133 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -117.01 111.78 20.04 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 56.7 m -103.38 146.14 28.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.414 0.626 . . . . 0.0 110.742 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.2 tmtt? -100.59 140.49 34.78 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.883 177.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.73 -24.46 0.3 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.909 -1.139 . . . . 0.0 112.992 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . . . -47.97 -45.85 31.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.0 111.135 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.2 t70 178.72 58.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.917 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.57 -0.16 65.71 Favored Glycine 0 C--O 1.229 -0.189 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.695 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -118.23 163.95 15.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.172 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 50.5 p90 -111.77 169.54 8.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.071 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -155.95 135.19 12.21 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -72.05 114.65 10.38 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.291 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.8 t -130.55 167.53 18.54 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.977 0.418 . . . . 0.0 110.418 -179.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.03 160.93 38.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.163 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.892 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 0.6 OUTLIER -146.04 126.25 13.86 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.327 -179.611 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -78.28 108.78 11.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.144 0.497 . . . . 0.0 109.874 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.56 ' HA ' HG21 ' A' ' 91' ' ' VAL . 13.1 mt -82.26 -9.25 59.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.586 -179.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -52.21 -26.27 11.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.489 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -116.54 17.76 15.27 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.066 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.61 ' HA ' ' O ' ' A' ' 102' ' ' CYS . 2.5 m -123.7 -10.57 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 121.188 0.518 . . . . 0.0 110.476 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -133.73 124.16 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -114.98 159.03 13.95 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.44 178.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -107.81 121.94 45.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.4 m -137.12 107.16 6.31 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.809 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 61.01 40.74 14.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.326 178.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.73 18.31 68.11 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.606 -0.725 . . . . 0.0 113.164 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -124.75 147.97 48.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -66.01 127.77 33.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.867 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -133.61 75.07 69.47 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.289 178.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 31.6 Cg_endo -62.19 135.48 54.71 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.734 2.289 . . . . 0.0 112.218 -179.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 5.7 p -123.45 111.6 16.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.578 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.446 ' HB2' ' CB ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -89.56 147.9 23.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.421 ' HB1' ' HE2' ' A' ' 50' ' ' TYR . . . -135.82 30.23 3.12 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.812 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.3 m -166.46 9.97 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.774 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 12.4 t-20 -99.86 -1.05 38.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.849 0.833 . . . . 0.0 109.661 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -86.75 -31.34 20.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.592 179.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.55 153.16 22.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.979 178.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -113.9 178.73 4.18 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.611 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 m 37.93 66.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 122.371 1.081 . . . . 0.0 112.023 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.657 HD21 ' H ' ' A' ' 111' ' ' LEU . 2.4 pt? -108.61 18.66 20.63 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.003 -178.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -65.86 115.89 6.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.123 179.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.7 p -77.48 68.9 3.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.404 0.621 . . . . 0.0 110.48 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 41.6 t -161.03 136.09 7.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.938 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -61.12 -33.66 73.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.525 178.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.25 1.079 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.327 -179.683 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 110.764 -0.087 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 58.96 102.17 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.896 0.855 . . . . 0.0 112.577 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.9 m -70.97 -77.38 0.09 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.742 179.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 41.82 76.04 0.08 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 3.4 p90 -62.19 -32.68 73.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.006 0.431 . . . . 0.0 111.035 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.6 -22.31 65.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -63.05 -27.18 69.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.0 m -129.87 28.7 5.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.733 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -129.75 144.81 51.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.927 0.394 . . . . 0.0 111.104 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.1 p -140.39 147.39 39.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.061 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.13 48.14 55.01 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.893 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.507 HG13 ' HA3' ' A' ' 21' ' ' GLY . 18.1 m -93.5 132.75 36.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.202 0.525 . . . . 0.0 111.083 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -126.6 154.86 43.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.672 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.711 HD23 HD23 ' A' ' 64' ' ' LEU . 16.2 tp -123.8 119.44 29.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.872 0.368 . . . . 0.0 111.41 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.535 ' O ' HG12 ' A' ' 18' ' ' ILE . 29.2 m-85 -118.01 99.21 6.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.158 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 62' ' ' THR . . . 73.44 -61.92 1.89 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.975 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 28.1 p90 -165.39 21.15 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.868 0.366 . . . . 0.0 111.211 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.569 HG22 ' ND2' ' A' ' 36' ' ' ASN . 35.4 pt -118.82 127.54 75.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.922 0.391 . . . . 0.0 110.552 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.519 HD22 ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -108.82 117.64 34.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.695 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 20' ' ' ARG . 6.1 tmm_? -128.85 138.22 51.92 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.737 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.507 ' HA3' HG13 ' A' ' 12' ' ' VAL . . . -166.78 -168.54 29.12 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.937 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -112.34 110.66 21.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.737 0.303 . . . . 0.0 111.078 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 m -106.38 132.98 51.78 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.7 mt -67.41 136.34 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.83 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.34 -174.46 2.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.355 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -52.79 -33.41 48.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.481 0.488 . . . . 0.0 112.098 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.68 -28.18 69.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.786 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.06 -4.04 48.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.514 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -104.87 146.08 31.95 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.808 0.337 . . . . 0.0 110.524 179.231 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 37.1 Cg_endo -67.52 130.6 22.6 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.805 2.337 . . . . 0.0 112.137 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -118.96 132.38 56.07 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.743 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.82 126.25 27.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.41 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 t -143.03 158.7 43.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.649 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 p -138.98 151.17 46.64 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.542 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -136.25 147.24 28.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.316 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.569 ' ND2' HG22 ' A' ' 18' ' ' ILE . 8.6 m120 -104.38 96.05 6.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.897 0.379 . . . . 0.0 110.785 179.299 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.515 HD22 HD21 ' A' ' 19' ' ' LEU . 1.2 mm? -60.39 -28.5 68.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.008 -179.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.461 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 24.4 t-20 -55.81 -26.56 46.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.2 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.05 11.93 22.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.484 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.9 m-85 -128.71 -20.28 3.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.69 141.32 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.597 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.32 176.54 17.05 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.105 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -116.71 106.62 13.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.889 0.376 . . . . 0.0 110.695 -178.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -111.87 107.27 16.25 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.376 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.842 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 55.1 t30 56.02 40.79 30.27 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.037 0.446 . . . . 0.0 110.533 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.41 19.6 79.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.509 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -123.89 157.06 35.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.848 0.356 . . . . 0.0 110.568 -179.584 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.05 116.63 21.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.234 -178.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.18 128.77 51.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.596 179.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.559 ' HD2' ' HE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -36.83 -76.22 0.04 OUTLIER Pre-proline 0 CA--C 1.43 -3.639 0 CA-C-O 117.697 -1.144 . . . . 0.0 112.819 -179.825 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.741 ' HG2' ' HA ' ' A' ' 106' ' ' ASN . 6.0 Cg_endo -108.68 123.98 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.273 1 C-N-CA 113.199 -4.067 . . . . 0.0 113.083 -178.661 . . . . . . . . 4 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.597 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -152.35 -160.75 9.77 Favored Glycine 0 C--N 1.281 -2.509 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.939 -177.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -154.87 142.76 20.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.693 0.282 . . . . 0.0 110.583 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.1 m 56.48 42.49 27.34 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.184 178.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 14.9 p90 -71.75 -35.61 70.17 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.07 -18.69 48.98 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.321 -178.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 m -64.4 -16.55 62.55 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.06 0.544 . . . . 0.0 111.01 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 m -148.22 23.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.884 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.7 m -129.99 138.67 50.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.26 0.552 . . . . 0.0 111.093 -179.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.1 m -133.06 178.09 6.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.295 179.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 62.81 37.09 12.6 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.415 0.447 . . . . 0.0 111.329 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 16' ' ' GLY . 12.6 p -67.84 123.2 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.86 149.73 27.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.92 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.711 HD23 HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -106.34 115.01 29.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.853 0.359 . . . . 0.0 110.724 -179.639 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -85.94 120.37 27.27 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.195 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.69 23.36 10.98 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.924 0.765 . . . . 0.0 111.925 179.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.93 32.19 59.1 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 114.361 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -148.09 -25.15 0.35 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.376 0.588 . . . . 0.0 111.436 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.6 m -114.81 126.39 54.77 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.777 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.493 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.0 tp -89.83 132.72 35.11 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.45 129.56 52.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.748 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.19 166.93 28.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 110.521 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 t -114.79 122.66 47.05 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 57.2 m -122.44 149.68 43.52 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.4 tmtt? -99.96 140.45 34.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.824 178.148 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.61 -32.07 0.3 Allowed Glycine 0 C--O 1.227 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.18 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.842 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -52.95 -41.16 64.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -173.55 52.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.618 0.723 . . . . 0.0 109.811 -179.094 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.21 10.01 61.65 Favored Glycine 0 C--O 1.225 -0.418 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.096 -179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -131.78 158.67 40.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 17.4 p90 -100.72 166.3 10.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -158.53 149.12 20.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -69.59 139.33 53.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.931 0.396 . . . . 0.0 110.636 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.3 t -152.01 162.99 40.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.038 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.58 164.55 27.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.908 0.385 . . . . 0.0 110.021 179.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.855 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 2.6 tpt -148.7 121.38 8.63 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.689 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' HB2' ' HH ' ' A' ' 90' ' ' TYR . 19.2 m-20 -73.94 106.5 5.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.559 ' HA ' HG23 ' A' ' 91' ' ' VAL . 18.3 mt -75.76 -9.11 58.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.523 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.38 -31.33 3.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.079 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.559 ' HE1' ' HD2' ' A' ' 50' ' ' TYR . 3.2 p90 -119.57 23.59 11.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 111.564 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -127.53 -14.35 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.102 0.477 . . . . 0.0 110.505 178.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 1.011 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.5 p -150.79 133.81 6.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.691 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -128.03 -179.82 16.08 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.523 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -126.01 135.85 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.0 t -147.66 120.61 8.77 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 57.99 41.49 24.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.58 28.98 68.59 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.764 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -136.29 151.44 49.64 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.835 0.35 . . . . 0.0 110.139 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -61.9 127.89 33.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.071 -179.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -140.45 71.48 32.02 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.246 178.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 1.011 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 51.7 Cg_endo -70.91 100.73 0.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.77 2.314 . . . . 0.0 112.871 -179.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.17 116.31 32.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.031 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.75 149.66 21.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.48 -179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.41 ' O ' HD21 ' A' ' 111' ' ' LEU . . . -131.79 24.55 4.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -163.17 46.2 0.13 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.735 0.302 . . . . 0.0 111.446 -178.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.741 ' HA ' ' HG2' ' A' ' 51' ' ' PRO . 2.5 t-20 -88.86 20.4 3.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.836 0.35 . . . . 0.0 111.778 -178.389 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 111' ' ' LEU . . . -167.16 166.53 14.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.778 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.74 -57.88 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.235 0.541 . . . . 0.0 111.061 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -118.79 -41.45 2.79 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.921 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.19 58.42 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 122.74 1.257 . . . . 0.0 110.026 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 54.7 tp -81.84 89.21 6.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.355 -179.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 5.4 mmpt? -110.33 112.9 25.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.638 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.0 m -94.66 37.45 1.13 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.1 p -148.54 168.1 23.63 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.183 -1.372 . . . . 0.0 108.981 -178.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 m -70.67 -49.45 47.11 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 . . . . . 0 C--O 1.248 1.009 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.642 178.811 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtm . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 61.17 -161.53 0.29 Allowed 'General case' 0 C--N 1.332 -0.167 0 O-C-N 123.476 0.485 . . . . 0.0 110.789 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.3 m -116.67 -70.09 0.81 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.309 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.418 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 44.2 m-80 62.51 80.5 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 178.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 6.2 p90 -65.01 -35.87 82.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.066 178.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.9 64.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.871 -178.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.418 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 7.3 t-20 -52.18 -31.27 30.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.51 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.0 m -144.12 30.77 1.27 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.893 0.378 . . . . 0.0 110.721 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -119.48 142.17 48.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.024 179.156 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -141.44 157.53 45.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.395 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.79 61.03 7.66 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.723 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.547 HG12 ' HA3' ' A' ' 21' ' ' GLY . 30.9 m -100.71 139.02 23.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.91 0.386 . . . . 0.0 110.991 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 11.3 pt-20 -130.32 139.72 50.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.393 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 64' ' ' LEU . 51.9 tp -124.62 123.74 40.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.469 ' O ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-85 -133.67 103.65 5.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.412 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' O ' HG22 ' A' ' 62' ' ' THR . . . 79.37 -65.2 3.67 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.161 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.6 p90 -167.6 21.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.813 0.339 . . . . 0.0 111.313 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 45.6 pt -117.02 129.05 74.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.47 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.552 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -119.79 114.45 22.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.609 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 21.2 ttm180 -114.0 136.0 53.38 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.547 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -154.93 168.32 32.89 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.399 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -100.66 105.15 16.49 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -104.97 131.79 52.02 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.4 mt -70.71 136.2 26.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.646 -178.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -99.73 -176.5 3.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.404 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.37 -32.79 57.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.89 -29.04 69.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.022 0.439 . . . . 0.0 111.66 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.12 0.8 41.5 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.096 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -107.56 141.52 23.2 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.791 0.329 . . . . 0.0 110.656 179.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.62 130.23 21.69 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 122.966 2.444 . . . . 0.0 112.532 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -114.72 132.61 56.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.95 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.38 124.27 23.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.171 0.51 . . . . 0.0 111.638 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 t -143.22 152.94 42.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.413 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.7 p -135.7 145.5 46.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.506 0.193 . . . . 0.0 111.117 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.84 151.81 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.788 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.481 ' ND2' HG21 ' A' ' 18' ' ' ILE . 5.4 m120 -103.07 93.61 5.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.171 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.552 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -60.18 -24.48 64.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.797 -178.911 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.5 t-20 -55.09 -30.9 60.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.969 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -105.7 15.17 27.27 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.537 -178.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.1 m-85 -130.38 -24.62 2.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 mp -112.71 141.78 27.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.652 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.35 169.7 12.99 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.547 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -119.33 114.2 21.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.973 0.416 . . . . 0.0 110.933 -179.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -111.02 108.12 17.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.241 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 51.87 42.56 30.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.077 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' HA2' ' HB2' ' A' ' 74' ' ' CYS . . . 80.07 18.05 73.03 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.539 179.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.67 150.17 46.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.047 0.451 . . . . 0.0 111.2 -179.83 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.463 HD11 ' HG ' ' A' ' 70' ' ' LEU . 43.4 mt -82.43 116.19 21.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.14 -179.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -112.49 132.04 55.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.567 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -33.17 -73.67 0.06 OUTLIER Pre-proline 0 CA--C 1.427 -3.765 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.598 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 4.9 Cg_endo -107.85 130.48 0.05 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.327 0 C-N-CA 113.563 -3.824 . . . . 0.0 113.212 -176.669 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.652 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -163.89 -160.46 11.8 Favored Glycine 0 C--N 1.286 -2.204 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.322 -177.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -151.53 145.53 25.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 111.401 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m 51.57 41.79 28.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.774 178.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -69.33 -39.37 78.23 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.523 178.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.03 -18.08 46.54 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.24 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 t -68.82 -20.44 64.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.002 0.43 . . . . 0.0 110.166 179.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -134.49 17.25 3.66 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.402 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.7 m -125.8 143.13 51.19 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.97 0.414 . . . . 0.0 111.17 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.31 172.81 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.454 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 62.0 37.54 14.85 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.597 0.56 . . . . 0.0 111.359 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 16' ' ' GLY . 18.0 p -63.94 127.43 31.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.972 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.55 160.28 43.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.231 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -118.54 112.92 20.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.805 0.336 . . . . 0.0 110.967 -179.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.566 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 15.9 m120 -70.28 114.61 8.58 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.316 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.7 t70 55.2 3.32 0.06 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.145 0.903 . . . . 0.0 112.766 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 65' ' ' ASN . . . 86.84 47.78 4.66 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.475 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 2.2 p-80 -162.04 -30.06 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 111.684 178.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.566 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 23.9 m -115.89 134.15 55.28 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.692 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.592 ' HB2' HD13 ' A' ' 88' ' ' LEU . 12.3 tp -94.92 131.24 41.06 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.541 0.21 . . . . 0.0 110.482 179.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 128.99 53.81 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.77 162.57 37.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.165 0.507 . . . . 0.0 111.149 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -110.76 120.95 44.09 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.441 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 21.3 m -121.36 148.21 44.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.277 0.56 . . . . 0.0 112.303 -177.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 8.2 tmtt? -99.41 147.48 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.226 178.046 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.68 -18.55 0.87 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.005 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.72 81.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.823 0.311 . . . . 0.0 110.815 179.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.7 t70 179.13 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.205 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.52 -3.75 16.22 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.635 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -116.19 161.51 18.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 44.3 p90 -106.11 166.58 10.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.299 -179.473 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -154.97 143.16 20.28 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.4 127.55 32.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.78 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 p -141.4 174.72 10.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.13 162.49 34.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 0.0 110.791 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.95 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 1.2 tpt -148.66 117.18 6.55 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.575 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 26.4 t70 -76.68 106.75 8.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 70' ' ' LEU . 12.5 mt -78.85 -10.05 59.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.387 -177.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -58.44 -16.72 16.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.06 -179.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -119.45 19.43 12.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.174 0.512 . . . . 0.0 110.823 177.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.756 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 2.6 m -125.52 -6.63 5.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.479 0.657 . . . . 0.0 109.84 177.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 101' ' ' PRO . 9.9 p -153.06 147.02 14.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.937 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -134.71 -177.09 14.71 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.793 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -122.71 127.01 48.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.716 0.293 . . . . 0.0 110.65 -179.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.2 m -127.68 92.9 3.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.77 178.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 60.99 54.29 3.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.996 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.25 27.37 62.8 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.965 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.88 142.83 51.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.898 0.38 . . . . 0.0 110.52 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -62.22 121.21 12.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.547 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -138.43 80.93 25.94 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.199 178.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.539 ' HA ' HG22 ' A' ' 92' ' ' VAL . 42.3 Cg_endo -68.67 102.06 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.909 2.406 . . . . 0.0 112.064 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.4 p -127.67 111.72 14.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.043 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.756 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -81.33 149.1 29.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.143 -179.962 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -105.29 54.29 0.71 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.095 0.474 . . . . 0.0 110.849 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.7 t -179.76 -106.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.46 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HB2' ' CG ' ' A' ' 103' ' ' ARG . 3.5 t-20 69.45 110.21 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.932 0.893 . . . . 0.0 112.008 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.26 148.03 31.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.808 178.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.2 t70 60.4 28.78 18.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.614 0.721 . . . . 0.0 111.245 179.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -153.46 154.18 33.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.3 p -93.99 81.45 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 122.195 0.998 . . . . 0.0 111.038 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.447 HD21 ' HB2' ' A' ' 51' ' ' PRO . 28.0 tp -144.64 39.19 1.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.37 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 39.8 ttpt -78.57 111.6 14.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.483 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.9 m -83.81 54.66 2.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.649 0.737 . . . . 0.0 110.016 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.7 m -153.16 132.96 13.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.222 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.2 m -61.62 -35.54 78.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.162 -179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.969 -179.939 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 121.256 0.551 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -100.1 125.59 46.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.411 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 2.1 m -71.62 -62.76 1.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.723 -178.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 56.73 70.38 0.66 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.162 0.289 . . . . 0.0 110.863 179.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 6.8 p90 -58.35 -38.35 77.03 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.071 0.462 . . . . 0.0 111.582 -178.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.91 -22.6 65.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -69.37 -19.48 63.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.784 0.326 . . . . 0.0 111.312 -178.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.2 m -128.94 10.01 5.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.154 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -118.29 138.55 52.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.218 0.532 . . . . 0.0 111.475 -179.615 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.7 p -132.48 151.42 51.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.921 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.03 49.22 80.88 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.947 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.498 ' HB ' HD23 ' A' ' 19' ' ' LEU . 15.7 m -83.39 127.53 39.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.275 0.56 . . . . 0.0 111.493 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -116.29 137.35 52.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.31 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.862 HD23 HD22 ' A' ' 64' ' ' LEU . 59.4 tp -119.08 129.05 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 111.763 -178.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.488 ' O ' HG12 ' A' ' 18' ' ' ILE . 52.5 m-85 -133.91 103.49 5.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.624 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 62' ' ' THR . . . 75.34 -66.82 2.24 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.655 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.653 ' HD1' HD22 ' A' ' 36' ' ' ASN . 5.8 p90 -164.18 21.02 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.993 0.425 . . . . 0.0 111.089 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.2 pt -121.42 127.28 75.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.176 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.5 mt -113.18 114.12 26.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.346 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -116.49 132.39 56.69 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.577 178.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.42 -173.56 26.0 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.052 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -109.04 109.65 20.72 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.719 0.295 . . . . 0.0 110.384 179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -106.79 132.54 52.64 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.267 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.9 mt -72.97 138.4 21.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.558 -178.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -102.94 -166.77 1.31 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.762 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.36 -28.41 69.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.907 0.384 . . . . 0.0 111.623 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.58 -26.89 68.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.649 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.83 -2.9 55.74 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.217 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -104.42 142.53 24.81 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.888 0.375 . . . . 0.0 110.707 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.41 133.46 30.29 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.817 2.345 . . . . 0.0 112.158 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -115.74 139.0 50.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.528 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.24 119.83 16.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.012 0.435 . . . . 0.0 111.291 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -142.19 153.04 43.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.035 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 p -138.2 136.25 36.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.664 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.75 144.17 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.829 -179.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.653 HD22 ' HD1' ' A' ' 17' ' ' TYR . 1.8 t-20 -103.62 87.51 2.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -57.78 -18.16 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.034 -178.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.447 ' ND2' ' HA ' ' A' ' 54' ' ' SER . 0.2 OUTLIER -52.95 -32.33 45.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.69 -178.489 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -107.1 18.58 21.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.7 0.286 . . . . 0.0 111.307 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -125.66 -30.1 3.09 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 mp -111.08 143.13 21.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.69 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -116.88 166.92 12.46 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.645 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -109.78 110.07 20.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.442 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -110.15 105.19 14.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.468 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 22.2 t30 54.48 41.53 31.9 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.897 178.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.43 4.77 89.17 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.083 179.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.84 151.63 33.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.025 0.441 . . . . 0.0 111.131 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.03 127.94 34.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.753 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 7.9 tp10 -120.18 138.89 53.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.536 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.707 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -40.47 -69.31 0.21 Allowed Pre-proline 0 CA--C 1.429 -3.692 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.197 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -109.73 124.9 0.03 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.46 0 C-N-CA 114.054 -3.498 . . . . 0.0 113.551 -177.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.69 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.4 -161.79 11.8 Favored Glycine 0 C--N 1.281 -2.505 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.006 -177.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -153.04 143.75 22.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.758 0.328 . . . . 0.0 110.643 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.447 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 8.2 t 60.22 45.2 11.77 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.824 177.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.471 ' CE2' HD22 ' A' ' 70' ' ' LEU . 9.2 p90 -80.88 -37.43 29.8 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.732 -0.605 . . . . 0.0 110.069 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.74 -18.42 68.27 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.33 -178.085 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.3 m -68.9 -25.59 64.68 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.85 0.357 . . . . 0.0 110.929 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.7 p -123.76 0.6 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.375 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.5 m -107.77 151.78 25.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.058 0.456 . . . . 0.0 111.14 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.09 168.53 13.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.406 178.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 mptt 64.4 36.4 9.0 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.542 0.526 . . . . 0.0 110.751 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 16' ' ' GLY . 1.4 p -63.97 132.03 49.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.087 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.17 162.17 41.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.801 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.862 HD22 HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -123.04 112.91 18.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.773 0.321 . . . . 0.0 111.335 -179.401 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -82.35 123.27 28.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.266 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 57.59 17.47 4.0 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.01 179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.68 29.9 76.14 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.401 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -143.39 -30.41 0.5 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 117.458 0.629 . . . . 0.0 111.391 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.8 m -105.43 125.37 50.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.099 0.476 . . . . 0.0 111.615 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.667 ' HB2' HD11 ' A' ' 88' ' ' LEU . 14.0 tp -90.54 129.29 36.71 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.65 129.01 51.37 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.87 169.38 21.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.27 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.423 ' OG ' ' HD1' ' A' ' 81' ' ' TYR . 14.6 t -119.25 121.02 38.72 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.72 155.86 26.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.657 0.741 . . . . 0.0 111.856 -179.537 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -101.04 148.25 25.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.371 178.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.33 -32.66 0.54 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.433 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.729 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -55.0 -43.42 73.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -173.5 56.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 110.661 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.55 -1.03 31.12 Favored Glycine 0 CA--C 1.516 0.147 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.783 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -119.01 168.54 10.71 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.423 ' HD1' ' OG ' ' A' ' 73' ' ' SER . 42.8 p90 -110.27 161.38 15.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.119 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -153.01 135.17 14.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -61.87 134.4 56.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.966 -179.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 t -147.65 157.78 43.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.057 -179.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.63 162.13 31.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.363 . . . . 0.0 110.338 179.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.707 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 17.9 tpp -150.37 127.69 11.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.548 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -80.77 111.22 17.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 70' ' ' LEU . 11.4 mt -81.33 -8.71 59.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.43 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -52.6 -26.09 12.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.888 179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -116.66 19.05 14.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.772 0.32 . . . . 0.0 111.093 179.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -129.55 -12.41 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.232 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.7 t -131.26 147.12 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.458 ' H ' ' HA ' ' A' ' 101' ' ' PRO . . . -138.47 172.89 22.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.907 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -130.31 123.58 30.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.439 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.6 m -124.82 98.63 5.79 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.219 179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 62.59 48.36 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.352 179.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.01 21.55 65.85 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.176 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -121.81 139.24 53.86 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.607 0.241 . . . . 0.0 110.379 -179.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -59.28 117.27 4.6 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.589 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -142.76 71.83 19.74 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.059 0.457 . . . . 0.0 110.654 179.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.709 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 51.8 Cg_endo -69.26 114.16 3.53 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.908 2.405 . . . . 0.0 112.772 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.9 p -118.34 137.71 52.91 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.17 145.13 34.64 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.49 16.79 16.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.199 0.523 . . . . 0.0 111.578 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.4 m -143.96 -139.4 0.11 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 59.88 21.82 10.78 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.451 0.644 . . . . 0.0 110.785 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.64 127.36 10.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.927 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.9 t70 67.25 155.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.762 0.664 . . . . 0.0 111.088 -179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 76.0 t60 73.38 155.89 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.73 0.776 . . . . 0.0 110.987 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.8 t -82.62 93.66 2.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.574 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.98 -23.01 67.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.743 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -74.06 100.47 3.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.736 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.0 m -81.63 73.21 8.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.299 0.571 . . . . 0.0 110.797 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.7 m -129.29 72.81 1.48 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.232 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.4 m -78.32 -24.01 46.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.653 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.943 -179.663 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -132.39 144.29 50.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.051 0.453 . . . . 0.0 110.39 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.1 m -60.6 -48.63 80.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.976 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 55.72 69.88 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 10.7 p90 -57.58 -39.51 76.93 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.324 0.583 . . . . 0.0 110.496 179.067 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.75 -22.34 61.95 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -177.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -72.01 -6.17 40.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.5 m -146.85 18.19 1.27 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.971 0.415 . . . . 0.0 110.399 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.5 m -127.31 133.39 50.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.786 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.9 p -136.13 154.59 50.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.11 57.38 10.76 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.649 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 31.5 m -93.24 138.2 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.297 0.57 . . . . 0.0 112.3 -178.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 43.2 mt-10 -126.67 144.26 50.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.825 179.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.725 HD22 HD22 ' A' ' 64' ' ' LEU . 12.2 tp -127.97 110.59 12.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.388 179.099 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.437 ' O ' HG12 ' A' ' 18' ' ' ILE . 83.2 t80 -116.95 101.61 8.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.055 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.31 -65.7 2.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.97 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.426 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 6.2 p90 -162.57 18.99 0.09 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.2 pt -118.79 131.52 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.342 . . . . 0.0 110.614 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.525 ' HB2' HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.45 113.81 26.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.087 -179.522 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 7.8 ttm180 -113.67 139.38 49.1 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.158 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.21 165.0 34.15 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.449 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -97.07 102.56 14.37 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 60.0 m -105.95 132.78 51.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mt -69.55 132.18 33.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.018 0.437 . . . . 0.0 111.184 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -103.57 -170.9 1.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.955 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.63 -28.92 61.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 111.712 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.24 -25.54 68.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.869 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.61 -1.02 63.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.629 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -110.03 142.88 26.83 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.36 122.3 10.42 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.062 2.508 . . . . 0.0 112.326 179.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -107.63 132.53 53.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.24 117.25 15.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.142 0.496 . . . . 0.0 111.469 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -133.52 160.85 36.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.286 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.5 p -136.43 147.49 47.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.22 142.7 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.94 88.5 3.56 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.525 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -54.36 -29.37 48.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.705 -178.342 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 24.5 t-20 -52.87 -35.8 58.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.82 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -100.9 12.47 37.56 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.792 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.7 m-85 -126.02 -23.55 3.91 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.26 141.56 30.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.634 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.5 169.14 12.76 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.153 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -117.42 110.49 18.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 111.305 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.57 108.82 18.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.725 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 47.75 48.34 17.48 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.256 1.022 . . . . 0.0 112.791 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.16 15.04 81.61 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.711 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.64 149.65 46.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.042 0.448 . . . . 0.0 111.591 -179.362 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.0 mp -81.1 123.44 28.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.984 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -114.99 131.97 56.75 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.635 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.35 -70.62 0.13 Allowed Pre-proline 0 CA--C 1.426 -3.816 0 CA-C-O 118.142 -0.932 . . . . 0.0 113.48 -179.213 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 10.2 Cg_endo -109.43 127.04 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.284 0 C-N-CA 113.724 -3.717 . . . . 0.0 113.399 -177.855 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.634 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -158.93 -160.64 10.5 Favored Glycine 0 C--N 1.281 -2.485 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.78 -177.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -153.42 138.82 17.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.831 0.371 . . . . 0.0 111.041 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 m 59.44 42.7 17.42 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 178.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -72.43 -36.18 68.51 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.56 -17.89 54.76 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.031 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -71.6 -12.94 61.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.295 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 p -144.73 13.59 1.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 111.149 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.4 m -125.87 149.51 48.62 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.019 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m -140.79 174.3 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.176 179.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.7 mptt 64.31 39.72 7.06 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.402 0.439 . . . . 0.0 111.32 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -68.32 120.81 15.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.391 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.43 162.33 39.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.725 HD22 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -118.68 112.86 20.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.681 -178.893 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.572 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 13.4 m120 -76.7 118.33 19.22 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.989 179.208 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 t70 54.66 19.64 2.57 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.869 0.731 . . . . 0.0 111.632 179.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.87 30.69 78.66 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.531 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -142.09 -26.04 0.66 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 117.538 0.669 . . . . 0.0 111.803 179.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 22.2 m -116.5 128.4 55.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.642 0.258 . . . . 0.0 111.489 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.506 ' HA ' HD21 ' A' ' 64' ' ' LEU . 14.7 tp -93.26 129.58 39.27 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.01 130.23 54.63 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.764 0.316 . . . . 0.0 110.512 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.58 156.75 30.68 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.515 178.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.5 t -106.34 125.55 51.14 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 22.9 m -122.7 150.99 41.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.231 0.539 . . . . 0.0 112.408 -178.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -100.14 148.92 24.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.138 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.47 -14.01 1.82 Allowed Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.098 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.12 -38.05 78.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.576 0.227 . . . . 0.0 110.986 179.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -175.81 54.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.255 0.55 . . . . 0.0 110.336 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.63 -7.38 13.68 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.402 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -117.84 168.99 9.98 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -111.03 162.34 14.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -148.89 149.32 31.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.08 141.98 47.57 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -151.08 157.07 42.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.013 0.435 . . . . 0.0 110.235 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.22 164.18 26.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.842 179.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.968 ' HE1' ' HA ' ' A' ' 86' ' ' MET . 1.6 tpt -150.02 121.45 7.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.862 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -75.75 106.11 7.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.367 0.603 . . . . 0.0 109.405 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.553 ' HA ' HG22 ' A' ' 91' ' ' VAL . 19.6 mt -72.74 -8.36 55.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.01 -179.253 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.89 -31.39 5.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.549 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -116.85 23.31 12.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.738 0.304 . . . . 0.0 111.23 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.553 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -130.48 -12.22 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.143 178.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.2 t -136.83 142.83 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -137.88 162.64 25.58 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -108.31 113.66 26.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.059 0.457 . . . . 0.0 110.489 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.9 m -116.74 82.88 1.87 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.417 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 62.99 55.99 1.89 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.171 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.36 27.28 57.85 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.77 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.1 141.01 51.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.025 0.44 . . . . 0.0 110.674 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 18.3 ptm -61.04 97.29 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.472 179.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -129.06 78.17 76.67 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.136 0.493 . . . . 0.0 111.007 179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.834 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 61.0 Cg_endo -75.22 96.02 1.01 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.47 2.113 . . . . 0.0 112.26 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.4 p -101.23 134.27 44.52 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.927 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.76 150.0 30.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.913 179.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -108.27 33.42 4.15 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.096 0.474 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.8 m -155.74 -115.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.379 -179.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 73.41 -66.5 0.3 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.156 0.982 . . . . 0.0 111.196 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.68 -4.17 34.32 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.495 -1.229 . . . . 0.0 111.199 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -65.45 -26.99 68.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.343 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' A' ' 111' ' ' LEU . 9.9 p-80 -130.41 176.53 8.07 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.9 m -72.69 62.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.691 0.758 . . . . 0.0 112.907 -178.428 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.545 ' HB2' ' CD2' ' A' ' 109' ' ' HIS . 33.9 tp -107.37 -29.61 9.17 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.483 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.431 ' C ' ' H ' ' A' ' 114' ' ' SER . 62.2 pttt -54.9 134.05 48.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.636 -179.424 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.8 m -77.28 42.08 0.33 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.457 0.646 . . . . 0.0 110.671 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 112' ' ' LYS . 28.0 p -150.7 149.97 30.49 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.389 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -79.59 -27.97 41.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.265 0.555 . . . . 0.0 109.867 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.064 -179.964 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 120.758 0.313 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -80.63 121.57 26.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.1 m -84.52 -50.73 7.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.395 -179.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 53.26 66.56 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.539 0.524 . . . . 0.0 112.071 177.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 11.3 p90 -61.79 -39.3 91.24 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 111.053 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.66 -22.61 61.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.505 -178.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -71.68 -7.07 45.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.969 0.414 . . . . 0.0 111.32 -178.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 31.2 m -138.49 15.44 2.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.178 179.249 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -127.2 140.65 52.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.147 -179.625 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 p -136.27 148.53 48.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.571 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.69 47.82 46.49 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.383 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.514 HG12 ' HA3' ' A' ' 21' ' ' GLY . 24.4 m -89.69 143.63 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.996 0.427 . . . . 0.0 111.252 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 6.3 tp10 -141.61 146.16 35.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.097 179.308 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.74 HD22 HD22 ' A' ' 64' ' ' LEU . 49.9 tp -126.76 123.32 37.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 111.403 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.435 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.0 t80 -132.82 112.74 12.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.714 178.394 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.88 -68.24 2.27 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.677 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.0 p90 -166.0 18.7 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 122.594 0.357 . . . . 0.0 111.114 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.569 HG23 ' ND2' ' A' ' 36' ' ' ASN . 41.6 pt -119.65 125.12 74.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.051 0.453 . . . . 0.0 110.891 -178.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.518 ' HB2' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -111.06 115.15 28.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.704 179.627 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.6 ttm180 -116.24 136.47 52.98 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.514 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -161.46 169.73 37.04 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.92 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.39 110.86 22.94 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.3 m -105.72 132.78 51.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 57.9 mt -68.65 136.53 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.438 -178.743 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -102.28 -175.18 2.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -55.42 -27.8 50.19 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.33 -23.44 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 0.0 111.768 -179.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.79 5.21 57.67 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.357 -179.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -111.65 142.52 26.76 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.286 -0.457 . . . . 0.0 109.87 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 56.1 Cg_endo -71.94 133.77 22.28 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.833 2.355 . . . . 0.0 112.536 179.547 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -119.97 131.55 55.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.695 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.82 126.35 28.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.145 0.498 . . . . 0.0 111.643 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 t -140.43 156.59 46.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.645 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -130.54 148.75 52.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.47 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.81 146.75 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.818 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.569 ' ND2' HG23 ' A' ' 18' ' ' ILE . 8.3 m120 -105.43 96.17 6.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.23 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -63.07 -25.96 68.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.048 -178.216 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.53 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.0 t-20 -56.31 -27.51 55.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.03 -179.096 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -107.56 11.63 28.48 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.646 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -128.02 -23.21 3.36 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.0 mp -111.52 140.81 29.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.674 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -111.83 163.34 12.22 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.268 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -112.43 106.62 15.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.183 -0.508 . . . . 0.0 110.176 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -111.51 107.17 16.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.373 -179.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 m120 57.86 42.13 23.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.306 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 74.47 17.49 79.83 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.849 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.76 143.04 51.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.036 0.446 . . . . 0.0 111.385 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.559 HD11 ' HG ' ' A' ' 70' ' ' LEU . 33.6 mt -73.16 124.02 24.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.618 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -117.21 137.15 52.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.634 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.1 -71.46 0.11 Allowed Pre-proline 0 CA--C 1.429 -3.687 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -111.45 126.78 0.03 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.366 0 C-N-CA 114.09 -3.473 . . . . 0.0 113.12 -177.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.674 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -159.89 -162.07 11.92 Favored Glycine 0 C--N 1.28 -2.547 0 CA-C-N 113.833 -1.531 . . . . 0.0 113.345 -177.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -152.76 142.16 21.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.531 -0.334 . . . . 0.0 111.015 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 m 55.32 43.16 29.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 17.7 p90 -70.24 -34.82 73.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.732 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.13 -18.38 27.29 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.545 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.1 t -52.7 -47.29 67.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.791 0.329 . . . . 0.0 110.544 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 42.8 m -119.7 12.39 12.2 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.0 m -111.14 137.47 48.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 111.903 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.8 m -136.67 175.56 9.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.393 178.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 60.82 43.19 12.31 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.915 0.388 . . . . 0.0 111.038 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 p -67.77 130.09 41.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.208 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.65 163.33 39.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.434 179.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.74 HD22 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -122.56 113.02 18.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.948 0.404 . . . . 0.0 111.642 -179.55 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -83.68 122.08 28.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.618 179.195 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.2 t70 58.01 16.95 4.06 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.93 0.769 . . . . 0.0 111.347 179.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.62 29.32 74.89 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.464 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 5.9 p80 -143.51 -28.22 0.54 Allowed 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 117.243 0.521 . . . . 0.0 111.471 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -110.51 129.65 55.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.802 0.334 . . . . 0.0 111.769 -179.077 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.559 ' HG ' HD11 ' A' ' 48' ' ' LEU . 14.4 tp -90.04 129.53 36.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.041 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.16 130.38 53.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.538 179.102 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.35 168.02 27.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.825 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -113.95 123.39 49.63 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.451 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 14.2 m -126.13 147.61 49.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -177.563 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.0 tmtt? -99.96 144.65 28.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.471 177.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.95 -26.31 0.63 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.684 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.75 80.31 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -171.58 52.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.83 2.2 50.41 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.431 -179.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -122.34 158.11 30.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.8 p90 -98.82 162.79 12.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.434 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -158.45 144.47 16.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -73.65 142.38 46.46 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.52 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.46 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 31.5 p -152.36 172.97 15.65 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.927 179.27 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -143.78 156.05 44.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.137 0.494 . . . . 0.0 111.016 -179.924 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.634 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 13.3 tpp -142.17 121.35 13.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.742 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -74.66 106.27 6.15 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.568 ' HA ' HG23 ' A' ' 91' ' ' VAL . 13.8 mt -78.82 -9.11 59.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.549 -178.808 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -52.26 -26.57 12.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.07 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -115.9 17.79 15.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.176 179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -125.31 -11.69 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.985 0.422 . . . . 0.0 110.49 178.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.94 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.6 t -134.04 144.57 35.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.203 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.05 174.66 21.79 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.071 179.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -122.98 134.54 54.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.834 0.35 . . . . 0.0 110.478 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.4 t -145.35 104.59 3.94 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 61.69 44.27 9.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.085 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.26 34.53 67.66 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.542 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -131.43 142.95 50.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.7 ptt? -59.34 114.9 2.89 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.764 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -135.23 73.14 65.0 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.197 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.94 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 46.4 Cg_endo -70.38 96.06 0.63 Allowed 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.471 2.114 . . . . 0.0 112.56 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p -104.67 125.22 50.57 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.055 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.446 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -111.59 149.53 31.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.724 179.325 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.87 33.44 3.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.096 0.474 . . . . 0.0 111.258 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 67.6 m -152.89 -130.13 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.578 -178.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 68.99 100.54 0.06 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.924 0.89 . . . . 0.0 111.676 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -167.39 -174.98 2.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.84 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.85 -68.81 0.78 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.054 0.454 . . . . 0.0 110.489 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -123.02 167.85 13.1 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.222 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p 39.37 73.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 122.44 1.114 . . . . 0.0 111.659 -179.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.7 tp -75.09 84.07 2.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.885 -179.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -93.59 106.35 18.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.236 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.9 m -82.72 -7.35 59.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.317 0.58 . . . . 0.0 109.926 178.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.2 t -114.34 91.43 3.62 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.168 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.6 m -83.02 -35.37 25.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.493 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.772 -179.43 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.477 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 10.7 tp60 64.24 -158.65 0.3 Allowed 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.564 0.54 . . . . 0.0 110.019 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.477 ' H ' ' CG ' ' A' ' 2' ' ' GLN . 59.5 m -131.37 -63.65 0.83 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 59.73 67.15 0.91 Allowed 'General case' 0 N--CA 1.462 0.148 0 O-C-N 123.145 0.278 . . . . 0.0 111.738 177.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.59 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 12.0 p90 -59.57 -42.75 93.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.296 0.569 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.74 -21.18 63.48 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.377 -178.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -60.33 -24.06 64.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.366 -178.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.0 m -136.92 25.5 3.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.459 179.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -125.64 134.88 51.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.823 179.634 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.1 p -131.41 158.71 40.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.739 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.89 61.37 7.26 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.588 179.054 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 27.8 m -95.65 149.96 4.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.081 0.467 . . . . 0.0 111.328 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -138.67 140.16 38.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.031 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.9 HD21 HD23 ' A' ' 64' ' ' LEU . 40.2 tp -126.41 122.68 36.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 110.993 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.534 ' O ' HG12 ' A' ' 18' ' ' ILE . 92.2 m-85 -130.09 106.3 8.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.334 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.451 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.74 -66.98 2.35 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.495 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.556 ' HD1' HD22 ' A' ' 36' ' ' ASN . 2.2 p90 -165.58 22.65 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.621 0.369 . . . . 0.0 111.209 179.794 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 15' ' ' TYR . 34.0 pt -119.86 127.48 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 110.263 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HB2' HD23 ' A' ' 37' ' ' LEU . 1.3 mt -112.78 119.87 39.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.415 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 1.4 ttt180 -120.32 138.01 53.94 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.36 175.16 40.45 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.517 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 23.4 m-20 -101.61 107.07 18.22 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 m -105.28 132.63 51.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mt -67.45 134.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.019 0.438 . . . . 0.0 111.511 -178.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -103.26 -171.44 1.94 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.45 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -51.32 -41.34 60.48 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.469 0.481 . . . . 0.0 111.846 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -59.79 -27.53 66.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.496 -179.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.75 -0.3 52.38 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.444 -178.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -105.51 138.44 19.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.554 0.693 . . . . 0.0 110.948 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.76 121.25 9.41 Favored 'Trans proline' 0 C--N 1.329 -0.475 0 C-N-CA 124.207 3.271 . . . . 0.0 112.027 178.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -111.92 126.79 55.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.941 -179.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.32 126.94 29.77 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.008 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 t -142.93 160.16 40.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.373 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.1 p -133.35 148.17 51.85 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.765 0.316 . . . . 0.0 110.601 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -133.69 143.95 37.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.556 HD22 ' HD1' ' A' ' 17' ' ' TYR . 2.1 t-20 -103.2 96.29 6.68 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.347 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.507 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -59.5 -22.17 61.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.919 -178.567 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -55.08 -31.53 61.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.768 -179.31 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -102.92 8.92 39.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.736 -179.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 43.8 m-85 -126.37 -22.63 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.1 139.13 41.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.623 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -112.32 170.06 13.36 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.718 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -115.33 107.44 15.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.901 0.381 . . . . 0.0 110.619 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.638 ' OD1' ' HA ' ' A' ' 112' ' ' LYS . 31.2 t70 -106.99 106.22 16.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.071 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 50.65 42.22 26.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.196 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.47 15.13 74.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.512 178.643 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.93 145.79 48.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.226 0.536 . . . . 0.0 111.011 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.515 HD12 ' HG ' ' A' ' 70' ' ' LEU . 23.7 mt -74.98 116.32 15.59 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.47 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.435 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.8 tt0 -107.53 132.31 53.39 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -39.0 -66.22 0.34 Allowed Pre-proline 0 CA--C 1.431 -3.634 0 CA-C-O 117.385 -1.293 . . . . 0.0 114.408 -179.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.559 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 5.6 Cg_endo -112.67 119.47 0.02 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.219 0 C-N-CA 113.552 -3.832 . . . . 0.0 113.361 -178.296 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.623 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -154.75 -163.9 12.44 Favored Glycine 0 C--N 1.275 -2.82 0 CA-C-N 113.754 -1.566 . . . . 0.0 113.745 -177.402 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -153.14 142.02 21.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.6 45.53 16.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.586 177.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -75.66 -38.96 58.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.916 0.389 . . . . 0.0 110.408 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.04 -18.55 41.41 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.747 -178.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.0 m -59.74 -19.57 50.98 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.814 0.446 . . . . 0.0 111.602 179.378 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.0 m -144.49 26.04 1.47 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.668 179.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.6 m -127.69 144.65 51.06 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.23 0.538 . . . . 0.0 111.624 -179.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -136.82 172.8 14.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.474 179.038 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mptt 62.83 37.88 11.95 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.377 0.423 . . . . 0.0 111.192 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.2 p -68.81 122.26 18.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.152 0.501 . . . . 0.0 111.278 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.12 154.64 35.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.866 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.9 HD23 HD21 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -109.65 116.84 32.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.918 -179.344 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 67' ' ' GLY . 5.0 m-80 -84.05 118.86 24.34 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.2 t70 65.61 -1.92 0.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 124.199 0.937 . . . . 0.0 111.729 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 65' ' ' ASN . . . 83.21 29.22 34.32 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.029 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -143.32 -29.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.056 0.428 . . . . 0.0 110.889 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.423 ' O ' HD11 ' A' ' 64' ' ' LEU . 15.9 m -113.39 130.28 56.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.354 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.526 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.9 tp -91.14 130.4 37.04 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.22 129.82 53.38 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.876 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.95 162.91 32.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.092 0.473 . . . . 0.0 110.868 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.7 t -111.02 122.57 48.23 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.7 m -122.77 149.0 44.7 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.532 0.682 . . . . 0.0 112.469 -177.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.2 tmtt? -99.17 142.34 30.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.229 178.152 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.13 -24.46 0.39 Allowed Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.661 179.4 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.59 88.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.872 0.368 . . . . 0.0 111.83 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -173.59 55.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.289 0.566 . . . . 0.0 109.5 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.32 -1.42 12.82 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.0 -179.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 24.9 pt20 -113.72 166.11 11.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.381 -178.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.4 p90 -106.2 168.84 8.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.239 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.88 133.19 5.28 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.51 123.17 23.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.93 0.395 . . . . 0.0 110.346 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 p -135.25 173.82 11.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.172 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.28 155.29 46.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.405 0.621 . . . . 0.0 111.241 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.5 tpp -141.22 115.39 9.3 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.472 179.056 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -72.2 108.05 5.16 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.497 0.665 . . . . 0.0 109.449 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.593 ' HA ' HG21 ' A' ' 91' ' ' VAL . 13.1 mt -77.64 -8.83 58.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.957 -178.19 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -51.14 -26.48 6.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.083 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -116.72 13.83 15.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.18 179.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.593 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -122.37 -8.76 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.201 0.524 . . . . 0.0 111.109 179.175 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.4 t -133.53 137.45 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.59 161.61 20.87 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.281 178.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -114.49 129.64 56.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.876 0.37 . . . . 0.0 110.432 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.2 m -143.83 113.11 6.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.939 178.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 56.32 36.89 28.25 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 123.39 0.431 . . . . 0.0 111.196 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.75 22.06 63.78 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.791 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -118.85 145.98 45.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.804 0.335 . . . . 0.0 110.323 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 16.0 ptm -58.59 110.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.794 179.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -135.15 74.79 61.52 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.042 0.448 . . . . 0.0 110.654 178.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.2 Cg_endo -70.95 150.44 60.95 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.729 2.286 . . . . 0.0 112.592 -179.632 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 27.3 p -136.41 144.42 44.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.83 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.417 ' HB2' ' CB ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -111.36 147.46 35.12 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.152 179.649 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -97.59 7.55 46.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.345 0.593 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.6 m -157.01 -115.3 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.085 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.559 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 8.5 t-20 48.76 37.91 10.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.059 0.944 . . . . 0.0 111.214 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.22 -0.02 11.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.728 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -107.51 -176.2 3.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.689 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -84.09 -68.36 0.72 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.901 0.381 . . . . 0.0 110.271 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.49 95.67 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.554 0.692 . . . . 0.0 110.546 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.786 ' H ' HD22 ' A' ' 111' ' ' LEU . 1.2 pt? -86.16 60.02 5.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.15 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.638 ' HA ' ' OD1' ' A' ' 44' ' ' ASP . 88.4 tttt -59.39 123.63 17.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.047 -179.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m -91.19 64.69 5.31 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.097 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 m -143.78 113.42 7.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.115 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.8 m -64.1 -42.38 96.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.102 179.38 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.986 179.601 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.803 0.335 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -73.54 163.42 28.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.093 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.4 m -71.26 -72.0 0.24 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.48 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.429 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 2.2 m-20 52.64 76.17 0.2 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.569 0.543 . . . . 0.0 111.525 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.485 ' CZ ' ' HA ' ' A' ' 68' ' ' HIS . 13.1 p90 -57.98 -44.28 87.05 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.149 0.499 . . . . 0.0 110.17 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.22 -21.34 65.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.587 -179.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.429 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 18.8 t-20 -57.72 -29.54 64.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.494 -178.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.421 ' HB2' HD21 ' A' ' 94' ' ' ASN . 13.5 m -132.94 17.46 4.18 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.62 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 80.9 m -117.96 133.49 55.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.777 0.322 . . . . 0.0 110.577 -179.255 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -130.59 149.28 52.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.749 -179.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.88 45.3 92.92 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.607 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.502 HG12 ' HA3' ' A' ' 21' ' ' GLY . 17.4 m -88.22 135.31 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.093 0.473 . . . . 0.0 111.353 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -129.45 156.41 44.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.169 -179.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 19.4 tp -130.03 125.01 34.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.976 0.417 . . . . 0.0 112.108 -178.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -126.32 99.18 5.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.12 178.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 62' ' ' THR . . . 77.45 -62.43 3.46 Favored Glycine 0 C--O 1.226 -0.368 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.857 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.46 25.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.29 0.566 . . . . 0.0 110.141 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 12.8 mt -119.52 115.55 47.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.708 -179.169 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -103.8 113.62 27.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.201 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 4.5 ttm180 -122.73 142.83 50.27 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.732 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -170.19 179.54 42.35 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.165 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.71 108.31 19.51 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 62.1 m -106.23 131.8 53.04 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.7 mt -75.37 136.29 25.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.33 0.586 . . . . 0.0 111.694 -177.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -102.97 -173.47 2.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.389 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -54.77 -36.55 64.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.932 0.396 . . . . 0.0 111.662 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -59.21 -27.56 65.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.73 -179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.04 1.33 57.13 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.845 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.19 140.1 20.94 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 121.302 0.572 . . . . 0.0 111.086 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.09 122.08 9.96 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 123.557 2.838 . . . . 0.0 112.454 179.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -105.3 130.02 53.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.51 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.65 115.69 12.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 t -136.73 156.88 47.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.063 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.3 p -140.06 142.75 36.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.732 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.12 144.91 35.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.864 0.364 . . . . 0.0 110.578 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -100.7 99.73 10.32 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -62.89 -22.23 66.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.76 -178.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.87 -32.81 64.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.09 -178.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -103.99 13.76 32.01 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.641 -178.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.637 ' HD1' HD12 ' A' ' 111' ' ' LEU . 46.7 m-85 -131.13 -17.27 3.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.6 142.05 35.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.564 0.221 . . . . 0.0 110.555 -179.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.676 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -120.06 165.04 13.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.319 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -117.69 112.01 19.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.57 0.7 . . . . 0.0 110.634 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -110.9 114.61 28.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.264 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.792 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 44.0 t30 59.52 33.82 22.29 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.148 0.499 . . . . 0.0 110.976 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.82 9.58 86.15 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.013 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -115.42 154.88 28.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.66 0.267 . . . . 0.0 110.707 179.951 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 30.9 mt -82.59 122.41 28.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.244 -179.303 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -111.31 137.35 49.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.217 179.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.454 ' N ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -39.87 -70.15 0.18 Allowed Pre-proline 0 CA--C 1.424 -3.889 0 CA-C-O 118.441 -0.79 . . . . 0.0 113.027 -179.272 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 5.6 Cg_endo -110.45 131.21 0.04 OUTLIER 'Trans proline' 1 N--CA 1.34 -7.519 0 C-N-CA 113.911 -3.593 . . . . 0.0 112.973 -177.619 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.676 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.48 -159.16 9.25 Favored Glycine 0 C--N 1.283 -2.385 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.87 -177.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -152.43 137.16 16.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.261 -0.469 . . . . 0.0 111.311 -178.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 t 48.58 45.01 21.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.037 177.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -65.75 -36.54 83.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.161 0.505 . . . . 0.0 109.671 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.76 -18.8 33.41 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.281 -179.143 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 t -62.68 -28.65 70.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.0 110.34 179.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.2 m -136.32 28.83 3.06 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.868 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.2 m -133.73 139.69 46.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 m -135.17 175.07 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.36 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 63.43 40.09 8.67 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.435 0.459 . . . . 0.0 111.648 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 16' ' ' GLY . 17.1 p -66.65 126.45 28.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.995 179.728 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.99 162.64 40.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.922 179.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.562 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -120.94 113.65 20.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.867 0.365 . . . . 0.0 111.06 -179.616 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -75.51 116.53 16.32 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.654 179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 55.29 15.35 1.32 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.901 0.75 . . . . 0.0 111.475 178.829 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.99 37.98 74.1 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.515 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.485 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 9.8 p80 -147.01 -30.73 0.34 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 117.396 0.598 . . . . 0.0 111.479 178.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 m -116.23 133.21 56.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.631 0.253 . . . . 0.0 111.403 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.562 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.7 tp -91.31 131.42 36.82 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.612 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.42 130.39 55.94 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.95 163.73 31.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.113 0.483 . . . . 0.0 110.817 179.277 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 t -112.94 123.67 50.85 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.1 m -123.51 154.94 38.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.15 0.5 . . . . 0.0 112.031 -178.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -99.81 150.08 22.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.072 178.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.13 -29.95 0.89 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.98 178.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.792 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.02 -38.56 70.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -175.22 52.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.252 0.549 . . . . 0.0 109.983 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.92 6.36 51.71 Favored Glycine 0 C--N 1.329 0.146 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.65 -179.108 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -123.97 170.52 10.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -110.84 164.74 12.47 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 123.448 0.467 . . . . 0.0 110.815 -179.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -155.34 150.03 26.37 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -81.02 141.23 34.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.849 0.357 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.3 p -153.01 167.52 28.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.963 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.17 162.83 30.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.962 0.41 . . . . 0.0 110.445 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.824 ' HE2' ' HA ' ' A' ' 86' ' ' MET . 3.4 tpt -145.99 112.98 6.09 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.97 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -71.78 106.86 4.3 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.573 ' HA ' HG21 ' A' ' 91' ' ' VAL . 15.1 mt -77.81 -8.62 58.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.265 -178.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -49.45 -29.62 6.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.244 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -116.68 20.26 14.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.49 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -125.94 -12.88 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.234 0.54 . . . . 0.0 110.031 177.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.811 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -134.5 147.39 29.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.157 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.23 171.9 23.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.005 -0.616 . . . . 0.0 111.678 179.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.421 HD21 ' HB2' ' A' ' 8' ' ' SER . 37.0 t30 -117.1 129.42 55.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.84 0.352 . . . . 0.0 110.849 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.7 m -134.42 100.31 4.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.436 178.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 61.0 44.46 10.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.558 179.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.57 29.73 70.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.167 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -128.9 148.21 50.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.693 0.282 . . . . 0.0 110.302 -179.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -62.63 119.61 9.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.167 -179.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -143.46 79.06 14.2 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.541 178.207 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.811 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 42.9 Cg_endo -69.95 93.34 0.54 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.766 2.31 . . . . 0.0 113.174 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.1 p -105.52 126.68 52.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.501 178.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.528 ' NH2' ' HG ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -96.6 147.44 23.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.175 -179.173 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.3 28.88 8.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.086 0.47 . . . . 0.0 110.984 179.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.1 m -154.65 -95.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.372 -179.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 69.94 106.85 0.06 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.591 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.57 -44.24 8.3 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.106 179.231 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -138.22 176.47 8.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.168 -179.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 65.78 149.1 0.04 OUTLIER 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.179 0.99 . . . . 0.0 113.259 -179.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.06 97.2 5.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.151 179.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.725 ' H ' HD22 ' A' ' 111' ' ' LEU . 1.6 pt? -102.44 80.08 1.9 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.948 -179.138 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -116.16 106.5 13.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.71 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 m -72.06 -49.16 38.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.422 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 t 64.61 80.07 0.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.6 m -56.15 -51.05 69.37 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.049 -178.522 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.277 179.761 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mmm . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -107.65 151.36 25.75 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.8 m -53.58 -82.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.089 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 53.68 78.18 0.16 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.554 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 4.4 p90 -56.91 -36.63 70.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.987 0.422 . . . . 0.0 111.506 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.01 -21.77 66.41 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.292 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -61.6 -18.35 59.01 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 69.7 m -145.21 29.55 1.17 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.696 0.284 . . . . 0.0 110.699 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -128.78 133.01 47.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.023 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -129.51 158.21 39.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.373 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.81 58.48 14.35 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.747 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.538 HG11 ' HA3' ' A' ' 21' ' ' GLY . 19.7 m -101.07 139.61 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.992 0.425 . . . . 0.0 111.546 -179.317 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -137.03 155.64 49.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.263 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.604 HD23 HD22 ' A' ' 64' ' ' LEU . 27.0 tp -127.78 123.66 35.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.428 . . . . 0.0 111.706 -179.29 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-85 -124.64 99.49 6.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.579 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 62' ' ' THR . . . 75.46 -63.18 2.63 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.167 -0.54 . . . . 0.0 113.077 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.443 ' HD1' HD22 ' A' ' 36' ' ' ASN . 3.9 p90 -165.27 21.93 0.05 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.0 pt -121.76 126.94 75.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.569 179.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.53 ' HB2' HD22 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -107.82 114.64 28.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.652 -179.922 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.2 ttt180 -118.13 141.24 48.7 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.641 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.538 ' HA3' HG11 ' A' ' 12' ' ' VAL . . . -167.99 177.6 42.14 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.796 179.405 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 16.1 m-20 -101.62 107.98 19.4 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -106.09 132.84 51.68 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.7 mt -69.15 139.89 19.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.472 -178.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 96' ' ' TYR . 6.0 p30 -110.14 -173.1 2.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.632 179.534 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.85 -27.98 54.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.92 -20.35 65.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.497 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.77 4.5 69.7 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.913 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -112.72 144.62 31.35 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.791 0.329 . . . . 0.0 110.175 179.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.21 123.68 10.86 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.021 2.48 . . . . 0.0 113.002 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -115.27 132.16 56.7 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.7 127.2 31.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.39 0.614 . . . . 0.0 112.142 -178.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 t -136.05 155.2 50.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.612 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 78.0 p -138.45 132.08 30.77 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.527 -179.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.85 143.96 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 O-C-N 123.517 0.511 . . . . 0.0 110.328 -179.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.443 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -99.37 92.19 5.29 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.933 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.53 -27.09 56.65 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.63 -178.376 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.2 t-20 -53.98 -30.66 48.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.967 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -103.15 10.39 37.89 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.613 -178.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.1 m-85 -129.35 -21.09 3.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -113.84 141.34 30.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.629 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -113.58 170.91 13.54 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.629 -179.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -114.76 104.42 11.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.027 -0.587 . . . . 0.0 109.753 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -111.24 106.16 15.06 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.786 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.71 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 24.6 t30 59.2 40.06 22.07 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.121 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.82 17.09 80.25 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.559 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.58 149.82 46.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 -179.511 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.417 HD11 ' HG ' ' A' ' 70' ' ' LEU . 28.9 mt -74.99 124.24 26.6 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.352 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -112.01 139.22 47.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.598 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -43.52 -75.51 0.05 OUTLIER Pre-proline 0 CA--C 1.433 -3.536 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.497 179.949 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 40' ' ' TYR . 2.5 Cg_endo -108.45 127.89 0.04 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.242 1 C-N-CA 113.196 -4.069 . . . . 0.0 112.779 -178.662 . . . . . . . . 4 3 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.629 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -155.16 -159.42 9.29 Favored Glycine 0 C--N 1.281 -2.514 0 CA-C-N 113.74 -1.573 . . . . 0.0 113.417 -177.629 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -151.23 147.32 26.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.917 0.389 . . . . 0.0 111.068 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.6 p 46.42 44.95 13.42 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 177.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -71.79 -38.8 70.22 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.7 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.21 -18.52 55.36 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.288 -178.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -65.26 -19.28 65.89 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.736 0.414 . . . . 0.0 110.896 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.4 m -142.16 20.76 2.09 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.006 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.5 m -126.75 144.09 51.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.601 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.457 HG23 ' HD2' ' A' ' 61' ' ' LYS . 23.2 m -136.78 173.62 13.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.734 179.315 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HD2' HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER 63.68 41.15 7.29 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.486 0.491 . . . . 0.0 110.829 179.405 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 16' ' ' GLY . 11.5 p -69.22 130.49 42.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.612 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.65 162.85 40.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.807 179.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.604 HD22 HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -121.61 112.55 18.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.596 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -85.47 122.04 29.04 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.216 -179.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.09 24.04 10.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.686 178.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.81 39.8 69.28 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.524 -0.762 . . . . 0.0 114.074 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.471 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 4.7 p80 -153.26 -28.53 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.272 0.536 . . . . 0.0 111.537 179.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 m -115.93 131.43 56.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.797 0.332 . . . . 0.0 111.461 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.586 ' HA ' HD21 ' A' ' 64' ' ' LEU . 12.7 tp -90.2 134.53 34.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 178.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.65 130.76 53.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.614 178.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.05 160.85 22.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.098 0.475 . . . . 0.0 111.464 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 13.1 t -106.62 125.06 50.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.891 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 48.5 m -125.5 149.16 48.52 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -99.25 143.3 29.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.585 178.139 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.58 -31.09 0.52 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.621 178.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.71 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -47.51 -45.42 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 179.128 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -171.89 49.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.466 0.65 . . . . 0.0 109.606 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.32 2.4 79.11 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.009 -179.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -121.91 160.35 24.97 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 51.3 p90 -101.02 160.43 14.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 -179.192 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -153.79 141.25 19.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 36.4 t70 -82.1 132.98 35.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.89 0.376 . . . . 0.0 110.693 -179.056 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.408 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 26.0 p -143.34 179.51 7.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.432 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.28 161.43 37.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.814 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.598 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 14.2 tpp -145.02 125.39 13.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.557 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 28.2 t70 -79.35 106.59 11.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.567 ' HA ' HG21 ' A' ' 91' ' ' VAL . 17.0 mt -76.61 -10.02 59.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.323 -177.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.557 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 5.9 m120 -48.51 -33.83 10.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.99 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -113.74 20.97 15.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.897 0.379 . . . . 0.0 111.326 -179.166 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.567 HG21 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -126.58 -8.66 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.549 178.575 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 1.029 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 8.9 p -153.22 138.35 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.097 0.475 . . . . 0.0 111.409 179.298 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.16 172.22 20.78 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.877 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.402 HD21 ' HB2' ' A' ' 8' ' ' SER . 18.4 t30 -113.74 116.76 29.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.33 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 96' ' ' TYR . 58.7 m -111.65 78.53 1.13 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.829 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 25' ' ' ASN . 43.1 m-85 66.28 60.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.581 178.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.78 23.0 60.54 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.774 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -126.98 132.02 50.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.907 0.384 . . . . 0.0 110.593 -178.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -64.28 117.36 7.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.742 179.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -142.26 81.59 13.89 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 121.314 0.578 . . . . 0.0 109.889 177.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 1.029 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 58.4 Cg_endo -71.47 125.83 11.62 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.864 2.376 . . . . 0.0 112.023 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 32.0 p -115.18 131.47 56.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.767 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.8 140.52 46.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.722 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -123.9 15.54 9.32 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.078 0.466 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.692 ' HA ' HD21 ' A' ' 111' ' ' LEU . 65.4 m -159.8 64.74 0.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.531 -178.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.616 ' H ' HD11 ' A' ' 111' ' ' LEU . 4.3 t-20 -114.09 79.61 1.28 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.234 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.71 116.11 5.4 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.752 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -160.19 -69.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.294 -179.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.426 ' ND1' HG23 ' A' ' 110' ' ' VAL . 16.3 t-80 -135.39 -74.39 0.45 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.591 -179.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.426 HG23 ' ND1' ' A' ' 109' ' ' HIS . 59.2 t -118.07 92.07 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.284 0.564 . . . . 0.0 110.291 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.692 HD21 ' HA ' ' A' ' 105' ' ' SER . 47.9 tp -90.78 89.26 7.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.036 179.189 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 60.01 29.18 18.77 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.469 0.652 . . . . 0.0 110.56 179.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.7 t 58.28 21.98 8.8 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.918 -178.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.6 t -140.76 53.73 1.59 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.232 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 m -66.59 -32.36 73.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.334 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.973 179.405 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.052 0.453 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -123.05 107.44 11.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 0.0 109.757 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -71.48 -62.56 1.36 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.084 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 52.32 76.96 0.17 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.839 0.352 . . . . 0.0 111.747 179.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 15.4 p90 -60.31 -41.96 94.55 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.019 0.438 . . . . 0.0 110.873 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.94 -23.91 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.99 -178.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -60.46 -29.73 69.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.168 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 8.3 m -123.36 16.4 9.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 -179.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -124.33 146.28 48.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.368 0.604 . . . . 0.0 112.029 -179.301 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.7 p -140.33 152.77 46.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.005 179.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.86 33.15 70.38 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.574 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 18.2 m -79.89 133.38 29.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.012 0.434 . . . . 0.0 111.655 -179.471 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' HD21 ' A' ' 19' ' ' LEU . 10.7 pt-20 -132.19 150.16 52.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.007 179.021 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.797 HD21 HD22 ' A' ' 64' ' ' LEU . 32.7 tp -122.01 120.71 35.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.2 0.524 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -125.1 101.02 6.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.956 179.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.01 -68.44 3.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.811 179.248 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.708 ' HD1' HD22 ' A' ' 36' ' ' ASN . 24.3 p90 -162.26 17.79 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.654 0.264 . . . . 0.0 111.294 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -121.6 131.29 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.966 0.412 . . . . 0.0 110.51 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.481 ' HB2' HD23 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -113.78 114.72 26.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.115 -179.632 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.2 ttt180 -118.12 141.68 48.23 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.734 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.28 -176.44 38.12 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.878 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -108.8 111.11 22.67 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.673 0.273 . . . . 0.0 110.907 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.3 m -106.28 133.18 51.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.8 mt -68.83 134.3 30.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.828 0.347 . . . . 0.0 110.704 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -105.5 -172.68 2.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.02 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -57.24 -25.31 58.92 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.16 -20.65 65.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.068 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.43 1.69 74.46 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.88 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -112.19 144.48 30.88 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.0 123.77 12.09 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.744 2.296 . . . . 0.0 112.445 179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -109.17 130.19 55.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.671 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.24 122.89 21.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.972 0.415 . . . . 0.0 111.613 -179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.6 t -142.57 164.03 31.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 p -138.69 149.67 45.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.024 0.44 . . . . 0.0 111.288 -179.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.87 142.65 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.723 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.708 HD22 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -103.37 92.0 4.3 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.641 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.95 -29.41 63.15 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.669 -178.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -52.21 -33.88 43.12 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.875 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -102.05 16.32 26.39 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.839 -178.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -130.86 -26.47 2.19 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.52 141.55 27.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.622 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -111.9 171.53 14.26 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.312 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -113.37 109.05 18.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.996 -179.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.05 105.89 15.18 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 0.0 OUTLIER 49.32 39.12 15.32 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 122.662 1.22 . . . . 0.0 111.867 179.652 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.65 3.66 77.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.415 178.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -110.06 154.4 23.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.988 0.423 . . . . 0.0 110.888 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.5 mt -85.47 117.22 24.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.074 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.547 ' CG ' HD11 ' A' ' 111' ' ' LEU . 31.3 tt0 -106.04 128.61 53.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.018 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.654 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.55 -66.8 0.25 Allowed Pre-proline 1 CA--C 1.42 -4.05 0 O-C-N 124.117 0.885 . . . . 0.0 112.754 -179.493 . . . . . . . . 4 4 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.53 ' HD2' ' HG2' ' A' ' 49' ' ' GLU . 3.0 Cg_endo -109.6 126.4 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.313 0 C-N-CA 113.821 -3.652 . . . . 0.0 113.413 -177.708 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.622 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -165.05 -161.83 14.84 Favored Glycine 0 C--N 1.285 -2.257 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.684 -177.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.48 146.45 25.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.381 -0.41 . . . . 0.0 110.665 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.6 m 54.5 40.65 31.97 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.427 ' HD2' ' SG ' ' A' ' 59' ' ' CYS . 13.2 p90 -72.2 -34.16 68.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.49 -18.26 67.55 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.998 -179.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 m -68.89 -9.34 51.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.153 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.8 m -145.62 8.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.726 179.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' A' ' 55' ' ' PHE . 6.4 m -109.33 153.28 24.14 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.101 0.477 . . . . 0.0 111.462 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.9 m -142.22 167.41 15.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.906 178.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 63.39 33.06 14.14 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.618 0.574 . . . . 0.0 111.293 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -59.68 122.09 13.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.324 179.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.94 161.39 42.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.869 -179.513 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.797 HD22 HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -114.4 113.78 24.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.815 0.341 . . . . 0.0 111.803 -179.003 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.548 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 90.0 m-20 -73.09 116.35 13.52 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.47 20.01 2.6 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.104 0.878 . . . . 0.0 111.558 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.85 29.24 73.54 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.072 -0.513 . . . . 0.0 114.375 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -142.57 -24.48 0.65 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.913 0.856 . . . . 0.0 112.036 179.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 20.3 m -116.24 132.53 56.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.475 ' HB2' HD13 ' A' ' 88' ' ' LEU . 16.0 tp -90.77 129.63 36.83 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.2 129.29 54.03 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.312 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -163.86 163.94 23.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.067 0.46 . . . . 0.0 110.776 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.6 t -114.5 119.48 36.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.474 -0.784 . . . . 0.0 108.98 179.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -116.17 156.36 26.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.329 0.585 . . . . 0.0 111.831 -179.172 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.9 tmtt? -99.5 143.34 29.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.304 178.471 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.72 -17.81 0.66 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.445 -1.359 . . . . 0.0 114.098 178.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -63.37 -38.06 89.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.426 0.613 . . . . 0.0 110.484 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -177.25 59.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.754 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.84 16.72 66.47 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.086 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -139.31 163.36 32.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 40.8 p90 -97.6 171.62 8.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.143 -179.075 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.13 136.63 11.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.69 128.64 37.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.162 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -146.02 169.0 19.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.264 -179.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.7 164.47 30.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.905 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.5 OUTLIER -149.21 125.95 11.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.492 -179.235 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.46 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 9.0 m-20 -75.25 106.31 6.71 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.458 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.573 ' HA ' HG23 ' A' ' 91' ' ' VAL . 14.8 mt -79.11 -8.63 59.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.163 0.506 . . . . 0.0 109.687 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -49.61 -28.43 5.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.731 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 10.4 p90 -119.11 21.52 12.29 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 179.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -127.2 -16.25 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.943 0.402 . . . . 0.0 110.563 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.1 t -132.94 148.74 31.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -147.72 164.26 28.81 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.89 179.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -107.93 135.06 49.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.899 0.38 . . . . 0.0 110.638 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.0 m -140.14 96.51 3.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.713 178.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 62.03 45.96 6.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.675 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 56.51 29.76 57.9 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.773 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -127.08 147.11 50.17 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.844 0.354 . . . . 0.0 110.665 -178.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.0 103.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.475 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -137.96 67.1 48.63 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.426 179.008 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 28.3 Cg_endo -62.72 114.41 2.39 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 123.32 2.68 . . . . 0.0 112.838 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.03 129.22 54.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.042 179.197 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -112.29 147.38 36.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.092 179.767 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.59 56.14 0.64 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.139 0.495 . . . . 0.0 110.366 179.373 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.3 t -167.22 -124.48 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.494 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 108' ' ' ASP . 28.9 t-20 63.63 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.861 0.865 . . . . 0.0 111.666 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 68.99 -32.7 0.23 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.826 0.85 . . . . 0.0 112.31 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 106' ' ' ASN . 28.1 t70 -62.92 -25.96 68.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.32 0.581 . . . . 0.0 110.756 179.321 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -136.57 155.41 49.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.821 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.405 HG13 ' HG2' ' A' ' 112' ' ' LYS . 25.0 t -112.16 96.3 4.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.788 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.559 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -82.2 74.85 9.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.617 0.722 . . . . 0.0 111.986 -178.466 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.775 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 7.4 mmpt? -101.45 95.08 6.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.985 179.02 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.3 p -82.92 61.94 6.22 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.667 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.7 t -157.51 94.67 1.39 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.194 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -72.14 -53.14 13.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.167 0.508 . . . . 0.0 109.651 179.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 C--O 1.247 0.928 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.992 179.754 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.569 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 71.5 m . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 89' ' ' ASN . 92.7 m-20 52.78 71.17 0.5 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.375 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.49 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.7 p90 -54.02 -36.76 63.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.264 0.554 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.14 -21.61 33.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -62.74 -27.78 69.52 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.559 ' HB2' HD22 ' A' ' 94' ' ' ASN . 26.7 m -134.62 16.7 3.63 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.049 0.452 . . . . 0.0 110.774 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.5 m -117.48 133.04 56.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.129 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -130.84 152.71 49.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.717 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.22 61.65 6.15 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.095 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 m -95.08 131.3 42.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.393 0.616 . . . . 0.0 111.898 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -124.59 157.44 35.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.099 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.618 HD22 HD23 ' A' ' 64' ' ' LEU . 14.2 tp -139.82 121.66 15.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.501 . . . . 0.0 111.295 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.42 102.17 6.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.98 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.7 -60.67 3.71 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.965 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -170.81 26.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 122.875 0.47 . . . . 0.0 110.38 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 15.2 mt -119.23 113.61 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.08 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.807 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -99.2 114.24 26.93 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -124.22 142.78 50.96 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.486 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.42 -179.27 41.19 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.401 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 8.7 m-20 -103.59 107.69 18.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 79.8 m -107.62 132.77 52.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.013 0.435 . . . . 0.0 110.025 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.1 mt -72.78 137.21 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.575 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -102.41 -169.09 1.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.028 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -62.83 -26.31 68.68 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 111.598 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.21 -23.26 64.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.296 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.45 5.92 58.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.351 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -110.43 142.16 25.47 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.678 0.275 . . . . 0.0 110.624 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.566 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 39.8 Cg_endo -69.51 122.15 8.9 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.819 2.346 . . . . 0.0 111.979 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -111.71 131.03 55.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.75 120.85 17.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.157 0.503 . . . . 0.0 111.104 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 t -136.69 152.75 50.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.122 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.7 p -131.22 148.22 52.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.472 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.04 145.53 34.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.463 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -101.95 98.75 8.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.163 0.506 . . . . 0.0 110.121 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.5 mm? -60.38 -26.81 66.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.64 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.02 -24.91 57.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.756 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -106.83 7.22 30.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 60.0 m-85 -128.68 -16.37 4.26 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.08 144.24 27.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.669 0.271 . . . . 0.0 110.974 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.576 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -117.79 179.26 17.18 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.138 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 19.1 p-10 -131.76 102.22 5.79 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.809 0.814 . . . . 0.0 110.618 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -105.27 121.85 44.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.068 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.818 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 53.6 t30 60.13 32.38 20.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.207 0.527 . . . . 0.0 110.171 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.01 21.31 79.97 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.043 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -121.84 157.52 30.93 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 86' ' ' MET . 33.4 mt -82.11 115.69 21.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.203 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HG2' ' C ' ' A' ' 42' ' ' GLY . 10.2 pt-20 -103.24 143.42 32.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.671 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -46.38 -74.06 0.08 OUTLIER Pre-proline 0 CA--C 1.431 -3.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.835 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.671 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 13.1 Cg_endo -110.24 124.28 0.03 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.393 0 C-N-CA 113.794 -3.671 . . . . 0.0 113.122 -177.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.576 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -150.32 -160.88 9.56 Favored Glycine 0 C--N 1.278 -2.648 0 CA-C-N 113.429 -1.714 . . . . 0.0 113.284 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -149.6 139.85 22.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.411 -0.395 . . . . 0.0 110.728 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.6 p 48.3 52.23 13.77 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.296 1.038 . . . . 0.0 113.569 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -75.69 -39.55 57.28 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -18.71 53.49 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.576 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.3 m -68.65 -22.72 64.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.291 -0.454 . . . . 0.0 110.728 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.2 m -135.02 22.42 3.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.7 m -131.92 145.38 51.47 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.63 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 m -134.13 169.98 20.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.107 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 66.43 37.09 4.83 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.404 0.44 . . . . 0.0 110.834 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.7 117.36 8.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.54 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.09 161.32 42.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.255 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -112.13 124.0 51.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.869 0.366 . . . . 0.0 110.813 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 2.7 t30 -95.53 127.28 41.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.833 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 14.4 t70 52.41 24.27 2.88 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.972 0.795 . . . . 0.0 112.249 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.33 38.5 79.05 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.859 -0.61 . . . . 0.0 114.1 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.603 ' CD2' ' HB3' ' A' ' 66' ' ' ASP . 1.3 p80 -153.46 -27.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.52 0.66 . . . . 0.0 111.798 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.4 m -115.74 130.3 56.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.697 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.622 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.2 tp -90.65 138.95 31.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.9 132.95 52.05 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.68 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -164.58 159.89 19.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.128 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 t -107.53 122.94 47.67 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 30.8 m -124.75 154.91 40.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -97.5 146.25 25.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.428 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.94 -31.18 0.74 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.919 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.818 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -52.91 -42.53 65.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -174.39 55.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.75 11.23 59.96 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.446 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -130.51 161.24 31.91 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 50.5 p90 -96.1 168.58 10.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.401 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.08 136.41 9.9 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.2 126.93 31.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.951 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.524 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 33.2 t -140.81 171.82 13.55 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.124 0.487 . . . . 0.0 111.072 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.78 158.22 44.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.419 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.686 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.7 OUTLIER -141.83 122.92 14.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.679 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.4 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 4.1 m-20 -73.75 105.66 5.15 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.709 ' HA ' HG22 ' A' ' 91' ' ' VAL . 21.0 mt -75.55 -8.97 58.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.025 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.507 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 18.1 m120 -47.55 -29.75 3.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.166 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 87' ' ' ASP . 16.6 p90 -118.37 21.32 12.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.977 0.418 . . . . 0.0 111.18 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -129.43 -9.63 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.752 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.926 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 14.5 p -152.58 143.73 15.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.41 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -146.77 169.69 27.87 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.135 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' A' ' 8' ' ' SER . 28.2 t30 -100.15 131.06 46.32 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.569 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 73.9 m -138.59 95.04 2.92 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.572 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 62.9 44.88 5.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.441 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.0 23.21 56.79 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.38 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -123.12 140.11 53.36 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 99' ' ' MET . 24.3 ptt? -56.17 112.09 1.13 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.85 0.719 . . . . 0.0 111.336 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 1.6 mm-40 -137.68 77.62 38.86 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.104 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.926 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 58.1 Cg_endo -74.42 93.96 0.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.428 2.085 . . . . 0.0 112.228 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.097 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.511 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 68.5 m . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 41.49 73.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.576 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.7 p90 -54.76 -39.76 68.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.981 0.419 . . . . 0.0 111.33 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.91 -22.94 41.29 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.53 -20.73 61.29 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.438 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.437 ' HB2' HD22 ' A' ' 94' ' ' ASN . 20.4 m -129.97 11.54 5.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.911 0.386 . . . . 0.0 110.928 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 91.2 m -120.14 132.9 55.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -127.07 160.23 31.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.65 45.34 90.62 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.741 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -87.09 123.94 40.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.449 0.642 . . . . 0.0 111.594 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 47.3 mt-10 -121.61 142.43 50.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.534 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.768 HD22 HD23 ' A' ' 64' ' ' LEU . 17.2 tp -117.83 112.31 20.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.952 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -133.83 104.92 6.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.077 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 70.36 51.54 21.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.771 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CD1' HG21 ' A' ' 62' ' ' THR . 7.7 m-85 63.81 16.18 9.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.214 0.605 . . . . 0.0 111.57 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 16' ' ' GLY . 20.9 mt -116.38 116.3 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 120.659 0.266 . . . . 0.0 110.534 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.766 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 mt -103.13 114.43 28.71 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.602 ' HG3' ' HB3' ' A' ' 34' ' ' SER . 6.9 ttt180 -121.07 145.05 48.2 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.79 -175.23 40.54 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.284 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.0 m-20 -109.07 110.41 21.66 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.894 0.378 . . . . 0.0 110.263 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 65.9 m -107.4 132.56 53.04 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.88 134.75 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.227 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.69 -174.24 2.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 96' ' ' TYR . 7.4 tp10 -49.43 -40.04 35.16 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.489 0.493 . . . . 0.0 111.52 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -57.96 -26.14 61.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.303 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.44 -0.44 58.35 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.712 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -106.77 146.08 32.37 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.886 0.374 . . . . 0.0 110.889 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.611 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 36.6 Cg_endo -68.62 122.16 9.11 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.136 2.557 . . . . 0.0 112.266 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -109.89 127.37 54.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.594 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.65 125.36 25.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.169 0.509 . . . . 0.0 111.475 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 t -143.56 158.85 43.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.342 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.602 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 4.7 p -139.63 147.0 40.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.857 0.36 . . . . 0.0 111.254 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 mp -130.9 143.44 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.29 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -104.31 95.3 5.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.766 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -59.11 -19.81 47.91 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.806 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.579 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 21.7 t-20 -54.84 -32.57 60.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.928 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -106.42 16.44 24.71 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.489 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 54.5 m-85 -127.91 -23.45 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.59 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -111.72 144.0 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.641 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -116.53 171.76 13.92 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.881 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -107.28 112.9 25.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.959 0.409 . . . . 0.0 111.222 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -110.61 105.09 13.88 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 2.7 p-10 42.19 44.82 3.36 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.822 1.249 . . . . 0.0 112.806 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 87.11 7.72 76.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.405 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 0.7 OUTLIER -117.85 160.85 20.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.987 0.422 . . . . 0.0 110.83 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 72' ' ' ALA . 31.2 mt -84.05 115.76 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.114 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -103.13 126.06 50.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.586 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.78 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -35.25 -71.28 0.11 Allowed Pre-proline 0 CA--C 1.429 -3.702 0 O-C-N 124.49 1.119 . . . . 0.0 113.736 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.78 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 10.1 Cg_endo -110.75 120.96 0.02 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.436 0 C-N-CA 113.776 -3.682 . . . . 0.0 113.097 -178.226 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.641 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -152.45 -161.73 10.42 Favored Glycine 0 C--N 1.274 -2.871 0 CA-C-N 113.541 -1.663 . . . . 0.0 113.211 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 20.4 mt-10 -156.69 141.94 17.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.996 0.468 . . . . 0.0 110.458 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.2 m 58.66 36.69 25.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.801 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.579 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 5.3 p90 -69.18 -33.48 73.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.23 -18.78 58.57 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.396 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.5 m -67.19 -14.05 62.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.83 0.347 . . . . 0.0 110.774 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.9 p -146.26 20.53 1.38 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.1 m -133.15 139.19 46.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.773 0.321 . . . . 0.0 111.194 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.461 HG23 ' HD3' ' A' ' 61' ' ' LYS . 21.4 m -134.16 177.63 6.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.167 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.9 mptt 59.84 44.08 14.28 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.406 0.441 . . . . 0.0 111.136 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.472 HG21 ' CD1' ' A' ' 17' ' ' TYR . 30.6 p -75.75 125.78 29.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 111.358 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.65 162.57 39.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.574 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.768 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -118.59 116.99 27.77 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.626 0.251 . . . . 0.0 111.039 -179.06 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -93.19 127.47 38.77 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.639 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.632 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 4.3 t70 54.0 23.31 3.92 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.914 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.48 28.66 67.8 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -149.22 -18.09 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 117.899 0.85 . . . . 0.0 112.334 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.0 m -116.38 127.42 54.63 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.749 0.309 . . . . 0.0 111.245 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -90.03 136.85 32.79 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.56 130.4 50.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.162 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -161.44 167.14 26.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.105 0.478 . . . . 0.0 110.713 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.403 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 8.5 t -116.75 122.02 43.27 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.415 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.4 m -121.51 149.64 42.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 0.0 112.108 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -99.88 146.73 26.31 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.05 -22.79 0.78 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.558 -1.306 . . . . 0.0 113.473 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -60.89 -40.64 93.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.716 0.293 . . . . 0.0 111.208 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -176.61 57.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.392 0.615 . . . . 0.0 110.08 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.84 0.14 40.13 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.811 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -122.53 163.6 19.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.403 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 40.9 p90 -112.45 167.19 10.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.844 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.53 152.76 27.71 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.78 129.45 37.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.231 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.54 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 25.1 t -142.06 166.53 24.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.516 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.86 163.17 32.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.657 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.3 tpt -144.73 121.49 11.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.674 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -75.31 105.55 6.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.71 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.0 mt -74.76 -8.64 57.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.522 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -46.86 -30.1 2.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.222 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -120.83 23.6 10.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 111.348 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.71 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.4 m -127.08 -9.28 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.081 0.467 . . . . 0.0 110.472 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.913 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.7 p -156.28 138.34 6.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.858 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -133.76 177.44 19.07 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.065 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.437 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.8 t30 -109.83 123.42 49.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.626 0.25 . . . . 0.0 110.559 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.519 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 6.0 t -127.57 101.15 6.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.431 ' CD1' ' HB2' ' A' ' 26' ' ' GLU . 98.0 m-85 57.98 47.62 14.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.5 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 58.9 25.22 59.0 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.034 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -129.82 148.93 51.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.813 0.34 . . . . 0.0 110.088 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -58.69 118.94 6.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.66 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.519 ' HG3' ' HB3' ' A' ' 95' ' ' SER . 12.4 mm-40 -143.9 77.9 14.43 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.958 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.913 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 57.6 Cg_endo -74.69 93.85 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.542 2.161 . . . . 0.0 112.675 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.182 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 53.15 68.39 0.85 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.516 ' CD1' ' HB ' ' A' ' 92' ' ' VAL . 10.9 p90 -55.02 -45.99 75.18 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.163 0.506 . . . . 0.0 111.123 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.21 -22.08 62.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -65.87 -20.48 66.25 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.612 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 m -135.69 25.26 3.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.915 0.388 . . . . 0.0 110.946 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.0 m -134.1 132.95 40.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.051 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 p -134.46 165.11 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.611 0.243 . . . . 0.0 110.867 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.12 98.37 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.185 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' HB ' ' CD1' ' A' ' 19' ' ' LEU . 35.8 m -83.17 139.81 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.304 0.574 . . . . 0.0 111.848 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.09 148.46 52.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.545 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.532 HD22 HD23 ' A' ' 64' ' ' LEU . 14.5 tp -132.21 117.38 18.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.023 0.439 . . . . 0.0 111.155 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.41 109.99 12.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.462 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.04 -68.91 2.78 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.366 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 17.5 p90 -170.45 28.94 0.02 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.326 0.584 . . . . 0.0 110.387 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 mt -121.2 115.64 47.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.643 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.862 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -96.99 113.7 25.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.265 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -124.44 139.38 53.95 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.129 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.45 -170.9 33.71 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.269 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 1.3 m-20 -108.25 111.01 22.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.931 0.396 . . . . 0.0 110.278 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 72.4 m -107.52 132.09 53.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.01 141.82 16.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.678 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -108.92 -171.46 1.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.78 -33.82 64.71 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -64.46 -24.69 67.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.909 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.0 6.98 57.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.623 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -111.55 144.78 31.26 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 40.2 Cg_endo -68.44 133.64 28.67 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.864 2.376 . . . . 0.0 112.166 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -118.07 133.24 56.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.378 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.75 122.89 19.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.005 0.431 . . . . 0.0 111.282 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 t -142.17 159.08 42.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.021 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.7 p -140.39 146.02 37.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.83 146.08 33.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.329 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -102.2 96.29 6.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.009 0.433 . . . . 0.0 110.07 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -59.32 -26.54 65.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.311 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 25.9 t-20 -55.0 -28.95 55.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.054 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -103.34 6.04 37.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 55.3 m-85 -125.25 -19.84 5.0 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.264 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 mt -117.3 143.59 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.801 0.334 . . . . 0.0 110.805 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.622 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -119.47 176.29 16.07 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.219 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -127.27 112.76 15.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.735 0.779 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -110.6 115.0 28.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.342 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.82 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 56.3 t30 59.4 38.36 22.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.286 0.565 . . . . 0.0 110.476 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.12 12.09 84.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.195 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -118.45 151.43 37.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.872 0.368 . . . . 0.0 110.797 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.8 mp -76.96 129.39 36.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.599 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.481 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 9.5 tp10 -121.87 132.92 54.83 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.231 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.768 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -37.94 -66.4 0.3 Allowed Pre-proline 0 CA--C 1.423 -3.924 0 O-C-N 124.216 0.948 . . . . 0.0 113.186 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.768 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 5.5 Cg_endo -109.94 129.29 0.04 OUTLIER 'Trans proline' 1 N--CA 1.34 -7.509 0 C-N-CA 113.742 -3.706 . . . . 0.0 113.064 -178.151 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.622 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -163.44 -162.85 14.95 Favored Glycine 0 C--N 1.283 -2.38 0 CA-C-N 114.012 -1.449 . . . . 0.0 113.403 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -150.58 142.94 24.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.935 0.398 . . . . 0.0 110.743 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.8 p 50.83 49.25 21.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.552 1.141 . . . . 0.0 113.585 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.439 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 11.1 p90 -73.91 -43.97 56.71 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.66 -19.01 47.39 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.893 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 m -66.5 -16.02 63.81 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.041 0.448 . . . . 0.0 110.889 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 m -146.55 28.74 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.466 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 55' ' ' PHE . 62.9 m -133.66 149.58 51.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.595 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.553 HG23 ' HD3' ' A' ' 61' ' ' LYS . 19.3 m -136.69 173.13 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.812 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.553 ' HD3' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER 63.22 39.31 9.81 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.062 0.545 . . . . 0.0 111.524 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.449 ' HB ' HD21 ' A' ' 14' ' ' LEU . 22.3 p -66.29 120.6 13.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.335 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.67 156.49 40.48 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.58 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -113.79 112.0 22.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.889 0.376 . . . . 0.0 111.766 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.518 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 6.2 m-20 -73.75 117.48 15.58 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.577 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 0.3 OUTLIER 56.44 23.58 7.6 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.733 0.646 . . . . 0.0 110.701 -179.373 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.85 28.46 65.9 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.024 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.577 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.3 p80 -139.58 -28.02 0.77 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.707 0.754 . . . . 0.0 111.544 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 22.2 m -110.72 126.16 54.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.707 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.697 ' HB2' HD11 ' A' ' 88' ' ' LEU . 19.3 tp -90.3 127.92 36.29 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.743 -0.383 . . . . 0.0 109.99 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.26 129.62 56.03 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.981 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.57 154.33 18.31 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.678 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 28.0 t -102.41 123.01 45.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 59.8 m -120.2 153.02 36.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.0 111.9 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 10.5 tmtt? -98.77 142.31 30.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.449 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.49 -32.74 0.53 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.278 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.82 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -54.33 -39.68 67.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -169.29 48.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.351 0.596 . . . . 0.0 109.524 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.31 6.48 47.91 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.296 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 28.5 pt20 -128.17 168.11 15.87 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 41.5 p90 -88.26 167.76 13.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.344 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.503 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.2 OUTLIER -155.29 129.55 8.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.531 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -70.6 114.7 8.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.674 0.273 . . . . 0.0 110.753 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.7 t -129.49 160.62 32.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.076 0.465 . . . . 0.0 111.238 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.6 OUTLIER -128.87 165.04 21.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.051 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.624 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.7 tpt -152.85 124.83 7.95 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.869 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 40.6 t0 -76.43 107.05 8.42 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.765 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.6 mt -78.42 -8.17 58.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.649 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -49.78 -28.62 6.5 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.276 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.454 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 45.1 p90 -116.37 21.31 13.66 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.242 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.765 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -129.18 -11.21 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.1 t -134.7 145.51 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.15 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.95 166.44 25.4 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 23' ' ' CYS . 20.3 t30 -130.85 132.64 45.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 111.319 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 m -140.39 113.14 8.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.515 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 59.99 42.67 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.477 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.25 22.03 62.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.449 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -123.55 137.6 54.73 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 127.05 31.57 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.574 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.57 68.68 13.39 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 121.75 0.786 . . . . 0.0 109.415 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 13.1 Cg_endo -54.68 115.12 2.19 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.539 2.826 . . . . 0.0 113.19 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.705 179.011 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.571 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 59.7 m . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 p30 33.04 78.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.534 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 2.8 p90 -60.14 -31.86 70.48 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.932 0.396 . . . . 0.0 111.76 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.73 -23.14 66.68 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -70.33 -7.46 42.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.285 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.468 ' HB2' HD22 ' A' ' 94' ' ' ASN . 53.4 m -145.15 27.01 1.3 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.071 0.462 . . . . 0.0 110.412 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -133.36 147.7 51.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.47 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -140.06 148.18 41.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.654 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.81 59.24 10.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.234 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.414 ' HB ' ' CD1' ' A' ' 19' ' ' LEU . 18.2 m -95.24 133.22 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.106 0.479 . . . . 0.0 110.618 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -128.36 142.4 51.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.501 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.643 HD22 HD23 ' A' ' 64' ' ' LEU . 12.7 tp -107.45 112.86 25.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.097 0.475 . . . . 0.0 110.759 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.479 ' O ' HG12 ' A' ' 18' ' ' ILE . 54.8 m-85 -105.17 97.81 7.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.803 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.78 -64.18 0.47 Allowed Glycine 0 CA--C 1.523 0.594 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.549 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 7.9 p90 -158.23 16.67 0.22 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.779 0.432 . . . . 0.0 111.38 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.0 pt -122.63 132.26 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 0.0 110.305 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -104.18 114.4 28.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.816 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -117.75 136.82 53.12 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -164.51 -179.24 38.51 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.385 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 11.1 m-20 -101.71 104.88 15.72 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -105.36 132.13 51.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.998 0.427 . . . . 0.0 110.106 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.6 mt -75.25 132.75 32.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.192 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -101.6 -171.65 2.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.929 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -55.85 -29.93 60.66 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.7 -22.56 66.97 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.053 0.454 . . . . 0.0 111.696 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.58 6.92 65.46 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.459 -0.876 . . . . 0.0 111.293 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -112.86 142.89 28.02 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.542 -0.329 . . . . 0.0 110.354 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.579 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 43.4 Cg_endo -69.94 121.9 8.54 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.819 2.346 . . . . 0.0 112.131 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -111.92 127.48 55.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.5 124.44 22.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.166 0.508 . . . . 0.0 111.326 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -136.96 159.51 41.67 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.419 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 p -140.05 140.74 36.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.49 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.1 146.87 30.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.414 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -101.86 94.62 5.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -59.86 -26.62 66.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.631 0.253 . . . . 0.0 111.461 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.527 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 27.9 t30 -60.37 -16.48 35.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -109.68 6.82 24.05 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.135 -0.353 . . . . 0.0 110.849 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.47 ' CE2' ' HG3' ' A' ' 101' ' ' PRO . 37.4 m-85 -127.56 -23.95 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.492 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.3 mp -113.56 142.45 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -117.16 173.9 14.95 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.005 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -110.14 103.23 11.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.829 0.347 . . . . 0.0 110.51 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -112.42 107.86 16.8 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.371 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.845 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 58.0 t30 59.73 39.05 21.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.243 0.544 . . . . 0.0 110.412 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 72.57 21.66 79.41 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.71 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -125.94 150.35 48.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.506 0.194 . . . . 0.0 111.358 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 1.8 mm? -72.77 114.69 11.18 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.609 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 39.4 tt0 -108.54 123.75 49.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.512 0.672 . . . . 0.0 110.305 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.792 ' CD2' ' HD3' ' A' ' 51' ' ' PRO 0.251 0.2 OUTLIER -36.66 -57.73 1.15 Allowed Pre-proline 0 CA--C 1.423 -3.912 0 CA-C-N 113.503 -1.68 . . . . 0.0 115.164 -178.691 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.792 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 17.2 Cg_endo -117.08 109.23 0.01 OUTLIER 'Trans proline' 1 N--CA 1.348 -7.083 0 C-N-CA 113.471 -3.886 . . . . 0.0 113.12 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -148.43 -164.63 11.55 Favored Glycine 0 C--N 1.271 -3.066 0 CA-C-N 112.988 -1.915 . . . . 0.0 113.851 -176.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -151.79 142.2 22.52 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.629 0.372 . . . . 0.0 110.309 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.4 m 53.67 54.39 10.01 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 19.4 p90 -78.95 -32.99 45.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.63 -19.23 54.13 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.935 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.2 m -65.08 -18.93 65.72 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.98 0.512 . . . . 0.0 111.432 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.3 m -144.83 14.32 1.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.816 0.341 . . . . 0.0 111.193 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.4 m -121.45 139.4 53.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.33 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.72 175.85 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.063 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 0.5 OUTLIER 58.42 43.8 19.16 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.604 0.565 . . . . 0.0 111.135 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 p -66.17 132.72 49.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.774 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.61 163.33 40.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.817 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.643 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -121.11 113.39 19.96 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.099 0.476 . . . . 0.0 110.518 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.65 120.15 25.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.612 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 54.04 30.75 12.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.901 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 51.33 36.64 37.7 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.442 -0.799 . . . . 0.0 114.644 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -150.76 -29.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.768 0.784 . . . . 0.0 111.415 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 m -113.02 130.73 56.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.27 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.609 ' HB2' HD11 ' A' ' 88' ' ' LEU . 13.2 tp -89.98 128.34 36.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.89 129.24 55.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.576 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.21 170.11 21.85 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.775 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 t -113.81 116.92 30.11 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.511 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.7 m -116.71 148.5 41.02 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.12 0.486 . . . . 0.0 111.859 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.8 tmtt? -100.2 142.62 31.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.232 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.07 -31.03 0.54 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.329 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.845 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.09 -41.28 64.78 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -172.13 52.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.525 0.679 . . . . 0.0 110.182 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.16 -0.28 32.13 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.852 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -119.7 162.92 18.2 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 24.2 p90 -91.03 165.98 13.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.07 127.58 7.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.644 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -67.19 123.03 19.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.787 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 p -142.88 176.07 9.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.349 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.28 160.49 40.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.121 0.486 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.668 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.5 tpt -143.91 124.84 14.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.009 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.485 ' H ' ' HE2' ' A' ' 86' ' ' MET . 26.0 t0 -78.29 106.77 10.43 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.542 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.754 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.1 mt -77.36 -8.93 58.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.987 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -49.37 -27.75 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.334 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 43.6 p90 -118.62 20.02 13.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.508 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 88' ' ' LEU . 2.0 m -125.22 -13.03 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.958 0.409 . . . . 0.0 110.651 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.89 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 6.9 p -147.26 136.37 16.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.789 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.571 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -133.17 173.89 20.85 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.47 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 8' ' ' SER . 20.7 t30 -111.93 124.57 52.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.4 m -133.07 103.4 6.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.75 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 63.84 41.42 6.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.24 28.28 66.61 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.883 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -125.55 147.19 49.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.897 0.38 . . . . 0.0 110.858 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 99' ' ' MET . 13.5 ptm -64.2 103.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.887 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -132.83 80.32 61.34 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.177 0.513 . . . . 0.0 110.48 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.89 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 65.6 Cg_endo -74.3 125.28 9.59 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.696 2.264 . . . . 0.0 112.148 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 121.372 0.606 . . . . 0.0 111.52 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.536 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 99.7 m . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 43.04 70.2 0.32 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.945 0.778 . . . . 0.0 113.071 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 11.7 p90 -53.25 -34.16 56.02 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.331 0.586 . . . . 0.0 110.402 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.86 -23.29 67.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.349 -0.842 . . . . 0.0 113.002 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -62.06 -27.48 68.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.7 m -129.88 15.91 5.78 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.525 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -117.53 139.89 50.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.371 0.605 . . . . 0.0 111.651 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -137.82 154.48 49.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.199 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.79 60.51 7.99 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.358 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 31.6 m -94.14 139.91 17.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.075 0.464 . . . . 0.0 111.532 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -131.32 148.74 52.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.13 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.68 HD22 HD23 ' A' ' 64' ' ' LEU . 14.9 tp -133.41 119.19 19.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.992 0.425 . . . . 0.0 110.974 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.487 ' O ' HG12 ' A' ' 18' ' ' ILE . 67.6 t80 -127.09 101.32 6.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.202 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.23 -63.08 3.65 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.625 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -167.82 20.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.585 0.231 . . . . 0.0 111.602 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 15' ' ' TYR . 35.8 pt -116.25 126.08 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.821 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -111.3 114.74 28.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.263 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 17.8 ttm180 -116.98 138.43 51.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.53 168.12 35.93 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.778 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 9.7 m-20 -101.66 109.56 21.37 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -106.91 133.41 51.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.933 0.396 . . . . 0.0 110.426 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.5 mt -67.85 139.57 20.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.378 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.7 p30 -112.49 -168.1 1.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.567 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -56.18 -33.94 65.74 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.689 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.88 -28.62 67.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.597 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.14 -3.77 58.48 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.596 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -107.3 144.67 29.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.664 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 31.6 Cg_endo -64.9 128.27 20.45 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.387 2.725 . . . . 0.0 112.795 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -114.75 131.5 56.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.095 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.02 127.29 30.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.271 0.558 . . . . 0.0 111.75 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 t -142.34 159.31 42.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.479 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.6 p -139.69 150.55 45.0 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.351 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.717 HG13 ' HG3' ' A' ' 99' ' ' MET . 2.7 mp -134.63 143.11 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.979 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -100.82 97.03 7.7 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.5 mm? -59.42 -22.55 61.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.383 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -55.11 -28.76 54.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.125 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -108.18 11.54 27.37 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.909 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' C ' HD12 ' A' ' 41' ' ' ILE . 43.9 m-85 -129.09 -6.91 4.89 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.559 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.5 mp -129.06 133.74 65.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.585 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.64 176.42 18.22 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.391 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -115.38 101.63 9.09 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.983 0.42 . . . . 0.0 109.982 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.78 107.18 16.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.331 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.513 ' CG ' ' HA ' ' A' ' 77' ' ' ALA . 13.7 t-20 56.53 45.2 22.8 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.553 0.692 . . . . 0.0 110.471 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.95 19.8 75.64 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.828 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 149.01 47.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.982 0.42 . . . . 0.0 111.359 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.5 mp -72.45 122.47 21.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.714 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.624 ' HG2' ' CD ' ' A' ' 51' ' ' PRO . 24.7 tt0 -111.57 124.27 51.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 110.68 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.539 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 34.2 p90 -46.55 -28.2 0.68 Allowed Pre-proline 0 CA--C 1.452 -2.817 0 N-CA-C 119.107 3.003 . . . . 0.0 119.107 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.624 ' CD ' ' HG2' ' A' ' 49' ' ' GLU . 6.8 Cg_endo -127.04 5.97 0.01 OUTLIER 'Trans proline' 1 N--CA 1.391 -4.545 1 C-N-CA 112.76 -4.36 . . . . 0.0 116.392 178.82 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.585 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -56.24 -175.11 0.21 Allowed Glycine 0 C--N 1.265 -3.386 0 CA-C-N 111.099 -2.773 . . . . 0.0 115.903 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -147.81 144.09 27.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.942 0.401 . . . . 0.0 111.302 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.2 t 65.76 43.53 3.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.561 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.9 p90 -74.5 -37.51 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.771 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.98 -18.97 20.72 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.567 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 t -63.05 -22.38 66.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.786 0.327 . . . . 0.0 110.92 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 m -143.48 19.12 1.87 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.608 0.242 . . . . 0.0 111.136 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 73' ' ' SER . 63.6 m -124.54 140.58 52.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 0.0 111.091 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.38 176.02 7.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.143 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 60.89 46.57 8.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 123.752 0.658 . . . . 0.0 111.028 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.535 ' HB ' HD21 ' A' ' 14' ' ' LEU . 36.5 p -73.07 126.98 31.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.262 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.4 153.99 34.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.68 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -109.95 113.21 25.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.816 0.341 . . . . 0.0 111.083 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -79.2 117.39 20.17 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.298 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 t70 51.53 35.51 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.489 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 52.28 35.59 43.29 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.106 -0.952 . . . . 0.0 115.373 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -148.0 -25.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.024 0.912 . . . . 0.0 112.33 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.6 m -117.34 129.94 56.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.702 0.287 . . . . 0.0 111.433 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.612 ' HB2' HD11 ' A' ' 88' ' ' LEU . 20.1 tp -90.62 132.88 35.49 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.02 129.83 51.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.655 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.493 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -161.3 169.43 22.11 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.539 0.524 . . . . 0.0 110.849 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 59' ' ' CYS . 35.9 t -114.63 125.26 53.55 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 35.4 m -125.17 151.86 45.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -98.78 140.34 33.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.615 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.63 -32.01 0.48 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.5 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.513 ' HA ' ' CG ' ' A' ' 45' ' ' ASN . . . -50.83 -42.61 58.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -169.84 53.23 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.247 0.546 . . . . 0.0 110.015 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.9 1.79 49.09 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.423 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -125.27 165.53 18.16 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 40.3 p90 -95.19 161.04 14.27 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 123.618 0.574 . . . . 0.0 110.616 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -155.43 140.48 17.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -72.74 135.63 45.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.466 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.9 p -150.54 174.68 12.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.137 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.14 164.18 30.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.886 0.374 . . . . 0.0 110.373 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.57 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.2 tpt -147.01 122.1 10.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.225 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.68 106.4 4.07 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.684 ' HA ' HG22 ' A' ' 91' ' ' VAL . 21.4 mt -78.56 -8.35 58.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.135 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -47.12 -32.12 3.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.999 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -117.7 21.91 12.66 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.198 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -124.35 -14.96 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.279 0.561 . . . . 0.0 110.605 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.496 ' HB ' ' CD1' ' A' ' 5' ' ' PHE . 2.7 t -132.41 127.79 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.536 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -124.77 153.76 17.91 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.956 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.462 HD22 ' HB2' ' A' ' 8' ' ' SER . 32.1 t30 -103.96 117.44 34.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.806 0.336 . . . . 0.0 110.564 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 57.9 m -112.45 84.7 2.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.099 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 60.74 61.44 1.68 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.418 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 57.13 28.56 58.69 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.84 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -134.01 144.95 49.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.116 0.484 . . . . 0.0 110.917 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.717 ' HG3' HG13 ' A' ' 35' ' ' ILE . 6.2 tmm? -67.09 115.82 7.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.363 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 14.0 mt-10 -144.27 73.59 15.97 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.711 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HD3' ' HG2' ' A' ' 99' ' ' MET . 18.7 Cg_endo -57.09 156.73 23.33 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.261 2.641 . . . . 0.0 112.313 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 24.3 p . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.67 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.486 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 80.4 m . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 80.3 m-20 56.11 77.48 0.24 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 10.1 p90 -61.1 -44.44 97.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.011 0.434 . . . . 0.0 110.595 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.25 -21.11 61.47 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.613 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 28.0 t-20 -54.46 -35.69 63.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.58 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.484 ' HB2' HD22 ' A' ' 94' ' ' ASN . 52.4 m -134.03 21.62 3.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.65 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.4 m -118.06 132.99 56.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.611 0.243 . . . . 0.0 110.358 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.0 p -132.65 155.26 49.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.541 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.5 67.81 1.99 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.915 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 11.3 m -107.32 129.64 60.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.274 0.559 . . . . 0.0 112.373 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 67.5 mm-40 -115.98 145.76 42.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.314 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.932 HD22 HD23 ' A' ' 64' ' ' LEU . 53.6 tp -133.0 122.26 23.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.0 111.089 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 18' ' ' ILE . 76.8 t80 -134.2 100.07 4.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.967 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 62' ' ' THR . . . 81.39 -64.01 4.25 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.645 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -166.49 19.83 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.735 0.302 . . . . 0.0 111.365 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.6 pt -116.4 119.08 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.753 0.311 . . . . 0.0 110.942 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.839 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.2 mt -111.91 114.5 27.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.4 ttt85 -120.68 138.75 53.79 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.117 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 179.37 38.83 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.268 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.613 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 4.5 m-20 -105.68 109.53 21.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.73 0.3 . . . . 0.0 110.318 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 8' ' ' SER . 61.3 m -108.19 133.38 52.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.133 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 55.0 mt -67.8 138.29 22.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.616 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -106.75 -170.83 1.78 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.118 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 15.3 pt-20 -57.67 -29.43 64.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.938 0.399 . . . . 0.0 111.691 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -64.71 -22.97 67.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.539 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.08 -1.4 62.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.929 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -108.32 148.02 36.78 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 55.0 Cg_endo -70.96 128.59 15.13 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.9 2.4 . . . . 0.0 112.732 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -116.49 127.64 54.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.061 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.86 126.69 28.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.963 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.0 t -144.67 160.54 41.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.317 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 p -140.47 142.51 35.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.096 0.474 . . . . 0.0 111.184 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' A' ' 99' ' ' MET . 2.6 mp -123.69 143.8 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.691 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -104.14 92.65 4.46 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.839 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -56.35 -23.45 37.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.299 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -54.9 -32.69 61.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.955 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -100.78 11.29 39.86 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.771 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 52.6 m-85 -128.55 -26.91 2.68 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.4 mp -110.66 142.08 24.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.72 0.295 . . . . 0.0 110.825 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.711 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -121.21 166.12 14.18 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.13 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -113.16 111.79 22.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.422 0.629 . . . . 0.0 110.23 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -110.59 113.27 25.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.411 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.711 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 14.7 t30 57.12 36.18 27.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.04 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.97 13.84 82.63 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.798 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -118.93 145.69 45.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.582 0.23 . . . . 0.0 110.767 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.4 mp -73.84 113.8 11.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.739 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 7.2 tp10 -104.91 133.35 49.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.376 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.714 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.87 -68.93 0.2 Allowed Pre-proline 0 CA--C 1.425 -3.836 0 O-C-N 124.352 1.033 . . . . 0.0 113.152 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.714 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 6.8 Cg_endo -109.6 129.43 0.04 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.441 0 C-N-CA 113.763 -3.691 . . . . 0.0 113.31 -177.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.711 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -161.02 -160.35 10.65 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 113.998 -1.456 . . . . 0.0 113.46 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -154.73 140.6 18.2 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.962 0.448 . . . . 0.0 110.468 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m 52.39 46.78 26.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -72.19 -38.92 68.96 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.98 -18.73 48.52 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.533 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.5 m -64.92 -20.43 66.45 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 122.74 0.416 . . . . 0.0 111.12 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.0 m -143.69 28.15 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.078 0.466 . . . . 0.0 110.74 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.5 m -131.44 145.79 51.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.563 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.3 173.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.615 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mptt 61.65 41.8 11.72 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.689 0.618 . . . . 0.0 111.265 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.497 HG21 ' O ' ' A' ' 16' ' ' GLY . 7.5 p -68.75 123.88 22.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.605 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.88 156.7 38.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.155 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.932 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -113.61 112.88 24.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.717 0.294 . . . . 0.0 110.981 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -76.9 117.52 18.58 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.203 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.735 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 20.8 t70 61.63 5.48 1.27 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.837 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.47 35.7 41.0 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.969 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.735 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.0 p80 -148.91 -26.34 0.3 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 111.274 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 m -115.71 129.93 56.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.911 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.604 ' HA ' HD22 ' A' ' 64' ' ' LEU . 17.9 tp -90.36 136.78 32.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.51 129.55 46.2 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -163.25 166.51 23.09 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.404 0.44 . . . . 0.0 110.725 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 t -116.06 127.33 54.79 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 18.5 m -127.65 156.43 42.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.214 0.53 . . . . 0.0 112.065 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 10.5 tmtt? -99.72 152.29 20.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.425 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.45 -26.4 1.22 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.103 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.711 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -54.28 -42.14 69.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.843 0.354 . . . . 0.0 111.481 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -178.68 58.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.391 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.471 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 73.06 -2.92 32.22 Favored Glycine 0 CA--C 1.518 0.225 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.135 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -118.75 165.23 14.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.805 0.336 . . . . 0.0 110.421 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 49.1 p90 -104.41 166.36 10.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.679 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -151.14 152.07 32.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.691 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.47 129.4 34.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.23 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.9 p -148.25 170.54 17.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 0.0 111.462 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.53 165.69 25.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.874 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.683 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 9.3 tpt -143.54 113.27 7.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.491 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.544 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 21.8 t70 -72.31 104.01 3.58 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.789 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.8 mt -76.36 -8.54 57.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.322 -177.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.544 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 8.0 m120 -49.88 -28.56 6.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.575 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 48.7 p90 -117.53 21.5 12.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.187 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -129.11 -14.79 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.606 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.2 t -133.58 147.0 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -143.78 149.73 21.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.167 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.484 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.7 t30 -89.37 116.63 27.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -116.94 84.37 2.13 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.365 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 26' ' ' GLU . 78.5 m-85 61.44 53.99 3.25 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.485 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.48 28.05 64.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.943 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -130.35 142.27 50.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.634 ' HB2' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -74.61 106.66 6.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.566 0.698 . . . . 0.0 112.507 -178.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -137.5 78.83 37.08 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.418 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 39.7 Cg_endo -65.71 104.97 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 123.296 2.664 . . . . 0.0 112.853 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.231 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 91.7 m . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 51.97 73.66 0.31 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.4 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.551 ' CD1' HG13 ' A' ' 92' ' ' VAL . 1.9 p90 -58.31 -36.89 74.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 111.164 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.19 -22.21 60.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.83 -20.47 65.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.695 0.283 . . . . 0.0 111.404 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.43 ' HB2' HD22 ' A' ' 94' ' ' ASN . 18.7 m -135.33 16.65 3.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 97.7 m -124.58 136.9 54.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.78 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -132.95 147.77 52.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.293 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.19 43.3 80.92 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.748 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 12' ' ' VAL . 3.1 m -81.99 119.48 31.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.436 0.636 . . . . 0.0 111.507 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.89 133.38 56.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.766 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.812 HD22 HD23 ' A' ' 64' ' ' LEU . 42.7 tp -108.14 121.08 44.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.471 ' O ' HG12 ' A' ' 18' ' ' ILE . 85.7 m-85 -124.74 105.18 9.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.689 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.35 -66.95 2.23 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.512 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 6.4 p90 -164.59 18.64 0.05 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.695 0.398 . . . . 0.0 111.24 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 15' ' ' TYR . 30.7 pt -122.26 133.96 66.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.128 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.698 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.3 mt -114.12 114.63 26.32 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.274 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -118.01 140.9 49.08 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.95 -174.37 37.47 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.277 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 8.2 m-20 -109.21 108.69 19.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.576 0.227 . . . . 0.0 110.54 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 74.9 m -106.81 132.37 52.86 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 53.6 mt -68.26 140.72 18.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.6 p30 -108.96 -174.99 2.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.986 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -50.53 -36.67 35.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.66 0.384 . . . . 0.0 111.993 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -59.39 -25.31 64.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.806 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.64 4.91 59.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.367 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -112.84 146.95 36.13 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.345 -0.428 . . . . 0.0 110.137 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.567 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 56.5 Cg_endo -72.02 133.75 22.09 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.907 2.405 . . . . 0.0 112.903 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -121.82 130.51 53.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.619 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.82 129.67 40.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.041 0.448 . . . . 0.0 111.337 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.0 t -144.07 160.16 41.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.745 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.9 p -140.02 140.02 36.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.61 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -124.61 144.87 33.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 123.225 0.328 . . . . 0.0 110.401 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -102.98 91.48 4.14 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -58.3 -26.14 62.68 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.081 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.52 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 42.3 t30 -59.19 -20.38 53.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -105.62 8.13 33.04 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.432 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -129.13 -25.54 2.73 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -107.85 140.52 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.697 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.31 164.6 12.12 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.239 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -113.61 108.29 16.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.125 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -110.76 108.95 18.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.328 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 43.9 m-20 53.96 39.18 30.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.187 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 80.27 19.0 70.28 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.042 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.27 154.99 39.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.045 0.45 . . . . 0.0 111.096 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.497 HD13 ' HG ' ' A' ' 70' ' ' LEU . 51.6 mt -88.1 113.78 24.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.363 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -109.09 138.21 45.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.477 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.687 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -38.9 -71.74 0.12 Allowed Pre-proline 0 CA--C 1.426 -3.79 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 2.5 Cg_endo -107.92 129.29 0.05 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.234 0 C-N-CA 113.876 -3.616 . . . . 0.0 113.209 -176.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.697 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -165.2 -162.97 17.47 Favored Glycine 0 C--N 1.284 -2.324 0 CA-C-N 113.976 -1.466 . . . . 0.0 113.408 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -156.28 144.73 19.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.445 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.0 t 59.59 41.75 18.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.725 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 17.1 p90 -72.26 -37.57 69.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.45 -18.69 44.79 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.322 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 t -61.87 -20.67 63.97 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 110.63 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 m -144.46 24.34 1.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 111.02 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.2 m -124.95 139.83 53.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.262 0.554 . . . . 0.0 111.467 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.91 177.12 6.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.041 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 61.75 39.78 13.72 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.284 0.365 . . . . 0.0 111.431 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 p -70.43 126.47 29.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.956 0.408 . . . . 0.0 111.92 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.56 150.34 29.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.866 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.812 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -105.62 113.52 27.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.95 0.405 . . . . 0.0 111.218 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -84.21 123.64 30.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.645 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 18.2 t70 61.0 8.24 1.83 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.768 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.55 30.83 68.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.993 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.409 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -150.7 -20.43 0.22 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.883 0.342 . . . . 0.0 111.453 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.458 ' O ' HD13 ' A' ' 64' ' ' LEU . 40.7 m -116.03 135.65 53.75 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.493 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.497 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.0 tp -97.6 129.78 44.69 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.66 129.85 53.07 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.62 173.11 17.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.067 0.46 . . . . 0.0 110.788 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.7 t -119.95 119.27 32.98 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.475 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.6 m -122.52 146.79 47.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.8 tmtt? -100.54 146.38 27.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.01 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.0 -24.75 0.41 Allowed Glycine 0 C--O 1.227 -0.328 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.477 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -68.97 -34.34 75.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.623 0.712 . . . . 0.0 111.828 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -169.64 54.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.187 0.517 . . . . 0.0 110.542 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.53 -1.77 8.91 Favored Glycine 0 CA--C 1.518 0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.143 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.56 160.55 22.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.808 0.337 . . . . 0.0 110.825 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 49.3 p90 -97.63 168.63 10.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.395 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -155.72 148.67 24.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.823 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.19 132.87 45.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.121 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -152.35 161.1 43.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.558 0.694 . . . . 0.0 112.131 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.47 159.74 41.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.919 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.526 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 7.8 tpt -146.29 116.96 7.6 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.615 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.444 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 32.9 t0 -77.02 104.39 7.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.409 0.623 . . . . 0.0 110.342 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.784 ' HA ' HG22 ' A' ' 91' ' ' VAL . 12.5 mt -73.81 -8.32 55.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.403 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -47.19 -31.73 3.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.794 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 42.0 p90 -118.79 24.35 10.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.79 0.329 . . . . 0.0 111.602 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.784 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -130.39 -4.32 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.044 0.45 . . . . 0.0 110.996 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 9.1 p -153.03 144.29 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.341 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -139.18 -171.78 12.34 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.282 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.43 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.4 t30 -132.5 137.92 47.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.828 0.347 . . . . 0.0 110.849 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.627 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 4.0 t -144.57 116.72 8.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 60.2 41.45 16.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.499 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 58.37 31.32 66.12 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.899 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -136.51 149.27 48.06 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 99' ' ' MET . 19.7 ptt? -55.44 127.11 28.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.442 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.627 ' HG3' ' CB ' ' A' ' 95' ' ' SER . 6.7 mm-40 -142.12 77.78 17.77 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.296 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 43.0 Cg_endo -68.82 93.5 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.561 2.174 . . . . 0.0 113.103 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.315 -0.894 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.28 179.275 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.625 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 94.3 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 111.277 0.103 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 62.56 83.9 0.15 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.528 ' CD1' HG13 ' A' ' 92' ' ' VAL . 3.3 p90 -64.46 -36.97 85.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.078 0.466 . . . . 0.0 111.167 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -63.12 -20.43 65.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.331 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -52.47 -32.83 41.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.122 0.487 . . . . 0.0 111.417 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.414 ' HB2' HD22 ' A' ' 94' ' ' ASN . 21.2 m -138.73 35.76 2.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.263 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -128.77 135.27 48.94 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.093 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.3 p -132.56 162.53 31.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.361 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.17 54.98 32.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.353 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 32.9 m -95.81 138.88 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.413 . . . . 0.0 111.263 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -134.99 140.67 45.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.888 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.775 HD22 HD23 ' A' ' 64' ' ' LEU . 20.1 tp -120.97 116.84 25.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.011 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.522 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.3 t80 -125.14 104.04 8.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.869 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.98 -68.45 2.83 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.553 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 39.6 p90 -163.81 19.54 0.07 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 122.445 0.298 . . . . 0.0 111.21 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 15' ' ' TYR . 38.8 pt -114.4 126.69 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.712 0.291 . . . . 0.0 110.729 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.923 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.15 113.95 26.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.0 ttm180 -119.08 139.18 52.19 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.388 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.555 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -160.96 168.99 36.48 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.632 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 9.2 m-20 -97.3 105.79 18.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -104.16 131.73 51.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.8 mt -74.61 135.86 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.097 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -95.1 -179.96 5.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.632 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -50.4 -39.93 48.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.63 -24.42 65.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.64 1.38 46.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.41 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -101.99 139.67 20.51 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 57.8 Cg_endo -72.12 135.14 24.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.886 2.39 . . . . 0.0 112.188 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -125.21 126.11 44.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.154 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.13 122.74 18.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.987 0.423 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 t -136.94 158.86 43.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.809 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 p -138.95 143.01 38.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.623 0.249 . . . . 0.0 110.909 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.32 146.74 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.572 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.42 ' OD1' HG22 ' A' ' 18' ' ' ILE . 80.6 m-20 -100.5 96.86 7.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.073 0.463 . . . . 0.0 110.244 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.923 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -60.43 -26.69 66.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.207 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.3 t-20 -53.93 -34.01 58.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.09 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -102.72 11.46 37.61 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.0 m-85 -127.37 -21.8 3.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.73 139.95 35.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.67 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.3 165.55 12.07 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.177 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -110.71 106.22 15.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.613 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -112.17 107.37 16.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.751 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.822 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 39.7 t30 60.8 39.43 17.16 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.93 17.74 79.46 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.559 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.47 144.4 50.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.834 0.35 . . . . 0.0 111.045 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.2 mp -72.69 123.76 23.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.883 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.484 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 10.3 tp10 -113.95 139.33 49.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.696 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -41.79 -69.42 0.22 Allowed Pre-proline 0 CA--C 1.426 -3.799 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.867 -179.437 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.696 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 3.5 Cg_endo -110.3 131.36 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.323 0 C-N-CA 113.81 -3.66 . . . . 0.0 113.2 -177.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -162.45 -159.29 10.2 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 114.108 -1.406 . . . . 0.0 113.604 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -155.17 144.94 21.45 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 124.026 0.486 . . . . 0.0 110.869 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 m 51.41 43.92 29.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -73.03 -38.8 66.41 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.23 -18.6 49.75 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.515 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.3 m -64.71 -24.79 67.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.846 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 m -136.86 20.27 3.05 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.9 m -126.56 140.42 52.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.522 HG23 ' HE2' ' A' ' 61' ' ' LYS . 27.8 m -131.27 176.45 8.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.146 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.522 ' HE2' HG23 ' A' ' 60' ' ' VAL . 2.4 mppt? 58.75 44.85 16.51 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.451 0.47 . . . . 0.0 111.248 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 p -71.41 123.19 21.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.611 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.3 163.09 38.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.305 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.775 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -121.24 112.65 18.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 0.0 111.524 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.07 119.27 20.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.294 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.842 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.6 t70 51.99 26.51 3.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 124.087 0.867 . . . . 0.0 110.956 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 6' ' ' ALA . . . 58.35 32.63 68.48 Favored Glycine 0 C--O 1.224 -0.472 0 CA-C-N 115.663 -0.698 . . . . 0.0 113.722 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.842 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 11.0 p80 -141.35 -29.82 0.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.708 0.754 . . . . 0.0 111.661 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 m -116.28 131.06 57.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.802 0.334 . . . . 0.0 111.359 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.589 ' HA ' HD22 ' A' ' 64' ' ' LEU . 16.1 tp -90.74 131.93 36.13 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -122.38 130.43 53.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.783 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -160.58 165.37 30.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 t -111.63 120.58 42.54 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 34.8 m -119.29 152.43 36.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 9.0 tmtt? -99.85 144.66 28.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.689 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.79 -27.85 0.66 Allowed Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.629 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.822 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.6 -40.3 75.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -174.33 54.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.349 0.595 . . . . 0.0 109.93 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 67.81 6.51 44.42 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.112 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 28.8 pt20 -126.01 169.91 12.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 45.7 p90 -98.78 171.55 8.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.822 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -160.21 145.2 14.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -76.41 132.87 39.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.21 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.9 p -152.1 166.22 32.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 111.369 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.5 OUTLIER -138.81 162.66 34.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.426 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.62 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 16.9 tpp -147.92 117.87 7.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.5 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 37.8 t0 -74.44 107.65 6.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.202 0.525 . . . . 0.0 109.677 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.72 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.8 mt -76.04 -9.52 58.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.523 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.411 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 1.8 m120 -48.41 -29.43 4.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.602 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 47.2 p90 -119.23 21.67 12.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.698 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -127.7 -10.46 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.037 0.446 . . . . 0.0 110.693 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.802 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.1 p -150.78 141.62 16.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.356 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.625 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -133.86 -168.51 11.84 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.063 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.414 HD22 ' HB2' ' A' ' 8' ' ' SER . 15.6 t30 -132.54 127.68 35.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.281 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.592 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 68.5 m -139.1 112.2 8.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.76 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 57.49 40.45 27.13 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.512 0.507 . . . . 0.0 111.185 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.44 20.05 58.42 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.743 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -116.74 147.13 42.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.721 0.296 . . . . 0.0 110.279 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 99' ' ' MET . 20.1 ptt? -61.48 117.31 5.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.367 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 19.0 mm-40 -135.03 79.33 51.22 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.735 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.802 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 53.7 Cg_endo -71.33 82.98 1.04 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.799 2.332 . . . . 0.0 112.392 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.306 -1.313 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.433 -179.763 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.522 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 78.4 m . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 111.417 0.154 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 54.79 75.68 0.29 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 15.0 p90 -60.18 -36.83 78.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.181 0.515 . . . . 0.0 110.94 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -69.16 -22.72 63.91 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -60.06 -25.43 65.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.931 0.396 . . . . 0.0 111.319 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.457 ' HB2' HD22 ' A' ' 94' ' ' ASN . 16.3 m -132.04 29.97 4.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.664 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -131.23 140.11 49.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -133.32 150.53 51.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.29 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.97 73.65 0.46 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.531 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 ' HA3' ' A' ' 21' ' ' GLY . 33.3 m -112.0 144.39 19.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.837 0.351 . . . . 0.0 111.249 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -128.45 155.67 44.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.215 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.719 HD22 HD23 ' A' ' 64' ' ' LEU . 23.1 tp -132.18 109.38 9.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.026 0.441 . . . . 0.0 110.59 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.477 ' O ' HG12 ' A' ' 18' ' ' ILE . 80.4 m-85 -114.37 100.43 8.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' HG21 ' A' ' 62' ' ' THR . . . 77.56 -63.64 3.36 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.919 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.415 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 8.7 p90 -166.04 23.45 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.618 0.247 . . . . 0.0 111.633 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 15' ' ' TYR . 42.2 pt -121.73 133.53 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.808 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -112.65 120.16 40.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.863 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -127.96 139.71 52.42 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.876 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.572 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.35 -175.51 37.38 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.335 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 3.6 m-20 -106.84 107.66 18.79 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 m -105.19 131.84 52.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 72.0 mt -72.46 137.43 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -100.82 -175.18 2.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.123 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.3 -27.5 62.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 112.048 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.62 -26.36 68.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.64 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.44 2.78 55.55 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.926 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -112.18 142.11 26.27 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.722 0.296 . . . . 0.0 110.374 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 42.1 Cg_endo -68.7 136.64 36.5 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.981 2.454 . . . . 0.0 112.596 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -123.87 134.27 53.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.132 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.83 126.06 28.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.431 . . . . 0.0 111.241 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 t -141.09 160.31 40.36 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.579 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -139.45 145.45 38.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.978 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.58 145.29 35.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.81 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -102.66 95.44 6.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.808 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.99 -26.7 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.691 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.415 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.0 t-20 -55.25 -27.91 49.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.281 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -104.7 7.94 34.95 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 30.9 m-85 -128.22 -21.94 3.5 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.2 mp -113.59 141.2 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.497 0.189 . . . . 0.0 110.722 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.658 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -118.61 170.07 13.66 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.371 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -109.56 110.89 22.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.963 0.411 . . . . 0.0 110.928 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -110.78 106.91 16.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.589 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 12.0 t30 52.12 41.55 30.08 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.909 0.484 . . . . 0.0 111.508 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.96 16.18 77.48 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.21 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.23 153.64 41.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.06 0.457 . . . . 0.0 110.92 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.578 HD13 ' HG ' ' A' ' 70' ' ' LEU . 37.1 mt -81.4 114.07 19.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.305 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.626 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.1 tt0 -107.31 132.75 52.78 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.772 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -32.49 -69.94 0.12 Allowed Pre-proline 0 CA--C 1.425 -3.837 0 O-C-N 124.762 1.289 . . . . 0.0 114.047 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.772 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -108.77 133.59 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.321 0 C-N-CA 113.939 -3.574 . . . . 0.0 112.655 -177.636 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.658 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -168.61 -162.94 21.73 Favored Glycine 0 C--N 1.283 -2.389 0 C-N-CA 119.559 -1.305 . . . . 0.0 113.65 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -154.29 146.3 23.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.352 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.1 m 53.43 41.9 32.05 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -71.93 -35.51 69.65 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.14 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.09 -18.64 57.96 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.259 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -63.32 -24.29 67.79 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.494 -0.353 . . . . 0.0 111.136 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -136.46 22.08 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.095 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.4 m -126.89 148.37 50.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.128 0.489 . . . . 0.0 111.476 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.413 HG23 ' HD3' ' A' ' 61' ' ' LYS . 30.5 m -138.11 173.75 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.532 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 73' ' ' SER . 0.1 OUTLIER 58.83 40.38 22.93 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.452 0.47 . . . . 0.0 111.648 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 16' ' ' GLY . 6.4 p -65.97 118.46 9.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.085 0.469 . . . . 0.0 111.822 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.91 149.56 31.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.095 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.719 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -109.0 115.02 29.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.772 0.32 . . . . 0.0 110.761 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -88.8 124.77 34.48 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.751 0.31 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.883 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 17.1 t70 58.1 19.74 6.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.603 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.436 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 58.43 31.31 66.31 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.929 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.883 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.5 p80 -139.36 -32.41 0.65 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.561 0.68 . . . . 0.0 111.142 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -116.01 131.9 56.81 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.268 0.556 . . . . 0.0 111.747 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.645 ' HA ' HD22 ' A' ' 64' ' ' LEU . 9.1 tp -90.1 130.84 36.22 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.613 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 129.22 53.88 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.0 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.85 164.36 31.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.446 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 7.7 t -111.76 124.37 52.2 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 21.9 m -126.47 150.09 48.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.325 0.583 . . . . 0.0 112.042 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.4 tmtt? -99.36 146.74 25.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.419 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.87 -30.69 0.66 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.209 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.589 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.09 -42.32 76.56 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -169.9 54.86 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.422 0.63 . . . . 0.0 110.293 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.449 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 67.54 3.43 26.49 Favored Glycine 0 C--N 1.328 0.108 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.454 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.7 160.78 25.15 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 12.2 p90 -101.98 169.88 8.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.851 0.358 . . . . 0.0 110.643 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -157.86 138.73 13.16 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.78 121.2 25.08 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.518 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.2 p -133.08 -179.81 5.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.148 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.48 164.51 28.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.044 0.449 . . . . 0.0 110.658 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.475 ' HB2' ' CB ' ' A' ' 48' ' ' LEU . 9.2 tpt -145.86 113.72 6.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.96 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.65 105.84 5.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.555 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.782 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.4 mt -75.78 -9.0 58.23 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.697 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -50.88 -26.04 5.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.591 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -119.41 22.21 11.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.325 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.782 HG22 ' HA ' ' A' ' 88' ' ' LEU . 2.2 m -127.62 -14.99 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.849 0.357 . . . . 0.0 110.569 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -139.22 145.42 27.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.924 177.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.522 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -134.18 179.96 17.01 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.89 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.457 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.5 t30 -131.85 127.79 37.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.684 0.278 . . . . 0.0 110.921 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.638 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 64.2 m -135.14 107.36 7.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.234 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 60.93 42.58 12.73 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.751 0.657 . . . . 0.0 110.622 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.26 22.47 63.16 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.692 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -118.24 147.18 43.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.484 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' A' ' 99' ' ' MET . 20.3 ptt? -60.82 121.08 11.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.043 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.638 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 57.6 mm-40 -137.02 80.45 35.51 Favored Pre-proline 0 CA--C 1.516 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.346 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 44.5 Cg_endo -68.81 89.02 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.672 2.248 . . . . 0.0 112.962 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.215 179.784 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.463 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 35.0 m . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.567 0.222 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.788 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 49.4 m-80 60.67 71.06 0.58 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.637 ' CD1' HG13 ' A' ' 92' ' ' VAL . 5.1 p90 -66.24 -37.5 85.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.025 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.56 -20.0 65.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.204 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.788 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 44.2 t-20 -51.57 -39.11 57.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.026 0.441 . . . . 0.0 110.769 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.474 ' HB2' HD22 ' A' ' 94' ' ' ASN . 19.2 m -132.01 27.71 4.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -118.53 139.99 50.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.012 0.434 . . . . 0.0 111.051 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -137.01 152.26 49.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.647 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.05 57.23 14.41 Favored Glycine 0 N--CA 1.455 -0.082 0 O-C-N 123.527 0.517 . . . . 0.0 112.764 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.563 HG12 ' HA3' ' A' ' 21' ' ' GLY . 15.9 m -101.17 134.03 42.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.065 0.459 . . . . 0.0 111.852 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -127.72 153.14 46.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.263 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.742 HD22 HD23 ' A' ' 64' ' ' LEU . 23.7 tp -128.33 120.55 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.97 0.414 . . . . 0.0 111.991 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.448 ' O ' HG12 ' A' ' 18' ' ' ILE . 73.0 t80 -126.66 108.55 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 62' ' ' THR . . . 78.5 -73.35 2.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.3 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -164.0 23.38 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.821 0.343 . . . . 0.0 111.377 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 15' ' ' TYR . 24.7 pt -121.13 127.84 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.702 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.857 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -109.29 114.59 28.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.176 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.06 139.74 51.22 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.014 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.563 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -165.93 -175.39 36.32 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.139 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 3.5 m-20 -107.89 108.05 19.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.572 0.225 . . . . 0.0 110.577 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -105.72 131.36 53.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 8' ' ' SER . 53.1 mt -69.65 140.78 18.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.982 0.42 . . . . 0.0 111.904 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -108.05 -172.8 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.331 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 7.2 tp10 -49.85 -41.79 45.96 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.469 0.48 . . . . 0.0 112.153 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.87 -22.97 63.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.408 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.78 5.03 60.14 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.346 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -109.47 145.39 31.8 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.483 -0.359 . . . . 0.0 110.573 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 38.3 Cg_endo -66.74 131.53 26.12 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.98 2.453 . . . . 0.0 112.52 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -115.24 130.64 56.97 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.503 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.65 120.16 12.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.715 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -140.94 159.52 42.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.386 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 p -140.16 148.02 41.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.029 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 99' ' ' MET . 3.5 mp -126.94 147.61 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.373 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -105.53 85.9 2.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.857 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -54.39 -25.29 23.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.046 0.451 . . . . 0.0 111.383 -178.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 23.1 t-20 -53.47 -24.81 13.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.391 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -113.5 10.36 18.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -126.79 -8.2 6.13 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 111.309 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.582 HD11 HD22 ' A' ' 88' ' ' LEU . 3.0 mp -127.41 134.55 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -117.04 -177.33 17.78 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 23.9 p-10 -127.96 101.66 6.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.648 0.737 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.92 113.81 27.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.957 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.43 ' CG ' ' HA ' ' A' ' 77' ' ' ALA . 8.4 t-20 58.84 36.69 24.81 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.645 0.736 . . . . 0.0 110.129 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.6 19.75 78.95 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.992 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -122.45 146.1 47.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.654 0.264 . . . . 0.0 110.432 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.5 mp -72.04 120.78 18.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.401 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.523 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 6.1 pt-20 -108.16 138.73 43.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.426 0.632 . . . . 0.0 110.254 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -58.8 -24.15 1.44 Allowed Pre-proline 0 CA--C 1.447 -2.991 0 N-CA-C 118.125 2.639 . . . . 0.0 118.125 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' A' ' 49' ' ' GLU . 4.4 Cg_endo -129.5 12.16 0.0 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.771 1 C-N-CA 112.787 -4.342 . . . . 0.0 116.353 179.253 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -62.13 -176.23 2.52 Favored Glycine 0 C--N 1.259 -3.707 0 CA-C-N 111.266 -2.697 . . . . 0.0 115.547 -176.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -146.95 147.98 31.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m 58.48 45.41 16.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.046 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 9.5 p90 -74.11 -38.26 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.01 -23.74 47.65 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.444 -0.408 . . . . 0.0 112.317 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -62.02 -18.1 59.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.293 -0.453 . . . . 0.0 111.365 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 m -148.93 27.54 0.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.614 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.3 m -132.24 145.09 51.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.985 0.422 . . . . 0.0 111.052 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.41 HG23 ' HD3' ' A' ' 61' ' ' LYS . 22.2 m -136.39 176.85 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.253 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.41 ' HD3' HG23 ' A' ' 60' ' ' VAL . 2.2 mptm? 61.9 40.65 12.31 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.241 0.338 . . . . 0.0 111.659 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 16' ' ' GLY . 2.4 p -69.13 123.03 19.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.094 0.473 . . . . 0.0 112.05 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.41 161.97 41.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.718 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.742 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -123.17 113.79 19.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.872 0.368 . . . . 0.0 111.34 -178.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.32 122.09 28.0 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.009 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.695 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 28.2 t70 52.5 25.24 3.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.776 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.49 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 56.62 39.62 86.02 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.624 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.695 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.9 p80 -149.24 -30.88 0.24 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 117.249 0.524 . . . . 0.0 111.078 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.428 ' O ' HD13 ' A' ' 64' ' ' LEU . 5.7 m -116.02 130.6 56.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.801 0.334 . . . . 0.0 111.282 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.691 ' HB2' HD11 ' A' ' 88' ' ' LEU . 14.0 tp -93.26 131.22 38.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.975 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.59 129.81 56.0 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.069 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.483 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -162.36 162.93 28.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 110.528 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 t -111.36 125.29 53.7 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 34.8 m -125.06 156.06 38.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -98.45 148.89 23.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.685 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.67 -28.37 0.84 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.269 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 45' ' ' ASN . . . -55.53 -42.64 74.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.841 0.353 . . . . 0.0 111.564 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -172.98 56.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.765 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.92 2.39 38.02 Favored Glycine 0 C--O 1.229 -0.213 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.45 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -122.87 162.45 22.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 48.2 p90 -91.45 160.85 15.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.713 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -146.98 147.17 30.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.53 135.5 35.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 p -155.7 173.19 17.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.744 0.307 . . . . 0.0 111.259 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.84 164.28 30.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.843 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.68 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.3 tpt -149.99 119.64 7.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.553 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.425 ' OD2' ' HB3' ' A' ' 89' ' ' ASN . 25.2 t0 -73.28 108.9 6.42 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.7 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.0 mt -81.59 -9.12 59.75 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.327 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.425 ' HB3' ' OD2' ' A' ' 87' ' ' ASP . 25.4 t-20 -47.88 -29.48 3.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.648 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -117.11 15.82 15.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.557 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -120.24 -3.58 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.654 0.74 . . . . 0.0 110.294 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 1.069 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.3 p -155.46 131.18 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.017 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.463 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -126.12 179.67 16.16 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.128 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.474 HD22 ' HB2' ' A' ' 8' ' ' SER . 21.9 t30 -118.62 126.17 51.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.441 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.486 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 72.7 m -130.27 97.3 4.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.547 ' CD2' ' HB2' ' A' ' 26' ' ' GLU . 71.8 m-85 61.7 52.38 3.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.262 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.36 16.79 60.98 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.814 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -119.87 143.13 48.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.401 ' HB2' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -72.31 120.99 18.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.218 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 25.1 mm-40 -127.71 75.57 77.79 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.47 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 1.069 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.7 Cg_endo -72.4 103.89 1.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.964 2.443 . . . . 0.0 112.391 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.724 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.713 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.529 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 55.6 m . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 2.6 m-20 46.25 73.31 0.18 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.649 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.3 p90 -59.24 -42.45 91.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.566 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.99 -21.38 44.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.67 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 10.6 t-20 -61.0 -28.68 69.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.502 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.52 ' HB2' HD22 ' A' ' 94' ' ' ASN . 50.4 m -139.44 23.9 2.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.871 0.367 . . . . 0.0 111.388 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.5 m -122.21 132.88 54.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.519 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -133.67 160.8 36.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.929 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.76 51.82 56.8 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.366 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.563 HG12 ' HA3' ' A' ' 21' ' ' GLY . 29.8 m -97.59 139.47 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.832 0.349 . . . . 0.0 111.231 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -136.02 151.8 50.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.583 HD22 HD23 ' A' ' 64' ' ' LEU . 13.1 tp -119.35 110.1 16.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.098 0.475 . . . . 0.0 111.661 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' HG12 ' A' ' 18' ' ' ILE . 36.2 m-85 -106.1 98.58 8.24 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' O ' HG21 ' A' ' 62' ' ' THR . . . 71.27 -65.13 0.99 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.16 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.433 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 4.3 p90 -156.34 12.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.782 -0.246 . . . . 0.0 111.645 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 15' ' ' TYR . 44.9 pt -114.45 133.54 60.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 110.896 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.818 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.29 113.97 26.48 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.118 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.3 ttm105 -120.28 138.38 53.71 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.563 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -158.85 -177.44 31.94 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.825 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.3 m-20 -108.51 103.5 12.64 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.454 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 66.2 m -107.13 131.98 53.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.845 0.355 . . . . 0.0 110.288 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.8 mt -70.14 139.18 20.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.1 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 6.3 p30 -112.01 -168.62 1.34 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.509 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.29 -28.11 64.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.726 0.298 . . . . 0.0 111.788 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.96 -28.51 69.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.01 0.433 . . . . 0.0 111.345 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.8 -9.29 60.12 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.424 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -101.39 142.84 25.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.641 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 24.3 Cg_endo -64.16 121.74 9.5 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.791 2.327 . . . . 0.0 112.317 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -104.39 134.99 46.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.504 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.26 124.95 25.68 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.497 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.3 t -143.95 159.79 41.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.81 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 p -139.45 154.78 47.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.67 145.5 25.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -100.87 104.6 15.82 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -64.61 -22.16 66.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 25.4 t30 -63.97 -13.23 44.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -108.03 -1.3 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.364 -0.21 . . . . 0.0 110.977 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -127.67 -9.43 5.6 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.538 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.6 mp -124.45 134.14 67.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.611 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -113.86 178.16 18.21 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.558 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -113.92 102.57 10.32 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.06 0.457 . . . . 0.0 110.452 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -102.42 103.92 14.36 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 47.48 45.42 17.32 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.535 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.3 14.69 76.0 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.769 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.13 147.39 47.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.041 0.42 . . . . 0.0 111.114 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.601 HD13 ' HG ' ' A' ' 70' ' ' LEU . 25.6 mt -72.35 121.64 19.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.014 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.601 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 6.7 tp10 -110.99 127.23 55.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.267 0.556 . . . . 0.0 110.792 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.575 ' HB3' ' SD ' ' A' ' 86' ' ' MET . 11.5 p90 -49.29 -29.13 1.72 Allowed Pre-proline 0 CA--C 1.453 -2.784 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.601 ' HD2' ' HG3' ' A' ' 49' ' ' GLU . 3.3 Cg_endo -129.57 17.63 0.0 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.764 1 C-N-CA 113.032 -4.179 . . . . 0.0 115.931 179.073 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.611 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -68.36 -174.86 9.13 Favored Glycine 1 C--N 1.254 -4.013 0 CA-C-N 111.16 -2.745 . . . . 0.0 115.508 -176.506 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -143.45 148.14 35.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.407 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m 57.83 60.47 2.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.915 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 12.5 p90 -90.1 -35.33 15.5 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.791 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.99 -19.03 43.03 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.607 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 m -62.19 -25.22 67.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.323 -0.439 . . . . 0.0 111.353 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.1 m -141.84 27.24 1.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.154 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.9 m -129.02 151.25 49.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.215 0.531 . . . . 0.0 111.732 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG23 ' HE2' ' A' ' 61' ' ' LYS . 15.7 m -146.81 175.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.25 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HE2' HG23 ' A' ' 60' ' ' VAL . 2.0 mppt? 63.14 41.94 7.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.873 0.368 . . . . 0.0 110.777 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.537 HG21 ' O ' ' A' ' 16' ' ' GLY . 12.5 p -72.1 125.21 26.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.987 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.79 156.68 40.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.802 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.583 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -117.11 112.01 20.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.899 0.38 . . . . 0.0 110.738 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.55 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 11.6 m120 -73.08 117.28 14.62 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.342 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.427 ' HB3' ' ND1' ' A' ' 68' ' ' HIS . 10.2 t70 51.95 21.17 1.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.017 0.823 . . . . 0.0 111.056 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.38 37.61 95.1 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.441 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.44 ' HD2' ' OD1' ' A' ' 87' ' ' ASP . 39.8 p-80 -144.96 -29.99 0.45 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 117.506 0.653 . . . . 0.0 111.296 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 16.9 m -116.6 135.15 54.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.639 0.257 . . . . 0.0 111.072 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.601 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.3 tp -95.91 131.72 41.96 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.62 132.29 54.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.171 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.41 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -164.05 163.5 23.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.375 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.6 t -110.96 125.07 53.32 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.8 m -125.46 148.02 49.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.306 0.574 . . . . 0.0 112.063 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.9 tmtt? -99.61 144.93 28.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.683 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.32 -21.64 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.834 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.17 89.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.878 0.339 . . . . 0.0 111.385 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -173.8 55.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.353 0.597 . . . . 0.0 109.759 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.14 -3.74 20.92 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.603 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -115.44 163.48 15.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.63 0.252 . . . . 0.0 110.604 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 29.4 p90 -103.69 166.99 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.194 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.07 127.49 5.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.419 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.01 123.1 18.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.498 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.2 p -136.79 175.91 9.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.198 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.07 162.27 35.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.902 0.382 . . . . 0.0 110.778 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.575 ' SD ' ' HB3' ' A' ' 50' ' ' TYR . 21.3 tpp -148.83 123.69 9.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.481 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.554 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 24.4 t0 -78.37 106.75 10.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.384 0.612 . . . . 0.0 109.762 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.737 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.6 mt -76.23 -9.52 58.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.733 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.471 ' HB3' ' OD2' ' A' ' 87' ' ' ASP . 27.9 t-20 -51.64 -26.72 9.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.041 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 43.9 p90 -116.86 19.25 14.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.782 0.325 . . . . 0.0 111.375 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.737 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -126.59 -9.25 4.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.108 0.48 . . . . 0.0 110.583 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.918 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 5.5 p -153.82 139.96 11.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.529 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.09 176.73 19.62 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.197 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.52 HD22 ' HB2' ' A' ' 8' ' ' SER . 28.7 t30 -118.57 123.44 45.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.012 0.434 . . . . 0.0 110.276 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.58 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 58.3 m -124.7 99.9 6.38 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.474 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.85 51.02 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.173 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 56.69 27.8 55.8 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.958 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -130.76 141.34 50.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.93 0.395 . . . . 0.0 110.469 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.6 ptm -55.21 116.68 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.349 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 9.9 mm-40 -141.43 75.63 22.32 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.111 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.918 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 61.2 Cg_endo -75.66 112.54 3.54 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.741 2.294 . . . . 0.0 112.156 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.417 -179.572 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.506 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 61.4 m . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 111.164 0.061 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 89' ' ' ASN . 50.5 m-80 51.64 75.45 0.21 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.843 0.457 . . . . 0.0 111.896 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CD1' HG13 ' A' ' 92' ' ' VAL . 3.1 p90 -56.94 -39.8 75.21 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.89 -22.57 38.27 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -68.4 -21.65 64.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.69 0.281 . . . . 0.0 111.569 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.44 ' HB2' HD22 ' A' ' 94' ' ' ASN . 49.9 m -134.29 19.09 3.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.929 0.395 . . . . 0.0 110.903 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 81.4 m -124.8 132.98 53.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.244 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.6 p -126.77 155.14 43.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.262 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.79 63.78 4.79 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.381 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.38 133.93 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.252 0.549 . . . . 0.0 111.473 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.62 136.28 48.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.656 HD22 HD23 ' A' ' 64' ' ' LEU . 23.0 tp -121.64 124.84 45.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.086 0.469 . . . . 0.0 111.07 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -133.35 114.93 14.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.683 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.13 -71.46 1.98 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.007 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -167.81 24.07 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.314 0.646 . . . . 0.0 109.573 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 mt -120.08 113.27 40.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.549 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -99.81 114.82 28.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.994 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -116.94 140.03 49.95 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.21 176.6 40.14 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.265 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 41.6 m-20 -105.87 107.95 19.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 82.5 m -105.81 131.69 52.83 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.084 0.469 . . . . 0.0 110.043 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mt -70.02 138.96 20.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.516 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -105.61 -169.46 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.331 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.96 -29.03 66.85 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 29' ' ' HIS . 24.9 t70 -68.76 -26.26 65.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.15 0.5 . . . . 0.0 111.751 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.34 57.29 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.132 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.452 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -107.78 138.95 20.17 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.604 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 24.6 Cg_endo -63.65 127.19 19.13 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.113 2.542 . . . . 0.0 112.808 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -109.79 133.17 53.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.184 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.39 118.73 16.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.903 0.383 . . . . 0.0 111.508 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.3 t -135.4 157.39 47.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.006 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.8 p -139.83 138.29 35.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.499 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.58 145.9 33.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.955 0.407 . . . . 0.0 111.258 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -103.57 99.16 8.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.049 0.452 . . . . 0.0 110.1 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -62.29 -23.67 66.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.895 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.98 -30.94 62.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.939 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -103.95 13.54 32.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -130.87 -25.85 2.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.538 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -109.08 141.95 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.664 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.94 -174.93 19.78 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.843 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -129.24 105.06 7.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.07 0.462 . . . . 0.0 111.292 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -103.27 111.17 23.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.544 ' HB2' ' HA ' ' A' ' 77' ' ' ALA . 5.4 p-10 42.18 47.08 3.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.675 1.19 . . . . 0.0 113.298 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.91 14.93 74.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.596 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.15 143.23 50.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.823 0.344 . . . . 0.0 111.23 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.543 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 8.9 mp -71.49 119.34 15.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.814 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -109.9 139.13 45.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.832 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -41.14 -68.97 0.23 Allowed Pre-proline 0 CA--C 1.428 -3.746 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.832 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 7.8 Cg_endo -111.46 122.97 0.03 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.361 0 C-N-CA 113.943 -3.571 . . . . 0.0 113.544 -177.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.664 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -158.67 -160.82 10.58 Favored Glycine 0 C--N 1.277 -2.703 0 CA-C-N 113.758 -1.565 . . . . 0.0 113.282 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 34.5 mt-10 -156.31 144.39 19.67 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.942 0.436 . . . . 0.0 110.818 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 m 57.14 41.24 27.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.15 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -72.09 -40.2 68.39 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.049 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.01 -18.99 49.62 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.733 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.2 m -65.14 -24.34 67.38 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.514 0.326 . . . . 0.0 110.955 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.1 m -138.32 24.76 2.71 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.916 0.389 . . . . 0.0 110.635 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.0 m -131.29 141.48 49.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.314 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.443 HG23 ' HD3' ' A' ' 61' ' ' LYS . 30.2 m -133.92 172.81 15.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.376 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.8 mptt 64.1 43.3 5.13 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.715 0.635 . . . . 0.0 110.873 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 p -68.83 124.4 23.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.386 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.2 156.07 37.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.86 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.656 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -110.48 120.39 42.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.541 0.21 . . . . 0.0 110.61 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.486 ' C ' ' H ' ' A' ' 67' ' ' GLY . 19.3 t-20 -87.46 121.18 29.57 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.9 t70 68.33 -25.76 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.437 1.085 . . . . 0.0 112.356 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 65' ' ' ASN . . . 110.19 22.02 6.71 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.84 -20.47 0.66 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.452 ' O ' HD13 ' A' ' 64' ' ' LEU . 43.3 m -116.95 127.36 54.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.251 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.543 ' HG ' ' CD2' ' A' ' 48' ' ' LEU . 16.6 tp -90.61 129.28 36.75 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.79 130.29 54.86 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.487 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.501 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -162.55 165.32 26.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.833 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -110.08 125.55 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.466 ' SG ' HD12 ' A' ' 48' ' ' LEU . 60.9 m -123.23 147.73 46.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.351 0.596 . . . . 0.0 112.582 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.9 tmtt? -99.69 145.3 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.923 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.73 -16.27 0.94 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.822 -1.18 . . . . 0.0 113.332 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' A' ' 45' ' ' ASN . . . -59.67 -39.46 84.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.875 0.369 . . . . 0.0 110.759 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 t70 178.91 60.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.843 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.79 4.48 54.11 Favored Glycine 0 C--O 1.228 -0.223 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.544 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -124.92 165.34 18.26 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.6 p90 -112.53 166.27 11.47 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.282 0.364 . . . . 0.0 111.488 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -158.55 144.61 16.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -76.29 142.36 41.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.786 0.327 . . . . 0.0 110.158 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.9 p -153.6 174.58 14.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.82 156.54 46.12 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.082 0.468 . . . . 0.0 110.586 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.517 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 12.3 tpp -140.78 123.18 15.92 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.644 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -76.06 106.24 7.55 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.747 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.3 mt -73.34 -9.09 58.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.747 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.441 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 16.3 m120 -47.58 -31.15 4.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.79 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -119.74 23.58 11.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.411 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.747 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -128.49 -7.85 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.02 0.438 . . . . 0.0 110.52 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.8 p -156.82 141.79 8.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.023 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.91 -174.96 13.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.229 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.44 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.9 t30 -130.0 133.26 46.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.938 0.399 . . . . 0.0 110.991 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 m -142.35 112.25 6.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.398 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 60.17 40.51 18.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.397 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.67 24.6 66.44 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -128.17 138.86 52.66 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 99' ' ' MET . 13.5 ptt? -64.46 129.17 38.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.347 0.594 . . . . 0.0 112.5 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.09 77.35 25.77 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.79 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 33.3 Cg_endo -61.79 93.25 0.12 Allowed 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.422 2.748 . . . . 0.0 112.951 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.315 -0.923 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.406 179.733 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.522 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 28.5 m . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.441 ' HB3' ' CG ' ' A' ' 7' ' ' ASN . 79.6 m-20 63.54 71.28 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.298 0.374 . . . . 0.0 110.891 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 9.8 p90 -54.43 -37.51 65.21 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 111.361 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.86 -22.15 64.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.78 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.441 ' CG ' ' HB3' ' A' ' 4' ' ' ASN . 6.0 m-20 -69.79 -16.1 63.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.68 0.276 . . . . 0.0 111.301 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -127.03 4.44 6.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.2 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 0.8 OUTLIER -118.49 137.53 53.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.162 0.506 . . . . 0.0 112.079 -178.787 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 p -128.59 153.07 47.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.096 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.65 64.9 3.95 Favored Glycine 0 N--CA 1.453 -0.22 0 O-C-N 123.518 0.511 . . . . 0.0 112.442 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.602 HG12 ' HA3' ' A' ' 21' ' ' GLY . 32.4 m -100.64 147.04 8.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 111.278 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -138.18 148.91 45.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.127 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.628 HD22 HD23 ' A' ' 64' ' ' LEU . 8.5 tp -122.19 105.36 10.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.023 0.439 . . . . 0.0 110.72 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -134.62 112.4 10.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.34 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 75.24 38.33 39.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.282 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.427 ' HA ' HD11 ' A' ' 14' ' ' LEU . 10.2 m-85 64.55 24.06 12.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.15 0.58 . . . . 0.0 110.675 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 16' ' ' GLY . 16.2 mt -117.77 122.23 69.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.253 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.805 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -102.6 113.64 27.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.351 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 20.4 ttm180 -118.84 134.3 55.25 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.426 -0.509 . . . . 0.0 109.835 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.602 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -157.63 175.3 34.98 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.898 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 26.6 m-20 -101.15 107.29 18.66 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -106.02 131.8 52.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.5 mt -70.09 135.25 28.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.568 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.4 p30 -103.64 -175.12 2.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.125 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -54.09 -31.33 51.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.06 -27.5 69.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.451 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.34 -0.04 53.83 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.121 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -108.66 144.54 29.76 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 120.802 0.334 . . . . 0.0 110.385 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 35.6 Cg_endo -66.91 121.27 8.45 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.057 2.505 . . . . 0.0 112.655 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -107.09 129.24 54.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.306 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.53 119.19 13.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.011 0.434 . . . . 0.0 110.871 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -132.19 159.48 38.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.808 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 99' ' ' MET . 78.4 p -138.5 147.97 43.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.847 0.356 . . . . 0.0 111.502 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.74 142.55 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.9 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.452 ' ND2' ' CE2' ' A' ' 39' ' ' TYR . 62.2 t30 -101.96 92.71 4.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.805 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.69 -23.72 53.05 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.322 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 21.1 t-20 -54.8 -30.9 58.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.98 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.452 ' CE2' ' ND2' ' A' ' 36' ' ' ASN . 77.6 m-85 -108.57 16.31 23.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.534 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.9 m-85 -126.97 -25.05 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -110.52 140.62 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.693 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -115.35 161.66 12.74 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.395 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -100.63 104.75 16.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.691 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -111.94 106.55 15.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.922 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.822 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 56.2 t30 58.41 36.98 25.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.121 0.486 . . . . 0.0 110.817 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.66 17.07 80.22 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.403 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.07 154.88 39.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.834 0.349 . . . . 0.0 110.825 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 31.5 mt -79.92 114.48 18.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.239 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -105.52 135.18 47.4 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.656 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.84 -72.45 0.11 Allowed Pre-proline 0 CA--C 1.426 -3.792 0 O-C-N 124.254 0.971 . . . . 0.0 113.333 -178.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.656 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 9.2 Cg_endo -108.36 126.14 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.319 0 C-N-CA 113.623 -3.784 . . . . 0.0 113.252 -177.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.693 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -156.65 -164.2 13.21 Favored Glycine 0 C--N 1.283 -2.398 0 CA-C-N 113.582 -1.645 . . . . 0.0 113.029 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -153.39 142.86 21.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.857 0.36 . . . . 0.0 111.013 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 m 53.4 42.37 32.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.226 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 10.5 p90 -68.47 -36.7 79.35 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.48 -18.12 28.69 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.377 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.7 t -64.54 -21.08 66.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.723 0.297 . . . . 0.0 110.487 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.5 m -140.8 23.38 2.26 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.099 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.5 m -128.97 142.61 50.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.954 0.407 . . . . 0.0 111.311 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -134.37 172.93 15.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.249 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? 63.25 37.74 10.91 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.501 0.5 . . . . 0.0 111.766 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.8 p -66.67 122.66 18.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.117 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.69 163.57 39.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.877 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.628 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -119.54 113.44 20.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.908 0.385 . . . . 0.0 111.471 -179.32 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.485 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 16.1 m120 -76.13 117.18 17.57 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.322 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.664 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 20.4 t70 58.9 9.53 1.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.907 0.755 . . . . 0.0 111.567 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.22 30.75 58.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.777 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.664 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 5.5 p80 -144.56 -26.06 0.51 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 117.547 0.674 . . . . 0.0 111.394 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 21.9 m -115.82 130.39 56.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.316 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.588 ' HA ' HD22 ' A' ' 64' ' ' LEU . 23.1 tp -91.02 130.67 36.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.71 129.82 55.48 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.59 159.84 25.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.231 0.538 . . . . 0.0 111.039 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.7 t -109.59 123.31 49.23 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 56.9 m -122.25 149.67 43.37 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.369 0.604 . . . . 0.0 112.534 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.7 tmtt? -99.74 139.56 35.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.024 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.91 -32.52 0.38 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.947 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.822 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -47.49 -43.33 24.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -171.69 49.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.85 5.56 65.05 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.608 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.83 165.72 16.17 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 33.4 p90 -101.2 162.55 12.82 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 123.292 0.37 . . . . 0.0 110.155 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.14 134.22 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -72.22 125.48 27.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.225 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.4 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 34.1 p -142.29 170.71 15.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.969 0.414 . . . . 0.0 110.719 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.37 164.95 26.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.692 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.4 tpt -145.74 120.02 9.57 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.067 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.27 105.01 5.25 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.778 ' HA ' HG22 ' A' ' 91' ' ' VAL . 17.5 mt -75.98 -8.44 56.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.528 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -47.15 -32.08 4.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.917 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -117.16 23.75 11.64 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.087 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.778 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -130.76 -5.71 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.989 0.423 . . . . 0.0 110.843 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.928 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.6 t -141.16 146.33 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.522 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -143.45 176.82 22.66 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.989 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -131.7 132.95 44.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 m -141.75 109.22 5.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.286 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 62.31 43.93 7.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.905 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.568 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 61.58 26.28 66.41 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.159 -0.543 . . . . 0.0 111.874 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -127.53 142.15 51.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 34' ' ' SER . 4.4 ppp? -67.68 134.14 50.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.115 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.07 71.09 7.07 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.039 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.928 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 12.3 Cg_endo -54.45 103.52 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.408 2.739 . . . . 0.0 112.432 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.828 179.425 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.575 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 1.1 m . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 120.376 0.132 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 62.4 m-80 53.8 85.31 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.681 0.613 . . . . 0.0 112.56 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.583 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 6.0 p90 -62.51 -37.6 86.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.182 0.515 . . . . 0.0 110.165 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.91 -20.25 66.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.092 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -52.11 -29.05 20.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.378 -178.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.453 ' HB2' HD22 ' A' ' 94' ' ' ASN . 33.9 m -145.16 28.87 1.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.759 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -119.27 141.65 48.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.898 0.38 . . . . 0.0 110.97 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.9 p -137.97 157.44 46.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.065 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.5 34.3 89.53 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.211 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 21.3 m -69.76 138.95 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.003 0.43 . . . . 0.0 111.762 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -132.56 133.18 43.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.348 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.781 HD22 HD23 ' A' ' 64' ' ' LEU . 46.5 tp -119.8 123.33 43.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.934 0.397 . . . . 0.0 111.168 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.53 101.97 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.703 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.83 -60.8 2.96 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.944 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 1.6 p90 -166.91 18.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 26.3 pt -119.95 127.15 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.847 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 mt -116.05 114.92 25.21 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.197 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 27.2 ttm180 -111.83 139.03 47.65 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.88 165.15 33.03 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.2 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.589 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 1.7 m-20 -99.37 105.72 17.72 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.8 m -104.57 132.21 51.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.261 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.6 mt -69.86 139.57 20.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.318 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -108.9 -171.54 1.87 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.837 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -55.21 -31.35 61.38 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.35 -20.92 66.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.712 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.33 4.09 66.63 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.74 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.34 148.5 39.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.787 0.327 . . . . 0.0 110.29 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -70.7 132.46 21.87 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.019 2.479 . . . . 0.0 113.027 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -118.39 132.45 56.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.269 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.94 127.29 31.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.169 0.509 . . . . 0.0 111.65 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -141.93 154.94 45.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.041 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 p -139.9 142.73 36.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.64 0.257 . . . . 0.0 111.155 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.55 143.8 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.485 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -102.51 90.49 3.88 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.35 -23.66 50.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.592 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.7 t-20 -52.74 -31.44 38.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.105 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -108.36 16.7 22.9 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.52 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 37.9 m-85 -129.69 -22.93 2.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.575 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -113.93 142.17 27.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.658 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -116.11 164.22 12.29 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.547 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -102.04 105.49 16.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.247 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -110.59 104.92 13.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.505 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.733 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 36.7 t30 52.96 43.64 31.43 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.199 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.13 16.55 80.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.948 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -123.68 157.48 33.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.862 0.363 . . . . 0.0 110.768 -179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.496 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 38.9 mt -83.97 113.4 20.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.472 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 26.1 tp10 -103.11 130.43 50.27 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.767 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.35 -71.79 0.11 Allowed Pre-proline 0 CA--C 1.424 -3.877 0 O-C-N 124.47 1.106 . . . . 0.0 113.063 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.767 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 3.1 Cg_endo -107.44 133.3 0.05 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.42 0 C-N-CA 113.704 -3.731 . . . . 0.0 112.179 -178.476 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.658 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -164.74 -163.64 18.3 Favored Glycine 0 C--N 1.285 -2.261 0 CA-C-N 114.379 -1.282 . . . . 0.0 113.665 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -151.37 143.59 24.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.283 -0.459 . . . . 0.0 110.921 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.4 m 52.07 45.0 29.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -74.27 -36.03 63.8 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.91 -19.37 50.07 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.281 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -62.27 -26.87 68.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.943 0.401 . . . . 0.0 110.816 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 m -134.16 15.15 3.84 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.268 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.1 m -121.64 140.33 52.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.448 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 m -136.82 174.52 11.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.886 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 62.48 41.49 9.73 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 110.725 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 16' ' ' GLY . 21.5 p -71.83 126.78 30.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.93 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.81 162.68 40.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.766 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.781 HD23 HD22 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -118.01 113.54 21.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.806 0.336 . . . . 0.0 111.566 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.487 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 3.9 m120 -73.51 116.13 13.71 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.403 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.95 5.21 0.49 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.114 0.884 . . . . 0.0 111.742 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.1 27.89 35.79 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.717 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -145.21 -23.06 0.49 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.504 0.652 . . . . 0.0 112.23 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 30.6 m -114.68 130.73 56.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.744 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.507 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.2 tp -91.88 127.79 37.47 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 129.69 55.46 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.84 171.11 20.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.805 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.3 t -118.58 121.21 39.67 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 32.8 m -121.4 149.84 42.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.181 0.515 . . . . 0.0 111.835 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.3 tmtt? -99.89 145.37 27.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.932 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.85 -28.1 0.74 Allowed Glycine 0 C--O 1.228 -0.256 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.251 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.733 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.14 -38.81 71.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.314 0.486 . . . . 0.0 112.314 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -172.02 50.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.385 0.612 . . . . 0.0 109.899 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.75 2.08 42.57 Favored Glycine 0 C--O 1.229 -0.174 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.112 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -125.25 167.29 15.08 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 42.8 p90 -104.99 169.64 8.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.459 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -161.78 147.01 13.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.95 130.24 42.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.139 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.42 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 45.0 t -144.66 161.13 39.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.225 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.03 160.25 37.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.496 ' HB2' ' CB ' ' A' ' 48' ' ' LEU . 9.7 tpt -144.25 112.83 6.58 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.156 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -72.08 105.11 3.81 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.752 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.4 mt -73.37 -9.18 58.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.534 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -48.82 -28.17 3.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.691 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -122.41 25.76 8.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.686 0.279 . . . . 0.0 111.441 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.752 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -129.78 -13.67 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.025 0.44 . . . . 0.0 110.708 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 1.082 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.7 p -155.36 136.56 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.539 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.575 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -131.85 -173.54 13.37 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.469 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.453 HD22 ' HB2' ' A' ' 8' ' ' SER . 18.1 t30 -123.81 133.31 53.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.428 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.572 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 72.6 m -137.42 104.72 5.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.208 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 60.34 45.86 10.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.912 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.94 20.27 70.51 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.276 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -127.4 145.18 50.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.055 0.427 . . . . 0.0 109.866 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 99' ' ' MET . 13.0 ptt? -64.11 130.71 45.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.977 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.572 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 5.6 mm-40 -140.77 77.93 21.24 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.613 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 1.082 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 38.7 Cg_endo -68.77 97.15 0.54 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.665 2.244 . . . . 0.0 112.714 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.0 p . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.458 179.218 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 65.5 m . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 120.516 0.198 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 52.44 73.16 0.36 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.989 0.516 . . . . 0.0 112.054 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.531 ' HE1' ' HB2' ' A' ' 88' ' ' LEU . 9.3 p90 -57.43 -33.6 68.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.063 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.97 64.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -68.94 -20.36 64.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.1 m -119.93 9.84 11.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -123.26 146.37 47.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.006 0.432 . . . . 0.0 111.432 -179.172 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -134.4 147.42 50.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.638 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.16 56.79 21.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.492 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.567 HG12 ' HA3' ' A' ' 21' ' ' GLY . 7.1 m -99.23 130.5 48.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.113 0.482 . . . . 0.0 111.433 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.98 152.81 47.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.601 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.648 HD22 HD23 ' A' ' 64' ' ' LEU . 11.5 tp -113.22 113.58 25.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.817 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.496 ' O ' HG12 ' A' ' 18' ' ' ILE . 26.3 m-85 -108.22 98.79 8.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.992 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.5 -65.5 1.36 Allowed Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.084 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 2.8 p90 -161.39 18.64 0.11 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.748 0.419 . . . . 0.0 111.128 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 15' ' ' TYR . 30.6 pt -122.16 133.1 69.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 110.271 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.819 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -108.69 116.9 32.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.724 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.8 tmm_? -121.9 142.29 50.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.1 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.567 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -168.4 -174.71 37.4 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.414 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.569 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 35.8 m-20 -108.49 109.19 20.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -105.73 131.98 52.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.03 0.443 . . . . 0.0 110.005 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 58.2 mt -70.16 138.17 22.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.421 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -102.36 -174.31 2.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.89 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.71 -37.81 63.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.191 0.519 . . . . 0.0 111.946 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.64 -25.11 66.07 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.086 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.89 50.33 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.575 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -105.35 140.52 21.22 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-O 120.854 0.359 . . . . 0.0 110.388 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 39.4 Cg_endo -67.84 134.36 32.1 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 123.082 2.521 . . . . 0.0 112.955 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -119.91 133.65 55.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.596 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.75 126.09 27.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.281 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -143.13 156.03 44.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 p -136.72 151.3 49.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.937 0.399 . . . . 0.0 111.156 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -134.07 143.67 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.221 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -99.97 93.62 5.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.819 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.83 -29.25 64.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.317 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.2 t-20 -52.78 -29.13 25.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.935 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -108.53 12.76 25.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.6 m-85 -128.9 -20.14 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -113.57 142.11 27.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.67 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -113.72 166.07 12.11 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.256 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -109.92 111.13 22.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.141 -0.53 . . . . 0.0 110.82 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -110.78 105.46 14.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.669 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.737 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 29.9 t30 53.09 42.21 32.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.046 0.451 . . . . 0.0 111.401 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.456 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 78.11 17.63 77.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.121 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.62 154.71 40.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.966 0.412 . . . . 0.0 110.827 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD13 ' HG ' ' A' ' 70' ' ' LEU . 35.7 mt -82.1 122.99 28.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.051 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -112.71 138.49 49.44 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.694 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -40.88 -75.14 0.05 OUTLIER Pre-proline 0 CA--C 1.433 -3.556 0 CA-C-O 118.11 -0.947 . . . . 0.0 113.186 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.694 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 23.2 Cg_endo -111.32 129.0 0.03 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.425 0 C-N-CA 114.009 -3.527 . . . . 0.0 113.042 -177.621 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.08 -158.02 8.6 Favored Glycine 0 C--N 1.28 -2.572 0 CA-C-N 113.529 -1.669 . . . . 0.0 113.143 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -155.2 138.45 15.71 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.897 0.41 . . . . 0.0 110.646 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.3 m 58.27 45.05 17.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 13.2 p90 -75.07 -37.61 61.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -19.04 54.47 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.705 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -64.67 -22.49 66.99 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 120.83 0.348 . . . . 0.0 110.911 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.2 m -135.87 18.37 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.841 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 81.9 m -125.23 145.55 49.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.174 0.511 . . . . 0.0 111.44 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.4 HG23 ' HD3' ' A' ' 61' ' ' LYS . 12.0 m -138.07 176.91 6.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.16 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.5 mptt 61.85 35.0 16.75 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.145 0.278 . . . . 0.0 111.474 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 p -64.16 123.82 20.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 111.187 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.95 148.87 27.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.836 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.648 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -107.18 113.45 26.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.453 0.168 . . . . 0.0 110.749 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -79.63 126.1 30.47 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.56 18.61 1.47 Allowed 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.354 1.034 . . . . 0.0 112.045 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.0 33.53 87.49 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.935 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.0 -25.55 0.35 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.525 0.663 . . . . 0.0 111.609 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.434 ' O ' HD13 ' A' ' 64' ' ' LEU . 44.4 m -116.71 131.13 57.03 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.207 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -90.97 134.21 34.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.787 0.327 . . . . 0.0 110.466 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.19 131.45 53.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.967 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -160.63 163.69 32.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.164 0.507 . . . . 0.0 111.544 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -110.8 118.21 35.53 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.456 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 37.4 m -119.17 147.48 44.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.4 tmtt? -100.1 142.92 30.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.473 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.72 -27.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.021 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.737 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -49.85 -41.07 44.42 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -179.34 51.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.449 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 77.22 -3.76 57.19 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.234 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -113.23 161.01 17.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.975 -0.612 . . . . 0.0 109.781 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 41.0 p90 -103.71 168.37 9.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.522 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -158.03 137.93 12.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.354 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.13 127.27 32.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.8 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.7 p -142.62 177.81 8.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.597 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.425 ' HA ' HD12 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -138.78 162.22 35.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.979 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.532 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 11.8 tpp -145.67 120.99 10.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.113 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -77.63 106.09 9.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.33 0.586 . . . . 0.0 109.439 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.72 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.0 mt -73.1 -8.98 58.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.124 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -48.72 -33.04 9.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.815 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -116.15 24.49 11.38 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.062 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -128.69 -12.09 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.536 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 1.8 t -138.52 144.29 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -140.28 171.5 23.92 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.731 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.413 HD22 ' CB ' ' A' ' 8' ' ' SER . 24.6 t30 -121.96 141.19 51.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.045 0.45 . . . . 0.0 110.855 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.537 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 73.2 m -146.93 109.31 4.52 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 58.58 42.05 21.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.633 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.9 13.11 63.51 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.473 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -116.29 141.72 47.79 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.94 129.78 40.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.401 0.619 . . . . 0.0 111.645 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.537 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 36.3 mm-40 -139.02 78.81 28.45 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.179 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.797 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 32.1 Cg_endo -65.36 96.55 0.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.779 2.319 . . . . 0.0 112.442 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.317 -0.847 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.952 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.582 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 68.5 m . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.143 0.053 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 12.5 m-20 55.46 78.77 0.18 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.919 0.488 . . . . 0.0 111.889 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.588 ' CD1' HG13 ' A' ' 92' ' ' VAL . 4.8 p90 -62.48 -46.18 89.64 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.719 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.46 -22.28 54.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.186 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 6.4 t-20 -57.91 -30.5 65.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.856 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.485 ' HB2' HD22 ' A' ' 94' ' ' ASN . 49.7 m -137.67 23.47 2.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.822 0.344 . . . . 0.0 111.353 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 92.3 m -120.96 132.83 55.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.985 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 p -132.19 152.99 51.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.531 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.78 42.88 94.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.622 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.601 HG12 ' HA3' ' A' ' 21' ' ' GLY . 26.8 m -89.33 141.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.794 0.331 . . . . 0.0 111.342 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.67 159.18 42.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.143 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.74 HD22 HD23 ' A' ' 64' ' ' LEU . 20.8 tp -127.08 126.89 43.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 111.588 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.561 ' O ' HG12 ' A' ' 18' ' ' ILE . 68.4 t80 -130.83 104.79 7.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.808 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.411 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.92 -71.27 1.95 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.738 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.8 OUTLIER -163.01 23.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.605 0.362 . . . . 0.0 111.337 179.141 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 15' ' ' TYR . 34.0 pt -117.24 131.11 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 110.544 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.827 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -112.41 114.66 27.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.688 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 13.2 ttm180 -121.56 140.44 52.22 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.601 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -164.69 179.31 39.47 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.449 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -104.44 105.42 15.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.416 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 69.3 m -106.16 132.18 52.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.213 0.53 . . . . 0.0 110.29 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.68 141.4 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -105.83 -172.26 2.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.305 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -56.23 -30.52 62.46 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.76 -26.82 66.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.0 111.371 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.82 1.67 55.15 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.506 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.58 139.31 19.98 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 121.158 0.504 . . . . 0.0 111.037 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.38 127.96 20.3 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 124.117 3.211 . . . . 0.0 112.674 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -116.86 138.09 51.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.615 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.46 121.71 23.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.937 0.398 . . . . 0.0 111.171 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.4 t -140.54 156.6 46.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.928 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 p -140.4 138.92 35.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 mp -124.54 147.86 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.709 HD22 ' HB3' ' A' ' 38' ' ' ASN . 34.8 t30 -103.75 107.55 18.47 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.827 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -66.1 -22.67 66.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.683 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.709 ' HB3' HD22 ' A' ' 36' ' ' ASN . 32.2 t30 -66.72 -12.93 60.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.017 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -110.57 0.89 17.81 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.325 -0.234 . . . . 0.0 110.981 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 50.8 m-85 -128.31 -20.47 3.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.7 138.79 40.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.705 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -116.33 165.51 12.28 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.529 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -108.82 106.05 15.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.89 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -110.92 107.19 16.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.586 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 13.4 t30 56.78 40.42 29.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.173 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.63 16.18 80.96 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.81 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.419 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -124.14 152.61 42.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 10.1 mp -80.52 123.49 28.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.895 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.592 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 9.3 tp10 -114.56 132.67 56.25 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.2 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.855 ' CD2' ' HD3' ' A' ' 51' ' ' PRO 0.251 0.1 OUTLIER -41.54 -63.11 0.89 Allowed Pre-proline 0 CA--C 1.423 -3.921 0 CA-C-O 117.87 -1.062 . . . . 0.0 113.522 -179.075 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.855 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 9.0 Cg_endo -112.28 123.36 0.02 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.471 0 C-N-CA 113.766 -3.689 . . . . 0.0 112.978 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.705 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.52 -165.89 18.24 Favored Glycine 0 C--N 1.281 -2.519 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.26 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -153.34 146.52 24.69 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 m 59.96 45.69 11.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 10.8 p90 -79.35 -37.81 36.59 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.83 55.03 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.538 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 m -63.22 -29.16 70.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.223 -0.489 . . . . 0.0 110.943 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.8 m -133.49 19.58 3.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.304 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 55' ' ' PHE . 84.1 m -123.04 149.07 44.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.283 0.563 . . . . 0.0 111.724 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG23 ' HG2' ' A' ' 61' ' ' LYS . 23.4 m -141.58 176.8 3.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.943 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' HG2' HG23 ' A' ' 60' ' ' VAL . 74.1 mmtt 62.81 37.3 12.44 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.246 0.342 . . . . 0.0 111.001 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -69.82 122.43 19.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.178 0.513 . . . . 0.0 111.75 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.73 149.23 28.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.438 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -106.34 113.29 26.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.741 0.305 . . . . 0.0 111.08 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -75.49 117.19 17.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.202 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.695 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 23.0 t70 55.05 23.32 5.09 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.084 0.865 . . . . 0.0 111.491 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.29 36.73 92.9 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.988 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.695 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 10.6 p80 -147.16 -29.94 0.35 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.692 0.746 . . . . 0.0 111.49 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 m -115.62 132.34 56.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.51 0.195 . . . . 0.0 111.115 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.55 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -92.8 130.06 38.52 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.1 OUTLIER -120.97 129.75 53.55 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.093 179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -159.03 163.32 36.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.09 0.472 . . . . 0.0 111.116 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 16.4 t -110.51 120.17 41.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.3 m -121.75 148.75 44.24 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.6 tmtt? -100.35 145.58 28.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.542 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.03 -30.9 0.49 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.852 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.599 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.46 -41.58 66.31 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -172.93 52.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.225 0.536 . . . . 0.0 109.892 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.439 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 73.4 -1.11 44.95 Favored Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.335 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -119.12 158.53 25.72 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 21.0 p90 -100.6 171.12 7.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.467 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -163.3 151.15 13.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.9 132.34 41.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.419 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 40.1 t -148.35 158.51 44.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.851 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -135.1 159.99 39.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.287 0.565 . . . . 0.0 110.93 179.51 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.523 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 20.9 tpp -147.3 118.67 7.86 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.589 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.469 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 32.3 t0 -75.93 106.89 7.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.408 0.623 . . . . 0.0 109.773 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.724 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.9 mt -73.55 -9.58 58.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.709 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -50.9 -27.33 7.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.197 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 46.1 p90 -117.82 19.28 13.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 111.583 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.4 m -126.18 -7.35 5.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.121 0.486 . . . . 0.0 110.603 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.5 p -157.69 145.08 9.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.321 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -135.82 -174.3 13.33 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.799 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.485 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.4 t30 -126.01 131.24 52.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.93 0.395 . . . . 0.0 110.946 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.592 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 67.8 m -135.95 111.08 8.94 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.678 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 59.66 42.92 16.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.938 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.85 24.31 64.44 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.198 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -127.0 147.58 50.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 110.165 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -60.02 128.85 38.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.145 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 36.4 mm-40 -140.38 78.16 22.92 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.004 178.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 44.0 Cg_endo -72.52 92.13 0.77 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.351 2.034 . . . . 0.0 111.859 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.313 -0.979 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.589 -179.54 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 56.14 73.96 0.41 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.474 ' CD1' ' HB ' ' A' ' 92' ' ' VAL . 12.5 p90 -57.93 -34.5 69.93 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.138 0.494 . . . . 0.0 111.366 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.94 -22.08 63.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -62.43 -26.52 68.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 46.6 m -124.64 13.4 8.67 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.2 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -119.15 135.56 54.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.051 0.453 . . . . 0.0 111.212 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -132.46 154.36 49.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.26 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.07 53.0 48.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.064 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.421 HG12 ' HA3' ' A' ' 21' ' ' GLY . 7.1 m -92.07 137.81 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.728 0.299 . . . . 0.0 110.874 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -135.21 149.85 49.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.178 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.564 HD22 HD23 ' A' ' 64' ' ' LEU . 11.9 tp -114.41 118.01 32.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.163 0.506 . . . . 0.0 111.485 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.507 ' O ' HG12 ' A' ' 18' ' ' ILE . 91.9 m-85 -115.51 99.75 7.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.82 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.82 -73.3 1.47 Allowed Glycine 0 C--O 1.224 -0.499 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.484 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -157.49 21.14 0.29 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.671 0.388 . . . . 0.0 110.848 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 15' ' ' TYR . 39.0 pt -121.4 132.77 69.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.054 0.454 . . . . 0.0 110.251 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -109.38 117.56 34.37 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.119 -179.136 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tmm_? -121.72 139.57 53.41 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.89 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.421 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -161.8 179.35 37.23 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.303 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 10.7 m-20 -100.98 106.14 17.43 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.0 OUTLIER -106.05 131.83 52.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.954 0.406 . . . . 0.0 109.944 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -69.15 138.12 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.692 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.7 p30 -108.26 -170.28 1.65 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.29 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.48 -28.58 60.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.81 -26.69 66.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.55 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.64 -2.89 57.4 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.159 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -104.86 143.53 26.89 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.932 0.396 . . . . 0.0 110.3 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.641 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 29.3 Cg_endo -64.84 121.97 9.65 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.937 2.425 . . . . 0.0 113.015 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -108.32 130.72 55.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.171 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.84 119.65 15.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.057 0.456 . . . . 0.0 111.716 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.9 t -135.54 160.05 39.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.502 ' O ' ' HG2' ' A' ' 99' ' ' MET . 13.2 p -136.7 152.72 50.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.184 0.516 . . . . 0.0 111.551 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.22 145.78 33.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.799 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -104.58 94.56 5.38 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.9 -30.24 63.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.587 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.4 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 4.2 t30 -54.53 -29.15 49.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -103.68 10.93 36.57 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.656 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 52.8 m-85 -129.67 -22.9 2.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.417 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.24 141.49 27.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.602 0.239 . . . . 0.0 110.83 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.572 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.54 -173.77 18.16 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.918 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -128.65 109.5 11.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.844 0.354 . . . . 0.0 111.128 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -113.11 109.62 19.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.66 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.647 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 22.1 t-20 56.08 45.48 23.48 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.72 0.772 . . . . 0.0 110.943 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.54 18.12 73.41 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.709 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.07 147.49 47.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.863 0.363 . . . . 0.0 110.364 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.4 mp -71.42 127.94 34.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.189 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -114.5 129.51 56.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.15 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.596 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.7 -70.53 0.14 Allowed Pre-proline 0 CA--C 1.425 -3.852 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.868 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.596 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 14.2 Cg_endo -110.36 124.36 0.03 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.444 0 C-N-CA 113.509 -3.861 . . . . 0.0 113.146 -178.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.572 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -159.08 -161.04 10.8 Favored Glycine 0 C--N 1.281 -2.527 0 CA-C-N 113.4 -1.727 . . . . 0.0 113.197 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -153.93 150.04 27.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 0.0 110.341 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.2 p 47.79 44.97 18.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 20.4 p90 -69.84 -40.93 75.54 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.33 -26.9 38.41 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.675 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -56.93 -25.99 58.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.221 0.208 . . . . 0.0 111.286 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.2 m -137.17 28.0 2.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 0.0 110.705 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.1 m -131.61 145.92 51.94 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.346 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.42 HG23 ' HD3' ' A' ' 61' ' ' LYS . 18.4 m -136.62 174.82 11.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.811 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HD3' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER 61.41 37.86 16.47 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.322 0.649 . . . . 0.0 112.265 -179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 p -63.11 123.0 17.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.895 0.379 . . . . 0.0 111.044 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.12 155.57 37.02 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -110.86 120.15 41.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.829 0.347 . . . . 0.0 110.838 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.57 119.1 23.82 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 68.75 -59.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 124.623 1.202 . . . . 0.0 111.113 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.88 34.64 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.342 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.471 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 0.3 OUTLIER -155.81 -19.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m -116.55 128.0 55.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.618 0.247 . . . . 0.0 111.587 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.603 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.8 tp -91.09 130.74 36.95 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -120.16 129.87 54.33 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.724 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -160.28 164.12 32.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.148 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.6 t -110.95 123.98 51.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 39.2 m -125.45 153.74 43.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.92 0.391 . . . . 0.0 111.809 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.9 tmtt? -99.26 144.51 28.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.693 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.1 -26.82 0.62 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.0 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.647 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . . . -52.25 -42.5 63.69 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.551 0.341 . . . . 0.0 111.715 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -175.83 55.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.017 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.42 20.84 73.93 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.464 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -142.67 159.34 42.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 46.7 p90 -101.26 166.72 10.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.248 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -159.53 145.53 16.1 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -78.6 131.6 36.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.002 0.43 . . . . 0.0 110.772 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 p -143.51 176.03 9.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.271 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.6 OUTLIER -138.85 164.9 28.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.226 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.882 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.8 OUTLIER -145.87 121.72 10.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.533 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.6 105.11 6.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.739 ' HA ' HG22 ' A' ' 91' ' ' VAL . 19.8 mt -77.34 -8.26 57.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.659 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.471 ' OD1' ' HB2' ' A' ' 68' ' ' HIS . 11.5 m120 -47.15 -32.82 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.72 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -116.45 22.76 12.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.427 . . . . 0.0 111.324 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -127.94 -13.5 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.818 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.843 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -132.17 147.97 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.286 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.99 174.61 22.63 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.204 -0.522 . . . . 0.0 111.799 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.447 HD22 ' HB2' ' A' ' 8' ' ' SER . 20.6 t30 -135.31 133.54 38.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.684 0.278 . . . . 0.0 111.124 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.446 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 8.2 m -142.89 115.65 8.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.264 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 58.93 41.13 21.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.389 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 66.09 12.36 57.51 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.721 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -114.63 139.81 49.33 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 34' ' ' SER . 4.6 ppp? -66.01 133.54 51.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.032 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -152.87 69.31 7.0 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.759 178.13 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.843 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 15.7 Cg_endo -56.08 102.82 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.312 2.675 . . . . 0.0 112.548 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 121.637 0.732 . . . . 0.0 110.983 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.602 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 71.2 m . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 42.77 79.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.58 ' CD1' HG13 ' A' ' 92' ' ' VAL . 3.1 p90 -59.23 -34.54 72.31 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.226 0.536 . . . . 0.0 110.618 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.66 -21.76 66.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.529 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.73 -18.79 65.34 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 50.2 m -142.65 18.39 2.01 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.525 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -118.17 136.07 53.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 110.822 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -133.8 154.19 51.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.572 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.26 61.8 6.9 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.291 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 35.6 m -93.3 144.59 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.293 0.568 . . . . 0.0 111.608 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -135.88 136.7 40.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.84 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.843 HD22 HD23 ' A' ' 64' ' ' LEU . 37.3 tp -122.63 119.77 31.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.976 0.417 . . . . 0.0 110.762 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.576 ' O ' HG12 ' A' ' 18' ' ' ILE . 28.8 t80 -127.93 109.39 11.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.019 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.449 ' O ' HG21 ' A' ' 62' ' ' THR . . . 72.98 -67.16 1.41 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.791 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.9 p90 -164.56 19.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.795 0.438 . . . . 0.0 110.653 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 15' ' ' TYR . 43.5 pt -117.47 122.61 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.02 0.438 . . . . 0.0 110.569 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.852 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -109.21 114.67 28.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.788 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.2 ttt85 -115.71 140.92 48.75 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.82 176.74 41.81 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.142 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.7 m-20 -104.88 109.06 20.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.621 0.248 . . . . 0.0 110.417 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -107.61 132.86 52.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.942 0.401 . . . . 0.0 110.403 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 57.9 mt -67.38 136.15 27.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.452 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -103.68 -174.03 2.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.197 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -54.62 -29.67 52.6 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.01 -25.82 68.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.819 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.52 -4.4 56.68 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.787 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -106.76 145.11 30.41 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 37.2 Cg_endo -66.37 134.02 34.59 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.904 2.403 . . . . 0.0 112.764 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -122.58 123.76 41.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.311 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.07 130.19 44.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.293 0.568 . . . . 0.0 111.761 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 t -144.05 164.96 29.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.478 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.3 p -140.47 138.33 34.57 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.65 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.419 HG13 ' HB3' ' A' ' 99' ' ' MET . 2.7 mp -122.02 145.48 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 120.838 0.351 . . . . 0.0 110.723 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.441 ' OD1' HG22 ' A' ' 18' ' ' ILE . 91.0 m-20 -104.07 91.58 4.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 110.015 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.852 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -57.75 -25.42 60.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.171 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.0 t-20 -55.29 -30.47 60.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.692 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -103.21 11.03 37.42 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.47 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.0 m-85 -126.71 -26.96 3.15 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.537 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.3 mp -110.64 140.89 27.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.672 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -112.6 171.5 14.04 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.481 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -113.86 108.25 16.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.608 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -111.92 105.94 14.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.635 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.831 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 52.6 t30 57.34 41.01 27.18 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.177 0.513 . . . . 0.0 110.78 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.62 15.75 81.3 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.132 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.03 145.74 48.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.832 0.349 . . . . 0.0 111.054 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.7 mp -75.09 119.31 19.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.268 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.535 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 49.0 tt0 -109.93 136.42 49.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.783 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.811 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.65 -68.01 0.26 Allowed Pre-proline 0 CA--C 1.426 -3.82 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.347 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.811 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 2.4 Cg_endo -109.74 126.62 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.32 0 C-N-CA 113.69 -3.74 . . . . 0.0 113.328 -178.103 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.672 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -164.49 -161.53 13.71 Favored Glycine 0 C--N 1.283 -2.408 0 CA-C-N 113.693 -1.594 . . . . 0.0 113.372 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -153.24 147.76 26.07 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.777 0.339 . . . . 0.0 110.586 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m 56.86 37.34 28.73 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 8.4 p90 -71.24 -35.7 71.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.4 0.619 . . . . 0.0 109.466 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.93 -18.38 70.59 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.165 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 m -72.47 -7.59 50.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.173 0.511 . . . . 0.0 110.894 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 56.3 m -146.3 23.01 1.33 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.16 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -128.25 154.79 45.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 111.893 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.524 HG23 ' HD2' ' A' ' 61' ' ' LYS . 25.3 m -141.39 174.38 7.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.73 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HD2' HG23 ' A' ' 60' ' ' VAL . 0.1 OUTLIER 63.17 29.61 16.06 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.238 0.215 . . . . 0.0 111.245 -179.199 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.449 HG21 ' O ' ' A' ' 16' ' ' GLY . 4.0 p -60.98 117.72 5.82 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.201 0.524 . . . . 0.0 111.193 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.35 161.39 42.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.93 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.843 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -120.04 113.32 20.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.022 -178.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -84.9 128.52 34.66 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.415 ' HB3' ' ND1' ' A' ' 68' ' ' HIS . 7.3 t70 52.59 20.09 1.41 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.414 1.071 . . . . 0.0 112.014 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 59.99 35.11 86.15 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.324 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.415 ' ND1' ' HB3' ' A' ' 66' ' ' ASP . 1.7 p-80 -148.49 -23.55 0.33 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.152 0.476 . . . . 0.0 111.549 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.419 ' O ' HD13 ' A' ' 64' ' ' LEU . 55.5 m -116.67 129.66 56.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.173 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.587 ' HB2' HD11 ' A' ' 88' ' ' LEU . 13.8 tp -96.14 128.08 42.73 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.1 130.17 56.68 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.863 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -161.47 155.4 22.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.378 0.608 . . . . 0.0 111.303 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.584 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 7.9 t -105.93 108.28 19.71 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.801 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.0 m -105.1 149.27 26.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.448 0.642 . . . . 0.0 111.765 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 11.3 tmtt? -100.43 141.31 33.46 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.572 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.33 -30.9 0.48 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.485 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.831 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -49.34 -41.24 38.22 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -172.67 49.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.215 0.531 . . . . 0.0 110.144 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.52 1.9 62.43 Favored Glycine 0 C--O 1.23 -0.132 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.249 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -122.0 162.34 21.31 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 36.3 p90 -104.73 170.31 7.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.91 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.3 OUTLIER -157.17 133.76 9.95 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 112.42 7.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.009 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.6 p -125.82 175.04 7.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.978 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.99 163.83 29.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.9 0.381 . . . . 0.0 110.819 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.579 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.4 tpt -151.88 120.9 6.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 50.4 m-20 -74.89 106.78 6.58 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.752 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.4 mt -75.28 -9.43 58.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -47.99 -31.18 5.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.399 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 87' ' ' ASP . 4.0 p90 -117.3 21.35 13.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.61 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.752 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -126.69 -11.64 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.064 0.459 . . . . 0.0 110.484 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.927 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.4 p -153.07 138.36 10.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.832 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.602 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.86 -169.45 11.93 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.013 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.451 HD22 ' HB2' ' A' ' 8' ' ' SER . 19.8 t30 -125.85 139.67 53.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.613 0.244 . . . . 0.0 110.451 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.582 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -150.14 109.64 4.01 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.625 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 62.54 43.27 7.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.49 25.02 62.47 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.529 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.17 148.72 52.04 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 120.919 0.39 . . . . 0.0 110.693 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 99' ' ' MET . 15.9 ptt? -57.44 118.49 5.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.925 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.582 ' HG3' ' CB ' ' A' ' 95' ' ' SER . 49.1 mm-40 -132.36 76.77 71.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.563 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.927 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.7 Cg_endo -71.86 87.88 0.82 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.785 2.323 . . . . 0.0 112.681 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.019 179.614 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.577 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 26.5 m . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.378 0.132 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 55.08 79.39 0.15 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.956 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.491 ' HE1' ' HB2' ' A' ' 88' ' ' LEU . 14.5 p90 -56.76 -38.18 72.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.523 . . . . 0.0 111.158 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.03 -26.61 67.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.677 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -71.38 -6.51 40.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.673 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.3 m -137.67 8.04 2.8 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.765 0.316 . . . . 0.0 110.661 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -120.96 149.99 41.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.843 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.3 p -137.93 147.53 44.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.362 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.67 57.51 17.42 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.567 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 15.3 m -98.57 130.35 47.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.139 0.495 . . . . 0.0 111.817 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -127.4 137.5 52.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.511 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.632 HD22 HD23 ' A' ' 64' ' ' LEU . 18.3 tp -111.09 105.39 14.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -135.79 117.11 14.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.485 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 77.59 34.66 38.93 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.886 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' HD1' HG21 ' A' ' 62' ' ' THR . 19.8 m-85 65.27 23.07 12.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.053 0.541 . . . . 0.0 110.701 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 16' ' ' GLY . 9.2 mt -122.05 125.49 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.003 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.736 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.4 mt -108.07 114.22 27.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.007 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 4.6 ttm180 -116.86 140.23 49.69 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.989 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.516 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.08 177.99 41.48 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.265 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 11.5 m-20 -104.69 110.86 23.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.591 0.234 . . . . 0.0 110.565 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.9 OUTLIER -107.09 132.52 52.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.283 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.6 mt -69.9 134.31 30.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.027 0.441 . . . . 0.0 111.497 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -103.14 -173.11 2.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.842 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.93 -26.12 64.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.813 0.339 . . . . 0.0 111.909 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.75 -23.43 67.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.69 2.07 63.36 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.811 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -113.02 146.11 34.47 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.828 0.347 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.639 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 33.0 Cg_endo -66.26 125.76 14.55 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.236 2.624 . . . . 0.0 112.705 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -109.59 127.46 54.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.255 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.81 126.63 30.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.973 0.416 . . . . 0.0 111.209 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -143.09 162.51 35.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.445 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.487 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 73.2 p -139.59 133.58 30.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.457 0.17 . . . . 0.0 110.709 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.416 HG13 ' CB ' ' A' ' 99' ' ' MET . 2.9 mp -115.23 143.01 25.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.253 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -101.08 92.82 5.17 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.736 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -58.56 -25.61 62.69 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.722 -178.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.556 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 22.8 t-20 -54.18 -31.7 53.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.376 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -107.61 16.4 23.77 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.0 m-85 -129.5 -22.32 3.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.54 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.66 141.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.634 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.0 174.26 15.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.363 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -112.82 108.32 17.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.9 0.381 . . . . 0.0 110.71 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -111.59 105.24 13.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.679 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.714 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 41.5 t30 56.75 42.59 26.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.146 0.498 . . . . 0.0 110.696 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 73.7 18.03 79.37 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.733 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.98 146.91 49.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 111.229 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 7.5 mp -72.38 114.32 10.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.616 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -108.79 132.04 54.37 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.879 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -31.21 -74.12 0.05 OUTLIER Pre-proline 0 CA--C 1.432 -3.568 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.184 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.879 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 10.7 Cg_endo -108.89 129.43 0.04 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.242 0 C-N-CA 113.852 -3.632 . . . . 0.0 112.913 -177.031 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.634 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -161.44 -163.28 14.08 Favored Glycine 0 C--N 1.278 -2.683 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.016 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -153.38 143.22 22.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.013 0.435 . . . . 0.0 110.892 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.5 m 57.15 35.1 25.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.169 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 7.2 p90 -64.81 -34.16 77.7 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.03 -17.61 37.56 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.165 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 t -68.26 -30.82 69.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.739 0.304 . . . . 0.0 110.625 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 m -125.29 6.32 7.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.192 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -120.48 141.38 50.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.684 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.424 HG23 ' HD3' ' A' ' 61' ' ' LYS . 29.8 m -137.5 171.84 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HD3' HG23 ' A' ' 60' ' ' VAL . 2.1 mptm? 63.61 43.35 5.8 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.774 0.671 . . . . 0.0 111.457 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.581 HG21 ' HD1' ' A' ' 17' ' ' TYR . 4.2 p -69.28 133.6 48.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.072 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.71 163.97 38.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.698 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.632 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -120.62 112.87 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.666 0.27 . . . . 0.0 111.647 -179.077 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.621 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 16.9 m120 -72.18 116.93 13.19 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.224 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.609 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 18.7 t70 54.08 15.17 0.83 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.955 0.784 . . . . 0.0 111.929 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.31 34.41 57.79 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.836 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.609 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.5 p80 -147.83 -26.1 0.36 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.7 0.75 . . . . 0.0 112.001 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 18.5 m -116.08 134.59 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.495 0.188 . . . . 0.0 111.058 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.539 ' HG ' ' CD2' ' A' ' 48' ' ' LEU . 24.3 tp -94.64 133.5 38.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.582 0.23 . . . . 0.0 110.613 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.71 130.57 52.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.855 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -163.19 163.31 25.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.8 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.421 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 23.0 t -109.68 126.82 54.08 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.454 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 17.5 m -124.85 150.36 46.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.22 0.533 . . . . 0.0 112.153 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.0 tmtt? -100.27 140.55 34.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.721 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.45 -30.49 0.52 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.145 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.714 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.19 -40.31 64.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -171.21 51.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.416 0.627 . . . . 0.0 110.053 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.43 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 70.71 5.21 56.11 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.782 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -129.34 162.14 28.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 47.9 p90 -90.14 160.11 16.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.309 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -153.87 133.04 12.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.48 124.75 24.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.702 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.8 p -138.45 171.0 15.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.766 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.17 159.41 41.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.965 0.412 . . . . 0.0 110.521 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.575 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 12.0 tpp -143.28 123.76 13.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.505 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.48 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 10.8 m-20 -73.1 105.74 4.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.247 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.736 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.1 mt -76.18 -8.61 57.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.909 0.385 . . . . 0.0 110.426 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.11 -28.73 7.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.943 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 87' ' ' ASP . 44.1 p90 -120.16 22.77 11.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.982 0.42 . . . . 0.0 110.973 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -128.72 -9.93 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.594 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.927 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -138.93 140.6 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.235 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.577 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -139.01 176.47 20.91 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.305 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -121.66 123.31 41.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.632 0.253 . . . . 0.0 110.972 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.533 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 57.9 m -127.82 94.34 3.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.601 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 64.67 47.07 2.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.49 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.62 20.97 66.57 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.366 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -124.17 139.0 54.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 99' ' ' MET . 12.9 ptt? -57.52 122.38 12.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.99 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.533 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 25.8 mm-40 -142.93 78.34 15.54 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.788 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.927 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.0 Cg_endo -71.78 96.38 0.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.884 2.389 . . . . 0.0 113.215 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.0 p . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.66 179.664 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.584 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 88.7 m . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 110.94 -0.022 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.495 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 58.4 m-80 52.17 82.73 0.06 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.598 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 14.4 p90 -60.77 -34.83 75.05 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.289 0.566 . . . . 0.0 110.507 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.85 -19.16 60.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.235 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.495 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 7.4 t-20 -51.22 -33.42 27.74 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.438 0.461 . . . . 0.0 111.532 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB2' HD22 ' A' ' 94' ' ' ASN . 19.8 m -136.5 27.14 3.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.941 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -120.41 132.81 55.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.088 0.471 . . . . 0.0 111.161 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 p -131.87 155.74 47.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.988 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.76 30.43 74.55 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.318 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.586 HG12 ' HA3' ' A' ' 21' ' ' GLY . 17.5 m -77.45 134.34 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.029 0.443 . . . . 0.0 111.669 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.73 151.88 49.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.697 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.663 HD22 HD23 ' A' ' 64' ' ' LEU . 8.8 tp -121.92 106.33 11.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.006 0.431 . . . . 0.0 111.176 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -134.21 114.73 13.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.789 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.469 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 73.76 38.45 49.97 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.738 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 62' ' ' THR . 18.1 m-85 64.2 25.6 13.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.199 0.6 . . . . 0.0 110.886 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 16' ' ' GLY . 12.2 mt -121.56 124.81 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.133 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.785 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -102.74 113.76 27.44 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.442 ' HG3' ' HB3' ' A' ' 34' ' ' SER . 15.2 ttm180 -123.04 133.74 54.32 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.7 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -162.79 -173.38 31.43 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.13 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -106.55 109.53 21.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.626 0.25 . . . . 0.0 110.662 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -104.82 132.08 51.5 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 8' ' ' SER . 54.1 mt -71.74 142.19 15.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -109.5 -171.12 1.78 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.399 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -54.91 -31.22 59.89 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.88 -9.68 58.8 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.16 5.23 85.87 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.845 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.4 133.94 20.4 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.869 0.366 . . . . 0.0 110.168 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.63 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 18.5 Cg_endo -60.48 138.53 81.04 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 123.246 2.63 . . . . 0.0 112.741 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -123.41 135.87 54.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.32 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 112.39 5.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.214 0.53 . . . . 0.0 110.828 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -131.1 156.75 44.71 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.601 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.442 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 19.9 p -139.57 147.0 40.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.102 0.477 . . . . 0.0 111.603 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -129.74 143.96 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.563 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -104.06 89.77 3.38 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.785 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -54.29 -30.44 50.82 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.61 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.54 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.3 t-20 -54.33 -28.34 41.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.468 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -108.76 14.67 24.18 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.643 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 43.0 m-85 -128.05 -24.2 3.21 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.2 mp -111.4 143.03 22.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.661 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -112.61 170.58 13.54 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.56 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -113.84 111.35 21.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.294 -0.453 . . . . 0.0 111.35 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -110.63 104.35 13.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.76 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 48.08 47.04 19.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.126 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 74' ' ' CYS . . . 78.51 12.51 84.19 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.673 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.39 143.97 47.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.832 0.349 . . . . 0.0 110.667 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.6 mp -76.94 114.29 15.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.516 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -103.39 136.97 42.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.089 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.661 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.23 -76.19 0.05 OUTLIER Pre-proline 0 CA--C 1.436 -3.416 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.661 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 20.5 Cg_endo -109.95 125.64 0.04 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.324 0 C-N-CA 113.751 -3.699 . . . . 0.0 113.165 -177.342 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.661 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -155.67 -157.55 8.33 Favored Glycine 0 C--N 1.284 -2.36 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.664 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -151.56 143.31 23.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 111.052 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 m 49.82 44.9 25.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.54 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 11.5 p90 -68.97 -31.08 69.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 59' ' ' CYS . . . -62.22 -18.21 57.47 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.196 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -53.9 -30.66 47.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.315 0.246 . . . . 0.0 110.904 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 25.1 m -135.48 17.75 3.36 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.446 ' HB2' ' HA2' ' A' ' 56' ' ' GLY . 7.5 m -108.08 147.73 30.79 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.45 0.643 . . . . 0.0 112.238 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.74 173.3 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.995 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 59.94 35.91 21.68 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.427 0.291 . . . . 0.0 111.432 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.451 HG21 ' CD1' ' A' ' 17' ' ' TYR . 16.7 p -68.31 120.09 13.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.992 0.425 . . . . 0.0 111.488 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.85 152.49 30.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.728 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.663 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -108.34 112.75 25.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.525 0.202 . . . . 0.0 110.59 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -76.08 117.49 17.84 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.705 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 24.8 t70 58.48 18.04 5.36 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.081 0.863 . . . . 0.0 111.044 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.06 32.52 84.38 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.413 -0.812 . . . . 0.0 114.082 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.705 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.0 p80 -141.9 -27.26 0.65 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 117.811 0.805 . . . . 0.0 111.249 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.403 ' O ' HD13 ' A' ' 64' ' ' LEU . 27.9 m -116.01 126.24 53.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.56 ' HA ' HD22 ' A' ' 64' ' ' LEU . 16.8 tp -89.97 126.58 35.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.162 0.506 . . . . 0.0 109.783 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -117.67 130.47 56.37 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.305 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.31 166.47 27.49 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.661 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 t -118.26 117.57 29.48 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.547 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -114.32 154.21 28.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.544 0.688 . . . . 0.0 111.828 -179.419 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 7.8 tmtt? -100.36 149.27 23.8 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.826 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.31 -15.53 1.87 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.829 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.77 84.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.687 0.28 . . . . 0.0 110.744 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 178.24 58.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.698 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.405 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 69.13 19.68 74.17 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -143.82 161.34 38.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 51.4 p90 -101.82 165.5 11.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.318 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.96 152.84 40.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.408 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.86 131.09 37.45 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.8 p -149.58 172.68 14.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.95 0.405 . . . . 0.0 111.286 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.6 OUTLIER -137.85 163.29 31.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.99 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.565 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 4.6 tpt -146.67 113.05 5.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.4 106.49 4.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.792 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.4 mt -74.47 -7.62 53.6 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.762 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -46.83 -30.76 2.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.874 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -118.63 19.14 13.33 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.628 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.792 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -125.14 -10.01 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.313 0.578 . . . . 0.0 110.154 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.827 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.1 t -141.79 139.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.525 178.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.584 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -129.92 176.42 18.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.519 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.441 HD22 ' HB2' ' A' ' 8' ' ' SER . 21.3 t30 -129.48 133.54 47.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.61 0.243 . . . . 0.0 110.454 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.408 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 5.4 t -142.38 111.49 6.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.88 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 57.65 43.55 22.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.401 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.56 7.56 65.01 Favored Glycine 0 C--N 1.33 0.218 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.455 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.9 145.16 41.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -68.91 131.22 44.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.224 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.408 ' HG3' ' CB ' ' A' ' 95' ' ' SER . 21.2 mm-40 -136.67 76.03 48.79 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.693 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.827 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 35.2 Cg_endo -66.27 119.36 6.38 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.438 2.092 . . . . 0.0 111.322 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.826 -178.994 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.402 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 82.0 m . . . . . 0 C--O 1.232 0.17 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.944 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 24.4 m-80 51.76 69.09 0.7 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.575 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.662 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 17.5 p90 -58.1 -41.66 83.98 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.25 0.547 . . . . 0.0 110.21 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.94 -21.62 65.09 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.821 -178.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 28.2 t-20 -54.71 -33.72 61.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.333 0.587 . . . . 0.0 110.802 -179.138 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.444 ' HB2' HD22 ' A' ' 94' ' ' ASN . 26.1 m -134.69 28.4 3.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.076 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.662 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -120.0 134.88 55.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.943 0.401 . . . . 0.0 110.584 179.267 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 p -128.25 152.19 48.39 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.985 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.84 57.91 12.68 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.756 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.598 HG12 ' HA3' ' A' ' 21' ' ' GLY . 15.5 m -104.83 132.12 52.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.962 0.41 . . . . 0.0 110.824 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -133.27 156.69 47.11 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.739 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.652 HD22 HD23 ' A' ' 64' ' ' LEU . 21.9 tp -121.33 127.73 51.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.542 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.448 ' O ' HG12 ' A' ' 18' ' ' ILE . 42.7 t80 -131.23 98.92 4.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.836 179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 62' ' ' THR . . . 78.41 -63.77 3.61 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.709 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -169.15 23.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.724 0.297 . . . . 0.0 111.47 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.7 pt -121.57 133.91 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.798 0.332 . . . . 0.0 110.659 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.791 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -115.72 114.28 24.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.828 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.46 140.55 51.23 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.598 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.22 -177.71 39.03 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.96 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 7.1 m-20 -109.63 108.3 18.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.439 0.162 . . . . 0.0 110.609 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.9 m -104.54 132.38 50.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.5 mt -69.58 133.43 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.56 -178.538 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -94.68 -176.59 3.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.917 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -54.72 -37.71 66.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.727 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.81 -30.02 67.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.938 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.03 -2.01 31.53 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.322 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -104.49 139.69 20.35 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.372 . . . . 0.0 110.944 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 42.8 Cg_endo -69.91 125.99 12.7 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.921 2.414 . . . . 0.0 111.67 179.1 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -112.02 136.88 50.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.048 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.3 123.77 21.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.453 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -140.01 158.36 44.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.602 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.0 p -140.1 141.86 36.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.743 0.306 . . . . 0.0 111.192 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -124.86 145.4 32.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.588 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -103.74 95.82 6.29 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -58.54 -26.9 64.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.742 0.306 . . . . 0.0 111.337 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -55.41 -24.12 28.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.863 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -112.86 12.37 19.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.58 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -129.02 -12.03 4.7 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.529 HD13 ' HB3' ' A' ' 37' ' ' LEU . 3.0 mp -124.62 133.9 68.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.55 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -108.67 170.92 15.13 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.577 -179.324 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -110.88 102.49 10.99 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.299 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -110.57 105.64 14.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.889 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 14.3 t-20 52.6 47.37 24.83 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.708 0.766 . . . . 0.0 111.094 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.69 75.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.933 179.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -120.27 151.79 38.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.797 0.332 . . . . 0.0 110.672 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.507 HD23 ' HG ' ' A' ' 70' ' ' LEU . 10.8 mp -85.5 117.01 24.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.892 -179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.673 ' HG3' ' CD ' ' A' ' 51' ' ' PRO . 12.8 tp10 -110.57 126.8 54.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.183 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.945 ' HB2' HG11 ' A' ' 91' ' ' VAL 0.252 53.5 p90 -61.13 -12.06 0.2 Allowed Pre-proline 0 CA--C 1.452 -2.811 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 -174.804 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.673 ' CD ' ' HG3' ' A' ' 49' ' ' GLU . 8.3 Cg_endo -128.62 9.22 0.0 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.601 1 C-N-CA 112.461 -4.56 . . . . 0.0 114.972 175.693 . . . . . . . . 4 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.55 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -66.94 -167.72 3.05 Favored Glycine 0 C--N 1.27 -3.106 0 CA-C-N 110.849 -2.887 . . . . 0.0 115.69 -177.183 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -145.59 154.56 42.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.721 0.296 . . . . 0.0 110.928 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.8 m 55.76 45.28 24.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 10.4 p90 -79.61 -36.7 37.63 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.845 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.54 -18.38 69.83 Favored Glycine 0 CA--C 1.505 -0.533 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.83 -178.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 m -66.7 -13.21 61.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.049 -0.576 . . . . 0.0 110.779 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.4 m -149.02 26.84 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.617 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -124.55 155.36 39.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.162 0.506 . . . . 0.0 111.123 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 61' ' ' LYS . 32.6 m -141.62 171.1 12.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.816 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.4 mptt 62.46 31.77 16.98 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.523 0.514 . . . . 0.0 111.345 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 16' ' ' GLY . 2.6 p -59.66 123.16 16.02 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.926 0.393 . . . . 0.0 111.489 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.45 162.88 40.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.315 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.652 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -121.98 112.62 18.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -85.33 124.8 32.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 110.959 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.629 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 11.1 t70 56.36 21.36 5.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.048 179.031 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.94 36.06 92.28 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.33 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.629 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -154.48 -23.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.571 0.686 . . . . 0.0 112.393 179.008 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 m -116.35 128.48 55.57 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.22 -0.3 . . . . 0.0 111.143 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.566 ' HA ' HD22 ' A' ' 64' ' ' LEU . 11.8 tp -91.3 129.73 37.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.297 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.402 ' N ' HD12 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -120.84 129.75 53.67 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.657 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -162.91 165.56 24.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.133 179.109 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.412 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 23.2 t -117.01 111.78 20.04 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.314 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 56.7 m -103.38 146.14 28.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.414 0.626 . . . . 0.0 110.742 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 10.2 tmtt? -100.59 140.49 34.78 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.883 177.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.73 -24.46 0.3 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.909 -1.139 . . . . 0.0 112.992 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.436 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . . . -47.97 -45.85 31.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.0 111.135 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.2 t70 178.72 58.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.917 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.454 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 76.57 -0.16 65.71 Favored Glycine 0 C--O 1.229 -0.189 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.695 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -118.23 163.95 15.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.172 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 50.5 p90 -111.77 169.54 8.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.071 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -155.95 135.19 12.21 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -72.05 114.65 10.38 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.291 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.467 ' HB3' HD13 ' A' ' 48' ' ' LEU . 18.8 t -130.55 167.53 18.54 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.977 0.418 . . . . 0.0 110.418 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.03 160.93 38.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.163 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.608 ' HA ' ' CE ' ' A' ' 86' ' ' MET . 0.6 OUTLIER -146.04 126.25 13.86 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.327 -179.611 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.565 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 45.9 t0 -78.28 108.78 11.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.144 0.497 . . . . 0.0 109.874 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.779 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.1 mt -82.26 -9.25 59.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.586 -179.177 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -52.21 -26.27 11.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.489 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 41.9 p90 -116.54 17.76 15.27 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.066 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.945 HG11 ' HB2' ' A' ' 50' ' ' TYR . 2.5 m -123.7 -10.57 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 121.188 0.518 . . . . 0.0 110.476 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -133.73 124.16 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -114.98 159.03 13.95 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.44 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.444 HD22 ' HB2' ' A' ' 8' ' ' SER . 22.9 t30 -107.81 121.94 45.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.559 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 74.4 m -137.12 107.16 6.31 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.809 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 61.01 40.74 14.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.326 178.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.73 18.31 68.11 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.606 -0.725 . . . . 0.0 113.164 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -124.75 147.97 48.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 99' ' ' MET . 8.2 ptt? -66.01 127.77 33.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.867 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 53.9 mm-40 -133.61 75.07 69.47 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.289 178.071 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 31.6 Cg_endo -62.19 135.48 54.71 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.734 2.289 . . . . 0.0 112.218 -179.195 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 5.7 p . . . . . 0 C--N 1.318 -0.791 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.578 -179.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.438 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 37.9 m . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 41.82 76.04 0.08 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.267 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.63 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 3.4 p90 -62.19 -32.68 73.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.006 0.431 . . . . 0.0 111.035 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.6 -22.31 65.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -63.05 -27.18 69.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.449 ' HB2' HD22 ' A' ' 94' ' ' ASN . 71.0 m -129.87 28.7 5.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.733 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -129.75 144.81 51.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.927 0.394 . . . . 0.0 111.104 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.1 p -140.39 147.39 39.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.061 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.13 48.14 55.01 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.893 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.543 HG12 ' HA3' ' A' ' 21' ' ' GLY . 18.1 m -93.5 132.75 36.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.202 0.525 . . . . 0.0 111.083 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -126.6 154.86 43.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.672 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.732 HD22 HD23 ' A' ' 64' ' ' LEU . 16.2 tp -123.8 119.44 29.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.872 0.368 . . . . 0.0 111.41 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.546 ' O ' HG12 ' A' ' 18' ' ' ILE . 29.2 m-85 -118.01 99.21 6.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.158 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.478 ' O ' HG21 ' A' ' 62' ' ' THR . . . 73.44 -61.92 1.89 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.975 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 28.1 p90 -165.39 21.15 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.868 0.366 . . . . 0.0 111.211 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 15' ' ' TYR . 35.4 pt -118.82 127.54 75.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.922 0.391 . . . . 0.0 110.552 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.889 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -108.82 117.64 34.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.695 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 20' ' ' ARG . 6.1 tmm_? -128.85 138.22 51.92 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.737 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.543 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -166.78 -168.54 29.12 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.937 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 5.1 m-20 -112.34 110.66 21.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.737 0.303 . . . . 0.0 111.078 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 m -106.38 132.98 51.78 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.7 mt -67.41 136.34 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.83 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.485 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.6 p30 -104.34 -174.46 2.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.355 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -52.79 -33.41 48.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.481 0.488 . . . . 0.0 112.098 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.68 -28.18 69.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.786 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.06 -4.04 48.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.514 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -104.87 146.08 31.95 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.808 0.337 . . . . 0.0 110.524 179.231 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 37.1 Cg_endo -67.52 130.6 22.6 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.805 2.337 . . . . 0.0 112.137 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -118.96 132.38 56.07 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.743 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.82 126.25 27.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.41 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 t -143.03 158.7 43.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.649 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 p -138.98 151.17 46.64 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.542 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -136.25 147.24 28.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.316 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.428 ' OD1' HG22 ' A' ' 18' ' ' ILE . 91.1 m-20 -104.38 96.05 6.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.897 0.379 . . . . 0.0 110.785 179.299 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.889 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -60.39 -28.5 68.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.008 -179.138 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.471 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 24.4 t-20 -55.81 -26.56 46.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.2 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.05 11.93 22.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.484 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.654 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.9 m-85 -128.71 -20.28 3.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -114.69 141.32 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.186 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.609 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.32 176.54 17.05 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.105 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -116.71 106.62 13.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.889 0.376 . . . . 0.0 110.695 -178.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -111.87 107.27 16.25 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.376 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.848 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 55.1 t30 56.02 40.79 30.27 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.037 0.446 . . . . 0.0 110.533 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.41 19.6 79.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.509 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.42 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -123.89 157.06 35.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.848 0.356 . . . . 0.0 110.568 -179.584 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.05 116.63 21.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.234 -178.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.18 128.77 51.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.596 179.178 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.706 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.83 -76.22 0.04 OUTLIER Pre-proline 0 CA--C 1.43 -3.639 0 CA-C-O 117.697 -1.144 . . . . 0.0 112.819 -179.825 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.706 ' HD3' ' HB2' ' A' ' 50' ' ' TYR . 6.0 Cg_endo -108.68 123.98 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.273 1 C-N-CA 113.199 -4.067 . . . . 0.0 113.083 -178.661 . . . . . . . . 4 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.609 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -152.35 -160.75 9.77 Favored Glycine 0 C--N 1.281 -2.509 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.939 -177.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -154.87 142.76 20.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.693 0.282 . . . . 0.0 110.583 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.1 m 56.48 42.49 27.34 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.184 178.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 14.9 p90 -71.75 -35.61 70.17 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.07 -18.69 48.98 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.321 -178.753 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 m -64.4 -16.55 62.55 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.06 0.544 . . . . 0.0 111.01 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 m -148.22 23.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.884 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.7 m -129.99 138.67 50.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.26 0.552 . . . . 0.0 111.093 -179.559 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.416 HG23 ' HG2' ' A' ' 61' ' ' LYS . 25.1 m -133.06 178.09 6.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.295 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HG2' HG23 ' A' ' 60' ' ' VAL . 34.4 mmtp 62.81 37.09 12.6 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.415 0.447 . . . . 0.0 111.329 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.478 HG21 ' O ' ' A' ' 16' ' ' GLY . 12.6 p -67.84 123.2 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.86 149.73 27.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.92 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.732 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -106.34 115.01 29.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.853 0.359 . . . . 0.0 110.724 -179.639 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -85.94 120.37 27.27 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.195 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.69 23.36 10.98 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.924 0.765 . . . . 0.0 111.925 179.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.93 32.19 59.1 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 114.361 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -148.09 -25.15 0.35 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.376 0.588 . . . . 0.0 111.436 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.6 m -114.81 126.39 54.77 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.777 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.535 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.0 tp -89.83 132.72 35.11 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.45 129.56 52.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.748 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.19 166.93 28.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 110.521 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 t -114.79 122.66 47.05 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 57.2 m -122.44 149.68 43.52 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.47 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.414 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 9.4 tmtt? -99.96 140.45 34.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.824 178.148 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.61 -32.07 0.3 Allowed Glycine 0 C--O 1.227 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.18 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.848 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -52.95 -41.16 64.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -173.55 52.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.618 0.723 . . . . 0.0 109.811 -179.094 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.414 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 69.21 10.01 61.65 Favored Glycine 0 C--O 1.225 -0.418 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.096 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -131.78 158.67 40.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 17.4 p90 -100.72 166.3 10.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -158.53 149.12 20.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.144 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -69.59 139.33 53.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.931 0.396 . . . . 0.0 110.636 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.42 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 34.3 t -152.01 162.99 40.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.038 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.58 164.55 27.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.908 0.385 . . . . 0.0 110.021 179.157 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.813 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 2.6 tpt -148.7 121.38 8.63 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.689 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 19.2 m-20 -73.94 106.5 5.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.015 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.709 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.3 mt -75.76 -9.11 58.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.523 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.38 -31.33 3.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.079 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.562 ' HE1' ' HD2' ' A' ' 50' ' ' TYR . 3.2 p90 -119.57 23.59 11.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 111.564 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -127.53 -14.35 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.102 0.477 . . . . 0.0 110.505 178.484 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.966 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.5 p -150.79 133.81 6.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.691 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -128.03 -179.82 16.08 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.523 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.449 HD22 ' HB2' ' A' ' 8' ' ' SER . 14.8 t30 -126.01 135.85 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.533 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 5.0 t -147.66 120.61 8.77 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 57.99 41.49 24.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 60.58 28.98 68.59 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.764 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -136.29 151.44 49.64 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.835 0.35 . . . . 0.0 110.139 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 99' ' ' MET . 20.0 ptt? -61.9 127.89 33.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.071 -179.345 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 95' ' ' SER . 14.2 mm-40 -140.45 71.48 32.02 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.246 178.034 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.966 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 51.7 Cg_endo -70.91 100.73 0.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.77 2.314 . . . . 0.0 112.871 -179.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.031 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.582 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 83.3 m . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 44.2 m-80 62.51 80.5 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 178.451 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.645 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 6.2 p90 -65.01 -35.87 82.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.066 178.042 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.9 64.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.871 -178.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 7.3 t-20 -52.18 -31.27 30.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.51 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.422 ' HB2' HD22 ' A' ' 94' ' ' ASN . 59.0 m -144.12 30.77 1.27 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.893 0.378 . . . . 0.0 110.721 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -119.48 142.17 48.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.024 179.156 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -141.44 157.53 45.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.395 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.79 61.03 7.66 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.723 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.584 HG12 ' HA3' ' A' ' 21' ' ' GLY . 30.9 m -100.71 139.02 23.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.91 0.386 . . . . 0.0 110.991 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 11.3 pt-20 -130.32 139.72 50.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.393 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.72 HD22 HD23 ' A' ' 64' ' ' LEU . 51.9 tp -124.62 123.74 40.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.484 ' O ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-85 -133.67 103.65 5.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.412 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 62' ' ' THR . . . 79.37 -65.2 3.67 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.161 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.6 p90 -167.6 21.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.813 0.339 . . . . 0.0 111.313 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 45.6 pt -117.02 129.05 74.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.47 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.917 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -119.79 114.45 22.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.609 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 21.2 ttm180 -114.0 136.0 53.38 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.584 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -154.93 168.32 32.89 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.399 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.657 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 17.8 m-20 -100.66 105.15 16.49 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -104.97 131.79 52.02 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 60.4 mt -70.71 136.2 26.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.646 -178.399 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -99.73 -176.5 3.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.404 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.37 -32.79 57.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.89 -29.04 69.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.022 0.439 . . . . 0.0 111.66 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.12 0.8 41.5 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.096 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -107.56 141.52 23.2 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.791 0.329 . . . . 0.0 110.656 179.507 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.657 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 36.5 Cg_endo -67.62 130.23 21.69 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 122.966 2.444 . . . . 0.0 112.532 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -114.72 132.61 56.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.95 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.38 124.27 23.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.171 0.51 . . . . 0.0 111.638 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 t -143.22 152.94 42.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.413 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 12.7 p -135.7 145.5 46.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.506 0.193 . . . . 0.0 111.117 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.84 151.81 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.788 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -103.07 93.61 5.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.171 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.917 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -60.18 -24.48 64.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.797 -178.911 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.5 t-20 -55.09 -30.9 60.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.969 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -105.7 15.17 27.27 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.537 -178.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.1 m-85 -130.38 -24.62 2.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.3 mp -112.71 141.78 27.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.671 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -114.35 169.7 12.99 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.547 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -119.33 114.2 21.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.973 0.416 . . . . 0.0 110.933 -179.082 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -111.02 108.12 17.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.241 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 51.87 42.56 30.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.077 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 74' ' ' CYS . . . 80.07 18.05 73.03 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.539 179.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.67 150.17 46.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.047 0.451 . . . . 0.0 111.2 -179.83 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.468 HD13 ' HG ' ' A' ' 70' ' ' LEU . 43.4 mt -82.43 116.19 21.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.14 -179.133 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -112.49 132.04 55.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.583 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -33.17 -73.67 0.06 OUTLIER Pre-proline 0 CA--C 1.427 -3.765 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.598 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.583 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 4.9 Cg_endo -107.85 130.48 0.05 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.327 0 C-N-CA 113.563 -3.824 . . . . 0.0 113.212 -176.669 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.671 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -163.89 -160.46 11.8 Favored Glycine 0 C--N 1.286 -2.204 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.322 -177.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -151.53 145.53 25.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 111.401 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m 51.57 41.79 28.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.774 178.325 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -69.33 -39.37 78.23 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.523 178.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.03 -18.08 46.54 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.24 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 t -68.82 -20.44 64.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.002 0.43 . . . . 0.0 110.166 179.691 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -134.49 17.25 3.66 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.402 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.7 m -125.8 143.13 51.19 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.97 0.414 . . . . 0.0 111.17 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.31 172.81 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.454 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 62.0 37.54 14.85 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.597 0.56 . . . . 0.0 111.359 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 16' ' ' GLY . 18.0 p -63.94 127.43 31.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.972 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.55 160.28 43.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.231 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.72 HD23 HD22 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -118.54 112.92 20.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.805 0.336 . . . . 0.0 110.967 -179.7 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.593 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 15.9 m120 -70.28 114.61 8.58 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.316 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.7 t70 55.2 3.32 0.06 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.145 0.903 . . . . 0.0 112.766 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 86.84 47.78 4.66 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.475 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 6.1 p80 -162.04 -30.06 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 111.684 178.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 23.9 m -115.89 134.15 55.28 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.692 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.605 ' HB2' HD11 ' A' ' 88' ' ' LEU . 12.3 tp -94.92 131.24 41.06 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.541 0.21 . . . . 0.0 110.482 179.099 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 128.99 53.81 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.77 162.57 37.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.165 0.507 . . . . 0.0 111.149 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -110.76 120.95 44.09 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.466 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 21.3 m -121.36 148.21 44.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.277 0.56 . . . . 0.0 112.303 -177.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 8.2 tmtt? -99.41 147.48 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.226 178.046 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.68 -18.55 0.87 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.005 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.72 81.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.823 0.311 . . . . 0.0 110.815 179.082 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.7 t70 179.13 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.205 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.49 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 71.52 -3.75 16.22 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.635 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -116.19 161.51 18.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 44.3 p90 -106.11 166.58 10.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.299 -179.473 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -154.97 143.16 20.28 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.4 127.55 32.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.78 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 p -141.4 174.72 10.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.13 162.49 34.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 0.0 110.791 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.795 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.2 tpt -148.66 117.18 6.55 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.575 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.563 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 26.4 t70 -76.68 106.75 8.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.708 ' HA ' HG22 ' A' ' 91' ' ' VAL . 12.5 mt -78.85 -10.05 59.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.387 -177.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -58.44 -16.72 16.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.06 -179.15 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.563 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 48.2 p90 -119.45 19.43 12.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.174 0.512 . . . . 0.0 110.823 177.431 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.708 HG22 ' HA ' ' A' ' 88' ' ' LEU . 2.6 m -125.52 -6.63 5.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.479 0.657 . . . . 0.0 109.84 177.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 9.9 p -153.06 147.02 14.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.937 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.71 -177.09 14.71 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.793 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.422 HD22 ' HB2' ' A' ' 8' ' ' SER . 17.3 t30 -122.71 127.01 48.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.716 0.293 . . . . 0.0 110.65 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.6 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 58.2 m -127.68 92.9 3.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.77 178.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 60.99 54.29 3.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.996 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.25 27.37 62.8 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.965 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.88 142.83 51.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.898 0.38 . . . . 0.0 110.52 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 99' ' ' MET . 21.5 ptt? -62.22 121.21 12.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.547 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.6 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 12.7 mm-40 -138.43 80.93 25.94 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.199 178.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 42.3 Cg_endo -68.67 102.06 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.909 2.406 . . . . 0.0 112.064 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.043 179.66 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.607 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 2.1 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 56.73 70.38 0.66 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.162 0.289 . . . . 0.0 110.863 179.233 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 6.8 p90 -58.35 -38.35 77.03 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.071 0.462 . . . . 0.0 111.582 -178.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.91 -22.6 65.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -69.37 -19.48 63.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.784 0.326 . . . . 0.0 111.312 -178.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.2 m -128.94 10.01 5.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.154 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -118.29 138.55 52.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.218 0.532 . . . . 0.0 111.475 -179.615 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.7 p -132.48 151.42 51.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.921 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.03 49.22 80.88 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.947 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.517 ' HB ' HD22 ' A' ' 19' ' ' LEU . 15.7 m -83.39 127.53 39.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.275 0.56 . . . . 0.0 111.493 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -116.29 137.35 52.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.31 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.841 HD22 HD23 ' A' ' 64' ' ' LEU . 59.4 tp -119.08 129.05 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 111.763 -178.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.506 ' O ' HG12 ' A' ' 18' ' ' ILE . 52.5 m-85 -133.91 103.49 5.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.624 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.34 -66.82 2.24 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.655 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -164.18 21.02 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.993 0.425 . . . . 0.0 111.089 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.2 pt -121.42 127.28 75.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.176 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.853 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.5 mt -113.18 114.12 26.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.346 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 34' ' ' SER . 10.8 ttm180 -116.49 132.39 56.69 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.577 178.785 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.42 -173.56 26.0 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.052 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.622 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.7 m-20 -109.04 109.65 20.72 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.719 0.295 . . . . 0.0 110.384 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -106.79 132.54 52.64 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.267 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.9 mt -72.97 138.4 21.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.558 -178.157 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -102.94 -166.77 1.31 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.762 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.36 -28.41 69.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.907 0.384 . . . . 0.0 111.623 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.58 -26.89 68.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.649 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.83 -2.9 55.74 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.217 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -104.42 142.53 24.81 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.888 0.375 . . . . 0.0 110.707 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.622 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 31.5 Cg_endo -67.41 133.46 30.29 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.817 2.345 . . . . 0.0 112.158 178.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -115.74 139.0 50.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.528 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.24 119.83 16.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.012 0.435 . . . . 0.0 111.291 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -142.19 153.04 43.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.035 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.543 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 5.1 p -138.2 136.25 36.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.664 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.75 144.17 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.829 -179.195 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.426 ' ND2' ' CE2' ' A' ' 39' ' ' TYR . 63.3 t30 -103.62 87.51 2.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -57.78 -18.16 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.034 -178.184 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -52.95 -32.33 45.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.69 -178.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.426 ' CE2' ' ND2' ' A' ' 36' ' ' ASN . 63.7 m-85 -107.1 18.58 21.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.7 0.286 . . . . 0.0 111.307 -179.235 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -125.66 -30.1 3.09 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.68 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.5 mp -111.08 143.13 21.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.717 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -116.88 166.92 12.46 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.645 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -109.78 110.07 20.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.442 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -110.15 105.19 14.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.468 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.739 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 22.2 t30 54.48 41.53 31.9 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.897 178.449 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.43 4.77 89.17 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.083 179.404 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.84 151.63 33.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.025 0.441 . . . . 0.0 111.131 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 84' ' ' SER . 10.8 mp -84.03 127.94 34.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.753 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -120.18 138.89 53.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.536 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.753 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -40.47 -69.31 0.21 Allowed Pre-proline 0 CA--C 1.429 -3.692 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.197 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.753 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 8.1 Cg_endo -109.73 124.9 0.03 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.46 0 C-N-CA 114.054 -3.498 . . . . 0.0 113.551 -177.28 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.717 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.4 -161.79 11.8 Favored Glycine 0 C--N 1.281 -2.505 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.006 -177.581 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -153.04 143.75 22.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.758 0.328 . . . . 0.0 110.643 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.2 t 60.22 45.2 11.77 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.824 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.48 ' CE2' HD21 ' A' ' 70' ' ' LEU . 9.2 p90 -80.88 -37.43 29.8 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.732 -0.605 . . . . 0.0 110.069 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.74 -18.42 68.27 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.33 -178.085 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.3 m -68.9 -25.59 64.68 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.85 0.357 . . . . 0.0 110.929 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.7 p -123.76 0.6 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.375 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.5 m -107.77 151.78 25.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.058 0.456 . . . . 0.0 111.14 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' HD3' ' A' ' 61' ' ' LYS . 17.2 m -143.09 168.53 13.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.406 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.515 ' HD3' HG23 ' A' ' 60' ' ' VAL . 14.0 mptt 64.4 36.4 9.0 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.542 0.526 . . . . 0.0 110.751 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.4 p -63.97 132.03 49.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.087 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.17 162.17 41.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.801 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.841 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -123.04 112.91 18.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.773 0.321 . . . . 0.0 111.335 -179.401 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -82.35 123.27 28.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.266 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.763 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.6 t70 57.59 17.47 4.0 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.01 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.68 29.9 76.14 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.401 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.763 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 6.1 p80 -143.39 -30.41 0.5 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 117.458 0.629 . . . . 0.0 111.391 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.8 m -105.43 125.37 50.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.099 0.476 . . . . 0.0 111.615 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.696 ' HB2' HD11 ' A' ' 88' ' ' LEU . 14.0 tp -90.54 129.29 36.71 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.0 OUTLIER -122.65 129.01 51.37 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 179.987 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.87 169.38 21.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.27 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.541 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 14.6 t -119.25 121.02 38.72 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.72 155.86 26.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.657 0.741 . . . . 0.0 111.856 -179.537 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.47 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 10.7 tmtt? -101.04 148.25 25.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.371 178.239 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.33 -32.66 0.54 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.433 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.739 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -55.0 -43.42 73.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -173.5 56.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 110.661 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 71.55 -1.03 31.12 Favored Glycine 0 CA--C 1.516 0.147 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.783 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -119.01 168.54 10.71 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 42.8 p90 -110.27 161.38 15.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.119 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -153.01 135.17 14.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -61.87 134.4 56.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.966 -179.606 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.448 ' HB3' HD13 ' A' ' 48' ' ' LEU . 41.6 t -147.65 157.78 43.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.057 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.5 OUTLIER -131.63 162.13 31.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.363 . . . . 0.0 110.338 179.393 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.707 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 17.9 tpp -150.37 127.69 11.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.548 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.734 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 22.3 t0 -80.77 111.22 17.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.805 ' HA ' HG22 ' A' ' 91' ' ' VAL . 11.4 mt -81.33 -8.71 59.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.43 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -52.6 -26.09 12.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.888 179.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.734 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 25.5 p90 -116.66 19.05 14.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.772 0.32 . . . . 0.0 111.093 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.805 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -129.55 -12.41 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.232 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.7 t -131.26 147.12 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.379 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.607 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -138.47 172.89 22.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.907 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.437 HD22 ' HB2' ' A' ' 8' ' ' SER . 17.3 t30 -130.31 123.58 30.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.439 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.627 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 75.6 m -124.82 98.63 5.79 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.219 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 62.59 48.36 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.352 179.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.01 21.55 65.85 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.176 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -121.81 139.24 53.86 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.607 0.241 . . . . 0.0 110.379 -179.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 99' ' ' MET . 22.2 ptt? -59.28 117.27 4.6 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.589 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.627 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 4.5 mm-40 -142.76 71.83 19.74 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.059 0.457 . . . . 0.0 110.654 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 51.8 Cg_endo -69.26 114.16 3.53 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.908 2.405 . . . . 0.0 112.772 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.999 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.48 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 74.1 m . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.424 0.154 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 55.72 69.88 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 10.7 p90 -57.58 -39.51 76.93 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.324 0.583 . . . . 0.0 110.496 179.067 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.75 -22.34 61.95 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -177.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -72.01 -6.17 40.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.441 ' CB ' HD22 ' A' ' 94' ' ' ASN . 40.5 m -146.85 18.19 1.27 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.971 0.415 . . . . 0.0 110.399 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.5 m -127.31 133.39 50.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.786 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.9 p -136.13 154.59 50.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.11 57.38 10.76 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.649 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 31.5 m -93.24 138.2 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.297 0.57 . . . . 0.0 112.3 -178.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 43.2 mt-10 -126.67 144.26 50.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.825 179.073 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.74 HD22 HD23 ' A' ' 64' ' ' LEU . 12.2 tp -127.97 110.59 12.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.388 179.099 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' HG12 ' A' ' 18' ' ' ILE . 83.2 t80 -116.95 101.61 8.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.055 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.31 -65.7 2.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.97 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 6.2 p90 -162.57 18.99 0.09 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.173 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.2 pt -118.79 131.52 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.342 . . . . 0.0 110.614 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.866 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.45 113.81 26.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.087 -179.522 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 7.8 ttm180 -113.67 139.38 49.1 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.158 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.21 165.0 34.15 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.449 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 6.0 m-20 -97.07 102.56 14.37 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.013 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 8' ' ' SER . 60.0 m -105.95 132.78 51.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mt -69.55 132.18 33.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.018 0.437 . . . . 0.0 111.184 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -103.57 -170.9 1.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.955 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.63 -28.92 61.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 111.712 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.24 -25.54 68.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.869 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.61 -1.02 63.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.629 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -110.03 142.88 26.83 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.632 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 25.9 Cg_endo -63.36 122.3 10.42 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.062 2.508 . . . . 0.0 112.326 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -107.63 132.53 53.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.24 117.25 15.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.142 0.496 . . . . 0.0 111.469 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -133.52 160.85 36.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.286 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 64.5 p -136.43 147.49 47.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.22 142.7 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -100.94 88.5 3.56 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -54.36 -29.37 48.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.705 -178.342 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 24.5 t-20 -52.87 -35.8 58.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.82 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -100.9 12.47 37.56 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.792 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.636 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.7 m-85 -126.02 -23.55 3.91 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -114.26 141.56 30.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.643 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.5 169.14 12.76 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.153 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -117.42 110.49 18.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 111.305 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.57 108.82 18.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.725 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 47.75 48.34 17.48 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.256 1.022 . . . . 0.0 112.791 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.16 15.04 81.61 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.711 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.64 149.65 46.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.042 0.448 . . . . 0.0 111.591 -179.362 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 10.0 mp -81.1 123.44 28.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.984 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 43.1 tp10 -114.99 131.97 56.75 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.713 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.35 -70.62 0.13 Allowed Pre-proline 0 CA--C 1.426 -3.816 0 CA-C-O 118.142 -0.932 . . . . 0.0 113.48 -179.213 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.713 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 10.2 Cg_endo -109.43 127.04 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.284 0 C-N-CA 113.724 -3.717 . . . . 0.0 113.399 -177.855 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.643 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -158.93 -160.64 10.5 Favored Glycine 0 C--N 1.281 -2.485 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.78 -177.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -153.42 138.82 17.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.831 0.371 . . . . 0.0 111.041 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 m 59.44 42.7 17.42 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 178.159 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -72.43 -36.18 68.51 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.56 -17.89 54.76 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.031 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -71.6 -12.94 61.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.295 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 p -144.73 13.59 1.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 111.149 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.4 m -125.87 149.51 48.62 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.019 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.433 HG23 ' HD3' ' A' ' 61' ' ' LYS . 18.0 m -140.79 174.3 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.176 179.06 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.7 mptt 64.31 39.72 7.06 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.402 0.439 . . . . 0.0 111.32 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -68.32 120.81 15.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.391 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.43 162.33 39.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -118.68 112.86 20.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.681 -178.893 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.604 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 13.4 m120 -76.7 118.33 19.22 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.989 179.208 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.749 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.3 t70 54.66 19.64 2.57 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.869 0.731 . . . . 0.0 111.632 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.87 30.69 78.66 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.531 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.749 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 5.2 p80 -142.09 -26.04 0.66 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 117.538 0.669 . . . . 0.0 111.803 179.184 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 22.2 m -116.5 128.4 55.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.642 0.258 . . . . 0.0 111.489 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.53 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.7 tp -93.26 129.58 39.27 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.01 130.23 54.63 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.764 0.316 . . . . 0.0 110.512 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.58 156.75 30.68 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.515 178.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.566 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 9.5 t -106.34 125.55 51.14 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 22.9 m -122.7 150.99 41.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.231 0.539 . . . . 0.0 112.408 -178.316 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 11.0 tmtt? -100.14 148.92 24.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.138 177.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.47 -14.01 1.82 Allowed Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.098 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.12 -38.05 78.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.576 0.227 . . . . 0.0 110.986 179.385 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -175.81 54.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.255 0.55 . . . . 0.0 110.336 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.443 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 73.63 -7.38 13.68 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.402 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -117.84 168.99 9.98 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.566 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 53.4 p90 -111.03 162.34 14.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -148.89 149.32 31.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.08 141.98 47.57 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.406 ' HB3' HD13 ' A' ' 48' ' ' LEU . 41.8 t -151.08 157.07 42.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.013 0.435 . . . . 0.0 110.235 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.22 164.18 26.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.842 179.353 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.676 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.6 tpt -150.02 121.45 7.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.862 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -75.75 106.11 7.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.367 0.603 . . . . 0.0 109.405 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.747 ' HA ' HG22 ' A' ' 91' ' ' VAL . 19.6 mt -72.74 -8.36 55.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.01 -179.253 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.89 -31.39 5.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.549 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -116.85 23.31 12.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.738 0.304 . . . . 0.0 111.23 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.747 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -130.48 -12.22 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.143 178.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.846 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.2 t -136.83 142.83 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.435 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -137.88 162.64 25.58 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.441 HD22 ' CB ' ' A' ' 8' ' ' SER . 34.3 t30 -108.31 113.66 26.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.059 0.457 . . . . 0.0 110.489 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.529 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 70.9 m -116.74 82.88 1.87 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.417 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 62.99 55.99 1.89 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.171 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.36 27.28 57.85 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.77 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.1 141.01 51.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.025 0.44 . . . . 0.0 110.674 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.407 ' O ' ' HG3' ' A' ' 99' ' ' MET . 18.3 ptm -61.04 97.29 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.472 179.055 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 11.5 mm-40 -129.06 78.17 76.67 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.136 0.493 . . . . 0.0 111.007 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.846 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 61.0 Cg_endo -75.22 96.02 1.01 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.47 2.113 . . . . 0.0 112.26 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.316 -0.891 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.927 179.833 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.545 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 75.1 m . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.54 ' HB3' ' CG ' ' A' ' 7' ' ' ASN . 16.4 m-20 53.26 66.56 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.539 0.524 . . . . 0.0 112.071 177.89 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 11.3 p90 -61.79 -39.3 91.24 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 111.053 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.66 -22.61 61.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.505 -178.15 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.54 ' CG ' ' HB3' ' A' ' 4' ' ' ASN . 4.1 m-20 -71.68 -7.07 45.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.969 0.414 . . . . 0.0 111.32 -178.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 31.2 m -138.49 15.44 2.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.178 179.249 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -127.2 140.65 52.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.147 -179.625 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 p -136.27 148.53 48.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.571 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.69 47.82 46.49 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.383 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.554 HG12 ' HA3' ' A' ' 21' ' ' GLY . 24.4 m -89.69 143.63 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.996 0.427 . . . . 0.0 111.252 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 6.3 tp10 -141.61 146.16 35.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.097 179.308 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.742 HD22 HD23 ' A' ' 64' ' ' LEU . 49.9 tp -126.76 123.32 37.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 111.403 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.0 t80 -132.82 112.74 12.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.714 178.394 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.88 -68.24 2.27 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.677 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.0 p90 -166.0 18.7 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 122.594 0.357 . . . . 0.0 111.114 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 15' ' ' TYR . 41.6 pt -119.65 125.12 74.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.051 0.453 . . . . 0.0 110.891 -178.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.845 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -111.06 115.15 28.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.704 179.627 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.6 ttm180 -116.24 136.47 52.98 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.554 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -161.46 169.73 37.04 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.92 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.4 m-20 -101.39 110.86 22.94 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.3 m -105.72 132.78 51.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 57.9 mt -68.65 136.53 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.438 -178.743 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -102.28 -175.18 2.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -55.42 -27.8 50.19 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.881 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.33 -23.44 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 0.0 111.768 -179.459 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.79 5.21 57.67 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.357 -179.079 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -111.65 142.52 26.76 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.286 -0.457 . . . . 0.0 109.87 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 56.1 Cg_endo -71.94 133.77 22.28 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.833 2.355 . . . . 0.0 112.536 179.547 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -119.97 131.55 55.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.695 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.82 126.35 28.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.145 0.498 . . . . 0.0 111.643 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 t -140.43 156.59 46.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.645 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -130.54 148.75 52.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.47 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.81 146.75 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.818 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.419 ' OD1' HG22 ' A' ' 18' ' ' ILE . 85.3 m-20 -105.43 96.17 6.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.23 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.845 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -63.07 -25.96 68.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.048 -178.216 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.539 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.0 t-20 -56.31 -27.51 55.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.03 -179.096 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -107.56 11.63 28.48 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.646 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 47.2 m-85 -128.02 -23.21 3.36 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.528 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -111.52 140.81 29.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.69 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.83 163.34 12.22 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.268 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -112.43 106.62 15.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.183 -0.508 . . . . 0.0 110.176 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -111.51 107.17 16.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.373 -179.401 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 57.86 42.13 23.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.306 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 74.47 17.49 79.83 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.849 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.76 143.04 51.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.036 0.446 . . . . 0.0 111.385 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.565 HD13 ' HG ' ' A' ' 70' ' ' LEU . 33.6 mt -73.16 124.02 24.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.618 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -117.21 137.15 52.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.798 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.1 -71.46 0.11 Allowed Pre-proline 0 CA--C 1.429 -3.687 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.798 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 11.6 Cg_endo -111.45 126.78 0.03 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.366 0 C-N-CA 114.09 -3.473 . . . . 0.0 113.12 -177.573 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.69 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -159.89 -162.07 11.92 Favored Glycine 0 C--N 1.28 -2.547 0 CA-C-N 113.833 -1.531 . . . . 0.0 113.345 -177.724 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -152.76 142.16 21.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.531 -0.334 . . . . 0.0 111.015 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 m 55.32 43.16 29.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.539 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 17.7 p90 -70.24 -34.82 73.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.732 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.13 -18.38 27.29 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.545 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.1 t -52.7 -47.29 67.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.791 0.329 . . . . 0.0 110.544 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 42.8 m -119.7 12.39 12.2 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.0 m -111.14 137.47 48.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 111.903 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.8 m -136.67 175.56 9.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.393 178.765 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 60.82 43.19 12.31 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.915 0.388 . . . . 0.0 111.038 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 p -67.77 130.09 41.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.208 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.65 163.33 39.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.434 179.768 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.742 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -122.56 113.02 18.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.948 0.404 . . . . 0.0 111.642 -179.55 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -83.68 122.08 28.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.618 179.195 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.786 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 30.2 t70 58.01 16.95 4.06 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.93 0.769 . . . . 0.0 111.347 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.62 29.32 74.89 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.464 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.786 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 5.9 p80 -143.51 -28.22 0.54 Allowed 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 117.243 0.521 . . . . 0.0 111.471 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -110.51 129.65 55.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.802 0.334 . . . . 0.0 111.769 -179.077 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.565 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.4 tp -90.04 129.53 36.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.041 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.16 130.38 53.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.538 179.102 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.35 168.02 27.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.825 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.443 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 9.1 t -113.95 123.39 49.63 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.463 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 14.2 m -126.13 147.61 49.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -177.563 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.0 tmtt? -99.96 144.65 28.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.471 177.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.95 -26.31 0.63 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.684 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.75 80.31 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -171.58 52.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.318 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.83 2.2 50.41 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.431 -179.405 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -122.34 158.11 30.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.8 p90 -98.82 162.79 12.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.434 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -158.45 144.47 16.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -73.65 142.38 46.46 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.52 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.468 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 31.5 p -152.36 172.97 15.65 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.927 179.27 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -143.78 156.05 44.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.137 0.494 . . . . 0.0 111.016 -179.924 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.633 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 13.3 tpp -142.17 121.35 13.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.742 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.619 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 22.9 t0 -74.66 106.27 6.15 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.1 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.78 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.8 mt -78.82 -9.11 59.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.549 -178.808 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -52.26 -26.57 12.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.07 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.619 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 39.7 p90 -115.9 17.79 15.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.176 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.78 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -125.31 -11.69 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.985 0.422 . . . . 0.0 110.49 178.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.938 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.6 t -134.04 144.57 35.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.203 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.545 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -138.05 174.66 21.79 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.071 179.126 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.4 HD22 ' CB ' ' A' ' 8' ' ' SER . 27.3 t30 -122.98 134.54 54.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.834 0.35 . . . . 0.0 110.478 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.63 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 5.4 t -145.35 104.59 3.94 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.245 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 61.69 44.27 9.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.085 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.26 34.53 67.66 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.542 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -131.43 142.95 50.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.547 ' HG3' ' O ' ' A' ' 99' ' ' MET . 14.7 ptt? -59.34 114.9 2.89 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.764 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.63 ' HG3' ' HB3' ' A' ' 95' ' ' SER . 6.2 mm-40 -135.23 73.14 65.0 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.197 178.841 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.938 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 46.4 Cg_endo -70.38 96.06 0.63 Allowed 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.471 2.114 . . . . 0.0 112.56 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.316 -0.875 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.055 179.692 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.612 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 59.5 m . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.856 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 70.5 m-20 59.73 67.15 0.91 Allowed 'General case' 0 N--CA 1.462 0.148 0 O-C-N 123.145 0.278 . . . . 0.0 111.738 177.892 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.6 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 12.0 p90 -59.57 -42.75 93.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.296 0.569 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.74 -21.18 63.48 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.377 -178.448 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.856 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 65.9 t30 -60.33 -24.06 64.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.366 -178.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB2' HD22 ' A' ' 94' ' ' ASN . 41.0 m -136.92 25.5 3.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.459 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -125.64 134.88 51.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.823 179.634 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.1 p -131.41 158.71 40.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.739 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.89 61.37 7.26 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.588 179.054 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 27.8 m -95.65 149.96 4.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.081 0.467 . . . . 0.0 111.328 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -138.67 140.16 38.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.031 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.922 HD22 HD23 ' A' ' 64' ' ' LEU . 40.2 tp -126.41 122.68 36.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 110.993 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.552 ' O ' HG12 ' A' ' 18' ' ' ILE . 92.2 m-85 -130.09 106.3 8.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.334 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.74 -66.98 2.35 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.495 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -165.58 22.65 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.621 0.369 . . . . 0.0 111.209 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 15' ' ' TYR . 34.0 pt -119.86 127.48 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 110.263 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.767 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.3 mt -112.78 119.87 39.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.415 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 1.4 ttt180 -120.32 138.01 53.94 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.36 175.16 40.45 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.517 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 23.4 m-20 -101.61 107.07 18.22 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 m -105.28 132.63 51.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mt -67.45 134.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.019 0.438 . . . . 0.0 111.511 -178.568 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -103.26 -171.44 1.94 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.45 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -51.32 -41.34 60.48 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.469 0.481 . . . . 0.0 111.846 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -59.79 -27.53 66.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.496 -179.279 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.75 -0.3 52.38 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.444 -178.545 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -105.51 138.44 19.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.554 0.693 . . . . 0.0 110.948 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 28.7 Cg_endo -60.76 121.25 9.41 Favored 'Trans proline' 0 C--N 1.329 -0.475 0 C-N-CA 124.207 3.271 . . . . 0.0 112.027 178.711 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -111.92 126.79 55.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.941 -179.867 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.32 126.94 29.77 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.008 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 t -142.93 160.16 40.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.373 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.1 p -133.35 148.17 51.85 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.765 0.316 . . . . 0.0 110.601 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -133.69 143.95 37.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 39' ' ' TYR . 63.2 t30 -103.2 96.29 6.68 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.347 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -59.5 -22.17 61.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.919 -178.567 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -55.08 -31.53 61.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.768 -179.31 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.433 ' CE2' ' ND2' ' A' ' 36' ' ' ASN . 74.8 m-85 -102.92 8.92 39.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.736 -179.484 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 43.8 m-85 -126.37 -22.63 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.576 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -114.1 139.13 41.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.122 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.633 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -112.32 170.06 13.36 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.718 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -115.33 107.44 15.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.901 0.381 . . . . 0.0 110.619 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -106.99 106.22 16.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.071 179.627 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 50.65 42.22 26.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.196 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 74' ' ' CYS . . . 82.47 15.13 74.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.512 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.93 145.79 48.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.226 0.536 . . . . 0.0 111.011 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.522 HD13 ' HG ' ' A' ' 70' ' ' LEU . 23.7 mt -74.98 116.32 15.59 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.47 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.8 tt0 -107.53 132.31 53.39 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.868 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -39.0 -66.22 0.34 Allowed Pre-proline 0 CA--C 1.431 -3.634 0 CA-C-O 117.385 -1.293 . . . . 0.0 114.408 -179.195 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.868 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 5.6 Cg_endo -112.67 119.47 0.02 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.219 0 C-N-CA 113.552 -3.832 . . . . 0.0 113.361 -178.296 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.633 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -154.75 -163.9 12.44 Favored Glycine 0 C--N 1.275 -2.82 0 CA-C-N 113.754 -1.566 . . . . 0.0 113.745 -177.402 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -153.14 142.02 21.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.6 45.53 16.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.586 177.612 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -75.66 -38.96 58.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.916 0.389 . . . . 0.0 110.408 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.04 -18.55 41.41 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.747 -178.196 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.0 m -59.74 -19.57 50.98 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.814 0.446 . . . . 0.0 111.602 179.378 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.0 m -144.49 26.04 1.47 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.668 179.496 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.6 m -127.69 144.65 51.06 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.23 0.538 . . . . 0.0 111.624 -179.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -136.82 172.8 14.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.474 179.038 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mptt 62.83 37.88 11.95 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.377 0.423 . . . . 0.0 111.192 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.2 p -68.81 122.26 18.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.152 0.501 . . . . 0.0 111.278 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.12 154.64 35.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.866 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.922 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -109.65 116.84 32.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.918 -179.344 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -84.05 118.86 24.34 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.2 t70 65.61 -1.92 0.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 124.199 0.937 . . . . 0.0 111.729 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.21 29.22 34.32 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.029 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -143.32 -29.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.056 0.428 . . . . 0.0 110.889 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.43 ' O ' HD13 ' A' ' 64' ' ' LEU . 15.9 m -113.39 130.28 56.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.354 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.547 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.9 tp -91.14 130.4 37.04 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.808 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.22 129.82 53.38 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.876 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.95 162.91 32.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.092 0.473 . . . . 0.0 110.868 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.444 ' HG ' ' HD2' ' A' ' 81' ' ' TYR . 12.7 t -111.02 122.57 48.23 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.7 m -122.77 149.0 44.7 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.532 0.682 . . . . 0.0 112.469 -177.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 10.2 tmtt? -99.17 142.34 30.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.229 178.152 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.13 -24.46 0.39 Allowed Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.661 179.4 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.59 88.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.872 0.368 . . . . 0.0 111.83 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -173.59 55.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.289 0.566 . . . . 0.0 109.5 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.4 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 69.32 -1.42 12.82 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.0 -179.097 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 24.9 pt20 -113.72 166.11 11.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.381 -178.882 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.4 p90 -106.2 168.84 8.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.239 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.88 133.19 5.28 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.51 123.17 23.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.93 0.395 . . . . 0.0 110.346 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 p -135.25 173.82 11.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.172 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.28 155.29 46.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.405 0.621 . . . . 0.0 111.241 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.5 tpp -141.22 115.39 9.3 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.472 179.056 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -72.2 108.05 5.16 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.497 0.665 . . . . 0.0 109.449 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.804 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.1 mt -77.64 -8.83 58.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.957 -178.19 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -51.14 -26.48 6.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.083 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -116.72 13.83 15.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.18 179.553 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.804 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -122.37 -8.76 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.201 0.524 . . . . 0.0 111.109 179.175 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.4 t -133.53 137.45 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.612 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -126.59 161.61 20.87 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.281 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.441 HD22 ' HB2' ' A' ' 8' ' ' SER . 14.3 t30 -114.49 129.64 56.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.876 0.37 . . . . 0.0 110.432 179.754 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.602 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 73.2 m -143.83 113.11 6.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.939 178.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 56.32 36.89 28.25 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 123.39 0.431 . . . . 0.0 111.196 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.75 22.06 63.78 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.791 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -118.85 145.98 45.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.804 0.335 . . . . 0.0 110.323 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 99' ' ' MET . 16.0 ptm -58.59 110.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.794 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 8.7 mm-40 -135.15 74.79 61.52 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.042 0.448 . . . . 0.0 110.654 178.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.2 Cg_endo -70.95 150.44 60.95 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.729 2.286 . . . . 0.0 112.592 -179.632 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 27.3 p . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.83 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 2.2 m-20 52.64 76.17 0.2 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.569 0.543 . . . . 0.0 111.525 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 68' ' ' HIS . 13.1 p90 -57.98 -44.28 87.05 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.149 0.499 . . . . 0.0 110.17 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.22 -21.34 65.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.587 -179.026 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.62 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 18.8 t-20 -57.72 -29.54 64.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.494 -178.631 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.488 ' HB2' HD22 ' A' ' 94' ' ' ASN . 13.5 m -132.94 17.46 4.18 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.62 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 80.9 m -117.96 133.49 55.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.777 0.322 . . . . 0.0 110.577 -179.255 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -130.59 149.28 52.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.749 -179.26 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.88 45.3 92.92 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.607 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.519 HG12 ' HA3' ' A' ' 21' ' ' GLY . 17.4 m -88.22 135.31 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.093 0.473 . . . . 0.0 111.353 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -129.45 156.41 44.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.169 -179.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.567 HD22 HD23 ' A' ' 64' ' ' LEU . 19.4 tp -130.03 125.01 34.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.976 0.417 . . . . 0.0 112.108 -178.737 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -126.32 99.18 5.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.12 178.58 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' HG21 ' A' ' 62' ' ' THR . . . 77.45 -62.43 3.46 Favored Glycine 0 C--O 1.226 -0.368 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.857 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.46 25.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.29 0.566 . . . . 0.0 110.141 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 12.8 mt -119.52 115.55 47.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.708 -179.169 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.832 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -103.8 113.62 27.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.201 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 4.5 ttm180 -122.73 142.83 50.27 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.732 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -170.19 179.54 42.35 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.165 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 11.7 m-20 -102.71 108.31 19.51 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 62.1 m -106.23 131.8 53.04 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.7 mt -75.37 136.29 25.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.33 0.586 . . . . 0.0 111.694 -177.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -102.97 -173.47 2.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.389 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -54.77 -36.55 64.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.932 0.396 . . . . 0.0 111.662 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' OD2' ' HB3' ' A' ' 29' ' ' HIS . 28.3 t70 -59.21 -27.56 65.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.73 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.04 1.33 57.13 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.845 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.42 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -106.19 140.1 20.94 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 121.302 0.572 . . . . 0.0 111.086 -179.994 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 30.2 Cg_endo -64.09 122.08 9.96 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 123.557 2.838 . . . . 0.0 112.454 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -105.3 130.02 53.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.51 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.65 115.69 12.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 t -136.73 156.88 47.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.063 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.428 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 35.3 p -140.06 142.75 36.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.732 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.12 144.91 35.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.864 0.364 . . . . 0.0 110.578 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -100.7 99.73 10.32 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.678 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -62.89 -22.23 66.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.76 -178.548 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.87 -32.81 64.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.09 -178.859 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -103.99 13.76 32.01 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.641 -178.291 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.569 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.7 m-85 -131.13 -17.27 3.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.609 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 37' ' ' LEU . 1.9 mp -118.6 142.05 35.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.564 0.221 . . . . 0.0 110.555 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.689 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -120.06 165.04 13.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.319 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -117.69 112.01 19.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.57 0.7 . . . . 0.0 110.634 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -110.9 114.61 28.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.264 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.802 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 44.0 t30 59.52 33.82 22.29 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.148 0.499 . . . . 0.0 110.976 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.82 9.58 86.15 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.013 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -115.42 154.88 28.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.66 0.267 . . . . 0.0 110.707 179.951 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.425 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 30.9 mt -82.59 122.41 28.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.244 -179.303 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 4.1 tp10 -111.31 137.35 49.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.217 179.069 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.655 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.87 -70.15 0.18 Allowed Pre-proline 0 CA--C 1.424 -3.889 0 CA-C-O 118.441 -0.79 . . . . 0.0 113.027 -179.272 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.655 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 5.6 Cg_endo -110.45 131.21 0.04 OUTLIER 'Trans proline' 1 N--CA 1.34 -7.519 0 C-N-CA 113.911 -3.593 . . . . 0.0 112.973 -177.619 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.689 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.48 -159.16 9.25 Favored Glycine 0 C--N 1.283 -2.385 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.87 -177.687 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -152.43 137.16 16.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.261 -0.469 . . . . 0.0 111.311 -178.703 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 t 48.58 45.01 21.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.037 177.847 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -65.75 -36.54 83.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.161 0.505 . . . . 0.0 109.671 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.76 -18.8 33.41 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.281 -179.143 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 t -62.68 -28.65 70.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.0 110.34 179.636 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.2 m -136.32 28.83 3.06 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.868 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.2 m -133.73 139.69 46.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 179.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 m -135.17 175.07 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.36 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 63.43 40.09 8.67 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.435 0.459 . . . . 0.0 111.648 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 16' ' ' GLY . 17.1 p -66.65 126.45 28.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.995 179.728 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.99 162.64 40.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.922 179.204 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.567 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -120.94 113.65 20.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.867 0.365 . . . . 0.0 111.06 -179.616 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 15.4 m120 -75.51 116.53 16.32 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.654 179.558 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.664 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.6 t70 55.29 15.35 1.32 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.901 0.75 . . . . 0.0 111.475 178.829 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.99 37.98 74.1 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.515 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.664 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 9.8 p80 -147.01 -30.73 0.34 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 117.396 0.598 . . . . 0.0 111.479 178.914 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 6.6 m -116.23 133.21 56.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.631 0.253 . . . . 0.0 111.403 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.564 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.7 tp -91.31 131.42 36.82 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.612 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.42 130.39 55.94 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.747 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.95 163.73 31.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.113 0.483 . . . . 0.0 110.817 179.277 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.465 ' HG ' ' HD2' ' A' ' 81' ' ' TYR . 20.1 t -112.94 123.67 50.85 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.1 m -123.51 154.94 38.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.15 0.5 . . . . 0.0 112.031 -178.725 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.462 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 9.2 tmtt? -99.81 150.08 22.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.072 178.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.13 -29.95 0.89 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.98 178.732 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.802 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.02 -38.56 70.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -175.22 52.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.252 0.549 . . . . 0.0 109.983 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.462 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 68.92 6.36 51.71 Favored Glycine 0 C--N 1.329 0.146 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.65 -179.108 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -123.97 170.52 10.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.465 ' HD2' ' HG ' ' A' ' 73' ' ' SER . 55.1 p90 -110.84 164.74 12.47 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 123.448 0.467 . . . . 0.0 110.815 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -155.34 150.03 26.37 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.07 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -81.02 141.23 34.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.849 0.357 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.3 p -153.01 167.52 28.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.963 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.17 162.83 30.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.962 0.41 . . . . 0.0 110.445 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.765 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.4 tpt -145.99 112.98 6.09 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.97 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.431 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 32.6 t0 -71.78 106.86 4.3 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.978 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.75 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.1 mt -77.81 -8.62 58.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.265 -178.953 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -49.45 -29.62 6.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.244 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 43.9 p90 -116.68 20.26 14.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.49 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.75 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -125.94 -12.88 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.234 0.54 . . . . 0.0 110.031 177.9 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.831 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -134.5 147.39 29.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.157 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.23 171.9 23.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.005 -0.616 . . . . 0.0 111.678 179.096 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.488 HD22 ' HB2' ' A' ' 8' ' ' SER . 37.0 t30 -117.1 129.42 55.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.84 0.352 . . . . 0.0 110.849 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.564 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 70.7 m -134.42 100.31 4.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.436 178.997 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 61.0 44.46 10.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.558 179.414 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.57 29.73 70.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.167 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -128.9 148.21 50.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.693 0.282 . . . . 0.0 110.302 -179.078 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.48 ' HG3' ' O ' ' A' ' 99' ' ' MET . 21.5 ptt? -62.63 119.61 9.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.167 -179.52 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 20.6 mm-40 -143.46 79.06 14.2 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.541 178.207 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.831 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 42.9 Cg_endo -69.95 93.34 0.54 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.766 2.31 . . . . 0.0 113.174 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.501 178.988 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.55 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 95.8 m . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 53.68 78.18 0.16 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.562 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 4.4 p90 -56.91 -36.63 70.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.987 0.422 . . . . 0.0 111.506 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.01 -21.77 66.41 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.292 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -61.6 -18.35 59.01 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.481 ' HB2' HD22 ' A' ' 94' ' ' ASN . 69.7 m -145.21 29.55 1.17 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.696 0.284 . . . . 0.0 110.699 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -128.78 133.01 47.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.023 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -129.51 158.21 39.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.373 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.81 58.48 14.35 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.747 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.585 HG12 ' HA3' ' A' ' 21' ' ' GLY . 19.7 m -101.07 139.61 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.992 0.425 . . . . 0.0 111.546 -179.317 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -137.03 155.64 49.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.263 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.623 HD22 HD23 ' A' ' 64' ' ' LEU . 27.0 tp -127.78 123.66 35.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.428 . . . . 0.0 111.706 -179.29 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.44 ' O ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-85 -124.64 99.49 6.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.579 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.46 -63.18 2.63 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.167 -0.54 . . . . 0.0 113.077 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 3.9 p90 -165.27 21.93 0.05 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.0 pt -121.76 126.94 75.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.569 179.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.832 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -107.82 114.64 28.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.652 -179.922 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.2 ttt180 -118.13 141.24 48.7 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.641 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.585 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.99 177.6 42.14 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.796 179.405 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 16.1 m-20 -101.62 107.98 19.4 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -106.09 132.84 51.68 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.7 mt -69.15 139.89 19.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.472 -178.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 96' ' ' TYR . 6.0 p30 -110.14 -173.1 2.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.632 179.534 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.85 -27.98 54.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.92 -20.35 65.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.497 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.77 4.5 69.7 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.913 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -112.72 144.62 31.35 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.791 0.329 . . . . 0.0 110.175 179.616 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.667 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 38.5 Cg_endo -68.21 123.68 10.86 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.021 2.48 . . . . 0.0 113.002 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -115.27 132.16 56.7 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.7 127.2 31.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.39 0.614 . . . . 0.0 112.142 -178.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 t -136.05 155.2 50.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.612 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 78.0 p -138.45 132.08 30.77 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.527 -179.424 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.85 143.96 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 O-C-N 123.517 0.511 . . . . 0.0 110.328 -179.669 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -99.37 92.19 5.29 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.53 -27.09 56.65 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.63 -178.376 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.2 t-20 -53.98 -30.66 48.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.967 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -103.15 10.39 37.89 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.613 -178.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.1 m-85 -129.35 -21.09 3.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.534 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -113.84 141.34 30.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.642 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -113.58 170.91 13.54 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.629 -179.507 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -114.76 104.42 11.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.027 -0.587 . . . . 0.0 109.753 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -111.24 106.16 15.06 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.786 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 24.6 t30 59.2 40.06 22.07 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.121 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.82 17.09 80.25 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.559 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.58 149.82 46.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 -179.511 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.422 HD13 ' HG ' ' A' ' 70' ' ' LEU . 28.9 mt -74.99 124.24 26.6 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.352 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -112.01 139.22 47.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.052 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.598 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -43.52 -75.51 0.05 OUTLIER Pre-proline 0 CA--C 1.433 -3.536 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.497 179.949 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 2.5 Cg_endo -108.45 127.89 0.04 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.242 1 C-N-CA 113.196 -4.069 . . . . 0.0 112.779 -178.662 . . . . . . . . 4 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.642 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -155.16 -159.42 9.29 Favored Glycine 0 C--N 1.281 -2.514 0 CA-C-N 113.74 -1.573 . . . . 0.0 113.417 -177.629 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -151.23 147.32 26.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.917 0.389 . . . . 0.0 111.068 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.6 p 46.42 44.95 13.42 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 177.877 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -71.79 -38.8 70.22 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.7 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.21 -18.52 55.36 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.288 -178.427 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -65.26 -19.28 65.89 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.736 0.414 . . . . 0.0 110.896 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.4 m -142.16 20.76 2.09 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.006 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.5 m -126.75 144.09 51.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.601 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.491 HG23 ' HD2' ' A' ' 61' ' ' LYS . 23.2 m -136.78 173.62 13.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.734 179.315 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HD2' HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER 63.68 41.15 7.29 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.486 0.491 . . . . 0.0 110.829 179.405 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.5 HG21 ' O ' ' A' ' 16' ' ' GLY . 11.5 p -69.22 130.49 42.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.612 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.65 162.85 40.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.807 179.058 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.623 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -121.61 112.55 18.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.596 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -85.47 122.04 29.04 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.216 -179.263 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.09 24.04 10.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.686 178.81 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.81 39.8 69.28 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.524 -0.762 . . . . 0.0 114.074 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.465 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 4.7 p80 -153.26 -28.53 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.272 0.536 . . . . 0.0 111.537 179.609 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 m -115.93 131.43 56.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.797 0.332 . . . . 0.0 111.461 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.605 ' HA ' HD22 ' A' ' 64' ' ' LEU . 12.7 tp -90.2 134.53 34.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 178.819 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.65 130.76 53.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.614 178.9 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.05 160.85 22.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.098 0.475 . . . . 0.0 111.464 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 13.1 t -106.62 125.06 50.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.891 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 48.5 m -125.5 149.16 48.52 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -99.25 143.3 29.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.585 178.139 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.58 -31.09 0.52 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.621 178.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.729 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -47.51 -45.42 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 179.128 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -171.89 49.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.466 0.65 . . . . 0.0 109.606 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.32 2.4 79.11 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.009 -179.036 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -121.91 160.35 24.97 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 51.3 p90 -101.02 160.43 14.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 -179.192 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -153.79 141.25 19.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 36.4 t70 -82.1 132.98 35.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.89 0.376 . . . . 0.0 110.693 -179.056 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.419 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 26.0 p -143.34 179.51 7.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.432 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.28 161.43 37.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.814 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.597 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 14.2 tpp -145.02 125.39 13.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.564 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 28.2 t70 -79.35 106.59 11.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.986 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.732 ' HA ' HG22 ' A' ' 91' ' ' VAL . 17.0 mt -76.61 -10.02 59.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.323 -177.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.564 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 5.9 m120 -48.51 -33.83 10.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.99 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 46.7 p90 -113.74 20.97 15.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.897 0.379 . . . . 0.0 111.326 -179.166 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.732 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -126.58 -8.66 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.549 178.575 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 1.019 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 8.9 p -153.22 138.35 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.097 0.475 . . . . 0.0 111.409 179.298 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.55 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -131.16 172.22 20.78 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.877 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.481 HD22 ' HB2' ' A' ' 8' ' ' SER . 18.4 t30 -113.74 116.76 29.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.33 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.547 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 58.7 m -111.65 78.53 1.13 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.829 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 25' ' ' ASN . 43.1 m-85 66.28 60.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.581 178.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.78 23.0 60.54 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.774 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -126.98 132.02 50.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.907 0.384 . . . . 0.0 110.593 -178.745 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.491 ' HG3' ' O ' ' A' ' 99' ' ' MET . 16.8 ptt? -64.28 117.36 7.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.742 179.415 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 4.6 mt-10 -142.26 81.59 13.89 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 121.314 0.578 . . . . 0.0 109.889 177.711 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 1.019 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 58.4 Cg_endo -71.47 125.83 11.62 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.864 2.376 . . . . 0.0 112.023 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 32.0 p . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.767 -179.18 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.477 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 72.1 m . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 119.964 -0.065 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.855 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 39.2 m-20 52.32 76.96 0.17 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.839 0.352 . . . . 0.0 111.747 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.556 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 15.4 p90 -60.31 -41.96 94.55 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.019 0.438 . . . . 0.0 110.873 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.94 -23.91 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.99 -178.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.855 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 62.7 t30 -60.46 -29.73 69.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.168 -179.123 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 8.3 m -123.36 16.4 9.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 -179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -124.33 146.28 48.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.368 0.604 . . . . 0.0 112.029 -179.301 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.7 p -140.33 152.77 46.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.005 179.324 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.86 33.15 70.38 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.574 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 18.2 m -79.89 133.38 29.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.012 0.434 . . . . 0.0 111.655 -179.471 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.442 ' O ' HD23 ' A' ' 19' ' ' LEU . 10.7 pt-20 -132.19 150.16 52.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.007 179.021 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.785 HD22 HD23 ' A' ' 64' ' ' LEU . 32.7 tp -122.01 120.71 35.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.2 0.524 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 18' ' ' ILE . 73.0 t80 -125.1 101.02 6.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.956 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.01 -68.44 3.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.811 179.248 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -162.26 17.79 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.654 0.264 . . . . 0.0 111.294 -179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 15' ' ' TYR . 29.9 pt -121.6 131.29 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.966 0.412 . . . . 0.0 110.51 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.723 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -113.78 114.72 26.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.115 -179.632 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.2 ttt180 -118.12 141.68 48.23 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.734 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.28 -176.44 38.12 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.878 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 8.8 m-20 -108.8 111.11 22.67 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.673 0.273 . . . . 0.0 110.907 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.3 m -106.28 133.18 51.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.8 mt -68.83 134.3 30.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.828 0.347 . . . . 0.0 110.704 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -105.5 -172.68 2.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.02 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -57.24 -25.31 58.92 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.16 -20.65 65.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.068 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.43 1.69 74.46 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.88 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -112.19 144.48 30.88 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.633 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 29.1 Cg_endo -65.0 123.77 12.09 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.744 2.296 . . . . 0.0 112.445 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -109.17 130.19 55.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.671 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.24 122.89 21.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.972 0.415 . . . . 0.0 111.613 -179.365 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.6 t -142.57 164.03 31.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.446 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 12.2 p -138.69 149.67 45.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.024 0.44 . . . . 0.0 111.288 -179.222 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.87 142.65 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.723 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -103.37 92.0 4.3 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.723 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.95 -29.41 63.15 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.669 -178.288 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -52.21 -33.88 43.12 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.875 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -102.05 16.32 26.39 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.839 -178.746 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.4 m-85 -130.86 -26.47 2.19 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.48 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.5 mp -112.52 141.55 27.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.633 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -111.9 171.53 14.26 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.312 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -113.37 109.05 18.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.996 -179.18 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.05 105.89 15.18 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 0.0 OUTLIER 49.32 39.12 15.32 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 122.662 1.22 . . . . 0.0 111.867 179.652 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 74' ' ' CYS . . . 88.65 3.66 77.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.415 178.538 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -110.06 154.4 23.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.988 0.423 . . . . 0.0 110.888 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.5 mt -85.47 117.22 24.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.074 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.571 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.3 tt0 -106.04 128.61 53.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.018 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.653 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.55 -66.8 0.25 Allowed Pre-proline 1 CA--C 1.42 -4.05 0 O-C-N 124.117 0.885 . . . . 0.0 112.754 -179.493 . . . . . . . . 4 4 . 1 . 030 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.594 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 3.0 Cg_endo -109.6 126.4 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.313 0 C-N-CA 113.821 -3.652 . . . . 0.0 113.413 -177.708 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.633 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -165.05 -161.83 14.84 Favored Glycine 0 C--N 1.285 -2.257 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.684 -177.76 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.48 146.45 25.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.381 -0.41 . . . . 0.0 110.665 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.6 m 54.5 40.65 31.97 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.47 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HD2' ' SG ' ' A' ' 59' ' ' CYS . 13.2 p90 -72.2 -34.16 68.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.512 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.49 -18.26 67.55 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.998 -179.139 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 m -68.89 -9.34 51.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.153 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.8 m -145.62 8.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.726 179.299 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.426 ' SG ' ' HD2' ' A' ' 55' ' ' PHE . 6.4 m -109.33 153.28 24.14 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.101 0.477 . . . . 0.0 111.462 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.402 HG23 ' HD3' ' A' ' 61' ' ' LYS . 18.9 m -142.22 167.41 15.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.906 178.387 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HD3' HG23 ' A' ' 60' ' ' VAL . 5.1 mptp? 63.39 33.06 14.14 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.618 0.574 . . . . 0.0 111.293 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -59.68 122.09 13.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.324 179.668 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.94 161.39 42.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.869 -179.513 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.785 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -114.4 113.78 24.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.815 0.341 . . . . 0.0 111.803 -179.003 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 90.0 m-20 -73.09 116.35 13.52 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.47 20.01 2.6 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.104 0.878 . . . . 0.0 111.558 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.85 29.24 73.54 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.072 -0.513 . . . . 0.0 114.375 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -142.57 -24.48 0.65 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.913 0.856 . . . . 0.0 112.036 179.276 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 20.3 m -116.24 132.53 56.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.562 ' HB3' HD21 ' A' ' 88' ' ' LEU . 16.0 tp -90.77 129.63 36.83 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.422 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.0 OUTLIER -120.2 129.29 54.03 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.312 179.857 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -163.86 163.94 23.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.067 0.46 . . . . 0.0 110.776 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.6 t -114.5 119.48 36.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.474 -0.784 . . . . 0.0 108.98 179.328 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -116.17 156.36 26.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.329 0.585 . . . . 0.0 111.831 -179.172 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.9 tmtt? -99.5 143.34 29.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.304 178.471 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.72 -17.81 0.66 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.445 -1.359 . . . . 0.0 114.098 178.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -63.37 -38.06 89.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.426 0.613 . . . . 0.0 110.484 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -177.25 59.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.754 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.84 16.72 66.47 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.086 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -139.31 163.36 32.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 40.8 p90 -97.6 171.62 8.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.143 -179.075 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.13 136.63 11.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.69 128.64 37.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.162 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -146.02 169.0 19.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.264 -179.132 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.422 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.9 OUTLIER -140.7 164.47 30.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.923 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.88 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.5 OUTLIER -149.21 125.95 11.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.492 -179.235 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.476 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 9.0 m-20 -75.25 106.31 6.71 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.458 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.785 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.8 mt -79.11 -8.63 59.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.163 0.506 . . . . 0.0 109.687 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -49.61 -28.43 5.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.731 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.476 ' CE2' ' HB2' ' A' ' 87' ' ' ASP . 10.4 p90 -119.11 21.52 12.29 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 179.658 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.785 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -127.2 -16.25 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.943 0.402 . . . . 0.0 110.563 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.1 t -132.94 148.74 31.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.477 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -147.72 164.26 28.81 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.89 179.533 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -107.93 135.06 49.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.899 0.38 . . . . 0.0 110.638 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.652 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 59.0 m -140.14 96.51 3.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.713 178.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 62.03 45.96 6.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.675 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 56.51 29.76 57.9 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.773 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -127.08 147.11 50.17 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.844 0.354 . . . . 0.0 110.665 -178.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.0 103.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.475 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.652 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 59.1 mm-40 -137.96 67.1 48.63 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.426 179.008 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 28.3 Cg_endo -62.72 114.41 2.39 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 123.32 2.68 . . . . 0.0 112.838 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.042 179.197 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 ttm . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 58.12 -159.23 0.27 Allowed 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.325 0.391 . . . . 0.0 110.398 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.569 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 71.5 m -108.53 -64.09 1.26 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 89' ' ' ASN . 92.7 m-20 52.78 71.17 0.5 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.375 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.49 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.7 p90 -54.02 -36.76 63.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.264 0.554 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.14 -21.61 33.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -62.74 -27.78 69.52 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.559 ' HB2' HD22 ' A' ' 94' ' ' ASN . 26.7 m -134.62 16.7 3.63 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.049 0.452 . . . . 0.0 110.774 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.5 m -117.48 133.04 56.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.129 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -130.84 152.71 49.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.717 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.22 61.65 6.15 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.095 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 m -95.08 131.3 42.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.393 0.616 . . . . 0.0 111.898 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -124.59 157.44 35.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.099 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.618 HD22 HD23 ' A' ' 64' ' ' LEU . 14.2 tp -139.82 121.66 15.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.501 . . . . 0.0 111.295 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.42 102.17 6.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.98 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.7 -60.67 3.71 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.965 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -170.81 26.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 122.875 0.47 . . . . 0.0 110.38 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 15.2 mt -119.23 113.61 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.08 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.807 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -99.2 114.24 26.93 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -124.22 142.78 50.96 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.486 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.42 -179.27 41.19 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.401 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 8.7 m-20 -103.59 107.69 18.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 79.8 m -107.62 132.77 52.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.013 0.435 . . . . 0.0 110.025 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.1 mt -72.78 137.21 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.575 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -102.41 -169.09 1.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.028 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -62.83 -26.31 68.68 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 111.598 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.21 -23.26 64.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.296 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.45 5.92 58.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.351 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -110.43 142.16 25.47 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.678 0.275 . . . . 0.0 110.624 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.566 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 39.8 Cg_endo -69.51 122.15 8.9 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.819 2.346 . . . . 0.0 111.979 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -111.71 131.03 55.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.75 120.85 17.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.157 0.503 . . . . 0.0 111.104 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 t -136.69 152.75 50.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.122 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.7 p -131.22 148.22 52.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.472 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.04 145.53 34.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.463 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -101.95 98.75 8.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.163 0.506 . . . . 0.0 110.121 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.5 mm? -60.38 -26.81 66.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.64 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.02 -24.91 57.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.756 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -106.83 7.22 30.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 60.0 m-85 -128.68 -16.37 4.26 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.08 144.24 27.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.669 0.271 . . . . 0.0 110.974 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.576 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -117.79 179.26 17.18 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.138 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.625 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 19.1 p-10 -131.76 102.22 5.79 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.809 0.814 . . . . 0.0 110.618 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -105.27 121.85 44.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.068 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.818 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 53.6 t30 60.13 32.38 20.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.207 0.527 . . . . 0.0 110.171 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.01 21.31 79.97 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.043 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -121.84 157.52 30.93 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 86' ' ' MET . 33.4 mt -82.11 115.69 21.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.203 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HG2' ' C ' ' A' ' 42' ' ' GLY . 10.2 pt-20 -103.24 143.42 32.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.671 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -46.38 -74.06 0.08 OUTLIER Pre-proline 0 CA--C 1.431 -3.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.835 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.671 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 13.1 Cg_endo -110.24 124.28 0.03 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.393 0 C-N-CA 113.794 -3.671 . . . . 0.0 113.122 -177.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.576 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -150.32 -160.88 9.56 Favored Glycine 0 C--N 1.278 -2.648 0 CA-C-N 113.429 -1.714 . . . . 0.0 113.284 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -149.6 139.85 22.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.411 -0.395 . . . . 0.0 110.728 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.6 p 48.3 52.23 13.77 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.296 1.038 . . . . 0.0 113.569 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -75.69 -39.55 57.28 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -18.71 53.49 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.576 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.3 m -68.65 -22.72 64.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.291 -0.454 . . . . 0.0 110.728 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.2 m -135.02 22.42 3.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.7 m -131.92 145.38 51.47 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.63 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 m -134.13 169.98 20.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.107 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 66.43 37.09 4.83 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.404 0.44 . . . . 0.0 110.834 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.7 117.36 8.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.54 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.09 161.32 42.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.255 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -112.13 124.0 51.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.869 0.366 . . . . 0.0 110.813 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 2.7 t30 -95.53 127.28 41.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.833 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 14.4 t70 52.41 24.27 2.88 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.972 0.795 . . . . 0.0 112.249 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.33 38.5 79.05 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.859 -0.61 . . . . 0.0 114.1 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.603 ' CD2' ' HB3' ' A' ' 66' ' ' ASP . 1.3 p80 -153.46 -27.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.52 0.66 . . . . 0.0 111.798 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.4 m -115.74 130.3 56.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.697 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.622 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.2 tp -90.65 138.95 31.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.9 132.95 52.05 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.68 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -164.58 159.89 19.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.128 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 t -107.53 122.94 47.67 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 30.8 m -124.75 154.91 40.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -97.5 146.25 25.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.428 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.94 -31.18 0.74 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.919 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.818 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -52.91 -42.53 65.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -174.39 55.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.75 11.23 59.96 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.446 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -130.51 161.24 31.91 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 50.5 p90 -96.1 168.58 10.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.401 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.08 136.41 9.9 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.2 126.93 31.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.951 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.524 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 33.2 t -140.81 171.82 13.55 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.124 0.487 . . . . 0.0 111.072 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.78 158.22 44.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.419 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.686 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.7 OUTLIER -141.83 122.92 14.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.679 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 4.1 m-20 -73.75 105.66 5.15 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.709 ' HA ' HG22 ' A' ' 91' ' ' VAL . 21.0 mt -75.55 -8.97 58.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.025 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.507 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 18.1 m120 -47.55 -29.75 3.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.166 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 87' ' ' ASP . 16.6 p90 -118.37 21.32 12.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.977 0.418 . . . . 0.0 111.18 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -129.43 -9.63 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.752 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.926 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 14.5 p -152.58 143.73 15.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.41 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -146.77 169.69 27.87 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.135 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' A' ' 8' ' ' SER . 28.2 t30 -100.15 131.06 46.32 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.569 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 73.9 m -138.59 95.04 2.92 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.572 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 62.9 44.88 5.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.441 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.0 23.21 56.79 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.38 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -123.12 140.11 53.36 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 99' ' ' MET . 24.3 ptt? -56.17 112.09 1.13 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.85 0.719 . . . . 0.0 111.336 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 1.6 mm-40 -137.68 77.62 38.86 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.104 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.926 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 58.1 Cg_endo -74.42 93.96 0.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.428 2.085 . . . . 0.0 112.228 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.84 111.51 23.22 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.097 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.637 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -88.76 149.77 23.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.914 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.67 56.04 0.63 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.013 0.435 . . . . 0.0 110.511 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.2 t -177.38 -117.72 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.352 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.542 ' HB2' ' HG3' ' A' ' 103' ' ' ARG . 38.1 t30 54.23 57.43 5.9 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.706 0.802 . . . . 0.0 111.155 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.8 -171.84 3.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.923 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 37.35 -102.51 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.127 0.971 . . . . 0.0 112.568 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -160.54 -67.49 0.07 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.4 m -104.12 75.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 122.035 0.921 . . . . 0.0 110.824 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.727 ' H ' HD23 ' A' ' 111' ' ' LEU . 2.5 pt? -77.08 -0.78 26.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.842 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.625 ' HE3' ' OD1' ' A' ' 43' ' ' ASN . 80.4 tttt -88.16 13.53 11.14 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.274 1.035 . . . . 0.0 110.134 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.5 t 50.3 51.83 15.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.635 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.0 m -118.18 102.48 9.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.911 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.7 t -67.43 -35.95 80.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.35 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.403 -179.189 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 67.0 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 110.781 -0.081 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.4 mp0 71.76 137.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.596 0.712 . . . . 0.0 111.071 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.511 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 68.5 m -86.33 -74.92 0.4 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.178 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 41.49 73.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.576 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.7 p90 -54.76 -39.76 68.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.981 0.419 . . . . 0.0 111.33 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.91 -22.94 41.29 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.53 -20.73 61.29 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.438 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.437 ' HB2' HD22 ' A' ' 94' ' ' ASN . 20.4 m -129.97 11.54 5.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.911 0.386 . . . . 0.0 110.928 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 91.2 m -120.14 132.9 55.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -127.07 160.23 31.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.65 45.34 90.62 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.741 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -87.09 123.94 40.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.449 0.642 . . . . 0.0 111.594 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 47.3 mt-10 -121.61 142.43 50.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.534 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.768 HD22 HD23 ' A' ' 64' ' ' LEU . 17.2 tp -117.83 112.31 20.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.952 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -133.83 104.92 6.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.077 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 70.36 51.54 21.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.771 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CD1' HG21 ' A' ' 62' ' ' THR . 7.7 m-85 63.81 16.18 9.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.214 0.605 . . . . 0.0 111.57 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 16' ' ' GLY . 20.9 mt -116.38 116.3 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 120.659 0.266 . . . . 0.0 110.534 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.766 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 mt -103.13 114.43 28.71 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.602 ' HG3' ' HB3' ' A' ' 34' ' ' SER . 6.9 ttt180 -121.07 145.05 48.2 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.79 -175.23 40.54 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.284 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.0 m-20 -109.07 110.41 21.66 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.894 0.378 . . . . 0.0 110.263 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 65.9 m -107.4 132.56 53.04 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.88 134.75 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.227 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.69 -174.24 2.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 96' ' ' TYR . 7.4 tp10 -49.43 -40.04 35.16 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.489 0.493 . . . . 0.0 111.52 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -57.96 -26.14 61.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.303 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.44 -0.44 58.35 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.712 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -106.77 146.08 32.37 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.886 0.374 . . . . 0.0 110.889 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.611 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 36.6 Cg_endo -68.62 122.16 9.11 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.136 2.557 . . . . 0.0 112.266 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -109.89 127.37 54.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.594 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.65 125.36 25.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.169 0.509 . . . . 0.0 111.475 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 t -143.56 158.85 43.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.342 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.602 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 4.7 p -139.63 147.0 40.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.857 0.36 . . . . 0.0 111.254 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 mp -130.9 143.44 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.29 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -104.31 95.3 5.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.766 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -59.11 -19.81 47.91 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.806 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.579 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 21.7 t-20 -54.84 -32.57 60.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.928 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -106.42 16.44 24.71 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.489 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 54.5 m-85 -127.91 -23.45 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.59 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -111.72 144.0 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.641 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -116.53 171.76 13.92 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.881 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -107.28 112.9 25.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.959 0.409 . . . . 0.0 111.222 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -110.61 105.09 13.88 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 2.7 p-10 42.19 44.82 3.36 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.822 1.249 . . . . 0.0 112.806 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 87.11 7.72 76.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.405 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 0.7 OUTLIER -117.85 160.85 20.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.987 0.422 . . . . 0.0 110.83 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 72' ' ' ALA . 31.2 mt -84.05 115.76 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.114 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -103.13 126.06 50.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.586 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.78 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -35.25 -71.28 0.11 Allowed Pre-proline 0 CA--C 1.429 -3.702 0 O-C-N 124.49 1.119 . . . . 0.0 113.736 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.78 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 10.1 Cg_endo -110.75 120.96 0.02 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.436 0 C-N-CA 113.776 -3.682 . . . . 0.0 113.097 -178.226 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.641 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -152.45 -161.73 10.42 Favored Glycine 0 C--N 1.274 -2.871 0 CA-C-N 113.541 -1.663 . . . . 0.0 113.211 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 20.4 mt-10 -156.69 141.94 17.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.996 0.468 . . . . 0.0 110.458 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.2 m 58.66 36.69 25.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.801 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.579 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 5.3 p90 -69.18 -33.48 73.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.23 -18.78 58.57 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.396 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.5 m -67.19 -14.05 62.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.83 0.347 . . . . 0.0 110.774 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.9 p -146.26 20.53 1.38 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.1 m -133.15 139.19 46.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.773 0.321 . . . . 0.0 111.194 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.461 HG23 ' HD3' ' A' ' 61' ' ' LYS . 21.4 m -134.16 177.63 6.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.167 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.9 mptt 59.84 44.08 14.28 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.406 0.441 . . . . 0.0 111.136 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.472 HG21 ' CD1' ' A' ' 17' ' ' TYR . 30.6 p -75.75 125.78 29.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 111.358 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.65 162.57 39.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.574 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.768 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -118.59 116.99 27.77 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.626 0.251 . . . . 0.0 111.039 -179.06 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -93.19 127.47 38.77 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.639 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.632 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 4.3 t70 54.0 23.31 3.92 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.914 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.48 28.66 67.8 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -149.22 -18.09 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 117.899 0.85 . . . . 0.0 112.334 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.0 m -116.38 127.42 54.63 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.749 0.309 . . . . 0.0 111.245 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -90.03 136.85 32.79 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.56 130.4 50.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.162 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -161.44 167.14 26.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.105 0.478 . . . . 0.0 110.713 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.403 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 8.5 t -116.75 122.02 43.27 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.415 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.4 m -121.51 149.64 42.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 0.0 112.108 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -99.88 146.73 26.31 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.05 -22.79 0.78 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.558 -1.306 . . . . 0.0 113.473 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -60.89 -40.64 93.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.716 0.293 . . . . 0.0 111.208 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -176.61 57.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.392 0.615 . . . . 0.0 110.08 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.84 0.14 40.13 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.811 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -122.53 163.6 19.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.403 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 40.9 p90 -112.45 167.19 10.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.844 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.53 152.76 27.71 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.78 129.45 37.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.231 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.54 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 25.1 t -142.06 166.53 24.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.516 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.86 163.17 32.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.657 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.3 tpt -144.73 121.49 11.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.674 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -75.31 105.55 6.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.71 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.0 mt -74.76 -8.64 57.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.522 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -46.86 -30.1 2.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.222 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -120.83 23.6 10.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 111.348 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.71 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.4 m -127.08 -9.28 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.081 0.467 . . . . 0.0 110.472 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.913 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.7 p -156.28 138.34 6.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.858 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -133.76 177.44 19.07 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.065 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.437 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.8 t30 -109.83 123.42 49.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.626 0.25 . . . . 0.0 110.559 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.519 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 6.0 t -127.57 101.15 6.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.431 ' CD1' ' HB2' ' A' ' 26' ' ' GLU . 98.0 m-85 57.98 47.62 14.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.5 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 58.9 25.22 59.0 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.034 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -129.82 148.93 51.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.813 0.34 . . . . 0.0 110.088 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -58.69 118.94 6.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.66 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.519 ' HG3' ' HB3' ' A' ' 95' ' ' SER . 12.4 mm-40 -143.9 77.9 14.43 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.958 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.913 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 57.6 Cg_endo -74.69 93.85 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.542 2.161 . . . . 0.0 112.675 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.78 112.32 24.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.182 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.685 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -86.88 144.94 26.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.126 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.42 42.15 1.17 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.215 0.531 . . . . 0.0 110.41 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.451 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 48.4 t -166.32 -121.12 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.578 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.685 ' HB2' ' HG3' ' A' ' 103' ' ' ARG . 7.4 t30 70.27 19.98 6.36 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.864 0.866 . . . . 0.0 110.001 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.37 115.51 14.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.765 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.22 -163.2 1.73 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -69.87 -59.17 3.1 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.9 p -104.82 52.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 122.862 1.315 . . . . 0.0 109.404 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.3 tp -156.2 90.85 1.22 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.584 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -106.48 128.98 54.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.241 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -72.04 57.17 0.33 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.471 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.8 m -152.67 124.89 8.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.76 0.315 . . . . 0.0 110.304 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.0 m -80.54 -23.73 39.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.459 0.647 . . . . 0.0 109.895 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.373 -179.33 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 62.99 -172.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.419 0.688 . . . . 0.0 111.42 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 62.1 m -127.64 -66.59 0.87 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.055 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 53.15 68.39 0.85 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.516 ' CD1' ' HB ' ' A' ' 92' ' ' VAL . 10.9 p90 -55.02 -45.99 75.18 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.163 0.506 . . . . 0.0 111.123 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.21 -22.08 62.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -65.87 -20.48 66.25 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.612 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 m -135.69 25.26 3.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.915 0.388 . . . . 0.0 110.946 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.0 m -134.1 132.95 40.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.051 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 p -134.46 165.11 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.611 0.243 . . . . 0.0 110.867 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.12 98.37 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.185 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' HB ' ' CD1' ' A' ' 19' ' ' LEU . 35.8 m -83.17 139.81 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.304 0.574 . . . . 0.0 111.848 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.09 148.46 52.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.545 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.532 HD22 HD23 ' A' ' 64' ' ' LEU . 14.5 tp -132.21 117.38 18.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.023 0.439 . . . . 0.0 111.155 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.41 109.99 12.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.462 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.04 -68.91 2.78 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.366 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 17.5 p90 -170.45 28.94 0.02 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.326 0.584 . . . . 0.0 110.387 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 mt -121.2 115.64 47.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.643 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.862 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -96.99 113.7 25.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.265 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -124.44 139.38 53.95 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.129 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.45 -170.9 33.71 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.269 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 1.3 m-20 -108.25 111.01 22.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.931 0.396 . . . . 0.0 110.278 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 72.4 m -107.52 132.09 53.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.01 141.82 16.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.678 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -108.92 -171.46 1.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.78 -33.82 64.71 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -64.46 -24.69 67.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.909 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.0 6.98 57.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.623 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -111.55 144.78 31.26 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 40.2 Cg_endo -68.44 133.64 28.67 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.864 2.376 . . . . 0.0 112.166 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -118.07 133.24 56.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.378 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.75 122.89 19.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.005 0.431 . . . . 0.0 111.282 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 t -142.17 159.08 42.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.021 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.7 p -140.39 146.02 37.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.83 146.08 33.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.329 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -102.2 96.29 6.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.009 0.433 . . . . 0.0 110.07 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -59.32 -26.54 65.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.311 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 25.9 t-20 -55.0 -28.95 55.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.054 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -103.34 6.04 37.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 55.3 m-85 -125.25 -19.84 5.0 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.264 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 mt -117.3 143.59 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.801 0.334 . . . . 0.0 110.805 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.622 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -119.47 176.29 16.07 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.219 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -127.27 112.76 15.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.735 0.779 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -110.6 115.0 28.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.342 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.82 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 56.3 t30 59.4 38.36 22.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.286 0.565 . . . . 0.0 110.476 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.12 12.09 84.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.195 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -118.45 151.43 37.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.872 0.368 . . . . 0.0 110.797 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.8 mp -76.96 129.39 36.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.599 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.481 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 9.5 tp10 -121.87 132.92 54.83 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.231 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.768 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -37.94 -66.4 0.3 Allowed Pre-proline 0 CA--C 1.423 -3.924 0 O-C-N 124.216 0.948 . . . . 0.0 113.186 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.768 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 5.5 Cg_endo -109.94 129.29 0.04 OUTLIER 'Trans proline' 1 N--CA 1.34 -7.509 0 C-N-CA 113.742 -3.706 . . . . 0.0 113.064 -178.151 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.622 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -163.44 -162.85 14.95 Favored Glycine 0 C--N 1.283 -2.38 0 CA-C-N 114.012 -1.449 . . . . 0.0 113.403 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -150.58 142.94 24.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.935 0.398 . . . . 0.0 110.743 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.8 p 50.83 49.25 21.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.552 1.141 . . . . 0.0 113.585 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.439 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 11.1 p90 -73.91 -43.97 56.71 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.66 -19.01 47.39 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.893 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 m -66.5 -16.02 63.81 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.041 0.448 . . . . 0.0 110.889 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 m -146.55 28.74 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.466 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 55' ' ' PHE . 62.9 m -133.66 149.58 51.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.595 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.553 HG23 ' HD3' ' A' ' 61' ' ' LYS . 19.3 m -136.69 173.13 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.812 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.553 ' HD3' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER 63.22 39.31 9.81 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.062 0.545 . . . . 0.0 111.524 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.449 ' HB ' HD21 ' A' ' 14' ' ' LEU . 22.3 p -66.29 120.6 13.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.335 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.67 156.49 40.48 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -113.79 112.0 22.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.889 0.376 . . . . 0.0 111.766 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.518 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 6.2 m-20 -73.75 117.48 15.58 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.577 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 0.3 OUTLIER 56.44 23.58 7.6 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.733 0.646 . . . . 0.0 110.701 -179.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.85 28.46 65.9 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.024 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.577 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.3 p80 -139.58 -28.02 0.77 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.707 0.754 . . . . 0.0 111.544 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 22.2 m -110.72 126.16 54.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.707 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.697 ' HB2' HD11 ' A' ' 88' ' ' LEU . 19.3 tp -90.3 127.92 36.29 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.743 -0.383 . . . . 0.0 109.99 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.26 129.62 56.03 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.981 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.57 154.33 18.31 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.678 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 28.0 t -102.41 123.01 45.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 59.8 m -120.2 153.02 36.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.0 111.9 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 10.5 tmtt? -98.77 142.31 30.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.449 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.49 -32.74 0.53 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.278 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.82 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -54.33 -39.68 67.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -169.29 48.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.351 0.596 . . . . 0.0 109.524 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.31 6.48 47.91 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.296 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 28.5 pt20 -128.17 168.11 15.87 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 41.5 p90 -88.26 167.76 13.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.344 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.503 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.2 OUTLIER -155.29 129.55 8.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.531 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -70.6 114.7 8.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.674 0.273 . . . . 0.0 110.753 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.7 t -129.49 160.62 32.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.076 0.465 . . . . 0.0 111.238 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.6 OUTLIER -128.87 165.04 21.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.051 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.624 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.7 tpt -152.85 124.83 7.95 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.869 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 40.6 t0 -76.43 107.05 8.42 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.765 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.6 mt -78.42 -8.17 58.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.649 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -49.78 -28.62 6.5 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.276 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.454 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 45.1 p90 -116.37 21.31 13.66 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.242 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.765 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -129.18 -11.21 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.1 t -134.7 145.51 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.15 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.95 166.44 25.4 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 23' ' ' CYS . 20.3 t30 -130.85 132.64 45.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 111.319 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 m -140.39 113.14 8.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.515 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 59.99 42.67 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.477 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.25 22.03 62.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.449 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -123.55 137.6 54.73 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 127.05 31.57 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.574 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.57 68.68 13.39 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 121.75 0.786 . . . . 0.0 109.415 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 13.1 Cg_endo -54.68 115.12 2.19 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.539 2.826 . . . . 0.0 113.19 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p -122.35 128.68 51.3 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.705 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.497 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -111.51 150.14 30.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.426 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.47 50.2 0.86 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.124 0.488 . . . . 0.0 110.58 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.438 ' HB3' ' HG3' ' A' ' 51' ' ' PRO . 23.1 t -165.29 -151.64 0.15 Allowed 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 63.3 23.1 13.64 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.063 0.945 . . . . 0.0 110.184 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -173.41 -49.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.936 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.32 163.24 13.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.306 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 22.6 t60 69.03 162.35 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.619 0.768 . . . . 0.0 110.822 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.4 t -107.62 95.5 3.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.996 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mp -83.22 68.61 9.69 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 0.0 109.443 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -144.08 33.71 1.23 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.013 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.8 t 57.53 27.21 13.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.359 0.6 . . . . 0.0 109.947 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 t -144.36 143.16 30.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.815 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.3 m -80.08 -31.15 39.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.041 0.448 . . . . 0.0 110.166 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.494 179.598 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 pm0 -83.87 130.01 34.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.571 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 59.7 m -123.66 -63.25 1.24 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.558 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 p30 33.04 78.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.534 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 2.8 p90 -60.14 -31.86 70.48 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.932 0.396 . . . . 0.0 111.76 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.73 -23.14 66.68 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -70.33 -7.46 42.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.285 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.468 ' HB2' HD22 ' A' ' 94' ' ' ASN . 53.4 m -145.15 27.01 1.3 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.071 0.462 . . . . 0.0 110.412 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -133.36 147.7 51.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.47 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -140.06 148.18 41.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.654 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.81 59.24 10.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.234 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.414 ' HB ' ' CD1' ' A' ' 19' ' ' LEU . 18.2 m -95.24 133.22 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.106 0.479 . . . . 0.0 110.618 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -128.36 142.4 51.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.501 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.643 HD22 HD23 ' A' ' 64' ' ' LEU . 12.7 tp -107.45 112.86 25.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.097 0.475 . . . . 0.0 110.759 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.479 ' O ' HG12 ' A' ' 18' ' ' ILE . 54.8 m-85 -105.17 97.81 7.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.803 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.78 -64.18 0.47 Allowed Glycine 0 CA--C 1.523 0.594 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.549 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 7.9 p90 -158.23 16.67 0.22 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.779 0.432 . . . . 0.0 111.38 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.0 pt -122.63 132.26 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 0.0 110.305 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -104.18 114.4 28.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.816 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -117.75 136.82 53.12 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -164.51 -179.24 38.51 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.385 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 11.1 m-20 -101.71 104.88 15.72 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -105.36 132.13 51.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.998 0.427 . . . . 0.0 110.106 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.6 mt -75.25 132.75 32.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.192 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -101.6 -171.65 2.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.929 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -55.85 -29.93 60.66 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.7 -22.56 66.97 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.053 0.454 . . . . 0.0 111.696 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.58 6.92 65.46 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.459 -0.876 . . . . 0.0 111.293 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -112.86 142.89 28.02 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.542 -0.329 . . . . 0.0 110.354 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.579 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 43.4 Cg_endo -69.94 121.9 8.54 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.819 2.346 . . . . 0.0 112.131 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -111.92 127.48 55.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.5 124.44 22.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.166 0.508 . . . . 0.0 111.326 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -136.96 159.51 41.67 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.419 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 p -140.05 140.74 36.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.49 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.1 146.87 30.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.414 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -101.86 94.62 5.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -59.86 -26.62 66.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.631 0.253 . . . . 0.0 111.461 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.527 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 27.9 t30 -60.37 -16.48 35.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -109.68 6.82 24.05 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.135 -0.353 . . . . 0.0 110.849 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.47 ' CE2' ' HG3' ' A' ' 101' ' ' PRO . 37.4 m-85 -127.56 -23.95 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.492 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.3 mp -113.56 142.45 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -117.16 173.9 14.95 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.005 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -110.14 103.23 11.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.829 0.347 . . . . 0.0 110.51 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -112.42 107.86 16.8 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.371 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.845 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 58.0 t30 59.73 39.05 21.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.243 0.544 . . . . 0.0 110.412 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 72.57 21.66 79.41 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.71 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -125.94 150.35 48.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.506 0.194 . . . . 0.0 111.358 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 1.8 mm? -72.77 114.69 11.18 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.609 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 39.4 tt0 -108.54 123.75 49.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.512 0.672 . . . . 0.0 110.305 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.792 ' CD2' ' HD3' ' A' ' 51' ' ' PRO 0.251 0.2 OUTLIER -36.66 -57.73 1.15 Allowed Pre-proline 0 CA--C 1.423 -3.912 0 CA-C-N 113.503 -1.68 . . . . 0.0 115.164 -178.691 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.792 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 17.2 Cg_endo -117.08 109.23 0.01 OUTLIER 'Trans proline' 1 N--CA 1.348 -7.083 0 C-N-CA 113.471 -3.886 . . . . 0.0 113.12 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -148.43 -164.63 11.55 Favored Glycine 0 C--N 1.271 -3.066 0 CA-C-N 112.988 -1.915 . . . . 0.0 113.851 -176.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -151.79 142.2 22.52 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.629 0.372 . . . . 0.0 110.309 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.4 m 53.67 54.39 10.01 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 19.4 p90 -78.95 -32.99 45.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.63 -19.23 54.13 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.935 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.2 m -65.08 -18.93 65.72 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.98 0.512 . . . . 0.0 111.432 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.3 m -144.83 14.32 1.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.816 0.341 . . . . 0.0 111.193 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.4 m -121.45 139.4 53.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.33 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.72 175.85 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.063 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 0.5 OUTLIER 58.42 43.8 19.16 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.604 0.565 . . . . 0.0 111.135 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 p -66.17 132.72 49.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.774 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.61 163.33 40.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.817 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.643 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -121.11 113.39 19.96 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.099 0.476 . . . . 0.0 110.518 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.65 120.15 25.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.612 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 54.04 30.75 12.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.901 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 51.33 36.64 37.7 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.442 -0.799 . . . . 0.0 114.644 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -150.76 -29.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.768 0.784 . . . . 0.0 111.415 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 m -113.02 130.73 56.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.27 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.609 ' HB2' HD11 ' A' ' 88' ' ' LEU . 13.2 tp -89.98 128.34 36.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.89 129.24 55.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.576 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.21 170.11 21.85 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.775 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 t -113.81 116.92 30.11 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.511 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.7 m -116.71 148.5 41.02 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.12 0.486 . . . . 0.0 111.859 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.8 tmtt? -100.2 142.62 31.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.232 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.07 -31.03 0.54 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.329 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.845 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.09 -41.28 64.78 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -172.13 52.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.525 0.679 . . . . 0.0 110.182 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.16 -0.28 32.13 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.852 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -119.7 162.92 18.2 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 24.2 p90 -91.03 165.98 13.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.07 127.58 7.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.644 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -67.19 123.03 19.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.787 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 p -142.88 176.07 9.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.349 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.28 160.49 40.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.121 0.486 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.668 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.5 tpt -143.91 124.84 14.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.009 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.485 ' H ' ' HE2' ' A' ' 86' ' ' MET . 26.0 t0 -78.29 106.77 10.43 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.542 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.754 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.1 mt -77.36 -8.93 58.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.987 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -49.37 -27.75 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.334 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 43.6 p90 -118.62 20.02 13.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.508 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 88' ' ' LEU . 2.0 m -125.22 -13.03 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.958 0.409 . . . . 0.0 110.651 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.89 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 6.9 p -147.26 136.37 16.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.789 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.571 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -133.17 173.89 20.85 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.47 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 8' ' ' SER . 20.7 t30 -111.93 124.57 52.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.4 m -133.07 103.4 6.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.75 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 63.84 41.42 6.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.24 28.28 66.61 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.883 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -125.55 147.19 49.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.897 0.38 . . . . 0.0 110.858 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 99' ' ' MET . 13.5 ptm -64.2 103.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.887 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -132.83 80.32 61.34 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.177 0.513 . . . . 0.0 110.48 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.89 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 65.6 Cg_endo -74.3 125.28 9.59 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.696 2.264 . . . . 0.0 112.148 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.37 125.35 25.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.372 0.606 . . . . 0.0 111.52 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.612 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -113.53 150.43 32.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.859 179.31 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.85 50.88 0.84 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.094 0.474 . . . . 0.0 110.483 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.433 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 38.2 t -160.64 -142.41 0.08 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 17.6 t-20 59.05 79.09 0.23 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.777 0.831 . . . . 0.0 111.022 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . . . -140.51 175.72 9.37 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.621 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.63 -57.45 10.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.925 0.393 . . . . 0.0 111.301 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -111.82 -18.74 12.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.44 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 107' ' ' ALA . 19.3 t -86.36 66.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.858 0.837 . . . . 0.0 109.605 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 53.3 tp -135.36 95.92 3.37 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.069 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -64.89 110.44 2.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.454 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.2 p -68.65 106.48 2.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.544 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -137.3 52.6 1.9 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.11 0.481 . . . . 0.0 111.646 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.493 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -67.21 -48.9 66.49 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 C--O 1.248 1.015 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.62 178.984 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' OE1' ' HA ' ' A' ' 2' ' ' GLN . 15.9 mm-40 66.83 114.7 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.749 0.785 . . . . 0.0 111.593 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.536 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 99.7 m -87.78 -63.63 1.27 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.282 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 43.04 70.2 0.32 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.945 0.778 . . . . 0.0 113.071 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 11.7 p90 -53.25 -34.16 56.02 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.331 0.586 . . . . 0.0 110.402 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.86 -23.29 67.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.349 -0.842 . . . . 0.0 113.002 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -62.06 -27.48 68.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.7 m -129.88 15.91 5.78 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.525 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -117.53 139.89 50.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.371 0.605 . . . . 0.0 111.651 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -137.82 154.48 49.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.199 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.79 60.51 7.99 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.358 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 31.6 m -94.14 139.91 17.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.075 0.464 . . . . 0.0 111.532 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -131.32 148.74 52.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.13 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.68 HD22 HD23 ' A' ' 64' ' ' LEU . 14.9 tp -133.41 119.19 19.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.992 0.425 . . . . 0.0 110.974 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.487 ' O ' HG12 ' A' ' 18' ' ' ILE . 67.6 t80 -127.09 101.32 6.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.202 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.23 -63.08 3.65 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.625 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -167.82 20.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.585 0.231 . . . . 0.0 111.602 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 15' ' ' TYR . 35.8 pt -116.25 126.08 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.821 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -111.3 114.74 28.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.263 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 17.8 ttm180 -116.98 138.43 51.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.53 168.12 35.93 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.778 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 9.7 m-20 -101.66 109.56 21.37 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -106.91 133.41 51.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.933 0.396 . . . . 0.0 110.426 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.5 mt -67.85 139.57 20.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.378 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.7 p30 -112.49 -168.1 1.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.567 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -56.18 -33.94 65.74 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.689 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.88 -28.62 67.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.597 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.14 -3.77 58.48 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.596 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -107.3 144.67 29.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.664 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 31.6 Cg_endo -64.9 128.27 20.45 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.387 2.725 . . . . 0.0 112.795 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -114.75 131.5 56.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.095 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.02 127.29 30.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.271 0.558 . . . . 0.0 111.75 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 t -142.34 159.31 42.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.479 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.6 p -139.69 150.55 45.0 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.351 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.717 HG13 ' HG3' ' A' ' 99' ' ' MET . 2.7 mp -134.63 143.11 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.979 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -100.82 97.03 7.7 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.5 mm? -59.42 -22.55 61.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.383 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -55.11 -28.76 54.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.125 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -108.18 11.54 27.37 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.909 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' C ' HD12 ' A' ' 41' ' ' ILE . 43.9 m-85 -129.09 -6.91 4.89 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.559 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.5 mp -129.06 133.74 65.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.585 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.64 176.42 18.22 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.391 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -115.38 101.63 9.09 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.983 0.42 . . . . 0.0 109.982 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.78 107.18 16.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.331 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.513 ' CG ' ' HA ' ' A' ' 77' ' ' ALA . 13.7 t-20 56.53 45.2 22.8 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.553 0.692 . . . . 0.0 110.471 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.95 19.8 75.64 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.828 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 149.01 47.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.982 0.42 . . . . 0.0 111.359 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.5 mp -72.45 122.47 21.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.714 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.624 ' HG2' ' CD ' ' A' ' 51' ' ' PRO . 24.7 tt0 -111.57 124.27 51.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 110.68 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.539 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 34.2 p90 -46.55 -28.2 0.68 Allowed Pre-proline 0 CA--C 1.452 -2.817 0 N-CA-C 119.107 3.003 . . . . 0.0 119.107 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.624 ' CD ' ' HG2' ' A' ' 49' ' ' GLU . 6.8 Cg_endo -127.04 5.97 0.01 OUTLIER 'Trans proline' 1 N--CA 1.391 -4.545 1 C-N-CA 112.76 -4.36 . . . . 0.0 116.392 178.82 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.585 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -56.24 -175.11 0.21 Allowed Glycine 0 C--N 1.265 -3.386 0 CA-C-N 111.099 -2.773 . . . . 0.0 115.903 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -147.81 144.09 27.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.942 0.401 . . . . 0.0 111.302 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.2 t 65.76 43.53 3.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.561 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.9 p90 -74.5 -37.51 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.771 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.98 -18.97 20.72 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.567 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 t -63.05 -22.38 66.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.786 0.327 . . . . 0.0 110.92 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 m -143.48 19.12 1.87 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.608 0.242 . . . . 0.0 111.136 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 73' ' ' SER . 63.6 m -124.54 140.58 52.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 0.0 111.091 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.38 176.02 7.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.143 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 60.89 46.57 8.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 123.752 0.658 . . . . 0.0 111.028 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.535 ' HB ' HD21 ' A' ' 14' ' ' LEU . 36.5 p -73.07 126.98 31.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.262 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.4 153.99 34.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.68 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -109.95 113.21 25.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.816 0.341 . . . . 0.0 111.083 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -79.2 117.39 20.17 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.298 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 t70 51.53 35.51 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.489 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 52.28 35.59 43.29 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.106 -0.952 . . . . 0.0 115.373 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -148.0 -25.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.024 0.912 . . . . 0.0 112.33 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.6 m -117.34 129.94 56.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.702 0.287 . . . . 0.0 111.433 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.612 ' HB2' HD11 ' A' ' 88' ' ' LEU . 20.1 tp -90.62 132.88 35.49 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.02 129.83 51.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.655 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.493 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -161.3 169.43 22.11 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.539 0.524 . . . . 0.0 110.849 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 59' ' ' CYS . 35.9 t -114.63 125.26 53.55 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 35.4 m -125.17 151.86 45.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -98.78 140.34 33.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.615 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.63 -32.01 0.48 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.5 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.513 ' HA ' ' CG ' ' A' ' 45' ' ' ASN . . . -50.83 -42.61 58.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -169.84 53.23 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.247 0.546 . . . . 0.0 110.015 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.9 1.79 49.09 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.423 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -125.27 165.53 18.16 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 40.3 p90 -95.19 161.04 14.27 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 123.618 0.574 . . . . 0.0 110.616 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -155.43 140.48 17.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -72.74 135.63 45.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.466 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.9 p -150.54 174.68 12.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.137 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.14 164.18 30.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.886 0.374 . . . . 0.0 110.373 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.57 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.2 tpt -147.01 122.1 10.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.225 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.68 106.4 4.07 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.684 ' HA ' HG22 ' A' ' 91' ' ' VAL . 21.4 mt -78.56 -8.35 58.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.135 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -47.12 -32.12 3.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.999 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -117.7 21.91 12.66 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.198 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -124.35 -14.96 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.279 0.561 . . . . 0.0 110.605 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.496 ' HB ' ' CD1' ' A' ' 5' ' ' PHE . 2.7 t -132.41 127.79 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.536 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -124.77 153.76 17.91 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.956 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.462 HD22 ' HB2' ' A' ' 8' ' ' SER . 32.1 t30 -103.96 117.44 34.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.806 0.336 . . . . 0.0 110.564 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 57.9 m -112.45 84.7 2.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.099 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 60.74 61.44 1.68 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.418 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 57.13 28.56 58.69 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.84 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -134.01 144.95 49.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.116 0.484 . . . . 0.0 110.917 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.717 ' HG3' HG13 ' A' ' 35' ' ' ILE . 6.2 tmm? -67.09 115.82 7.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.363 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 14.0 mt-10 -144.27 73.59 15.97 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.711 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HD3' ' HG2' ' A' ' 99' ' ' MET . 18.7 Cg_endo -57.09 156.73 23.33 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.261 2.641 . . . . 0.0 112.313 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 24.3 p -140.46 142.02 35.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.67 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.628 ' HG3' ' HB3' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -111.85 147.34 35.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.081 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.63 15.47 19.85 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.54 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.434 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 19.8 p -176.62 -93.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.333 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.628 ' HB3' ' HG3' ' A' ' 103' ' ' ARG . 19.7 t-20 53.03 36.75 22.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.788 -1.097 . . . . 0.0 110.108 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.68 142.38 22.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.273 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -75.6 63.06 1.5 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -132.27 -51.45 0.95 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.93 47.17 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.882 0.849 . . . . 0.0 109.88 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.6 tp -155.87 83.57 1.02 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.49 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 19.3 ptmt -133.63 101.43 5.12 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.522 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.3 m -77.25 51.61 0.86 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.6 0.714 . . . . 0.0 110.122 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.3 m -131.4 105.51 7.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.801 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.3 m -68.55 -53.4 23.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.155 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.496 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.8 ttm . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 74.63 149.7 0.1 Allowed 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.357 0.663 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.486 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 80.4 m -65.15 -67.61 0.43 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.52 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 80.3 m-20 56.11 77.48 0.24 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 10.1 p90 -61.1 -44.44 97.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.011 0.434 . . . . 0.0 110.595 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.25 -21.11 61.47 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.613 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 28.0 t-20 -54.46 -35.69 63.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.58 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.484 ' HB2' HD22 ' A' ' 94' ' ' ASN . 52.4 m -134.03 21.62 3.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.65 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.4 m -118.06 132.99 56.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.611 0.243 . . . . 0.0 110.358 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.0 p -132.65 155.26 49.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.541 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.5 67.81 1.99 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.915 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 11.3 m -107.32 129.64 60.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.274 0.559 . . . . 0.0 112.373 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 67.5 mm-40 -115.98 145.76 42.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.314 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.932 HD22 HD23 ' A' ' 64' ' ' LEU . 53.6 tp -133.0 122.26 23.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.0 111.089 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 18' ' ' ILE . 76.8 t80 -134.2 100.07 4.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.967 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 62' ' ' THR . . . 81.39 -64.01 4.25 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.645 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -166.49 19.83 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.735 0.302 . . . . 0.0 111.365 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.6 pt -116.4 119.08 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.753 0.311 . . . . 0.0 110.942 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.839 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.2 mt -111.91 114.5 27.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.4 ttt85 -120.68 138.75 53.79 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.117 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 179.37 38.83 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.268 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.613 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 4.5 m-20 -105.68 109.53 21.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.73 0.3 . . . . 0.0 110.318 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 8' ' ' SER . 61.3 m -108.19 133.38 52.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.133 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 55.0 mt -67.8 138.29 22.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.616 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -106.75 -170.83 1.78 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.118 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 15.3 pt-20 -57.67 -29.43 64.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.938 0.399 . . . . 0.0 111.691 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -64.71 -22.97 67.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.539 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.08 -1.4 62.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.929 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -108.32 148.02 36.78 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 55.0 Cg_endo -70.96 128.59 15.13 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.9 2.4 . . . . 0.0 112.732 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -116.49 127.64 54.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.061 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.86 126.69 28.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.963 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.0 t -144.67 160.54 41.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.317 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 p -140.47 142.51 35.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.096 0.474 . . . . 0.0 111.184 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' A' ' 99' ' ' MET . 2.6 mp -123.69 143.8 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.691 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -104.14 92.65 4.46 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.839 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -56.35 -23.45 37.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.299 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -54.9 -32.69 61.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.955 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -100.78 11.29 39.86 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.771 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 52.6 m-85 -128.55 -26.91 2.68 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.4 mp -110.66 142.08 24.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.72 0.295 . . . . 0.0 110.825 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.711 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -121.21 166.12 14.18 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.13 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -113.16 111.79 22.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.422 0.629 . . . . 0.0 110.23 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -110.59 113.27 25.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.411 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.711 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 14.7 t30 57.12 36.18 27.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.04 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.97 13.84 82.63 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.798 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -118.93 145.69 45.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.582 0.23 . . . . 0.0 110.767 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.4 mp -73.84 113.8 11.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.739 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 7.2 tp10 -104.91 133.35 49.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.376 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.714 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.87 -68.93 0.2 Allowed Pre-proline 0 CA--C 1.425 -3.836 0 O-C-N 124.352 1.033 . . . . 0.0 113.152 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.714 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 6.8 Cg_endo -109.6 129.43 0.04 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.441 0 C-N-CA 113.763 -3.691 . . . . 0.0 113.31 -177.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.711 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -161.02 -160.35 10.65 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 113.998 -1.456 . . . . 0.0 113.46 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -154.73 140.6 18.2 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.962 0.448 . . . . 0.0 110.468 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m 52.39 46.78 26.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -72.19 -38.92 68.96 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.98 -18.73 48.52 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.533 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.5 m -64.92 -20.43 66.45 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 122.74 0.416 . . . . 0.0 111.12 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.0 m -143.69 28.15 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.078 0.466 . . . . 0.0 110.74 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.5 m -131.44 145.79 51.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.563 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.3 173.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.615 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mptt 61.65 41.8 11.72 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.689 0.618 . . . . 0.0 111.265 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.497 HG21 ' O ' ' A' ' 16' ' ' GLY . 7.5 p -68.75 123.88 22.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.605 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.88 156.7 38.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.155 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.932 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -113.61 112.88 24.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.717 0.294 . . . . 0.0 110.981 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -76.9 117.52 18.58 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.203 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.735 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 20.8 t70 61.63 5.48 1.27 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.837 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.47 35.7 41.0 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.969 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.735 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.0 p80 -148.91 -26.34 0.3 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 111.274 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 m -115.71 129.93 56.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.911 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.604 ' HA ' HD22 ' A' ' 64' ' ' LEU . 17.9 tp -90.36 136.78 32.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.51 129.55 46.2 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -163.25 166.51 23.09 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.404 0.44 . . . . 0.0 110.725 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 t -116.06 127.33 54.79 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 18.5 m -127.65 156.43 42.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.214 0.53 . . . . 0.0 112.065 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 10.5 tmtt? -99.72 152.29 20.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.425 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.45 -26.4 1.22 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.103 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.711 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -54.28 -42.14 69.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.843 0.354 . . . . 0.0 111.481 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -178.68 58.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.391 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.471 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 73.06 -2.92 32.22 Favored Glycine 0 CA--C 1.518 0.225 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.135 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -118.75 165.23 14.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.805 0.336 . . . . 0.0 110.421 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 49.1 p90 -104.41 166.36 10.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.679 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -151.14 152.07 32.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.691 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.47 129.4 34.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.23 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.9 p -148.25 170.54 17.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 0.0 111.462 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.53 165.69 25.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.874 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.683 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 9.3 tpt -143.54 113.27 7.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.491 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.544 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 21.8 t70 -72.31 104.01 3.58 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.789 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.8 mt -76.36 -8.54 57.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.322 -177.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.544 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 8.0 m120 -49.88 -28.56 6.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.575 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 48.7 p90 -117.53 21.5 12.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.187 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -129.11 -14.79 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.606 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.2 t -133.58 147.0 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -143.78 149.73 21.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.167 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.484 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.7 t30 -89.37 116.63 27.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -116.94 84.37 2.13 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.365 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 26' ' ' GLU . 78.5 m-85 61.44 53.99 3.25 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.485 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.48 28.05 64.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.943 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -130.35 142.27 50.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.634 ' HB2' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -74.61 106.66 6.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.566 0.698 . . . . 0.0 112.507 -178.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -137.5 78.83 37.08 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.418 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 39.7 Cg_endo -65.71 104.97 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 123.296 2.664 . . . . 0.0 112.853 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -102.7 120.16 40.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.231 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -84.32 147.0 27.43 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.9 19.11 15.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.004 0.43 . . . . 0.0 111.64 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.502 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 48.7 m -152.66 -129.03 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.797 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.0 t30 69.5 3.14 4.05 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.788 0.835 . . . . 0.0 111.55 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 66.89 -60.48 0.35 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.696 0.798 . . . . 0.0 111.749 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -161.02 -64.48 0.06 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.134 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -156.13 -52.04 0.08 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.543 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.3 t -101.31 87.08 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.511 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 111' ' ' LEU . 2.6 pt? -86.12 1.12 51.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.798 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -76.26 118.74 19.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.41 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.2 p -76.25 77.67 3.04 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.577 0.703 . . . . 0.0 109.484 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 t -155.21 142.92 19.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.097 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.7 m -70.2 -30.01 67.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.071 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 . . . . . 0 C--O 1.245 0.837 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.404 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -134.56 131.56 38.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.783 0.325 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 91.7 m -90.07 -51.74 5.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.813 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 51.97 73.66 0.31 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.4 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.551 ' CD1' HG13 ' A' ' 92' ' ' VAL . 1.9 p90 -58.31 -36.89 74.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 111.164 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.19 -22.21 60.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.83 -20.47 65.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.695 0.283 . . . . 0.0 111.404 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.43 ' HB2' HD22 ' A' ' 94' ' ' ASN . 18.7 m -135.33 16.65 3.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 97.7 m -124.58 136.9 54.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.78 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -132.95 147.77 52.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.293 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.19 43.3 80.92 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.748 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 12' ' ' VAL . 3.1 m -81.99 119.48 31.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.436 0.636 . . . . 0.0 111.507 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.89 133.38 56.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.766 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.812 HD22 HD23 ' A' ' 64' ' ' LEU . 42.7 tp -108.14 121.08 44.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.471 ' O ' HG12 ' A' ' 18' ' ' ILE . 85.7 m-85 -124.74 105.18 9.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.689 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.35 -66.95 2.23 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.512 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 6.4 p90 -164.59 18.64 0.05 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.695 0.398 . . . . 0.0 111.24 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 15' ' ' TYR . 30.7 pt -122.26 133.96 66.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.128 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.698 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.3 mt -114.12 114.63 26.32 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.274 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -118.01 140.9 49.08 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.95 -174.37 37.47 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.277 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 8.2 m-20 -109.21 108.69 19.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.576 0.227 . . . . 0.0 110.54 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 74.9 m -106.81 132.37 52.86 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 53.6 mt -68.26 140.72 18.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.6 p30 -108.96 -174.99 2.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.986 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -50.53 -36.67 35.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.66 0.384 . . . . 0.0 111.993 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -59.39 -25.31 64.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.806 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.64 4.91 59.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.367 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -112.84 146.95 36.13 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.345 -0.428 . . . . 0.0 110.137 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.567 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 56.5 Cg_endo -72.02 133.75 22.09 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.907 2.405 . . . . 0.0 112.903 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -121.82 130.51 53.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.619 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.82 129.67 40.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.041 0.448 . . . . 0.0 111.337 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.0 t -144.07 160.16 41.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.745 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.9 p -140.02 140.02 36.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.61 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -124.61 144.87 33.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 123.225 0.328 . . . . 0.0 110.401 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -102.98 91.48 4.14 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -58.3 -26.14 62.68 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.081 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.52 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 42.3 t30 -59.19 -20.38 53.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -105.62 8.13 33.04 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.432 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -129.13 -25.54 2.73 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -107.85 140.52 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.697 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.31 164.6 12.12 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.239 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -113.61 108.29 16.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.125 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -110.76 108.95 18.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.328 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 43.9 m-20 53.96 39.18 30.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.187 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 80.27 19.0 70.28 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.042 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.27 154.99 39.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.045 0.45 . . . . 0.0 111.096 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.497 HD13 ' HG ' ' A' ' 70' ' ' LEU . 51.6 mt -88.1 113.78 24.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.363 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -109.09 138.21 45.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.477 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.687 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -38.9 -71.74 0.12 Allowed Pre-proline 0 CA--C 1.426 -3.79 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 2.5 Cg_endo -107.92 129.29 0.05 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.234 0 C-N-CA 113.876 -3.616 . . . . 0.0 113.209 -176.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.697 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -165.2 -162.97 17.47 Favored Glycine 0 C--N 1.284 -2.324 0 CA-C-N 113.976 -1.466 . . . . 0.0 113.408 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -156.28 144.73 19.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.445 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.0 t 59.59 41.75 18.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.725 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 17.1 p90 -72.26 -37.57 69.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.45 -18.69 44.79 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.322 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 t -61.87 -20.67 63.97 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 110.63 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 m -144.46 24.34 1.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 111.02 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.2 m -124.95 139.83 53.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.262 0.554 . . . . 0.0 111.467 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.91 177.12 6.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.041 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 61.75 39.78 13.72 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.284 0.365 . . . . 0.0 111.431 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 p -70.43 126.47 29.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.956 0.408 . . . . 0.0 111.92 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.56 150.34 29.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.866 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.812 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -105.62 113.52 27.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.95 0.405 . . . . 0.0 111.218 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -84.21 123.64 30.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.645 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 18.2 t70 61.0 8.24 1.83 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.768 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.55 30.83 68.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.993 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.409 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -150.7 -20.43 0.22 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.883 0.342 . . . . 0.0 111.453 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.458 ' O ' HD13 ' A' ' 64' ' ' LEU . 40.7 m -116.03 135.65 53.75 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.493 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.497 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.0 tp -97.6 129.78 44.69 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.66 129.85 53.07 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.62 173.11 17.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.067 0.46 . . . . 0.0 110.788 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.7 t -119.95 119.27 32.98 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.475 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.6 m -122.52 146.79 47.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.8 tmtt? -100.54 146.38 27.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.01 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.0 -24.75 0.41 Allowed Glycine 0 C--O 1.227 -0.328 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.477 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -68.97 -34.34 75.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.623 0.712 . . . . 0.0 111.828 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -169.64 54.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.187 0.517 . . . . 0.0 110.542 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.53 -1.77 8.91 Favored Glycine 0 CA--C 1.518 0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.143 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.56 160.55 22.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.808 0.337 . . . . 0.0 110.825 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 49.3 p90 -97.63 168.63 10.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.395 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -155.72 148.67 24.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.823 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.19 132.87 45.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.121 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -152.35 161.1 43.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.558 0.694 . . . . 0.0 112.131 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.47 159.74 41.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.919 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.526 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 7.8 tpt -146.29 116.96 7.6 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.615 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.444 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 32.9 t0 -77.02 104.39 7.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.409 0.623 . . . . 0.0 110.342 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.784 ' HA ' HG22 ' A' ' 91' ' ' VAL . 12.5 mt -73.81 -8.32 55.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.403 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -47.19 -31.73 3.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.794 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 42.0 p90 -118.79 24.35 10.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.79 0.329 . . . . 0.0 111.602 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.784 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -130.39 -4.32 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.044 0.45 . . . . 0.0 110.996 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 9.1 p -153.03 144.29 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.341 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -139.18 -171.78 12.34 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.282 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.43 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.4 t30 -132.5 137.92 47.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.828 0.347 . . . . 0.0 110.849 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.627 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 4.0 t -144.57 116.72 8.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 60.2 41.45 16.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.499 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 58.37 31.32 66.12 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.899 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -136.51 149.27 48.06 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 99' ' ' MET . 19.7 ptt? -55.44 127.11 28.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.442 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.627 ' HG3' ' CB ' ' A' ' 95' ' ' SER . 6.7 mm-40 -142.12 77.78 17.77 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.296 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 43.0 Cg_endo -68.82 93.5 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.561 2.174 . . . . 0.0 113.103 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.7 p -111.23 116.53 31.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.28 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.726 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -91.34 147.07 23.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.769 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.23 34.93 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.37 0.605 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.454 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 74.8 m -154.95 -132.79 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 63.93 19.87 11.94 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.822 0.82 . . . . 0.0 110.466 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.08 156.67 38.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.129 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.43 93.82 4.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.276 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -162.31 176.57 10.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.27 83.05 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.529 0.68 . . . . 0.0 110.265 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 111' ' ' LEU . 2.4 pt? -90.99 73.21 6.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.698 0.761 . . . . 0.0 110.366 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -78.08 42.26 0.39 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.869 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.8 t 54.19 28.14 8.69 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.289 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.1 t -166.24 147.06 6.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.343 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.9 m -77.82 -16.73 58.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.386 0.612 . . . . 0.0 109.39 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--O 1.248 1.013 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.492 179.091 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 tpt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -83.05 151.56 25.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.856 0.36 . . . . 0.0 110.968 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.625 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 94.3 m -122.15 -76.03 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.277 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 62.56 83.9 0.15 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.528 ' CD1' HG13 ' A' ' 92' ' ' VAL . 3.3 p90 -64.46 -36.97 85.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.078 0.466 . . . . 0.0 111.167 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -63.12 -20.43 65.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.331 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -52.47 -32.83 41.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.122 0.487 . . . . 0.0 111.417 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.414 ' HB2' HD22 ' A' ' 94' ' ' ASN . 21.2 m -138.73 35.76 2.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.263 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -128.77 135.27 48.94 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.093 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.3 p -132.56 162.53 31.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.361 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.17 54.98 32.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.353 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 32.9 m -95.81 138.88 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.413 . . . . 0.0 111.263 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -134.99 140.67 45.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.888 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.775 HD22 HD23 ' A' ' 64' ' ' LEU . 20.1 tp -120.97 116.84 25.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.011 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.522 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.3 t80 -125.14 104.04 8.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.869 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.98 -68.45 2.83 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.553 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 39.6 p90 -163.81 19.54 0.07 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 122.445 0.298 . . . . 0.0 111.21 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 15' ' ' TYR . 38.8 pt -114.4 126.69 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.712 0.291 . . . . 0.0 110.729 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.923 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.15 113.95 26.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.0 ttm180 -119.08 139.18 52.19 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.388 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.555 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -160.96 168.99 36.48 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.632 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 9.2 m-20 -97.3 105.79 18.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -104.16 131.73 51.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.8 mt -74.61 135.86 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.097 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -95.1 -179.96 5.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.632 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -50.4 -39.93 48.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.63 -24.42 65.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.64 1.38 46.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.41 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -101.99 139.67 20.51 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 57.8 Cg_endo -72.12 135.14 24.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.886 2.39 . . . . 0.0 112.188 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -125.21 126.11 44.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.154 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.13 122.74 18.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.987 0.423 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 t -136.94 158.86 43.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.809 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 p -138.95 143.01 38.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.623 0.249 . . . . 0.0 110.909 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.32 146.74 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.572 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.42 ' OD1' HG22 ' A' ' 18' ' ' ILE . 80.6 m-20 -100.5 96.86 7.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.073 0.463 . . . . 0.0 110.244 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.923 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -60.43 -26.69 66.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.207 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.3 t-20 -53.93 -34.01 58.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.09 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -102.72 11.46 37.61 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.0 m-85 -127.37 -21.8 3.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.73 139.95 35.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.67 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.3 165.55 12.07 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.177 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -110.71 106.22 15.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.613 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -112.17 107.37 16.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.751 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.822 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 39.7 t30 60.8 39.43 17.16 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.93 17.74 79.46 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.559 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.47 144.4 50.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.834 0.35 . . . . 0.0 111.045 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.2 mp -72.69 123.76 23.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.883 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.484 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 10.3 tp10 -113.95 139.33 49.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.696 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -41.79 -69.42 0.22 Allowed Pre-proline 0 CA--C 1.426 -3.799 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.867 -179.437 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.696 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 3.5 Cg_endo -110.3 131.36 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.323 0 C-N-CA 113.81 -3.66 . . . . 0.0 113.2 -177.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -162.45 -159.29 10.2 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 114.108 -1.406 . . . . 0.0 113.604 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -155.17 144.94 21.45 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 124.026 0.486 . . . . 0.0 110.869 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 m 51.41 43.92 29.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -73.03 -38.8 66.41 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.23 -18.6 49.75 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.515 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.3 m -64.71 -24.79 67.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.846 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 m -136.86 20.27 3.05 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.9 m -126.56 140.42 52.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.522 HG23 ' HE2' ' A' ' 61' ' ' LYS . 27.8 m -131.27 176.45 8.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.146 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.522 ' HE2' HG23 ' A' ' 60' ' ' VAL . 2.4 mppt? 58.75 44.85 16.51 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.451 0.47 . . . . 0.0 111.248 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 p -71.41 123.19 21.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.611 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.3 163.09 38.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.305 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.775 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -121.24 112.65 18.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 0.0 111.524 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.07 119.27 20.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.294 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.842 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.6 t70 51.99 26.51 3.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 124.087 0.867 . . . . 0.0 110.956 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 6' ' ' ALA . . . 58.35 32.63 68.48 Favored Glycine 0 C--O 1.224 -0.472 0 CA-C-N 115.663 -0.698 . . . . 0.0 113.722 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.842 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 11.0 p80 -141.35 -29.82 0.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.708 0.754 . . . . 0.0 111.661 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 m -116.28 131.06 57.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.802 0.334 . . . . 0.0 111.359 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.589 ' HA ' HD22 ' A' ' 64' ' ' LEU . 16.1 tp -90.74 131.93 36.13 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -122.38 130.43 53.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.783 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -160.58 165.37 30.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 t -111.63 120.58 42.54 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 34.8 m -119.29 152.43 36.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 9.0 tmtt? -99.85 144.66 28.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.689 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.79 -27.85 0.66 Allowed Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.629 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.822 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.6 -40.3 75.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -174.33 54.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.349 0.595 . . . . 0.0 109.93 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 67.81 6.51 44.42 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.112 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 28.8 pt20 -126.01 169.91 12.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 45.7 p90 -98.78 171.55 8.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.822 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -160.21 145.2 14.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -76.41 132.87 39.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.21 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.9 p -152.1 166.22 32.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 111.369 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.5 OUTLIER -138.81 162.66 34.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.426 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.62 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 16.9 tpp -147.92 117.87 7.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.5 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 37.8 t0 -74.44 107.65 6.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.202 0.525 . . . . 0.0 109.677 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.72 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.8 mt -76.04 -9.52 58.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.523 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.411 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 1.8 m120 -48.41 -29.43 4.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.602 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 47.2 p90 -119.23 21.67 12.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.698 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -127.7 -10.46 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.037 0.446 . . . . 0.0 110.693 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.802 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.1 p -150.78 141.62 16.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.356 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.625 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -133.86 -168.51 11.84 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.063 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.414 HD22 ' HB2' ' A' ' 8' ' ' SER . 15.6 t30 -132.54 127.68 35.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.281 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.592 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 68.5 m -139.1 112.2 8.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.76 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 57.49 40.45 27.13 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.512 0.507 . . . . 0.0 111.185 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.44 20.05 58.42 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.743 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -116.74 147.13 42.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.721 0.296 . . . . 0.0 110.279 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 99' ' ' MET . 20.1 ptt? -61.48 117.31 5.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.367 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 19.0 mm-40 -135.03 79.33 51.22 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.735 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.802 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 53.7 Cg_endo -71.33 82.98 1.04 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.799 2.332 . . . . 0.0 112.392 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 p -104.28 127.26 51.9 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.433 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.558 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -111.71 149.96 30.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.191 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.38 39.92 1.36 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.136 0.493 . . . . 0.0 111.008 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.451 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 58.2 m -159.09 -127.07 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.1 t30 70.23 -68.35 0.21 Allowed 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 123.706 0.802 . . . . 0.0 110.902 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.48 -25.2 23.83 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.474 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -90.78 47.76 1.45 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.749 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -166.09 157.53 13.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.165 0.507 . . . . 0.0 110.168 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 m -79.3 77.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.616 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.1 tp -112.58 33.02 5.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.908 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -80.44 117.71 21.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.689 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 p -79.14 62.3 3.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.198 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.2 m -147.22 115.6 6.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.109 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 p -64.59 -44.73 89.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.552 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.834 179.877 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.795 0.331 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -89.81 149.3 22.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.522 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 78.4 m -74.97 -76.18 0.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.417 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 m120 54.79 75.68 0.29 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 15.0 p90 -60.18 -36.83 78.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.181 0.515 . . . . 0.0 110.94 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -69.16 -22.72 63.91 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -60.06 -25.43 65.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.931 0.396 . . . . 0.0 111.319 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.457 ' HB2' HD22 ' A' ' 94' ' ' ASN . 16.3 m -132.04 29.97 4.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.664 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -131.23 140.11 49.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -133.32 150.53 51.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.29 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.97 73.65 0.46 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.531 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 ' HA3' ' A' ' 21' ' ' GLY . 33.3 m -112.0 144.39 19.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.837 0.351 . . . . 0.0 111.249 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -128.45 155.67 44.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.215 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.719 HD22 HD23 ' A' ' 64' ' ' LEU . 23.1 tp -132.18 109.38 9.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.026 0.441 . . . . 0.0 110.59 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.477 ' O ' HG12 ' A' ' 18' ' ' ILE . 80.4 m-85 -114.37 100.43 8.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' HG21 ' A' ' 62' ' ' THR . . . 77.56 -63.64 3.36 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.919 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.415 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 8.7 p90 -166.04 23.45 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.618 0.247 . . . . 0.0 111.633 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 15' ' ' TYR . 42.2 pt -121.73 133.53 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.808 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -112.65 120.16 40.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.863 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -127.96 139.71 52.42 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.876 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.572 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.35 -175.51 37.38 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.335 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 3.6 m-20 -106.84 107.66 18.79 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 m -105.19 131.84 52.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 72.0 mt -72.46 137.43 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -100.82 -175.18 2.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.123 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.3 -27.5 62.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 112.048 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.62 -26.36 68.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.64 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.44 2.78 55.55 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.926 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -112.18 142.11 26.27 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.722 0.296 . . . . 0.0 110.374 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 42.1 Cg_endo -68.7 136.64 36.5 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.981 2.454 . . . . 0.0 112.596 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -123.87 134.27 53.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.132 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.83 126.06 28.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.431 . . . . 0.0 111.241 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 t -141.09 160.31 40.36 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.579 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -139.45 145.45 38.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.978 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.58 145.29 35.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.81 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -102.66 95.44 6.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.808 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.99 -26.7 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.691 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.415 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.0 t-20 -55.25 -27.91 49.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.281 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -104.7 7.94 34.95 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 30.9 m-85 -128.22 -21.94 3.5 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.2 mp -113.59 141.2 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.497 0.189 . . . . 0.0 110.722 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.658 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -118.61 170.07 13.66 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.371 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -109.56 110.89 22.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.963 0.411 . . . . 0.0 110.928 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -110.78 106.91 16.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.589 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 12.0 t30 52.12 41.55 30.08 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.909 0.484 . . . . 0.0 111.508 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.96 16.18 77.48 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.21 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.23 153.64 41.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.06 0.457 . . . . 0.0 110.92 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.578 HD13 ' HG ' ' A' ' 70' ' ' LEU . 37.1 mt -81.4 114.07 19.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.305 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.626 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.1 tt0 -107.31 132.75 52.78 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.772 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -32.49 -69.94 0.12 Allowed Pre-proline 0 CA--C 1.425 -3.837 0 O-C-N 124.762 1.289 . . . . 0.0 114.047 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.772 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -108.77 133.59 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.321 0 C-N-CA 113.939 -3.574 . . . . 0.0 112.655 -177.636 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.658 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -168.61 -162.94 21.73 Favored Glycine 0 C--N 1.283 -2.389 0 C-N-CA 119.559 -1.305 . . . . 0.0 113.65 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -154.29 146.3 23.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.352 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.1 m 53.43 41.9 32.05 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -71.93 -35.51 69.65 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.14 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.09 -18.64 57.96 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.259 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -63.32 -24.29 67.79 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.494 -0.353 . . . . 0.0 111.136 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -136.46 22.08 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.095 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.4 m -126.89 148.37 50.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.128 0.489 . . . . 0.0 111.476 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.413 HG23 ' HD3' ' A' ' 61' ' ' LYS . 30.5 m -138.11 173.75 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.532 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 73' ' ' SER . 0.1 OUTLIER 58.83 40.38 22.93 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.452 0.47 . . . . 0.0 111.648 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 16' ' ' GLY . 6.4 p -65.97 118.46 9.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.085 0.469 . . . . 0.0 111.822 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.91 149.56 31.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.095 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.719 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -109.0 115.02 29.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.772 0.32 . . . . 0.0 110.761 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -88.8 124.77 34.48 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.751 0.31 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.883 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 17.1 t70 58.1 19.74 6.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.603 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.436 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 58.43 31.31 66.31 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.929 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.883 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.5 p80 -139.36 -32.41 0.65 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.561 0.68 . . . . 0.0 111.142 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -116.01 131.9 56.81 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.268 0.556 . . . . 0.0 111.747 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.645 ' HA ' HD22 ' A' ' 64' ' ' LEU . 9.1 tp -90.1 130.84 36.22 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.613 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 129.22 53.88 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.0 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.85 164.36 31.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.446 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 7.7 t -111.76 124.37 52.2 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 21.9 m -126.47 150.09 48.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.325 0.583 . . . . 0.0 112.042 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.4 tmtt? -99.36 146.74 25.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.419 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.87 -30.69 0.66 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.209 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.589 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.09 -42.32 76.56 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -169.9 54.86 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.422 0.63 . . . . 0.0 110.293 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.449 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 67.54 3.43 26.49 Favored Glycine 0 C--N 1.328 0.108 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.454 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.7 160.78 25.15 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 12.2 p90 -101.98 169.88 8.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.851 0.358 . . . . 0.0 110.643 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -157.86 138.73 13.16 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.78 121.2 25.08 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.518 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.2 p -133.08 -179.81 5.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.148 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.48 164.51 28.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.044 0.449 . . . . 0.0 110.658 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.475 ' HB2' ' CB ' ' A' ' 48' ' ' LEU . 9.2 tpt -145.86 113.72 6.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.96 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.65 105.84 5.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.555 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.782 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.4 mt -75.78 -9.0 58.23 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.697 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -50.88 -26.04 5.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.591 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 51.4 p90 -119.41 22.21 11.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.325 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.782 HG22 ' HA ' ' A' ' 88' ' ' LEU . 2.2 m -127.62 -14.99 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.849 0.357 . . . . 0.0 110.569 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -139.22 145.42 27.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.924 177.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.522 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -134.18 179.96 17.01 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.89 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.457 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.5 t30 -131.85 127.79 37.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.684 0.278 . . . . 0.0 110.921 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.638 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 64.2 m -135.14 107.36 7.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.234 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 60.93 42.58 12.73 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.751 0.657 . . . . 0.0 110.622 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.26 22.47 63.16 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.692 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -118.24 147.18 43.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.484 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' A' ' 99' ' ' MET . 20.3 ptt? -60.82 121.08 11.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.043 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.638 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 57.6 mm-40 -137.02 80.45 35.51 Favored Pre-proline 0 CA--C 1.516 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.346 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 44.5 Cg_endo -68.81 89.02 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.672 2.248 . . . . 0.0 112.962 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.7 p -114.66 123.55 49.58 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.215 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -99.94 149.81 23.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.386 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -100.33 23.51 10.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.939 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.446 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 68.9 m -145.67 -141.11 0.12 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.631 ' HB2' ' HG3' ' A' ' 51' ' ' PRO . 29.0 t-20 64.05 104.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.592 0.757 . . . . 0.0 111.584 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.96 -28.19 19.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.389 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -133.12 133.16 42.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -78.15 -28.39 48.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.15 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.64 73.19 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 122.57 1.176 . . . . 0.0 110.339 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.719 ' H ' HD23 ' A' ' 111' ' ' LEU . 2.7 pt? -104.57 23.57 13.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.159 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -80.52 100.61 8.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.088 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.6 t -80.84 79.85 7.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.227 0.537 . . . . 0.0 109.663 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.9 m -155.31 -173.49 4.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.229 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.9 m -84.08 -53.14 5.74 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.623 -179.654 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 65.45 -171.83 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.98 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.463 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 35.0 m -122.85 -74.44 0.62 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.608 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.788 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 49.4 m-80 60.67 71.06 0.58 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.637 ' CD1' HG13 ' A' ' 92' ' ' VAL . 5.1 p90 -66.24 -37.5 85.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.025 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.56 -20.0 65.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.204 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.788 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 44.2 t-20 -51.57 -39.11 57.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.026 0.441 . . . . 0.0 110.769 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.474 ' HB2' HD22 ' A' ' 94' ' ' ASN . 19.2 m -132.01 27.71 4.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -118.53 139.99 50.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.012 0.434 . . . . 0.0 111.051 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -137.01 152.26 49.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.647 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.05 57.23 14.41 Favored Glycine 0 N--CA 1.455 -0.082 0 O-C-N 123.527 0.517 . . . . 0.0 112.764 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.563 HG12 ' HA3' ' A' ' 21' ' ' GLY . 15.9 m -101.17 134.03 42.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.065 0.459 . . . . 0.0 111.852 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -127.72 153.14 46.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.263 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.742 HD22 HD23 ' A' ' 64' ' ' LEU . 23.7 tp -128.33 120.55 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.97 0.414 . . . . 0.0 111.991 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.448 ' O ' HG12 ' A' ' 18' ' ' ILE . 73.0 t80 -126.66 108.55 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 62' ' ' THR . . . 78.5 -73.35 2.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.3 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -164.0 23.38 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.821 0.343 . . . . 0.0 111.377 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 15' ' ' TYR . 24.7 pt -121.13 127.84 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.702 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.857 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -109.29 114.59 28.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.176 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.06 139.74 51.22 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.014 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.563 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -165.93 -175.39 36.32 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.139 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 3.5 m-20 -107.89 108.05 19.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.572 0.225 . . . . 0.0 110.577 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -105.72 131.36 53.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 8' ' ' SER . 53.1 mt -69.65 140.78 18.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.982 0.42 . . . . 0.0 111.904 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -108.05 -172.8 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.331 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 7.2 tp10 -49.85 -41.79 45.96 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.469 0.48 . . . . 0.0 112.153 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.87 -22.97 63.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.408 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.78 5.03 60.14 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.346 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -109.47 145.39 31.8 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.483 -0.359 . . . . 0.0 110.573 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 38.3 Cg_endo -66.74 131.53 26.12 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.98 2.453 . . . . 0.0 112.52 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -115.24 130.64 56.97 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.503 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.65 120.16 12.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.715 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -140.94 159.52 42.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.386 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 p -140.16 148.02 41.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.029 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 99' ' ' MET . 3.5 mp -126.94 147.61 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.373 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -105.53 85.9 2.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.857 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -54.39 -25.29 23.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.046 0.451 . . . . 0.0 111.383 -178.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 23.1 t-20 -53.47 -24.81 13.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.391 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -113.5 10.36 18.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -126.79 -8.2 6.13 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 111.309 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.582 HD11 HD22 ' A' ' 88' ' ' LEU . 3.0 mp -127.41 134.55 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -117.04 -177.33 17.78 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 23.9 p-10 -127.96 101.66 6.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.648 0.737 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.92 113.81 27.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.957 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.43 ' CG ' ' HA ' ' A' ' 77' ' ' ALA . 8.4 t-20 58.84 36.69 24.81 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.645 0.736 . . . . 0.0 110.129 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.6 19.75 78.95 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.992 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -122.45 146.1 47.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.654 0.264 . . . . 0.0 110.432 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.5 mp -72.04 120.78 18.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.401 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.523 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 6.1 pt-20 -108.16 138.73 43.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.426 0.632 . . . . 0.0 110.254 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -58.8 -24.15 1.44 Allowed Pre-proline 0 CA--C 1.447 -2.991 0 N-CA-C 118.125 2.639 . . . . 0.0 118.125 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.601 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 4.4 Cg_endo -129.5 12.16 0.0 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.771 1 C-N-CA 112.787 -4.342 . . . . 0.0 116.353 179.253 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -62.13 -176.23 2.52 Favored Glycine 0 C--N 1.259 -3.707 0 CA-C-N 111.266 -2.697 . . . . 0.0 115.547 -176.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -146.95 147.98 31.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m 58.48 45.41 16.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.046 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 9.5 p90 -74.11 -38.26 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.01 -23.74 47.65 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.444 -0.408 . . . . 0.0 112.317 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -62.02 -18.1 59.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.293 -0.453 . . . . 0.0 111.365 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 m -148.93 27.54 0.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.614 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.3 m -132.24 145.09 51.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.985 0.422 . . . . 0.0 111.052 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.41 HG23 ' HD3' ' A' ' 61' ' ' LYS . 22.2 m -136.39 176.85 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.253 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.41 ' HD3' HG23 ' A' ' 60' ' ' VAL . 2.2 mptm? 61.9 40.65 12.31 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.241 0.338 . . . . 0.0 111.659 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 16' ' ' GLY . 2.4 p -69.13 123.03 19.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.094 0.473 . . . . 0.0 112.05 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.41 161.97 41.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.718 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.742 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -123.17 113.79 19.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.872 0.368 . . . . 0.0 111.34 -178.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.32 122.09 28.0 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.009 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.695 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 28.2 t70 52.5 25.24 3.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.776 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.49 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 56.62 39.62 86.02 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.624 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.695 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.9 p80 -149.24 -30.88 0.24 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 117.249 0.524 . . . . 0.0 111.078 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.428 ' O ' HD13 ' A' ' 64' ' ' LEU . 5.7 m -116.02 130.6 56.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.801 0.334 . . . . 0.0 111.282 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.691 ' HB2' HD11 ' A' ' 88' ' ' LEU . 14.0 tp -93.26 131.22 38.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.975 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.59 129.81 56.0 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.069 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.483 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -162.36 162.93 28.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 110.528 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 t -111.36 125.29 53.7 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 34.8 m -125.06 156.06 38.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -98.45 148.89 23.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.685 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.67 -28.37 0.84 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.269 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 45' ' ' ASN . . . -55.53 -42.64 74.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.841 0.353 . . . . 0.0 111.564 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -172.98 56.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.765 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.92 2.39 38.02 Favored Glycine 0 C--O 1.229 -0.213 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.45 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -122.87 162.45 22.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 48.2 p90 -91.45 160.85 15.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.713 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -146.98 147.17 30.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.53 135.5 35.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 p -155.7 173.19 17.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.744 0.307 . . . . 0.0 111.259 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.84 164.28 30.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.843 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.68 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.3 tpt -149.99 119.64 7.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.553 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' OD2' ' HB3' ' A' ' 89' ' ' ASN . 25.2 t0 -73.28 108.9 6.42 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.7 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.0 mt -81.59 -9.12 59.75 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.327 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.425 ' HB3' ' OD2' ' A' ' 87' ' ' ASP . 25.4 t-20 -47.88 -29.48 3.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.648 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -117.11 15.82 15.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.557 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -120.24 -3.58 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.654 0.74 . . . . 0.0 110.294 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 1.069 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.3 p -155.46 131.18 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.017 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.463 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -126.12 179.67 16.16 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.128 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.474 HD22 ' HB2' ' A' ' 8' ' ' SER . 21.9 t30 -118.62 126.17 51.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.441 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.486 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 72.7 m -130.27 97.3 4.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.547 ' CD2' ' HB2' ' A' ' 26' ' ' GLU . 71.8 m-85 61.7 52.38 3.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.262 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.36 16.79 60.98 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.814 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -119.87 143.13 48.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.401 ' HB2' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -72.31 120.99 18.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.218 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 25.1 mm-40 -127.71 75.57 77.79 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.47 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 1.069 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.7 Cg_endo -72.4 103.89 1.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.964 2.443 . . . . 0.0 112.391 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.23 110.35 22.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.713 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.38 150.52 38.35 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.45 99.25 10.92 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.2 m 74.96 -66.12 0.31 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.155 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.601 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 17.0 t-20 60.48 100.06 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.274 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -154.87 132.39 11.26 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.336 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -78.68 -22.75 46.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.361 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -124.5 -60.44 1.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.816 0.341 . . . . 0.0 111.55 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.1 m -85.09 55.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.726 0.774 . . . . 0.0 112.165 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.1 tp -82.05 71.06 9.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.557 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -120.22 108.18 13.9 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.796 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 t -60.93 92.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.445 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.8 p -169.75 60.96 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.982 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.5 m -61.39 -43.08 99.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.698 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.793 -179.495 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 ttp . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.569 0.223 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -74.58 125.43 28.62 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.529 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 55.6 m -65.43 -67.96 0.4 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.292 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 2.6 m-20 46.25 73.31 0.18 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.649 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.3 p90 -59.24 -42.45 91.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.566 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.99 -21.38 44.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.67 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 10.6 t-20 -61.0 -28.68 69.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.502 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.52 ' HB2' HD22 ' A' ' 94' ' ' ASN . 50.4 m -139.44 23.9 2.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.871 0.367 . . . . 0.0 111.388 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.5 m -122.21 132.88 54.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.519 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -133.67 160.8 36.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.929 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.76 51.82 56.8 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.366 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.563 HG12 ' HA3' ' A' ' 21' ' ' GLY . 29.8 m -97.59 139.47 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.832 0.349 . . . . 0.0 111.231 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -136.02 151.8 50.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.583 HD22 HD23 ' A' ' 64' ' ' LEU . 13.1 tp -119.35 110.1 16.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.098 0.475 . . . . 0.0 111.661 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' HG12 ' A' ' 18' ' ' ILE . 36.2 m-85 -106.1 98.58 8.24 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' O ' HG21 ' A' ' 62' ' ' THR . . . 71.27 -65.13 0.99 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.16 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.433 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 4.3 p90 -156.34 12.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.782 -0.246 . . . . 0.0 111.645 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 15' ' ' TYR . 44.9 pt -114.45 133.54 60.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 110.896 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.818 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.29 113.97 26.48 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.118 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.3 ttm105 -120.28 138.38 53.71 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.563 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -158.85 -177.44 31.94 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.825 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.3 m-20 -108.51 103.5 12.64 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.454 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 66.2 m -107.13 131.98 53.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.845 0.355 . . . . 0.0 110.288 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.8 mt -70.14 139.18 20.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.1 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 6.3 p30 -112.01 -168.62 1.34 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.509 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.29 -28.11 64.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.726 0.298 . . . . 0.0 111.788 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.96 -28.51 69.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.01 0.433 . . . . 0.0 111.345 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.8 -9.29 60.12 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.424 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -101.39 142.84 25.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.641 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 24.3 Cg_endo -64.16 121.74 9.5 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.791 2.327 . . . . 0.0 112.317 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -104.39 134.99 46.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.504 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.26 124.95 25.68 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.497 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.3 t -143.95 159.79 41.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.81 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 p -139.45 154.78 47.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.67 145.5 25.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -100.87 104.6 15.82 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -64.61 -22.16 66.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 25.4 t30 -63.97 -13.23 44.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -108.03 -1.3 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.364 -0.21 . . . . 0.0 110.977 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.413 ' HD1' ' NH2' ' A' ' 103' ' ' ARG . 52.3 m-85 -127.67 -9.43 5.6 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.538 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.6 mp -124.45 134.14 67.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.611 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -113.86 178.16 18.21 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.558 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -113.92 102.57 10.32 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.06 0.457 . . . . 0.0 110.452 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -102.42 103.92 14.36 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 47.48 45.42 17.32 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.535 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.3 14.69 76.0 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.769 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.13 147.39 47.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.041 0.42 . . . . 0.0 111.114 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.601 HD13 ' HG ' ' A' ' 70' ' ' LEU . 25.6 mt -72.35 121.64 19.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.014 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.601 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 6.7 tp10 -110.99 127.23 55.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.267 0.556 . . . . 0.0 110.792 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.575 ' HB3' ' SD ' ' A' ' 86' ' ' MET . 11.5 p90 -49.29 -29.13 1.72 Allowed Pre-proline 0 CA--C 1.453 -2.784 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.601 ' HD2' ' HG3' ' A' ' 49' ' ' GLU . 3.3 Cg_endo -129.57 17.63 0.0 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.764 1 C-N-CA 113.032 -4.179 . . . . 0.0 115.931 179.073 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.611 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -68.36 -174.86 9.13 Favored Glycine 1 C--N 1.254 -4.013 0 CA-C-N 111.16 -2.745 . . . . 0.0 115.508 -176.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -143.45 148.14 35.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.407 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m 57.83 60.47 2.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.915 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 12.5 p90 -90.1 -35.33 15.5 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.791 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.99 -19.03 43.03 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.607 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 m -62.19 -25.22 67.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.323 -0.439 . . . . 0.0 111.353 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.1 m -141.84 27.24 1.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.154 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.9 m -129.02 151.25 49.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.215 0.531 . . . . 0.0 111.732 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.517 HG23 ' HE2' ' A' ' 61' ' ' LYS . 15.7 m -146.81 175.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.25 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HE2' HG23 ' A' ' 60' ' ' VAL . 2.0 mppt? 63.14 41.94 7.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.873 0.368 . . . . 0.0 110.777 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.537 HG21 ' O ' ' A' ' 16' ' ' GLY . 12.5 p -72.1 125.21 26.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.987 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.79 156.68 40.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.802 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.583 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -117.11 112.01 20.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.899 0.38 . . . . 0.0 110.738 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.55 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 11.6 m120 -73.08 117.28 14.62 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.342 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.427 ' HB3' ' ND1' ' A' ' 68' ' ' HIS . 10.2 t70 51.95 21.17 1.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.017 0.823 . . . . 0.0 111.056 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.38 37.61 95.1 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.441 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.44 ' HD2' ' OD1' ' A' ' 87' ' ' ASP . 39.8 p-80 -144.96 -29.99 0.45 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 117.506 0.653 . . . . 0.0 111.296 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 16.9 m -116.6 135.15 54.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.639 0.257 . . . . 0.0 111.072 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.601 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.3 tp -95.91 131.72 41.96 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.62 132.29 54.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.171 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.41 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -164.05 163.5 23.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.375 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.6 t -110.96 125.07 53.32 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.8 m -125.46 148.02 49.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.306 0.574 . . . . 0.0 112.063 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.9 tmtt? -99.61 144.93 28.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.683 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.32 -21.64 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.834 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.17 89.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.878 0.339 . . . . 0.0 111.385 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -173.8 55.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.353 0.597 . . . . 0.0 109.759 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.14 -3.74 20.92 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.603 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -115.44 163.48 15.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.63 0.252 . . . . 0.0 110.604 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 29.4 p90 -103.69 166.99 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.194 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.07 127.49 5.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.419 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.01 123.1 18.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.498 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.2 p -136.79 175.91 9.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.198 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.07 162.27 35.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.902 0.382 . . . . 0.0 110.778 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.575 ' SD ' ' HB3' ' A' ' 50' ' ' TYR . 21.3 tpp -148.83 123.69 9.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.481 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.554 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 24.4 t0 -78.37 106.75 10.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.384 0.612 . . . . 0.0 109.762 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.737 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.6 mt -76.23 -9.52 58.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.733 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.471 ' HB3' ' OD2' ' A' ' 87' ' ' ASP . 27.9 t-20 -51.64 -26.72 9.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.041 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 43.9 p90 -116.86 19.25 14.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.782 0.325 . . . . 0.0 111.375 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.737 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -126.59 -9.25 4.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.108 0.48 . . . . 0.0 110.583 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.918 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 5.5 p -153.82 139.96 11.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.529 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.09 176.73 19.62 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.197 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.52 HD22 ' HB2' ' A' ' 8' ' ' SER . 28.7 t30 -118.57 123.44 45.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.012 0.434 . . . . 0.0 110.276 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.58 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 58.3 m -124.7 99.9 6.38 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.474 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.85 51.02 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.173 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 56.69 27.8 55.8 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.958 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -130.76 141.34 50.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.93 0.395 . . . . 0.0 110.469 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.6 ptm -55.21 116.68 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.349 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 9.9 mm-40 -141.43 75.63 22.32 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.111 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.918 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 61.2 Cg_endo -75.66 112.54 3.54 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.741 2.294 . . . . 0.0 112.156 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p -128.41 130.0 47.0 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.417 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.557 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -113.36 149.68 33.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.546 179.082 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.84 49.96 0.8 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.261 0.553 . . . . 0.0 110.737 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 22.3 p -165.95 -122.83 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 6.4 t30 67.77 -53.02 0.51 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.096 0.958 . . . . 0.0 113.526 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -113.67 -27.86 7.68 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.992 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 105' ' ' SER . 24.0 t70 -144.13 -172.34 3.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.457 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 47.2 t-80 72.91 -67.41 0.27 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.65 0.78 . . . . 0.0 110.958 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.7 p -146.85 94.96 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.989 0.899 . . . . 0.0 110.498 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.7 tp -135.88 73.03 1.45 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.664 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -120.38 101.8 8.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.742 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.3 m -70.56 115.98 10.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.893 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.5 p -115.71 82.48 1.77 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.131 0.491 . . . . 0.0 110.987 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.2 m -67.7 -53.88 23.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.747 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.933 179.589 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.711 0.291 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -88.91 117.21 27.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.91 0.386 . . . . 0.0 110.049 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.506 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 61.4 m -83.99 -74.02 0.39 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.164 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 89' ' ' ASN . 50.5 m-80 51.64 75.45 0.21 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.843 0.457 . . . . 0.0 111.896 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CD1' HG13 ' A' ' 92' ' ' VAL . 3.1 p90 -56.94 -39.8 75.21 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.89 -22.57 38.27 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -68.4 -21.65 64.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.69 0.281 . . . . 0.0 111.569 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.44 ' HB2' HD22 ' A' ' 94' ' ' ASN . 49.9 m -134.29 19.09 3.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.929 0.395 . . . . 0.0 110.903 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 81.4 m -124.8 132.98 53.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.244 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.6 p -126.77 155.14 43.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.262 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.79 63.78 4.79 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.381 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.38 133.93 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.252 0.549 . . . . 0.0 111.473 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.62 136.28 48.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.656 HD22 HD23 ' A' ' 64' ' ' LEU . 23.0 tp -121.64 124.84 45.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.086 0.469 . . . . 0.0 111.07 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -133.35 114.93 14.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.683 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.13 -71.46 1.98 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.007 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -167.81 24.07 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.314 0.646 . . . . 0.0 109.573 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 mt -120.08 113.27 40.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.549 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -99.81 114.82 28.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.994 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -116.94 140.03 49.95 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.21 176.6 40.14 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.265 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 41.6 m-20 -105.87 107.95 19.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 82.5 m -105.81 131.69 52.83 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.084 0.469 . . . . 0.0 110.043 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mt -70.02 138.96 20.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.516 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -105.61 -169.46 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.331 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.96 -29.03 66.85 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 29' ' ' HIS . 24.9 t70 -68.76 -26.26 65.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.15 0.5 . . . . 0.0 111.751 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.34 57.29 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.132 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.452 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -107.78 138.95 20.17 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.604 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 24.6 Cg_endo -63.65 127.19 19.13 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.113 2.542 . . . . 0.0 112.808 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -109.79 133.17 53.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.184 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.39 118.73 16.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.903 0.383 . . . . 0.0 111.508 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.3 t -135.4 157.39 47.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.006 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.8 p -139.83 138.29 35.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.499 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.58 145.9 33.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.955 0.407 . . . . 0.0 111.258 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -103.57 99.16 8.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.049 0.452 . . . . 0.0 110.1 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -62.29 -23.67 66.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.895 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.98 -30.94 62.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.939 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -103.95 13.54 32.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -130.87 -25.85 2.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.538 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -109.08 141.95 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.664 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.94 -174.93 19.78 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.843 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -129.24 105.06 7.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.07 0.462 . . . . 0.0 111.292 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -103.27 111.17 23.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.544 ' HB2' ' HA ' ' A' ' 77' ' ' ALA . 5.4 p-10 42.18 47.08 3.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.675 1.19 . . . . 0.0 113.298 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.91 14.93 74.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.596 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.15 143.23 50.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.823 0.344 . . . . 0.0 111.23 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.543 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 8.9 mp -71.49 119.34 15.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.814 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -109.9 139.13 45.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.832 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -41.14 -68.97 0.23 Allowed Pre-proline 0 CA--C 1.428 -3.746 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.832 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 7.8 Cg_endo -111.46 122.97 0.03 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.361 0 C-N-CA 113.943 -3.571 . . . . 0.0 113.544 -177.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.664 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -158.67 -160.82 10.58 Favored Glycine 0 C--N 1.277 -2.703 0 CA-C-N 113.758 -1.565 . . . . 0.0 113.282 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 34.5 mt-10 -156.31 144.39 19.67 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.942 0.436 . . . . 0.0 110.818 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 m 57.14 41.24 27.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.15 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -72.09 -40.2 68.39 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.049 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.01 -18.99 49.62 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.733 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.2 m -65.14 -24.34 67.38 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.514 0.326 . . . . 0.0 110.955 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.1 m -138.32 24.76 2.71 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.916 0.389 . . . . 0.0 110.635 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.0 m -131.29 141.48 49.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.314 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.443 HG23 ' HD3' ' A' ' 61' ' ' LYS . 30.2 m -133.92 172.81 15.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.376 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.8 mptt 64.1 43.3 5.13 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.715 0.635 . . . . 0.0 110.873 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 p -68.83 124.4 23.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.386 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.2 156.07 37.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.86 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.656 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -110.48 120.39 42.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.541 0.21 . . . . 0.0 110.61 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.486 ' C ' ' H ' ' A' ' 67' ' ' GLY . 19.3 t-20 -87.46 121.18 29.57 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.9 t70 68.33 -25.76 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.437 1.085 . . . . 0.0 112.356 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 65' ' ' ASN . . . 110.19 22.02 6.71 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.84 -20.47 0.66 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.452 ' O ' HD13 ' A' ' 64' ' ' LEU . 43.3 m -116.95 127.36 54.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.251 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.543 ' HG ' ' CD2' ' A' ' 48' ' ' LEU . 16.6 tp -90.61 129.28 36.75 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.79 130.29 54.86 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.487 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.501 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -162.55 165.32 26.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.833 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -110.08 125.55 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.466 ' SG ' HD12 ' A' ' 48' ' ' LEU . 60.9 m -123.23 147.73 46.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.351 0.596 . . . . 0.0 112.582 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.9 tmtt? -99.69 145.3 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.923 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.73 -16.27 0.94 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.822 -1.18 . . . . 0.0 113.332 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' A' ' 45' ' ' ASN . . . -59.67 -39.46 84.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.875 0.369 . . . . 0.0 110.759 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 t70 178.91 60.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.843 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.79 4.48 54.11 Favored Glycine 0 C--O 1.228 -0.223 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.544 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -124.92 165.34 18.26 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.6 p90 -112.53 166.27 11.47 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.282 0.364 . . . . 0.0 111.488 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -158.55 144.61 16.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -76.29 142.36 41.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.786 0.327 . . . . 0.0 110.158 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.9 p -153.6 174.58 14.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.82 156.54 46.12 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.082 0.468 . . . . 0.0 110.586 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.517 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 12.3 tpp -140.78 123.18 15.92 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.644 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -76.06 106.24 7.55 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.747 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.3 mt -73.34 -9.09 58.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.747 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.441 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 16.3 m120 -47.58 -31.15 4.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.79 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 26.7 p90 -119.74 23.58 11.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.411 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.747 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -128.49 -7.85 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.02 0.438 . . . . 0.0 110.52 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.8 p -156.82 141.79 8.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.023 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.91 -174.96 13.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.229 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.44 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.9 t30 -130.0 133.26 46.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.938 0.399 . . . . 0.0 110.991 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 m -142.35 112.25 6.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.398 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 60.17 40.51 18.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.397 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.67 24.6 66.44 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -128.17 138.86 52.66 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 99' ' ' MET . 13.5 ptt? -64.46 129.17 38.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.347 0.594 . . . . 0.0 112.5 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.09 77.35 25.77 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.79 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 33.3 Cg_endo -61.79 93.25 0.12 Allowed 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.422 2.748 . . . . 0.0 112.951 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 p -106.88 119.47 39.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.406 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.522 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -102.78 149.52 24.39 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.032 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -99.51 35.83 1.89 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.18 0.514 . . . . 0.0 111.237 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.48 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 21.6 t -161.49 -132.89 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 7.8 t30 62.83 96.74 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.607 0.763 . . . . 0.0 110.432 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 73.29 -13.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.737 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 12.3 m-20 -129.61 168.12 16.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.662 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.522 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 63.4 t60 74.3 154.46 0.15 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.813 0.816 . . . . 0.0 110.856 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.09 91.67 2.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 122.242 1.02 . . . . 0.0 110.71 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.845 ' H ' HD23 ' A' ' 111' ' ' LEU . 1.8 pt? -97.82 69.39 2.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.949 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.79 118.2 30.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.817 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.2 t -93.35 75.46 4.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.7 m -100.26 86.18 3.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.331 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -54.04 48.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.187 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.607 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 tpp . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.987 0.423 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -120.44 101.85 8.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.522 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 28.5 m -75.55 -57.85 3.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.33 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' HB3' ' CG ' ' A' ' 7' ' ' ASN . 79.6 m-20 63.54 71.28 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.298 0.374 . . . . 0.0 110.891 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 9.8 p90 -54.43 -37.51 65.21 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 111.361 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.86 -22.15 64.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.78 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.441 ' CG ' ' HB3' ' A' ' 4' ' ' ASN . 6.0 m-20 -69.79 -16.1 63.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.68 0.276 . . . . 0.0 111.301 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -127.03 4.44 6.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.2 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 0.8 OUTLIER -118.49 137.53 53.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.162 0.506 . . . . 0.0 112.079 -178.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 p -128.59 153.07 47.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.096 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.65 64.9 3.95 Favored Glycine 0 N--CA 1.453 -0.22 0 O-C-N 123.518 0.511 . . . . 0.0 112.442 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.602 HG12 ' HA3' ' A' ' 21' ' ' GLY . 32.4 m -100.64 147.04 8.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 111.278 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -138.18 148.91 45.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.127 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.628 HD22 HD23 ' A' ' 64' ' ' LEU . 8.5 tp -122.19 105.36 10.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.023 0.439 . . . . 0.0 110.72 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -134.62 112.4 10.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.34 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 75.24 38.33 39.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.282 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.427 ' HA ' HD11 ' A' ' 14' ' ' LEU . 10.2 m-85 64.55 24.06 12.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.15 0.58 . . . . 0.0 110.675 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 16' ' ' GLY . 16.2 mt -117.77 122.23 69.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.253 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.805 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -102.6 113.64 27.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.351 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 20.4 ttm180 -118.84 134.3 55.25 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.426 -0.509 . . . . 0.0 109.835 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.602 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -157.63 175.3 34.98 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.898 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 26.6 m-20 -101.15 107.29 18.66 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -106.02 131.8 52.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.5 mt -70.09 135.25 28.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.568 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.4 p30 -103.64 -175.12 2.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.125 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -54.09 -31.33 51.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.06 -27.5 69.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.451 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.34 -0.04 53.83 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.121 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -108.66 144.54 29.76 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 120.802 0.334 . . . . 0.0 110.385 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 35.6 Cg_endo -66.91 121.27 8.45 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.057 2.505 . . . . 0.0 112.655 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -107.09 129.24 54.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.306 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.53 119.19 13.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.011 0.434 . . . . 0.0 110.871 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -132.19 159.48 38.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.808 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 99' ' ' MET . 78.4 p -138.5 147.97 43.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.847 0.356 . . . . 0.0 111.502 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.74 142.55 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.9 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.452 ' ND2' ' CE2' ' A' ' 39' ' ' TYR . 62.2 t30 -101.96 92.71 4.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.805 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.69 -23.72 53.05 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.322 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 21.1 t-20 -54.8 -30.9 58.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.98 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.452 ' CE2' ' ND2' ' A' ' 36' ' ' ASN . 77.6 m-85 -108.57 16.31 23.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.534 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.9 m-85 -126.97 -25.05 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -110.52 140.62 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.693 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -115.35 161.66 12.74 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.395 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -100.63 104.75 16.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.691 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -111.94 106.55 15.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.922 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.822 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 56.2 t30 58.41 36.98 25.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.121 0.486 . . . . 0.0 110.817 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.66 17.07 80.22 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.403 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.07 154.88 39.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.834 0.349 . . . . 0.0 110.825 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 31.5 mt -79.92 114.48 18.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.239 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -105.52 135.18 47.4 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.656 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.84 -72.45 0.11 Allowed Pre-proline 0 CA--C 1.426 -3.792 0 O-C-N 124.254 0.971 . . . . 0.0 113.333 -178.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.656 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 9.2 Cg_endo -108.36 126.14 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.319 0 C-N-CA 113.623 -3.784 . . . . 0.0 113.252 -177.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.693 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -156.65 -164.2 13.21 Favored Glycine 0 C--N 1.283 -2.398 0 CA-C-N 113.582 -1.645 . . . . 0.0 113.029 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -153.39 142.86 21.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.857 0.36 . . . . 0.0 111.013 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 m 53.4 42.37 32.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.226 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 10.5 p90 -68.47 -36.7 79.35 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.48 -18.12 28.69 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.377 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.7 t -64.54 -21.08 66.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.723 0.297 . . . . 0.0 110.487 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.5 m -140.8 23.38 2.26 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.099 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.5 m -128.97 142.61 50.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.954 0.407 . . . . 0.0 111.311 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -134.37 172.93 15.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.249 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? 63.25 37.74 10.91 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.501 0.5 . . . . 0.0 111.766 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.8 p -66.67 122.66 18.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.117 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.69 163.57 39.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.877 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.628 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -119.54 113.44 20.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.908 0.385 . . . . 0.0 111.471 -179.32 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.485 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 16.1 m120 -76.13 117.18 17.57 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.322 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.664 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 20.4 t70 58.9 9.53 1.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.907 0.755 . . . . 0.0 111.567 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.22 30.75 58.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.777 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.664 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 5.5 p80 -144.56 -26.06 0.51 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 117.547 0.674 . . . . 0.0 111.394 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 21.9 m -115.82 130.39 56.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.316 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.588 ' HA ' HD22 ' A' ' 64' ' ' LEU . 23.1 tp -91.02 130.67 36.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.71 129.82 55.48 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.59 159.84 25.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.231 0.538 . . . . 0.0 111.039 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.7 t -109.59 123.31 49.23 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 56.9 m -122.25 149.67 43.37 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.369 0.604 . . . . 0.0 112.534 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.7 tmtt? -99.74 139.56 35.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.024 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.91 -32.52 0.38 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.947 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.822 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -47.49 -43.33 24.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -171.69 49.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.85 5.56 65.05 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.608 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.83 165.72 16.17 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 33.4 p90 -101.2 162.55 12.82 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 123.292 0.37 . . . . 0.0 110.155 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.14 134.22 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -72.22 125.48 27.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.225 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.4 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 34.1 p -142.29 170.71 15.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.969 0.414 . . . . 0.0 110.719 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.37 164.95 26.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.692 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.4 tpt -145.74 120.02 9.57 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.067 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.27 105.01 5.25 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.778 ' HA ' HG22 ' A' ' 91' ' ' VAL . 17.5 mt -75.98 -8.44 56.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.528 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -47.15 -32.08 4.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.917 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 36.7 p90 -117.16 23.75 11.64 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.087 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.778 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -130.76 -5.71 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.989 0.423 . . . . 0.0 110.843 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.928 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.6 t -141.16 146.33 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.522 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -143.45 176.82 22.66 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.989 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -131.7 132.95 44.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 m -141.75 109.22 5.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.286 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 62.31 43.93 7.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.905 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.568 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 61.58 26.28 66.41 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.159 -0.543 . . . . 0.0 111.874 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -127.53 142.15 51.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 34' ' ' SER . 4.4 ppp? -67.68 134.14 50.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.115 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.07 71.09 7.07 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.039 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.928 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 12.3 Cg_endo -54.45 103.52 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.408 2.739 . . . . 0.0 112.432 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 p -108.17 136.77 47.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.828 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -112.16 149.22 32.51 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.42 58.15 0.64 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.023 0.44 . . . . 0.0 111.06 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.1 t -176.48 -107.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.947 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 64.08 102.09 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.771 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.37 133.33 20.24 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.088 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.84 127.55 35.34 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.928 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 71.16 -52.05 0.69 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.642 0.777 . . . . 0.0 111.984 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.9 m -88.12 60.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 111.713 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.3 tp -128.48 43.66 3.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.017 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -124.74 27.32 6.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.991 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 86.8 p 46.62 -121.92 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.186 0.594 . . . . 0.0 110.786 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.6 t 74.03 102.66 0.07 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.522 0.677 . . . . 0.0 109.652 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.1 m -63.02 -43.15 99.53 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.649 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.016 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 tpp . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.846 0.355 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.66 132.51 36.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.098 0.475 . . . . 0.0 109.85 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.575 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 1.1 m -108.93 -72.55 0.72 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.823 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 62.4 m-80 53.8 85.31 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.681 0.613 . . . . 0.0 112.56 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.583 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 6.0 p90 -62.51 -37.6 86.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.182 0.515 . . . . 0.0 110.165 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.91 -20.25 66.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.092 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -52.11 -29.05 20.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.378 -178.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.453 ' HB2' HD22 ' A' ' 94' ' ' ASN . 33.9 m -145.16 28.87 1.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.759 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -119.27 141.65 48.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.898 0.38 . . . . 0.0 110.97 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.9 p -137.97 157.44 46.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.065 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.5 34.3 89.53 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.211 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 21.3 m -69.76 138.95 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.003 0.43 . . . . 0.0 111.762 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -132.56 133.18 43.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.348 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.781 HD22 HD23 ' A' ' 64' ' ' LEU . 46.5 tp -119.8 123.33 43.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.934 0.397 . . . . 0.0 111.168 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.53 101.97 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.703 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.83 -60.8 2.96 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.944 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 1.6 p90 -166.91 18.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 26.3 pt -119.95 127.15 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.847 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 mt -116.05 114.92 25.21 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.197 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 27.2 ttm180 -111.83 139.03 47.65 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.88 165.15 33.03 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.2 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.589 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 1.7 m-20 -99.37 105.72 17.72 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.8 m -104.57 132.21 51.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.261 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.6 mt -69.86 139.57 20.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.318 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -108.9 -171.54 1.87 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.837 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -55.21 -31.35 61.38 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.35 -20.92 66.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.712 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.33 4.09 66.63 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.74 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.34 148.5 39.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.787 0.327 . . . . 0.0 110.29 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -70.7 132.46 21.87 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.019 2.479 . . . . 0.0 113.027 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -118.39 132.45 56.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.269 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.94 127.29 31.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.169 0.509 . . . . 0.0 111.65 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -141.93 154.94 45.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.041 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 p -139.9 142.73 36.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.64 0.257 . . . . 0.0 111.155 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.55 143.8 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.485 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -102.51 90.49 3.88 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.35 -23.66 50.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.592 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.7 t-20 -52.74 -31.44 38.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.105 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -108.36 16.7 22.9 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.52 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 37.9 m-85 -129.69 -22.93 2.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.575 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -113.93 142.17 27.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.658 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -116.11 164.22 12.29 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.547 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -102.04 105.49 16.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.247 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -110.59 104.92 13.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.505 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.733 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 36.7 t30 52.96 43.64 31.43 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.199 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.13 16.55 80.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.948 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -123.68 157.48 33.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.862 0.363 . . . . 0.0 110.768 -179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.496 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 38.9 mt -83.97 113.4 20.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.472 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 26.1 tp10 -103.11 130.43 50.27 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.767 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.35 -71.79 0.11 Allowed Pre-proline 0 CA--C 1.424 -3.877 0 O-C-N 124.47 1.106 . . . . 0.0 113.063 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.767 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 3.1 Cg_endo -107.44 133.3 0.05 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.42 0 C-N-CA 113.704 -3.731 . . . . 0.0 112.179 -178.476 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.658 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -164.74 -163.64 18.3 Favored Glycine 0 C--N 1.285 -2.261 0 CA-C-N 114.379 -1.282 . . . . 0.0 113.665 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -151.37 143.59 24.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.283 -0.459 . . . . 0.0 110.921 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.4 m 52.07 45.0 29.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -74.27 -36.03 63.8 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.91 -19.37 50.07 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.281 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -62.27 -26.87 68.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.943 0.401 . . . . 0.0 110.816 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 m -134.16 15.15 3.84 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.268 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.1 m -121.64 140.33 52.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.448 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 m -136.82 174.52 11.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.886 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 62.48 41.49 9.73 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 110.725 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 16' ' ' GLY . 21.5 p -71.83 126.78 30.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.93 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.81 162.68 40.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.766 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.781 HD23 HD22 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -118.01 113.54 21.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.806 0.336 . . . . 0.0 111.566 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.487 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 3.9 m120 -73.51 116.13 13.71 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.403 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.95 5.21 0.49 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.114 0.884 . . . . 0.0 111.742 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.1 27.89 35.79 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.717 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -145.21 -23.06 0.49 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.504 0.652 . . . . 0.0 112.23 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 30.6 m -114.68 130.73 56.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.744 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.507 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.2 tp -91.88 127.79 37.47 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 129.69 55.46 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.84 171.11 20.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.805 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.3 t -118.58 121.21 39.67 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 32.8 m -121.4 149.84 42.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.181 0.515 . . . . 0.0 111.835 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.3 tmtt? -99.89 145.37 27.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.932 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.85 -28.1 0.74 Allowed Glycine 0 C--O 1.228 -0.256 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.251 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.733 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.14 -38.81 71.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.314 0.486 . . . . 0.0 112.314 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -172.02 50.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.385 0.612 . . . . 0.0 109.899 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.75 2.08 42.57 Favored Glycine 0 C--O 1.229 -0.174 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.112 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -125.25 167.29 15.08 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 42.8 p90 -104.99 169.64 8.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.459 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -161.78 147.01 13.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.95 130.24 42.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.139 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.42 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 45.0 t -144.66 161.13 39.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.225 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.03 160.25 37.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.496 ' HB2' ' CB ' ' A' ' 48' ' ' LEU . 9.7 tpt -144.25 112.83 6.58 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.156 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -72.08 105.11 3.81 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.752 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.4 mt -73.37 -9.18 58.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.534 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -48.82 -28.17 3.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.691 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.527 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 36.2 p90 -122.41 25.76 8.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.686 0.279 . . . . 0.0 111.441 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.752 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -129.78 -13.67 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.025 0.44 . . . . 0.0 110.708 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 1.082 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.7 p -155.36 136.56 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.539 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.575 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -131.85 -173.54 13.37 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.469 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.453 HD22 ' HB2' ' A' ' 8' ' ' SER . 18.1 t30 -123.81 133.31 53.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.428 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.572 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 72.6 m -137.42 104.72 5.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.208 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 60.34 45.86 10.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.912 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.94 20.27 70.51 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.276 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -127.4 145.18 50.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.055 0.427 . . . . 0.0 109.866 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 99' ' ' MET . 13.0 ptt? -64.11 130.71 45.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.977 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.572 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 5.6 mm-40 -140.77 77.93 21.24 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.613 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 1.082 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 38.7 Cg_endo -68.77 97.15 0.54 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.665 2.244 . . . . 0.0 112.714 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.0 p -116.68 133.48 55.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.458 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.572 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -90.99 138.0 31.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 90' ' ' TYR . . . -109.4 28.18 8.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.181 0.515 . . . . 0.0 110.714 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.3 m -152.99 -76.07 0.12 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.639 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.572 ' HB2' ' HG3' ' A' ' 103' ' ' ARG . 3.3 t-20 64.08 97.54 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.777 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.46 -58.44 3.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.835 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.06 130.29 41.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.79 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -78.34 -51.81 9.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.752 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.5 t -92.7 63.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.881 0.848 . . . . 0.0 110.257 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 35.2 tp -107.01 78.47 1.23 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.609 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -147.13 86.56 1.64 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -79.26 41.1 0.44 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.237 0.541 . . . . 0.0 110.675 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.6 m -113.03 71.31 0.74 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.777 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.5 m -78.09 -46.78 19.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.266 0.555 . . . . 0.0 109.647 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.683 179.513 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -79.07 133.0 36.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.836 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 65.5 m -73.83 -54.96 6.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.903 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 52.44 73.16 0.36 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.989 0.516 . . . . 0.0 112.054 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.531 ' HE1' ' HB2' ' A' ' 88' ' ' LEU . 9.3 p90 -57.43 -33.6 68.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.063 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.97 64.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -68.94 -20.36 64.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.1 m -119.93 9.84 11.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -123.26 146.37 47.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.006 0.432 . . . . 0.0 111.432 -179.172 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -134.4 147.42 50.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.638 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.16 56.79 21.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.492 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.567 HG12 ' HA3' ' A' ' 21' ' ' GLY . 7.1 m -99.23 130.5 48.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.113 0.482 . . . . 0.0 111.433 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.98 152.81 47.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.601 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.648 HD22 HD23 ' A' ' 64' ' ' LEU . 11.5 tp -113.22 113.58 25.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.817 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.496 ' O ' HG12 ' A' ' 18' ' ' ILE . 26.3 m-85 -108.22 98.79 8.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.992 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.5 -65.5 1.36 Allowed Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.084 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 2.8 p90 -161.39 18.64 0.11 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.748 0.419 . . . . 0.0 111.128 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 15' ' ' TYR . 30.6 pt -122.16 133.1 69.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 110.271 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.819 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -108.69 116.9 32.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.724 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.8 tmm_? -121.9 142.29 50.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.1 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.567 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -168.4 -174.71 37.4 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.414 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.569 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 35.8 m-20 -108.49 109.19 20.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -105.73 131.98 52.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.03 0.443 . . . . 0.0 110.005 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 58.2 mt -70.16 138.17 22.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.421 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -102.36 -174.31 2.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.89 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.71 -37.81 63.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.191 0.519 . . . . 0.0 111.946 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.64 -25.11 66.07 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.086 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.89 50.33 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.575 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -105.35 140.52 21.22 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-O 120.854 0.359 . . . . 0.0 110.388 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 39.4 Cg_endo -67.84 134.36 32.1 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 123.082 2.521 . . . . 0.0 112.955 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -119.91 133.65 55.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.596 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.75 126.09 27.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.281 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -143.13 156.03 44.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 p -136.72 151.3 49.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.937 0.399 . . . . 0.0 111.156 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -134.07 143.67 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.221 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -99.97 93.62 5.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.819 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.83 -29.25 64.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.317 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.2 t-20 -52.78 -29.13 25.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.935 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -108.53 12.76 25.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.6 m-85 -128.9 -20.14 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -113.57 142.11 27.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.67 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -113.72 166.07 12.11 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.256 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -109.92 111.13 22.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.141 -0.53 . . . . 0.0 110.82 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -110.78 105.46 14.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.669 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.737 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 29.9 t30 53.09 42.21 32.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.046 0.451 . . . . 0.0 111.401 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.456 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 78.11 17.63 77.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.121 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.62 154.71 40.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.966 0.412 . . . . 0.0 110.827 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD13 ' HG ' ' A' ' 70' ' ' LEU . 35.7 mt -82.1 122.99 28.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.051 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -112.71 138.49 49.44 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.694 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -40.88 -75.14 0.05 OUTLIER Pre-proline 0 CA--C 1.433 -3.556 0 CA-C-O 118.11 -0.947 . . . . 0.0 113.186 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.694 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 23.2 Cg_endo -111.32 129.0 0.03 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.425 0 C-N-CA 114.009 -3.527 . . . . 0.0 113.042 -177.621 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.08 -158.02 8.6 Favored Glycine 0 C--N 1.28 -2.572 0 CA-C-N 113.529 -1.669 . . . . 0.0 113.143 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -155.2 138.45 15.71 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.897 0.41 . . . . 0.0 110.646 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.3 m 58.27 45.05 17.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 13.2 p90 -75.07 -37.61 61.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -19.04 54.47 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.705 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -64.67 -22.49 66.99 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 120.83 0.348 . . . . 0.0 110.911 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.2 m -135.87 18.37 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.841 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 81.9 m -125.23 145.55 49.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.174 0.511 . . . . 0.0 111.44 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.4 HG23 ' HD3' ' A' ' 61' ' ' LYS . 12.0 m -138.07 176.91 6.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.16 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.5 mptt 61.85 35.0 16.75 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.145 0.278 . . . . 0.0 111.474 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 p -64.16 123.82 20.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 111.187 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.95 148.87 27.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.836 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.648 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -107.18 113.45 26.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.453 0.168 . . . . 0.0 110.749 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -79.63 126.1 30.47 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.56 18.61 1.47 Allowed 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.354 1.034 . . . . 0.0 112.045 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.0 33.53 87.49 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.935 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.0 -25.55 0.35 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.525 0.663 . . . . 0.0 111.609 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.434 ' O ' HD13 ' A' ' 64' ' ' LEU . 44.4 m -116.71 131.13 57.03 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.207 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -90.97 134.21 34.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.787 0.327 . . . . 0.0 110.466 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.19 131.45 53.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.967 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -160.63 163.69 32.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.164 0.507 . . . . 0.0 111.544 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -110.8 118.21 35.53 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.456 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 37.4 m -119.17 147.48 44.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.4 tmtt? -100.1 142.92 30.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.473 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.72 -27.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.021 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.737 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -49.85 -41.07 44.42 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -179.34 51.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.449 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 77.22 -3.76 57.19 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.234 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -113.23 161.01 17.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.975 -0.612 . . . . 0.0 109.781 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 41.0 p90 -103.71 168.37 9.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.522 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -158.03 137.93 12.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.354 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.13 127.27 32.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.8 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.7 p -142.62 177.81 8.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.597 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.425 ' HA ' HD12 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -138.78 162.22 35.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.979 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.532 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 11.8 tpp -145.67 120.99 10.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.113 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -77.63 106.09 9.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.33 0.586 . . . . 0.0 109.439 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.72 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.0 mt -73.1 -8.98 58.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.124 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -48.72 -33.04 9.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.815 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -116.15 24.49 11.38 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.062 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -128.69 -12.09 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.536 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 1.8 t -138.52 144.29 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -140.28 171.5 23.92 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.731 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.413 HD22 ' CB ' ' A' ' 8' ' ' SER . 24.6 t30 -121.96 141.19 51.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.045 0.45 . . . . 0.0 110.855 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.537 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 73.2 m -146.93 109.31 4.52 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 58.58 42.05 21.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.633 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.9 13.11 63.51 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.473 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -116.29 141.72 47.79 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.94 129.78 40.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.401 0.619 . . . . 0.0 111.645 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.537 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 36.3 mm-40 -139.02 78.81 28.45 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.179 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.797 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 32.1 Cg_endo -65.36 96.55 0.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.779 2.319 . . . . 0.0 112.442 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -102.67 131.82 49.2 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.952 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.67 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -102.31 146.43 28.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.916 0.388 . . . . 0.0 110.517 -179.189 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -99.5 19.24 16.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.04 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.475 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 68.8 m -156.01 -120.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 1.003 ' HA ' HD23 ' A' ' 111' ' ' LEU . 13.3 t-20 64.34 43.96 4.48 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.049 0.939 . . . . 0.0 110.402 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 54.93 -153.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.898 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.97 -32.89 57.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.231 0.538 . . . . 0.0 110.099 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -136.69 -75.86 0.42 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.234 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 112' ' ' LYS . 45.2 t -136.94 111.27 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.787 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 106' ' ' ASN . 4.2 pp -72.45 -11.02 60.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.281 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -77.83 76.27 4.36 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.88 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.9 m -62.94 118.27 7.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.375 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.4 t -165.45 136.88 3.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.326 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.7 m -72.76 -24.32 60.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 N--CA 1.441 -0.901 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.246 179.767 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -92.2 117.57 30.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.582 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 68.5 m -98.24 -72.29 0.66 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.143 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 12.5 m-20 55.46 78.77 0.18 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.919 0.488 . . . . 0.0 111.889 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.588 ' CD1' HG13 ' A' ' 92' ' ' VAL . 4.8 p90 -62.48 -46.18 89.64 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.719 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.46 -22.28 54.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.186 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 6.4 t-20 -57.91 -30.5 65.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.856 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.485 ' HB2' HD22 ' A' ' 94' ' ' ASN . 49.7 m -137.67 23.47 2.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.822 0.344 . . . . 0.0 111.353 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 92.3 m -120.96 132.83 55.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.985 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 p -132.19 152.99 51.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.531 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.78 42.88 94.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.622 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.601 HG12 ' HA3' ' A' ' 21' ' ' GLY . 26.8 m -89.33 141.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.794 0.331 . . . . 0.0 111.342 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.67 159.18 42.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.143 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.74 HD22 HD23 ' A' ' 64' ' ' LEU . 20.8 tp -127.08 126.89 43.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 111.588 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.561 ' O ' HG12 ' A' ' 18' ' ' ILE . 68.4 t80 -130.83 104.79 7.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.808 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.411 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.92 -71.27 1.95 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.738 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 0.8 OUTLIER -163.01 23.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.605 0.362 . . . . 0.0 111.337 179.141 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 15' ' ' TYR . 34.0 pt -117.24 131.11 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 110.544 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.827 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -112.41 114.66 27.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.688 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 13.2 ttm180 -121.56 140.44 52.22 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.601 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -164.69 179.31 39.47 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.449 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -104.44 105.42 15.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.416 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 69.3 m -106.16 132.18 52.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.213 0.53 . . . . 0.0 110.29 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.68 141.4 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -105.83 -172.26 2.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.305 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -56.23 -30.52 62.46 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.76 -26.82 66.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.0 111.371 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.82 1.67 55.15 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.506 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.58 139.31 19.98 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 121.158 0.504 . . . . 0.0 111.037 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.38 127.96 20.3 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 124.117 3.211 . . . . 0.0 112.674 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -116.86 138.09 51.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.615 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.46 121.71 23.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.937 0.398 . . . . 0.0 111.171 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.4 t -140.54 156.6 46.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.928 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 p -140.4 138.92 35.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 mp -124.54 147.86 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.709 HD22 ' HB3' ' A' ' 38' ' ' ASN . 34.8 t30 -103.75 107.55 18.47 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.827 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -66.1 -22.67 66.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.683 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.709 ' HB3' HD22 ' A' ' 36' ' ' ASN . 32.2 t30 -66.72 -12.93 60.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.017 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -110.57 0.89 17.81 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.325 -0.234 . . . . 0.0 110.981 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 50.8 m-85 -128.31 -20.47 3.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.7 138.79 40.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.705 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -116.33 165.51 12.28 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.529 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -108.82 106.05 15.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.89 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -110.92 107.19 16.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.586 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 13.4 t30 56.78 40.42 29.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.173 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.63 16.18 80.96 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.81 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.419 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -124.14 152.61 42.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 10.1 mp -80.52 123.49 28.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.895 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.592 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 9.3 tp10 -114.56 132.67 56.25 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.2 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.855 ' CD2' ' HD3' ' A' ' 51' ' ' PRO 0.251 0.1 OUTLIER -41.54 -63.11 0.89 Allowed Pre-proline 0 CA--C 1.423 -3.921 0 CA-C-O 117.87 -1.062 . . . . 0.0 113.522 -179.075 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.855 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 9.0 Cg_endo -112.28 123.36 0.02 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.471 0 C-N-CA 113.766 -3.689 . . . . 0.0 112.978 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.705 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.52 -165.89 18.24 Favored Glycine 0 C--N 1.281 -2.519 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.26 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -153.34 146.52 24.69 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 m 59.96 45.69 11.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 10.8 p90 -79.35 -37.81 36.59 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.83 55.03 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.538 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 m -63.22 -29.16 70.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.223 -0.489 . . . . 0.0 110.943 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.8 m -133.49 19.58 3.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.304 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 55' ' ' PHE . 84.1 m -123.04 149.07 44.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.283 0.563 . . . . 0.0 111.724 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG23 ' HG2' ' A' ' 61' ' ' LYS . 23.4 m -141.58 176.8 3.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.943 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' HG2' HG23 ' A' ' 60' ' ' VAL . 74.1 mmtt 62.81 37.3 12.44 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.246 0.342 . . . . 0.0 111.001 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -69.82 122.43 19.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.178 0.513 . . . . 0.0 111.75 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.73 149.23 28.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.438 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -106.34 113.29 26.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.741 0.305 . . . . 0.0 111.08 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -75.49 117.19 17.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.202 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.695 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 23.0 t70 55.05 23.32 5.09 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.084 0.865 . . . . 0.0 111.491 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.29 36.73 92.9 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.988 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.695 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 10.6 p80 -147.16 -29.94 0.35 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.692 0.746 . . . . 0.0 111.49 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 m -115.62 132.34 56.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.51 0.195 . . . . 0.0 111.115 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.55 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -92.8 130.06 38.52 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.1 OUTLIER -120.97 129.75 53.55 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.093 179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -159.03 163.32 36.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.09 0.472 . . . . 0.0 111.116 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 16.4 t -110.51 120.17 41.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.3 m -121.75 148.75 44.24 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.6 tmtt? -100.35 145.58 28.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.542 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.03 -30.9 0.49 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.852 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.599 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.46 -41.58 66.31 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -172.93 52.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.225 0.536 . . . . 0.0 109.892 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.439 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 73.4 -1.11 44.95 Favored Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.335 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -119.12 158.53 25.72 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 21.0 p90 -100.6 171.12 7.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.467 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -163.3 151.15 13.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.9 132.34 41.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.419 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 40.1 t -148.35 158.51 44.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.851 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -135.1 159.99 39.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.287 0.565 . . . . 0.0 110.93 179.51 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.523 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 20.9 tpp -147.3 118.67 7.86 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.589 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.469 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 32.3 t0 -75.93 106.89 7.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.408 0.623 . . . . 0.0 109.773 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.724 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.9 mt -73.55 -9.58 58.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.709 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -50.9 -27.33 7.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.197 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 46.1 p90 -117.82 19.28 13.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 111.583 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.4 m -126.18 -7.35 5.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.121 0.486 . . . . 0.0 110.603 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.5 p -157.69 145.08 9.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.321 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -135.82 -174.3 13.33 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.799 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.485 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.4 t30 -126.01 131.24 52.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.93 0.395 . . . . 0.0 110.946 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.592 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 67.8 m -135.95 111.08 8.94 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.678 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 59.66 42.92 16.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.938 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.85 24.31 64.44 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.198 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -127.0 147.58 50.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 110.165 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -60.02 128.85 38.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.145 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 36.4 mm-40 -140.38 78.16 22.92 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.004 178.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 44.0 Cg_endo -72.52 92.13 0.77 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.351 2.034 . . . . 0.0 111.859 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p -114.38 121.58 44.03 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.589 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.594 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -113.52 149.02 34.98 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.056 178.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -99.91 48.56 0.93 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.158 0.504 . . . . 0.0 110.368 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.469 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 25.8 t -169.7 -133.82 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.7 t30 72.71 107.65 0.07 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.343 1.057 . . . . 0.0 112.028 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' A' ' 111' ' ' LEU . . . -164.39 163.54 22.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.507 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -70.01 -70.33 0.3 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.178 0.513 . . . . 0.0 110.516 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -121.62 -41.39 2.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.732 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.6 p -82.31 78.79 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 122.266 1.031 . . . . 0.0 109.683 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.521 ' HA ' ' HB3' ' A' ' 107' ' ' ALA . 13.5 tp -71.25 82.62 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.553 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 18.4 ptmt -90.92 109.37 20.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.335 0.588 . . . . 0.0 111.36 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 37.7 m -88.77 64.46 7.29 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.3 m -149.85 137.98 20.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.405 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -72.36 -33.23 67.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.715 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.297 179.502 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.691 0.281 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -142.14 146.91 35.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.7 m -130.99 -63.46 0.86 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.284 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 56.14 73.96 0.41 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.474 ' CD1' ' HB ' ' A' ' 92' ' ' VAL . 12.5 p90 -57.93 -34.5 69.93 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.138 0.494 . . . . 0.0 111.366 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.94 -22.08 63.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -62.43 -26.52 68.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 46.6 m -124.64 13.4 8.67 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.2 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -119.15 135.56 54.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.051 0.453 . . . . 0.0 111.212 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -132.46 154.36 49.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.26 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.07 53.0 48.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.064 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.421 HG12 ' HA3' ' A' ' 21' ' ' GLY . 7.1 m -92.07 137.81 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.728 0.299 . . . . 0.0 110.874 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -135.21 149.85 49.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.178 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.564 HD22 HD23 ' A' ' 64' ' ' LEU . 11.9 tp -114.41 118.01 32.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.163 0.506 . . . . 0.0 111.485 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.507 ' O ' HG12 ' A' ' 18' ' ' ILE . 91.9 m-85 -115.51 99.75 7.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.82 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.82 -73.3 1.47 Allowed Glycine 0 C--O 1.224 -0.499 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.484 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -157.49 21.14 0.29 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.671 0.388 . . . . 0.0 110.848 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 15' ' ' TYR . 39.0 pt -121.4 132.77 69.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.054 0.454 . . . . 0.0 110.251 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -109.38 117.56 34.37 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.119 -179.136 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tmm_? -121.72 139.57 53.41 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.89 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.421 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -161.8 179.35 37.23 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.303 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 10.7 m-20 -100.98 106.14 17.43 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.0 OUTLIER -106.05 131.83 52.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.954 0.406 . . . . 0.0 109.944 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -69.15 138.12 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.692 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.7 p30 -108.26 -170.28 1.65 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.29 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.48 -28.58 60.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.81 -26.69 66.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.55 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.64 -2.89 57.4 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.159 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -104.86 143.53 26.89 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.932 0.396 . . . . 0.0 110.3 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.641 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 29.3 Cg_endo -64.84 121.97 9.65 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.937 2.425 . . . . 0.0 113.015 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -108.32 130.72 55.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.171 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.84 119.65 15.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.057 0.456 . . . . 0.0 111.716 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.9 t -135.54 160.05 39.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.502 ' O ' ' HG2' ' A' ' 99' ' ' MET . 13.2 p -136.7 152.72 50.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.184 0.516 . . . . 0.0 111.551 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.22 145.78 33.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.799 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -104.58 94.56 5.38 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.9 -30.24 63.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.587 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.4 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 4.2 t30 -54.53 -29.15 49.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -103.68 10.93 36.57 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.656 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 52.8 m-85 -129.67 -22.9 2.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.417 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.24 141.49 27.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.602 0.239 . . . . 0.0 110.83 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.572 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.54 -173.77 18.16 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.918 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -128.65 109.5 11.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.844 0.354 . . . . 0.0 111.128 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -113.11 109.62 19.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.66 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.647 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 22.1 t-20 56.08 45.48 23.48 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.72 0.772 . . . . 0.0 110.943 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.54 18.12 73.41 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.709 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.07 147.49 47.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.863 0.363 . . . . 0.0 110.364 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.4 mp -71.42 127.94 34.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.189 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -114.5 129.51 56.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.15 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.596 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.7 -70.53 0.14 Allowed Pre-proline 0 CA--C 1.425 -3.852 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.868 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.953 ' HB3' ' HG3' ' A' ' 103' ' ' ARG . 14.2 Cg_endo -110.36 124.36 0.03 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.444 0 C-N-CA 113.509 -3.861 . . . . 0.0 113.146 -178.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.572 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -159.08 -161.04 10.8 Favored Glycine 0 C--N 1.281 -2.527 0 CA-C-N 113.4 -1.727 . . . . 0.0 113.197 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -153.93 150.04 27.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 0.0 110.341 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.2 p 47.79 44.97 18.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 20.4 p90 -69.84 -40.93 75.54 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.33 -26.9 38.41 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.675 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -56.93 -25.99 58.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.221 0.208 . . . . 0.0 111.286 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.2 m -137.17 28.0 2.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 0.0 110.705 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.1 m -131.61 145.92 51.94 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.346 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.42 HG23 ' HD3' ' A' ' 61' ' ' LYS . 18.4 m -136.62 174.82 11.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.811 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HD3' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER 61.41 37.86 16.47 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.322 0.649 . . . . 0.0 112.265 -179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 p -63.11 123.0 17.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.895 0.379 . . . . 0.0 111.044 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.12 155.57 37.02 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -110.86 120.15 41.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.829 0.347 . . . . 0.0 110.838 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.57 119.1 23.82 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 68.75 -59.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 124.623 1.202 . . . . 0.0 111.113 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.88 34.64 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.342 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.471 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 0.3 OUTLIER -155.81 -19.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -179.206 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m -116.55 128.0 55.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.618 0.247 . . . . 0.0 111.587 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.603 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.8 tp -91.09 130.74 36.95 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -120.16 129.87 54.33 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.724 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -160.28 164.12 32.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.148 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.6 t -110.95 123.98 51.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 39.2 m -125.45 153.74 43.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.92 0.391 . . . . 0.0 111.809 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.9 tmtt? -99.26 144.51 28.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.693 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.1 -26.82 0.62 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.0 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.647 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . . . -52.25 -42.5 63.69 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.551 0.341 . . . . 0.0 111.715 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -175.83 55.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.017 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.42 20.84 73.93 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.464 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -142.67 159.34 42.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 46.7 p90 -101.26 166.72 10.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.248 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -159.53 145.53 16.1 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -78.6 131.6 36.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.002 0.43 . . . . 0.0 110.772 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 p -143.51 176.03 9.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.271 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.6 OUTLIER -138.85 164.9 28.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.226 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.882 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.8 OUTLIER -145.87 121.72 10.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.533 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.6 105.11 6.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.739 ' HA ' HG22 ' A' ' 91' ' ' VAL . 19.8 mt -77.34 -8.26 57.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.659 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.471 ' OD1' ' HB2' ' A' ' 68' ' ' HIS . 11.5 m120 -47.15 -32.82 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.72 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -116.45 22.76 12.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.427 . . . . 0.0 111.324 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -127.94 -13.5 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.818 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.843 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -132.17 147.97 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.286 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.99 174.61 22.63 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.204 -0.522 . . . . 0.0 111.799 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.447 HD22 ' HB2' ' A' ' 8' ' ' SER . 20.6 t30 -135.31 133.54 38.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.684 0.278 . . . . 0.0 111.124 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.446 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 8.2 m -142.89 115.65 8.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.264 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 58.93 41.13 21.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.389 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 66.09 12.36 57.51 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.721 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -114.63 139.81 49.33 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 34' ' ' SER . 4.6 ppp? -66.01 133.54 51.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.032 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -152.87 69.31 7.0 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.759 178.13 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.843 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 15.7 Cg_endo -56.08 102.82 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.312 2.675 . . . . 0.0 112.548 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.83 110.09 21.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.637 0.732 . . . . 0.0 110.983 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.953 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -114.83 149.99 36.19 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.068 178.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -129.11 65.49 1.45 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.501 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.446 ' HB3' ' HD2' ' A' ' 50' ' ' TYR . 7.4 t -160.96 14.69 0.11 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.974 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.812 ' H ' HD22 ' A' ' 111' ' ' LEU . 65.1 t30 -103.21 16.86 25.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.462 0.648 . . . . 0.0 110.386 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -161.83 141.45 10.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.034 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -85.94 -23.34 26.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.356 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -89.4 -79.77 0.32 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.728 0.299 . . . . 0.0 110.498 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.45 111.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.608 0.718 . . . . 0.0 110.847 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.812 HD22 ' H ' ' A' ' 106' ' ' ASN . 31.1 tp -92.18 62.04 4.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.468 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 114' ' ' SER . 86.9 tttt -94.32 122.94 37.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.3 m -76.12 35.27 0.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.308 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.534 ' HB3' ' HE2' ' A' ' 112' ' ' LYS . 11.4 t -159.79 83.01 0.73 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.6 m -59.13 -31.23 68.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.249 0.547 . . . . 0.0 110.493 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.272 179.278 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.834 0.35 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -73.96 140.74 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.336 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.602 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 71.2 m -75.98 -66.4 0.79 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.489 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 42.77 79.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.58 ' CD1' HG13 ' A' ' 92' ' ' VAL . 3.1 p90 -59.23 -34.54 72.31 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.226 0.536 . . . . 0.0 110.618 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.66 -21.76 66.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.529 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.73 -18.79 65.34 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 50.2 m -142.65 18.39 2.01 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.525 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -118.17 136.07 53.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 110.822 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -133.8 154.19 51.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.572 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.26 61.8 6.9 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.291 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 35.6 m -93.3 144.59 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.293 0.568 . . . . 0.0 111.608 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -135.88 136.7 40.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.84 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.843 HD22 HD23 ' A' ' 64' ' ' LEU . 37.3 tp -122.63 119.77 31.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.976 0.417 . . . . 0.0 110.762 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.576 ' O ' HG12 ' A' ' 18' ' ' ILE . 28.8 t80 -127.93 109.39 11.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.019 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.449 ' O ' HG21 ' A' ' 62' ' ' THR . . . 72.98 -67.16 1.41 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.791 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.9 p90 -164.56 19.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.795 0.438 . . . . 0.0 110.653 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 15' ' ' TYR . 43.5 pt -117.47 122.61 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.02 0.438 . . . . 0.0 110.569 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.852 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -109.21 114.67 28.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.788 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.2 ttt85 -115.71 140.92 48.75 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.82 176.74 41.81 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.142 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.7 m-20 -104.88 109.06 20.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.621 0.248 . . . . 0.0 110.417 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -107.61 132.86 52.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.942 0.401 . . . . 0.0 110.403 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 57.9 mt -67.38 136.15 27.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.452 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -103.68 -174.03 2.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.197 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -54.62 -29.67 52.6 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.01 -25.82 68.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.819 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.52 -4.4 56.68 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.787 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -106.76 145.11 30.41 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 37.2 Cg_endo -66.37 134.02 34.59 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.904 2.403 . . . . 0.0 112.764 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -122.58 123.76 41.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.311 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.07 130.19 44.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.293 0.568 . . . . 0.0 111.761 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 t -144.05 164.96 29.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.478 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.3 p -140.47 138.33 34.57 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.65 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.419 HG13 ' HB3' ' A' ' 99' ' ' MET . 2.7 mp -122.02 145.48 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 120.838 0.351 . . . . 0.0 110.723 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.441 ' OD1' HG22 ' A' ' 18' ' ' ILE . 91.0 m-20 -104.07 91.58 4.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 110.015 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.852 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -57.75 -25.42 60.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.171 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.0 t-20 -55.29 -30.47 60.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.692 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -103.21 11.03 37.42 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.47 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.0 m-85 -126.71 -26.96 3.15 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.537 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.3 mp -110.64 140.89 27.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.672 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -112.6 171.5 14.04 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.481 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -113.86 108.25 16.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.608 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -111.92 105.94 14.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.635 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.831 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 52.6 t30 57.34 41.01 27.18 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.177 0.513 . . . . 0.0 110.78 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.62 15.75 81.3 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.132 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.03 145.74 48.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.832 0.349 . . . . 0.0 111.054 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.7 mp -75.09 119.31 19.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.268 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.535 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 49.0 tt0 -109.93 136.42 49.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.783 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.811 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.65 -68.01 0.26 Allowed Pre-proline 0 CA--C 1.426 -3.82 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.347 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.811 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 2.4 Cg_endo -109.74 126.62 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.32 0 C-N-CA 113.69 -3.74 . . . . 0.0 113.328 -178.103 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.672 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -164.49 -161.53 13.71 Favored Glycine 0 C--N 1.283 -2.408 0 CA-C-N 113.693 -1.594 . . . . 0.0 113.372 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -153.24 147.76 26.07 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.777 0.339 . . . . 0.0 110.586 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m 56.86 37.34 28.73 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 8.4 p90 -71.24 -35.7 71.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.4 0.619 . . . . 0.0 109.466 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.93 -18.38 70.59 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.165 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 m -72.47 -7.59 50.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.173 0.511 . . . . 0.0 110.894 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 56.3 m -146.3 23.01 1.33 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.16 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -128.25 154.79 45.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 111.893 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.524 HG23 ' HD2' ' A' ' 61' ' ' LYS . 25.3 m -141.39 174.38 7.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.73 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HD2' HG23 ' A' ' 60' ' ' VAL . 0.1 OUTLIER 63.17 29.61 16.06 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.238 0.215 . . . . 0.0 111.245 -179.199 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.449 HG21 ' O ' ' A' ' 16' ' ' GLY . 4.0 p -60.98 117.72 5.82 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.201 0.524 . . . . 0.0 111.193 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.35 161.39 42.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.93 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.843 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -120.04 113.32 20.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.022 -178.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -84.9 128.52 34.66 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.415 ' HB3' ' ND1' ' A' ' 68' ' ' HIS . 7.3 t70 52.59 20.09 1.41 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.414 1.071 . . . . 0.0 112.014 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 59.99 35.11 86.15 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.324 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.415 ' ND1' ' HB3' ' A' ' 66' ' ' ASP . 1.7 p-80 -148.49 -23.55 0.33 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.152 0.476 . . . . 0.0 111.549 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.419 ' O ' HD13 ' A' ' 64' ' ' LEU . 55.5 m -116.67 129.66 56.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.173 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.587 ' HB2' HD11 ' A' ' 88' ' ' LEU . 13.8 tp -96.14 128.08 42.73 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.1 130.17 56.68 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.863 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -161.47 155.4 22.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.378 0.608 . . . . 0.0 111.303 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.584 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 7.9 t -105.93 108.28 19.71 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.801 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.0 m -105.1 149.27 26.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.448 0.642 . . . . 0.0 111.765 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 11.3 tmtt? -100.43 141.31 33.46 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.572 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.33 -30.9 0.48 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.485 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.831 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -49.34 -41.24 38.22 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -172.67 49.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.215 0.531 . . . . 0.0 110.144 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.52 1.9 62.43 Favored Glycine 0 C--O 1.23 -0.132 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.249 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -122.0 162.34 21.31 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 36.3 p90 -104.73 170.31 7.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.91 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.3 OUTLIER -157.17 133.76 9.95 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 112.42 7.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.009 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.6 p -125.82 175.04 7.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.978 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.99 163.83 29.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.9 0.381 . . . . 0.0 110.819 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.579 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.4 tpt -151.88 120.9 6.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 50.4 m-20 -74.89 106.78 6.58 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.752 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.4 mt -75.28 -9.43 58.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -47.99 -31.18 5.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.399 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 87' ' ' ASP . 4.0 p90 -117.3 21.35 13.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.61 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.752 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -126.69 -11.64 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.064 0.459 . . . . 0.0 110.484 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.927 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.4 p -153.07 138.36 10.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.832 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.602 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.86 -169.45 11.93 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.013 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.451 HD22 ' HB2' ' A' ' 8' ' ' SER . 19.8 t30 -125.85 139.67 53.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.613 0.244 . . . . 0.0 110.451 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.582 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -150.14 109.64 4.01 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.625 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 62.54 43.27 7.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.49 25.02 62.47 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.529 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.17 148.72 52.04 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 120.919 0.39 . . . . 0.0 110.693 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.505 ' HG3' ' O ' ' A' ' 99' ' ' MET . 15.9 ptt? -57.44 118.49 5.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.925 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.582 ' HG3' ' CB ' ' A' ' 95' ' ' SER . 49.1 mm-40 -132.36 76.77 71.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.563 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.927 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.7 Cg_endo -71.86 87.88 0.82 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.785 2.323 . . . . 0.0 112.681 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.8 p -110.79 130.87 55.46 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.019 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.505 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -112.44 149.63 32.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.454 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.31 61.12 0.62 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.025 0.441 . . . . 0.0 110.19 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.9 t -175.39 -113.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.495 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.2 t30 66.3 105.16 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.849 0.718 . . . . 0.0 111.161 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 64.85 109.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.901 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 111' ' ' LEU . 18.5 t70 -138.21 156.51 47.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.861 -178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -52.4 -45.55 65.93 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.66 0.6 . . . . 0.0 111.134 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.51 57.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.698 0.761 . . . . 0.0 111.677 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 108' ' ' ASP . 1.1 tt -78.38 73.93 4.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.972 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -132.88 28.1 4.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.076 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.9 t 56.27 41.05 29.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.627 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.4 m -144.38 94.9 2.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.633 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.0 t -70.99 -29.3 65.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.354 -179.361 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.786 0.327 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -106.48 142.42 36.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.654 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.577 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 26.5 m -118.83 -55.32 2.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.74 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 55.08 79.39 0.15 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.956 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.491 ' HE1' ' HB2' ' A' ' 88' ' ' LEU . 14.5 p90 -56.76 -38.18 72.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.523 . . . . 0.0 111.158 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.03 -26.61 67.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.677 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -71.38 -6.51 40.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.673 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.3 m -137.67 8.04 2.8 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.765 0.316 . . . . 0.0 110.661 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -120.96 149.99 41.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.843 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.3 p -137.93 147.53 44.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.362 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.67 57.51 17.42 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.567 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 15.3 m -98.57 130.35 47.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.139 0.495 . . . . 0.0 111.817 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -127.4 137.5 52.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.511 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.632 HD22 HD23 ' A' ' 64' ' ' LEU . 18.3 tp -111.09 105.39 14.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -135.79 117.11 14.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.485 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 77.59 34.66 38.93 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.886 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' HD1' HG21 ' A' ' 62' ' ' THR . 19.8 m-85 65.27 23.07 12.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.053 0.541 . . . . 0.0 110.701 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 16' ' ' GLY . 9.2 mt -122.05 125.49 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.003 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.736 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.4 mt -108.07 114.22 27.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.007 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 4.6 ttm180 -116.86 140.23 49.69 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.989 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.516 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.08 177.99 41.48 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.265 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 11.5 m-20 -104.69 110.86 23.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.591 0.234 . . . . 0.0 110.565 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.9 OUTLIER -107.09 132.52 52.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.283 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.6 mt -69.9 134.31 30.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.027 0.441 . . . . 0.0 111.497 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -103.14 -173.11 2.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.842 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.93 -26.12 64.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.813 0.339 . . . . 0.0 111.909 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.75 -23.43 67.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.69 2.07 63.36 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.811 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -113.02 146.11 34.47 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.828 0.347 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.639 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 33.0 Cg_endo -66.26 125.76 14.55 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.236 2.624 . . . . 0.0 112.705 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -109.59 127.46 54.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.255 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.81 126.63 30.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.973 0.416 . . . . 0.0 111.209 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -143.09 162.51 35.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.445 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.487 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 73.2 p -139.59 133.58 30.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.457 0.17 . . . . 0.0 110.709 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.416 HG13 ' CB ' ' A' ' 99' ' ' MET . 2.9 mp -115.23 143.01 25.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.253 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -101.08 92.82 5.17 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.736 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -58.56 -25.61 62.69 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.722 -178.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.556 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 22.8 t-20 -54.18 -31.7 53.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.376 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -107.61 16.4 23.77 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.0 m-85 -129.5 -22.32 3.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.54 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.66 141.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.634 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.0 174.26 15.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.363 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -112.82 108.32 17.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.9 0.381 . . . . 0.0 110.71 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -111.59 105.24 13.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.679 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.714 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 41.5 t30 56.75 42.59 26.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.146 0.498 . . . . 0.0 110.696 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 73.7 18.03 79.37 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.733 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.98 146.91 49.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 111.229 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 7.5 mp -72.38 114.32 10.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.616 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -108.79 132.04 54.37 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.879 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -31.21 -74.12 0.05 OUTLIER Pre-proline 0 CA--C 1.432 -3.568 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.184 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.879 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 10.7 Cg_endo -108.89 129.43 0.04 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.242 0 C-N-CA 113.852 -3.632 . . . . 0.0 112.913 -177.031 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.634 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -161.44 -163.28 14.08 Favored Glycine 0 C--N 1.278 -2.683 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.016 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -153.38 143.22 22.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.013 0.435 . . . . 0.0 110.892 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.5 m 57.15 35.1 25.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.169 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 7.2 p90 -64.81 -34.16 77.7 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.03 -17.61 37.56 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.165 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 t -68.26 -30.82 69.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.739 0.304 . . . . 0.0 110.625 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 m -125.29 6.32 7.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.192 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -120.48 141.38 50.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.684 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.424 HG23 ' HD3' ' A' ' 61' ' ' LYS . 29.8 m -137.5 171.84 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HD3' HG23 ' A' ' 60' ' ' VAL . 2.1 mptm? 63.61 43.35 5.8 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.774 0.671 . . . . 0.0 111.457 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.581 HG21 ' HD1' ' A' ' 17' ' ' TYR . 4.2 p -69.28 133.6 48.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.072 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.71 163.97 38.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.698 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.632 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -120.62 112.87 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.666 0.27 . . . . 0.0 111.647 -179.077 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.621 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 16.9 m120 -72.18 116.93 13.19 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.224 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.609 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 18.7 t70 54.08 15.17 0.83 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.955 0.784 . . . . 0.0 111.929 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.31 34.41 57.79 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.836 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.609 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.5 p80 -147.83 -26.1 0.36 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.7 0.75 . . . . 0.0 112.001 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 18.5 m -116.08 134.59 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.495 0.188 . . . . 0.0 111.058 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.539 ' HG ' ' CD2' ' A' ' 48' ' ' LEU . 24.3 tp -94.64 133.5 38.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.582 0.23 . . . . 0.0 110.613 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.71 130.57 52.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.855 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -163.19 163.31 25.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.8 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.421 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 23.0 t -109.68 126.82 54.08 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.454 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 17.5 m -124.85 150.36 46.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.22 0.533 . . . . 0.0 112.153 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.0 tmtt? -100.27 140.55 34.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.721 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.45 -30.49 0.52 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.145 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.714 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.19 -40.31 64.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -171.21 51.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.416 0.627 . . . . 0.0 110.053 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.43 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 70.71 5.21 56.11 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.782 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -129.34 162.14 28.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 47.9 p90 -90.14 160.11 16.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.309 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -153.87 133.04 12.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.48 124.75 24.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.702 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.8 p -138.45 171.0 15.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.766 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.17 159.41 41.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.965 0.412 . . . . 0.0 110.521 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.575 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 12.0 tpp -143.28 123.76 13.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.505 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.48 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 10.8 m-20 -73.1 105.74 4.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.247 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.736 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.1 mt -76.18 -8.61 57.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.909 0.385 . . . . 0.0 110.426 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.11 -28.73 7.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.943 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 87' ' ' ASP . 44.1 p90 -120.16 22.77 11.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.982 0.42 . . . . 0.0 110.973 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -128.72 -9.93 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.594 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.927 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -138.93 140.6 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.235 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.577 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -139.01 176.47 20.91 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.305 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -121.66 123.31 41.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.632 0.253 . . . . 0.0 110.972 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.533 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 57.9 m -127.82 94.34 3.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.601 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 64.67 47.07 2.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.49 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.62 20.97 66.57 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.366 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -124.17 139.0 54.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 99' ' ' MET . 12.9 ptt? -57.52 122.38 12.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.99 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.533 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 25.8 mm-40 -142.93 78.34 15.54 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.788 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.927 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.0 Cg_endo -71.78 96.38 0.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.884 2.389 . . . . 0.0 113.215 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.0 p -90.76 133.0 35.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.66 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.446 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -114.38 147.2 39.54 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.487 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -103.72 45.2 0.97 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.292 0.568 . . . . 0.0 110.489 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.5 t -165.89 -125.89 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.309 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.739 ' HA ' HD23 ' A' ' 111' ' ' LEU . 6.8 t-20 63.16 33.72 14.18 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.922 0.889 . . . . 0.0 110.583 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -154.4 -171.07 3.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.132 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 66.99 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.733 0.813 . . . . 0.0 111.547 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -67.31 157.44 33.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.846 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.9 m -70.65 60.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.762 0.792 . . . . 0.0 112.689 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 106' ' ' ASN . 39.7 tp -82.27 3.81 26.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.179 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 84.5 tttt -109.16 13.44 24.45 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.556 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.0 t 54.32 39.61 31.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.084 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -97.84 74.18 2.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.023 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.5 m -65.26 -46.03 82.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.696 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.197 179.815 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.643 0.258 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -131.73 -167.53 1.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.584 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 88.7 m -119.59 -72.45 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.94 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.495 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 58.4 m-80 52.17 82.73 0.06 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.598 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 14.4 p90 -60.77 -34.83 75.05 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.289 0.566 . . . . 0.0 110.507 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.85 -19.16 60.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.235 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.495 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 7.4 t-20 -51.22 -33.42 27.74 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.438 0.461 . . . . 0.0 111.532 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB2' HD22 ' A' ' 94' ' ' ASN . 19.8 m -136.5 27.14 3.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.941 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -120.41 132.81 55.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.088 0.471 . . . . 0.0 111.161 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 p -131.87 155.74 47.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.988 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.76 30.43 74.55 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.318 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.586 HG12 ' HA3' ' A' ' 21' ' ' GLY . 17.5 m -77.45 134.34 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.029 0.443 . . . . 0.0 111.669 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.73 151.88 49.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.697 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.663 HD22 HD23 ' A' ' 64' ' ' LEU . 8.8 tp -121.92 106.33 11.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.006 0.431 . . . . 0.0 111.176 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -134.21 114.73 13.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.789 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.469 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 73.76 38.45 49.97 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.738 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 62' ' ' THR . 18.1 m-85 64.2 25.6 13.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.199 0.6 . . . . 0.0 110.886 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 16' ' ' GLY . 12.2 mt -121.56 124.81 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.133 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.785 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -102.74 113.76 27.44 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.442 ' HG3' ' HB3' ' A' ' 34' ' ' SER . 15.2 ttm180 -123.04 133.74 54.32 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.7 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -162.79 -173.38 31.43 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.13 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -106.55 109.53 21.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.626 0.25 . . . . 0.0 110.662 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -104.82 132.08 51.5 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 8' ' ' SER . 54.1 mt -71.74 142.19 15.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -109.5 -171.12 1.78 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.399 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -54.91 -31.22 59.89 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.88 -9.68 58.8 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.16 5.23 85.87 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.845 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.4 133.94 20.4 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.869 0.366 . . . . 0.0 110.168 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.63 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 18.5 Cg_endo -60.48 138.53 81.04 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 123.246 2.63 . . . . 0.0 112.741 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -123.41 135.87 54.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.32 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 112.39 5.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.214 0.53 . . . . 0.0 110.828 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -131.1 156.75 44.71 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.601 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.442 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 19.9 p -139.57 147.0 40.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.102 0.477 . . . . 0.0 111.603 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -129.74 143.96 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.563 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -104.06 89.77 3.38 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.785 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -54.29 -30.44 50.82 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.61 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.54 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.3 t-20 -54.33 -28.34 41.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.468 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -108.76 14.67 24.18 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.643 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 43.0 m-85 -128.05 -24.2 3.21 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.2 mp -111.4 143.03 22.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.661 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -112.61 170.58 13.54 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.56 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -113.84 111.35 21.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.294 -0.453 . . . . 0.0 111.35 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -110.63 104.35 13.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.76 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 48.08 47.04 19.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.126 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 74' ' ' CYS . . . 78.51 12.51 84.19 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.673 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.39 143.97 47.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.832 0.349 . . . . 0.0 110.667 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.6 mp -76.94 114.29 15.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.516 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -103.39 136.97 42.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.089 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.661 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.23 -76.19 0.05 OUTLIER Pre-proline 0 CA--C 1.436 -3.416 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.661 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 20.5 Cg_endo -109.95 125.64 0.04 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.324 0 C-N-CA 113.751 -3.699 . . . . 0.0 113.165 -177.342 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.661 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -155.67 -157.55 8.33 Favored Glycine 0 C--N 1.284 -2.36 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.664 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -151.56 143.31 23.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 111.052 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 m 49.82 44.9 25.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.54 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 11.5 p90 -68.97 -31.08 69.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 59' ' ' CYS . . . -62.22 -18.21 57.47 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.196 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -53.9 -30.66 47.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.315 0.246 . . . . 0.0 110.904 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 25.1 m -135.48 17.75 3.36 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.446 ' HB2' ' HA2' ' A' ' 56' ' ' GLY . 7.5 m -108.08 147.73 30.79 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.45 0.643 . . . . 0.0 112.238 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.74 173.3 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.995 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 59.94 35.91 21.68 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.427 0.291 . . . . 0.0 111.432 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.451 HG21 ' CD1' ' A' ' 17' ' ' TYR . 16.7 p -68.31 120.09 13.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.992 0.425 . . . . 0.0 111.488 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.85 152.49 30.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.728 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.663 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -108.34 112.75 25.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.525 0.202 . . . . 0.0 110.59 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -76.08 117.49 17.84 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.705 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 24.8 t70 58.48 18.04 5.36 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.081 0.863 . . . . 0.0 111.044 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.06 32.52 84.38 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.413 -0.812 . . . . 0.0 114.082 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.705 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.0 p80 -141.9 -27.26 0.65 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 117.811 0.805 . . . . 0.0 111.249 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.403 ' O ' HD13 ' A' ' 64' ' ' LEU . 27.9 m -116.01 126.24 53.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.56 ' HA ' HD22 ' A' ' 64' ' ' LEU . 16.8 tp -89.97 126.58 35.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.162 0.506 . . . . 0.0 109.783 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -117.67 130.47 56.37 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.305 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.31 166.47 27.49 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.661 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 t -118.26 117.57 29.48 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.547 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -114.32 154.21 28.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.544 0.688 . . . . 0.0 111.828 -179.419 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 7.8 tmtt? -100.36 149.27 23.8 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.826 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.31 -15.53 1.87 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.829 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.77 84.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.687 0.28 . . . . 0.0 110.744 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 178.24 58.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.698 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.405 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 69.13 19.68 74.17 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -143.82 161.34 38.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 51.4 p90 -101.82 165.5 11.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.318 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.96 152.84 40.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.408 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.86 131.09 37.45 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.8 p -149.58 172.68 14.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.95 0.405 . . . . 0.0 111.286 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.6 OUTLIER -137.85 163.29 31.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.99 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.565 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 4.6 tpt -146.67 113.05 5.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.4 106.49 4.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.792 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.4 mt -74.47 -7.62 53.6 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.762 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -46.83 -30.76 2.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.874 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -118.63 19.14 13.33 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.628 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.792 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -125.14 -10.01 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.313 0.578 . . . . 0.0 110.154 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.827 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.1 t -141.79 139.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.525 178.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.584 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -129.92 176.42 18.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.519 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.441 HD22 ' HB2' ' A' ' 8' ' ' SER . 21.3 t30 -129.48 133.54 47.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.61 0.243 . . . . 0.0 110.454 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.408 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 5.4 t -142.38 111.49 6.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.88 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 57.65 43.55 22.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.401 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.56 7.56 65.01 Favored Glycine 0 C--N 1.33 0.218 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.455 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.9 145.16 41.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -68.91 131.22 44.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.224 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.408 ' HG3' ' CB ' ' A' ' 95' ' ' SER . 21.2 mm-40 -136.67 76.03 48.79 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.693 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.827 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 35.2 Cg_endo -66.27 119.36 6.38 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.438 2.092 . . . . 0.0 111.322 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 p -109.3 144.63 37.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.826 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.813 ' HG3' ' HB3' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -111.37 129.9 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.349 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.69 15.6 17.57 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.971 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.0 m -157.16 9.78 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.813 ' HB3' ' HG3' ' A' ' 103' ' ' ARG . 14.9 t-20 -111.13 74.79 0.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.589 0.709 . . . . 0.0 109.832 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.5 -47.01 0.07 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.93 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.37 177.27 7.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.833 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -115.71 -21.12 9.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.688 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.9 64.54 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.72 0.771 . . . . 0.0 110.369 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 tt -92.95 78.27 4.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.335 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -128.75 96.21 4.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.908 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.6 t -56.61 112.31 1.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.458 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 41.3 t -144.44 125.57 14.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.049 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.0 m -75.19 -43.13 53.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.066 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.359 179.445 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -82.27 137.94 34.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.601 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.402 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 82.0 m -75.81 -81.49 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.821 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.944 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 24.4 m-80 51.76 69.09 0.7 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.575 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.662 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 17.5 p90 -58.1 -41.66 83.98 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.25 0.547 . . . . 0.0 110.21 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.94 -21.62 65.09 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.821 -178.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 28.2 t-20 -54.71 -33.72 61.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.333 0.587 . . . . 0.0 110.802 -179.138 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.444 ' HB2' HD22 ' A' ' 94' ' ' ASN . 26.1 m -134.69 28.4 3.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.076 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.662 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -120.0 134.88 55.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.943 0.401 . . . . 0.0 110.584 179.267 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 p -128.25 152.19 48.39 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.985 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.84 57.91 12.68 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.756 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.598 HG12 ' HA3' ' A' ' 21' ' ' GLY . 15.5 m -104.83 132.12 52.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.962 0.41 . . . . 0.0 110.824 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -133.27 156.69 47.11 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.739 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.652 HD22 HD23 ' A' ' 64' ' ' LEU . 21.9 tp -121.33 127.73 51.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.542 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.448 ' O ' HG12 ' A' ' 18' ' ' ILE . 42.7 t80 -131.23 98.92 4.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.836 179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 62' ' ' THR . . . 78.41 -63.77 3.61 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.709 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -169.15 23.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.724 0.297 . . . . 0.0 111.47 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.7 pt -121.57 133.91 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.798 0.332 . . . . 0.0 110.659 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.791 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -115.72 114.28 24.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.828 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.46 140.55 51.23 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.598 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.22 -177.71 39.03 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.96 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 7.1 m-20 -109.63 108.3 18.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.439 0.162 . . . . 0.0 110.609 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.9 m -104.54 132.38 50.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.5 mt -69.58 133.43 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.56 -178.538 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -94.68 -176.59 3.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.917 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -54.72 -37.71 66.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.727 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.81 -30.02 67.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.938 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.03 -2.01 31.53 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.322 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -104.49 139.69 20.35 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.372 . . . . 0.0 110.944 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 42.8 Cg_endo -69.91 125.99 12.7 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.921 2.414 . . . . 0.0 111.67 179.1 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -112.02 136.88 50.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.048 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.3 123.77 21.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.453 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -140.01 158.36 44.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.602 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.0 p -140.1 141.86 36.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.743 0.306 . . . . 0.0 111.192 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -124.86 145.4 32.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.588 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -103.74 95.82 6.29 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -58.54 -26.9 64.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.742 0.306 . . . . 0.0 111.337 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -55.41 -24.12 28.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.863 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -112.86 12.37 19.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.58 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -129.02 -12.03 4.7 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.529 HD13 ' HB3' ' A' ' 37' ' ' LEU . 3.0 mp -124.62 133.9 68.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.55 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -108.67 170.92 15.13 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.577 -179.324 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -110.88 102.49 10.99 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.299 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -110.57 105.64 14.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.889 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 14.3 t-20 52.6 47.37 24.83 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.708 0.766 . . . . 0.0 111.094 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.69 75.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.933 179.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -120.27 151.79 38.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.797 0.332 . . . . 0.0 110.672 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.507 HD23 ' HG ' ' A' ' 70' ' ' LEU . 10.8 mp -85.5 117.01 24.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.892 -179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.673 ' HG3' ' CD ' ' A' ' 51' ' ' PRO . 12.8 tp10 -110.57 126.8 54.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.183 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.945 ' HB2' HG11 ' A' ' 91' ' ' VAL 0.252 53.5 p90 -61.13 -12.06 0.2 Allowed Pre-proline 0 CA--C 1.452 -2.811 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 -174.804 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.836 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 8.3 Cg_endo -128.62 9.22 0.0 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.601 1 C-N-CA 112.461 -4.56 . . . . 0.0 114.972 175.693 . . . . . . . . 4 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.55 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -66.94 -167.72 3.05 Favored Glycine 0 C--N 1.27 -3.106 0 CA-C-N 110.849 -2.887 . . . . 0.0 115.69 -177.183 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -145.59 154.56 42.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.721 0.296 . . . . 0.0 110.928 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.8 m 55.76 45.28 24.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 10.4 p90 -79.61 -36.7 37.63 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.845 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.54 -18.38 69.83 Favored Glycine 0 CA--C 1.505 -0.533 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.83 -178.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 m -66.7 -13.21 61.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.049 -0.576 . . . . 0.0 110.779 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.4 m -149.02 26.84 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.617 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -124.55 155.36 39.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.162 0.506 . . . . 0.0 111.123 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 61' ' ' LYS . 32.6 m -141.62 171.1 12.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.816 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.4 mptt 62.46 31.77 16.98 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.523 0.514 . . . . 0.0 111.345 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 16' ' ' GLY . 2.6 p -59.66 123.16 16.02 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.926 0.393 . . . . 0.0 111.489 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.45 162.88 40.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.315 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.652 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -121.98 112.62 18.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -85.33 124.8 32.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 110.959 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.629 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 11.1 t70 56.36 21.36 5.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.048 179.031 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.94 36.06 92.28 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.33 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.629 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -154.48 -23.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.571 0.686 . . . . 0.0 112.393 179.008 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 m -116.35 128.48 55.57 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.22 -0.3 . . . . 0.0 111.143 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.566 ' HA ' HD22 ' A' ' 64' ' ' LEU . 11.8 tp -91.3 129.73 37.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.297 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.402 ' N ' HD12 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -120.84 129.75 53.67 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.657 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -162.91 165.56 24.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.133 179.109 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.412 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 23.2 t -117.01 111.78 20.04 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.314 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 56.7 m -103.38 146.14 28.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.414 0.626 . . . . 0.0 110.742 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 10.2 tmtt? -100.59 140.49 34.78 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.883 177.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.73 -24.46 0.3 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.909 -1.139 . . . . 0.0 112.992 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.436 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . . . -47.97 -45.85 31.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.0 111.135 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.2 t70 178.72 58.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.917 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.454 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 76.57 -0.16 65.71 Favored Glycine 0 C--O 1.229 -0.189 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.695 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -118.23 163.95 15.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.172 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 50.5 p90 -111.77 169.54 8.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.071 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -155.95 135.19 12.21 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -72.05 114.65 10.38 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.291 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.467 ' HB3' HD13 ' A' ' 48' ' ' LEU . 18.8 t -130.55 167.53 18.54 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.977 0.418 . . . . 0.0 110.418 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.03 160.93 38.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.163 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.608 ' HA ' ' CE ' ' A' ' 86' ' ' MET . 0.6 OUTLIER -146.04 126.25 13.86 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.327 -179.611 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.565 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 45.9 t0 -78.28 108.78 11.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.144 0.497 . . . . 0.0 109.874 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.779 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.1 mt -82.26 -9.25 59.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.586 -179.177 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -52.21 -26.27 11.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.489 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 41.9 p90 -116.54 17.76 15.27 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.066 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.945 HG11 ' HB2' ' A' ' 50' ' ' TYR . 2.5 m -123.7 -10.57 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 121.188 0.518 . . . . 0.0 110.476 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -133.73 124.16 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -114.98 159.03 13.95 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.44 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.444 HD22 ' HB2' ' A' ' 8' ' ' SER . 22.9 t30 -107.81 121.94 45.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.559 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 74.4 m -137.12 107.16 6.31 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.809 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 61.01 40.74 14.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.326 178.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.73 18.31 68.11 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.606 -0.725 . . . . 0.0 113.164 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -124.75 147.97 48.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 99' ' ' MET . 8.2 ptt? -66.01 127.77 33.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.867 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 53.9 mm-40 -133.61 75.07 69.47 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.289 178.071 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 31.6 Cg_endo -62.19 135.48 54.71 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.734 2.289 . . . . 0.0 112.218 -179.195 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 5.7 p -123.45 111.6 16.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.578 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.459 ' HB2' ' CB ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -89.56 147.9 23.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.418 ' HB3' ' HE2' ' A' ' 50' ' ' TYR . . . -135.82 30.23 3.12 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.812 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.545 ' HB2' ' HG3' ' A' ' 51' ' ' PRO . 11.3 m -166.46 9.97 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.836 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 12.4 t-20 -99.86 -1.05 38.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.849 0.833 . . . . 0.0 109.661 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -86.75 -31.34 20.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.592 179.285 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.55 153.16 22.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.979 178.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -113.9 178.73 4.18 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.611 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 m 37.93 66.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 122.371 1.081 . . . . 0.0 112.023 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.719 ' H ' HD23 ' A' ' 111' ' ' LEU . 2.4 pt? -108.61 18.66 20.63 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.003 -178.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -65.86 115.89 6.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.123 179.3 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.7 p -77.48 68.9 3.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.404 0.621 . . . . 0.0 110.48 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 41.6 t -161.03 136.09 7.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.938 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -61.12 -33.66 73.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.525 178.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.25 1.079 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.327 -179.683 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 110.764 -0.087 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 58.96 102.17 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.896 0.855 . . . . 0.0 112.577 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.438 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 37.9 m -70.97 -77.38 0.09 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.742 179.286 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 41.82 76.04 0.08 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.267 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.63 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 3.4 p90 -62.19 -32.68 73.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.006 0.431 . . . . 0.0 111.035 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.6 -22.31 65.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -63.05 -27.18 69.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HB2' HD22 ' A' ' 94' ' ' ASN . 71.0 m -129.87 28.7 5.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.733 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -129.75 144.81 51.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.927 0.394 . . . . 0.0 111.104 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.1 p -140.39 147.39 39.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.061 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.13 48.14 55.01 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.893 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.543 HG12 ' HA3' ' A' ' 21' ' ' GLY . 18.1 m -93.5 132.75 36.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.202 0.525 . . . . 0.0 111.083 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -126.6 154.86 43.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.672 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.732 HD22 HD23 ' A' ' 64' ' ' LEU . 16.2 tp -123.8 119.44 29.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.872 0.368 . . . . 0.0 111.41 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.546 ' O ' HG12 ' A' ' 18' ' ' ILE . 29.2 m-85 -118.01 99.21 6.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.158 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.478 ' O ' HG21 ' A' ' 62' ' ' THR . . . 73.44 -61.92 1.89 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.975 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 28.1 p90 -165.39 21.15 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.868 0.366 . . . . 0.0 111.211 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 15' ' ' TYR . 35.4 pt -118.82 127.54 75.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.922 0.391 . . . . 0.0 110.552 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.889 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -108.82 117.64 34.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.695 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 20' ' ' ARG . 6.1 tmm_? -128.85 138.22 51.92 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.737 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.543 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -166.78 -168.54 29.12 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.937 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 5.1 m-20 -112.34 110.66 21.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.737 0.303 . . . . 0.0 111.078 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 m -106.38 132.98 51.78 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.7 mt -67.41 136.34 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.83 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.485 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.6 p30 -104.34 -174.46 2.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.355 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -52.79 -33.41 48.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.481 0.488 . . . . 0.0 112.098 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.68 -28.18 69.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.786 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.06 -4.04 48.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.514 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -104.87 146.08 31.95 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.808 0.337 . . . . 0.0 110.524 179.231 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 37.1 Cg_endo -67.52 130.6 22.6 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.805 2.337 . . . . 0.0 112.137 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -118.96 132.38 56.07 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.743 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.82 126.25 27.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.41 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 t -143.03 158.7 43.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.649 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 p -138.98 151.17 46.64 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.542 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -136.25 147.24 28.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.316 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.428 ' OD1' HG22 ' A' ' 18' ' ' ILE . 91.1 m-20 -104.38 96.05 6.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.897 0.379 . . . . 0.0 110.785 179.299 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.889 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -60.39 -28.5 68.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.008 -179.138 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.471 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 24.4 t-20 -55.81 -26.56 46.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.2 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.05 11.93 22.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.484 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.654 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.9 m-85 -128.71 -20.28 3.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -114.69 141.32 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.609 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.32 176.54 17.05 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.105 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -116.71 106.62 13.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.889 0.376 . . . . 0.0 110.695 -178.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -111.87 107.27 16.25 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.376 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.848 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 55.1 t30 56.02 40.79 30.27 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.037 0.446 . . . . 0.0 110.533 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.41 19.6 79.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.509 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.42 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -123.89 157.06 35.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.848 0.356 . . . . 0.0 110.568 -179.584 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.05 116.63 21.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.234 -178.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.18 128.77 51.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.596 179.178 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.706 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.83 -76.22 0.04 OUTLIER Pre-proline 0 CA--C 1.43 -3.639 0 CA-C-O 117.697 -1.144 . . . . 0.0 112.819 -179.825 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.751 ' HG2' ' HA ' ' A' ' 106' ' ' ASN . 6.0 Cg_endo -108.68 123.98 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.273 1 C-N-CA 113.199 -4.067 . . . . 0.0 113.083 -178.661 . . . . . . . . 4 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.609 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -152.35 -160.75 9.77 Favored Glycine 0 C--N 1.281 -2.509 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.939 -177.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -154.87 142.76 20.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.693 0.282 . . . . 0.0 110.583 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.1 m 56.48 42.49 27.34 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.184 178.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 14.9 p90 -71.75 -35.61 70.17 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.07 -18.69 48.98 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.321 -178.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 m -64.4 -16.55 62.55 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.06 0.544 . . . . 0.0 111.01 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 m -148.22 23.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.884 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.7 m -129.99 138.67 50.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.26 0.552 . . . . 0.0 111.093 -179.559 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.416 HG23 ' HG2' ' A' ' 61' ' ' LYS . 25.1 m -133.06 178.09 6.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.295 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HG2' HG23 ' A' ' 60' ' ' VAL . 34.4 mmtp 62.81 37.09 12.6 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.415 0.447 . . . . 0.0 111.329 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.478 HG21 ' O ' ' A' ' 16' ' ' GLY . 12.6 p -67.84 123.2 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.86 149.73 27.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.92 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.732 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -106.34 115.01 29.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.853 0.359 . . . . 0.0 110.724 -179.639 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -85.94 120.37 27.27 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.195 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.69 23.36 10.98 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.924 0.765 . . . . 0.0 111.925 179.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.93 32.19 59.1 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 114.361 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -148.09 -25.15 0.35 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.376 0.588 . . . . 0.0 111.436 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.6 m -114.81 126.39 54.77 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.777 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.535 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.0 tp -89.83 132.72 35.11 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.45 129.56 52.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.748 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.19 166.93 28.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 110.521 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 t -114.79 122.66 47.05 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 57.2 m -122.44 149.68 43.52 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.47 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.414 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 9.4 tmtt? -99.96 140.45 34.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.824 178.148 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.61 -32.07 0.3 Allowed Glycine 0 C--O 1.227 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.18 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.848 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -52.95 -41.16 64.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -173.55 52.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.618 0.723 . . . . 0.0 109.811 -179.094 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.414 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 69.21 10.01 61.65 Favored Glycine 0 C--O 1.225 -0.418 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.096 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -131.78 158.67 40.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 17.4 p90 -100.72 166.3 10.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -158.53 149.12 20.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.144 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -69.59 139.33 53.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.931 0.396 . . . . 0.0 110.636 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.42 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 34.3 t -152.01 162.99 40.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.038 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.58 164.55 27.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.908 0.385 . . . . 0.0 110.021 179.157 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.813 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 2.6 tpt -148.7 121.38 8.63 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.689 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 19.2 m-20 -73.94 106.5 5.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.015 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.709 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.3 mt -75.76 -9.11 58.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.523 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.38 -31.33 3.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.079 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.562 ' HE1' ' HD2' ' A' ' 50' ' ' TYR . 3.2 p90 -119.57 23.59 11.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 111.564 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -127.53 -14.35 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.102 0.477 . . . . 0.0 110.505 178.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.966 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.5 p -150.79 133.81 6.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.691 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -128.03 -179.82 16.08 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.523 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.449 HD22 ' HB2' ' A' ' 8' ' ' SER . 14.8 t30 -126.01 135.85 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.533 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 5.0 t -147.66 120.61 8.77 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 57.99 41.49 24.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 60.58 28.98 68.59 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.764 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -136.29 151.44 49.64 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.835 0.35 . . . . 0.0 110.139 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.431 ' HG3' ' O ' ' A' ' 99' ' ' MET . 20.0 ptt? -61.9 127.89 33.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.071 -179.345 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 95' ' ' SER . 14.2 mm-40 -140.45 71.48 32.02 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.246 178.034 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.966 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 51.7 Cg_endo -70.91 100.73 0.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.77 2.314 . . . . 0.0 112.871 -179.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.17 116.31 32.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.031 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -91.75 149.66 21.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.48 -179.407 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.79 24.55 4.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -163.17 46.2 0.13 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.735 0.302 . . . . 0.0 111.446 -178.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.751 ' HA ' ' HG2' ' A' ' 51' ' ' PRO . 66.7 t30 -88.86 20.4 3.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.836 0.35 . . . . 0.0 111.778 -178.389 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 111' ' ' LEU . . . -167.16 166.53 14.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.778 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.74 -57.88 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.235 0.541 . . . . 0.0 111.061 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -118.79 -41.45 2.79 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.921 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.19 58.42 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 122.74 1.257 . . . . 0.0 110.026 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 107' ' ' ALA . 54.7 tp -81.84 89.21 6.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.355 -179.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.649 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 5.4 mmpt? -110.33 112.9 25.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.638 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.0 m -94.66 37.45 1.13 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.1 p -148.54 168.1 23.63 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.183 -1.372 . . . . 0.0 108.981 -178.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 m -70.67 -49.45 47.11 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 . . . . . 0 C--O 1.248 1.009 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.642 178.811 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtm . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 61.17 -161.53 0.29 Allowed 'General case' 0 C--N 1.332 -0.167 0 O-C-N 123.476 0.485 . . . . 0.0 110.789 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.582 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 83.3 m -116.67 -70.09 0.81 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.309 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 44.2 m-80 62.51 80.5 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 178.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.645 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 6.2 p90 -65.01 -35.87 82.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.066 178.042 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.9 64.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.871 -178.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 7.3 t-20 -52.18 -31.27 30.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.51 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.422 ' HB2' HD22 ' A' ' 94' ' ' ASN . 59.0 m -144.12 30.77 1.27 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.893 0.378 . . . . 0.0 110.721 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -119.48 142.17 48.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.024 179.156 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -141.44 157.53 45.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.395 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.79 61.03 7.66 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.723 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.584 HG12 ' HA3' ' A' ' 21' ' ' GLY . 30.9 m -100.71 139.02 23.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.91 0.386 . . . . 0.0 110.991 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 11.3 pt-20 -130.32 139.72 50.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.393 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.72 HD22 HD23 ' A' ' 64' ' ' LEU . 51.9 tp -124.62 123.74 40.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.484 ' O ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-85 -133.67 103.65 5.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.412 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 62' ' ' THR . . . 79.37 -65.2 3.67 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.161 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.6 p90 -167.6 21.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.813 0.339 . . . . 0.0 111.313 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 45.6 pt -117.02 129.05 74.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.47 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.917 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -119.79 114.45 22.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.609 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 21.2 ttm180 -114.0 136.0 53.38 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.584 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -154.93 168.32 32.89 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.399 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.657 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 17.8 m-20 -100.66 105.15 16.49 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -104.97 131.79 52.02 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 60.4 mt -70.71 136.2 26.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.646 -178.399 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -99.73 -176.5 3.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.404 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.37 -32.79 57.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.89 -29.04 69.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.022 0.439 . . . . 0.0 111.66 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.12 0.8 41.5 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.096 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -107.56 141.52 23.2 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.791 0.329 . . . . 0.0 110.656 179.507 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.657 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 36.5 Cg_endo -67.62 130.23 21.69 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 122.966 2.444 . . . . 0.0 112.532 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -114.72 132.61 56.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.95 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.38 124.27 23.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.171 0.51 . . . . 0.0 111.638 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 t -143.22 152.94 42.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.413 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 12.7 p -135.7 145.5 46.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.506 0.193 . . . . 0.0 111.117 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.84 151.81 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.788 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -103.07 93.61 5.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.171 178.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.917 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -60.18 -24.48 64.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.797 -178.911 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.5 t-20 -55.09 -30.9 60.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.969 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -105.7 15.17 27.27 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.537 -178.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.1 m-85 -130.38 -24.62 2.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.3 mp -112.71 141.78 27.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.671 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -114.35 169.7 12.99 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.547 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -119.33 114.2 21.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.973 0.416 . . . . 0.0 110.933 -179.082 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -111.02 108.12 17.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.241 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 51.87 42.56 30.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.077 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 74' ' ' CYS . . . 80.07 18.05 73.03 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.539 179.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.67 150.17 46.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.047 0.451 . . . . 0.0 111.2 -179.83 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.468 HD13 ' HG ' ' A' ' 70' ' ' LEU . 43.4 mt -82.43 116.19 21.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.14 -179.133 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -112.49 132.04 55.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.583 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -33.17 -73.67 0.06 OUTLIER Pre-proline 0 CA--C 1.427 -3.765 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.598 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.583 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 4.9 Cg_endo -107.85 130.48 0.05 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.327 0 C-N-CA 113.563 -3.824 . . . . 0.0 113.212 -176.669 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.671 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -163.89 -160.46 11.8 Favored Glycine 0 C--N 1.286 -2.204 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.322 -177.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -151.53 145.53 25.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 111.401 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m 51.57 41.79 28.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.774 178.325 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -69.33 -39.37 78.23 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.523 178.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.03 -18.08 46.54 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.24 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 t -68.82 -20.44 64.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.002 0.43 . . . . 0.0 110.166 179.691 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -134.49 17.25 3.66 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.402 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.7 m -125.8 143.13 51.19 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.97 0.414 . . . . 0.0 111.17 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.31 172.81 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.454 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 62.0 37.54 14.85 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.597 0.56 . . . . 0.0 111.359 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 16' ' ' GLY . 18.0 p -63.94 127.43 31.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.972 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.55 160.28 43.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.231 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.72 HD23 HD22 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -118.54 112.92 20.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.805 0.336 . . . . 0.0 110.967 -179.7 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.593 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 15.9 m120 -70.28 114.61 8.58 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.316 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.7 t70 55.2 3.32 0.06 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.145 0.903 . . . . 0.0 112.766 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 86.84 47.78 4.66 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.475 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 6.1 p80 -162.04 -30.06 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 111.684 178.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 23.9 m -115.89 134.15 55.28 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.692 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.605 ' HB2' HD11 ' A' ' 88' ' ' LEU . 12.3 tp -94.92 131.24 41.06 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.541 0.21 . . . . 0.0 110.482 179.099 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 128.99 53.81 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.77 162.57 37.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.165 0.507 . . . . 0.0 111.149 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -110.76 120.95 44.09 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.466 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 21.3 m -121.36 148.21 44.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.277 0.56 . . . . 0.0 112.303 -177.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 8.2 tmtt? -99.41 147.48 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.226 178.046 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.68 -18.55 0.87 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.005 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.72 81.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.823 0.311 . . . . 0.0 110.815 179.082 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.7 t70 179.13 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.205 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.49 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 71.52 -3.75 16.22 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.635 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -116.19 161.51 18.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 44.3 p90 -106.11 166.58 10.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.299 -179.473 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -154.97 143.16 20.28 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.4 127.55 32.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.78 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 p -141.4 174.72 10.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.13 162.49 34.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 0.0 110.791 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.795 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.2 tpt -148.66 117.18 6.55 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.575 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 26.4 t70 -76.68 106.75 8.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.708 ' HA ' HG22 ' A' ' 91' ' ' VAL . 12.5 mt -78.85 -10.05 59.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.387 -177.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -58.44 -16.72 16.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.06 -179.15 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.563 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 48.2 p90 -119.45 19.43 12.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.174 0.512 . . . . 0.0 110.823 177.431 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 2.6 m -125.52 -6.63 5.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.479 0.657 . . . . 0.0 109.84 177.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 9.9 p -153.06 147.02 14.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.937 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.71 -177.09 14.71 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.793 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.422 HD22 ' HB2' ' A' ' 8' ' ' SER . 17.3 t30 -122.71 127.01 48.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.716 0.293 . . . . 0.0 110.65 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.6 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 58.2 m -127.68 92.9 3.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.77 178.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 60.99 54.29 3.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.996 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.25 27.37 62.8 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.965 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.88 142.83 51.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.898 0.38 . . . . 0.0 110.52 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 99' ' ' MET . 21.5 ptt? -62.22 121.21 12.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.547 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.6 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 12.7 mm-40 -138.43 80.93 25.94 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.199 178.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 42.3 Cg_endo -68.67 102.06 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.909 2.406 . . . . 0.0 112.064 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.4 p -127.67 111.72 14.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.043 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.773 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -81.33 149.1 29.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.143 -179.962 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -105.29 54.29 0.71 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.095 0.474 . . . . 0.0 110.849 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.7 t -179.76 -106.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.46 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.726 ' HB2' ' HG3' ' A' ' 103' ' ' ARG . 3.5 t-20 69.45 110.21 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.932 0.893 . . . . 0.0 112.008 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.26 148.03 31.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.808 178.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.2 t70 60.4 28.78 18.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.614 0.721 . . . . 0.0 111.245 179.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB3' HD21 ' A' ' 106' ' ' ASN . 8.3 t60 -153.46 154.18 33.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 110' ' ' VAL . 7.3 p -93.99 81.45 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 122.195 0.998 . . . . 0.0 111.038 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.451 HD23 ' HB2' ' A' ' 51' ' ' PRO . 28.0 tp -144.64 39.19 1.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.37 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.469 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 39.8 ttpt -78.57 111.6 14.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.483 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.9 m -83.81 54.66 2.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.649 0.737 . . . . 0.0 110.016 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.7 m -153.16 132.96 13.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.222 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.2 m -61.62 -35.54 78.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.162 -179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.969 -179.939 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 121.256 0.551 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -100.1 125.59 46.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.607 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 2.1 m -71.62 -62.76 1.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.723 -178.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 56.73 70.38 0.66 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.162 0.289 . . . . 0.0 110.863 179.233 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 6.8 p90 -58.35 -38.35 77.03 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.071 0.462 . . . . 0.0 111.582 -178.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.91 -22.6 65.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -69.37 -19.48 63.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.784 0.326 . . . . 0.0 111.312 -178.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.2 m -128.94 10.01 5.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.154 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -118.29 138.55 52.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.218 0.532 . . . . 0.0 111.475 -179.615 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.7 p -132.48 151.42 51.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.921 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.03 49.22 80.88 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.947 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.517 ' HB ' HD22 ' A' ' 19' ' ' LEU . 15.7 m -83.39 127.53 39.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.275 0.56 . . . . 0.0 111.493 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -116.29 137.35 52.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.31 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.841 HD22 HD23 ' A' ' 64' ' ' LEU . 59.4 tp -119.08 129.05 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 111.763 -178.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.506 ' O ' HG12 ' A' ' 18' ' ' ILE . 52.5 m-85 -133.91 103.49 5.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.624 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.34 -66.82 2.24 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.655 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -164.18 21.02 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.993 0.425 . . . . 0.0 111.089 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.2 pt -121.42 127.28 75.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.176 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.853 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.5 mt -113.18 114.12 26.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.346 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 34' ' ' SER . 10.8 ttm180 -116.49 132.39 56.69 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.577 178.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.42 -173.56 26.0 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.052 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.622 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.7 m-20 -109.04 109.65 20.72 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.719 0.295 . . . . 0.0 110.384 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -106.79 132.54 52.64 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.267 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.9 mt -72.97 138.4 21.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.558 -178.157 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -102.94 -166.77 1.31 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.762 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.36 -28.41 69.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.907 0.384 . . . . 0.0 111.623 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.58 -26.89 68.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.649 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.83 -2.9 55.74 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.217 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -104.42 142.53 24.81 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.888 0.375 . . . . 0.0 110.707 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.622 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 31.5 Cg_endo -67.41 133.46 30.29 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.817 2.345 . . . . 0.0 112.158 178.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -115.74 139.0 50.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.528 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.24 119.83 16.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.012 0.435 . . . . 0.0 111.291 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -142.19 153.04 43.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.035 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.543 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 5.1 p -138.2 136.25 36.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.664 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.75 144.17 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.829 -179.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.426 ' ND2' ' CE2' ' A' ' 39' ' ' TYR . 63.3 t30 -103.62 87.51 2.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -57.78 -18.16 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.034 -178.184 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -52.95 -32.33 45.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.69 -178.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.426 ' CE2' ' ND2' ' A' ' 36' ' ' ASN . 63.7 m-85 -107.1 18.58 21.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.7 0.286 . . . . 0.0 111.307 -179.235 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -125.66 -30.1 3.09 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.68 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.5 mp -111.08 143.13 21.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.717 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -116.88 166.92 12.46 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.645 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -109.78 110.07 20.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.442 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -110.15 105.19 14.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.468 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.739 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 22.2 t30 54.48 41.53 31.9 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.897 178.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.43 4.77 89.17 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.083 179.404 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.84 151.63 33.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.025 0.441 . . . . 0.0 111.131 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 84' ' ' SER . 10.8 mp -84.03 127.94 34.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.753 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -120.18 138.89 53.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.536 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.753 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -40.47 -69.31 0.21 Allowed Pre-proline 0 CA--C 1.429 -3.692 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.197 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.753 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 8.1 Cg_endo -109.73 124.9 0.03 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.46 0 C-N-CA 114.054 -3.498 . . . . 0.0 113.551 -177.28 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.717 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.4 -161.79 11.8 Favored Glycine 0 C--N 1.281 -2.505 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.006 -177.581 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -153.04 143.75 22.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.758 0.328 . . . . 0.0 110.643 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.2 t 60.22 45.2 11.77 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.824 177.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.48 ' CE2' HD21 ' A' ' 70' ' ' LEU . 9.2 p90 -80.88 -37.43 29.8 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.732 -0.605 . . . . 0.0 110.069 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.74 -18.42 68.27 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.33 -178.085 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.3 m -68.9 -25.59 64.68 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.85 0.357 . . . . 0.0 110.929 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.7 p -123.76 0.6 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.375 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.5 m -107.77 151.78 25.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.058 0.456 . . . . 0.0 111.14 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' HD3' ' A' ' 61' ' ' LYS . 17.2 m -143.09 168.53 13.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.406 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.515 ' HD3' HG23 ' A' ' 60' ' ' VAL . 14.0 mptt 64.4 36.4 9.0 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.542 0.526 . . . . 0.0 110.751 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.4 p -63.97 132.03 49.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.087 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.17 162.17 41.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.801 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.841 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -123.04 112.91 18.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.773 0.321 . . . . 0.0 111.335 -179.401 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -82.35 123.27 28.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.266 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.763 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.6 t70 57.59 17.47 4.0 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.01 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.68 29.9 76.14 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.401 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.763 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 6.1 p80 -143.39 -30.41 0.5 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 117.458 0.629 . . . . 0.0 111.391 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.8 m -105.43 125.37 50.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.099 0.476 . . . . 0.0 111.615 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.696 ' HB2' HD11 ' A' ' 88' ' ' LEU . 14.0 tp -90.54 129.29 36.71 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.0 OUTLIER -122.65 129.01 51.37 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 179.987 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.87 169.38 21.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.27 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.541 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 14.6 t -119.25 121.02 38.72 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.72 155.86 26.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.657 0.741 . . . . 0.0 111.856 -179.537 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.47 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 10.7 tmtt? -101.04 148.25 25.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.371 178.239 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.33 -32.66 0.54 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.433 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.739 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -55.0 -43.42 73.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -173.5 56.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 110.661 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 71.55 -1.03 31.12 Favored Glycine 0 CA--C 1.516 0.147 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.783 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -119.01 168.54 10.71 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 42.8 p90 -110.27 161.38 15.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.119 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -153.01 135.17 14.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -61.87 134.4 56.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.966 -179.606 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.448 ' HB3' HD13 ' A' ' 48' ' ' LEU . 41.6 t -147.65 157.78 43.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.057 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.5 OUTLIER -131.63 162.13 31.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.363 . . . . 0.0 110.338 179.393 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.707 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 17.9 tpp -150.37 127.69 11.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.548 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.734 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 22.3 t0 -80.77 111.22 17.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.805 ' HA ' HG22 ' A' ' 91' ' ' VAL . 11.4 mt -81.33 -8.71 59.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.43 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -52.6 -26.09 12.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.888 179.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.734 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 25.5 p90 -116.66 19.05 14.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.772 0.32 . . . . 0.0 111.093 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.805 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -129.55 -12.41 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.232 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.7 t -131.26 147.12 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.379 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.607 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -138.47 172.89 22.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.907 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.437 HD22 ' HB2' ' A' ' 8' ' ' SER . 17.3 t30 -130.31 123.58 30.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.439 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.627 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 75.6 m -124.82 98.63 5.79 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.219 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 62.59 48.36 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.352 179.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.01 21.55 65.85 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.176 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -121.81 139.24 53.86 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.607 0.241 . . . . 0.0 110.379 -179.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 99' ' ' MET . 22.2 ptt? -59.28 117.27 4.6 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.589 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.627 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 4.5 mm-40 -142.76 71.83 19.74 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.059 0.457 . . . . 0.0 110.654 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 51.8 Cg_endo -69.26 114.16 3.53 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.908 2.405 . . . . 0.0 112.772 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.9 p -118.34 137.71 52.91 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.444 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -108.17 145.13 34.64 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.23 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.49 16.79 16.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.199 0.523 . . . . 0.0 111.578 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.432 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 48.4 m -143.96 -139.4 0.11 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 59.88 21.82 10.78 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.451 0.644 . . . . 0.0 110.785 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.64 127.36 10.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.927 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 17.9 t70 67.25 155.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.762 0.664 . . . . 0.0 111.088 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 76.0 t60 73.38 155.89 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.73 0.776 . . . . 0.0 110.987 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.8 t -82.62 93.66 2.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.574 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.98 -23.01 67.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.743 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -74.06 100.47 3.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.736 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.0 m -81.63 73.21 8.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.299 0.571 . . . . 0.0 110.797 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.7 m -129.29 72.81 1.48 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.232 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.4 m -78.32 -24.01 46.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.653 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.943 -179.663 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -132.39 144.29 50.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.051 0.453 . . . . 0.0 110.39 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.48 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 74.1 m -60.6 -48.63 80.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.976 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 55.72 69.88 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 10.7 p90 -57.58 -39.51 76.93 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.324 0.583 . . . . 0.0 110.496 179.067 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.75 -22.34 61.95 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -177.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -72.01 -6.17 40.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.441 ' CB ' HD22 ' A' ' 94' ' ' ASN . 40.5 m -146.85 18.19 1.27 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.971 0.415 . . . . 0.0 110.399 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.5 m -127.31 133.39 50.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.786 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.9 p -136.13 154.59 50.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.11 57.38 10.76 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.649 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 31.5 m -93.24 138.2 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.297 0.57 . . . . 0.0 112.3 -178.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 43.2 mt-10 -126.67 144.26 50.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.825 179.073 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.74 HD22 HD23 ' A' ' 64' ' ' LEU . 12.2 tp -127.97 110.59 12.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.388 179.099 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' HG12 ' A' ' 18' ' ' ILE . 83.2 t80 -116.95 101.61 8.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.055 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.31 -65.7 2.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.97 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 6.2 p90 -162.57 18.99 0.09 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.173 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.2 pt -118.79 131.52 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.342 . . . . 0.0 110.614 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.866 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.45 113.81 26.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.087 -179.522 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 7.8 ttm180 -113.67 139.38 49.1 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.158 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.21 165.0 34.15 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.449 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 6.0 m-20 -97.07 102.56 14.37 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.013 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 8' ' ' SER . 60.0 m -105.95 132.78 51.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mt -69.55 132.18 33.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.018 0.437 . . . . 0.0 111.184 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -103.57 -170.9 1.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.955 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.63 -28.92 61.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 111.712 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.24 -25.54 68.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.869 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.61 -1.02 63.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.629 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -110.03 142.88 26.83 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.632 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 25.9 Cg_endo -63.36 122.3 10.42 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.062 2.508 . . . . 0.0 112.326 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -107.63 132.53 53.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.24 117.25 15.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.142 0.496 . . . . 0.0 111.469 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -133.52 160.85 36.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.286 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 64.5 p -136.43 147.49 47.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.22 142.7 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -100.94 88.5 3.56 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -54.36 -29.37 48.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.705 -178.342 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 24.5 t-20 -52.87 -35.8 58.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.82 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -100.9 12.47 37.56 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.792 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.636 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.7 m-85 -126.02 -23.55 3.91 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -114.26 141.56 30.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.643 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.5 169.14 12.76 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.153 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -117.42 110.49 18.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 111.305 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.57 108.82 18.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.725 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 47.75 48.34 17.48 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.256 1.022 . . . . 0.0 112.791 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.16 15.04 81.61 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.711 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.64 149.65 46.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.042 0.448 . . . . 0.0 111.591 -179.362 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 10.0 mp -81.1 123.44 28.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.984 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 43.1 tp10 -114.99 131.97 56.75 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.713 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.35 -70.62 0.13 Allowed Pre-proline 0 CA--C 1.426 -3.816 0 CA-C-O 118.142 -0.932 . . . . 0.0 113.48 -179.213 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.713 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 10.2 Cg_endo -109.43 127.04 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.284 0 C-N-CA 113.724 -3.717 . . . . 0.0 113.399 -177.855 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.643 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -158.93 -160.64 10.5 Favored Glycine 0 C--N 1.281 -2.485 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.78 -177.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -153.42 138.82 17.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.831 0.371 . . . . 0.0 111.041 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 m 59.44 42.7 17.42 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 178.159 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -72.43 -36.18 68.51 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.56 -17.89 54.76 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.031 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -71.6 -12.94 61.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.295 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 p -144.73 13.59 1.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 111.149 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.4 m -125.87 149.51 48.62 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.019 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.433 HG23 ' HD3' ' A' ' 61' ' ' LYS . 18.0 m -140.79 174.3 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.176 179.06 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.7 mptt 64.31 39.72 7.06 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.402 0.439 . . . . 0.0 111.32 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -68.32 120.81 15.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.391 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.43 162.33 39.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -118.68 112.86 20.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.681 -178.893 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.604 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 13.4 m120 -76.7 118.33 19.22 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.989 179.208 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.749 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.3 t70 54.66 19.64 2.57 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.869 0.731 . . . . 0.0 111.632 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.87 30.69 78.66 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.531 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.749 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 5.2 p80 -142.09 -26.04 0.66 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 117.538 0.669 . . . . 0.0 111.803 179.184 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 22.2 m -116.5 128.4 55.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.642 0.258 . . . . 0.0 111.489 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.53 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.7 tp -93.26 129.58 39.27 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.01 130.23 54.63 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.764 0.316 . . . . 0.0 110.512 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.58 156.75 30.68 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.515 178.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.566 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 9.5 t -106.34 125.55 51.14 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 22.9 m -122.7 150.99 41.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.231 0.539 . . . . 0.0 112.408 -178.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 11.0 tmtt? -100.14 148.92 24.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.138 177.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.47 -14.01 1.82 Allowed Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.098 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.12 -38.05 78.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.576 0.227 . . . . 0.0 110.986 179.385 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -175.81 54.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.255 0.55 . . . . 0.0 110.336 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.443 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 73.63 -7.38 13.68 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.402 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -117.84 168.99 9.98 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.566 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 53.4 p90 -111.03 162.34 14.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -148.89 149.32 31.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.08 141.98 47.57 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.406 ' HB3' HD13 ' A' ' 48' ' ' LEU . 41.8 t -151.08 157.07 42.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.013 0.435 . . . . 0.0 110.235 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.22 164.18 26.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.842 179.353 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.676 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.6 tpt -150.02 121.45 7.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.862 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -75.75 106.11 7.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.367 0.603 . . . . 0.0 109.405 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.747 ' HA ' HG22 ' A' ' 91' ' ' VAL . 19.6 mt -72.74 -8.36 55.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.01 -179.253 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.89 -31.39 5.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.549 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -116.85 23.31 12.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.738 0.304 . . . . 0.0 111.23 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.747 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -130.48 -12.22 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.143 178.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.846 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.2 t -136.83 142.83 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.435 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -137.88 162.64 25.58 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.441 HD22 ' CB ' ' A' ' 8' ' ' SER . 34.3 t30 -108.31 113.66 26.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.059 0.457 . . . . 0.0 110.489 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.529 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 70.9 m -116.74 82.88 1.87 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.417 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 62.99 55.99 1.89 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.171 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.36 27.28 57.85 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.77 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.1 141.01 51.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.025 0.44 . . . . 0.0 110.674 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.407 ' O ' ' HG3' ' A' ' 99' ' ' MET . 18.3 ptm -61.04 97.29 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.472 179.055 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 11.5 mm-40 -129.06 78.17 76.67 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.136 0.493 . . . . 0.0 111.007 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.846 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 61.0 Cg_endo -75.22 96.02 1.01 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.47 2.113 . . . . 0.0 112.26 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.4 p -101.23 134.27 44.52 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.927 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -111.76 150.0 30.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.913 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -108.27 33.42 4.15 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.096 0.474 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.8 m -155.74 -115.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.379 -179.045 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 51' ' ' PRO . 7.2 t30 73.41 -66.5 0.3 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.156 0.982 . . . . 0.0 111.196 -179.595 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.68 -4.17 34.32 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.495 -1.229 . . . . 0.0 111.199 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -65.45 -26.99 68.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.343 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.556 ' CD2' ' HB2' ' A' ' 111' ' ' LEU . 9.9 p-80 -130.41 176.53 8.07 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.9 m -72.69 62.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.691 0.758 . . . . 0.0 112.907 -178.428 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.556 ' HB2' ' CD2' ' A' ' 109' ' ' HIS . 33.9 tp -107.37 -29.61 9.17 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.483 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -54.9 134.05 48.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.636 -179.424 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.8 m -77.28 42.08 0.33 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.457 0.646 . . . . 0.0 110.671 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.0 p -150.7 149.97 30.49 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.389 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -79.59 -27.97 41.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.265 0.555 . . . . 0.0 109.867 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.064 -179.964 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 120.758 0.313 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -80.63 121.57 26.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.545 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 75.1 m -84.52 -50.73 7.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.395 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.54 ' HB3' ' CG ' ' A' ' 7' ' ' ASN . 16.4 m-20 53.26 66.56 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.539 0.524 . . . . 0.0 112.071 177.89 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 11.3 p90 -61.79 -39.3 91.24 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 111.053 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.66 -22.61 61.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.505 -178.15 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.54 ' CG ' ' HB3' ' A' ' 4' ' ' ASN . 4.1 m-20 -71.68 -7.07 45.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.969 0.414 . . . . 0.0 111.32 -178.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 31.2 m -138.49 15.44 2.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.178 179.249 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -127.2 140.65 52.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.147 -179.625 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 p -136.27 148.53 48.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.571 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.69 47.82 46.49 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.383 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.554 HG12 ' HA3' ' A' ' 21' ' ' GLY . 24.4 m -89.69 143.63 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.996 0.427 . . . . 0.0 111.252 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 6.3 tp10 -141.61 146.16 35.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.097 179.308 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.742 HD22 HD23 ' A' ' 64' ' ' LEU . 49.9 tp -126.76 123.32 37.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 111.403 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.0 t80 -132.82 112.74 12.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.714 178.394 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.88 -68.24 2.27 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.677 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.0 p90 -166.0 18.7 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 122.594 0.357 . . . . 0.0 111.114 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 15' ' ' TYR . 41.6 pt -119.65 125.12 74.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.051 0.453 . . . . 0.0 110.891 -178.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.845 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -111.06 115.15 28.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.704 179.627 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.6 ttm180 -116.24 136.47 52.98 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.554 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -161.46 169.73 37.04 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.92 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.4 m-20 -101.39 110.86 22.94 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.3 m -105.72 132.78 51.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 57.9 mt -68.65 136.53 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.438 -178.743 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -102.28 -175.18 2.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -55.42 -27.8 50.19 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.881 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.33 -23.44 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 0.0 111.768 -179.459 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.79 5.21 57.67 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.357 -179.079 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -111.65 142.52 26.76 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.286 -0.457 . . . . 0.0 109.87 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 56.1 Cg_endo -71.94 133.77 22.28 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.833 2.355 . . . . 0.0 112.536 179.547 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -119.97 131.55 55.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.695 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.82 126.35 28.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.145 0.498 . . . . 0.0 111.643 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 t -140.43 156.59 46.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.645 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -130.54 148.75 52.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.47 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.81 146.75 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.818 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.419 ' OD1' HG22 ' A' ' 18' ' ' ILE . 85.3 m-20 -105.43 96.17 6.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.23 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.845 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -63.07 -25.96 68.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.048 -178.216 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.539 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.0 t-20 -56.31 -27.51 55.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.03 -179.096 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -107.56 11.63 28.48 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.646 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 47.2 m-85 -128.02 -23.21 3.36 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.528 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -111.52 140.81 29.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.69 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.83 163.34 12.22 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.268 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -112.43 106.62 15.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.183 -0.508 . . . . 0.0 110.176 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -111.51 107.17 16.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.373 -179.401 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 57.86 42.13 23.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.306 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 74.47 17.49 79.83 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.849 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.76 143.04 51.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.036 0.446 . . . . 0.0 111.385 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.565 HD13 ' HG ' ' A' ' 70' ' ' LEU . 33.6 mt -73.16 124.02 24.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.618 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -117.21 137.15 52.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.798 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.1 -71.46 0.11 Allowed Pre-proline 0 CA--C 1.429 -3.687 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.798 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 11.6 Cg_endo -111.45 126.78 0.03 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.366 0 C-N-CA 114.09 -3.473 . . . . 0.0 113.12 -177.573 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.69 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -159.89 -162.07 11.92 Favored Glycine 0 C--N 1.28 -2.547 0 CA-C-N 113.833 -1.531 . . . . 0.0 113.345 -177.724 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -152.76 142.16 21.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.531 -0.334 . . . . 0.0 111.015 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 m 55.32 43.16 29.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.539 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 17.7 p90 -70.24 -34.82 73.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.732 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.13 -18.38 27.29 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.545 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.1 t -52.7 -47.29 67.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.791 0.329 . . . . 0.0 110.544 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 42.8 m -119.7 12.39 12.2 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.0 m -111.14 137.47 48.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 111.903 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.8 m -136.67 175.56 9.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.393 178.765 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 60.82 43.19 12.31 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.915 0.388 . . . . 0.0 111.038 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 p -67.77 130.09 41.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.208 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.65 163.33 39.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.434 179.768 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.742 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -122.56 113.02 18.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.948 0.404 . . . . 0.0 111.642 -179.55 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -83.68 122.08 28.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.618 179.195 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.786 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 30.2 t70 58.01 16.95 4.06 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.93 0.769 . . . . 0.0 111.347 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.62 29.32 74.89 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.464 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.786 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 5.9 p80 -143.51 -28.22 0.54 Allowed 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 117.243 0.521 . . . . 0.0 111.471 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -110.51 129.65 55.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.802 0.334 . . . . 0.0 111.769 -179.077 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.565 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.4 tp -90.04 129.53 36.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.041 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.16 130.38 53.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.538 179.102 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.35 168.02 27.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.825 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.443 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 9.1 t -113.95 123.39 49.63 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.463 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 14.2 m -126.13 147.61 49.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -177.563 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.0 tmtt? -99.96 144.65 28.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.471 177.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.95 -26.31 0.63 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.684 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.75 80.31 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -171.58 52.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.318 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.83 2.2 50.41 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.431 -179.405 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -122.34 158.11 30.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.8 p90 -98.82 162.79 12.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.434 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -158.45 144.47 16.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -73.65 142.38 46.46 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.52 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.468 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 31.5 p -152.36 172.97 15.65 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.927 179.27 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -143.78 156.05 44.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.137 0.494 . . . . 0.0 111.016 -179.924 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.633 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 13.3 tpp -142.17 121.35 13.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.742 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.619 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 22.9 t0 -74.66 106.27 6.15 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.1 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.78 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.8 mt -78.82 -9.11 59.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.549 -178.808 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -52.26 -26.57 12.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.07 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.619 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 39.7 p90 -115.9 17.79 15.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.176 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.78 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -125.31 -11.69 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.985 0.422 . . . . 0.0 110.49 178.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.938 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.6 t -134.04 144.57 35.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.203 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.545 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -138.05 174.66 21.79 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.071 179.126 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.4 HD22 ' CB ' ' A' ' 8' ' ' SER . 27.3 t30 -122.98 134.54 54.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.834 0.35 . . . . 0.0 110.478 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.63 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 5.4 t -145.35 104.59 3.94 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.245 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 61.69 44.27 9.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.085 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.26 34.53 67.66 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.542 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -131.43 142.95 50.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.547 ' HG3' ' O ' ' A' ' 99' ' ' MET . 14.7 ptt? -59.34 114.9 2.89 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.764 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.63 ' HG3' ' HB3' ' A' ' 95' ' ' SER . 6.2 mm-40 -135.23 73.14 65.0 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.197 178.841 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.938 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 46.4 Cg_endo -70.38 96.06 0.63 Allowed 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.471 2.114 . . . . 0.0 112.56 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p -104.67 125.22 50.57 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.055 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.537 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -111.59 149.53 31.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.724 179.325 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.87 33.44 3.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.096 0.474 . . . . 0.0 111.258 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.636 ' HB3' HD21 ' A' ' 111' ' ' LEU . 67.6 m -152.89 -130.13 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.578 -178.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 68.99 100.54 0.06 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.924 0.89 . . . . 0.0 111.676 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -167.39 -174.98 2.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.84 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.85 -68.81 0.78 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.054 0.454 . . . . 0.0 110.489 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -123.02 167.85 13.1 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.222 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.401 HG22 ' HG2' ' A' ' 112' ' ' LYS . 8.7 p 39.37 73.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 122.44 1.114 . . . . 0.0 111.659 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.636 HD21 ' HB3' ' A' ' 105' ' ' SER . 40.7 tp -75.09 84.07 2.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.885 -179.006 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.401 ' HG2' HG22 ' A' ' 110' ' ' VAL . 10.5 mmmm -93.59 106.35 18.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.236 179.609 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.9 m -82.72 -7.35 59.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.317 0.58 . . . . 0.0 109.926 178.755 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.2 t -114.34 91.43 3.62 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.168 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.6 m -83.02 -35.37 25.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.493 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 116' ' ' GLU . 7.7 pt-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.772 -179.43 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.77 ' HG3' ' H ' ' A' ' 3' ' ' CYS . 10.7 tp60 64.24 -158.65 0.3 Allowed 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.564 0.54 . . . . 0.0 110.019 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.77 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 59.5 m -131.37 -63.65 0.83 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.856 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 70.5 m-20 59.73 67.15 0.91 Allowed 'General case' 0 N--CA 1.462 0.148 0 O-C-N 123.145 0.278 . . . . 0.0 111.738 177.892 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.6 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 12.0 p90 -59.57 -42.75 93.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.296 0.569 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.74 -21.18 63.48 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.377 -178.448 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.856 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 65.9 t30 -60.33 -24.06 64.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.366 -178.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB2' HD22 ' A' ' 94' ' ' ASN . 41.0 m -136.92 25.5 3.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.459 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -125.64 134.88 51.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.823 179.634 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.1 p -131.41 158.71 40.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.739 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.89 61.37 7.26 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.588 179.054 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 27.8 m -95.65 149.96 4.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.081 0.467 . . . . 0.0 111.328 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -138.67 140.16 38.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.031 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.922 HD22 HD23 ' A' ' 64' ' ' LEU . 40.2 tp -126.41 122.68 36.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 110.993 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.552 ' O ' HG12 ' A' ' 18' ' ' ILE . 92.2 m-85 -130.09 106.3 8.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.334 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.74 -66.98 2.35 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.495 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -165.58 22.65 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.621 0.369 . . . . 0.0 111.209 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 15' ' ' TYR . 34.0 pt -119.86 127.48 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 110.263 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.767 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.3 mt -112.78 119.87 39.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.415 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 1.4 ttt180 -120.32 138.01 53.94 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.36 175.16 40.45 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.517 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 23.4 m-20 -101.61 107.07 18.22 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 m -105.28 132.63 51.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mt -67.45 134.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.019 0.438 . . . . 0.0 111.511 -178.568 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -103.26 -171.44 1.94 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.45 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -51.32 -41.34 60.48 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.469 0.481 . . . . 0.0 111.846 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -59.79 -27.53 66.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.496 -179.279 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.75 -0.3 52.38 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.444 -178.545 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -105.51 138.44 19.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.554 0.693 . . . . 0.0 110.948 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 28.7 Cg_endo -60.76 121.25 9.41 Favored 'Trans proline' 0 C--N 1.329 -0.475 0 C-N-CA 124.207 3.271 . . . . 0.0 112.027 178.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -111.92 126.79 55.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.941 -179.867 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.32 126.94 29.77 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.008 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 t -142.93 160.16 40.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.373 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.1 p -133.35 148.17 51.85 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.765 0.316 . . . . 0.0 110.601 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -133.69 143.95 37.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 39' ' ' TYR . 63.2 t30 -103.2 96.29 6.68 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.347 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -59.5 -22.17 61.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.919 -178.567 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -55.08 -31.53 61.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.768 -179.31 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.433 ' CE2' ' ND2' ' A' ' 36' ' ' ASN . 74.8 m-85 -102.92 8.92 39.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.736 -179.484 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 43.8 m-85 -126.37 -22.63 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.576 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -114.1 139.13 41.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.122 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.633 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -112.32 170.06 13.36 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.718 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -115.33 107.44 15.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.901 0.381 . . . . 0.0 110.619 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.648 ' OD1' ' HA ' ' A' ' 112' ' ' LYS . 31.2 t70 -106.99 106.22 16.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.071 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 50.65 42.22 26.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.196 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 74' ' ' CYS . . . 82.47 15.13 74.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.512 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.93 145.79 48.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.226 0.536 . . . . 0.0 111.011 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.522 HD13 ' HG ' ' A' ' 70' ' ' LEU . 23.7 mt -74.98 116.32 15.59 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.47 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.8 tt0 -107.53 132.31 53.39 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.868 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -39.0 -66.22 0.34 Allowed Pre-proline 0 CA--C 1.431 -3.634 0 CA-C-O 117.385 -1.293 . . . . 0.0 114.408 -179.195 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.868 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 5.6 Cg_endo -112.67 119.47 0.02 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.219 0 C-N-CA 113.552 -3.832 . . . . 0.0 113.361 -178.296 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.633 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -154.75 -163.9 12.44 Favored Glycine 0 C--N 1.275 -2.82 0 CA-C-N 113.754 -1.566 . . . . 0.0 113.745 -177.402 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -153.14 142.02 21.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.6 45.53 16.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.586 177.612 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -75.66 -38.96 58.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.916 0.389 . . . . 0.0 110.408 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.04 -18.55 41.41 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.747 -178.196 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.0 m -59.74 -19.57 50.98 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.814 0.446 . . . . 0.0 111.602 179.378 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.0 m -144.49 26.04 1.47 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.668 179.496 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.6 m -127.69 144.65 51.06 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.23 0.538 . . . . 0.0 111.624 -179.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -136.82 172.8 14.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.474 179.038 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mptt 62.83 37.88 11.95 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.377 0.423 . . . . 0.0 111.192 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.2 p -68.81 122.26 18.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.152 0.501 . . . . 0.0 111.278 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.12 154.64 35.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.866 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.922 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -109.65 116.84 32.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.918 -179.344 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -84.05 118.86 24.34 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.2 t70 65.61 -1.92 0.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 124.199 0.937 . . . . 0.0 111.729 179.1 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.21 29.22 34.32 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.029 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -143.32 -29.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.056 0.428 . . . . 0.0 110.889 179.455 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.43 ' O ' HD13 ' A' ' 64' ' ' LEU . 15.9 m -113.39 130.28 56.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.354 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.547 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.9 tp -91.14 130.4 37.04 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.808 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.22 129.82 53.38 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.876 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.95 162.91 32.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.092 0.473 . . . . 0.0 110.868 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.444 ' HG ' ' HD2' ' A' ' 81' ' ' TYR . 12.7 t -111.02 122.57 48.23 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.7 m -122.77 149.0 44.7 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.532 0.682 . . . . 0.0 112.469 -177.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 10.2 tmtt? -99.17 142.34 30.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.229 178.152 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.13 -24.46 0.39 Allowed Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.661 179.4 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.59 88.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.872 0.368 . . . . 0.0 111.83 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -173.59 55.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.289 0.566 . . . . 0.0 109.5 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.4 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 69.32 -1.42 12.82 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.0 -179.097 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 24.9 pt20 -113.72 166.11 11.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.381 -178.882 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.4 p90 -106.2 168.84 8.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.239 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.88 133.19 5.28 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.51 123.17 23.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.93 0.395 . . . . 0.0 110.346 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 p -135.25 173.82 11.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.172 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.28 155.29 46.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.405 0.621 . . . . 0.0 111.241 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.5 tpp -141.22 115.39 9.3 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.472 179.056 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -72.2 108.05 5.16 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.497 0.665 . . . . 0.0 109.449 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.804 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.1 mt -77.64 -8.83 58.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.957 -178.19 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -51.14 -26.48 6.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.083 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -116.72 13.83 15.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.18 179.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.804 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -122.37 -8.76 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.201 0.524 . . . . 0.0 111.109 179.175 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.4 t -133.53 137.45 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.612 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -126.59 161.61 20.87 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.281 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.441 HD22 ' HB2' ' A' ' 8' ' ' SER . 14.3 t30 -114.49 129.64 56.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.876 0.37 . . . . 0.0 110.432 179.754 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.602 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 73.2 m -143.83 113.11 6.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.939 178.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 56.32 36.89 28.25 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 123.39 0.431 . . . . 0.0 111.196 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.75 22.06 63.78 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.791 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -118.85 145.98 45.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.804 0.335 . . . . 0.0 110.323 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 99' ' ' MET . 16.0 ptm -58.59 110.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.794 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 8.7 mm-40 -135.15 74.79 61.52 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.042 0.448 . . . . 0.0 110.654 178.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.2 Cg_endo -70.95 150.44 60.95 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.729 2.286 . . . . 0.0 112.592 -179.632 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 27.3 p -136.41 144.42 44.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.83 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.696 ' HB2' ' HB3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -111.36 147.46 35.12 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.152 179.649 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -97.59 7.55 46.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.345 0.593 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.411 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 50.6 m -157.01 -115.3 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.085 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.666 ' HB3' ' HG3' ' A' ' 103' ' ' ARG . 8.5 t-20 48.76 37.91 10.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.059 0.944 . . . . 0.0 111.214 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.22 -0.02 11.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.728 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -107.51 -176.2 3.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.689 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -84.09 -68.36 0.72 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.901 0.381 . . . . 0.0 110.271 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.49 95.67 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.554 0.692 . . . . 0.0 110.546 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.871 ' H ' HD23 ' A' ' 111' ' ' LEU . 1.2 pt? -86.16 60.02 5.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.15 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.648 ' HA ' ' OD1' ' A' ' 44' ' ' ASP . 88.4 tttt -59.39 123.63 17.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.047 -179.195 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m -91.19 64.69 5.31 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.097 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 m -143.78 113.42 7.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.115 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.8 m -64.1 -42.38 96.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.102 179.38 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.986 179.601 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.803 0.335 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -73.54 163.42 28.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.093 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.4 m -71.26 -72.0 0.24 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.48 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 2.2 m-20 52.64 76.17 0.2 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.569 0.543 . . . . 0.0 111.525 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 68' ' ' HIS . 13.1 p90 -57.98 -44.28 87.05 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.149 0.499 . . . . 0.0 110.17 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.22 -21.34 65.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.587 -179.026 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.62 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 18.8 t-20 -57.72 -29.54 64.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.494 -178.631 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.488 ' HB2' HD22 ' A' ' 94' ' ' ASN . 13.5 m -132.94 17.46 4.18 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.62 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 80.9 m -117.96 133.49 55.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.777 0.322 . . . . 0.0 110.577 -179.255 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -130.59 149.28 52.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.749 -179.26 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.88 45.3 92.92 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.607 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.519 HG12 ' HA3' ' A' ' 21' ' ' GLY . 17.4 m -88.22 135.31 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.093 0.473 . . . . 0.0 111.353 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -129.45 156.41 44.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.169 -179.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.567 HD22 HD23 ' A' ' 64' ' ' LEU . 19.4 tp -130.03 125.01 34.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.976 0.417 . . . . 0.0 112.108 -178.737 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -126.32 99.18 5.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.12 178.58 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' HG21 ' A' ' 62' ' ' THR . . . 77.45 -62.43 3.46 Favored Glycine 0 C--O 1.226 -0.368 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.857 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.46 25.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.29 0.566 . . . . 0.0 110.141 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 12.8 mt -119.52 115.55 47.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.708 -179.169 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.832 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -103.8 113.62 27.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.201 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 4.5 ttm180 -122.73 142.83 50.27 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.732 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -170.19 179.54 42.35 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.165 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 11.7 m-20 -102.71 108.31 19.51 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 62.1 m -106.23 131.8 53.04 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.7 mt -75.37 136.29 25.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.33 0.586 . . . . 0.0 111.694 -177.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -102.97 -173.47 2.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.389 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -54.77 -36.55 64.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.932 0.396 . . . . 0.0 111.662 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' OD2' ' HB3' ' A' ' 29' ' ' HIS . 28.3 t70 -59.21 -27.56 65.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.73 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.04 1.33 57.13 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.845 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.42 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -106.19 140.1 20.94 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 121.302 0.572 . . . . 0.0 111.086 -179.994 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 30.2 Cg_endo -64.09 122.08 9.96 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 123.557 2.838 . . . . 0.0 112.454 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -105.3 130.02 53.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.51 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.65 115.69 12.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 t -136.73 156.88 47.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.063 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.428 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 35.3 p -140.06 142.75 36.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.732 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.12 144.91 35.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.864 0.364 . . . . 0.0 110.578 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -100.7 99.73 10.32 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.678 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -62.89 -22.23 66.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.76 -178.548 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.87 -32.81 64.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.09 -178.859 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -103.99 13.76 32.01 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.641 -178.291 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.644 ' HD1' HD12 ' A' ' 111' ' ' LEU . 46.7 m-85 -131.13 -17.27 3.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.609 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 37' ' ' LEU . 1.9 mp -118.6 142.05 35.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.564 0.221 . . . . 0.0 110.555 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.689 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -120.06 165.04 13.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.319 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -117.69 112.01 19.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.57 0.7 . . . . 0.0 110.634 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -110.9 114.61 28.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.264 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.802 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 44.0 t30 59.52 33.82 22.29 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.148 0.499 . . . . 0.0 110.976 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.82 9.58 86.15 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.013 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -115.42 154.88 28.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.66 0.267 . . . . 0.0 110.707 179.951 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 30.9 mt -82.59 122.41 28.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.244 -179.303 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 4.1 tp10 -111.31 137.35 49.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.217 179.069 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.655 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.87 -70.15 0.18 Allowed Pre-proline 0 CA--C 1.424 -3.889 0 CA-C-O 118.441 -0.79 . . . . 0.0 113.027 -179.272 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.655 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 5.6 Cg_endo -110.45 131.21 0.04 OUTLIER 'Trans proline' 1 N--CA 1.34 -7.519 0 C-N-CA 113.911 -3.593 . . . . 0.0 112.973 -177.619 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.689 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.48 -159.16 9.25 Favored Glycine 0 C--N 1.283 -2.385 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.87 -177.687 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -152.43 137.16 16.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.261 -0.469 . . . . 0.0 111.311 -178.703 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 t 48.58 45.01 21.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.037 177.847 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -65.75 -36.54 83.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.161 0.505 . . . . 0.0 109.671 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.76 -18.8 33.41 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.281 -179.143 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 t -62.68 -28.65 70.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.0 110.34 179.636 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.2 m -136.32 28.83 3.06 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.868 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.2 m -133.73 139.69 46.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 179.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 m -135.17 175.07 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.36 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 63.43 40.09 8.67 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.435 0.459 . . . . 0.0 111.648 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 16' ' ' GLY . 17.1 p -66.65 126.45 28.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.995 179.728 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.99 162.64 40.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.922 179.204 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.567 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -120.94 113.65 20.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.867 0.365 . . . . 0.0 111.06 -179.616 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 15.4 m120 -75.51 116.53 16.32 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.654 179.558 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.664 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.6 t70 55.29 15.35 1.32 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.901 0.75 . . . . 0.0 111.475 178.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.99 37.98 74.1 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.515 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.664 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 9.8 p80 -147.01 -30.73 0.34 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 117.396 0.598 . . . . 0.0 111.479 178.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 6.6 m -116.23 133.21 56.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.631 0.253 . . . . 0.0 111.403 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.564 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.7 tp -91.31 131.42 36.82 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.612 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.42 130.39 55.94 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.747 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.95 163.73 31.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.113 0.483 . . . . 0.0 110.817 179.277 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.465 ' HG ' ' HD2' ' A' ' 81' ' ' TYR . 20.1 t -112.94 123.67 50.85 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.1 m -123.51 154.94 38.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.15 0.5 . . . . 0.0 112.031 -178.725 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.462 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 9.2 tmtt? -99.81 150.08 22.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.072 178.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.13 -29.95 0.89 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.98 178.732 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.802 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.02 -38.56 70.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -175.22 52.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.252 0.549 . . . . 0.0 109.983 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.462 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 68.92 6.36 51.71 Favored Glycine 0 C--N 1.329 0.146 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.65 -179.108 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -123.97 170.52 10.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.683 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.465 ' HD2' ' HG ' ' A' ' 73' ' ' SER . 55.1 p90 -110.84 164.74 12.47 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 123.448 0.467 . . . . 0.0 110.815 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -155.34 150.03 26.37 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.07 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -81.02 141.23 34.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.849 0.357 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.3 p -153.01 167.52 28.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.963 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.17 162.83 30.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.962 0.41 . . . . 0.0 110.445 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.765 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.4 tpt -145.99 112.98 6.09 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.97 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.431 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 32.6 t0 -71.78 106.86 4.3 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.978 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.75 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.1 mt -77.81 -8.62 58.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.265 -178.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -49.45 -29.62 6.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.244 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 43.9 p90 -116.68 20.26 14.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.49 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.75 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -125.94 -12.88 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.234 0.54 . . . . 0.0 110.031 177.9 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.831 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -134.5 147.39 29.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.157 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.23 171.9 23.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.005 -0.616 . . . . 0.0 111.678 179.096 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.488 HD22 ' HB2' ' A' ' 8' ' ' SER . 37.0 t30 -117.1 129.42 55.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.84 0.352 . . . . 0.0 110.849 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.564 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 70.7 m -134.42 100.31 4.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.436 178.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 61.0 44.46 10.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.558 179.414 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.57 29.73 70.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.167 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -128.9 148.21 50.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.693 0.282 . . . . 0.0 110.302 -179.078 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.48 ' HG3' ' O ' ' A' ' 99' ' ' MET . 21.5 ptt? -62.63 119.61 9.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.167 -179.52 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 20.6 mm-40 -143.46 79.06 14.2 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.541 178.207 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.831 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 42.9 Cg_endo -69.95 93.34 0.54 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.766 2.31 . . . . 0.0 113.174 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.1 p -105.52 126.68 52.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.501 178.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.566 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -96.6 147.44 23.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.175 -179.173 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.3 28.88 8.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.086 0.47 . . . . 0.0 110.984 179.789 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.1 m -154.65 -95.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.372 -179.086 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.607 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . 23.8 t-20 69.94 106.85 0.06 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.591 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.57 -44.24 8.3 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.106 179.231 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -138.22 176.47 8.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.168 -179.688 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 65.78 149.1 0.04 OUTLIER 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.179 0.99 . . . . 0.0 113.259 -179.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.06 97.2 5.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.151 179.097 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.807 ' H ' HD23 ' A' ' 111' ' ' LEU . 1.6 pt? -102.44 80.08 1.9 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.948 -179.138 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -116.16 106.5 13.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.71 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 m -72.06 -49.16 38.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.422 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 t 64.61 80.07 0.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.6 m -56.15 -51.05 69.37 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.049 -178.522 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.277 179.761 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mmm . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -107.65 151.36 25.75 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.55 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 95.8 m -53.58 -82.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.089 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 53.68 78.18 0.16 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.562 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 4.4 p90 -56.91 -36.63 70.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.987 0.422 . . . . 0.0 111.506 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.01 -21.77 66.41 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.292 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -61.6 -18.35 59.01 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.481 ' HB2' HD22 ' A' ' 94' ' ' ASN . 69.7 m -145.21 29.55 1.17 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.696 0.284 . . . . 0.0 110.699 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -128.78 133.01 47.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.023 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -129.51 158.21 39.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.373 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.81 58.48 14.35 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.747 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.585 HG12 ' HA3' ' A' ' 21' ' ' GLY . 19.7 m -101.07 139.61 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.992 0.425 . . . . 0.0 111.546 -179.317 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -137.03 155.64 49.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.263 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.623 HD22 HD23 ' A' ' 64' ' ' LEU . 27.0 tp -127.78 123.66 35.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.428 . . . . 0.0 111.706 -179.29 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.44 ' O ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-85 -124.64 99.49 6.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.579 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.46 -63.18 2.63 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.167 -0.54 . . . . 0.0 113.077 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 3.9 p90 -165.27 21.93 0.05 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.0 pt -121.76 126.94 75.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.569 179.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.832 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -107.82 114.64 28.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.652 -179.922 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.2 ttt180 -118.13 141.24 48.7 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.641 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.585 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.99 177.6 42.14 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.796 179.405 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 16.1 m-20 -101.62 107.98 19.4 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -106.09 132.84 51.68 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.7 mt -69.15 139.89 19.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.472 -178.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 96' ' ' TYR . 6.0 p30 -110.14 -173.1 2.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.632 179.534 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.85 -27.98 54.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.92 -20.35 65.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.497 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.77 4.5 69.7 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.913 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -112.72 144.62 31.35 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.791 0.329 . . . . 0.0 110.175 179.616 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.667 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 38.5 Cg_endo -68.21 123.68 10.86 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.021 2.48 . . . . 0.0 113.002 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -115.27 132.16 56.7 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.7 127.2 31.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.39 0.614 . . . . 0.0 112.142 -178.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 t -136.05 155.2 50.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.612 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 78.0 p -138.45 132.08 30.77 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.527 -179.424 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.85 143.96 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 O-C-N 123.517 0.511 . . . . 0.0 110.328 -179.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -99.37 92.19 5.29 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.53 -27.09 56.65 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.63 -178.376 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.2 t-20 -53.98 -30.66 48.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.967 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -103.15 10.39 37.89 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.613 -178.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.1 m-85 -129.35 -21.09 3.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.534 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -113.84 141.34 30.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.642 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -113.58 170.91 13.54 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.629 -179.507 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -114.76 104.42 11.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.027 -0.587 . . . . 0.0 109.753 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -111.24 106.16 15.06 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.786 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 24.6 t30 59.2 40.06 22.07 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.121 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.82 17.09 80.25 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.559 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.58 149.82 46.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 -179.511 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.422 HD13 ' HG ' ' A' ' 70' ' ' LEU . 28.9 mt -74.99 124.24 26.6 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.352 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -112.01 139.22 47.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.052 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.598 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -43.52 -75.51 0.05 OUTLIER Pre-proline 0 CA--C 1.433 -3.536 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.497 179.949 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 2.5 Cg_endo -108.45 127.89 0.04 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.242 1 C-N-CA 113.196 -4.069 . . . . 0.0 112.779 -178.662 . . . . . . . . 4 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.642 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -155.16 -159.42 9.29 Favored Glycine 0 C--N 1.281 -2.514 0 CA-C-N 113.74 -1.573 . . . . 0.0 113.417 -177.629 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -151.23 147.32 26.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.917 0.389 . . . . 0.0 111.068 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.6 p 46.42 44.95 13.42 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 177.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -71.79 -38.8 70.22 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.7 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.21 -18.52 55.36 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.288 -178.427 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -65.26 -19.28 65.89 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.736 0.414 . . . . 0.0 110.896 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.4 m -142.16 20.76 2.09 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.006 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.5 m -126.75 144.09 51.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.601 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG23 ' HD2' ' A' ' 61' ' ' LYS . 23.2 m -136.78 173.62 13.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.734 179.315 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HD2' HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER 63.68 41.15 7.29 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.486 0.491 . . . . 0.0 110.829 179.405 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.5 HG21 ' O ' ' A' ' 16' ' ' GLY . 11.5 p -69.22 130.49 42.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.612 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.65 162.85 40.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.807 179.058 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.623 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -121.61 112.55 18.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.596 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -85.47 122.04 29.04 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.216 -179.263 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.09 24.04 10.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.686 178.81 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.81 39.8 69.28 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.524 -0.762 . . . . 0.0 114.074 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.465 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 4.7 p80 -153.26 -28.53 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.272 0.536 . . . . 0.0 111.537 179.609 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 m -115.93 131.43 56.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.797 0.332 . . . . 0.0 111.461 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.605 ' HA ' HD22 ' A' ' 64' ' ' LEU . 12.7 tp -90.2 134.53 34.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 178.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.65 130.76 53.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.614 178.9 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.05 160.85 22.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.098 0.475 . . . . 0.0 111.464 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 13.1 t -106.62 125.06 50.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.891 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 48.5 m -125.5 149.16 48.52 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -99.25 143.3 29.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.585 178.139 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.58 -31.09 0.52 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.621 178.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.729 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -47.51 -45.42 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 179.128 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -171.89 49.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.466 0.65 . . . . 0.0 109.606 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.32 2.4 79.11 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.009 -179.036 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -121.91 160.35 24.97 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 51.3 p90 -101.02 160.43 14.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 -179.192 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -153.79 141.25 19.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 36.4 t70 -82.1 132.98 35.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.89 0.376 . . . . 0.0 110.693 -179.056 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.419 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 26.0 p -143.34 179.51 7.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.432 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.28 161.43 37.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.814 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.597 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 14.2 tpp -145.02 125.39 13.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.564 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 28.2 t70 -79.35 106.59 11.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.986 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.732 ' HA ' HG22 ' A' ' 91' ' ' VAL . 17.0 mt -76.61 -10.02 59.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.323 -177.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.564 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 5.9 m120 -48.51 -33.83 10.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.99 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 46.7 p90 -113.74 20.97 15.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.897 0.379 . . . . 0.0 111.326 -179.166 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.732 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -126.58 -8.66 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.549 178.575 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 1.019 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 8.9 p -153.22 138.35 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.097 0.475 . . . . 0.0 111.409 179.298 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.55 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -131.16 172.22 20.78 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.877 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.481 HD22 ' HB2' ' A' ' 8' ' ' SER . 18.4 t30 -113.74 116.76 29.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.33 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.547 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 58.7 m -111.65 78.53 1.13 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.829 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 25' ' ' ASN . 43.1 m-85 66.28 60.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.581 178.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.78 23.0 60.54 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.774 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -126.98 132.02 50.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.907 0.384 . . . . 0.0 110.593 -178.745 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.491 ' HG3' ' O ' ' A' ' 99' ' ' MET . 16.8 ptt? -64.28 117.36 7.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.742 179.415 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 4.6 mt-10 -142.26 81.59 13.89 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 121.314 0.578 . . . . 0.0 109.889 177.711 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 1.019 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 58.4 Cg_endo -71.47 125.83 11.62 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.864 2.376 . . . . 0.0 112.023 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 32.0 p -115.18 131.47 56.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.767 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.47 ' O ' ' HD3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -111.8 140.52 46.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.722 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -123.9 15.54 9.32 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.078 0.466 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.734 ' HA ' HD21 ' A' ' 111' ' ' LEU . 65.4 m -159.8 64.74 0.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.531 -178.667 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.695 ' H ' HD13 ' A' ' 111' ' ' LEU . 51.3 t30 -114.09 79.61 1.28 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.234 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.71 116.11 5.4 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.752 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -160.19 -69.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.294 -179.562 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.438 ' ND1' HG23 ' A' ' 110' ' ' VAL . 16.3 t-80 -135.39 -74.39 0.45 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.591 -179.771 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.438 HG23 ' ND1' ' A' ' 109' ' ' HIS . 59.2 t -118.07 92.07 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.284 0.564 . . . . 0.0 110.291 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.734 HD21 ' HA ' ' A' ' 105' ' ' SER . 47.9 tp -90.78 89.26 7.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.036 179.189 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 60.01 29.18 18.77 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.469 0.652 . . . . 0.0 110.56 179.03 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.7 t 58.28 21.98 8.8 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.918 -178.549 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.6 t -140.76 53.73 1.59 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.232 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 m -66.59 -32.36 73.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.334 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.973 179.405 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.052 0.453 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -123.05 107.44 11.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 0.0 109.757 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.477 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 72.1 m -71.48 -62.56 1.36 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.084 -179.272 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.855 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 39.2 m-20 52.32 76.96 0.17 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.839 0.352 . . . . 0.0 111.747 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.556 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 15.4 p90 -60.31 -41.96 94.55 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.019 0.438 . . . . 0.0 110.873 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.94 -23.91 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.99 -178.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.855 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 62.7 t30 -60.46 -29.73 69.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.168 -179.123 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 8.3 m -123.36 16.4 9.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 -179.665 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -124.33 146.28 48.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.368 0.604 . . . . 0.0 112.029 -179.301 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.7 p -140.33 152.77 46.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.005 179.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.86 33.15 70.38 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.574 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 18.2 m -79.89 133.38 29.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.012 0.434 . . . . 0.0 111.655 -179.471 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' O ' HD23 ' A' ' 19' ' ' LEU . 10.7 pt-20 -132.19 150.16 52.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.007 179.021 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.785 HD22 HD23 ' A' ' 64' ' ' LEU . 32.7 tp -122.01 120.71 35.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.2 0.524 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 18' ' ' ILE . 73.0 t80 -125.1 101.02 6.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.956 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.01 -68.44 3.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.811 179.248 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -162.26 17.79 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.654 0.264 . . . . 0.0 111.294 -179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 15' ' ' TYR . 29.9 pt -121.6 131.29 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.966 0.412 . . . . 0.0 110.51 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.723 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -113.78 114.72 26.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.115 -179.632 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.2 ttt180 -118.12 141.68 48.23 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.734 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.28 -176.44 38.12 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.878 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 8.8 m-20 -108.8 111.11 22.67 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.673 0.273 . . . . 0.0 110.907 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.3 m -106.28 133.18 51.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.8 mt -68.83 134.3 30.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.828 0.347 . . . . 0.0 110.704 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -105.5 -172.68 2.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.02 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -57.24 -25.31 58.92 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.16 -20.65 65.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.068 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.43 1.69 74.46 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.88 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -112.19 144.48 30.88 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.633 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 29.1 Cg_endo -65.0 123.77 12.09 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.744 2.296 . . . . 0.0 112.445 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -109.17 130.19 55.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.671 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.24 122.89 21.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.972 0.415 . . . . 0.0 111.613 -179.365 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.6 t -142.57 164.03 31.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.446 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 12.2 p -138.69 149.67 45.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.024 0.44 . . . . 0.0 111.288 -179.222 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.87 142.65 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.723 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -103.37 92.0 4.3 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.723 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.95 -29.41 63.15 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.669 -178.288 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -52.21 -33.88 43.12 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.875 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -102.05 16.32 26.39 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.839 -178.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.4 m-85 -130.86 -26.47 2.19 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.48 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.5 mp -112.52 141.55 27.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.633 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -111.9 171.53 14.26 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.312 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -113.37 109.05 18.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.996 -179.18 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.05 105.89 15.18 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 0.0 OUTLIER 49.32 39.12 15.32 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 122.662 1.22 . . . . 0.0 111.867 179.652 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 74' ' ' CYS . . . 88.65 3.66 77.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.415 178.538 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -110.06 154.4 23.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.988 0.423 . . . . 0.0 110.888 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.5 mt -85.47 117.22 24.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.074 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.952 ' HG3' HD11 ' A' ' 111' ' ' LEU . 31.3 tt0 -106.04 128.61 53.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.018 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.653 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.55 -66.8 0.25 Allowed Pre-proline 1 CA--C 1.42 -4.05 0 O-C-N 124.117 0.885 . . . . 0.0 112.754 -179.493 . . . . . . . . 4 4 . 1 . 030 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.594 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 3.0 Cg_endo -109.6 126.4 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.313 0 C-N-CA 113.821 -3.652 . . . . 0.0 113.413 -177.708 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.633 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -165.05 -161.83 14.84 Favored Glycine 0 C--N 1.285 -2.257 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.684 -177.76 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.48 146.45 25.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.381 -0.41 . . . . 0.0 110.665 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.6 m 54.5 40.65 31.97 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.47 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HD2' ' SG ' ' A' ' 59' ' ' CYS . 13.2 p90 -72.2 -34.16 68.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.512 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.49 -18.26 67.55 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.998 -179.139 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 m -68.89 -9.34 51.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.153 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.8 m -145.62 8.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.726 179.299 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.426 ' SG ' ' HD2' ' A' ' 55' ' ' PHE . 6.4 m -109.33 153.28 24.14 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.101 0.477 . . . . 0.0 111.462 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.402 HG23 ' HD3' ' A' ' 61' ' ' LYS . 18.9 m -142.22 167.41 15.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.906 178.387 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HD3' HG23 ' A' ' 60' ' ' VAL . 5.1 mptp? 63.39 33.06 14.14 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.618 0.574 . . . . 0.0 111.293 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -59.68 122.09 13.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.324 179.668 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.94 161.39 42.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.869 -179.513 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.785 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -114.4 113.78 24.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.815 0.341 . . . . 0.0 111.803 -179.003 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 90.0 m-20 -73.09 116.35 13.52 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.47 20.01 2.6 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.104 0.878 . . . . 0.0 111.558 179.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.85 29.24 73.54 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.072 -0.513 . . . . 0.0 114.375 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -142.57 -24.48 0.65 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.913 0.856 . . . . 0.0 112.036 179.276 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 20.3 m -116.24 132.53 56.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.562 ' HB3' HD21 ' A' ' 88' ' ' LEU . 16.0 tp -90.77 129.63 36.83 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.422 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.0 OUTLIER -120.2 129.29 54.03 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.312 179.857 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -163.86 163.94 23.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.067 0.46 . . . . 0.0 110.776 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.6 t -114.5 119.48 36.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.474 -0.784 . . . . 0.0 108.98 179.328 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -116.17 156.36 26.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.329 0.585 . . . . 0.0 111.831 -179.172 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.9 tmtt? -99.5 143.34 29.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.304 178.471 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.72 -17.81 0.66 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.445 -1.359 . . . . 0.0 114.098 178.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -63.37 -38.06 89.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.426 0.613 . . . . 0.0 110.484 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -177.25 59.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.754 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.84 16.72 66.47 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.086 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -139.31 163.36 32.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 40.8 p90 -97.6 171.62 8.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.143 -179.075 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.13 136.63 11.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.69 128.64 37.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.162 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -146.02 169.0 19.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.264 -179.132 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.422 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.9 OUTLIER -140.7 164.47 30.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.923 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.88 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.5 OUTLIER -149.21 125.95 11.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.492 -179.235 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.476 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 9.0 m-20 -75.25 106.31 6.71 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.458 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.785 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.8 mt -79.11 -8.63 59.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.163 0.506 . . . . 0.0 109.687 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -49.61 -28.43 5.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.731 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 10.4 p90 -119.11 21.52 12.29 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 179.658 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.785 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -127.2 -16.25 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.943 0.402 . . . . 0.0 110.563 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.1 t -132.94 148.74 31.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.477 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -147.72 164.26 28.81 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.89 179.533 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -107.93 135.06 49.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.899 0.38 . . . . 0.0 110.638 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.652 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 59.0 m -140.14 96.51 3.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.713 178.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 62.03 45.96 6.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.675 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 56.51 29.76 57.9 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.773 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -127.08 147.11 50.17 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.844 0.354 . . . . 0.0 110.665 -178.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.0 103.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.475 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.652 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 59.1 mm-40 -137.96 67.1 48.63 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.426 179.008 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 28.3 Cg_endo -62.72 114.41 2.39 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 123.32 2.68 . . . . 0.0 112.838 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.03 129.22 54.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.042 179.197 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -112.29 147.38 36.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.092 179.767 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.59 56.14 0.64 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.139 0.495 . . . . 0.0 110.366 179.373 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.3 t -167.22 -124.48 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.494 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.465 ' C ' ' H ' ' A' ' 108' ' ' ASP . 28.9 t-20 63.63 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.861 0.865 . . . . 0.0 111.666 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 68.99 -32.7 0.23 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.826 0.85 . . . . 0.0 112.31 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 106' ' ' ASN . 28.1 t70 -62.92 -25.96 68.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.32 0.581 . . . . 0.0 110.756 179.321 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -136.57 155.41 49.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.821 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.429 HG12 ' HG2' ' A' ' 112' ' ' LYS . 25.0 t -112.16 96.3 4.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.788 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.952 HD11 ' HG3' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -82.2 74.85 9.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.617 0.722 . . . . 0.0 111.986 -178.466 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.802 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 7.4 mmpt? -101.45 95.08 6.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.985 179.02 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.3 p -82.92 61.94 6.22 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.667 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.7 t -157.51 94.67 1.39 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.194 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -72.14 -53.14 13.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.167 0.508 . . . . 0.0 109.651 179.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 C--O 1.247 0.928 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.992 179.754 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.569 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 71.5 m . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 89' ' ' ASN . 92.7 m-20 52.78 71.17 0.5 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.375 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.49 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.7 p90 -54.02 -36.76 63.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.264 0.554 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.14 -21.61 33.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -62.74 -27.78 69.52 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.559 ' HB2' HD22 ' A' ' 94' ' ' ASN . 26.7 m -134.62 16.7 3.63 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.049 0.452 . . . . 0.0 110.774 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.5 m -117.48 133.04 56.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.129 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -130.84 152.71 49.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.717 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.22 61.65 6.15 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.095 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 m -95.08 131.3 42.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.393 0.616 . . . . 0.0 111.898 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -124.59 157.44 35.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.099 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.618 HD22 HD23 ' A' ' 64' ' ' LEU . 14.2 tp -139.82 121.66 15.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.501 . . . . 0.0 111.295 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.42 102.17 6.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.98 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.7 -60.67 3.71 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.965 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -170.81 26.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 122.875 0.47 . . . . 0.0 110.38 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 15.2 mt -119.23 113.61 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.08 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.807 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -99.2 114.24 26.93 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -124.22 142.78 50.96 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.486 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.42 -179.27 41.19 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.401 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 8.7 m-20 -103.59 107.69 18.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 79.8 m -107.62 132.77 52.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.013 0.435 . . . . 0.0 110.025 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.1 mt -72.78 137.21 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.575 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -102.41 -169.09 1.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.028 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -62.83 -26.31 68.68 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 111.598 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.21 -23.26 64.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.296 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.45 5.92 58.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.351 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -110.43 142.16 25.47 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.678 0.275 . . . . 0.0 110.624 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.566 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 39.8 Cg_endo -69.51 122.15 8.9 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.819 2.346 . . . . 0.0 111.979 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -111.71 131.03 55.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.75 120.85 17.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.157 0.503 . . . . 0.0 111.104 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 t -136.69 152.75 50.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.122 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.7 p -131.22 148.22 52.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.472 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.04 145.53 34.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.463 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -101.95 98.75 8.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.163 0.506 . . . . 0.0 110.121 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.5 mm? -60.38 -26.81 66.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.64 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.02 -24.91 57.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.756 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -106.83 7.22 30.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 60.0 m-85 -128.68 -16.37 4.26 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.08 144.24 27.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.669 0.271 . . . . 0.0 110.974 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.576 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -117.79 179.26 17.18 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.138 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 19.1 p-10 -131.76 102.22 5.79 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.809 0.814 . . . . 0.0 110.618 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -105.27 121.85 44.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.068 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.818 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 53.6 t30 60.13 32.38 20.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.207 0.527 . . . . 0.0 110.171 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.01 21.31 79.97 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.043 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -121.84 157.52 30.93 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 86' ' ' MET . 33.4 mt -82.11 115.69 21.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.203 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HG2' ' C ' ' A' ' 42' ' ' GLY . 10.2 pt-20 -103.24 143.42 32.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.671 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -46.38 -74.06 0.08 OUTLIER Pre-proline 0 CA--C 1.431 -3.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.835 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.671 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 13.1 Cg_endo -110.24 124.28 0.03 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.393 0 C-N-CA 113.794 -3.671 . . . . 0.0 113.122 -177.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.576 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -150.32 -160.88 9.56 Favored Glycine 0 C--N 1.278 -2.648 0 CA-C-N 113.429 -1.714 . . . . 0.0 113.284 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -149.6 139.85 22.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.411 -0.395 . . . . 0.0 110.728 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.6 p 48.3 52.23 13.77 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.296 1.038 . . . . 0.0 113.569 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -75.69 -39.55 57.28 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -18.71 53.49 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.576 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.3 m -68.65 -22.72 64.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.291 -0.454 . . . . 0.0 110.728 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.2 m -135.02 22.42 3.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.7 m -131.92 145.38 51.47 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.63 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 m -134.13 169.98 20.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.107 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 66.43 37.09 4.83 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.404 0.44 . . . . 0.0 110.834 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.7 117.36 8.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.54 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.09 161.32 42.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.255 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -112.13 124.0 51.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.869 0.366 . . . . 0.0 110.813 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 2.7 t30 -95.53 127.28 41.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.833 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 14.4 t70 52.41 24.27 2.88 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.972 0.795 . . . . 0.0 112.249 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.33 38.5 79.05 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.859 -0.61 . . . . 0.0 114.1 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.603 ' CD2' ' HB3' ' A' ' 66' ' ' ASP . 1.3 p80 -153.46 -27.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.52 0.66 . . . . 0.0 111.798 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.4 m -115.74 130.3 56.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.697 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.622 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.2 tp -90.65 138.95 31.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.9 132.95 52.05 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.68 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -164.58 159.89 19.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.128 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 t -107.53 122.94 47.67 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 30.8 m -124.75 154.91 40.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -97.5 146.25 25.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.428 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.94 -31.18 0.74 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.919 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.818 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -52.91 -42.53 65.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -174.39 55.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.75 11.23 59.96 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.446 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -130.51 161.24 31.91 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 50.5 p90 -96.1 168.58 10.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.401 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.08 136.41 9.9 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.2 126.93 31.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.951 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.524 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 33.2 t -140.81 171.82 13.55 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.124 0.487 . . . . 0.0 111.072 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.78 158.22 44.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.419 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.686 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.7 OUTLIER -141.83 122.92 14.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.679 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.4 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 4.1 m-20 -73.75 105.66 5.15 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.709 ' HA ' HG22 ' A' ' 91' ' ' VAL . 21.0 mt -75.55 -8.97 58.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.025 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.507 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 18.1 m120 -47.55 -29.75 3.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.166 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 87' ' ' ASP . 16.6 p90 -118.37 21.32 12.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.977 0.418 . . . . 0.0 111.18 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -129.43 -9.63 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.752 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.926 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 14.5 p -152.58 143.73 15.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.41 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -146.77 169.69 27.87 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.135 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' A' ' 8' ' ' SER . 28.2 t30 -100.15 131.06 46.32 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.569 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 73.9 m -138.59 95.04 2.92 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.572 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 62.9 44.88 5.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.441 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.0 23.21 56.79 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.38 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -123.12 140.11 53.36 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 99' ' ' MET . 24.3 ptt? -56.17 112.09 1.13 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.85 0.719 . . . . 0.0 111.336 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 1.6 mm-40 -137.68 77.62 38.86 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.104 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.926 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 58.1 Cg_endo -74.42 93.96 0.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.428 2.085 . . . . 0.0 112.228 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.097 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.511 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 68.5 m . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 41.49 73.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.576 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.7 p90 -54.76 -39.76 68.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.981 0.419 . . . . 0.0 111.33 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.91 -22.94 41.29 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.53 -20.73 61.29 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.438 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.437 ' HB2' HD22 ' A' ' 94' ' ' ASN . 20.4 m -129.97 11.54 5.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.911 0.386 . . . . 0.0 110.928 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 91.2 m -120.14 132.9 55.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -127.07 160.23 31.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.65 45.34 90.62 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.741 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -87.09 123.94 40.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.449 0.642 . . . . 0.0 111.594 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 47.3 mt-10 -121.61 142.43 50.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.534 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.768 HD22 HD23 ' A' ' 64' ' ' LEU . 17.2 tp -117.83 112.31 20.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.952 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -133.83 104.92 6.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.077 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 70.36 51.54 21.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.771 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CD1' HG21 ' A' ' 62' ' ' THR . 7.7 m-85 63.81 16.18 9.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.214 0.605 . . . . 0.0 111.57 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 16' ' ' GLY . 20.9 mt -116.38 116.3 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 120.659 0.266 . . . . 0.0 110.534 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.766 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 mt -103.13 114.43 28.71 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.602 ' HG3' ' HB3' ' A' ' 34' ' ' SER . 6.9 ttt180 -121.07 145.05 48.2 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.79 -175.23 40.54 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.284 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.0 m-20 -109.07 110.41 21.66 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.894 0.378 . . . . 0.0 110.263 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 65.9 m -107.4 132.56 53.04 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.88 134.75 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.227 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.69 -174.24 2.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 96' ' ' TYR . 7.4 tp10 -49.43 -40.04 35.16 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.489 0.493 . . . . 0.0 111.52 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -57.96 -26.14 61.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.303 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.44 -0.44 58.35 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.712 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -106.77 146.08 32.37 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.886 0.374 . . . . 0.0 110.889 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.611 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 36.6 Cg_endo -68.62 122.16 9.11 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.136 2.557 . . . . 0.0 112.266 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -109.89 127.37 54.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.594 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.65 125.36 25.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.169 0.509 . . . . 0.0 111.475 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 t -143.56 158.85 43.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.342 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.602 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 4.7 p -139.63 147.0 40.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.857 0.36 . . . . 0.0 111.254 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 mp -130.9 143.44 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.29 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.4 ' HA ' HD22 ' A' ' 36' ' ' ASN . 1.8 t-20 -104.31 95.3 5.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.766 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -59.11 -19.81 47.91 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.806 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.579 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 21.7 t-20 -54.84 -32.57 60.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.928 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -106.42 16.44 24.71 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.489 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 54.5 m-85 -127.91 -23.45 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.59 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -111.72 144.0 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.641 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -116.53 171.76 13.92 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.881 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -107.28 112.9 25.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.959 0.409 . . . . 0.0 111.222 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -110.61 105.09 13.88 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 2.7 p-10 42.19 44.82 3.36 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.822 1.249 . . . . 0.0 112.806 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 87.11 7.72 76.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.405 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 0.7 OUTLIER -117.85 160.85 20.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.987 0.422 . . . . 0.0 110.83 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 72' ' ' ALA . 31.2 mt -84.05 115.76 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.114 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -103.13 126.06 50.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.586 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.78 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -35.25 -71.28 0.11 Allowed Pre-proline 0 CA--C 1.429 -3.702 0 O-C-N 124.49 1.119 . . . . 0.0 113.736 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.78 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 10.1 Cg_endo -110.75 120.96 0.02 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.436 0 C-N-CA 113.776 -3.682 . . . . 0.0 113.097 -178.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.641 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -152.45 -161.73 10.42 Favored Glycine 0 C--N 1.274 -2.871 0 CA-C-N 113.541 -1.663 . . . . 0.0 113.211 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 20.4 mt-10 -156.69 141.94 17.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.996 0.468 . . . . 0.0 110.458 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.2 m 58.66 36.69 25.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.801 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.579 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 5.3 p90 -69.18 -33.48 73.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.23 -18.78 58.57 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.396 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.5 m -67.19 -14.05 62.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.83 0.347 . . . . 0.0 110.774 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.9 p -146.26 20.53 1.38 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.1 m -133.15 139.19 46.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.773 0.321 . . . . 0.0 111.194 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.461 HG23 ' HD3' ' A' ' 61' ' ' LYS . 21.4 m -134.16 177.63 6.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.167 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.9 mptt 59.84 44.08 14.28 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.406 0.441 . . . . 0.0 111.136 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.472 HG21 ' CD1' ' A' ' 17' ' ' TYR . 30.6 p -75.75 125.78 29.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 111.358 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.65 162.57 39.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.574 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.768 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -118.59 116.99 27.77 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.626 0.251 . . . . 0.0 111.039 -179.06 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -93.19 127.47 38.77 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.639 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.436 ' HB3' ' NE2' ' A' ' 68' ' ' HIS . 4.3 t70 54.0 23.31 3.92 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.914 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.48 28.66 67.8 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.436 ' NE2' ' HB3' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -149.22 -18.09 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 117.899 0.85 . . . . 0.0 112.334 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.0 m -116.38 127.42 54.63 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.749 0.309 . . . . 0.0 111.245 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -90.03 136.85 32.79 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.56 130.4 50.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.162 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -161.44 167.14 26.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.105 0.478 . . . . 0.0 110.713 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.403 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 8.5 t -116.75 122.02 43.27 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.415 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.4 m -121.51 149.64 42.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 0.0 112.108 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -99.88 146.73 26.31 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.05 -22.79 0.78 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.558 -1.306 . . . . 0.0 113.473 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -60.89 -40.64 93.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.716 0.293 . . . . 0.0 111.208 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -176.61 57.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.392 0.615 . . . . 0.0 110.08 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.84 0.14 40.13 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.811 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -122.53 163.6 19.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.403 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 40.9 p90 -112.45 167.19 10.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.844 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.53 152.76 27.71 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.78 129.45 37.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.231 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.54 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 25.1 t -142.06 166.53 24.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.516 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.86 163.17 32.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.657 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.3 tpt -144.73 121.49 11.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.674 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -75.31 105.55 6.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.71 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.0 mt -74.76 -8.64 57.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.522 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -46.86 -30.1 2.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.222 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -120.83 23.6 10.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 111.348 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.71 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.4 m -127.08 -9.28 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.081 0.467 . . . . 0.0 110.472 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.913 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.7 p -156.28 138.34 6.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.858 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -133.76 177.44 19.07 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.065 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.437 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.8 t30 -109.83 123.42 49.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.626 0.25 . . . . 0.0 110.559 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.519 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 6.0 t -127.57 101.15 6.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.431 ' CD1' ' HB2' ' A' ' 26' ' ' GLU . 98.0 m-85 57.98 47.62 14.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.5 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 58.9 25.22 59.0 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.034 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -129.82 148.93 51.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.813 0.34 . . . . 0.0 110.088 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -58.69 118.94 6.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.66 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.519 ' HG3' ' HB3' ' A' ' 95' ' ' SER . 12.4 mm-40 -143.9 77.9 14.43 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.958 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.913 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 57.6 Cg_endo -74.69 93.85 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.542 2.161 . . . . 0.0 112.675 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.182 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 53.15 68.39 0.85 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.516 ' CD1' ' HB ' ' A' ' 92' ' ' VAL . 10.9 p90 -55.02 -45.99 75.18 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.163 0.506 . . . . 0.0 111.123 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.21 -22.08 62.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.87 -20.48 66.25 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.612 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 m -135.69 25.26 3.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.915 0.388 . . . . 0.0 110.946 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.0 m -134.1 132.95 40.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.051 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 p -134.46 165.11 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.611 0.243 . . . . 0.0 110.867 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.12 98.37 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.185 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' HB ' ' CD1' ' A' ' 19' ' ' LEU . 35.8 m -83.17 139.81 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.304 0.574 . . . . 0.0 111.848 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.09 148.46 52.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.545 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.532 HD22 HD23 ' A' ' 64' ' ' LEU . 14.5 tp -132.21 117.38 18.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.023 0.439 . . . . 0.0 111.155 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.41 109.99 12.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.462 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.04 -68.91 2.78 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.366 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 17.5 p90 -170.45 28.94 0.02 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.326 0.584 . . . . 0.0 110.387 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 mt -121.2 115.64 47.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.643 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.862 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -96.99 113.7 25.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -124.44 139.38 53.95 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.129 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.45 -170.9 33.71 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.269 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 1.3 m-20 -108.25 111.01 22.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.931 0.396 . . . . 0.0 110.278 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 72.4 m -107.52 132.09 53.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.01 141.82 16.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.678 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -108.92 -171.46 1.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.78 -33.82 64.71 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -64.46 -24.69 67.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.909 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.0 6.98 57.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.623 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -111.55 144.78 31.26 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 40.2 Cg_endo -68.44 133.64 28.67 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.864 2.376 . . . . 0.0 112.166 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -118.07 133.24 56.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.378 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.75 122.89 19.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.005 0.431 . . . . 0.0 111.282 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 t -142.17 159.08 42.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.021 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.7 p -140.39 146.02 37.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.83 146.08 33.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.329 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.425 ' HA ' HD22 ' A' ' 36' ' ' ASN . 4.3 m120 -102.2 96.29 6.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.009 0.433 . . . . 0.0 110.07 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -59.32 -26.54 65.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.311 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 25.9 t-20 -55.0 -28.95 55.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.054 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -103.34 6.04 37.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 55.3 m-85 -125.25 -19.84 5.0 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.264 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 mt -117.3 143.59 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.801 0.334 . . . . 0.0 110.805 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.622 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -119.47 176.29 16.07 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.219 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -127.27 112.76 15.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.735 0.779 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -110.6 115.0 28.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.342 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.82 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 56.3 t30 59.4 38.36 22.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.286 0.565 . . . . 0.0 110.476 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.12 12.09 84.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.195 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -118.45 151.43 37.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.872 0.368 . . . . 0.0 110.797 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.8 mp -76.96 129.39 36.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.599 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.481 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 9.5 tp10 -121.87 132.92 54.83 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.231 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.768 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -37.94 -66.4 0.3 Allowed Pre-proline 0 CA--C 1.423 -3.924 0 O-C-N 124.216 0.948 . . . . 0.0 113.186 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.768 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 5.5 Cg_endo -109.94 129.29 0.04 OUTLIER 'Trans proline' 1 N--CA 1.34 -7.509 0 C-N-CA 113.742 -3.706 . . . . 0.0 113.064 -178.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.622 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -163.44 -162.85 14.95 Favored Glycine 0 C--N 1.283 -2.38 0 CA-C-N 114.012 -1.449 . . . . 0.0 113.403 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -150.58 142.94 24.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.935 0.398 . . . . 0.0 110.743 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.8 p 50.83 49.25 21.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.552 1.141 . . . . 0.0 113.585 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.439 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 11.1 p90 -73.91 -43.97 56.71 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.66 -19.01 47.39 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.893 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 m -66.5 -16.02 63.81 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.041 0.448 . . . . 0.0 110.889 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 m -146.55 28.74 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.466 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 55' ' ' PHE . 62.9 m -133.66 149.58 51.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.595 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.553 HG23 ' HD3' ' A' ' 61' ' ' LYS . 19.3 m -136.69 173.13 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.812 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.553 ' HD3' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER 63.22 39.31 9.81 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.062 0.545 . . . . 0.0 111.524 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.449 ' HB ' HD21 ' A' ' 14' ' ' LEU . 22.3 p -66.29 120.6 13.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.335 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.67 156.49 40.48 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.58 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -113.79 112.0 22.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.889 0.376 . . . . 0.0 111.766 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.518 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 6.2 m-20 -73.75 117.48 15.58 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.577 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 0.3 OUTLIER 56.44 23.58 7.6 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.733 0.646 . . . . 0.0 110.701 -179.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.85 28.46 65.9 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.024 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.577 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.3 p80 -139.58 -28.02 0.77 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.707 0.754 . . . . 0.0 111.544 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 22.2 m -110.72 126.16 54.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.707 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.697 ' HB2' HD11 ' A' ' 88' ' ' LEU . 19.3 tp -90.3 127.92 36.29 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.743 -0.383 . . . . 0.0 109.99 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.26 129.62 56.03 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.981 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.57 154.33 18.31 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.678 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 28.0 t -102.41 123.01 45.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 59.8 m -120.2 153.02 36.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.0 111.9 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 10.5 tmtt? -98.77 142.31 30.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.449 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.49 -32.74 0.53 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.278 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.82 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -54.33 -39.68 67.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -169.29 48.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.351 0.596 . . . . 0.0 109.524 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.31 6.48 47.91 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.296 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 28.5 pt20 -128.17 168.11 15.87 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 41.5 p90 -88.26 167.76 13.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.344 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.503 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.2 OUTLIER -155.29 129.55 8.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.531 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -70.6 114.7 8.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.674 0.273 . . . . 0.0 110.753 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.7 t -129.49 160.62 32.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.076 0.465 . . . . 0.0 111.238 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.6 OUTLIER -128.87 165.04 21.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.051 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.624 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.7 tpt -152.85 124.83 7.95 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.869 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 40.6 t0 -76.43 107.05 8.42 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.765 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.6 mt -78.42 -8.17 58.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.649 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -49.78 -28.62 6.5 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.276 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.454 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 45.1 p90 -116.37 21.31 13.66 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.242 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.765 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -129.18 -11.21 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.1 t -134.7 145.51 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.15 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.95 166.44 25.4 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 23' ' ' CYS . 20.3 t30 -130.85 132.64 45.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 111.319 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 m -140.39 113.14 8.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.515 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 59.99 42.67 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.477 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.25 22.03 62.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.449 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -123.55 137.6 54.73 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 127.05 31.57 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.574 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.57 68.68 13.39 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 121.75 0.786 . . . . 0.0 109.415 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 13.1 Cg_endo -54.68 115.12 2.19 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.539 2.826 . . . . 0.0 113.19 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.705 179.011 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.571 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 59.7 m . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 p30 33.04 78.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.534 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 2.8 p90 -60.14 -31.86 70.48 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.932 0.396 . . . . 0.0 111.76 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.73 -23.14 66.68 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -70.33 -7.46 42.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.285 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.468 ' HB2' HD22 ' A' ' 94' ' ' ASN . 53.4 m -145.15 27.01 1.3 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.071 0.462 . . . . 0.0 110.412 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -133.36 147.7 51.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.47 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -140.06 148.18 41.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.654 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.81 59.24 10.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.234 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.414 ' HB ' ' CD1' ' A' ' 19' ' ' LEU . 18.2 m -95.24 133.22 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.106 0.479 . . . . 0.0 110.618 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -128.36 142.4 51.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.501 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.643 HD22 HD23 ' A' ' 64' ' ' LEU . 12.7 tp -107.45 112.86 25.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.097 0.475 . . . . 0.0 110.759 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.479 ' O ' HG12 ' A' ' 18' ' ' ILE . 54.8 m-85 -105.17 97.81 7.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.803 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.78 -64.18 0.47 Allowed Glycine 0 CA--C 1.523 0.594 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.549 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.645 ' HD1' HD21 ' A' ' 36' ' ' ASN . 7.9 p90 -158.23 16.67 0.22 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.779 0.432 . . . . 0.0 111.38 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.0 pt -122.63 132.26 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 0.0 110.305 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -104.18 114.4 28.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.816 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -117.75 136.82 53.12 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -164.51 -179.24 38.51 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.385 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 11.1 m-20 -101.71 104.88 15.72 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -105.36 132.13 51.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.998 0.427 . . . . 0.0 110.106 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.6 mt -75.25 132.75 32.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.192 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -101.6 -171.65 2.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.929 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -55.85 -29.93 60.66 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.7 -22.56 66.97 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.053 0.454 . . . . 0.0 111.696 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.58 6.92 65.46 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.459 -0.876 . . . . 0.0 111.293 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -112.86 142.89 28.02 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.542 -0.329 . . . . 0.0 110.354 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.579 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 43.4 Cg_endo -69.94 121.9 8.54 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.819 2.346 . . . . 0.0 112.131 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -111.92 127.48 55.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.5 124.44 22.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.166 0.508 . . . . 0.0 111.326 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -136.96 159.51 41.67 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.419 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 p -140.05 140.74 36.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.49 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.1 146.87 30.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.414 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.645 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -101.86 94.62 5.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -59.86 -26.62 66.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.631 0.253 . . . . 0.0 111.461 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.527 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 27.9 t30 -60.37 -16.48 35.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -109.68 6.82 24.05 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.135 -0.353 . . . . 0.0 110.849 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.47 ' CE2' ' HG3' ' A' ' 101' ' ' PRO . 37.4 m-85 -127.56 -23.95 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.492 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.3 mp -113.56 142.45 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -117.16 173.9 14.95 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.005 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -110.14 103.23 11.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.829 0.347 . . . . 0.0 110.51 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -112.42 107.86 16.8 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.371 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.845 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 58.0 t30 59.73 39.05 21.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.243 0.544 . . . . 0.0 110.412 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 72.57 21.66 79.41 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.71 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -125.94 150.35 48.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.506 0.194 . . . . 0.0 111.358 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 1.8 mm? -72.77 114.69 11.18 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.609 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 39.4 tt0 -108.54 123.75 49.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.512 0.672 . . . . 0.0 110.305 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.792 ' CD2' ' HD3' ' A' ' 51' ' ' PRO 0.251 0.2 OUTLIER -36.66 -57.73 1.15 Allowed Pre-proline 0 CA--C 1.423 -3.912 0 CA-C-N 113.503 -1.68 . . . . 0.0 115.164 -178.691 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.792 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 17.2 Cg_endo -117.08 109.23 0.01 OUTLIER 'Trans proline' 1 N--CA 1.348 -7.083 0 C-N-CA 113.471 -3.886 . . . . 0.0 113.12 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -148.43 -164.63 11.55 Favored Glycine 0 C--N 1.271 -3.066 0 CA-C-N 112.988 -1.915 . . . . 0.0 113.851 -176.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -151.79 142.2 22.52 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.629 0.372 . . . . 0.0 110.309 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.4 m 53.67 54.39 10.01 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 19.4 p90 -78.95 -32.99 45.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.63 -19.23 54.13 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.935 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.2 m -65.08 -18.93 65.72 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.98 0.512 . . . . 0.0 111.432 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.3 m -144.83 14.32 1.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.816 0.341 . . . . 0.0 111.193 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.4 m -121.45 139.4 53.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.33 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.72 175.85 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.063 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 0.5 OUTLIER 58.42 43.8 19.16 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.604 0.565 . . . . 0.0 111.135 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 p -66.17 132.72 49.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.774 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.61 163.33 40.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.817 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.643 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -121.11 113.39 19.96 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.099 0.476 . . . . 0.0 110.518 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.65 120.15 25.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.612 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 54.04 30.75 12.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.901 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 51.33 36.64 37.7 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.442 -0.799 . . . . 0.0 114.644 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -150.76 -29.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.768 0.784 . . . . 0.0 111.415 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 m -113.02 130.73 56.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.27 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.609 ' HB2' HD11 ' A' ' 88' ' ' LEU . 13.2 tp -89.98 128.34 36.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.89 129.24 55.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.576 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.21 170.11 21.85 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.775 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 t -113.81 116.92 30.11 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.511 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.7 m -116.71 148.5 41.02 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.12 0.486 . . . . 0.0 111.859 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.8 tmtt? -100.2 142.62 31.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.232 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.07 -31.03 0.54 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.329 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.845 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.09 -41.28 64.78 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -172.13 52.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.525 0.679 . . . . 0.0 110.182 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.16 -0.28 32.13 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.852 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -119.7 162.92 18.2 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 24.2 p90 -91.03 165.98 13.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.07 127.58 7.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.644 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -67.19 123.03 19.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.787 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 p -142.88 176.07 9.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.349 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.28 160.49 40.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.121 0.486 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.668 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.5 tpt -143.91 124.84 14.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.009 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.485 ' H ' ' HE2' ' A' ' 86' ' ' MET . 26.0 t0 -78.29 106.77 10.43 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.542 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.754 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.1 mt -77.36 -8.93 58.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.987 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -49.37 -27.75 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.334 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 43.6 p90 -118.62 20.02 13.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.508 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 88' ' ' LEU . 2.0 m -125.22 -13.03 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.958 0.409 . . . . 0.0 110.651 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.89 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 6.9 p -147.26 136.37 16.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.789 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.571 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -133.17 173.89 20.85 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.47 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 8' ' ' SER . 20.7 t30 -111.93 124.57 52.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.4 m -133.07 103.4 6.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.75 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 63.84 41.42 6.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.24 28.28 66.61 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.883 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -125.55 147.19 49.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.897 0.38 . . . . 0.0 110.858 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.451 ' O ' ' HG3' ' A' ' 99' ' ' MET . 13.5 ptm -64.2 103.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.887 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -132.83 80.32 61.34 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.177 0.513 . . . . 0.0 110.48 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.89 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 65.6 Cg_endo -74.3 125.28 9.59 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.696 2.264 . . . . 0.0 112.148 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.681 0 CA-C-O 121.372 0.606 . . . . 0.0 111.52 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.536 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 99.7 m . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 43.04 70.2 0.32 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.945 0.778 . . . . 0.0 113.071 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 11.7 p90 -53.25 -34.16 56.02 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.331 0.586 . . . . 0.0 110.402 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.86 -23.29 67.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.349 -0.842 . . . . 0.0 113.002 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -62.06 -27.48 68.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.7 m -129.88 15.91 5.78 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.525 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -117.53 139.89 50.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.371 0.605 . . . . 0.0 111.651 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -137.82 154.48 49.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.199 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.79 60.51 7.99 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.358 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 31.6 m -94.14 139.91 17.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.075 0.464 . . . . 0.0 111.532 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -131.32 148.74 52.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.13 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.68 HD22 HD23 ' A' ' 64' ' ' LEU . 14.9 tp -133.41 119.19 19.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.992 0.425 . . . . 0.0 110.974 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.487 ' O ' HG12 ' A' ' 18' ' ' ILE . 67.6 t80 -127.09 101.32 6.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.202 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.23 -63.08 3.65 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.625 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.685 ' HD1' HD21 ' A' ' 36' ' ' ASN . 8.3 p90 -167.82 20.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.585 0.231 . . . . 0.0 111.602 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 15' ' ' TYR . 35.8 pt -116.25 126.08 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.821 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -111.3 114.74 28.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.263 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 17.8 ttm180 -116.98 138.43 51.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.53 168.12 35.93 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.778 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 9.7 m-20 -101.66 109.56 21.37 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -106.91 133.41 51.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.933 0.396 . . . . 0.0 110.426 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.5 mt -67.85 139.57 20.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.378 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.7 p30 -112.49 -168.1 1.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.567 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -56.18 -33.94 65.74 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.689 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.88 -28.62 67.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.597 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.14 -3.77 58.48 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.596 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -107.3 144.67 29.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.664 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 31.6 Cg_endo -64.9 128.27 20.45 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.387 2.725 . . . . 0.0 112.795 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -114.75 131.5 56.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.095 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.02 127.29 30.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.271 0.558 . . . . 0.0 111.75 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 t -142.34 159.31 42.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.479 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.6 p -139.69 150.55 45.0 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.351 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.717 HG13 ' HG3' ' A' ' 99' ' ' MET . 2.7 mp -134.63 143.11 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.979 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.685 HD21 ' HD1' ' A' ' 17' ' ' TYR . 1.8 t-20 -100.82 97.03 7.7 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.5 mm? -59.42 -22.55 61.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.383 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -55.11 -28.76 54.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.125 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -108.18 11.54 27.37 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.909 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' C ' HD12 ' A' ' 41' ' ' ILE . 43.9 m-85 -129.09 -6.91 4.89 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.559 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.5 mp -129.06 133.74 65.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.585 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.64 176.42 18.22 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.391 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -115.38 101.63 9.09 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.983 0.42 . . . . 0.0 109.982 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.78 107.18 16.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.331 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.513 ' CG ' ' HA ' ' A' ' 77' ' ' ALA . 13.7 t-20 56.53 45.2 22.8 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.553 0.692 . . . . 0.0 110.471 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.95 19.8 75.64 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.828 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 149.01 47.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.982 0.42 . . . . 0.0 111.359 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.5 mp -72.45 122.47 21.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.714 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.624 ' HG2' ' CD ' ' A' ' 51' ' ' PRO . 24.7 tt0 -111.57 124.27 51.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 110.68 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.539 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 34.2 p90 -46.55 -28.2 0.68 Allowed Pre-proline 0 CA--C 1.452 -2.817 0 N-CA-C 119.107 3.003 . . . . 0.0 119.107 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.624 ' CD ' ' HG2' ' A' ' 49' ' ' GLU . 6.8 Cg_endo -127.04 5.97 0.01 OUTLIER 'Trans proline' 1 N--CA 1.391 -4.545 1 C-N-CA 112.76 -4.36 . . . . 0.0 116.392 178.82 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.585 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -56.24 -175.11 0.21 Allowed Glycine 0 C--N 1.265 -3.386 0 CA-C-N 111.099 -2.773 . . . . 0.0 115.903 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -147.81 144.09 27.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.942 0.401 . . . . 0.0 111.302 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.2 t 65.76 43.53 3.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.561 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.9 p90 -74.5 -37.51 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.771 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.98 -18.97 20.72 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.567 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 t -63.05 -22.38 66.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.786 0.327 . . . . 0.0 110.92 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 m -143.48 19.12 1.87 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.608 0.242 . . . . 0.0 111.136 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 73' ' ' SER . 63.6 m -124.54 140.58 52.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 0.0 111.091 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.38 176.02 7.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.143 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 60.89 46.57 8.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 123.752 0.658 . . . . 0.0 111.028 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.535 ' HB ' HD21 ' A' ' 14' ' ' LEU . 36.5 p -73.07 126.98 31.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.262 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.4 153.99 34.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.68 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -109.95 113.21 25.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.816 0.341 . . . . 0.0 111.083 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.2 117.39 20.17 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.298 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 12.5 t70 51.53 35.51 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.489 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 52.28 35.59 43.29 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.106 -0.952 . . . . 0.0 115.373 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.488 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 1.9 p-80 -148.0 -25.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.024 0.912 . . . . 0.0 112.33 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.6 m -117.34 129.94 56.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.702 0.287 . . . . 0.0 111.433 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.612 ' HB2' HD11 ' A' ' 88' ' ' LEU . 20.1 tp -90.62 132.88 35.49 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.02 129.83 51.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.655 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.493 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -161.3 169.43 22.11 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.539 0.524 . . . . 0.0 110.849 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 59' ' ' CYS . 35.9 t -114.63 125.26 53.55 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 35.4 m -125.17 151.86 45.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -98.78 140.34 33.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.615 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.63 -32.01 0.48 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.5 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.513 ' HA ' ' CG ' ' A' ' 45' ' ' ASN . . . -50.83 -42.61 58.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -169.84 53.23 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.247 0.546 . . . . 0.0 110.015 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.9 1.79 49.09 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.423 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -125.27 165.53 18.16 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 40.3 p90 -95.19 161.04 14.27 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 123.618 0.574 . . . . 0.0 110.616 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -155.43 140.48 17.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -72.74 135.63 45.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.466 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.9 p -150.54 174.68 12.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.137 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.14 164.18 30.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.886 0.374 . . . . 0.0 110.373 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.57 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.2 tpt -147.01 122.1 10.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.225 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.68 106.4 4.07 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.684 ' HA ' HG22 ' A' ' 91' ' ' VAL . 21.4 mt -78.56 -8.35 58.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.135 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -47.12 -32.12 3.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.999 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -117.7 21.91 12.66 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.198 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -124.35 -14.96 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.279 0.561 . . . . 0.0 110.605 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.496 ' HB ' ' CD1' ' A' ' 5' ' ' PHE . 2.7 t -132.41 127.79 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.536 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -124.77 153.76 17.91 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.956 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.462 HD22 ' HB2' ' A' ' 8' ' ' SER . 32.1 t30 -103.96 117.44 34.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.806 0.336 . . . . 0.0 110.564 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 57.9 m -112.45 84.7 2.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.099 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 60.74 61.44 1.68 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.418 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 57.13 28.56 58.69 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.84 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -134.01 144.95 49.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.116 0.484 . . . . 0.0 110.917 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.717 ' HG3' HG13 ' A' ' 35' ' ' ILE . 6.2 tmm? -67.09 115.82 7.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.363 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 14.0 mt-10 -144.27 73.59 15.97 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.711 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HD3' ' HG2' ' A' ' 99' ' ' MET . 18.7 Cg_endo -57.09 156.73 23.33 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.261 2.641 . . . . 0.0 112.313 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 24.3 p . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.67 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.486 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 80.4 m . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 80.3 m-20 56.11 77.48 0.24 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 10.1 p90 -61.1 -44.44 97.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.011 0.434 . . . . 0.0 110.595 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.25 -21.11 61.47 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.613 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 28.0 t-20 -54.46 -35.69 63.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.58 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.484 ' HB2' HD22 ' A' ' 94' ' ' ASN . 52.4 m -134.03 21.62 3.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.65 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.4 m -118.06 132.99 56.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.611 0.243 . . . . 0.0 110.358 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.0 p -132.65 155.26 49.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.541 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.5 67.81 1.99 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.915 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 11.3 m -107.32 129.64 60.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.274 0.559 . . . . 0.0 112.373 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 67.5 mm-40 -115.98 145.76 42.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.314 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.932 HD22 HD23 ' A' ' 64' ' ' LEU . 53.6 tp -133.0 122.26 23.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.0 111.089 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 18' ' ' ILE . 76.8 t80 -134.2 100.07 4.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.967 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 62' ' ' THR . . . 81.39 -64.01 4.25 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.645 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -166.49 19.83 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.735 0.302 . . . . 0.0 111.365 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.513 HG22 ' ND2' ' A' ' 36' ' ' ASN . 33.6 pt -116.4 119.08 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.753 0.311 . . . . 0.0 110.942 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.839 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.2 mt -111.91 114.5 27.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.4 ttt85 -120.68 138.75 53.79 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.117 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 179.37 38.83 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.268 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.613 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 4.5 m-20 -105.68 109.53 21.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.73 0.3 . . . . 0.0 110.318 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 8' ' ' SER . 61.3 m -108.19 133.38 52.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.133 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 55.0 mt -67.8 138.29 22.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.616 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -106.75 -170.83 1.78 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.118 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 15.3 pt-20 -57.67 -29.43 64.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.938 0.399 . . . . 0.0 111.691 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -64.71 -22.97 67.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.539 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.08 -1.4 62.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.929 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -108.32 148.02 36.78 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 55.0 Cg_endo -70.96 128.59 15.13 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.9 2.4 . . . . 0.0 112.732 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -116.49 127.64 54.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.061 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.86 126.69 28.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.963 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.0 t -144.67 160.54 41.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.317 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 p -140.47 142.51 35.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.096 0.474 . . . . 0.0 111.184 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' A' ' 99' ' ' MET . 2.6 mp -123.69 143.8 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.691 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.513 ' ND2' HG22 ' A' ' 18' ' ' ILE . 9.2 m120 -104.14 92.65 4.46 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.839 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -56.35 -23.45 37.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.299 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -54.9 -32.69 61.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.955 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -100.78 11.29 39.86 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.771 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 52.6 m-85 -128.55 -26.91 2.68 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.4 mp -110.66 142.08 24.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.72 0.295 . . . . 0.0 110.825 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.711 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -121.21 166.12 14.18 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.13 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -113.16 111.79 22.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.422 0.629 . . . . 0.0 110.23 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -110.59 113.27 25.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.411 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.711 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 14.7 t30 57.12 36.18 27.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.04 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.97 13.84 82.63 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.798 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -118.93 145.69 45.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.582 0.23 . . . . 0.0 110.767 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.4 mp -73.84 113.8 11.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.739 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 7.2 tp10 -104.91 133.35 49.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.376 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.714 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.87 -68.93 0.2 Allowed Pre-proline 0 CA--C 1.425 -3.836 0 O-C-N 124.352 1.033 . . . . 0.0 113.152 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.714 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 6.8 Cg_endo -109.6 129.43 0.04 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.441 0 C-N-CA 113.763 -3.691 . . . . 0.0 113.31 -177.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.711 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -161.02 -160.35 10.65 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 113.998 -1.456 . . . . 0.0 113.46 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -154.73 140.6 18.2 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.962 0.448 . . . . 0.0 110.468 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m 52.39 46.78 26.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -72.19 -38.92 68.96 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.98 -18.73 48.52 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.533 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.5 m -64.92 -20.43 66.45 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 122.74 0.416 . . . . 0.0 111.12 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.0 m -143.69 28.15 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.078 0.466 . . . . 0.0 110.74 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.5 m -131.44 145.79 51.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.563 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.3 173.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.615 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mptt 61.65 41.8 11.72 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.689 0.618 . . . . 0.0 111.265 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.497 HG21 ' O ' ' A' ' 16' ' ' GLY . 7.5 p -68.75 123.88 22.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.605 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.88 156.7 38.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.155 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.932 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -113.61 112.88 24.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.717 0.294 . . . . 0.0 110.981 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -76.9 117.52 18.58 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.203 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.735 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 20.8 t70 61.63 5.48 1.27 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.837 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.47 35.7 41.0 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.969 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.735 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.0 p80 -148.91 -26.34 0.3 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 111.274 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 m -115.71 129.93 56.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.911 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.604 ' HA ' HD22 ' A' ' 64' ' ' LEU . 17.9 tp -90.36 136.78 32.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.51 129.55 46.2 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -163.25 166.51 23.09 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.404 0.44 . . . . 0.0 110.725 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 t -116.06 127.33 54.79 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 18.5 m -127.65 156.43 42.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.214 0.53 . . . . 0.0 112.065 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 10.5 tmtt? -99.72 152.29 20.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.425 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.45 -26.4 1.22 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.103 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.711 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -54.28 -42.14 69.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.843 0.354 . . . . 0.0 111.481 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -178.68 58.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.391 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.471 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 73.06 -2.92 32.22 Favored Glycine 0 CA--C 1.518 0.225 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.135 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -118.75 165.23 14.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.805 0.336 . . . . 0.0 110.421 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 49.1 p90 -104.41 166.36 10.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.679 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -151.14 152.07 32.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.691 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.47 129.4 34.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.23 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.9 p -148.25 170.54 17.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 0.0 111.462 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.53 165.69 25.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.874 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.683 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 9.3 tpt -143.54 113.27 7.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.491 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.544 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 21.8 t70 -72.31 104.01 3.58 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.789 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.8 mt -76.36 -8.54 57.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.322 -177.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.544 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 8.0 m120 -49.88 -28.56 6.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.575 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 48.7 p90 -117.53 21.5 12.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.187 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -129.11 -14.79 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.606 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.2 t -133.58 147.0 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -143.78 149.73 21.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.167 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.484 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.7 t30 -89.37 116.63 27.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -116.94 84.37 2.13 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.365 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 26' ' ' GLU . 78.5 m-85 61.44 53.99 3.25 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.485 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.48 28.05 64.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.943 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -130.35 142.27 50.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.634 ' HB2' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -74.61 106.66 6.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.566 0.698 . . . . 0.0 112.507 -178.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -137.5 78.83 37.08 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.418 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 39.7 Cg_endo -65.71 104.97 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 123.296 2.664 . . . . 0.0 112.853 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.231 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 91.7 m . . . . . 0 N--CA 1.456 -0.127 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 51.97 73.66 0.31 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.4 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.551 ' CD1' HG13 ' A' ' 92' ' ' VAL . 1.9 p90 -58.31 -36.89 74.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 111.164 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.19 -22.21 60.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.83 -20.47 65.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.695 0.283 . . . . 0.0 111.404 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.43 ' HB2' HD22 ' A' ' 94' ' ' ASN . 18.7 m -135.33 16.65 3.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 97.7 m -124.58 136.9 54.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.78 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -132.95 147.77 52.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.293 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.19 43.3 80.92 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.748 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 12' ' ' VAL . 3.1 m -81.99 119.48 31.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.436 0.636 . . . . 0.0 111.507 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.89 133.38 56.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.766 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.812 HD22 HD23 ' A' ' 64' ' ' LEU . 42.7 tp -108.14 121.08 44.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.471 ' O ' HG12 ' A' ' 18' ' ' ILE . 85.7 m-85 -124.74 105.18 9.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.689 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.35 -66.95 2.23 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.512 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.561 ' HD1' HD21 ' A' ' 36' ' ' ASN . 6.4 p90 -164.59 18.64 0.05 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.695 0.398 . . . . 0.0 111.24 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 15' ' ' TYR . 30.7 pt -122.26 133.96 66.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.128 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.698 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.3 mt -114.12 114.63 26.32 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.274 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -118.01 140.9 49.08 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.95 -174.37 37.47 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.277 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 8.2 m-20 -109.21 108.69 19.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.576 0.227 . . . . 0.0 110.54 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 74.9 m -106.81 132.37 52.86 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 53.6 mt -68.26 140.72 18.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.6 p30 -108.96 -174.99 2.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.986 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -50.53 -36.67 35.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.66 0.384 . . . . 0.0 111.993 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -59.39 -25.31 64.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.806 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.64 4.91 59.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.367 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -112.84 146.95 36.13 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.345 -0.428 . . . . 0.0 110.137 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.567 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 56.5 Cg_endo -72.02 133.75 22.09 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.907 2.405 . . . . 0.0 112.903 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -121.82 130.51 53.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.619 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.82 129.67 40.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.041 0.448 . . . . 0.0 111.337 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.0 t -144.07 160.16 41.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.745 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.9 p -140.02 140.02 36.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.61 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -124.61 144.87 33.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 123.225 0.328 . . . . 0.0 110.401 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.561 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -102.98 91.48 4.14 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -58.3 -26.14 62.68 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.081 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.52 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 42.3 t30 -59.19 -20.38 53.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -105.62 8.13 33.04 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.432 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -129.13 -25.54 2.73 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -107.85 140.52 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.697 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.31 164.6 12.12 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.239 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -113.61 108.29 16.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.125 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -110.76 108.95 18.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.328 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 43.9 m-20 53.96 39.18 30.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.187 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 80.27 19.0 70.28 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.042 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.27 154.99 39.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.045 0.45 . . . . 0.0 111.096 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.497 HD13 ' HG ' ' A' ' 70' ' ' LEU . 51.6 mt -88.1 113.78 24.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.363 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -109.09 138.21 45.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.477 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.687 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -38.9 -71.74 0.12 Allowed Pre-proline 0 CA--C 1.426 -3.79 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 2.5 Cg_endo -107.92 129.29 0.05 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.234 0 C-N-CA 113.876 -3.616 . . . . 0.0 113.209 -176.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.697 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -165.2 -162.97 17.47 Favored Glycine 0 C--N 1.284 -2.324 0 CA-C-N 113.976 -1.466 . . . . 0.0 113.408 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -156.28 144.73 19.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.445 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.0 t 59.59 41.75 18.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.725 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 17.1 p90 -72.26 -37.57 69.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.45 -18.69 44.79 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.322 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 t -61.87 -20.67 63.97 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 110.63 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 m -144.46 24.34 1.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 111.02 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.2 m -124.95 139.83 53.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.262 0.554 . . . . 0.0 111.467 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.91 177.12 6.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.041 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 61.75 39.78 13.72 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.284 0.365 . . . . 0.0 111.431 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 p -70.43 126.47 29.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.956 0.408 . . . . 0.0 111.92 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.56 150.34 29.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.866 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.812 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -105.62 113.52 27.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.95 0.405 . . . . 0.0 111.218 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.453 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 4.7 t30 -84.21 123.64 30.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.645 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.607 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 18.2 t70 61.0 8.24 1.83 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.768 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.55 30.83 68.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.993 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.607 ' CD2' ' HB3' ' A' ' 66' ' ' ASP . 0.5 OUTLIER -150.7 -20.43 0.22 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.883 0.342 . . . . 0.0 111.453 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.458 ' O ' HD13 ' A' ' 64' ' ' LEU . 40.7 m -116.03 135.65 53.75 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.493 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.497 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.0 tp -97.6 129.78 44.69 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.66 129.85 53.07 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.62 173.11 17.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.067 0.46 . . . . 0.0 110.788 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.7 t -119.95 119.27 32.98 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.475 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.6 m -122.52 146.79 47.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.8 tmtt? -100.54 146.38 27.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.01 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.0 -24.75 0.41 Allowed Glycine 0 C--O 1.227 -0.328 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.477 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -68.97 -34.34 75.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.623 0.712 . . . . 0.0 111.828 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -169.64 54.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.187 0.517 . . . . 0.0 110.542 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.53 -1.77 8.91 Favored Glycine 0 CA--C 1.518 0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.143 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.56 160.55 22.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.808 0.337 . . . . 0.0 110.825 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 49.3 p90 -97.63 168.63 10.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.395 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -155.72 148.67 24.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.823 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.19 132.87 45.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.121 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -152.35 161.1 43.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.558 0.694 . . . . 0.0 112.131 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.47 159.74 41.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.919 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.526 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 7.8 tpt -146.29 116.96 7.6 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.615 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.444 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 32.9 t0 -77.02 104.39 7.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.409 0.623 . . . . 0.0 110.342 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.784 ' HA ' HG22 ' A' ' 91' ' ' VAL . 12.5 mt -73.81 -8.32 55.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.403 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -47.19 -31.73 3.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.794 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 42.0 p90 -118.79 24.35 10.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.79 0.329 . . . . 0.0 111.602 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.784 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -130.39 -4.32 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.044 0.45 . . . . 0.0 110.996 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 9.1 p -153.03 144.29 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.341 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -139.18 -171.78 12.34 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.282 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.43 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.4 t30 -132.5 137.92 47.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.828 0.347 . . . . 0.0 110.849 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.627 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 4.0 t -144.57 116.72 8.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 60.2 41.45 16.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.499 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 58.37 31.32 66.12 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.899 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -136.51 149.27 48.06 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.449 ' O ' ' HG3' ' A' ' 99' ' ' MET . 19.7 ptt? -55.44 127.11 28.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.442 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.627 ' HG3' ' CB ' ' A' ' 95' ' ' SER . 6.7 mm-40 -142.12 77.78 17.77 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.296 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 43.0 Cg_endo -68.82 93.5 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.561 2.174 . . . . 0.0 113.103 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.315 -0.894 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.28 179.275 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.625 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 94.3 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 111.277 0.103 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 62.56 83.9 0.15 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.528 ' CD1' HG13 ' A' ' 92' ' ' VAL . 3.3 p90 -64.46 -36.97 85.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.078 0.466 . . . . 0.0 111.167 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -63.12 -20.43 65.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.331 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -52.47 -32.83 41.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.122 0.487 . . . . 0.0 111.417 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.414 ' HB2' HD22 ' A' ' 94' ' ' ASN . 21.2 m -138.73 35.76 2.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.263 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -128.77 135.27 48.94 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.093 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.3 p -132.56 162.53 31.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.361 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.17 54.98 32.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.353 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 32.9 m -95.81 138.88 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.413 . . . . 0.0 111.263 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -134.99 140.67 45.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.888 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.775 HD22 HD23 ' A' ' 64' ' ' LEU . 20.1 tp -120.97 116.84 25.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.011 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.522 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.3 t80 -125.14 104.04 8.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.869 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.98 -68.45 2.83 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.553 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 39.6 p90 -163.81 19.54 0.07 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 122.445 0.298 . . . . 0.0 111.21 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.579 HG22 ' ND2' ' A' ' 36' ' ' ASN . 38.8 pt -114.4 126.69 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.712 0.291 . . . . 0.0 110.729 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.923 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.15 113.95 26.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.0 ttm180 -119.08 139.18 52.19 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.388 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.555 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -160.96 168.99 36.48 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.632 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 9.2 m-20 -97.3 105.79 18.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -104.16 131.73 51.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.8 mt -74.61 135.86 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.097 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -95.1 -179.96 5.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.632 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -50.4 -39.93 48.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.63 -24.42 65.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.64 1.38 46.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.41 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -101.99 139.67 20.51 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 57.8 Cg_endo -72.12 135.14 24.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.886 2.39 . . . . 0.0 112.188 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -125.21 126.11 44.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.154 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.13 122.74 18.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.987 0.423 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 t -136.94 158.86 43.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.809 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 p -138.95 143.01 38.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.623 0.249 . . . . 0.0 110.909 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.32 146.74 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.572 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.579 ' ND2' HG22 ' A' ' 18' ' ' ILE . 7.1 m120 -100.5 96.86 7.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.073 0.463 . . . . 0.0 110.244 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.923 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -60.43 -26.69 66.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.207 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.3 t-20 -53.93 -34.01 58.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.09 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -102.72 11.46 37.61 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.0 m-85 -127.37 -21.8 3.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.73 139.95 35.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.67 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.3 165.55 12.07 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.177 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -110.71 106.22 15.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.613 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -112.17 107.37 16.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.751 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.822 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 39.7 t30 60.8 39.43 17.16 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.93 17.74 79.46 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.559 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.47 144.4 50.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.834 0.35 . . . . 0.0 111.045 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.2 mp -72.69 123.76 23.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.883 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.484 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 10.3 tp10 -113.95 139.33 49.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.696 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -41.79 -69.42 0.22 Allowed Pre-proline 0 CA--C 1.426 -3.799 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.867 -179.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.696 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 3.5 Cg_endo -110.3 131.36 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.323 0 C-N-CA 113.81 -3.66 . . . . 0.0 113.2 -177.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -162.45 -159.29 10.2 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 114.108 -1.406 . . . . 0.0 113.604 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -155.17 144.94 21.45 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 124.026 0.486 . . . . 0.0 110.869 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 m 51.41 43.92 29.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -73.03 -38.8 66.41 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.23 -18.6 49.75 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.515 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.3 m -64.71 -24.79 67.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.846 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 m -136.86 20.27 3.05 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.9 m -126.56 140.42 52.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.522 HG23 ' HE2' ' A' ' 61' ' ' LYS . 27.8 m -131.27 176.45 8.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.146 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.522 ' HE2' HG23 ' A' ' 60' ' ' VAL . 2.4 mppt? 58.75 44.85 16.51 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.451 0.47 . . . . 0.0 111.248 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 p -71.41 123.19 21.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.611 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.3 163.09 38.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.305 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.775 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -121.24 112.65 18.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 0.0 111.524 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.07 119.27 20.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.294 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.842 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.6 t70 51.99 26.51 3.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 124.087 0.867 . . . . 0.0 110.956 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 6' ' ' ALA . . . 58.35 32.63 68.48 Favored Glycine 0 C--O 1.224 -0.472 0 CA-C-N 115.663 -0.698 . . . . 0.0 113.722 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.842 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 11.0 p80 -141.35 -29.82 0.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.708 0.754 . . . . 0.0 111.661 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 m -116.28 131.06 57.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.802 0.334 . . . . 0.0 111.359 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.589 ' HA ' HD22 ' A' ' 64' ' ' LEU . 16.1 tp -90.74 131.93 36.13 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -122.38 130.43 53.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.783 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -160.58 165.37 30.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 t -111.63 120.58 42.54 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 34.8 m -119.29 152.43 36.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 9.0 tmtt? -99.85 144.66 28.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.689 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.79 -27.85 0.66 Allowed Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.629 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.822 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.6 -40.3 75.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -174.33 54.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.349 0.595 . . . . 0.0 109.93 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 67.81 6.51 44.42 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.112 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 28.8 pt20 -126.01 169.91 12.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 45.7 p90 -98.78 171.55 8.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.822 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -160.21 145.2 14.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -76.41 132.87 39.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.21 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.9 p -152.1 166.22 32.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 111.369 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.5 OUTLIER -138.81 162.66 34.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.426 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.62 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 16.9 tpp -147.92 117.87 7.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.5 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 37.8 t0 -74.44 107.65 6.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.202 0.525 . . . . 0.0 109.677 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.72 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.8 mt -76.04 -9.52 58.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.523 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.411 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 1.8 m120 -48.41 -29.43 4.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.602 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 47.2 p90 -119.23 21.67 12.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.698 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -127.7 -10.46 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.037 0.446 . . . . 0.0 110.693 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.802 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.1 p -150.78 141.62 16.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.356 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.625 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -133.86 -168.51 11.84 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.063 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.414 HD22 ' HB2' ' A' ' 8' ' ' SER . 15.6 t30 -132.54 127.68 35.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.281 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.592 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 68.5 m -139.1 112.2 8.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.76 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 57.49 40.45 27.13 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.512 0.507 . . . . 0.0 111.185 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.44 20.05 58.42 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.743 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -116.74 147.13 42.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.721 0.296 . . . . 0.0 110.279 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.502 ' O ' ' HG3' ' A' ' 99' ' ' MET . 20.1 ptt? -61.48 117.31 5.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.367 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 19.0 mm-40 -135.03 79.33 51.22 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.735 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.802 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 53.7 Cg_endo -71.33 82.98 1.04 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.799 2.332 . . . . 0.0 112.392 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.306 -1.313 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.433 -179.763 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.522 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 78.4 m . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 111.417 0.154 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 54.79 75.68 0.29 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 15.0 p90 -60.18 -36.83 78.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.181 0.515 . . . . 0.0 110.94 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -69.16 -22.72 63.91 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -60.06 -25.43 65.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.931 0.396 . . . . 0.0 111.319 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.457 ' HB2' HD22 ' A' ' 94' ' ' ASN . 16.3 m -132.04 29.97 4.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.664 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -131.23 140.11 49.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -133.32 150.53 51.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.29 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.97 73.65 0.46 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.531 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 ' HA3' ' A' ' 21' ' ' GLY . 33.3 m -112.0 144.39 19.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.837 0.351 . . . . 0.0 111.249 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -128.45 155.67 44.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.215 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.719 HD22 HD23 ' A' ' 64' ' ' LEU . 23.1 tp -132.18 109.38 9.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.026 0.441 . . . . 0.0 110.59 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.477 ' O ' HG12 ' A' ' 18' ' ' ILE . 80.4 m-85 -114.37 100.43 8.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' HG21 ' A' ' 62' ' ' THR . . . 77.56 -63.64 3.36 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.919 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.733 ' HD1' HD21 ' A' ' 36' ' ' ASN . 8.7 p90 -166.04 23.45 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.618 0.247 . . . . 0.0 111.633 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 15' ' ' TYR . 42.2 pt -121.73 133.53 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.808 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -112.65 120.16 40.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.863 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -127.96 139.71 52.42 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.876 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.572 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.35 -175.51 37.38 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.335 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 3.6 m-20 -106.84 107.66 18.79 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 m -105.19 131.84 52.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 72.0 mt -72.46 137.43 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -100.82 -175.18 2.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.123 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.3 -27.5 62.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 112.048 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.62 -26.36 68.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.64 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.44 2.78 55.55 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.926 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -112.18 142.11 26.27 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.722 0.296 . . . . 0.0 110.374 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 42.1 Cg_endo -68.7 136.64 36.5 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.981 2.454 . . . . 0.0 112.596 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -123.87 134.27 53.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.132 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.83 126.06 28.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.431 . . . . 0.0 111.241 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 t -141.09 160.31 40.36 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.579 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -139.45 145.45 38.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.978 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.58 145.29 35.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.81 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.733 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -102.66 95.44 6.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.808 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.99 -26.7 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.691 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.415 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.0 t-20 -55.25 -27.91 49.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.281 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -104.7 7.94 34.95 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 30.9 m-85 -128.22 -21.94 3.5 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.2 mp -113.59 141.2 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.497 0.189 . . . . 0.0 110.722 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.658 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -118.61 170.07 13.66 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.371 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -109.56 110.89 22.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.963 0.411 . . . . 0.0 110.928 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -110.78 106.91 16.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.589 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 12.0 t30 52.12 41.55 30.08 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.909 0.484 . . . . 0.0 111.508 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.96 16.18 77.48 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.21 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.23 153.64 41.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.06 0.457 . . . . 0.0 110.92 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.578 HD13 ' HG ' ' A' ' 70' ' ' LEU . 37.1 mt -81.4 114.07 19.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.305 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.626 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.1 tt0 -107.31 132.75 52.78 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.772 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -32.49 -69.94 0.12 Allowed Pre-proline 0 CA--C 1.425 -3.837 0 O-C-N 124.762 1.289 . . . . 0.0 114.047 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.772 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -108.77 133.59 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.321 0 C-N-CA 113.939 -3.574 . . . . 0.0 112.655 -177.636 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.658 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -168.61 -162.94 21.73 Favored Glycine 0 C--N 1.283 -2.389 0 C-N-CA 119.559 -1.305 . . . . 0.0 113.65 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -154.29 146.3 23.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.352 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.1 m 53.43 41.9 32.05 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -71.93 -35.51 69.65 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.14 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.09 -18.64 57.96 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.259 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -63.32 -24.29 67.79 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.494 -0.353 . . . . 0.0 111.136 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -136.46 22.08 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.095 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.4 m -126.89 148.37 50.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.128 0.489 . . . . 0.0 111.476 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.413 HG23 ' HD3' ' A' ' 61' ' ' LYS . 30.5 m -138.11 173.75 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.532 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 73' ' ' SER . 0.1 OUTLIER 58.83 40.38 22.93 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.452 0.47 . . . . 0.0 111.648 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 16' ' ' GLY . 6.4 p -65.97 118.46 9.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.085 0.469 . . . . 0.0 111.822 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.91 149.56 31.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.095 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.719 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -109.0 115.02 29.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.772 0.32 . . . . 0.0 110.761 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -88.8 124.77 34.48 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.751 0.31 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.883 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 17.1 t70 58.1 19.74 6.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.603 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.436 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 58.43 31.31 66.31 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.929 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.883 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.5 p80 -139.36 -32.41 0.65 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.561 0.68 . . . . 0.0 111.142 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -116.01 131.9 56.81 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.268 0.556 . . . . 0.0 111.747 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.645 ' HA ' HD22 ' A' ' 64' ' ' LEU . 9.1 tp -90.1 130.84 36.22 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.613 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 129.22 53.88 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.0 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.85 164.36 31.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.446 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 7.7 t -111.76 124.37 52.2 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 21.9 m -126.47 150.09 48.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.325 0.583 . . . . 0.0 112.042 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.4 tmtt? -99.36 146.74 25.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.419 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.87 -30.69 0.66 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.209 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.589 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.09 -42.32 76.56 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -169.9 54.86 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.422 0.63 . . . . 0.0 110.293 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.449 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 67.54 3.43 26.49 Favored Glycine 0 C--N 1.328 0.108 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.454 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.7 160.78 25.15 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 12.2 p90 -101.98 169.88 8.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.851 0.358 . . . . 0.0 110.643 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -157.86 138.73 13.16 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.78 121.2 25.08 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.518 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.2 p -133.08 -179.81 5.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.148 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.48 164.51 28.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.044 0.449 . . . . 0.0 110.658 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.475 ' HB2' ' CB ' ' A' ' 48' ' ' LEU . 9.2 tpt -145.86 113.72 6.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.96 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.65 105.84 5.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.555 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.782 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.4 mt -75.78 -9.0 58.23 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.697 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -50.88 -26.04 5.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.591 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -119.41 22.21 11.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.325 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.782 HG22 ' HA ' ' A' ' 88' ' ' LEU . 2.2 m -127.62 -14.99 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.849 0.357 . . . . 0.0 110.569 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -139.22 145.42 27.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.924 177.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.522 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -134.18 179.96 17.01 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.89 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.457 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.5 t30 -131.85 127.79 37.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.684 0.278 . . . . 0.0 110.921 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.638 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 64.2 m -135.14 107.36 7.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.234 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 60.93 42.58 12.73 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.751 0.657 . . . . 0.0 110.622 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.26 22.47 63.16 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.692 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -118.24 147.18 43.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.484 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.439 ' O ' ' HG3' ' A' ' 99' ' ' MET . 20.3 ptt? -60.82 121.08 11.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.043 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.638 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 57.6 mm-40 -137.02 80.45 35.51 Favored Pre-proline 0 CA--C 1.516 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.346 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 44.5 Cg_endo -68.81 89.02 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.672 2.248 . . . . 0.0 112.962 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.215 179.784 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.463 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 35.0 m . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 120.567 0.222 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.788 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 49.4 m-80 60.67 71.06 0.58 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.637 ' CD1' HG13 ' A' ' 92' ' ' VAL . 5.1 p90 -66.24 -37.5 85.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.025 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.56 -20.0 65.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.204 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.788 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 44.2 t-20 -51.57 -39.11 57.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.026 0.441 . . . . 0.0 110.769 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.474 ' HB2' HD22 ' A' ' 94' ' ' ASN . 19.2 m -132.01 27.71 4.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -118.53 139.99 50.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.012 0.434 . . . . 0.0 111.051 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -137.01 152.26 49.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.647 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.05 57.23 14.41 Favored Glycine 0 N--CA 1.455 -0.082 0 O-C-N 123.527 0.517 . . . . 0.0 112.764 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.563 HG12 ' HA3' ' A' ' 21' ' ' GLY . 15.9 m -101.17 134.03 42.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.065 0.459 . . . . 0.0 111.852 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -127.72 153.14 46.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.263 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.742 HD22 HD23 ' A' ' 64' ' ' LEU . 23.7 tp -128.33 120.55 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.97 0.414 . . . . 0.0 111.991 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.448 ' O ' HG12 ' A' ' 18' ' ' ILE . 73.0 t80 -126.66 108.55 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 62' ' ' THR . . . 78.5 -73.35 2.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.3 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' HD1' HD21 ' A' ' 36' ' ' ASN . 13.6 p90 -164.0 23.38 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.821 0.343 . . . . 0.0 111.377 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 15' ' ' TYR . 24.7 pt -121.13 127.84 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.702 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.857 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -109.29 114.59 28.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.176 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.06 139.74 51.22 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.014 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.563 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -165.93 -175.39 36.32 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.139 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 3.5 m-20 -107.89 108.05 19.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.572 0.225 . . . . 0.0 110.577 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -105.72 131.36 53.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 8' ' ' SER . 53.1 mt -69.65 140.78 18.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.982 0.42 . . . . 0.0 111.904 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -108.05 -172.8 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.331 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 7.2 tp10 -49.85 -41.79 45.96 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.469 0.48 . . . . 0.0 112.153 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.87 -22.97 63.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.408 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.78 5.03 60.14 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.346 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -109.47 145.39 31.8 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.483 -0.359 . . . . 0.0 110.573 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 38.3 Cg_endo -66.74 131.53 26.12 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.98 2.453 . . . . 0.0 112.52 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -115.24 130.64 56.97 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.503 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.65 120.16 12.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.715 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -140.94 159.52 42.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.386 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 p -140.16 148.02 41.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.029 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 99' ' ' MET . 3.5 mp -126.94 147.61 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.373 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.4 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -105.53 85.9 2.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.857 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -54.39 -25.29 23.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.046 0.451 . . . . 0.0 111.383 -178.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 23.1 t-20 -53.47 -24.81 13.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.391 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -113.5 10.36 18.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -126.79 -8.2 6.13 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 111.309 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.582 HD11 HD22 ' A' ' 88' ' ' LEU . 3.0 mp -127.41 134.55 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -117.04 -177.33 17.78 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 23.9 p-10 -127.96 101.66 6.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.648 0.737 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.92 113.81 27.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.957 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.43 ' CG ' ' HA ' ' A' ' 77' ' ' ALA . 8.4 t-20 58.84 36.69 24.81 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.645 0.736 . . . . 0.0 110.129 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.6 19.75 78.95 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.992 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -122.45 146.1 47.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.654 0.264 . . . . 0.0 110.432 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.5 mp -72.04 120.78 18.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.401 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.523 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 6.1 pt-20 -108.16 138.73 43.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.426 0.632 . . . . 0.0 110.254 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -58.8 -24.15 1.44 Allowed Pre-proline 0 CA--C 1.447 -2.991 0 N-CA-C 118.125 2.639 . . . . 0.0 118.125 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HD2' ' HG3' ' A' ' 49' ' ' GLU . 4.4 Cg_endo -129.5 12.16 0.0 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.771 1 C-N-CA 112.787 -4.342 . . . . 0.0 116.353 179.253 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -62.13 -176.23 2.52 Favored Glycine 0 C--N 1.259 -3.707 0 CA-C-N 111.266 -2.697 . . . . 0.0 115.547 -176.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -146.95 147.98 31.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m 58.48 45.41 16.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.046 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 9.5 p90 -74.11 -38.26 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.01 -23.74 47.65 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.444 -0.408 . . . . 0.0 112.317 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -62.02 -18.1 59.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.293 -0.453 . . . . 0.0 111.365 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 m -148.93 27.54 0.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.614 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.3 m -132.24 145.09 51.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.985 0.422 . . . . 0.0 111.052 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.41 HG23 ' HD3' ' A' ' 61' ' ' LYS . 22.2 m -136.39 176.85 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.253 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.41 ' HD3' HG23 ' A' ' 60' ' ' VAL . 2.2 mptm? 61.9 40.65 12.31 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.241 0.338 . . . . 0.0 111.659 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 16' ' ' GLY . 2.4 p -69.13 123.03 19.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.094 0.473 . . . . 0.0 112.05 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.41 161.97 41.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.718 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.742 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -123.17 113.79 19.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.872 0.368 . . . . 0.0 111.34 -178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.32 122.09 28.0 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.009 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.695 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 28.2 t70 52.5 25.24 3.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.776 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.49 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 56.62 39.62 86.02 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.624 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.695 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.9 p80 -149.24 -30.88 0.24 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 117.249 0.524 . . . . 0.0 111.078 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.428 ' O ' HD13 ' A' ' 64' ' ' LEU . 5.7 m -116.02 130.6 56.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.801 0.334 . . . . 0.0 111.282 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.691 ' HB2' HD11 ' A' ' 88' ' ' LEU . 14.0 tp -93.26 131.22 38.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.975 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.59 129.81 56.0 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.069 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.483 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -162.36 162.93 28.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 110.528 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 t -111.36 125.29 53.7 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 34.8 m -125.06 156.06 38.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -98.45 148.89 23.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.685 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.67 -28.37 0.84 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.269 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 45' ' ' ASN . . . -55.53 -42.64 74.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.841 0.353 . . . . 0.0 111.564 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -172.98 56.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.765 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.92 2.39 38.02 Favored Glycine 0 C--O 1.229 -0.213 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.45 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -122.87 162.45 22.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 48.2 p90 -91.45 160.85 15.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.713 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -146.98 147.17 30.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.53 135.5 35.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 p -155.7 173.19 17.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.744 0.307 . . . . 0.0 111.259 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.84 164.28 30.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.843 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.68 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.3 tpt -149.99 119.64 7.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.553 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.425 ' OD2' ' HB3' ' A' ' 89' ' ' ASN . 25.2 t0 -73.28 108.9 6.42 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.7 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.0 mt -81.59 -9.12 59.75 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.327 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.425 ' HB3' ' OD2' ' A' ' 87' ' ' ASP . 25.4 t-20 -47.88 -29.48 3.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.648 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -117.11 15.82 15.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.557 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -120.24 -3.58 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.654 0.74 . . . . 0.0 110.294 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 1.069 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.3 p -155.46 131.18 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.017 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.463 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -126.12 179.67 16.16 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.128 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.474 HD22 ' HB2' ' A' ' 8' ' ' SER . 21.9 t30 -118.62 126.17 51.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.441 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.486 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 72.7 m -130.27 97.3 4.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.547 ' CD2' ' HB2' ' A' ' 26' ' ' GLU . 71.8 m-85 61.7 52.38 3.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.262 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.36 16.79 60.98 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.814 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -119.87 143.13 48.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.401 ' HB2' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -72.31 120.99 18.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.218 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 25.1 mm-40 -127.71 75.57 77.79 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.47 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 1.069 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.7 Cg_endo -72.4 103.89 1.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.964 2.443 . . . . 0.0 112.391 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.724 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.713 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.529 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 55.6 m . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 2.6 m-20 46.25 73.31 0.18 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.649 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.3 p90 -59.24 -42.45 91.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.566 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.99 -21.38 44.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.67 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 10.6 t-20 -61.0 -28.68 69.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.502 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.52 ' HB2' HD22 ' A' ' 94' ' ' ASN . 50.4 m -139.44 23.9 2.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.871 0.367 . . . . 0.0 111.388 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.5 m -122.21 132.88 54.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.519 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -133.67 160.8 36.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.929 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.76 51.82 56.8 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.366 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.563 HG12 ' HA3' ' A' ' 21' ' ' GLY . 29.8 m -97.59 139.47 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.832 0.349 . . . . 0.0 111.231 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -136.02 151.8 50.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.583 HD22 HD23 ' A' ' 64' ' ' LEU . 13.1 tp -119.35 110.1 16.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.098 0.475 . . . . 0.0 111.661 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' HG12 ' A' ' 18' ' ' ILE . 36.2 m-85 -106.1 98.58 8.24 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' O ' HG21 ' A' ' 62' ' ' THR . . . 71.27 -65.13 0.99 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.16 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.793 ' HD1' HD21 ' A' ' 36' ' ' ASN . 4.3 p90 -156.34 12.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.782 -0.246 . . . . 0.0 111.645 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 15' ' ' TYR . 44.9 pt -114.45 133.54 60.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 110.896 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.818 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.29 113.97 26.48 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.118 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.3 ttm105 -120.28 138.38 53.71 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.563 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -158.85 -177.44 31.94 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.825 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.3 m-20 -108.51 103.5 12.64 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.454 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 66.2 m -107.13 131.98 53.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.845 0.355 . . . . 0.0 110.288 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.8 mt -70.14 139.18 20.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.1 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 6.3 p30 -112.01 -168.62 1.34 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.509 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.29 -28.11 64.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.726 0.298 . . . . 0.0 111.788 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.96 -28.51 69.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.01 0.433 . . . . 0.0 111.345 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.8 -9.29 60.12 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.424 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -101.39 142.84 25.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.641 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 24.3 Cg_endo -64.16 121.74 9.5 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.791 2.327 . . . . 0.0 112.317 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -104.39 134.99 46.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.504 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.26 124.95 25.68 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.497 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.3 t -143.95 159.79 41.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.81 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 p -139.45 154.78 47.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.67 145.5 25.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.793 HD21 ' HD1' ' A' ' 17' ' ' TYR . 2.9 t-20 -100.87 104.6 15.82 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -64.61 -22.16 66.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 25.4 t30 -63.97 -13.23 44.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -108.03 -1.3 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.364 -0.21 . . . . 0.0 110.977 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -127.67 -9.43 5.6 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.538 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.6 mp -124.45 134.14 67.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.611 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -113.86 178.16 18.21 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.558 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -113.92 102.57 10.32 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.06 0.457 . . . . 0.0 110.452 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -102.42 103.92 14.36 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 47.48 45.42 17.32 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.535 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.3 14.69 76.0 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.769 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.13 147.39 47.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.041 0.42 . . . . 0.0 111.114 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.601 HD13 ' HG ' ' A' ' 70' ' ' LEU . 25.6 mt -72.35 121.64 19.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.014 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.601 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 6.7 tp10 -110.99 127.23 55.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.267 0.556 . . . . 0.0 110.792 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.575 ' HB3' ' SD ' ' A' ' 86' ' ' MET . 11.5 p90 -49.29 -29.13 1.72 Allowed Pre-proline 0 CA--C 1.453 -2.784 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.601 ' HD2' ' HG3' ' A' ' 49' ' ' GLU . 3.3 Cg_endo -129.57 17.63 0.0 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.764 1 C-N-CA 113.032 -4.179 . . . . 0.0 115.931 179.073 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.611 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -68.36 -174.86 9.13 Favored Glycine 1 C--N 1.254 -4.013 0 CA-C-N 111.16 -2.745 . . . . 0.0 115.508 -176.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -143.45 148.14 35.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.407 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m 57.83 60.47 2.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.915 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 12.5 p90 -90.1 -35.33 15.5 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.791 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.99 -19.03 43.03 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.607 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 m -62.19 -25.22 67.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.323 -0.439 . . . . 0.0 111.353 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.1 m -141.84 27.24 1.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.154 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.9 m -129.02 151.25 49.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.215 0.531 . . . . 0.0 111.732 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG23 ' HE2' ' A' ' 61' ' ' LYS . 15.7 m -146.81 175.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.25 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HE2' HG23 ' A' ' 60' ' ' VAL . 2.0 mppt? 63.14 41.94 7.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.873 0.368 . . . . 0.0 110.777 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.537 HG21 ' O ' ' A' ' 16' ' ' GLY . 12.5 p -72.1 125.21 26.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.987 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.79 156.68 40.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.802 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.583 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -117.11 112.01 20.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.899 0.38 . . . . 0.0 110.738 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.55 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 11.6 m120 -73.08 117.28 14.62 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.342 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.788 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 10.2 t70 51.95 21.17 1.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.017 0.823 . . . . 0.0 111.056 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.38 37.61 95.1 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.441 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.788 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 8.5 p80 -144.96 -29.99 0.45 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 117.506 0.653 . . . . 0.0 111.296 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 16.9 m -116.6 135.15 54.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.639 0.257 . . . . 0.0 111.072 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.601 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.3 tp -95.91 131.72 41.96 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.62 132.29 54.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.171 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.41 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -164.05 163.5 23.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.375 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.6 t -110.96 125.07 53.32 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.8 m -125.46 148.02 49.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.306 0.574 . . . . 0.0 112.063 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.9 tmtt? -99.61 144.93 28.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.683 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.32 -21.64 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.834 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.17 89.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.878 0.339 . . . . 0.0 111.385 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -173.8 55.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.353 0.597 . . . . 0.0 109.759 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.14 -3.74 20.92 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.603 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -115.44 163.48 15.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.63 0.252 . . . . 0.0 110.604 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 29.4 p90 -103.69 166.99 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.194 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.07 127.49 5.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.419 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.01 123.1 18.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.498 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.2 p -136.79 175.91 9.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.198 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.07 162.27 35.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.902 0.382 . . . . 0.0 110.778 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.575 ' SD ' ' HB3' ' A' ' 50' ' ' TYR . 21.3 tpp -148.83 123.69 9.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.481 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.554 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 24.4 t0 -78.37 106.75 10.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.384 0.612 . . . . 0.0 109.762 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.737 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.6 mt -76.23 -9.52 58.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.733 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.471 ' HB3' ' OD2' ' A' ' 87' ' ' ASP . 27.9 t-20 -51.64 -26.72 9.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.041 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 43.9 p90 -116.86 19.25 14.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.782 0.325 . . . . 0.0 111.375 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.737 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -126.59 -9.25 4.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.108 0.48 . . . . 0.0 110.583 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.918 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 5.5 p -153.82 139.96 11.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.529 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.09 176.73 19.62 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.197 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.52 HD22 ' HB2' ' A' ' 8' ' ' SER . 28.7 t30 -118.57 123.44 45.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.012 0.434 . . . . 0.0 110.276 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.58 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 58.3 m -124.7 99.9 6.38 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.474 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.85 51.02 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.173 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 56.69 27.8 55.8 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.958 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -130.76 141.34 50.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.93 0.395 . . . . 0.0 110.469 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.6 ptm -55.21 116.68 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.349 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 9.9 mm-40 -141.43 75.63 22.32 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.111 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.918 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 61.2 Cg_endo -75.66 112.54 3.54 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.741 2.294 . . . . 0.0 112.156 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.417 -179.572 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.506 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 61.4 m . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 111.164 0.061 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 89' ' ' ASN . 50.5 m-80 51.64 75.45 0.21 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.843 0.457 . . . . 0.0 111.896 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CD1' HG13 ' A' ' 92' ' ' VAL . 3.1 p90 -56.94 -39.8 75.21 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.89 -22.57 38.27 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -68.4 -21.65 64.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.69 0.281 . . . . 0.0 111.569 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.44 ' HB2' HD22 ' A' ' 94' ' ' ASN . 49.9 m -134.29 19.09 3.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.929 0.395 . . . . 0.0 110.903 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 81.4 m -124.8 132.98 53.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.244 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.6 p -126.77 155.14 43.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.262 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.79 63.78 4.79 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.381 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.38 133.93 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.252 0.549 . . . . 0.0 111.473 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.62 136.28 48.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.656 HD22 HD23 ' A' ' 64' ' ' LEU . 23.0 tp -121.64 124.84 45.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.086 0.469 . . . . 0.0 111.07 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -133.35 114.93 14.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.683 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.13 -71.46 1.98 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.007 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -167.81 24.07 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.314 0.646 . . . . 0.0 109.573 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.419 HG12 HD21 ' A' ' 36' ' ' ASN . 7.5 mt -120.08 113.27 40.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.549 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -99.81 114.82 28.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.994 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -116.94 140.03 49.95 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.21 176.6 40.14 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.265 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 41.6 m-20 -105.87 107.95 19.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 82.5 m -105.81 131.69 52.83 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.084 0.469 . . . . 0.0 110.043 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mt -70.02 138.96 20.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.516 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.445 HD21 ' CD2' ' A' ' 29' ' ' HIS . 4.7 p30 -105.61 -169.46 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.331 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.96 -29.03 66.85 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 29' ' ' HIS . 24.9 t70 -68.76 -26.26 65.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.15 0.5 . . . . 0.0 111.751 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.34 57.29 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.132 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.452 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -107.78 138.95 20.17 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.604 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 24.6 Cg_endo -63.65 127.19 19.13 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.113 2.542 . . . . 0.0 112.808 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -109.79 133.17 53.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.184 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.39 118.73 16.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.903 0.383 . . . . 0.0 111.508 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.3 t -135.4 157.39 47.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.006 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.8 p -139.83 138.29 35.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.499 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.58 145.9 33.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.955 0.407 . . . . 0.0 111.258 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.492 HD22 ' HA ' ' A' ' 36' ' ' ASN . 3.4 m120 -103.57 99.16 8.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.049 0.452 . . . . 0.0 110.1 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -62.29 -23.67 66.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.895 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.98 -30.94 62.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.939 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -103.95 13.54 32.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -130.87 -25.85 2.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.538 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -109.08 141.95 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.664 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.94 -174.93 19.78 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.843 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -129.24 105.06 7.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.07 0.462 . . . . 0.0 111.292 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -103.27 111.17 23.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.544 ' HB2' ' HA ' ' A' ' 77' ' ' ALA . 5.4 p-10 42.18 47.08 3.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.675 1.19 . . . . 0.0 113.298 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.91 14.93 74.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.596 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.15 143.23 50.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.823 0.344 . . . . 0.0 111.23 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.543 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 8.9 mp -71.49 119.34 15.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.814 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -109.9 139.13 45.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.832 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -41.14 -68.97 0.23 Allowed Pre-proline 0 CA--C 1.428 -3.746 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.832 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 7.8 Cg_endo -111.46 122.97 0.03 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.361 0 C-N-CA 113.943 -3.571 . . . . 0.0 113.544 -177.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.664 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -158.67 -160.82 10.58 Favored Glycine 0 C--N 1.277 -2.703 0 CA-C-N 113.758 -1.565 . . . . 0.0 113.282 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 34.5 mt-10 -156.31 144.39 19.67 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.942 0.436 . . . . 0.0 110.818 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 m 57.14 41.24 27.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.15 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -72.09 -40.2 68.39 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.049 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.01 -18.99 49.62 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.733 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.2 m -65.14 -24.34 67.38 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.514 0.326 . . . . 0.0 110.955 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.1 m -138.32 24.76 2.71 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.916 0.389 . . . . 0.0 110.635 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.0 m -131.29 141.48 49.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.314 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.443 HG23 ' HD3' ' A' ' 61' ' ' LYS . 30.2 m -133.92 172.81 15.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.376 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.8 mptt 64.1 43.3 5.13 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.715 0.635 . . . . 0.0 110.873 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 p -68.83 124.4 23.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.386 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.2 156.07 37.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.86 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.656 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -110.48 120.39 42.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.541 0.21 . . . . 0.0 110.61 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.486 ' C ' ' H ' ' A' ' 67' ' ' GLY . 19.3 t-20 -87.46 121.18 29.57 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.9 t70 68.33 -25.76 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.437 1.085 . . . . 0.0 112.356 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 65' ' ' ASN . . . 110.19 22.02 6.71 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -142.84 -20.47 0.66 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.452 ' O ' HD13 ' A' ' 64' ' ' LEU . 43.3 m -116.95 127.36 54.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.251 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.543 ' HG ' ' CD2' ' A' ' 48' ' ' LEU . 16.6 tp -90.61 129.28 36.75 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.79 130.29 54.86 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.487 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.501 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -162.55 165.32 26.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.833 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -110.08 125.55 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.466 ' SG ' HD12 ' A' ' 48' ' ' LEU . 60.9 m -123.23 147.73 46.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.351 0.596 . . . . 0.0 112.582 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.9 tmtt? -99.69 145.3 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.923 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.73 -16.27 0.94 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.822 -1.18 . . . . 0.0 113.332 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' A' ' 45' ' ' ASN . . . -59.67 -39.46 84.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.875 0.369 . . . . 0.0 110.759 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 t70 178.91 60.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.843 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.79 4.48 54.11 Favored Glycine 0 C--O 1.228 -0.223 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.544 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -124.92 165.34 18.26 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.6 p90 -112.53 166.27 11.47 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.282 0.364 . . . . 0.0 111.488 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -158.55 144.61 16.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -76.29 142.36 41.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.786 0.327 . . . . 0.0 110.158 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.9 p -153.6 174.58 14.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.82 156.54 46.12 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.082 0.468 . . . . 0.0 110.586 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.517 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 12.3 tpp -140.78 123.18 15.92 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.644 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -76.06 106.24 7.55 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.747 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.3 mt -73.34 -9.09 58.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.747 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.441 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 16.3 m120 -47.58 -31.15 4.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.79 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -119.74 23.58 11.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.411 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.747 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -128.49 -7.85 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.02 0.438 . . . . 0.0 110.52 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.8 p -156.82 141.79 8.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.023 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.91 -174.96 13.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.229 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.44 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.9 t30 -130.0 133.26 46.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.938 0.399 . . . . 0.0 110.991 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 m -142.35 112.25 6.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.398 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 60.17 40.51 18.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.397 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.67 24.6 66.44 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -128.17 138.86 52.66 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.445 ' O ' ' HG3' ' A' ' 99' ' ' MET . 13.5 ptt? -64.46 129.17 38.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.347 0.594 . . . . 0.0 112.5 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.09 77.35 25.77 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.79 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 33.3 Cg_endo -61.79 93.25 0.12 Allowed 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.422 2.748 . . . . 0.0 112.951 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.315 -0.923 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.406 179.733 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.522 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 28.5 m . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.441 ' HB3' ' CG ' ' A' ' 7' ' ' ASN . 79.6 m-20 63.54 71.28 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.298 0.374 . . . . 0.0 110.891 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 9.8 p90 -54.43 -37.51 65.21 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 111.361 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.86 -22.15 64.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.78 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.441 ' CG ' ' HB3' ' A' ' 4' ' ' ASN . 6.0 m-20 -69.79 -16.1 63.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.68 0.276 . . . . 0.0 111.301 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -127.03 4.44 6.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.2 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 0.8 OUTLIER -118.49 137.53 53.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.162 0.506 . . . . 0.0 112.079 -178.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 p -128.59 153.07 47.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.096 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.65 64.9 3.95 Favored Glycine 0 N--CA 1.453 -0.22 0 O-C-N 123.518 0.511 . . . . 0.0 112.442 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.602 HG12 ' HA3' ' A' ' 21' ' ' GLY . 32.4 m -100.64 147.04 8.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 111.278 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -138.18 148.91 45.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.127 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.628 HD22 HD23 ' A' ' 64' ' ' LEU . 8.5 tp -122.19 105.36 10.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.023 0.439 . . . . 0.0 110.72 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -134.62 112.4 10.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.34 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 75.24 38.33 39.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.282 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.427 ' HA ' HD11 ' A' ' 14' ' ' LEU . 10.2 m-85 64.55 24.06 12.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.15 0.58 . . . . 0.0 110.675 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 16' ' ' GLY . 16.2 mt -117.77 122.23 69.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.253 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.805 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -102.6 113.64 27.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.351 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 20.4 ttm180 -118.84 134.3 55.25 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.426 -0.509 . . . . 0.0 109.835 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.602 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -157.63 175.3 34.98 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.898 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 26.6 m-20 -101.15 107.29 18.66 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -106.02 131.8 52.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.5 mt -70.09 135.25 28.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.568 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.4 p30 -103.64 -175.12 2.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.125 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -54.09 -31.33 51.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.06 -27.5 69.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.451 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.34 -0.04 53.83 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.121 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -108.66 144.54 29.76 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 120.802 0.334 . . . . 0.0 110.385 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 35.6 Cg_endo -66.91 121.27 8.45 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.057 2.505 . . . . 0.0 112.655 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -107.09 129.24 54.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.306 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.53 119.19 13.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.011 0.434 . . . . 0.0 110.871 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -132.19 159.48 38.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.808 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 99' ' ' MET . 78.4 p -138.5 147.97 43.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.847 0.356 . . . . 0.0 111.502 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.74 142.55 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.9 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 36' ' ' ASN . 1.7 t-20 -101.96 92.71 4.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.805 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.69 -23.72 53.05 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.322 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 21.1 t-20 -54.8 -30.9 58.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.98 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -108.57 16.31 23.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.534 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.9 m-85 -126.97 -25.05 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -110.52 140.62 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.693 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -115.35 161.66 12.74 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.395 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -100.63 104.75 16.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.691 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -111.94 106.55 15.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.922 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.822 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 56.2 t30 58.41 36.98 25.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.121 0.486 . . . . 0.0 110.817 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.66 17.07 80.22 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.403 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.07 154.88 39.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.834 0.349 . . . . 0.0 110.825 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 31.5 mt -79.92 114.48 18.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.239 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -105.52 135.18 47.4 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.656 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.84 -72.45 0.11 Allowed Pre-proline 0 CA--C 1.426 -3.792 0 O-C-N 124.254 0.971 . . . . 0.0 113.333 -178.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.656 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 9.2 Cg_endo -108.36 126.14 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.319 0 C-N-CA 113.623 -3.784 . . . . 0.0 113.252 -177.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.693 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -156.65 -164.2 13.21 Favored Glycine 0 C--N 1.283 -2.398 0 CA-C-N 113.582 -1.645 . . . . 0.0 113.029 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -153.39 142.86 21.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.857 0.36 . . . . 0.0 111.013 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 m 53.4 42.37 32.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.226 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 10.5 p90 -68.47 -36.7 79.35 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.48 -18.12 28.69 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.377 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.7 t -64.54 -21.08 66.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.723 0.297 . . . . 0.0 110.487 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.5 m -140.8 23.38 2.26 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.099 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.5 m -128.97 142.61 50.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.954 0.407 . . . . 0.0 111.311 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -134.37 172.93 15.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.249 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? 63.25 37.74 10.91 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.501 0.5 . . . . 0.0 111.766 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.8 p -66.67 122.66 18.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.117 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.69 163.57 39.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.877 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.628 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -119.54 113.44 20.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.908 0.385 . . . . 0.0 111.471 -179.32 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.485 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 16.1 m120 -76.13 117.18 17.57 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.322 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.664 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 20.4 t70 58.9 9.53 1.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.907 0.755 . . . . 0.0 111.567 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.22 30.75 58.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.777 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.664 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 5.5 p80 -144.56 -26.06 0.51 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 117.547 0.674 . . . . 0.0 111.394 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 21.9 m -115.82 130.39 56.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.316 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.588 ' HA ' HD22 ' A' ' 64' ' ' LEU . 23.1 tp -91.02 130.67 36.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.71 129.82 55.48 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.59 159.84 25.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.231 0.538 . . . . 0.0 111.039 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.7 t -109.59 123.31 49.23 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 56.9 m -122.25 149.67 43.37 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.369 0.604 . . . . 0.0 112.534 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.7 tmtt? -99.74 139.56 35.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.024 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.91 -32.52 0.38 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.947 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.822 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -47.49 -43.33 24.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -171.69 49.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.85 5.56 65.05 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.608 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.83 165.72 16.17 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 33.4 p90 -101.2 162.55 12.82 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 123.292 0.37 . . . . 0.0 110.155 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.14 134.22 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -72.22 125.48 27.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.225 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.4 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 34.1 p -142.29 170.71 15.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.969 0.414 . . . . 0.0 110.719 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.37 164.95 26.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.692 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.4 tpt -145.74 120.02 9.57 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.067 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.27 105.01 5.25 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.778 ' HA ' HG22 ' A' ' 91' ' ' VAL . 17.5 mt -75.98 -8.44 56.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.528 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -47.15 -32.08 4.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.917 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -117.16 23.75 11.64 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.087 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.778 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -130.76 -5.71 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.989 0.423 . . . . 0.0 110.843 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.928 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.6 t -141.16 146.33 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.522 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -143.45 176.82 22.66 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.989 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -131.7 132.95 44.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 m -141.75 109.22 5.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.286 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 62.31 43.93 7.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.905 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.568 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 61.58 26.28 66.41 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.159 -0.543 . . . . 0.0 111.874 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -127.53 142.15 51.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 34' ' ' SER . 4.4 ppp? -67.68 134.14 50.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.115 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.07 71.09 7.07 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.039 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.928 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 12.3 Cg_endo -54.45 103.52 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.408 2.739 . . . . 0.0 112.432 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.828 179.425 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.575 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 1.1 m . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 120.376 0.132 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 62.4 m-80 53.8 85.31 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.681 0.613 . . . . 0.0 112.56 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.583 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 6.0 p90 -62.51 -37.6 86.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.182 0.515 . . . . 0.0 110.165 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.91 -20.25 66.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.092 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 11.2 t-20 -52.11 -29.05 20.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.378 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.453 ' HB2' HD22 ' A' ' 94' ' ' ASN . 33.9 m -145.16 28.87 1.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.759 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -119.27 141.65 48.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.898 0.38 . . . . 0.0 110.97 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.9 p -137.97 157.44 46.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.065 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.5 34.3 89.53 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.211 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 21.3 m -69.76 138.95 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.003 0.43 . . . . 0.0 111.762 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -132.56 133.18 43.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.348 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.781 HD22 HD23 ' A' ' 64' ' ' LEU . 46.5 tp -119.8 123.33 43.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.934 0.397 . . . . 0.0 111.168 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.53 101.97 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.703 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.83 -60.8 2.96 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.944 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 1.6 p90 -166.91 18.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 26.3 pt -119.95 127.15 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.847 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 mt -116.05 114.92 25.21 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.197 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 27.2 ttm180 -111.83 139.03 47.65 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.88 165.15 33.03 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.2 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.589 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 1.7 m-20 -99.37 105.72 17.72 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.8 m -104.57 132.21 51.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.261 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.6 mt -69.86 139.57 20.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.318 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -108.9 -171.54 1.87 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.837 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -55.21 -31.35 61.38 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.35 -20.92 66.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.712 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.33 4.09 66.63 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.74 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.34 148.5 39.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.787 0.327 . . . . 0.0 110.29 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -70.7 132.46 21.87 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.019 2.479 . . . . 0.0 113.027 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -118.39 132.45 56.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.269 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.94 127.29 31.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.169 0.509 . . . . 0.0 111.65 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -141.93 154.94 45.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.041 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 p -139.9 142.73 36.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.64 0.257 . . . . 0.0 111.155 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.55 143.8 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.485 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.51 90.49 3.88 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.35 -23.66 50.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.592 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.7 t-20 -52.74 -31.44 38.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.105 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -108.36 16.7 22.9 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.52 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 37.9 m-85 -129.69 -22.93 2.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.575 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -113.93 142.17 27.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.658 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -116.11 164.22 12.29 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.547 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -102.04 105.49 16.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.247 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -110.59 104.92 13.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.505 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.733 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 36.7 t30 52.96 43.64 31.43 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.199 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.13 16.55 80.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.948 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -123.68 157.48 33.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.862 0.363 . . . . 0.0 110.768 -179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.496 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 38.9 mt -83.97 113.4 20.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.472 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 26.1 tp10 -103.11 130.43 50.27 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.767 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.35 -71.79 0.11 Allowed Pre-proline 0 CA--C 1.424 -3.877 0 O-C-N 124.47 1.106 . . . . 0.0 113.063 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.767 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 3.1 Cg_endo -107.44 133.3 0.05 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.42 0 C-N-CA 113.704 -3.731 . . . . 0.0 112.179 -178.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.658 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -164.74 -163.64 18.3 Favored Glycine 0 C--N 1.285 -2.261 0 CA-C-N 114.379 -1.282 . . . . 0.0 113.665 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -151.37 143.59 24.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.283 -0.459 . . . . 0.0 110.921 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.4 m 52.07 45.0 29.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -74.27 -36.03 63.8 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.91 -19.37 50.07 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.281 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -62.27 -26.87 68.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.943 0.401 . . . . 0.0 110.816 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 m -134.16 15.15 3.84 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.268 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.1 m -121.64 140.33 52.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.448 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 m -136.82 174.52 11.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.886 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 62.48 41.49 9.73 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 110.725 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 16' ' ' GLY . 21.5 p -71.83 126.78 30.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.93 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.81 162.68 40.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.766 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.781 HD23 HD22 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -118.01 113.54 21.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.806 0.336 . . . . 0.0 111.566 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.487 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 3.9 m120 -73.51 116.13 13.71 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.403 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 14.2 t70 58.95 5.21 0.49 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.114 0.884 . . . . 0.0 111.742 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.1 27.89 35.79 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.717 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.4 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 2.1 p-80 -145.21 -23.06 0.49 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.504 0.652 . . . . 0.0 112.23 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 30.6 m -114.68 130.73 56.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.744 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.507 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.2 tp -91.88 127.79 37.47 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 129.69 55.46 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.84 171.11 20.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.805 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.3 t -118.58 121.21 39.67 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 32.8 m -121.4 149.84 42.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.181 0.515 . . . . 0.0 111.835 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.3 tmtt? -99.89 145.37 27.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.932 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.85 -28.1 0.74 Allowed Glycine 0 C--O 1.228 -0.256 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.251 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.733 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.14 -38.81 71.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.314 0.486 . . . . 0.0 112.314 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -172.02 50.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.385 0.612 . . . . 0.0 109.899 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.75 2.08 42.57 Favored Glycine 0 C--O 1.229 -0.174 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.112 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -125.25 167.29 15.08 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 42.8 p90 -104.99 169.64 8.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.459 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -161.78 147.01 13.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.95 130.24 42.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.139 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.42 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 45.0 t -144.66 161.13 39.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.225 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.03 160.25 37.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.496 ' HB2' ' CB ' ' A' ' 48' ' ' LEU . 9.7 tpt -144.25 112.83 6.58 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.156 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -72.08 105.11 3.81 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.752 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.4 mt -73.37 -9.18 58.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.534 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -48.82 -28.17 3.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.691 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -122.41 25.76 8.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.686 0.279 . . . . 0.0 111.441 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.752 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -129.78 -13.67 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.025 0.44 . . . . 0.0 110.708 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 1.082 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.7 p -155.36 136.56 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.539 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.575 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -131.85 -173.54 13.37 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.469 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.453 HD22 ' HB2' ' A' ' 8' ' ' SER . 18.1 t30 -123.81 133.31 53.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.428 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.572 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 72.6 m -137.42 104.72 5.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.208 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 60.34 45.86 10.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.912 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.94 20.27 70.51 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.276 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -127.4 145.18 50.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.055 0.427 . . . . 0.0 109.866 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 99' ' ' MET . 13.0 ptt? -64.11 130.71 45.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.977 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.572 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 5.6 mm-40 -140.77 77.93 21.24 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.613 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 1.082 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 38.7 Cg_endo -68.77 97.15 0.54 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.665 2.244 . . . . 0.0 112.714 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.0 p . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.458 179.218 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 65.5 m . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 120.516 0.198 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 52.44 73.16 0.36 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.989 0.516 . . . . 0.0 112.054 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.531 ' HE1' ' HB2' ' A' ' 88' ' ' LEU . 9.3 p90 -57.43 -33.6 68.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.063 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.97 64.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -68.94 -20.36 64.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.1 m -119.93 9.84 11.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -123.26 146.37 47.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.006 0.432 . . . . 0.0 111.432 -179.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -134.4 147.42 50.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.638 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.16 56.79 21.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.492 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.567 HG12 ' HA3' ' A' ' 21' ' ' GLY . 7.1 m -99.23 130.5 48.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.113 0.482 . . . . 0.0 111.433 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.98 152.81 47.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.601 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.648 HD22 HD23 ' A' ' 64' ' ' LEU . 11.5 tp -113.22 113.58 25.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.817 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.496 ' O ' HG12 ' A' ' 18' ' ' ILE . 26.3 m-85 -108.22 98.79 8.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.992 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.5 -65.5 1.36 Allowed Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.084 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 2.8 p90 -161.39 18.64 0.11 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.748 0.419 . . . . 0.0 111.128 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 15' ' ' TYR . 30.6 pt -122.16 133.1 69.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 110.271 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.819 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -108.69 116.9 32.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.724 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.8 tmm_? -121.9 142.29 50.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.1 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.567 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -168.4 -174.71 37.4 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.414 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.569 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 35.8 m-20 -108.49 109.19 20.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -105.73 131.98 52.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.03 0.443 . . . . 0.0 110.005 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 58.2 mt -70.16 138.17 22.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.421 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -102.36 -174.31 2.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.89 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.71 -37.81 63.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.191 0.519 . . . . 0.0 111.946 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.64 -25.11 66.07 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.086 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.89 50.33 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.575 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -105.35 140.52 21.22 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-O 120.854 0.359 . . . . 0.0 110.388 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 39.4 Cg_endo -67.84 134.36 32.1 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 123.082 2.521 . . . . 0.0 112.955 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -119.91 133.65 55.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.596 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.75 126.09 27.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.281 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -143.13 156.03 44.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 p -136.72 151.3 49.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.937 0.399 . . . . 0.0 111.156 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -134.07 143.67 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.221 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.97 93.62 5.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.819 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.83 -29.25 64.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.317 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.2 t-20 -52.78 -29.13 25.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.935 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -108.53 12.76 25.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.6 m-85 -128.9 -20.14 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -113.57 142.11 27.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.67 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -113.72 166.07 12.11 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.256 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -109.92 111.13 22.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.141 -0.53 . . . . 0.0 110.82 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -110.78 105.46 14.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.669 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.737 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 29.9 t30 53.09 42.21 32.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.046 0.451 . . . . 0.0 111.401 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.456 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 78.11 17.63 77.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.121 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.62 154.71 40.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.966 0.412 . . . . 0.0 110.827 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD13 ' HG ' ' A' ' 70' ' ' LEU . 35.7 mt -82.1 122.99 28.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.051 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -112.71 138.49 49.44 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.694 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -40.88 -75.14 0.05 OUTLIER Pre-proline 0 CA--C 1.433 -3.556 0 CA-C-O 118.11 -0.947 . . . . 0.0 113.186 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.694 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 23.2 Cg_endo -111.32 129.0 0.03 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.425 0 C-N-CA 114.009 -3.527 . . . . 0.0 113.042 -177.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.08 -158.02 8.6 Favored Glycine 0 C--N 1.28 -2.572 0 CA-C-N 113.529 -1.669 . . . . 0.0 113.143 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -155.2 138.45 15.71 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.897 0.41 . . . . 0.0 110.646 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.3 m 58.27 45.05 17.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 13.2 p90 -75.07 -37.61 61.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -19.04 54.47 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.705 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -64.67 -22.49 66.99 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 120.83 0.348 . . . . 0.0 110.911 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.2 m -135.87 18.37 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.841 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 81.9 m -125.23 145.55 49.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.174 0.511 . . . . 0.0 111.44 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.4 HG23 ' HD3' ' A' ' 61' ' ' LYS . 12.0 m -138.07 176.91 6.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.16 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.5 mptt 61.85 35.0 16.75 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.145 0.278 . . . . 0.0 111.474 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 p -64.16 123.82 20.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 111.187 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.95 148.87 27.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.836 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.648 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -107.18 113.45 26.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.453 0.168 . . . . 0.0 110.749 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.571 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 40.6 t-20 -79.63 126.1 30.47 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 33.1 t70 53.56 18.61 1.47 Allowed 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.354 1.034 . . . . 0.0 112.045 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.0 33.53 87.49 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.935 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.571 ' HD2' ' O ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -148.0 -25.55 0.35 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.525 0.663 . . . . 0.0 111.609 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.434 ' O ' HD13 ' A' ' 64' ' ' LEU . 44.4 m -116.71 131.13 57.03 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.207 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -90.97 134.21 34.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.787 0.327 . . . . 0.0 110.466 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.19 131.45 53.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.967 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -160.63 163.69 32.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.164 0.507 . . . . 0.0 111.544 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -110.8 118.21 35.53 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.456 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 37.4 m -119.17 147.48 44.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.4 tmtt? -100.1 142.92 30.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.473 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.72 -27.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.021 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.737 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -49.85 -41.07 44.42 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -179.34 51.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.449 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 77.22 -3.76 57.19 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.234 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -113.23 161.01 17.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.975 -0.612 . . . . 0.0 109.781 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 41.0 p90 -103.71 168.37 9.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.522 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -158.03 137.93 12.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.354 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.13 127.27 32.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.8 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.7 p -142.62 177.81 8.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.597 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.425 ' HA ' HD12 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -138.78 162.22 35.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.979 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.532 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 11.8 tpp -145.67 120.99 10.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.113 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -77.63 106.09 9.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.33 0.586 . . . . 0.0 109.439 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.72 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.0 mt -73.1 -8.98 58.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.124 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -48.72 -33.04 9.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.815 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -116.15 24.49 11.38 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.062 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -128.69 -12.09 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.536 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 1.8 t -138.52 144.29 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -140.28 171.5 23.92 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.731 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.413 HD22 ' CB ' ' A' ' 8' ' ' SER . 24.6 t30 -121.96 141.19 51.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.045 0.45 . . . . 0.0 110.855 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.537 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 73.2 m -146.93 109.31 4.52 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 58.58 42.05 21.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.633 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.9 13.11 63.51 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.473 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -116.29 141.72 47.79 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.94 129.78 40.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.401 0.619 . . . . 0.0 111.645 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.537 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 36.3 mm-40 -139.02 78.81 28.45 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.179 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.797 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 32.1 Cg_endo -65.36 96.55 0.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.779 2.319 . . . . 0.0 112.442 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.317 -0.847 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.952 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.582 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 68.5 m . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.143 0.053 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 12.5 m-20 55.46 78.77 0.18 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.919 0.488 . . . . 0.0 111.889 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.588 ' CD1' HG13 ' A' ' 92' ' ' VAL . 4.8 p90 -62.48 -46.18 89.64 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.719 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.46 -22.28 54.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.186 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 6.4 t-20 -57.91 -30.5 65.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.856 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.485 ' HB2' HD22 ' A' ' 94' ' ' ASN . 49.7 m -137.67 23.47 2.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.822 0.344 . . . . 0.0 111.353 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 92.3 m -120.96 132.83 55.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.985 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 p -132.19 152.99 51.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.531 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.78 42.88 94.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.622 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.601 HG12 ' HA3' ' A' ' 21' ' ' GLY . 26.8 m -89.33 141.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.794 0.331 . . . . 0.0 111.342 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.67 159.18 42.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.143 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.74 HD22 HD23 ' A' ' 64' ' ' LEU . 20.8 tp -127.08 126.89 43.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 111.588 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.561 ' O ' HG12 ' A' ' 18' ' ' ILE . 68.4 t80 -130.83 104.79 7.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.808 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.411 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.92 -71.27 1.95 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.738 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.494 ' HD1' HD21 ' A' ' 36' ' ' ASN . 0.8 OUTLIER -163.01 23.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.605 0.362 . . . . 0.0 111.337 179.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.584 HG22 HD22 ' A' ' 36' ' ' ASN . 34.0 pt -117.24 131.11 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 110.544 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.827 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -112.41 114.66 27.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.688 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 13.2 ttm180 -121.56 140.44 52.22 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.601 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -164.69 179.31 39.47 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.449 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -104.44 105.42 15.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.416 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 69.3 m -106.16 132.18 52.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.213 0.53 . . . . 0.0 110.29 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.68 141.4 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -105.83 -172.26 2.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.305 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -56.23 -30.52 62.46 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.76 -26.82 66.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.0 111.371 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.82 1.67 55.15 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.506 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.58 139.31 19.98 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 121.158 0.504 . . . . 0.0 111.037 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.38 127.96 20.3 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 124.117 3.211 . . . . 0.0 112.674 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -116.86 138.09 51.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.615 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.46 121.71 23.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.937 0.398 . . . . 0.0 111.171 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.4 t -140.54 156.6 46.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.928 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 p -140.4 138.92 35.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 mp -124.54 147.86 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.584 HD22 HG22 ' A' ' 18' ' ' ILE . 13.4 t-20 -103.75 107.55 18.47 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.827 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -66.1 -22.67 66.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.683 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 32.2 t30 -66.72 -12.93 60.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.017 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -110.57 0.89 17.81 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.325 -0.234 . . . . 0.0 110.981 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 50.8 m-85 -128.31 -20.47 3.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.7 138.79 40.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.705 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -116.33 165.51 12.28 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.529 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -108.82 106.05 15.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.89 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -110.92 107.19 16.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.586 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 13.4 t30 56.78 40.42 29.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.173 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.63 16.18 80.96 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.81 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.419 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -124.14 152.61 42.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 10.1 mp -80.52 123.49 28.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.895 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.592 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 9.3 tp10 -114.56 132.67 56.25 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.2 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.855 ' CD2' ' HD3' ' A' ' 51' ' ' PRO 0.251 0.1 OUTLIER -41.54 -63.11 0.89 Allowed Pre-proline 0 CA--C 1.423 -3.921 0 CA-C-O 117.87 -1.062 . . . . 0.0 113.522 -179.075 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.855 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 9.0 Cg_endo -112.28 123.36 0.02 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.471 0 C-N-CA 113.766 -3.689 . . . . 0.0 112.978 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.705 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.52 -165.89 18.24 Favored Glycine 0 C--N 1.281 -2.519 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.26 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -153.34 146.52 24.69 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 m 59.96 45.69 11.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 10.8 p90 -79.35 -37.81 36.59 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.83 55.03 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.538 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 m -63.22 -29.16 70.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.223 -0.489 . . . . 0.0 110.943 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.8 m -133.49 19.58 3.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.304 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 55' ' ' PHE . 84.1 m -123.04 149.07 44.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.283 0.563 . . . . 0.0 111.724 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG23 ' HG2' ' A' ' 61' ' ' LYS . 23.4 m -141.58 176.8 3.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.943 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' HG2' HG23 ' A' ' 60' ' ' VAL . 74.1 mmtt 62.81 37.3 12.44 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.246 0.342 . . . . 0.0 111.001 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -69.82 122.43 19.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.178 0.513 . . . . 0.0 111.75 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.73 149.23 28.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.438 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -106.34 113.29 26.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.741 0.305 . . . . 0.0 111.08 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -75.49 117.19 17.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.202 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.695 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 23.0 t70 55.05 23.32 5.09 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.084 0.865 . . . . 0.0 111.491 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.29 36.73 92.9 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.988 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.695 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 10.6 p80 -147.16 -29.94 0.35 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.692 0.746 . . . . 0.0 111.49 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 m -115.62 132.34 56.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.51 0.195 . . . . 0.0 111.115 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.55 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -92.8 130.06 38.52 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.1 OUTLIER -120.97 129.75 53.55 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.093 179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -159.03 163.32 36.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.09 0.472 . . . . 0.0 111.116 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 16.4 t -110.51 120.17 41.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.3 m -121.75 148.75 44.24 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.6 tmtt? -100.35 145.58 28.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.542 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.03 -30.9 0.49 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.852 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.599 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.46 -41.58 66.31 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -172.93 52.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.225 0.536 . . . . 0.0 109.892 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.439 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 73.4 -1.11 44.95 Favored Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.335 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -119.12 158.53 25.72 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 21.0 p90 -100.6 171.12 7.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.467 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -163.3 151.15 13.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.9 132.34 41.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.419 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 40.1 t -148.35 158.51 44.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.851 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -135.1 159.99 39.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.287 0.565 . . . . 0.0 110.93 179.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.523 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 20.9 tpp -147.3 118.67 7.86 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.589 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.469 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 32.3 t0 -75.93 106.89 7.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.408 0.623 . . . . 0.0 109.773 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.724 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.9 mt -73.55 -9.58 58.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.709 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -50.9 -27.33 7.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.197 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 46.1 p90 -117.82 19.28 13.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 111.583 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.4 m -126.18 -7.35 5.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.121 0.486 . . . . 0.0 110.603 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.5 p -157.69 145.08 9.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.321 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -135.82 -174.3 13.33 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.799 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.485 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.4 t30 -126.01 131.24 52.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.93 0.395 . . . . 0.0 110.946 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.592 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 67.8 m -135.95 111.08 8.94 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.678 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 59.66 42.92 16.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.938 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.85 24.31 64.44 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.198 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -127.0 147.58 50.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 110.165 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -60.02 128.85 38.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.145 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 36.4 mm-40 -140.38 78.16 22.92 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.004 178.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 44.0 Cg_endo -72.52 92.13 0.77 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.351 2.034 . . . . 0.0 111.859 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.313 -0.979 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.589 -179.54 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 56.14 73.96 0.41 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.474 ' CD1' ' HB ' ' A' ' 92' ' ' VAL . 12.5 p90 -57.93 -34.5 69.93 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.138 0.494 . . . . 0.0 111.366 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.94 -22.08 63.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -62.43 -26.52 68.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 46.6 m -124.64 13.4 8.67 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.2 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -119.15 135.56 54.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.051 0.453 . . . . 0.0 111.212 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -132.46 154.36 49.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.26 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.07 53.0 48.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.064 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.421 HG12 ' HA3' ' A' ' 21' ' ' GLY . 7.1 m -92.07 137.81 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.728 0.299 . . . . 0.0 110.874 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -135.21 149.85 49.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.178 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.564 HD22 HD23 ' A' ' 64' ' ' LEU . 11.9 tp -114.41 118.01 32.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.163 0.506 . . . . 0.0 111.485 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.507 ' O ' HG12 ' A' ' 18' ' ' ILE . 91.9 m-85 -115.51 99.75 7.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.82 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.82 -73.3 1.47 Allowed Glycine 0 C--O 1.224 -0.499 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.484 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.517 ' HD1' HD21 ' A' ' 36' ' ' ASN . 3.9 p90 -157.49 21.14 0.29 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.671 0.388 . . . . 0.0 110.848 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 15' ' ' TYR . 39.0 pt -121.4 132.77 69.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.054 0.454 . . . . 0.0 110.251 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -109.38 117.56 34.37 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.119 -179.136 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tmm_? -121.72 139.57 53.41 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.89 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.421 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -161.8 179.35 37.23 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.303 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 10.7 m-20 -100.98 106.14 17.43 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.0 OUTLIER -106.05 131.83 52.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.954 0.406 . . . . 0.0 109.944 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -69.15 138.12 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.692 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.7 p30 -108.26 -170.28 1.65 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.29 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.48 -28.58 60.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.81 -26.69 66.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.55 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.64 -2.89 57.4 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.159 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -104.86 143.53 26.89 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.932 0.396 . . . . 0.0 110.3 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.641 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 29.3 Cg_endo -64.84 121.97 9.65 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.937 2.425 . . . . 0.0 113.015 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -108.32 130.72 55.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.171 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.84 119.65 15.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.057 0.456 . . . . 0.0 111.716 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.9 t -135.54 160.05 39.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.502 ' O ' ' HG2' ' A' ' 99' ' ' MET . 13.2 p -136.7 152.72 50.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.184 0.516 . . . . 0.0 111.551 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.22 145.78 33.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.799 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.517 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -104.58 94.56 5.38 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.9 -30.24 63.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.587 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.4 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.2 t-20 -54.53 -29.15 49.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -103.68 10.93 36.57 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.656 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 52.8 m-85 -129.67 -22.9 2.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.417 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.24 141.49 27.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.602 0.239 . . . . 0.0 110.83 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.572 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.54 -173.77 18.16 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.918 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -128.65 109.5 11.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.844 0.354 . . . . 0.0 111.128 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -113.11 109.62 19.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.66 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.647 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 22.1 t-20 56.08 45.48 23.48 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.72 0.772 . . . . 0.0 110.943 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.54 18.12 73.41 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.709 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.07 147.49 47.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.863 0.363 . . . . 0.0 110.364 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.4 mp -71.42 127.94 34.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.189 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -114.5 129.51 56.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.15 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.596 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.7 -70.53 0.14 Allowed Pre-proline 0 CA--C 1.425 -3.852 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.868 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.596 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 14.2 Cg_endo -110.36 124.36 0.03 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.444 0 C-N-CA 113.509 -3.861 . . . . 0.0 113.146 -178.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.572 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -159.08 -161.04 10.8 Favored Glycine 0 C--N 1.281 -2.527 0 CA-C-N 113.4 -1.727 . . . . 0.0 113.197 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -153.93 150.04 27.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 0.0 110.341 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.2 p 47.79 44.97 18.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 20.4 p90 -69.84 -40.93 75.54 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.33 -26.9 38.41 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.675 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -56.93 -25.99 58.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.221 0.208 . . . . 0.0 111.286 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.2 m -137.17 28.0 2.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 0.0 110.705 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.1 m -131.61 145.92 51.94 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.346 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.42 HG23 ' HD3' ' A' ' 61' ' ' LYS . 18.4 m -136.62 174.82 11.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.811 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HD3' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER 61.41 37.86 16.47 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.322 0.649 . . . . 0.0 112.265 -179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 p -63.11 123.0 17.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.895 0.379 . . . . 0.0 111.044 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.12 155.57 37.02 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -110.86 120.15 41.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.829 0.347 . . . . 0.0 110.838 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.57 119.1 23.82 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 68.75 -59.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 124.623 1.202 . . . . 0.0 111.113 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.88 34.64 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.342 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.471 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 1.2 p-80 -155.81 -19.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m -116.55 128.0 55.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.618 0.247 . . . . 0.0 111.587 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.603 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.8 tp -91.09 130.74 36.95 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -120.16 129.87 54.33 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.724 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -160.28 164.12 32.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.148 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.6 t -110.95 123.98 51.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 39.2 m -125.45 153.74 43.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.92 0.391 . . . . 0.0 111.809 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.9 tmtt? -99.26 144.51 28.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.693 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.1 -26.82 0.62 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.0 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.647 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . . . -52.25 -42.5 63.69 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.551 0.341 . . . . 0.0 111.715 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -175.83 55.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.017 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.42 20.84 73.93 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.464 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -142.67 159.34 42.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 46.7 p90 -101.26 166.72 10.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.248 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -159.53 145.53 16.1 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -78.6 131.6 36.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.002 0.43 . . . . 0.0 110.772 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 p -143.51 176.03 9.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.271 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.6 OUTLIER -138.85 164.9 28.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.226 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.882 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.8 OUTLIER -145.87 121.72 10.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.533 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.6 105.11 6.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.739 ' HA ' HG22 ' A' ' 91' ' ' VAL . 19.8 mt -77.34 -8.26 57.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.659 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.471 ' OD1' ' HB2' ' A' ' 68' ' ' HIS . 11.5 m120 -47.15 -32.82 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.72 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -116.45 22.76 12.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.427 . . . . 0.0 111.324 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -127.94 -13.5 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.818 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.843 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -132.17 147.97 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.286 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.99 174.61 22.63 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.204 -0.522 . . . . 0.0 111.799 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.447 HD22 ' HB2' ' A' ' 8' ' ' SER . 20.6 t30 -135.31 133.54 38.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.684 0.278 . . . . 0.0 111.124 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.446 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 8.2 m -142.89 115.65 8.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.264 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 58.93 41.13 21.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.389 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 66.09 12.36 57.51 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.721 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -114.63 139.81 49.33 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 34' ' ' SER . 4.6 ppp? -66.01 133.54 51.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.032 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -152.87 69.31 7.0 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.759 178.13 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.843 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 15.7 Cg_endo -56.08 102.82 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.312 2.675 . . . . 0.0 112.548 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 121.637 0.732 . . . . 0.0 110.983 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.602 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 71.2 m . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 42.77 79.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.58 ' CD1' HG13 ' A' ' 92' ' ' VAL . 3.1 p90 -59.23 -34.54 72.31 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.226 0.536 . . . . 0.0 110.618 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.66 -21.76 66.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.529 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.73 -18.79 65.34 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 50.2 m -142.65 18.39 2.01 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.525 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -118.17 136.07 53.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 110.822 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -133.8 154.19 51.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.572 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.26 61.8 6.9 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.291 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 35.6 m -93.3 144.59 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.293 0.568 . . . . 0.0 111.608 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -135.88 136.7 40.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.84 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.843 HD22 HD23 ' A' ' 64' ' ' LEU . 37.3 tp -122.63 119.77 31.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.976 0.417 . . . . 0.0 110.762 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.576 ' O ' HG12 ' A' ' 18' ' ' ILE . 28.8 t80 -127.93 109.39 11.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.019 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.449 ' O ' HG21 ' A' ' 62' ' ' THR . . . 72.98 -67.16 1.41 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.791 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.9 p90 -164.56 19.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.795 0.438 . . . . 0.0 110.653 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.591 HG22 ' ND2' ' A' ' 36' ' ' ASN . 43.5 pt -117.47 122.61 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.02 0.438 . . . . 0.0 110.569 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.852 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -109.21 114.67 28.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.788 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.2 ttt85 -115.71 140.92 48.75 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.82 176.74 41.81 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.142 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.7 m-20 -104.88 109.06 20.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.621 0.248 . . . . 0.0 110.417 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -107.61 132.86 52.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.942 0.401 . . . . 0.0 110.403 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 57.9 mt -67.38 136.15 27.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.452 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -103.68 -174.03 2.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.197 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -54.62 -29.67 52.6 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.01 -25.82 68.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.819 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.52 -4.4 56.68 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.787 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -106.76 145.11 30.41 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 37.2 Cg_endo -66.37 134.02 34.59 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.904 2.403 . . . . 0.0 112.764 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -122.58 123.76 41.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.311 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.07 130.19 44.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.293 0.568 . . . . 0.0 111.761 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 t -144.05 164.96 29.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.478 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.3 p -140.47 138.33 34.57 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.65 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.419 HG13 ' HB3' ' A' ' 99' ' ' MET . 2.7 mp -122.02 145.48 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 120.838 0.351 . . . . 0.0 110.723 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.591 ' ND2' HG22 ' A' ' 18' ' ' ILE . 9.5 m120 -104.07 91.58 4.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 110.015 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.852 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -57.75 -25.42 60.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.171 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.0 t-20 -55.29 -30.47 60.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.692 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -103.21 11.03 37.42 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.47 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.0 m-85 -126.71 -26.96 3.15 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.537 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.3 mp -110.64 140.89 27.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.672 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -112.6 171.5 14.04 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.481 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -113.86 108.25 16.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.608 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -111.92 105.94 14.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.635 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.831 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 52.6 t30 57.34 41.01 27.18 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.177 0.513 . . . . 0.0 110.78 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.62 15.75 81.3 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.132 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.03 145.74 48.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.832 0.349 . . . . 0.0 111.054 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.7 mp -75.09 119.31 19.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.268 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.535 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 49.0 tt0 -109.93 136.42 49.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.783 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.811 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.65 -68.01 0.26 Allowed Pre-proline 0 CA--C 1.426 -3.82 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.347 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.811 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 2.4 Cg_endo -109.74 126.62 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.32 0 C-N-CA 113.69 -3.74 . . . . 0.0 113.328 -178.103 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.672 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -164.49 -161.53 13.71 Favored Glycine 0 C--N 1.283 -2.408 0 CA-C-N 113.693 -1.594 . . . . 0.0 113.372 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -153.24 147.76 26.07 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.777 0.339 . . . . 0.0 110.586 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m 56.86 37.34 28.73 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 8.4 p90 -71.24 -35.7 71.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.4 0.619 . . . . 0.0 109.466 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.93 -18.38 70.59 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.165 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 m -72.47 -7.59 50.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.173 0.511 . . . . 0.0 110.894 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 56.3 m -146.3 23.01 1.33 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.16 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -128.25 154.79 45.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 111.893 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.524 HG23 ' HD2' ' A' ' 61' ' ' LYS . 25.3 m -141.39 174.38 7.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.73 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HD2' HG23 ' A' ' 60' ' ' VAL . 0.1 OUTLIER 63.17 29.61 16.06 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.238 0.215 . . . . 0.0 111.245 -179.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.449 HG21 ' O ' ' A' ' 16' ' ' GLY . 4.0 p -60.98 117.72 5.82 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.201 0.524 . . . . 0.0 111.193 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.35 161.39 42.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.93 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.843 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -120.04 113.32 20.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.022 -178.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.572 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 2.6 t-20 -84.9 128.52 34.66 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.612 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 7.3 t70 52.59 20.09 1.41 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.414 1.071 . . . . 0.0 112.014 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 59.99 35.11 86.15 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.324 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.612 ' CD2' ' HB3' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -148.49 -23.55 0.33 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.152 0.476 . . . . 0.0 111.549 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.419 ' O ' HD13 ' A' ' 64' ' ' LEU . 55.5 m -116.67 129.66 56.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.173 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.587 ' HB2' HD11 ' A' ' 88' ' ' LEU . 13.8 tp -96.14 128.08 42.73 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.1 130.17 56.68 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.863 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -161.47 155.4 22.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.378 0.608 . . . . 0.0 111.303 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.584 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 7.9 t -105.93 108.28 19.71 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.801 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.0 m -105.1 149.27 26.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.448 0.642 . . . . 0.0 111.765 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 11.3 tmtt? -100.43 141.31 33.46 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.572 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.33 -30.9 0.48 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.485 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.831 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -49.34 -41.24 38.22 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -172.67 49.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.215 0.531 . . . . 0.0 110.144 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.52 1.9 62.43 Favored Glycine 0 C--O 1.23 -0.132 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.249 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -122.0 162.34 21.31 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 36.3 p90 -104.73 170.31 7.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.91 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.3 OUTLIER -157.17 133.76 9.95 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 112.42 7.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.009 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.6 p -125.82 175.04 7.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.978 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.99 163.83 29.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.9 0.381 . . . . 0.0 110.819 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.579 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.4 tpt -151.88 120.9 6.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 50.4 m-20 -74.89 106.78 6.58 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.752 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.4 mt -75.28 -9.43 58.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -47.99 -31.18 5.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.399 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 87' ' ' ASP . 4.0 p90 -117.3 21.35 13.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.61 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.752 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -126.69 -11.64 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.064 0.459 . . . . 0.0 110.484 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.927 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.4 p -153.07 138.36 10.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.832 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.602 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.86 -169.45 11.93 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.013 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.451 HD22 ' HB2' ' A' ' 8' ' ' SER . 19.8 t30 -125.85 139.67 53.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.613 0.244 . . . . 0.0 110.451 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.582 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -150.14 109.64 4.01 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 62.54 43.27 7.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.49 25.02 62.47 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.529 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.17 148.72 52.04 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 120.919 0.39 . . . . 0.0 110.693 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.505 ' O ' ' HG3' ' A' ' 99' ' ' MET . 15.9 ptt? -57.44 118.49 5.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.925 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.582 ' HG3' ' CB ' ' A' ' 95' ' ' SER . 49.1 mm-40 -132.36 76.77 71.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.563 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.927 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.7 Cg_endo -71.86 87.88 0.82 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.785 2.323 . . . . 0.0 112.681 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--N 1.309 -1.167 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.019 179.614 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.577 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 26.5 m . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.378 0.132 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 55.08 79.39 0.15 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.956 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.491 ' HE1' ' HB2' ' A' ' 88' ' ' LEU . 14.5 p90 -56.76 -38.18 72.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.523 . . . . 0.0 111.158 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.03 -26.61 67.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.677 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -71.38 -6.51 40.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.673 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.3 m -137.67 8.04 2.8 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.765 0.316 . . . . 0.0 110.661 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -120.96 149.99 41.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.843 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.3 p -137.93 147.53 44.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.362 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.67 57.51 17.42 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.567 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 15.3 m -98.57 130.35 47.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.139 0.495 . . . . 0.0 111.817 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -127.4 137.5 52.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.511 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.632 HD22 HD23 ' A' ' 64' ' ' LEU . 18.3 tp -111.09 105.39 14.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -135.79 117.11 14.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.485 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 77.59 34.66 38.93 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.886 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' HD1' HG21 ' A' ' 62' ' ' THR . 19.8 m-85 65.27 23.07 12.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.053 0.541 . . . . 0.0 110.701 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 16' ' ' GLY . 9.2 mt -122.05 125.49 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.003 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.736 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.4 mt -108.07 114.22 27.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.007 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 4.6 ttm180 -116.86 140.23 49.69 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.989 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.516 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.08 177.99 41.48 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.265 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 11.5 m-20 -104.69 110.86 23.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.591 0.234 . . . . 0.0 110.565 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.9 OUTLIER -107.09 132.52 52.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.6 mt -69.9 134.31 30.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.027 0.441 . . . . 0.0 111.497 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -103.14 -173.11 2.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.842 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.93 -26.12 64.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.813 0.339 . . . . 0.0 111.909 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.75 -23.43 67.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.69 2.07 63.36 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.811 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -113.02 146.11 34.47 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.828 0.347 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.639 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 33.0 Cg_endo -66.26 125.76 14.55 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.236 2.624 . . . . 0.0 112.705 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -109.59 127.46 54.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.255 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.81 126.63 30.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.973 0.416 . . . . 0.0 111.209 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -143.09 162.51 35.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.445 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.487 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 73.2 p -139.59 133.58 30.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.457 0.17 . . . . 0.0 110.709 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.416 HG13 ' CB ' ' A' ' 99' ' ' MET . 2.9 mp -115.23 143.01 25.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.253 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.08 92.82 5.17 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.736 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -58.56 -25.61 62.69 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.722 -178.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.556 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 22.8 t-20 -54.18 -31.7 53.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.376 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -107.61 16.4 23.77 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.0 m-85 -129.5 -22.32 3.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.54 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.66 141.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.634 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.0 174.26 15.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.363 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -112.82 108.32 17.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.9 0.381 . . . . 0.0 110.71 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -111.59 105.24 13.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.679 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.714 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 41.5 t30 56.75 42.59 26.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.146 0.498 . . . . 0.0 110.696 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 73.7 18.03 79.37 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.733 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.98 146.91 49.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 111.229 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 7.5 mp -72.38 114.32 10.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.616 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -108.79 132.04 54.37 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.879 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -31.21 -74.12 0.05 OUTLIER Pre-proline 0 CA--C 1.432 -3.568 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.879 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 10.7 Cg_endo -108.89 129.43 0.04 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.242 0 C-N-CA 113.852 -3.632 . . . . 0.0 112.913 -177.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.634 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -161.44 -163.28 14.08 Favored Glycine 0 C--N 1.278 -2.683 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.016 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -153.38 143.22 22.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.013 0.435 . . . . 0.0 110.892 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.5 m 57.15 35.1 25.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.169 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 7.2 p90 -64.81 -34.16 77.7 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.03 -17.61 37.56 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.165 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 t -68.26 -30.82 69.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.739 0.304 . . . . 0.0 110.625 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 m -125.29 6.32 7.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.192 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -120.48 141.38 50.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.684 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.424 HG23 ' HD3' ' A' ' 61' ' ' LYS . 29.8 m -137.5 171.84 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HD3' HG23 ' A' ' 60' ' ' VAL . 2.1 mptm? 63.61 43.35 5.8 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.774 0.671 . . . . 0.0 111.457 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.581 HG21 ' HD1' ' A' ' 17' ' ' TYR . 4.2 p -69.28 133.6 48.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.072 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.71 163.97 38.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.698 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.632 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -120.62 112.87 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.666 0.27 . . . . 0.0 111.647 -179.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.621 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 16.9 m120 -72.18 116.93 13.19 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.224 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.609 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 18.7 t70 54.08 15.17 0.83 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.955 0.784 . . . . 0.0 111.929 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.31 34.41 57.79 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.836 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.609 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.5 p80 -147.83 -26.1 0.36 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.7 0.75 . . . . 0.0 112.001 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 18.5 m -116.08 134.59 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.495 0.188 . . . . 0.0 111.058 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.539 ' HG ' ' CD2' ' A' ' 48' ' ' LEU . 24.3 tp -94.64 133.5 38.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.582 0.23 . . . . 0.0 110.613 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.71 130.57 52.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.855 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -163.19 163.31 25.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.8 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.421 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 23.0 t -109.68 126.82 54.08 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.454 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 17.5 m -124.85 150.36 46.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.22 0.533 . . . . 0.0 112.153 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.0 tmtt? -100.27 140.55 34.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.721 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.45 -30.49 0.52 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.145 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.714 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.19 -40.31 64.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -171.21 51.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.416 0.627 . . . . 0.0 110.053 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.43 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 70.71 5.21 56.11 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.782 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -129.34 162.14 28.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 47.9 p90 -90.14 160.11 16.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.309 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -153.87 133.04 12.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.48 124.75 24.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.702 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.8 p -138.45 171.0 15.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.766 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.17 159.41 41.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.965 0.412 . . . . 0.0 110.521 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.575 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 12.0 tpp -143.28 123.76 13.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.505 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.48 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 10.8 m-20 -73.1 105.74 4.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.247 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.736 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.1 mt -76.18 -8.61 57.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.909 0.385 . . . . 0.0 110.426 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.11 -28.73 7.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.943 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 87' ' ' ASP . 44.1 p90 -120.16 22.77 11.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.982 0.42 . . . . 0.0 110.973 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -128.72 -9.93 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.594 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.927 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -138.93 140.6 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.235 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.577 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -139.01 176.47 20.91 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.305 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -121.66 123.31 41.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.632 0.253 . . . . 0.0 110.972 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.533 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 57.9 m -127.82 94.34 3.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.601 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 64.67 47.07 2.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.49 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.62 20.97 66.57 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.366 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -124.17 139.0 54.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' A' ' 99' ' ' MET . 12.9 ptt? -57.52 122.38 12.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.99 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.533 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 25.8 mm-40 -142.93 78.34 15.54 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.788 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.927 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.0 Cg_endo -71.78 96.38 0.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.884 2.389 . . . . 0.0 113.215 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.0 p . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.66 179.664 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.584 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 88.7 m . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 110.94 -0.022 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.495 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 58.4 m-80 52.17 82.73 0.06 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.598 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 14.4 p90 -60.77 -34.83 75.05 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.289 0.566 . . . . 0.0 110.507 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.85 -19.16 60.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.235 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.495 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 7.4 t-20 -51.22 -33.42 27.74 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.438 0.461 . . . . 0.0 111.532 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB2' HD22 ' A' ' 94' ' ' ASN . 19.8 m -136.5 27.14 3.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.941 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -120.41 132.81 55.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.088 0.471 . . . . 0.0 111.161 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 p -131.87 155.74 47.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.988 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.76 30.43 74.55 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.318 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.586 HG12 ' HA3' ' A' ' 21' ' ' GLY . 17.5 m -77.45 134.34 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.029 0.443 . . . . 0.0 111.669 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.73 151.88 49.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.697 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.663 HD22 HD23 ' A' ' 64' ' ' LEU . 8.8 tp -121.92 106.33 11.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.006 0.431 . . . . 0.0 111.176 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -134.21 114.73 13.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.789 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.469 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 73.76 38.45 49.97 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.738 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 62' ' ' THR . 18.1 m-85 64.2 25.6 13.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.199 0.6 . . . . 0.0 110.886 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 16' ' ' GLY . 12.2 mt -121.56 124.81 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.133 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.785 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -102.74 113.76 27.44 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.442 ' HG3' ' HB3' ' A' ' 34' ' ' SER . 15.2 ttm180 -123.04 133.74 54.32 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.7 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -162.79 -173.38 31.43 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.13 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -106.55 109.53 21.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.626 0.25 . . . . 0.0 110.662 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -104.82 132.08 51.5 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 8' ' ' SER . 54.1 mt -71.74 142.19 15.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.427 HD21 ' CD2' ' A' ' 29' ' ' HIS . 4.2 p30 -109.5 -171.12 1.78 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.399 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -54.91 -31.22 59.89 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.88 -9.68 58.8 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.16 5.23 85.87 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.845 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.427 ' CD2' HD21 ' A' ' 25' ' ' ASN . 0.0 OUTLIER -108.4 133.94 20.4 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.869 0.366 . . . . 0.0 110.168 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.63 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 18.5 Cg_endo -60.48 138.53 81.04 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 123.246 2.63 . . . . 0.0 112.741 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -123.41 135.87 54.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.32 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 112.39 5.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.214 0.53 . . . . 0.0 110.828 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -131.1 156.75 44.71 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.601 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.442 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 19.9 p -139.57 147.0 40.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.102 0.477 . . . . 0.0 111.603 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -129.74 143.96 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.563 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.06 89.77 3.38 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.785 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -54.29 -30.44 50.82 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.61 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.54 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.3 t-20 -54.33 -28.34 41.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.468 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -108.76 14.67 24.18 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.643 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 43.0 m-85 -128.05 -24.2 3.21 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.2 mp -111.4 143.03 22.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.661 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -112.61 170.58 13.54 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.56 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -113.84 111.35 21.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.294 -0.453 . . . . 0.0 111.35 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -110.63 104.35 13.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.76 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.563 HD22 ' HA ' ' A' ' 77' ' ' ALA . 9.4 m120 48.08 47.04 19.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.126 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 74' ' ' CYS . . . 78.51 12.51 84.19 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.673 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.39 143.97 47.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.832 0.349 . . . . 0.0 110.667 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.6 mp -76.94 114.29 15.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.516 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -103.39 136.97 42.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.089 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.661 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.23 -76.19 0.05 OUTLIER Pre-proline 0 CA--C 1.436 -3.416 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.661 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 20.5 Cg_endo -109.95 125.64 0.04 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.324 0 C-N-CA 113.751 -3.699 . . . . 0.0 113.165 -177.342 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.661 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -155.67 -157.55 8.33 Favored Glycine 0 C--N 1.284 -2.36 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.664 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -151.56 143.31 23.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 111.052 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 m 49.82 44.9 25.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.54 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 11.5 p90 -68.97 -31.08 69.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 59' ' ' CYS . . . -62.22 -18.21 57.47 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.196 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -53.9 -30.66 47.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.315 0.246 . . . . 0.0 110.904 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 25.1 m -135.48 17.75 3.36 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.446 ' HB2' ' HA2' ' A' ' 56' ' ' GLY . 7.5 m -108.08 147.73 30.79 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.45 0.643 . . . . 0.0 112.238 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.74 173.3 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.995 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 59.94 35.91 21.68 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.427 0.291 . . . . 0.0 111.432 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.451 HG21 ' CD1' ' A' ' 17' ' ' TYR . 16.7 p -68.31 120.09 13.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.992 0.425 . . . . 0.0 111.488 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.85 152.49 30.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.728 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.663 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -108.34 112.75 25.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.525 0.202 . . . . 0.0 110.59 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -76.08 117.49 17.84 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.705 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 24.8 t70 58.48 18.04 5.36 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.081 0.863 . . . . 0.0 111.044 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.06 32.52 84.38 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.413 -0.812 . . . . 0.0 114.082 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.705 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.0 p80 -141.9 -27.26 0.65 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 117.811 0.805 . . . . 0.0 111.249 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.403 ' O ' HD13 ' A' ' 64' ' ' LEU . 27.9 m -116.01 126.24 53.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.56 ' HA ' HD22 ' A' ' 64' ' ' LEU . 16.8 tp -89.97 126.58 35.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.162 0.506 . . . . 0.0 109.783 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -117.67 130.47 56.37 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.305 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.31 166.47 27.49 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.661 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 t -118.26 117.57 29.48 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.547 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -114.32 154.21 28.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.544 0.688 . . . . 0.0 111.828 -179.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 7.8 tmtt? -100.36 149.27 23.8 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.826 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.31 -15.53 1.87 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.829 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.563 ' HA ' HD22 ' A' ' 45' ' ' ASN . . . -58.78 -40.77 84.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.687 0.28 . . . . 0.0 110.744 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 178.24 58.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.698 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.405 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 69.13 19.68 74.17 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -143.82 161.34 38.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 51.4 p90 -101.82 165.5 11.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.318 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.96 152.84 40.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.408 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.86 131.09 37.45 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.8 p -149.58 172.68 14.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.95 0.405 . . . . 0.0 111.286 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.6 OUTLIER -137.85 163.29 31.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.99 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.565 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 4.6 tpt -146.67 113.05 5.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.4 106.49 4.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.792 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.4 mt -74.47 -7.62 53.6 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.762 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -46.83 -30.76 2.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.874 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -118.63 19.14 13.33 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.628 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.792 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -125.14 -10.01 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.313 0.578 . . . . 0.0 110.154 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.827 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.1 t -141.79 139.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.525 178.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.584 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -129.92 176.42 18.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.519 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.441 HD22 ' HB2' ' A' ' 8' ' ' SER . 21.3 t30 -129.48 133.54 47.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.61 0.243 . . . . 0.0 110.454 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.408 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 5.4 t -142.38 111.49 6.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.88 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 57.65 43.55 22.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.401 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.56 7.56 65.01 Favored Glycine 0 C--N 1.33 0.218 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.455 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.9 145.16 41.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -68.91 131.22 44.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.224 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.408 ' HG3' ' CB ' ' A' ' 95' ' ' SER . 21.2 mm-40 -136.67 76.03 48.79 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.693 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.827 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 35.2 Cg_endo -66.27 119.36 6.38 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.438 2.092 . . . . 0.0 111.322 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.826 -178.994 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.402 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 82.0 m . . . . . 0 C--O 1.232 0.17 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.944 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 24.4 m-80 51.76 69.09 0.7 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.662 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 17.5 p90 -58.1 -41.66 83.98 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.25 0.547 . . . . 0.0 110.21 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.94 -21.62 65.09 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.821 -178.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 28.2 t-20 -54.71 -33.72 61.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.333 0.587 . . . . 0.0 110.802 -179.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.444 ' HB2' HD22 ' A' ' 94' ' ' ASN . 26.1 m -134.69 28.4 3.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.076 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.662 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -120.0 134.88 55.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.943 0.401 . . . . 0.0 110.584 179.267 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 p -128.25 152.19 48.39 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.985 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.84 57.91 12.68 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.756 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.598 HG12 ' HA3' ' A' ' 21' ' ' GLY . 15.5 m -104.83 132.12 52.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.962 0.41 . . . . 0.0 110.824 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -133.27 156.69 47.11 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.739 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.652 HD22 HD23 ' A' ' 64' ' ' LEU . 21.9 tp -121.33 127.73 51.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.542 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.448 ' O ' HG12 ' A' ' 18' ' ' ILE . 42.7 t80 -131.23 98.92 4.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.836 179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 62' ' ' THR . . . 78.41 -63.77 3.61 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.709 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.518 ' HD1' HD21 ' A' ' 36' ' ' ASN . 6.4 p90 -169.15 23.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.724 0.297 . . . . 0.0 111.47 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.7 pt -121.57 133.91 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.798 0.332 . . . . 0.0 110.659 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.791 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -115.72 114.28 24.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.828 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.46 140.55 51.23 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.598 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.22 -177.71 39.03 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.96 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 7.1 m-20 -109.63 108.3 18.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.439 0.162 . . . . 0.0 110.609 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.9 m -104.54 132.38 50.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.5 mt -69.58 133.43 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.56 -178.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -94.68 -176.59 3.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.917 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -54.72 -37.71 66.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.727 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.81 -30.02 67.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.938 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.03 -2.01 31.53 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.322 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -104.49 139.69 20.35 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.372 . . . . 0.0 110.944 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 42.8 Cg_endo -69.91 125.99 12.7 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.921 2.414 . . . . 0.0 111.67 179.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -112.02 136.88 50.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.048 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.3 123.77 21.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.453 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -140.01 158.36 44.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.602 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.0 p -140.1 141.86 36.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.743 0.306 . . . . 0.0 111.192 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -124.86 145.4 32.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.588 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.518 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -103.74 95.82 6.29 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.75 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -58.54 -26.9 64.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.742 0.306 . . . . 0.0 111.337 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -55.41 -24.12 28.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.863 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -112.86 12.37 19.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.58 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -129.02 -12.03 4.7 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.529 HD13 ' HB3' ' A' ' 37' ' ' LEU . 3.0 mp -124.62 133.9 68.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.55 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -108.67 170.92 15.13 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.577 -179.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -110.88 102.49 10.99 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.299 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -110.57 105.64 14.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.889 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 14.3 t-20 52.6 47.37 24.83 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.708 0.766 . . . . 0.0 111.094 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.69 75.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.933 179.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -120.27 151.79 38.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.797 0.332 . . . . 0.0 110.672 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.507 HD23 ' HG ' ' A' ' 70' ' ' LEU . 10.8 mp -85.5 117.01 24.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.892 -179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.673 ' HG3' ' CD ' ' A' ' 51' ' ' PRO . 12.8 tp10 -110.57 126.8 54.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.183 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.945 ' HB2' HG11 ' A' ' 91' ' ' VAL 0.252 53.5 p90 -61.13 -12.06 0.2 Allowed Pre-proline 0 CA--C 1.452 -2.811 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 -174.804 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.673 ' CD ' ' HG3' ' A' ' 49' ' ' GLU . 8.3 Cg_endo -128.62 9.22 0.0 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.601 1 C-N-CA 112.461 -4.56 . . . . 0.0 114.972 175.693 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.55 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -66.94 -167.72 3.05 Favored Glycine 0 C--N 1.27 -3.106 0 CA-C-N 110.849 -2.887 . . . . 0.0 115.69 -177.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -145.59 154.56 42.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.721 0.296 . . . . 0.0 110.928 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.8 m 55.76 45.28 24.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 10.4 p90 -79.61 -36.7 37.63 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.845 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.54 -18.38 69.83 Favored Glycine 0 CA--C 1.505 -0.533 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.83 -178.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 m -66.7 -13.21 61.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.049 -0.576 . . . . 0.0 110.779 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.4 m -149.02 26.84 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.617 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -124.55 155.36 39.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.162 0.506 . . . . 0.0 111.123 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 61' ' ' LYS . 32.6 m -141.62 171.1 12.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.816 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.4 mptt 62.46 31.77 16.98 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.523 0.514 . . . . 0.0 111.345 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 16' ' ' GLY . 2.6 p -59.66 123.16 16.02 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.926 0.393 . . . . 0.0 111.489 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.45 162.88 40.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.315 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.652 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -121.98 112.62 18.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -85.33 124.8 32.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 110.959 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' HB3' ' NE2' ' A' ' 68' ' ' HIS . 11.1 t70 56.36 21.36 5.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.048 179.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.94 36.06 92.28 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.33 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.429 ' NE2' ' HB3' ' A' ' 66' ' ' ASP . 0.9 OUTLIER -154.48 -23.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.571 0.686 . . . . 0.0 112.393 179.008 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 m -116.35 128.48 55.57 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.22 -0.3 . . . . 0.0 111.143 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.566 ' HA ' HD22 ' A' ' 64' ' ' LEU . 11.8 tp -91.3 129.73 37.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.297 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.402 ' N ' HD12 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -120.84 129.75 53.67 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.657 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -162.91 165.56 24.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.133 179.109 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.412 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 23.2 t -117.01 111.78 20.04 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 56.7 m -103.38 146.14 28.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.414 0.626 . . . . 0.0 110.742 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 10.2 tmtt? -100.59 140.49 34.78 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.883 177.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.73 -24.46 0.3 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.909 -1.139 . . . . 0.0 112.992 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.436 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . . . -47.97 -45.85 31.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.0 111.135 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.2 t70 178.72 58.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.917 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.454 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 76.57 -0.16 65.71 Favored Glycine 0 C--O 1.229 -0.189 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.695 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -118.23 163.95 15.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.172 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.412 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 50.5 p90 -111.77 169.54 8.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.071 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -155.95 135.19 12.21 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -72.05 114.65 10.38 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.291 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.467 ' HB3' HD13 ' A' ' 48' ' ' LEU . 18.8 t -130.55 167.53 18.54 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.977 0.418 . . . . 0.0 110.418 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.03 160.93 38.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.163 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.608 ' CE ' ' HA ' ' A' ' 86' ' ' MET . 0.6 OUTLIER -146.04 126.25 13.86 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.327 -179.611 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.565 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 45.9 t0 -78.28 108.78 11.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.144 0.497 . . . . 0.0 109.874 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.779 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.1 mt -82.26 -9.25 59.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.586 -179.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -52.21 -26.27 11.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.489 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 41.9 p90 -116.54 17.76 15.27 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.066 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.945 HG11 ' HB2' ' A' ' 50' ' ' TYR . 2.5 m -123.7 -10.57 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 121.188 0.518 . . . . 0.0 110.476 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -133.73 124.16 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -114.98 159.03 13.95 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.44 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.444 HD22 ' HB2' ' A' ' 8' ' ' SER . 22.9 t30 -107.81 121.94 45.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.559 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 74.4 m -137.12 107.16 6.31 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.809 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 61.01 40.74 14.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.326 178.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.73 18.31 68.11 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.606 -0.725 . . . . 0.0 113.164 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -124.75 147.97 48.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.504 ' O ' ' HG3' ' A' ' 99' ' ' MET . 8.2 ptt? -66.01 127.77 33.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.867 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 53.9 mm-40 -133.61 75.07 69.47 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.289 178.071 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 31.6 Cg_endo -62.19 135.48 54.71 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.734 2.289 . . . . 0.0 112.218 -179.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 5.7 p . . . . . 0 C--N 1.318 -0.791 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.578 -179.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.438 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 37.9 m . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 41.82 76.04 0.08 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.63 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 3.4 p90 -62.19 -32.68 73.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.006 0.431 . . . . 0.0 111.035 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.6 -22.31 65.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -63.05 -27.18 69.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.449 ' HB2' HD22 ' A' ' 94' ' ' ASN . 71.0 m -129.87 28.7 5.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.733 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -129.75 144.81 51.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.927 0.394 . . . . 0.0 111.104 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.1 p -140.39 147.39 39.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.061 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.13 48.14 55.01 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.893 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.543 HG12 ' HA3' ' A' ' 21' ' ' GLY . 18.1 m -93.5 132.75 36.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.202 0.525 . . . . 0.0 111.083 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -126.6 154.86 43.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.672 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.732 HD22 HD23 ' A' ' 64' ' ' LEU . 16.2 tp -123.8 119.44 29.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.872 0.368 . . . . 0.0 111.41 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.546 ' O ' HG12 ' A' ' 18' ' ' ILE . 29.2 m-85 -118.01 99.21 6.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.158 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.478 ' O ' HG21 ' A' ' 62' ' ' THR . . . 73.44 -61.92 1.89 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.975 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 28.1 p90 -165.39 21.15 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.868 0.366 . . . . 0.0 111.211 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.583 HG22 ' ND2' ' A' ' 36' ' ' ASN . 35.4 pt -118.82 127.54 75.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.922 0.391 . . . . 0.0 110.552 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.889 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -108.82 117.64 34.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.695 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 20' ' ' ARG . 6.1 tmm_? -128.85 138.22 51.92 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.737 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.543 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -166.78 -168.54 29.12 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.937 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 5.1 m-20 -112.34 110.66 21.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.737 0.303 . . . . 0.0 111.078 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 m -106.38 132.98 51.78 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.7 mt -67.41 136.34 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.83 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.485 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.6 p30 -104.34 -174.46 2.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.355 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -52.79 -33.41 48.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.481 0.488 . . . . 0.0 112.098 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.68 -28.18 69.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.786 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.06 -4.04 48.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.514 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -104.87 146.08 31.95 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.808 0.337 . . . . 0.0 110.524 179.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 37.1 Cg_endo -67.52 130.6 22.6 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.805 2.337 . . . . 0.0 112.137 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -118.96 132.38 56.07 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.743 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.82 126.25 27.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.41 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 t -143.03 158.7 43.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.649 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 p -138.98 151.17 46.64 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.542 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -136.25 147.24 28.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.316 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 18' ' ' ILE . 8.6 m120 -104.38 96.05 6.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.897 0.379 . . . . 0.0 110.785 179.299 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.889 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -60.39 -28.5 68.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.008 -179.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.471 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 24.4 t-20 -55.81 -26.56 46.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.2 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.05 11.93 22.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.484 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.654 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.9 m-85 -128.71 -20.28 3.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -114.69 141.32 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.609 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.32 176.54 17.05 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.105 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -116.71 106.62 13.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.889 0.376 . . . . 0.0 110.695 -178.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -111.87 107.27 16.25 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.376 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.848 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 55.1 t30 56.02 40.79 30.27 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.037 0.446 . . . . 0.0 110.533 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.41 19.6 79.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.509 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -123.89 157.06 35.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.848 0.356 . . . . 0.0 110.568 -179.584 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.05 116.63 21.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.234 -178.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.18 128.77 51.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.596 179.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.706 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.83 -76.22 0.04 OUTLIER Pre-proline 0 CA--C 1.43 -3.639 0 CA-C-O 117.697 -1.144 . . . . 0.0 112.819 -179.825 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.706 ' HD3' ' HB2' ' A' ' 50' ' ' TYR . 6.0 Cg_endo -108.68 123.98 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.273 1 C-N-CA 113.199 -4.067 . . . . 0.0 113.083 -178.661 . . . . . . . . 4 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.609 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -152.35 -160.75 9.77 Favored Glycine 0 C--N 1.281 -2.509 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.939 -177.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -154.87 142.76 20.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.693 0.282 . . . . 0.0 110.583 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.1 m 56.48 42.49 27.34 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.184 178.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 14.9 p90 -71.75 -35.61 70.17 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.07 -18.69 48.98 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.321 -178.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 m -64.4 -16.55 62.55 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.06 0.544 . . . . 0.0 111.01 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 m -148.22 23.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.884 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.7 m -129.99 138.67 50.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.26 0.552 . . . . 0.0 111.093 -179.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.416 HG23 ' HG2' ' A' ' 61' ' ' LYS . 25.1 m -133.06 178.09 6.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.295 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HG2' HG23 ' A' ' 60' ' ' VAL . 34.4 mmtp 62.81 37.09 12.6 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.415 0.447 . . . . 0.0 111.329 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.478 HG21 ' O ' ' A' ' 16' ' ' GLY . 12.6 p -67.84 123.2 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.86 149.73 27.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.92 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.732 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -106.34 115.01 29.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.853 0.359 . . . . 0.0 110.724 -179.639 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -85.94 120.37 27.27 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.195 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.69 23.36 10.98 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.924 0.765 . . . . 0.0 111.925 179.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.93 32.19 59.1 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 114.361 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -148.09 -25.15 0.35 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.376 0.588 . . . . 0.0 111.436 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.6 m -114.81 126.39 54.77 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.777 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.535 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.0 tp -89.83 132.72 35.11 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.45 129.56 52.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.748 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.19 166.93 28.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 110.521 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 t -114.79 122.66 47.05 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 57.2 m -122.44 149.68 43.52 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.47 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.414 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 9.4 tmtt? -99.96 140.45 34.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.824 178.148 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.61 -32.07 0.3 Allowed Glycine 0 C--O 1.227 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.18 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.848 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -52.95 -41.16 64.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -173.55 52.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.618 0.723 . . . . 0.0 109.811 -179.094 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.414 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 69.21 10.01 61.65 Favored Glycine 0 C--O 1.225 -0.418 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.096 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -131.78 158.67 40.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 17.4 p90 -100.72 166.3 10.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -158.53 149.12 20.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -69.59 139.33 53.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.931 0.396 . . . . 0.0 110.636 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.42 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 34.3 t -152.01 162.99 40.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.038 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.58 164.55 27.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.908 0.385 . . . . 0.0 110.021 179.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.813 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 2.6 tpt -148.7 121.38 8.63 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.689 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 19.2 m-20 -73.94 106.5 5.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.709 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.3 mt -75.76 -9.11 58.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.523 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.38 -31.33 3.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.079 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.562 ' HE1' ' HD2' ' A' ' 50' ' ' TYR . 3.2 p90 -119.57 23.59 11.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 111.564 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -127.53 -14.35 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.102 0.477 . . . . 0.0 110.505 178.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.966 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.5 p -150.79 133.81 6.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.691 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -128.03 -179.82 16.08 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.523 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.449 HD22 ' HB2' ' A' ' 8' ' ' SER . 14.8 t30 -126.01 135.85 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.533 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 5.0 t -147.66 120.61 8.77 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 57.99 41.49 24.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 60.58 28.98 68.59 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.764 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -136.29 151.44 49.64 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.835 0.35 . . . . 0.0 110.139 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.431 ' O ' ' HG3' ' A' ' 99' ' ' MET . 20.0 ptt? -61.9 127.89 33.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.071 -179.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 95' ' ' SER . 14.2 mm-40 -140.45 71.48 32.02 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.246 178.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.966 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 51.7 Cg_endo -70.91 100.73 0.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.77 2.314 . . . . 0.0 112.871 -179.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.031 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.582 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 83.3 m . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 44.2 m-80 62.51 80.5 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 178.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.645 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 6.2 p90 -65.01 -35.87 82.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.066 178.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.9 64.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.871 -178.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 7.3 t-20 -52.18 -31.27 30.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.51 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.422 ' HB2' HD22 ' A' ' 94' ' ' ASN . 59.0 m -144.12 30.77 1.27 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.893 0.378 . . . . 0.0 110.721 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -119.48 142.17 48.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.024 179.156 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -141.44 157.53 45.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.395 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.79 61.03 7.66 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.723 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.584 HG12 ' HA3' ' A' ' 21' ' ' GLY . 30.9 m -100.71 139.02 23.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.91 0.386 . . . . 0.0 110.991 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 11.3 pt-20 -130.32 139.72 50.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.393 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.72 HD22 HD23 ' A' ' 64' ' ' LEU . 51.9 tp -124.62 123.74 40.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.484 ' O ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-85 -133.67 103.65 5.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.412 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 62' ' ' THR . . . 79.37 -65.2 3.67 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.161 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.6 p90 -167.6 21.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.813 0.339 . . . . 0.0 111.313 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 45.6 pt -117.02 129.05 74.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.47 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.917 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -119.79 114.45 22.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.609 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 21.2 ttm180 -114.0 136.0 53.38 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.584 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -154.93 168.32 32.89 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.399 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.657 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 17.8 m-20 -100.66 105.15 16.49 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -104.97 131.79 52.02 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 60.4 mt -70.71 136.2 26.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.646 -178.399 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -99.73 -176.5 3.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.404 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.37 -32.79 57.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.89 -29.04 69.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.022 0.439 . . . . 0.0 111.66 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.12 0.8 41.5 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.096 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -107.56 141.52 23.2 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.791 0.329 . . . . 0.0 110.656 179.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.657 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 36.5 Cg_endo -67.62 130.23 21.69 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 122.966 2.444 . . . . 0.0 112.532 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -114.72 132.61 56.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.95 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.38 124.27 23.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.171 0.51 . . . . 0.0 111.638 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 t -143.22 152.94 42.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.413 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 12.7 p -135.7 145.5 46.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.506 0.193 . . . . 0.0 111.117 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.84 151.81 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.788 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.491 ' ND2' HG22 ' A' ' 18' ' ' ILE . 5.4 m120 -103.07 93.61 5.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.171 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.917 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -60.18 -24.48 64.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.797 -178.911 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.5 t-20 -55.09 -30.9 60.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.969 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -105.7 15.17 27.27 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.537 -178.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.1 m-85 -130.38 -24.62 2.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.3 mp -112.71 141.78 27.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.671 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -114.35 169.7 12.99 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.547 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -119.33 114.2 21.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.973 0.416 . . . . 0.0 110.933 -179.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -111.02 108.12 17.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.241 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 51.87 42.56 30.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.077 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 74' ' ' CYS . . . 80.07 18.05 73.03 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.539 179.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.67 150.17 46.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.047 0.451 . . . . 0.0 111.2 -179.83 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.468 HD13 ' HG ' ' A' ' 70' ' ' LEU . 43.4 mt -82.43 116.19 21.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.14 -179.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -112.49 132.04 55.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.583 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -33.17 -73.67 0.06 OUTLIER Pre-proline 0 CA--C 1.427 -3.765 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.598 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.583 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 4.9 Cg_endo -107.85 130.48 0.05 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.327 0 C-N-CA 113.563 -3.824 . . . . 0.0 113.212 -176.669 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.671 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -163.89 -160.46 11.8 Favored Glycine 0 C--N 1.286 -2.204 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.322 -177.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -151.53 145.53 25.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 111.401 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m 51.57 41.79 28.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.774 178.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -69.33 -39.37 78.23 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.523 178.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.03 -18.08 46.54 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.24 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 t -68.82 -20.44 64.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.002 0.43 . . . . 0.0 110.166 179.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -134.49 17.25 3.66 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.402 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.7 m -125.8 143.13 51.19 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.97 0.414 . . . . 0.0 111.17 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.31 172.81 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.454 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 62.0 37.54 14.85 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.597 0.56 . . . . 0.0 111.359 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 16' ' ' GLY . 18.0 p -63.94 127.43 31.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.972 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.55 160.28 43.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.231 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.72 HD23 HD22 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -118.54 112.92 20.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.805 0.336 . . . . 0.0 110.967 -179.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.593 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 15.9 m120 -70.28 114.61 8.58 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.316 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.57 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 27.7 t70 55.2 3.32 0.06 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.145 0.903 . . . . 0.0 112.766 179.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 86.84 47.78 4.66 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.475 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 2.2 p-80 -162.04 -30.06 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 111.684 178.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 23.9 m -115.89 134.15 55.28 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.692 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.605 ' HB2' HD11 ' A' ' 88' ' ' LEU . 12.3 tp -94.92 131.24 41.06 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.541 0.21 . . . . 0.0 110.482 179.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 128.99 53.81 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.77 162.57 37.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.165 0.507 . . . . 0.0 111.149 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -110.76 120.95 44.09 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.466 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 21.3 m -121.36 148.21 44.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.277 0.56 . . . . 0.0 112.303 -177.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 8.2 tmtt? -99.41 147.48 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.226 178.046 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.68 -18.55 0.87 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.005 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.72 81.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.823 0.311 . . . . 0.0 110.815 179.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.7 t70 179.13 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.205 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.49 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 71.52 -3.75 16.22 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.635 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -116.19 161.51 18.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 44.3 p90 -106.11 166.58 10.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.299 -179.473 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -154.97 143.16 20.28 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.4 127.55 32.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.78 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 p -141.4 174.72 10.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.13 162.49 34.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 0.0 110.791 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.795 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.2 tpt -148.66 117.18 6.55 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.575 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.563 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 26.4 t70 -76.68 106.75 8.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.708 ' HA ' HG22 ' A' ' 91' ' ' VAL . 12.5 mt -78.85 -10.05 59.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.387 -177.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -58.44 -16.72 16.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.06 -179.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.563 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 48.2 p90 -119.45 19.43 12.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.174 0.512 . . . . 0.0 110.823 177.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.708 HG22 ' HA ' ' A' ' 88' ' ' LEU . 2.6 m -125.52 -6.63 5.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.479 0.657 . . . . 0.0 109.84 177.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 9.9 p -153.06 147.02 14.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.937 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.71 -177.09 14.71 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.793 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.422 HD22 ' HB2' ' A' ' 8' ' ' SER . 17.3 t30 -122.71 127.01 48.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.716 0.293 . . . . 0.0 110.65 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.6 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 58.2 m -127.68 92.9 3.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.77 178.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 60.99 54.29 3.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.996 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.25 27.37 62.8 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.965 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.88 142.83 51.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.898 0.38 . . . . 0.0 110.52 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 99' ' ' MET . 21.5 ptt? -62.22 121.21 12.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.547 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.6 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 12.7 mm-40 -138.43 80.93 25.94 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.199 178.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 42.3 Cg_endo -68.67 102.06 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.909 2.406 . . . . 0.0 112.064 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.043 179.66 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.607 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 2.1 m . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 56.73 70.38 0.66 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.162 0.289 . . . . 0.0 110.863 179.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 6.8 p90 -58.35 -38.35 77.03 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.071 0.462 . . . . 0.0 111.582 -178.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.91 -22.6 65.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -69.37 -19.48 63.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.784 0.326 . . . . 0.0 111.312 -178.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.2 m -128.94 10.01 5.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.154 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -118.29 138.55 52.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.218 0.532 . . . . 0.0 111.475 -179.615 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.7 p -132.48 151.42 51.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.921 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.03 49.22 80.88 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.947 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.517 ' HB ' HD22 ' A' ' 19' ' ' LEU . 15.7 m -83.39 127.53 39.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.275 0.56 . . . . 0.0 111.493 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -116.29 137.35 52.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.31 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.841 HD22 HD23 ' A' ' 64' ' ' LEU . 59.4 tp -119.08 129.05 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 111.763 -178.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.506 ' O ' HG12 ' A' ' 18' ' ' ILE . 52.5 m-85 -133.91 103.49 5.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.624 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.34 -66.82 2.24 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.655 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.712 ' HD1' HD21 ' A' ' 36' ' ' ASN . 5.8 p90 -164.18 21.02 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.993 0.425 . . . . 0.0 111.089 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.2 pt -121.42 127.28 75.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.176 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.853 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.5 mt -113.18 114.12 26.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.346 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 34' ' ' SER . 10.8 ttm180 -116.49 132.39 56.69 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.577 178.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.42 -173.56 26.0 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.052 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.622 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.7 m-20 -109.04 109.65 20.72 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.719 0.295 . . . . 0.0 110.384 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -106.79 132.54 52.64 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.267 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.9 mt -72.97 138.4 21.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.558 -178.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -102.94 -166.77 1.31 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.762 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.36 -28.41 69.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.907 0.384 . . . . 0.0 111.623 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.58 -26.89 68.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.649 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.83 -2.9 55.74 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.217 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -104.42 142.53 24.81 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.888 0.375 . . . . 0.0 110.707 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.622 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 31.5 Cg_endo -67.41 133.46 30.29 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.817 2.345 . . . . 0.0 112.158 178.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -115.74 139.0 50.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.528 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.24 119.83 16.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.012 0.435 . . . . 0.0 111.291 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -142.19 153.04 43.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.035 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.543 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 5.1 p -138.2 136.25 36.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.664 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.75 144.17 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.829 -179.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.712 HD21 ' HD1' ' A' ' 17' ' ' TYR . 1.8 t-20 -103.62 87.51 2.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -57.78 -18.16 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.034 -178.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' A' ' 54' ' ' SER . 0.2 OUTLIER -52.95 -32.33 45.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.69 -178.489 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -107.1 18.58 21.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.7 0.286 . . . . 0.0 111.307 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -125.66 -30.1 3.09 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.68 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.5 mp -111.08 143.13 21.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.717 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -116.88 166.92 12.46 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.645 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -109.78 110.07 20.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.442 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -110.15 105.19 14.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.468 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.739 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 22.2 t30 54.48 41.53 31.9 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.897 178.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.43 4.77 89.17 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.083 179.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.84 151.63 33.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.025 0.441 . . . . 0.0 111.131 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 84' ' ' SER . 10.8 mp -84.03 127.94 34.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.753 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -120.18 138.89 53.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.536 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.753 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -40.47 -69.31 0.21 Allowed Pre-proline 0 CA--C 1.429 -3.692 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.197 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.753 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 8.1 Cg_endo -109.73 124.9 0.03 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.46 0 C-N-CA 114.054 -3.498 . . . . 0.0 113.551 -177.28 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.717 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.4 -161.79 11.8 Favored Glycine 0 C--N 1.281 -2.505 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.006 -177.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -153.04 143.75 22.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.758 0.328 . . . . 0.0 110.643 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.472 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 8.2 t 60.22 45.2 11.77 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.824 177.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.48 ' CE2' HD21 ' A' ' 70' ' ' LEU . 9.2 p90 -80.88 -37.43 29.8 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.732 -0.605 . . . . 0.0 110.069 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.74 -18.42 68.27 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.33 -178.085 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.3 m -68.9 -25.59 64.68 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.85 0.357 . . . . 0.0 110.929 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.7 p -123.76 0.6 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.375 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.5 m -107.77 151.78 25.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.058 0.456 . . . . 0.0 111.14 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' HD3' ' A' ' 61' ' ' LYS . 17.2 m -143.09 168.53 13.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.406 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.515 ' HD3' HG23 ' A' ' 60' ' ' VAL . 14.0 mptt 64.4 36.4 9.0 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.542 0.526 . . . . 0.0 110.751 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.4 p -63.97 132.03 49.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.087 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.17 162.17 41.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.801 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.841 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -123.04 112.91 18.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.773 0.321 . . . . 0.0 111.335 -179.401 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -82.35 123.27 28.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.266 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.763 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.6 t70 57.59 17.47 4.0 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.01 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.68 29.9 76.14 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.401 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.763 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 6.1 p80 -143.39 -30.41 0.5 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 117.458 0.629 . . . . 0.0 111.391 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.8 m -105.43 125.37 50.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.099 0.476 . . . . 0.0 111.615 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.696 ' HB2' HD11 ' A' ' 88' ' ' LEU . 14.0 tp -90.54 129.29 36.71 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.0 OUTLIER -122.65 129.01 51.37 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 179.987 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.87 169.38 21.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.27 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.541 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 14.6 t -119.25 121.02 38.72 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.72 155.86 26.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.657 0.741 . . . . 0.0 111.856 -179.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.47 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 10.7 tmtt? -101.04 148.25 25.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.371 178.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.33 -32.66 0.54 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.433 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.739 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -55.0 -43.42 73.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -173.5 56.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 110.661 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 71.55 -1.03 31.12 Favored Glycine 0 CA--C 1.516 0.147 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.783 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -119.01 168.54 10.71 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 42.8 p90 -110.27 161.38 15.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.119 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -153.01 135.17 14.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -61.87 134.4 56.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.966 -179.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.448 ' HB3' HD13 ' A' ' 48' ' ' LEU . 41.6 t -147.65 157.78 43.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.057 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.5 OUTLIER -131.63 162.13 31.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.363 . . . . 0.0 110.338 179.393 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.707 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 17.9 tpp -150.37 127.69 11.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.548 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.734 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 22.3 t0 -80.77 111.22 17.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.805 ' HA ' HG22 ' A' ' 91' ' ' VAL . 11.4 mt -81.33 -8.71 59.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.43 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -52.6 -26.09 12.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.888 179.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.734 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 25.5 p90 -116.66 19.05 14.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.772 0.32 . . . . 0.0 111.093 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.805 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -129.55 -12.41 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.232 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.7 t -131.26 147.12 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.607 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -138.47 172.89 22.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.907 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.437 HD22 ' HB2' ' A' ' 8' ' ' SER . 17.3 t30 -130.31 123.58 30.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.439 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.627 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 75.6 m -124.82 98.63 5.79 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.219 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 62.59 48.36 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.352 179.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.01 21.55 65.85 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.176 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -121.81 139.24 53.86 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.607 0.241 . . . . 0.0 110.379 -179.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.468 ' O ' ' HG3' ' A' ' 99' ' ' MET . 22.2 ptt? -59.28 117.27 4.6 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.589 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.627 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 4.5 mm-40 -142.76 71.83 19.74 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.059 0.457 . . . . 0.0 110.654 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 51.8 Cg_endo -69.26 114.16 3.53 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.908 2.405 . . . . 0.0 112.772 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.999 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.48 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 74.1 m . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.424 0.154 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 55.72 69.88 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 10.7 p90 -57.58 -39.51 76.93 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.324 0.583 . . . . 0.0 110.496 179.067 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.75 -22.34 61.95 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -177.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -72.01 -6.17 40.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.441 ' CB ' HD22 ' A' ' 94' ' ' ASN . 40.5 m -146.85 18.19 1.27 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.971 0.415 . . . . 0.0 110.399 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.5 m -127.31 133.39 50.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.786 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.9 p -136.13 154.59 50.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.11 57.38 10.76 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.649 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 31.5 m -93.24 138.2 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.297 0.57 . . . . 0.0 112.3 -178.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 43.2 mt-10 -126.67 144.26 50.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.825 179.073 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.74 HD22 HD23 ' A' ' 64' ' ' LEU . 12.2 tp -127.97 110.59 12.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.388 179.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' HG12 ' A' ' 18' ' ' ILE . 83.2 t80 -116.95 101.61 8.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.055 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.31 -65.7 2.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.97 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 6.2 p90 -162.57 18.99 0.09 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.2 pt -118.79 131.52 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.342 . . . . 0.0 110.614 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.866 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.45 113.81 26.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.087 -179.522 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 7.8 ttm180 -113.67 139.38 49.1 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.158 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.21 165.0 34.15 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.449 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 6.0 m-20 -97.07 102.56 14.37 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.013 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 8' ' ' SER . 60.0 m -105.95 132.78 51.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mt -69.55 132.18 33.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.018 0.437 . . . . 0.0 111.184 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -103.57 -170.9 1.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.955 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.63 -28.92 61.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 111.712 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.24 -25.54 68.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.869 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.61 -1.02 63.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.629 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -110.03 142.88 26.83 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.632 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 25.9 Cg_endo -63.36 122.3 10.42 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.062 2.508 . . . . 0.0 112.326 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -107.63 132.53 53.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.24 117.25 15.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.142 0.496 . . . . 0.0 111.469 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -133.52 160.85 36.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.286 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 64.5 p -136.43 147.49 47.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.22 142.7 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.94 88.5 3.56 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -54.36 -29.37 48.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.705 -178.342 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 24.5 t-20 -52.87 -35.8 58.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.82 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -100.9 12.47 37.56 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.792 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.636 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.7 m-85 -126.02 -23.55 3.91 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -114.26 141.56 30.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.643 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.5 169.14 12.76 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.153 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -117.42 110.49 18.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 111.305 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.57 108.82 18.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.725 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 47.75 48.34 17.48 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.256 1.022 . . . . 0.0 112.791 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.16 15.04 81.61 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.711 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.64 149.65 46.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.042 0.448 . . . . 0.0 111.591 -179.362 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 10.0 mp -81.1 123.44 28.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.984 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 43.1 tp10 -114.99 131.97 56.75 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.713 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.35 -70.62 0.13 Allowed Pre-proline 0 CA--C 1.426 -3.816 0 CA-C-O 118.142 -0.932 . . . . 0.0 113.48 -179.213 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.713 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 10.2 Cg_endo -109.43 127.04 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.284 0 C-N-CA 113.724 -3.717 . . . . 0.0 113.399 -177.855 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.643 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -158.93 -160.64 10.5 Favored Glycine 0 C--N 1.281 -2.485 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.78 -177.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -153.42 138.82 17.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.831 0.371 . . . . 0.0 111.041 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 m 59.44 42.7 17.42 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 178.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -72.43 -36.18 68.51 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.56 -17.89 54.76 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.031 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -71.6 -12.94 61.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.295 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 p -144.73 13.59 1.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 111.149 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.4 m -125.87 149.51 48.62 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.019 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.433 HG23 ' HD3' ' A' ' 61' ' ' LYS . 18.0 m -140.79 174.3 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.176 179.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.7 mptt 64.31 39.72 7.06 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.402 0.439 . . . . 0.0 111.32 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -68.32 120.81 15.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.391 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.43 162.33 39.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -118.68 112.86 20.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.681 -178.893 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.604 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 13.4 m120 -76.7 118.33 19.22 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.989 179.208 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.749 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.3 t70 54.66 19.64 2.57 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.869 0.731 . . . . 0.0 111.632 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.87 30.69 78.66 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.531 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.749 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 5.2 p80 -142.09 -26.04 0.66 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 117.538 0.669 . . . . 0.0 111.803 179.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 22.2 m -116.5 128.4 55.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.642 0.258 . . . . 0.0 111.489 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.53 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.7 tp -93.26 129.58 39.27 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.01 130.23 54.63 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.764 0.316 . . . . 0.0 110.512 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.58 156.75 30.68 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.515 178.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.566 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 9.5 t -106.34 125.55 51.14 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 22.9 m -122.7 150.99 41.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.231 0.539 . . . . 0.0 112.408 -178.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 11.0 tmtt? -100.14 148.92 24.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.138 177.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.47 -14.01 1.82 Allowed Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.098 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.12 -38.05 78.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.576 0.227 . . . . 0.0 110.986 179.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -175.81 54.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.255 0.55 . . . . 0.0 110.336 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.443 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 73.63 -7.38 13.68 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.402 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -117.84 168.99 9.98 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.566 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 53.4 p90 -111.03 162.34 14.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -148.89 149.32 31.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.08 141.98 47.57 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.406 ' HB3' HD13 ' A' ' 48' ' ' LEU . 41.8 t -151.08 157.07 42.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.013 0.435 . . . . 0.0 110.235 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.22 164.18 26.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.842 179.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.676 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.6 tpt -150.02 121.45 7.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.862 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -75.75 106.11 7.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.367 0.603 . . . . 0.0 109.405 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.747 ' HA ' HG22 ' A' ' 91' ' ' VAL . 19.6 mt -72.74 -8.36 55.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.01 -179.253 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.89 -31.39 5.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.549 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -116.85 23.31 12.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.738 0.304 . . . . 0.0 111.23 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.747 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -130.48 -12.22 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.143 178.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.846 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.2 t -136.83 142.83 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -137.88 162.64 25.58 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.441 HD22 ' CB ' ' A' ' 8' ' ' SER . 34.3 t30 -108.31 113.66 26.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.059 0.457 . . . . 0.0 110.489 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.529 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 70.9 m -116.74 82.88 1.87 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.417 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 62.99 55.99 1.89 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.171 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.36 27.28 57.85 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.77 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.1 141.01 51.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.025 0.44 . . . . 0.0 110.674 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.407 ' O ' ' HG3' ' A' ' 99' ' ' MET . 18.3 ptm -61.04 97.29 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.472 179.055 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 11.5 mm-40 -129.06 78.17 76.67 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.136 0.493 . . . . 0.0 111.007 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.846 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 61.0 Cg_endo -75.22 96.02 1.01 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.47 2.113 . . . . 0.0 112.26 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.316 -0.891 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.927 179.833 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.545 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 75.1 m . . . . . 0 N--CA 1.449 -0.505 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.54 ' HB3' ' CG ' ' A' ' 7' ' ' ASN . 16.4 m-20 53.26 66.56 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.539 0.524 . . . . 0.0 112.071 177.89 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 11.3 p90 -61.79 -39.3 91.24 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 111.053 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.66 -22.61 61.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.505 -178.15 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.54 ' CG ' ' HB3' ' A' ' 4' ' ' ASN . 4.1 m-20 -71.68 -7.07 45.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.969 0.414 . . . . 0.0 111.32 -178.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 31.2 m -138.49 15.44 2.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.178 179.249 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -127.2 140.65 52.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.147 -179.625 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 p -136.27 148.53 48.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.571 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.69 47.82 46.49 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.383 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.554 HG12 ' HA3' ' A' ' 21' ' ' GLY . 24.4 m -89.69 143.63 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.996 0.427 . . . . 0.0 111.252 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 6.3 tp10 -141.61 146.16 35.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.097 179.308 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.742 HD22 HD23 ' A' ' 64' ' ' LEU . 49.9 tp -126.76 123.32 37.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 111.403 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.0 t80 -132.82 112.74 12.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.714 178.394 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.88 -68.24 2.27 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.677 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.0 p90 -166.0 18.7 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 122.594 0.357 . . . . 0.0 111.114 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.581 HG22 ' ND2' ' A' ' 36' ' ' ASN . 41.6 pt -119.65 125.12 74.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.051 0.453 . . . . 0.0 110.891 -178.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.845 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -111.06 115.15 28.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.704 179.627 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.6 ttm180 -116.24 136.47 52.98 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.554 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -161.46 169.73 37.04 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.92 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.4 m-20 -101.39 110.86 22.94 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.3 m -105.72 132.78 51.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 57.9 mt -68.65 136.53 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.438 -178.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -102.28 -175.18 2.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -55.42 -27.8 50.19 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.33 -23.44 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 0.0 111.768 -179.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.79 5.21 57.67 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.357 -179.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -111.65 142.52 26.76 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.286 -0.457 . . . . 0.0 109.87 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 56.1 Cg_endo -71.94 133.77 22.28 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.833 2.355 . . . . 0.0 112.536 179.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -119.97 131.55 55.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.695 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.82 126.35 28.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.145 0.498 . . . . 0.0 111.643 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 t -140.43 156.59 46.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.645 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -130.54 148.75 52.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.47 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.81 146.75 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.818 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.581 ' ND2' HG22 ' A' ' 18' ' ' ILE . 8.3 m120 -105.43 96.17 6.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.23 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.845 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -63.07 -25.96 68.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.048 -178.216 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.539 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.0 t-20 -56.31 -27.51 55.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.03 -179.096 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -107.56 11.63 28.48 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.646 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 47.2 m-85 -128.02 -23.21 3.36 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.528 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -111.52 140.81 29.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.69 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.83 163.34 12.22 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.268 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -112.43 106.62 15.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.183 -0.508 . . . . 0.0 110.176 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -111.51 107.17 16.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.373 -179.401 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 m120 57.86 42.13 23.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.306 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 74.47 17.49 79.83 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.849 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.76 143.04 51.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.036 0.446 . . . . 0.0 111.385 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.565 HD13 ' HG ' ' A' ' 70' ' ' LEU . 33.6 mt -73.16 124.02 24.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.618 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -117.21 137.15 52.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.798 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.1 -71.46 0.11 Allowed Pre-proline 0 CA--C 1.429 -3.687 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.798 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 11.6 Cg_endo -111.45 126.78 0.03 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.366 0 C-N-CA 114.09 -3.473 . . . . 0.0 113.12 -177.573 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.69 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -159.89 -162.07 11.92 Favored Glycine 0 C--N 1.28 -2.547 0 CA-C-N 113.833 -1.531 . . . . 0.0 113.345 -177.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -152.76 142.16 21.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.531 -0.334 . . . . 0.0 111.015 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 m 55.32 43.16 29.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.539 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 17.7 p90 -70.24 -34.82 73.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.13 -18.38 27.29 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.545 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.1 t -52.7 -47.29 67.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.791 0.329 . . . . 0.0 110.544 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 42.8 m -119.7 12.39 12.2 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.0 m -111.14 137.47 48.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 111.903 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.8 m -136.67 175.56 9.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.393 178.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 60.82 43.19 12.31 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.915 0.388 . . . . 0.0 111.038 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 p -67.77 130.09 41.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.208 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.65 163.33 39.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.434 179.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.742 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -122.56 113.02 18.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.948 0.404 . . . . 0.0 111.642 -179.55 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -83.68 122.08 28.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.618 179.195 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.786 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 30.2 t70 58.01 16.95 4.06 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.93 0.769 . . . . 0.0 111.347 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.62 29.32 74.89 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.464 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.786 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 5.9 p80 -143.51 -28.22 0.54 Allowed 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 117.243 0.521 . . . . 0.0 111.471 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -110.51 129.65 55.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.802 0.334 . . . . 0.0 111.769 -179.077 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.565 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.4 tp -90.04 129.53 36.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.041 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.16 130.38 53.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.538 179.102 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.35 168.02 27.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.825 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.443 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 9.1 t -113.95 123.39 49.63 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.463 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 14.2 m -126.13 147.61 49.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -177.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.0 tmtt? -99.96 144.65 28.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.471 177.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.95 -26.31 0.63 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.684 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.75 80.31 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -171.58 52.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.83 2.2 50.41 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.431 -179.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -122.34 158.11 30.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.8 p90 -98.82 162.79 12.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.434 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -158.45 144.47 16.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -73.65 142.38 46.46 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.52 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.468 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 31.5 p -152.36 172.97 15.65 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.927 179.27 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -143.78 156.05 44.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.137 0.494 . . . . 0.0 111.016 -179.924 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.633 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 13.3 tpp -142.17 121.35 13.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.742 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.619 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 22.9 t0 -74.66 106.27 6.15 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.1 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.78 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.8 mt -78.82 -9.11 59.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.549 -178.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -52.26 -26.57 12.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.07 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.619 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 39.7 p90 -115.9 17.79 15.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.176 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.78 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -125.31 -11.69 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.985 0.422 . . . . 0.0 110.49 178.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.938 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.6 t -134.04 144.57 35.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.203 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.545 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -138.05 174.66 21.79 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.071 179.126 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.4 HD22 ' CB ' ' A' ' 8' ' ' SER . 27.3 t30 -122.98 134.54 54.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.834 0.35 . . . . 0.0 110.478 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.63 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 5.4 t -145.35 104.59 3.94 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 61.69 44.27 9.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.085 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.26 34.53 67.66 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.542 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -131.43 142.95 50.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.547 ' O ' ' HG3' ' A' ' 99' ' ' MET . 14.7 ptt? -59.34 114.9 2.89 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.764 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.63 ' HG3' ' HB3' ' A' ' 95' ' ' SER . 6.2 mm-40 -135.23 73.14 65.0 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.197 178.841 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.938 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 46.4 Cg_endo -70.38 96.06 0.63 Allowed 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.471 2.114 . . . . 0.0 112.56 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--N 1.316 -0.875 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.055 179.692 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.612 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 59.5 m . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.856 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 70.5 m-20 59.73 67.15 0.91 Allowed 'General case' 0 N--CA 1.462 0.148 0 O-C-N 123.145 0.278 . . . . 0.0 111.738 177.892 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.6 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 12.0 p90 -59.57 -42.75 93.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.296 0.569 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.74 -21.18 63.48 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.377 -178.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.856 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 65.9 t30 -60.33 -24.06 64.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.366 -178.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB2' HD22 ' A' ' 94' ' ' ASN . 41.0 m -136.92 25.5 3.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.459 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -125.64 134.88 51.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.823 179.634 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.1 p -131.41 158.71 40.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.739 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.89 61.37 7.26 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.588 179.054 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 27.8 m -95.65 149.96 4.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.081 0.467 . . . . 0.0 111.328 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -138.67 140.16 38.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.031 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.922 HD22 HD23 ' A' ' 64' ' ' LEU . 40.2 tp -126.41 122.68 36.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 110.993 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.552 ' O ' HG12 ' A' ' 18' ' ' ILE . 92.2 m-85 -130.09 106.3 8.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.334 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.74 -66.98 2.35 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.495 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.616 ' HD1' HD21 ' A' ' 36' ' ' ASN . 2.2 p90 -165.58 22.65 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.621 0.369 . . . . 0.0 111.209 179.794 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 15' ' ' TYR . 34.0 pt -119.86 127.48 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 110.263 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.767 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.3 mt -112.78 119.87 39.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.415 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 1.4 ttt180 -120.32 138.01 53.94 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.36 175.16 40.45 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.517 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 23.4 m-20 -101.61 107.07 18.22 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 m -105.28 132.63 51.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mt -67.45 134.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.019 0.438 . . . . 0.0 111.511 -178.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -103.26 -171.44 1.94 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.45 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -51.32 -41.34 60.48 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.469 0.481 . . . . 0.0 111.846 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -59.79 -27.53 66.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.496 -179.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.75 -0.3 52.38 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.444 -178.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -105.51 138.44 19.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.554 0.693 . . . . 0.0 110.948 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 28.7 Cg_endo -60.76 121.25 9.41 Favored 'Trans proline' 0 C--N 1.329 -0.475 0 C-N-CA 124.207 3.271 . . . . 0.0 112.027 178.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -111.92 126.79 55.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.941 -179.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.32 126.94 29.77 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.008 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 t -142.93 160.16 40.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.373 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.1 p -133.35 148.17 51.85 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.765 0.316 . . . . 0.0 110.601 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -133.69 143.95 37.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.616 HD21 ' HD1' ' A' ' 17' ' ' TYR . 2.1 t-20 -103.2 96.29 6.68 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.347 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -59.5 -22.17 61.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.919 -178.567 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -55.08 -31.53 61.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.768 -179.31 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -102.92 8.92 39.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.736 -179.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 43.8 m-85 -126.37 -22.63 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.576 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -114.1 139.13 41.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.122 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.633 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -112.32 170.06 13.36 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.718 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -115.33 107.44 15.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.901 0.381 . . . . 0.0 110.619 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -106.99 106.22 16.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.071 179.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 50.65 42.22 26.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.196 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 74' ' ' CYS . . . 82.47 15.13 74.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.512 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.93 145.79 48.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.226 0.536 . . . . 0.0 111.011 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.522 HD13 ' HG ' ' A' ' 70' ' ' LEU . 23.7 mt -74.98 116.32 15.59 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.47 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.8 tt0 -107.53 132.31 53.39 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.868 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -39.0 -66.22 0.34 Allowed Pre-proline 0 CA--C 1.431 -3.634 0 CA-C-O 117.385 -1.293 . . . . 0.0 114.408 -179.195 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.868 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 5.6 Cg_endo -112.67 119.47 0.02 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.219 0 C-N-CA 113.552 -3.832 . . . . 0.0 113.361 -178.296 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.633 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -154.75 -163.9 12.44 Favored Glycine 0 C--N 1.275 -2.82 0 CA-C-N 113.754 -1.566 . . . . 0.0 113.745 -177.402 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -153.14 142.02 21.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.6 45.53 16.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.586 177.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -75.66 -38.96 58.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.916 0.389 . . . . 0.0 110.408 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.04 -18.55 41.41 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.747 -178.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.0 m -59.74 -19.57 50.98 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.814 0.446 . . . . 0.0 111.602 179.378 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.0 m -144.49 26.04 1.47 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.668 179.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.6 m -127.69 144.65 51.06 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.23 0.538 . . . . 0.0 111.624 -179.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -136.82 172.8 14.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.474 179.038 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mptt 62.83 37.88 11.95 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.377 0.423 . . . . 0.0 111.192 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.2 p -68.81 122.26 18.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.152 0.501 . . . . 0.0 111.278 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.12 154.64 35.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.866 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.922 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -109.65 116.84 32.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.918 -179.344 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -84.05 118.86 24.34 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.701 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 33.2 t70 65.61 -1.92 0.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 124.199 0.937 . . . . 0.0 111.729 179.1 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.21 29.22 34.32 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.029 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.701 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 6.0 p80 -143.32 -29.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.056 0.428 . . . . 0.0 110.889 179.455 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.43 ' O ' HD13 ' A' ' 64' ' ' LEU . 15.9 m -113.39 130.28 56.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.354 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.547 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.9 tp -91.14 130.4 37.04 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.22 129.82 53.38 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.876 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.95 162.91 32.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.092 0.473 . . . . 0.0 110.868 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.444 ' HG ' ' HD2' ' A' ' 81' ' ' TYR . 12.7 t -111.02 122.57 48.23 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.7 m -122.77 149.0 44.7 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.532 0.682 . . . . 0.0 112.469 -177.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 10.2 tmtt? -99.17 142.34 30.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.229 178.152 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.13 -24.46 0.39 Allowed Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.661 179.4 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.59 88.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.872 0.368 . . . . 0.0 111.83 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -173.59 55.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.289 0.566 . . . . 0.0 109.5 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.4 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 69.32 -1.42 12.82 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.0 -179.097 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 24.9 pt20 -113.72 166.11 11.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.381 -178.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.4 p90 -106.2 168.84 8.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.239 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.88 133.19 5.28 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.51 123.17 23.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.93 0.395 . . . . 0.0 110.346 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 p -135.25 173.82 11.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.172 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.28 155.29 46.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.405 0.621 . . . . 0.0 111.241 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.5 tpp -141.22 115.39 9.3 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.472 179.056 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -72.2 108.05 5.16 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.497 0.665 . . . . 0.0 109.449 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.804 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.1 mt -77.64 -8.83 58.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.957 -178.19 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -51.14 -26.48 6.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.083 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -116.72 13.83 15.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.18 179.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.804 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -122.37 -8.76 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.201 0.524 . . . . 0.0 111.109 179.175 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.4 t -133.53 137.45 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.612 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -126.59 161.61 20.87 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.281 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.441 HD22 ' HB2' ' A' ' 8' ' ' SER . 14.3 t30 -114.49 129.64 56.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.876 0.37 . . . . 0.0 110.432 179.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.602 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 73.2 m -143.83 113.11 6.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.939 178.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 56.32 36.89 28.25 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 123.39 0.431 . . . . 0.0 111.196 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.75 22.06 63.78 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.791 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -118.85 145.98 45.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.804 0.335 . . . . 0.0 110.323 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 99' ' ' MET . 16.0 ptm -58.59 110.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.794 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 8.7 mm-40 -135.15 74.79 61.52 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.042 0.448 . . . . 0.0 110.654 178.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.2 Cg_endo -70.95 150.44 60.95 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.729 2.286 . . . . 0.0 112.592 -179.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 27.3 p . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.83 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 C--O 1.231 0.097 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 2.2 m-20 52.64 76.17 0.2 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.569 0.543 . . . . 0.0 111.525 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 68' ' ' HIS . 13.1 p90 -57.98 -44.28 87.05 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.149 0.499 . . . . 0.0 110.17 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.22 -21.34 65.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.587 -179.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.62 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 18.8 t-20 -57.72 -29.54 64.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.494 -178.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.488 ' HB2' HD22 ' A' ' 94' ' ' ASN . 13.5 m -132.94 17.46 4.18 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.62 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 80.9 m -117.96 133.49 55.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.777 0.322 . . . . 0.0 110.577 -179.255 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -130.59 149.28 52.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.749 -179.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.88 45.3 92.92 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.607 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.519 HG12 ' HA3' ' A' ' 21' ' ' GLY . 17.4 m -88.22 135.31 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.093 0.473 . . . . 0.0 111.353 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -129.45 156.41 44.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.169 -179.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.567 HD22 HD23 ' A' ' 64' ' ' LEU . 19.4 tp -130.03 125.01 34.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.976 0.417 . . . . 0.0 112.108 -178.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -126.32 99.18 5.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.12 178.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' HG21 ' A' ' 62' ' ' THR . . . 77.45 -62.43 3.46 Favored Glycine 0 C--O 1.226 -0.368 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.857 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.46 25.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.29 0.566 . . . . 0.0 110.141 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 12.8 mt -119.52 115.55 47.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.708 -179.169 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.832 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -103.8 113.62 27.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.201 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 4.5 ttm180 -122.73 142.83 50.27 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.732 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -170.19 179.54 42.35 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.165 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 11.7 m-20 -102.71 108.31 19.51 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 62.1 m -106.23 131.8 53.04 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.7 mt -75.37 136.29 25.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.33 0.586 . . . . 0.0 111.694 -177.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -102.97 -173.47 2.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.389 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -54.77 -36.55 64.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.932 0.396 . . . . 0.0 111.662 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.42 ' OD2' ' HB3' ' A' ' 29' ' ' HIS . 28.3 t70 -59.21 -27.56 65.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.73 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.04 1.33 57.13 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.845 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.42 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -106.19 140.1 20.94 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 121.302 0.572 . . . . 0.0 111.086 -179.994 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 30.2 Cg_endo -64.09 122.08 9.96 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 123.557 2.838 . . . . 0.0 112.454 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -105.3 130.02 53.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.51 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.65 115.69 12.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 t -136.73 156.88 47.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.063 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.428 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 35.3 p -140.06 142.75 36.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.732 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.12 144.91 35.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.864 0.364 . . . . 0.0 110.578 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -100.7 99.73 10.32 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -62.89 -22.23 66.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.76 -178.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.87 -32.81 64.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.09 -178.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -103.99 13.76 32.01 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.641 -178.291 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.569 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.7 m-85 -131.13 -17.27 3.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 37' ' ' LEU . 1.9 mp -118.6 142.05 35.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.564 0.221 . . . . 0.0 110.555 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.689 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -120.06 165.04 13.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.319 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -117.69 112.01 19.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.57 0.7 . . . . 0.0 110.634 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -110.9 114.61 28.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.264 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.802 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 44.0 t30 59.52 33.82 22.29 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.148 0.499 . . . . 0.0 110.976 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.82 9.58 86.15 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.013 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -115.42 154.88 28.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.66 0.267 . . . . 0.0 110.707 179.951 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.425 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 30.9 mt -82.59 122.41 28.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.244 -179.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 4.1 tp10 -111.31 137.35 49.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.217 179.069 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.655 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.87 -70.15 0.18 Allowed Pre-proline 0 CA--C 1.424 -3.889 0 CA-C-O 118.441 -0.79 . . . . 0.0 113.027 -179.272 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.655 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 5.6 Cg_endo -110.45 131.21 0.04 OUTLIER 'Trans proline' 1 N--CA 1.34 -7.519 0 C-N-CA 113.911 -3.593 . . . . 0.0 112.973 -177.619 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.689 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.48 -159.16 9.25 Favored Glycine 0 C--N 1.283 -2.385 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.87 -177.687 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -152.43 137.16 16.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.261 -0.469 . . . . 0.0 111.311 -178.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 t 48.58 45.01 21.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.037 177.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -65.75 -36.54 83.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.161 0.505 . . . . 0.0 109.671 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.76 -18.8 33.41 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.281 -179.143 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 t -62.68 -28.65 70.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.0 110.34 179.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.2 m -136.32 28.83 3.06 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.868 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.2 m -133.73 139.69 46.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 179.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 m -135.17 175.07 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.36 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 63.43 40.09 8.67 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.435 0.459 . . . . 0.0 111.648 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 16' ' ' GLY . 17.1 p -66.65 126.45 28.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.995 179.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.99 162.64 40.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.922 179.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.567 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -120.94 113.65 20.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.867 0.365 . . . . 0.0 111.06 -179.616 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 15.4 m120 -75.51 116.53 16.32 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.654 179.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.664 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.6 t70 55.29 15.35 1.32 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.901 0.75 . . . . 0.0 111.475 178.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.99 37.98 74.1 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.515 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.664 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 9.8 p80 -147.01 -30.73 0.34 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 117.396 0.598 . . . . 0.0 111.479 178.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 6.6 m -116.23 133.21 56.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.631 0.253 . . . . 0.0 111.403 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.564 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.7 tp -91.31 131.42 36.82 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.612 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.42 130.39 55.94 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.95 163.73 31.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.113 0.483 . . . . 0.0 110.817 179.277 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.465 ' HG ' ' HD2' ' A' ' 81' ' ' TYR . 20.1 t -112.94 123.67 50.85 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.1 m -123.51 154.94 38.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.15 0.5 . . . . 0.0 112.031 -178.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.462 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 9.2 tmtt? -99.81 150.08 22.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.072 178.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.13 -29.95 0.89 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.98 178.732 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.802 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.02 -38.56 70.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.456 ' HB3' HE21 ' A' ' 80' ' ' GLN . 21.0 t70 -175.22 52.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.252 0.549 . . . . 0.0 109.983 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.462 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 68.92 6.36 51.71 Favored Glycine 0 C--N 1.329 0.146 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.65 -179.108 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.456 HE21 ' HB3' ' A' ' 78' ' ' ASP . 27.8 pt20 -123.97 170.52 10.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.465 ' HD2' ' HG ' ' A' ' 73' ' ' SER . 55.1 p90 -110.84 164.74 12.47 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 123.448 0.467 . . . . 0.0 110.815 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -155.34 150.03 26.37 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.07 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -81.02 141.23 34.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.849 0.357 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.3 p -153.01 167.52 28.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.963 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.17 162.83 30.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.962 0.41 . . . . 0.0 110.445 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.765 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.4 tpt -145.99 112.98 6.09 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.97 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.431 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 32.6 t0 -71.78 106.86 4.3 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.75 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.1 mt -77.81 -8.62 58.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.265 -178.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -49.45 -29.62 6.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.244 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 43.9 p90 -116.68 20.26 14.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.49 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.75 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -125.94 -12.88 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.234 0.54 . . . . 0.0 110.031 177.9 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.831 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -134.5 147.39 29.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.23 171.9 23.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.005 -0.616 . . . . 0.0 111.678 179.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.488 HD22 ' HB2' ' A' ' 8' ' ' SER . 37.0 t30 -117.1 129.42 55.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.84 0.352 . . . . 0.0 110.849 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.564 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 70.7 m -134.42 100.31 4.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.436 178.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 61.0 44.46 10.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.558 179.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.57 29.73 70.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.167 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -128.9 148.21 50.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.693 0.282 . . . . 0.0 110.302 -179.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 99' ' ' MET . 21.5 ptt? -62.63 119.61 9.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.167 -179.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 20.6 mm-40 -143.46 79.06 14.2 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.541 178.207 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.831 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 42.9 Cg_endo -69.95 93.34 0.54 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.766 2.31 . . . . 0.0 113.174 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.501 178.988 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.55 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 95.8 m . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 53.68 78.18 0.16 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.562 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 4.4 p90 -56.91 -36.63 70.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.987 0.422 . . . . 0.0 111.506 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.01 -21.77 66.41 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.292 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -61.6 -18.35 59.01 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.481 ' HB2' HD22 ' A' ' 94' ' ' ASN . 69.7 m -145.21 29.55 1.17 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.696 0.284 . . . . 0.0 110.699 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -128.78 133.01 47.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.023 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -129.51 158.21 39.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.373 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.81 58.48 14.35 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.747 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.585 HG12 ' HA3' ' A' ' 21' ' ' GLY . 19.7 m -101.07 139.61 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.992 0.425 . . . . 0.0 111.546 -179.317 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -137.03 155.64 49.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.263 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.623 HD22 HD23 ' A' ' 64' ' ' LEU . 27.0 tp -127.78 123.66 35.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.428 . . . . 0.0 111.706 -179.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.44 ' O ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-85 -124.64 99.49 6.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.579 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.46 -63.18 2.63 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.167 -0.54 . . . . 0.0 113.077 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' HD1' HD21 ' A' ' 36' ' ' ASN . 3.9 p90 -165.27 21.93 0.05 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.0 pt -121.76 126.94 75.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.569 179.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.832 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -107.82 114.64 28.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.652 -179.922 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.2 ttt180 -118.13 141.24 48.7 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.641 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.585 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.99 177.6 42.14 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.796 179.405 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 16.1 m-20 -101.62 107.98 19.4 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -106.09 132.84 51.68 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.7 mt -69.15 139.89 19.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.472 -178.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 96' ' ' TYR . 6.0 p30 -110.14 -173.1 2.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.632 179.534 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.85 -27.98 54.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.92 -20.35 65.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.497 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.77 4.5 69.7 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.913 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -112.72 144.62 31.35 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.791 0.329 . . . . 0.0 110.175 179.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.667 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 38.5 Cg_endo -68.21 123.68 10.86 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.021 2.48 . . . . 0.0 113.002 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -115.27 132.16 56.7 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.7 127.2 31.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.39 0.614 . . . . 0.0 112.142 -178.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 t -136.05 155.2 50.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.612 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 78.0 p -138.45 132.08 30.77 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.527 -179.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.85 143.96 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 O-C-N 123.517 0.511 . . . . 0.0 110.328 -179.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.5 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -99.37 92.19 5.29 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.933 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.53 -27.09 56.65 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.63 -178.376 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.2 t-20 -53.98 -30.66 48.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.967 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -103.15 10.39 37.89 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.613 -178.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.1 m-85 -129.35 -21.09 3.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.534 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -113.84 141.34 30.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.642 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -113.58 170.91 13.54 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.629 -179.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -114.76 104.42 11.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.027 -0.587 . . . . 0.0 109.753 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -111.24 106.16 15.06 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.786 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 24.6 t30 59.2 40.06 22.07 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.121 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.82 17.09 80.25 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.559 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.58 149.82 46.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 -179.511 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.422 HD13 ' HG ' ' A' ' 70' ' ' LEU . 28.9 mt -74.99 124.24 26.6 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.352 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -112.01 139.22 47.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.598 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -43.52 -75.51 0.05 OUTLIER Pre-proline 0 CA--C 1.433 -3.536 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.497 179.949 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 2.5 Cg_endo -108.45 127.89 0.04 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.242 1 C-N-CA 113.196 -4.069 . . . . 0.0 112.779 -178.662 . . . . . . . . 4 3 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.642 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -155.16 -159.42 9.29 Favored Glycine 0 C--N 1.281 -2.514 0 CA-C-N 113.74 -1.573 . . . . 0.0 113.417 -177.629 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -151.23 147.32 26.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.917 0.389 . . . . 0.0 111.068 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.6 p 46.42 44.95 13.42 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 177.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -71.79 -38.8 70.22 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.7 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.21 -18.52 55.36 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.288 -178.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -65.26 -19.28 65.89 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.736 0.414 . . . . 0.0 110.896 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.4 m -142.16 20.76 2.09 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.006 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.5 m -126.75 144.09 51.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.601 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.491 HG23 ' HD2' ' A' ' 61' ' ' LYS . 23.2 m -136.78 173.62 13.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.734 179.315 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HD2' HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER 63.68 41.15 7.29 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.486 0.491 . . . . 0.0 110.829 179.405 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.5 HG21 ' O ' ' A' ' 16' ' ' GLY . 11.5 p -69.22 130.49 42.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.612 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.65 162.85 40.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.807 179.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.623 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -121.61 112.55 18.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.596 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -85.47 122.04 29.04 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.216 -179.263 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.09 24.04 10.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.686 178.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.81 39.8 69.28 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.524 -0.762 . . . . 0.0 114.074 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.465 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 4.7 p80 -153.26 -28.53 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.272 0.536 . . . . 0.0 111.537 179.609 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 m -115.93 131.43 56.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.797 0.332 . . . . 0.0 111.461 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.605 ' HA ' HD22 ' A' ' 64' ' ' LEU . 12.7 tp -90.2 134.53 34.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 178.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.65 130.76 53.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.614 178.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.05 160.85 22.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.098 0.475 . . . . 0.0 111.464 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 13.1 t -106.62 125.06 50.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.891 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 48.5 m -125.5 149.16 48.52 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -99.25 143.3 29.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.585 178.139 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.58 -31.09 0.52 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.621 178.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.729 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -47.51 -45.42 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 179.128 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -171.89 49.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.466 0.65 . . . . 0.0 109.606 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.32 2.4 79.11 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.009 -179.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -121.91 160.35 24.97 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 51.3 p90 -101.02 160.43 14.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 -179.192 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -153.79 141.25 19.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 36.4 t70 -82.1 132.98 35.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.89 0.376 . . . . 0.0 110.693 -179.056 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.419 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 26.0 p -143.34 179.51 7.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.432 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.28 161.43 37.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.814 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.597 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 14.2 tpp -145.02 125.39 13.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.564 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 28.2 t70 -79.35 106.59 11.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.732 ' HA ' HG22 ' A' ' 91' ' ' VAL . 17.0 mt -76.61 -10.02 59.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.323 -177.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.564 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 5.9 m120 -48.51 -33.83 10.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.99 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 46.7 p90 -113.74 20.97 15.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.897 0.379 . . . . 0.0 111.326 -179.166 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.732 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -126.58 -8.66 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.549 178.575 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 1.019 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 8.9 p -153.22 138.35 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.097 0.475 . . . . 0.0 111.409 179.298 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.55 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -131.16 172.22 20.78 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.877 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.481 HD22 ' HB2' ' A' ' 8' ' ' SER . 18.4 t30 -113.74 116.76 29.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.33 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.547 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 58.7 m -111.65 78.53 1.13 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.829 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 25' ' ' ASN . 43.1 m-85 66.28 60.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.581 178.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.78 23.0 60.54 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.774 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -126.98 132.02 50.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.907 0.384 . . . . 0.0 110.593 -178.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 99' ' ' MET . 16.8 ptt? -64.28 117.36 7.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.742 179.415 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 4.6 mt-10 -142.26 81.59 13.89 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 121.314 0.578 . . . . 0.0 109.889 177.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 1.019 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 58.4 Cg_endo -71.47 125.83 11.62 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.864 2.376 . . . . 0.0 112.023 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 32.0 p . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.767 -179.18 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.477 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 72.1 m . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 119.964 -0.065 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.855 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 39.2 m-20 52.32 76.96 0.17 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.839 0.352 . . . . 0.0 111.747 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.556 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 15.4 p90 -60.31 -41.96 94.55 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.019 0.438 . . . . 0.0 110.873 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.94 -23.91 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.99 -178.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.855 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 62.7 t30 -60.46 -29.73 69.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.168 -179.123 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 8.3 m -123.36 16.4 9.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 -179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -124.33 146.28 48.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.368 0.604 . . . . 0.0 112.029 -179.301 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.7 p -140.33 152.77 46.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.005 179.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.86 33.15 70.38 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.574 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 18.2 m -79.89 133.38 29.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.012 0.434 . . . . 0.0 111.655 -179.471 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.442 ' O ' HD23 ' A' ' 19' ' ' LEU . 10.7 pt-20 -132.19 150.16 52.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.007 179.021 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.785 HD22 HD23 ' A' ' 64' ' ' LEU . 32.7 tp -122.01 120.71 35.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.2 0.524 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 18' ' ' ILE . 73.0 t80 -125.1 101.02 6.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.956 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.01 -68.44 3.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.811 179.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.769 ' HD1' HD21 ' A' ' 36' ' ' ASN . 24.3 p90 -162.26 17.79 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.654 0.264 . . . . 0.0 111.294 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 15' ' ' TYR . 29.9 pt -121.6 131.29 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.966 0.412 . . . . 0.0 110.51 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.723 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -113.78 114.72 26.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.115 -179.632 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.2 ttt180 -118.12 141.68 48.23 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.734 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.28 -176.44 38.12 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.878 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 8.8 m-20 -108.8 111.11 22.67 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.673 0.273 . . . . 0.0 110.907 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.3 m -106.28 133.18 51.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.8 mt -68.83 134.3 30.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.828 0.347 . . . . 0.0 110.704 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -105.5 -172.68 2.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.02 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -57.24 -25.31 58.92 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.16 -20.65 65.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.068 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.43 1.69 74.46 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.88 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -112.19 144.48 30.88 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.633 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 29.1 Cg_endo -65.0 123.77 12.09 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.744 2.296 . . . . 0.0 112.445 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -109.17 130.19 55.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.671 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.24 122.89 21.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.972 0.415 . . . . 0.0 111.613 -179.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.6 t -142.57 164.03 31.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.446 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 12.2 p -138.69 149.67 45.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.024 0.44 . . . . 0.0 111.288 -179.222 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.87 142.65 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.723 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.769 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -103.37 92.0 4.3 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.641 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.723 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.95 -29.41 63.15 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.669 -178.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -52.21 -33.88 43.12 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.875 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -102.05 16.32 26.39 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.839 -178.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.4 m-85 -130.86 -26.47 2.19 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.48 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.5 mp -112.52 141.55 27.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.633 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -111.9 171.53 14.26 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.312 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -113.37 109.05 18.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.996 -179.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.05 105.89 15.18 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 0.0 OUTLIER 49.32 39.12 15.32 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 122.662 1.22 . . . . 0.0 111.867 179.652 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 74' ' ' CYS . . . 88.65 3.66 77.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.415 178.538 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -110.06 154.4 23.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.988 0.423 . . . . 0.0 110.888 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.5 mt -85.47 117.22 24.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.074 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.571 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.3 tt0 -106.04 128.61 53.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.018 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.653 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.55 -66.8 0.25 Allowed Pre-proline 1 CA--C 1.42 -4.05 0 O-C-N 124.117 0.885 . . . . 0.0 112.754 -179.493 . . . . . . . . 4 4 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.594 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 3.0 Cg_endo -109.6 126.4 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.313 0 C-N-CA 113.821 -3.652 . . . . 0.0 113.413 -177.708 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.633 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -165.05 -161.83 14.84 Favored Glycine 0 C--N 1.285 -2.257 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.684 -177.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.48 146.45 25.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.381 -0.41 . . . . 0.0 110.665 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.6 m 54.5 40.65 31.97 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HD2' ' SG ' ' A' ' 59' ' ' CYS . 13.2 p90 -72.2 -34.16 68.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.49 -18.26 67.55 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.998 -179.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 m -68.89 -9.34 51.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.153 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.8 m -145.62 8.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.726 179.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.426 ' SG ' ' HD2' ' A' ' 55' ' ' PHE . 6.4 m -109.33 153.28 24.14 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.101 0.477 . . . . 0.0 111.462 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.402 HG23 ' HD3' ' A' ' 61' ' ' LYS . 18.9 m -142.22 167.41 15.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.906 178.387 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HD3' HG23 ' A' ' 60' ' ' VAL . 5.1 mptp? 63.39 33.06 14.14 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.618 0.574 . . . . 0.0 111.293 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -59.68 122.09 13.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.324 179.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.94 161.39 42.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.869 -179.513 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.785 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -114.4 113.78 24.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.815 0.341 . . . . 0.0 111.803 -179.003 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 90.0 m-20 -73.09 116.35 13.52 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.526 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 6.1 t70 54.47 20.01 2.6 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.104 0.878 . . . . 0.0 111.558 179.303 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.85 29.24 73.54 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.072 -0.513 . . . . 0.0 114.375 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.526 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 1.9 p-80 -142.57 -24.48 0.65 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.913 0.856 . . . . 0.0 112.036 179.276 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 20.3 m -116.24 132.53 56.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.562 ' HB3' HD21 ' A' ' 88' ' ' LEU . 16.0 tp -90.77 129.63 36.83 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.422 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.0 OUTLIER -120.2 129.29 54.03 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.312 179.857 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -163.86 163.94 23.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.067 0.46 . . . . 0.0 110.776 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.6 t -114.5 119.48 36.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.474 -0.784 . . . . 0.0 108.98 179.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -116.17 156.36 26.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.329 0.585 . . . . 0.0 111.831 -179.172 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.9 tmtt? -99.5 143.34 29.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.304 178.471 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.72 -17.81 0.66 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.445 -1.359 . . . . 0.0 114.098 178.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -63.37 -38.06 89.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.426 0.613 . . . . 0.0 110.484 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -177.25 59.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.754 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.84 16.72 66.47 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.086 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -139.31 163.36 32.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 40.8 p90 -97.6 171.62 8.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.143 -179.075 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.13 136.63 11.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.69 128.64 37.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.162 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -146.02 169.0 19.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.264 -179.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.422 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.9 OUTLIER -140.7 164.47 30.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.923 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.88 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.5 OUTLIER -149.21 125.95 11.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.492 -179.235 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.476 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 9.0 m-20 -75.25 106.31 6.71 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.458 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.785 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.8 mt -79.11 -8.63 59.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.163 0.506 . . . . 0.0 109.687 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -49.61 -28.43 5.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.731 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.476 ' CE2' ' HB2' ' A' ' 87' ' ' ASP . 10.4 p90 -119.11 21.52 12.29 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 179.658 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.785 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -127.2 -16.25 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.943 0.402 . . . . 0.0 110.563 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.1 t -132.94 148.74 31.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.477 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -147.72 164.26 28.81 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.89 179.533 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -107.93 135.06 49.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.899 0.38 . . . . 0.0 110.638 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.652 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 59.0 m -140.14 96.51 3.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.713 178.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 62.03 45.96 6.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.675 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 56.51 29.76 57.9 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.773 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -127.08 147.11 50.17 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.844 0.354 . . . . 0.0 110.665 -178.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.0 103.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.475 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.652 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 59.1 mm-40 -137.96 67.1 48.63 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.426 179.008 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 28.3 Cg_endo -62.72 114.41 2.39 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 123.32 2.68 . . . . 0.0 112.838 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.042 179.197 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 ttm . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 58.12 -159.23 0.27 Allowed 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.325 0.391 . . . . 0.0 110.398 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.569 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 71.5 m -108.53 -64.09 1.26 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' A' ' 89' ' ' ASN . 92.7 m-20 52.78 71.17 0.5 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.375 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.49 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.7 p90 -54.02 -36.76 63.35 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.264 0.554 . . . . 0.0 110.856 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.14 -21.61 33.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -62.74 -27.78 69.52 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.559 ' HB2' HD22 ' A' ' 94' ' ' ASN . 26.7 m -134.62 16.7 3.63 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.049 0.452 . . . . 0.0 110.774 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.5 m -117.48 133.04 56.41 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.129 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -130.84 152.71 49.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.717 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.22 61.65 6.15 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.095 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 m -95.08 131.3 42.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.393 0.616 . . . . 0.0 111.898 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -124.59 157.44 35.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.099 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.618 HD22 HD23 ' A' ' 64' ' ' LEU . 14.2 tp -139.82 121.66 15.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.501 . . . . 0.0 111.295 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -127.42 102.17 6.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.98 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.7 -60.67 3.71 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.965 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -170.81 26.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 122.875 0.47 . . . . 0.0 110.38 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 15.2 mt -119.23 113.61 41.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.08 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.807 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -99.2 114.24 26.93 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -124.22 142.78 50.96 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.486 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.42 -179.27 41.19 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.401 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 8.7 m-20 -103.59 107.69 18.65 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 79.8 m -107.62 132.77 52.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.013 0.435 . . . . 0.0 110.025 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.1 mt -72.78 137.21 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.575 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -102.41 -169.09 1.62 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.028 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -62.83 -26.31 68.68 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 111.598 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.21 -23.26 64.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.296 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.45 5.92 58.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.351 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -110.43 142.16 25.47 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.678 0.275 . . . . 0.0 110.624 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.566 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 39.8 Cg_endo -69.51 122.15 8.9 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.819 2.346 . . . . 0.0 111.979 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -111.71 131.03 55.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.75 120.85 17.92 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.157 0.503 . . . . 0.0 111.104 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.4 t -136.69 152.75 50.74 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.122 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.7 p -131.22 148.22 52.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.472 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.04 145.53 34.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.463 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -101.95 98.75 8.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.163 0.506 . . . . 0.0 110.121 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.5 mm? -60.38 -26.81 66.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.64 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -57.02 -24.91 57.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.756 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -106.83 7.22 30.09 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 60.0 m-85 -128.68 -16.37 4.26 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 mt -119.08 144.24 27.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.669 0.271 . . . . 0.0 110.974 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.576 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -117.79 179.26 17.18 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.138 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.625 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 19.1 p-10 -131.76 102.22 5.79 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.809 0.814 . . . . 0.0 110.618 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -105.27 121.85 44.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.068 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.818 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 53.6 t30 60.13 32.38 20.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.207 0.527 . . . . 0.0 110.171 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.01 21.31 79.97 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.043 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -121.84 157.52 30.93 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 86' ' ' MET . 33.4 mt -82.11 115.69 21.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.203 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HG2' ' C ' ' A' ' 42' ' ' GLY . 10.2 pt-20 -103.24 143.42 32.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.671 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -46.38 -74.06 0.08 OUTLIER Pre-proline 0 CA--C 1.431 -3.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 112.835 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.671 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 13.1 Cg_endo -110.24 124.28 0.03 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.393 0 C-N-CA 113.794 -3.671 . . . . 0.0 113.122 -177.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.576 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -150.32 -160.88 9.56 Favored Glycine 0 C--N 1.278 -2.648 0 CA-C-N 113.429 -1.714 . . . . 0.0 113.284 -177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -149.6 139.85 22.23 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.411 -0.395 . . . . 0.0 110.728 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.6 p 48.3 52.23 13.77 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.296 1.038 . . . . 0.0 113.569 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -75.69 -39.55 57.28 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -18.71 53.49 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.576 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.3 m -68.65 -22.72 64.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.291 -0.454 . . . . 0.0 110.728 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.2 m -135.02 22.42 3.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.496 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.7 m -131.92 145.38 51.47 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.63 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 m -134.13 169.98 20.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.107 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 66.43 37.09 4.83 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.404 0.44 . . . . 0.0 110.834 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.7 117.36 8.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.54 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.09 161.32 42.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.255 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -112.13 124.0 51.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.869 0.366 . . . . 0.0 110.813 -179.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 2.7 t30 -95.53 127.28 41.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.833 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.603 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 14.4 t70 52.41 24.27 2.88 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.972 0.795 . . . . 0.0 112.249 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.33 38.5 79.05 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.859 -0.61 . . . . 0.0 114.1 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.603 ' CD2' ' HB3' ' A' ' 66' ' ' ASP . 1.3 p80 -153.46 -27.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.52 0.66 . . . . 0.0 111.798 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.4 m -115.74 130.3 56.79 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.697 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.622 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.2 tp -90.65 138.95 31.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.9 132.95 52.05 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.68 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -164.58 159.89 19.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.128 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.2 t -107.53 122.94 47.67 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 30.8 m -124.75 154.91 40.16 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -97.5 146.25 25.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.428 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.94 -31.18 0.74 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.919 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.818 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -52.91 -42.53 65.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -174.39 55.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.75 11.23 59.96 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.446 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -130.51 161.24 31.91 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 50.5 p90 -96.1 168.58 10.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.401 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.08 136.41 9.9 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.2 126.93 31.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.951 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.524 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 33.2 t -140.81 171.82 13.55 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.124 0.487 . . . . 0.0 111.072 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.78 158.22 44.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.419 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.686 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.7 OUTLIER -141.83 122.92 14.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.679 -179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 4.1 m-20 -73.75 105.66 5.15 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.709 ' HA ' HG22 ' A' ' 91' ' ' VAL . 21.0 mt -75.55 -8.97 58.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.025 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.507 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 18.1 m120 -47.55 -29.75 3.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.166 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 87' ' ' ASP . 16.6 p90 -118.37 21.32 12.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.977 0.418 . . . . 0.0 111.18 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -129.43 -9.63 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.752 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.926 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 14.5 p -152.58 143.73 15.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.41 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -146.77 169.69 27.87 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.135 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' A' ' 8' ' ' SER . 28.2 t30 -100.15 131.06 46.32 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.569 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 73.9 m -138.59 95.04 2.92 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.572 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 62.9 44.88 5.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.441 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.0 23.21 56.79 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.38 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -123.12 140.11 53.36 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 99' ' ' MET . 24.3 ptt? -56.17 112.09 1.13 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.85 0.719 . . . . 0.0 111.336 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.569 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 1.6 mm-40 -137.68 77.62 38.86 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.104 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.926 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 58.1 Cg_endo -74.42 93.96 0.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.428 2.085 . . . . 0.0 112.228 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.84 111.51 23.22 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.097 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.637 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -88.76 149.77 23.28 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.914 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.67 56.04 0.63 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.013 0.435 . . . . 0.0 110.511 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.2 t -177.38 -117.72 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.352 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.542 ' HB2' ' HG3' ' A' ' 103' ' ' ARG . 1.6 t-20 54.23 57.43 5.9 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.706 0.802 . . . . 0.0 111.155 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.8 -171.84 3.82 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.923 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 37.35 -102.51 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.127 0.971 . . . . 0.0 112.568 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -160.54 -67.49 0.07 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.4 m -104.12 75.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 122.035 0.921 . . . . 0.0 110.824 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 111' ' ' LEU . 2.5 pt? -77.08 -0.78 26.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.842 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.625 ' HE3' ' OD1' ' A' ' 43' ' ' ASN . 80.4 tttt -88.16 13.53 11.14 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.274 1.035 . . . . 0.0 110.134 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.5 t 50.3 51.83 15.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.635 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.0 m -118.18 102.48 9.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.911 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.7 t -67.43 -35.95 80.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.35 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.403 -179.189 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 67.0 mtt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 110.781 -0.081 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.4 mp0 71.76 137.17 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.596 0.712 . . . . 0.0 111.071 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.511 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 68.5 m -86.33 -74.92 0.4 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.178 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 41.49 73.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.576 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.7 p90 -54.76 -39.76 68.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.981 0.419 . . . . 0.0 111.33 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.91 -22.94 41.29 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.53 -20.73 61.29 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.438 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.437 ' HB2' HD22 ' A' ' 94' ' ' ASN . 20.4 m -129.97 11.54 5.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.911 0.386 . . . . 0.0 110.928 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 91.2 m -120.14 132.9 55.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -127.07 160.23 31.79 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.65 45.34 90.62 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.741 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -87.09 123.94 40.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.449 0.642 . . . . 0.0 111.594 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 47.3 mt-10 -121.61 142.43 50.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.534 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.768 HD22 HD23 ' A' ' 64' ' ' LEU . 17.2 tp -117.83 112.31 20.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.952 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -133.83 104.92 6.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.077 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 70.36 51.54 21.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.771 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CD1' HG21 ' A' ' 62' ' ' THR . 7.7 m-85 63.81 16.18 9.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.214 0.605 . . . . 0.0 111.57 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 16' ' ' GLY . 20.9 mt -116.38 116.3 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 120.659 0.266 . . . . 0.0 110.534 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.766 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 mt -103.13 114.43 28.71 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.602 ' HG3' ' HB3' ' A' ' 34' ' ' SER . 6.9 ttt180 -121.07 145.05 48.2 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.79 -175.23 40.54 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.284 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.0 m-20 -109.07 110.41 21.66 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.894 0.378 . . . . 0.0 110.263 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 65.9 m -107.4 132.56 53.04 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.0 mt -69.88 134.75 29.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.227 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -104.69 -174.24 2.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.928 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 96' ' ' TYR . 7.4 tp10 -49.43 -40.04 35.16 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.489 0.493 . . . . 0.0 111.52 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -57.96 -26.14 61.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.303 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.44 -0.44 58.35 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.712 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -106.77 146.08 32.37 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 120.886 0.374 . . . . 0.0 110.889 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.611 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 36.6 Cg_endo -68.62 122.16 9.11 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 123.136 2.557 . . . . 0.0 112.266 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -109.89 127.37 54.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.594 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.65 125.36 25.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.169 0.509 . . . . 0.0 111.475 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.6 t -143.56 158.85 43.34 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.342 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.602 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 4.7 p -139.63 147.0 40.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.857 0.36 . . . . 0.0 111.254 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.4 mp -130.9 143.44 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.29 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.4 ' HA ' HD22 ' A' ' 36' ' ' ASN . 1.8 t-20 -104.31 95.3 5.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.766 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -59.11 -19.81 47.91 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.806 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.579 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 21.7 t-20 -54.84 -32.57 60.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.928 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -106.42 16.44 24.71 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.489 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 54.5 m-85 -127.91 -23.45 3.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.59 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -111.72 144.0 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.641 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -116.53 171.76 13.92 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.881 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -107.28 112.9 25.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.959 0.409 . . . . 0.0 111.222 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -110.61 105.09 13.88 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 2.7 p-10 42.19 44.82 3.36 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.822 1.249 . . . . 0.0 112.806 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 87.11 7.72 76.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.405 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 0.7 OUTLIER -117.85 160.85 20.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.987 0.422 . . . . 0.0 110.83 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 72' ' ' ALA . 31.2 mt -84.05 115.76 22.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.114 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -103.13 126.06 50.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.586 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.78 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -35.25 -71.28 0.11 Allowed Pre-proline 0 CA--C 1.429 -3.702 0 O-C-N 124.49 1.119 . . . . 0.0 113.736 -179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.78 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 10.1 Cg_endo -110.75 120.96 0.02 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.436 0 C-N-CA 113.776 -3.682 . . . . 0.0 113.097 -178.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.641 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -152.45 -161.73 10.42 Favored Glycine 0 C--N 1.274 -2.871 0 CA-C-N 113.541 -1.663 . . . . 0.0 113.211 -177.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 20.4 mt-10 -156.69 141.94 17.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.996 0.468 . . . . 0.0 110.458 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.2 m 58.66 36.69 25.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.801 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.579 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 5.3 p90 -69.18 -33.48 73.45 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.23 -18.78 58.57 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.396 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.5 m -67.19 -14.05 62.54 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.83 0.347 . . . . 0.0 110.774 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.9 p -146.26 20.53 1.38 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.1 m -133.15 139.19 46.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.773 0.321 . . . . 0.0 111.194 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.461 HG23 ' HD3' ' A' ' 61' ' ' LYS . 21.4 m -134.16 177.63 6.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.167 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.9 mptt 59.84 44.08 14.28 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.406 0.441 . . . . 0.0 111.136 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.472 HG21 ' CD1' ' A' ' 17' ' ' TYR . 30.6 p -75.75 125.78 29.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 111.358 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.65 162.57 39.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.574 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.768 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -118.59 116.99 27.77 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.626 0.251 . . . . 0.0 111.039 -179.06 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -93.19 127.47 38.77 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.639 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.436 ' HB3' ' NE2' ' A' ' 68' ' ' HIS . 4.3 t70 54.0 23.31 3.92 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.914 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.48 28.66 67.8 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 115.018 0.767 . . . . 0.0 115.018 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.436 ' NE2' ' HB3' ' A' ' 66' ' ' ASP . 0.8 OUTLIER -149.22 -18.09 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 117.899 0.85 . . . . 0.0 112.334 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.0 m -116.38 127.42 54.63 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.749 0.309 . . . . 0.0 111.245 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -90.03 136.85 32.79 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.56 130.4 50.46 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.162 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -161.44 167.14 26.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.105 0.478 . . . . 0.0 110.713 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.403 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 8.5 t -116.75 122.02 43.27 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.415 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.4 m -121.51 149.64 42.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 0.0 112.108 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -99.88 146.73 26.31 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.05 -22.79 0.78 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 119.558 -1.306 . . . . 0.0 113.473 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -60.89 -40.64 93.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.716 0.293 . . . . 0.0 111.208 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -176.61 57.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.392 0.615 . . . . 0.0 110.08 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.84 0.14 40.13 Favored Glycine 0 CA--C 1.519 0.316 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.811 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -122.53 163.6 19.64 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.403 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 40.9 p90 -112.45 167.19 10.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.844 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.53 152.76 27.71 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.78 129.45 37.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.231 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.54 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 25.1 t -142.06 166.53 24.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.516 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.86 163.17 32.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.657 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.3 tpt -144.73 121.49 11.21 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.674 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -75.31 105.55 6.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.71 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.0 mt -74.76 -8.64 57.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.522 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -46.86 -30.1 2.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.222 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -120.83 23.6 10.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.9 0.381 . . . . 0.0 111.348 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.71 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.4 m -127.08 -9.28 4.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.081 0.467 . . . . 0.0 110.472 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.913 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.7 p -156.28 138.34 6.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.858 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -133.76 177.44 19.07 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.065 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.437 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.8 t30 -109.83 123.42 49.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.626 0.25 . . . . 0.0 110.559 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.519 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 6.0 t -127.57 101.15 6.29 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.431 ' CD1' ' HB2' ' A' ' 26' ' ' GLU . 98.0 m-85 57.98 47.62 14.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.5 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 58.9 25.22 59.0 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.034 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -129.82 148.93 51.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.813 0.34 . . . . 0.0 110.088 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -58.69 118.94 6.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.333 -0.848 . . . . 0.0 112.66 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.519 ' HG3' ' HB3' ' A' ' 95' ' ' SER . 12.4 mm-40 -143.9 77.9 14.43 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.958 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.913 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 57.6 Cg_endo -74.69 93.85 0.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.542 2.161 . . . . 0.0 112.675 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.78 112.32 24.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.182 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.685 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -86.88 144.94 26.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.126 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.42 42.15 1.17 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.215 0.531 . . . . 0.0 110.41 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.451 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 48.4 t -166.32 -121.12 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.578 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.685 ' HB2' ' HG3' ' A' ' 103' ' ' ARG . 9.3 t-20 70.27 19.98 6.36 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.864 0.866 . . . . 0.0 110.001 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.37 115.51 14.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.765 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -149.22 -163.2 1.73 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -69.87 -59.17 3.1 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.9 p -104.82 52.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 122.862 1.315 . . . . 0.0 109.404 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.3 tp -156.2 90.85 1.22 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.584 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -106.48 128.98 54.51 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.241 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.4 m -72.04 57.17 0.33 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.471 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.8 m -152.67 124.89 8.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.76 0.315 . . . . 0.0 110.304 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.0 m -80.54 -23.73 39.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.459 0.647 . . . . 0.0 109.895 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 C--O 1.248 1.006 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.373 -179.33 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 62.99 -172.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.419 0.688 . . . . 0.0 111.42 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 62.1 m -127.64 -66.59 0.87 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.055 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 53.15 68.39 0.85 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.516 ' CD1' ' HB ' ' A' ' 92' ' ' VAL . 10.9 p90 -55.02 -45.99 75.18 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.163 0.506 . . . . 0.0 111.123 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.21 -22.08 62.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.87 -20.48 66.25 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.612 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 m -135.69 25.26 3.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.915 0.388 . . . . 0.0 110.946 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.0 m -134.1 132.95 40.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.051 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 p -134.46 165.11 25.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.611 0.243 . . . . 0.0 110.867 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.78 44.12 98.37 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.185 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' HB ' ' CD1' ' A' ' 19' ' ' LEU . 35.8 m -83.17 139.81 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.304 0.574 . . . . 0.0 111.848 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.09 148.46 52.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.545 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.532 HD22 HD23 ' A' ' 64' ' ' LEU . 14.5 tp -132.21 117.38 18.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.023 0.439 . . . . 0.0 111.155 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.41 109.99 12.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.462 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.04 -68.91 2.78 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.366 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 17.5 p90 -170.45 28.94 0.02 OUTLIER 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.326 0.584 . . . . 0.0 110.387 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 mt -121.2 115.64 47.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.643 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.862 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -96.99 113.7 25.26 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.265 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -124.44 139.38 53.95 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.129 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.45 -170.9 33.71 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.269 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 1.3 m-20 -108.25 111.01 22.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.931 0.396 . . . . 0.0 110.278 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 72.4 m -107.52 132.09 53.61 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.01 141.82 16.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.678 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -108.92 -171.46 1.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.259 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.78 -33.82 64.71 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -64.46 -24.69 67.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.909 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.0 6.98 57.71 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.623 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -111.55 144.78 31.26 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 40.2 Cg_endo -68.44 133.64 28.67 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.864 2.376 . . . . 0.0 112.166 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -118.07 133.24 56.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.378 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.75 122.89 19.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.005 0.431 . . . . 0.0 111.282 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.9 t -142.17 159.08 42.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.021 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.7 p -140.39 146.02 37.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.83 146.08 33.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.329 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.425 ' HA ' HD22 ' A' ' 36' ' ' ASN . 4.3 m120 -102.2 96.29 6.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.009 0.433 . . . . 0.0 110.07 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -59.32 -26.54 65.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.311 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 25.9 t-20 -55.0 -28.95 55.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.054 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -103.34 6.04 37.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.423 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 55.3 m-85 -125.25 -19.84 5.0 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.422 -0.511 . . . . 0.0 112.264 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.7 mt -117.3 143.59 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.801 0.334 . . . . 0.0 110.805 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.622 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -119.47 176.29 16.07 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.219 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -127.27 112.76 15.45 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.735 0.779 . . . . 0.0 110.592 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -110.6 115.0 28.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.342 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.82 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 56.3 t30 59.4 38.36 22.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.286 0.565 . . . . 0.0 110.476 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.12 12.09 84.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.195 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -118.45 151.43 37.81 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.872 0.368 . . . . 0.0 110.797 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.8 mp -76.96 129.39 36.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.599 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.481 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 9.5 tp10 -121.87 132.92 54.83 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.231 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.768 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -37.94 -66.4 0.3 Allowed Pre-proline 0 CA--C 1.423 -3.924 0 O-C-N 124.216 0.948 . . . . 0.0 113.186 -179.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.768 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 5.5 Cg_endo -109.94 129.29 0.04 OUTLIER 'Trans proline' 1 N--CA 1.34 -7.509 0 C-N-CA 113.742 -3.706 . . . . 0.0 113.064 -178.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.622 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -163.44 -162.85 14.95 Favored Glycine 0 C--N 1.283 -2.38 0 CA-C-N 114.012 -1.449 . . . . 0.0 113.403 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -150.58 142.94 24.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.935 0.398 . . . . 0.0 110.743 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 85.8 p 50.83 49.25 21.42 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.552 1.141 . . . . 0.0 113.585 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.439 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 11.1 p90 -73.91 -43.97 56.71 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.66 -19.01 47.39 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.893 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.5 m -66.5 -16.02 63.81 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.041 0.448 . . . . 0.0 110.889 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.5 m -146.55 28.74 1.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.466 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 55' ' ' PHE . 62.9 m -133.66 149.58 51.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.595 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.553 HG23 ' HD3' ' A' ' 61' ' ' LYS . 19.3 m -136.69 173.13 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.812 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.553 ' HD3' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER 63.22 39.31 9.81 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.062 0.545 . . . . 0.0 111.524 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.449 ' HB ' HD21 ' A' ' 14' ' ' LEU . 22.3 p -66.29 120.6 13.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.335 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.67 156.49 40.48 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -113.79 112.0 22.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.889 0.376 . . . . 0.0 111.766 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.518 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 6.2 m-20 -73.75 117.48 15.58 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.577 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 0.3 OUTLIER 56.44 23.58 7.6 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.733 0.646 . . . . 0.0 110.701 -179.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.85 28.46 65.9 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.024 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.577 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.3 p80 -139.58 -28.02 0.77 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 117.707 0.754 . . . . 0.0 111.544 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 22.2 m -110.72 126.16 54.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.707 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.697 ' HB2' HD11 ' A' ' 88' ' ' LEU . 19.3 tp -90.3 127.92 36.29 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.743 -0.383 . . . . 0.0 109.99 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.26 129.62 56.03 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.981 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.57 154.33 18.31 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.678 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 28.0 t -102.41 123.01 45.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 59.8 m -120.2 153.02 36.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.0 111.9 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 10.5 tmtt? -98.77 142.31 30.47 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.449 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.49 -32.74 0.53 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.278 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.82 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -54.33 -39.68 67.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -169.29 48.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.351 0.596 . . . . 0.0 109.524 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.31 6.48 47.91 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.296 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 28.5 pt20 -128.17 168.11 15.87 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 41.5 p90 -88.26 167.76 13.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.344 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.503 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.2 OUTLIER -155.29 129.55 8.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.531 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -70.6 114.7 8.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.674 0.273 . . . . 0.0 110.753 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.7 t -129.49 160.62 32.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.076 0.465 . . . . 0.0 111.238 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.6 OUTLIER -128.87 165.04 21.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.051 179.107 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.624 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.7 tpt -152.85 124.83 7.95 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.869 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.454 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 40.6 t0 -76.43 107.05 8.42 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.765 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.6 mt -78.42 -8.17 58.18 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.649 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -49.78 -28.62 6.5 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.276 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.454 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 45.1 p90 -116.37 21.31 13.66 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.242 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.765 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -129.18 -11.21 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 178.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.1 t -134.7 145.51 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.15 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.95 166.44 25.4 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 23' ' ' CYS . 20.3 t30 -130.85 132.64 45.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.821 0.343 . . . . 0.0 111.319 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.6 m -140.39 113.14 8.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.515 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 59.99 42.67 15.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.477 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.25 22.03 62.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.449 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -123.55 137.6 54.73 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.42 127.05 31.57 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.574 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.57 68.68 13.39 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-O 121.75 0.786 . . . . 0.0 109.415 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.617 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 13.1 Cg_endo -54.68 115.12 2.19 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.539 2.826 . . . . 0.0 113.19 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p -122.35 128.68 51.3 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.705 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.497 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -111.51 150.14 30.37 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.426 -179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.47 50.2 0.86 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.124 0.488 . . . . 0.0 110.58 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.438 ' HB3' ' HG3' ' A' ' 51' ' ' PRO . 23.1 t -165.29 -151.64 0.15 Allowed 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 63.3 23.1 13.64 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.063 0.945 . . . . 0.0 110.184 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -173.41 -49.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.936 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -94.32 163.24 13.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.306 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 22.6 t60 69.03 162.35 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.619 0.768 . . . . 0.0 110.822 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.4 t -107.62 95.5 3.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.996 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.1 mp -83.22 68.61 9.69 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 0.0 109.443 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.9 tttm -144.08 33.71 1.23 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.013 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.8 t 57.53 27.21 13.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.359 0.6 . . . . 0.0 109.947 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 t -144.36 143.16 30.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.376 -0.829 . . . . 0.0 108.815 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.3 m -80.08 -31.15 39.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.041 0.448 . . . . 0.0 110.166 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.494 179.598 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 pm0 -83.87 130.01 34.92 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.571 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 59.7 m -123.66 -63.25 1.24 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.558 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 p30 33.04 78.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.534 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 2.8 p90 -60.14 -31.86 70.48 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.932 0.396 . . . . 0.0 111.76 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.73 -23.14 66.68 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -70.33 -7.46 42.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.856 0.36 . . . . 0.0 111.285 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.468 ' HB2' HD22 ' A' ' 94' ' ' ASN . 53.4 m -145.15 27.01 1.3 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.071 0.462 . . . . 0.0 110.412 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -133.36 147.7 51.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.47 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.4 p -140.06 148.18 41.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.654 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.81 59.24 10.02 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.234 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.414 ' HB ' ' CD1' ' A' ' 19' ' ' LEU . 18.2 m -95.24 133.22 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.106 0.479 . . . . 0.0 110.618 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -128.36 142.4 51.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.501 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.643 HD22 HD23 ' A' ' 64' ' ' LEU . 12.7 tp -107.45 112.86 25.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.097 0.475 . . . . 0.0 110.759 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.479 ' O ' HG12 ' A' ' 18' ' ' ILE . 54.8 m-85 -105.17 97.81 7.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.803 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.78 -64.18 0.47 Allowed Glycine 0 CA--C 1.523 0.594 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.549 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.645 ' HD1' HD21 ' A' ' 36' ' ' ASN . 7.9 p90 -158.23 16.67 0.22 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.779 0.432 . . . . 0.0 111.38 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.0 pt -122.63 132.26 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 0.0 110.305 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -104.18 114.4 28.62 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.816 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -117.75 136.82 53.12 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -164.51 -179.24 38.51 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.385 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 11.1 m-20 -101.71 104.88 15.72 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.6 m -105.36 132.13 51.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.998 0.427 . . . . 0.0 110.106 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.6 mt -75.25 132.75 32.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.192 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -101.6 -171.65 2.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.929 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -55.85 -29.93 60.66 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -63.7 -22.56 66.97 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.053 0.454 . . . . 0.0 111.696 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.58 6.92 65.46 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.459 -0.876 . . . . 0.0 111.293 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -112.86 142.89 28.02 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.542 -0.329 . . . . 0.0 110.354 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.579 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 43.4 Cg_endo -69.94 121.9 8.54 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.819 2.346 . . . . 0.0 112.131 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -111.92 127.48 55.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.5 124.44 22.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.166 0.508 . . . . 0.0 111.326 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -136.96 159.51 41.67 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.419 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 p -140.05 140.74 36.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.49 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.1 146.87 30.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.414 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.645 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -101.86 94.62 5.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -59.86 -26.62 66.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.631 0.253 . . . . 0.0 111.461 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.527 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 27.9 t30 -60.37 -16.48 35.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -109.68 6.82 24.05 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.135 -0.353 . . . . 0.0 110.849 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.47 ' CE2' ' HG3' ' A' ' 101' ' ' PRO . 37.4 m-85 -127.56 -23.95 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.492 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.3 mp -113.56 142.45 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -117.16 173.9 14.95 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.005 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -110.14 103.23 11.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.829 0.347 . . . . 0.0 110.51 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -112.42 107.86 16.8 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.371 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.845 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 58.0 t30 59.73 39.05 21.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.243 0.544 . . . . 0.0 110.412 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 72.57 21.66 79.41 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.71 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -125.94 150.35 48.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.506 0.194 . . . . 0.0 111.358 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 1.8 mm? -72.77 114.69 11.18 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.609 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 39.4 tt0 -108.54 123.75 49.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.512 0.672 . . . . 0.0 110.305 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.792 ' CD2' ' HD3' ' A' ' 51' ' ' PRO 0.251 0.2 OUTLIER -36.66 -57.73 1.15 Allowed Pre-proline 0 CA--C 1.423 -3.912 0 CA-C-N 113.503 -1.68 . . . . 0.0 115.164 -178.691 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.792 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 17.2 Cg_endo -117.08 109.23 0.01 OUTLIER 'Trans proline' 1 N--CA 1.348 -7.083 0 C-N-CA 113.471 -3.886 . . . . 0.0 113.12 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.573 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -148.43 -164.63 11.55 Favored Glycine 0 C--N 1.271 -3.066 0 CA-C-N 112.988 -1.915 . . . . 0.0 113.851 -176.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -151.79 142.2 22.52 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.629 0.372 . . . . 0.0 110.309 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.4 m 53.67 54.39 10.01 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 19.4 p90 -78.95 -32.99 45.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.63 -19.23 54.13 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.935 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.2 m -65.08 -18.93 65.72 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.98 0.512 . . . . 0.0 111.432 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.3 m -144.83 14.32 1.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.816 0.341 . . . . 0.0 111.193 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.4 m -121.45 139.4 53.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.33 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.72 175.85 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.063 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 0.5 OUTLIER 58.42 43.8 19.16 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.604 0.565 . . . . 0.0 111.135 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 p -66.17 132.72 49.1 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.774 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.61 163.33 40.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.817 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.643 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -121.11 113.39 19.96 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.099 0.476 . . . . 0.0 110.518 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -83.65 120.15 25.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.612 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 54.04 30.75 12.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.901 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 51.33 36.64 37.7 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.442 -0.799 . . . . 0.0 114.644 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -150.76 -29.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.768 0.784 . . . . 0.0 111.415 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 m -113.02 130.73 56.04 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.27 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.609 ' HB2' HD11 ' A' ' 88' ' ' LEU . 13.2 tp -89.98 128.34 36.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.89 129.24 55.09 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.576 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.21 170.11 21.85 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.775 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 t -113.81 116.92 30.11 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.511 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.7 m -116.71 148.5 41.02 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.12 0.486 . . . . 0.0 111.859 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.8 tmtt? -100.2 142.62 31.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.232 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.07 -31.03 0.54 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.329 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.845 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.09 -41.28 64.78 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -172.13 52.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.525 0.679 . . . . 0.0 110.182 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.16 -0.28 32.13 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.852 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -119.7 162.92 18.2 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 24.2 p90 -91.03 165.98 13.24 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.07 127.58 7.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.723 0.297 . . . . 0.0 110.644 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -67.19 123.03 19.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.787 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.5 p -142.88 176.07 9.35 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.349 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.28 160.49 40.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.121 0.486 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.668 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.5 tpt -143.91 124.84 14.31 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.009 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.485 ' H ' ' HE2' ' A' ' 86' ' ' MET . 26.0 t0 -78.29 106.77 10.43 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.542 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.754 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.1 mt -77.36 -8.93 58.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.987 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -49.37 -27.75 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.334 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 43.6 p90 -118.62 20.02 13.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.508 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 88' ' ' LEU . 2.0 m -125.22 -13.03 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.958 0.409 . . . . 0.0 110.651 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.89 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 6.9 p -147.26 136.37 16.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.789 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.571 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -133.17 173.89 20.85 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.47 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 8' ' ' SER . 20.7 t30 -111.93 124.57 52.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.4 m -133.07 103.4 6.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.75 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 63.84 41.42 6.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.24 28.28 66.61 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.883 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -125.55 147.19 49.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.897 0.38 . . . . 0.0 110.858 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.451 ' O ' ' HG3' ' A' ' 99' ' ' MET . 13.5 ptm -64.2 103.01 0.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.887 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -132.83 80.32 61.34 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.177 0.513 . . . . 0.0 110.48 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.89 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 65.6 Cg_endo -74.3 125.28 9.59 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.696 2.264 . . . . 0.0 112.148 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -135.37 125.35 25.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.372 0.606 . . . . 0.0 111.52 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.612 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -113.53 150.43 32.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.859 179.31 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.85 50.88 0.84 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.094 0.474 . . . . 0.0 110.483 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.433 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 38.2 t -160.64 -142.41 0.08 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 17.6 t-20 59.05 79.09 0.23 Allowed 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 123.777 0.831 . . . . 0.0 111.022 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' A' ' 110' ' ' VAL . . . -140.51 175.72 9.37 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.621 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.63 -57.45 10.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.925 0.393 . . . . 0.0 111.301 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -111.82 -18.74 12.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.44 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 107' ' ' ALA . 19.3 t -86.36 66.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.858 0.837 . . . . 0.0 109.605 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 53.3 tp -135.36 95.92 3.37 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.069 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -64.89 110.44 2.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.454 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.2 p -68.65 106.48 2.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.544 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -137.3 52.6 1.9 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.11 0.481 . . . . 0.0 111.646 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.493 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -67.21 -48.9 66.49 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 C--O 1.248 1.015 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.62 178.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.695 -0.113 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' OE1' ' HA ' ' A' ' 2' ' ' GLN . 15.9 mm-40 66.83 114.7 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.749 0.785 . . . . 0.0 111.593 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.536 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 99.7 m -87.78 -63.63 1.27 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.282 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 43.04 70.2 0.32 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.945 0.778 . . . . 0.0 113.071 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.526 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 11.7 p90 -53.25 -34.16 56.02 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.331 0.586 . . . . 0.0 110.402 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.86 -23.29 67.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.349 -0.842 . . . . 0.0 113.002 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -62.06 -27.48 68.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.7 m -129.88 15.91 5.78 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.525 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -117.53 139.89 50.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.371 0.605 . . . . 0.0 111.651 -179.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -137.82 154.48 49.53 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.199 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.79 60.51 7.99 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.358 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 31.6 m -94.14 139.91 17.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.075 0.464 . . . . 0.0 111.532 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -131.32 148.74 52.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.13 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.68 HD22 HD23 ' A' ' 64' ' ' LEU . 14.9 tp -133.41 119.19 19.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.992 0.425 . . . . 0.0 110.974 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.487 ' O ' HG12 ' A' ' 18' ' ' ILE . 67.6 t80 -127.09 101.32 6.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.202 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.23 -63.08 3.65 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.625 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.685 ' HD1' HD21 ' A' ' 36' ' ' ASN . 8.3 p90 -167.82 20.83 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.585 0.231 . . . . 0.0 111.602 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 15' ' ' TYR . 35.8 pt -116.25 126.08 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 110.504 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.821 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -111.3 114.74 28.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.263 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 17.8 ttm180 -116.98 138.43 51.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.53 168.12 35.93 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.778 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 9.7 m-20 -101.66 109.56 21.37 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -106.91 133.41 51.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.933 0.396 . . . . 0.0 110.426 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.5 mt -67.85 139.57 20.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.378 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.7 p30 -112.49 -168.1 1.27 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.567 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -56.18 -33.94 65.74 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.74 0.305 . . . . 0.0 111.689 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -59.88 -28.62 67.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.597 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.14 -3.77 58.48 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.596 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -107.3 144.67 29.65 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.664 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 31.6 Cg_endo -64.9 128.27 20.45 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.387 2.725 . . . . 0.0 112.795 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -114.75 131.5 56.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.095 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.02 127.29 30.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.271 0.558 . . . . 0.0 111.75 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 t -142.34 159.31 42.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.479 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.6 p -139.69 150.55 45.0 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.351 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.717 HG13 ' HG3' ' A' ' 99' ' ' MET . 2.7 mp -134.63 143.11 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.979 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.685 HD21 ' HD1' ' A' ' 17' ' ' TYR . 1.8 t-20 -100.82 97.03 7.7 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.5 mm? -59.42 -22.55 61.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.383 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -55.11 -28.76 54.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.125 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -108.18 11.54 27.37 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.909 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' C ' HD12 ' A' ' 41' ' ' ILE . 43.9 m-85 -129.09 -6.91 4.89 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.559 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.5 mp -129.06 133.74 65.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.585 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.64 176.42 18.22 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.391 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -115.38 101.63 9.09 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.983 0.42 . . . . 0.0 109.982 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.78 107.18 16.15 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.331 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.513 ' CG ' ' HA ' ' A' ' 77' ' ' ALA . 13.7 t-20 56.53 45.2 22.8 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.553 0.692 . . . . 0.0 110.471 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.95 19.8 75.64 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.828 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 149.01 47.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.982 0.42 . . . . 0.0 111.359 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.5 mp -72.45 122.47 21.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.714 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.624 ' HG2' ' CD ' ' A' ' 51' ' ' PRO . 24.7 tt0 -111.57 124.27 51.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 110.68 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.539 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 34.2 p90 -46.55 -28.2 0.68 Allowed Pre-proline 0 CA--C 1.452 -2.817 0 N-CA-C 119.107 3.003 . . . . 0.0 119.107 -177.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.624 ' CD ' ' HG2' ' A' ' 49' ' ' GLU . 6.8 Cg_endo -127.04 5.97 0.01 OUTLIER 'Trans proline' 1 N--CA 1.391 -4.545 1 C-N-CA 112.76 -4.36 . . . . 0.0 116.392 178.82 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.585 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -56.24 -175.11 0.21 Allowed Glycine 0 C--N 1.265 -3.386 0 CA-C-N 111.099 -2.773 . . . . 0.0 115.903 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -147.81 144.09 27.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.942 0.401 . . . . 0.0 111.302 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.2 t 65.76 43.53 3.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.561 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.9 p90 -74.5 -37.51 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.771 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.98 -18.97 20.72 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.567 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 t -63.05 -22.38 66.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.786 0.327 . . . . 0.0 110.92 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 m -143.48 19.12 1.87 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.608 0.242 . . . . 0.0 111.136 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 73' ' ' SER . 63.6 m -124.54 140.58 52.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 0.0 111.091 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.0 m -138.38 176.02 7.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.143 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 60.89 46.57 8.51 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 123.752 0.658 . . . . 0.0 111.028 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.535 ' HB ' HD21 ' A' ' 14' ' ' LEU . 36.5 p -73.07 126.98 31.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.262 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.4 153.99 34.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.68 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -109.95 113.21 25.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.816 0.341 . . . . 0.0 111.083 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -79.2 117.39 20.17 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.298 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.488 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 12.5 t70 51.53 35.51 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.489 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 52.28 35.59 43.29 Favored Glycine 0 C--O 1.226 -0.379 0 CA-C-N 115.106 -0.952 . . . . 0.0 115.373 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.488 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 1.9 p-80 -148.0 -25.67 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.024 0.912 . . . . 0.0 112.33 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.6 m -117.34 129.94 56.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.702 0.287 . . . . 0.0 111.433 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.612 ' HB2' HD11 ' A' ' 88' ' ' LEU . 20.1 tp -90.62 132.88 35.49 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.02 129.83 51.1 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.655 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.493 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -161.3 169.43 22.11 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.539 0.524 . . . . 0.0 110.849 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 59' ' ' CYS . 35.9 t -114.63 125.26 53.55 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 35.4 m -125.17 151.86 45.25 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -98.78 140.34 33.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.615 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.63 -32.01 0.48 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.5 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.513 ' HA ' ' CG ' ' A' ' 45' ' ' ASN . . . -50.83 -42.61 58.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -169.84 53.23 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.247 0.546 . . . . 0.0 110.015 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.9 1.79 49.09 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.423 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -125.27 165.53 18.16 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 40.3 p90 -95.19 161.04 14.27 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 123.618 0.574 . . . . 0.0 110.616 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -155.43 140.48 17.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -72.74 135.63 45.36 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.466 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.9 p -150.54 174.68 12.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.137 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.14 164.18 30.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.886 0.374 . . . . 0.0 110.373 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.57 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.2 tpt -147.01 122.1 10.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.225 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.68 106.4 4.07 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.684 ' HA ' HG22 ' A' ' 91' ' ' VAL . 21.4 mt -78.56 -8.35 58.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.135 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -47.12 -32.12 3.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.999 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -117.7 21.91 12.66 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.198 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 102' ' ' CYS . 1.3 m -124.35 -14.96 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.279 0.561 . . . . 0.0 110.605 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.496 ' HB ' ' CD1' ' A' ' 5' ' ' PHE . 2.7 t -132.41 127.79 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.536 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -124.77 153.76 17.91 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.956 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.462 HD22 ' HB2' ' A' ' 8' ' ' SER . 32.1 t30 -103.96 117.44 34.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.806 0.336 . . . . 0.0 110.564 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.435 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 57.9 m -112.45 84.7 2.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.099 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 60.74 61.44 1.68 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.418 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 57.13 28.56 58.69 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.84 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -134.01 144.95 49.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.116 0.484 . . . . 0.0 110.917 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.717 ' HG3' HG13 ' A' ' 35' ' ' ILE . 6.2 tmm? -67.09 115.82 7.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.363 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 14.0 mt-10 -144.27 73.59 15.97 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.711 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.51 ' HD3' ' HG2' ' A' ' 99' ' ' MET . 18.7 Cg_endo -57.09 156.73 23.33 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.261 2.641 . . . . 0.0 112.313 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.707 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 24.3 p -140.46 142.02 35.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.67 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.628 ' HG3' ' HB3' ' A' ' 106' ' ' ASN . 0.1 OUTLIER -111.85 147.34 35.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.081 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.63 15.47 19.85 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.54 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.434 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 19.8 p -176.62 -93.53 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.333 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.628 ' HB3' ' HG3' ' A' ' 103' ' ' ARG . 19.7 t-20 53.03 36.75 22.96 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.788 -1.097 . . . . 0.0 110.108 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.449 ' HB3' ' CD2' ' A' ' 109' ' ' HIS . . . -151.68 142.38 22.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.273 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -75.6 63.06 1.5 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.508 ' CE1' HG22 ' A' ' 110' ' ' VAL . 5.0 p80 -132.27 -51.45 0.95 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.508 HG22 ' CE1' ' A' ' 109' ' ' HIS . 26.9 m -128.93 47.17 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.882 0.849 . . . . 0.0 109.88 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.6 tp -155.87 83.57 1.02 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.49 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 19.3 ptmt -133.63 101.43 5.12 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.522 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.3 m -77.25 51.61 0.86 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.6 0.714 . . . . 0.0 110.122 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.3 m -131.4 105.51 7.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.801 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 25.3 m -68.55 -53.4 23.22 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.155 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.529 -0.748 . . . . 0.0 110.496 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.8 ttm . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 74.63 149.7 0.1 Allowed 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.357 0.663 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.486 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 80.4 m -65.15 -67.61 0.43 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.52 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 80.3 m-20 56.11 77.48 0.24 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 10.1 p90 -61.1 -44.44 97.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.011 0.434 . . . . 0.0 110.595 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.25 -21.11 61.47 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.613 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 28.0 t-20 -54.46 -35.69 63.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.58 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.484 ' HB2' HD22 ' A' ' 94' ' ' ASN . 52.4 m -134.03 21.62 3.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.65 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 87.4 m -118.06 132.99 56.32 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.611 0.243 . . . . 0.0 110.358 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.0 p -132.65 155.26 49.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.541 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.5 67.81 1.99 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.915 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 11.3 m -107.32 129.64 60.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.274 0.559 . . . . 0.0 112.373 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 67.5 mm-40 -115.98 145.76 42.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.314 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.932 HD22 HD23 ' A' ' 64' ' ' LEU . 53.6 tp -133.0 122.26 23.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.0 111.089 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 18' ' ' ILE . 76.8 t80 -134.2 100.07 4.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.967 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 62' ' ' THR . . . 81.39 -64.01 4.25 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.645 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -166.49 19.83 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.735 0.302 . . . . 0.0 111.365 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.513 HG22 ' ND2' ' A' ' 36' ' ' ASN . 33.6 pt -116.4 119.08 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.753 0.311 . . . . 0.0 110.942 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.839 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.2 mt -111.91 114.5 27.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.4 ttt85 -120.68 138.75 53.79 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.117 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 179.37 38.83 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.268 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.613 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 4.5 m-20 -105.68 109.53 21.52 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.73 0.3 . . . . 0.0 110.318 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 8' ' ' SER . 61.3 m -108.19 133.38 52.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.133 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 55.0 mt -67.8 138.29 22.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.616 -178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -106.75 -170.83 1.78 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.118 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HB3' ' CD1' ' A' ' 96' ' ' TYR . 15.3 pt-20 -57.67 -29.43 64.63 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.938 0.399 . . . . 0.0 111.691 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -64.71 -22.97 67.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.539 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.08 -1.4 62.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.929 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 -108.32 148.02 36.78 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 55.0 Cg_endo -70.96 128.59 15.13 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.9 2.4 . . . . 0.0 112.732 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -116.49 127.64 54.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.061 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.86 126.69 28.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.963 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.0 t -144.67 160.54 41.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.317 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 p -140.47 142.51 35.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.096 0.474 . . . . 0.0 111.184 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' A' ' 99' ' ' MET . 2.6 mp -123.69 143.8 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.691 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.513 ' ND2' HG22 ' A' ' 18' ' ' ILE . 9.2 m120 -104.14 92.65 4.46 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.839 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -56.35 -23.45 37.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.299 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -54.9 -32.69 61.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.955 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -100.78 11.29 39.86 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.771 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 52.6 m-85 -128.55 -26.91 2.68 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.552 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.4 mp -110.66 142.08 24.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.72 0.295 . . . . 0.0 110.825 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.711 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -121.21 166.12 14.18 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.13 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -113.16 111.79 22.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.422 0.629 . . . . 0.0 110.23 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -110.59 113.27 25.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.411 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.711 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 14.7 t30 57.12 36.18 27.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.04 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.97 13.84 82.63 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.798 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -118.93 145.69 45.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.582 0.23 . . . . 0.0 110.767 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.683 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.4 mp -73.84 113.8 11.41 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.739 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 7.2 tp10 -104.91 133.35 49.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.376 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.714 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.87 -68.93 0.2 Allowed Pre-proline 0 CA--C 1.425 -3.836 0 O-C-N 124.352 1.033 . . . . 0.0 113.152 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.714 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 6.8 Cg_endo -109.6 129.43 0.04 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.441 0 C-N-CA 113.763 -3.691 . . . . 0.0 113.31 -177.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.711 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -161.02 -160.35 10.65 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 113.998 -1.456 . . . . 0.0 113.46 -177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -154.73 140.6 18.2 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.962 0.448 . . . . 0.0 110.468 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m 52.39 46.78 26.05 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -72.19 -38.92 68.96 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.98 -18.73 48.52 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.533 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.5 m -64.92 -20.43 66.45 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 122.74 0.416 . . . . 0.0 111.12 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.0 m -143.69 28.15 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.078 0.466 . . . . 0.0 110.74 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 75.5 m -131.44 145.79 51.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.563 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.3 173.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.615 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mptt 61.65 41.8 11.72 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.689 0.618 . . . . 0.0 111.265 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.497 HG21 ' O ' ' A' ' 16' ' ' GLY . 7.5 p -68.75 123.88 22.14 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.605 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.88 156.7 38.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.155 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.932 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -113.61 112.88 24.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.717 0.294 . . . . 0.0 110.981 -179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -76.9 117.52 18.58 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.203 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.735 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 20.8 t70 61.63 5.48 1.27 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.837 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.47 35.7 41.0 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.969 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.735 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.0 p80 -148.91 -26.34 0.3 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 111.274 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 m -115.71 129.93 56.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.911 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.604 ' HA ' HD22 ' A' ' 64' ' ' LEU . 17.9 tp -90.36 136.78 32.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.51 129.55 46.2 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -163.25 166.51 23.09 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.404 0.44 . . . . 0.0 110.725 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 t -116.06 127.33 54.79 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 18.5 m -127.65 156.43 42.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.214 0.53 . . . . 0.0 112.065 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 10.5 tmtt? -99.72 152.29 20.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.425 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.45 -26.4 1.22 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.103 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.711 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -54.28 -42.14 69.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.843 0.354 . . . . 0.0 111.481 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -178.68 58.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.391 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.471 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 73.06 -2.92 32.22 Favored Glycine 0 CA--C 1.518 0.225 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.135 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -118.75 165.23 14.27 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.805 0.336 . . . . 0.0 110.421 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 49.1 p90 -104.41 166.36 10.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.679 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -151.14 152.07 32.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.691 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -83.47 129.4 34.98 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.23 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.9 p -148.25 170.54 17.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.027 0.441 . . . . 0.0 111.462 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.53 165.69 25.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.874 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.683 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 9.3 tpt -143.54 113.27 7.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.491 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.544 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 21.8 t70 -72.31 104.01 3.58 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.789 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.8 mt -76.36 -8.54 57.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.322 -177.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.544 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 8.0 m120 -49.88 -28.56 6.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.575 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 48.7 p90 -117.53 21.5 12.98 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.187 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -129.11 -14.79 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.606 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.2 t -133.58 147.0 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -143.78 149.73 21.72 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.167 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.484 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.7 t30 -89.37 116.63 27.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 68.3 m -116.94 84.37 2.13 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.365 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 26' ' ' GLU . 78.5 m-85 61.44 53.99 3.25 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.485 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.48 28.05 64.36 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.943 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -130.35 142.27 50.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.634 ' HB2' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -74.61 106.66 6.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.566 0.698 . . . . 0.0 112.507 -178.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -137.5 78.83 37.08 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.418 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 39.7 Cg_endo -65.71 104.97 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 123.296 2.664 . . . . 0.0 112.853 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -102.7 120.16 40.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.231 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -84.32 147.0 27.43 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -98.9 19.11 15.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.004 0.43 . . . . 0.0 111.64 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.502 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 48.7 m -152.66 -129.03 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.797 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.403 HD22 ' HG2' ' A' ' 51' ' ' PRO . 23.5 t-20 69.5 3.14 4.05 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.788 0.835 . . . . 0.0 111.55 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 66.89 -60.48 0.35 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.696 0.798 . . . . 0.0 111.749 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -161.02 -64.48 0.06 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.134 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -156.13 -52.04 0.08 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.543 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.3 t -101.31 87.08 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.511 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 111' ' ' LEU . 2.6 pt? -86.12 1.12 51.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.798 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -76.26 118.74 19.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.41 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.2 p -76.25 77.67 3.04 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.577 0.703 . . . . 0.0 109.484 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 t -155.21 142.92 19.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.097 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.7 m -70.2 -30.01 67.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.071 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 . . . . . 0 C--O 1.245 0.837 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.404 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -134.56 131.56 38.07 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.783 0.325 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 91.7 m -90.07 -51.74 5.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.813 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 51.97 73.66 0.31 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.4 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.551 ' CD1' HG13 ' A' ' 92' ' ' VAL . 1.9 p90 -58.31 -36.89 74.03 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.083 0.468 . . . . 0.0 111.164 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.19 -22.21 60.65 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -66.83 -20.47 65.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.695 0.283 . . . . 0.0 111.404 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.43 ' HB2' HD22 ' A' ' 94' ' ' ASN . 18.7 m -135.33 16.65 3.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 97.7 m -124.58 136.9 54.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.78 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -132.95 147.77 52.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.293 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.19 43.3 80.92 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.748 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 12' ' ' VAL . 3.1 m -81.99 119.48 31.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.436 0.636 . . . . 0.0 111.507 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -116.89 133.38 56.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.766 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.812 HD22 HD23 ' A' ' 64' ' ' LEU . 42.7 tp -108.14 121.08 44.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.204 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.471 ' O ' HG12 ' A' ' 18' ' ' ILE . 85.7 m-85 -124.74 105.18 9.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.689 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.35 -66.95 2.23 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.512 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.561 ' HD1' HD21 ' A' ' 36' ' ' ASN . 6.4 p90 -164.59 18.64 0.05 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 122.695 0.398 . . . . 0.0 111.24 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 15' ' ' TYR . 30.7 pt -122.26 133.96 66.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.128 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.698 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.3 mt -114.12 114.63 26.32 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.274 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -118.01 140.9 49.08 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.95 -174.37 37.47 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.277 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 8.2 m-20 -109.21 108.69 19.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.576 0.227 . . . . 0.0 110.54 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 74.9 m -106.81 132.37 52.86 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 53.6 mt -68.26 140.72 18.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.6 p30 -108.96 -174.99 2.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.986 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -50.53 -36.67 35.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.66 0.384 . . . . 0.0 111.993 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -59.39 -25.31 64.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.806 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.64 4.91 59.05 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.367 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -112.84 146.95 36.13 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.345 -0.428 . . . . 0.0 110.137 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.567 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 56.5 Cg_endo -72.02 133.75 22.09 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.907 2.405 . . . . 0.0 112.903 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -121.82 130.51 53.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.619 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.82 129.67 40.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.041 0.448 . . . . 0.0 111.337 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.0 t -144.07 160.16 41.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.745 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.9 p -140.02 140.02 36.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.738 -0.21 . . . . 0.0 110.61 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -124.61 144.87 33.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 123.225 0.328 . . . . 0.0 110.401 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.561 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -102.98 91.48 4.14 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -58.3 -26.14 62.68 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.081 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.52 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 42.3 t30 -59.19 -20.38 53.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -105.62 8.13 33.04 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.432 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -129.13 -25.54 2.73 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -107.85 140.52 25.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.697 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.31 164.6 12.12 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.239 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -113.61 108.29 16.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.125 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -110.76 108.95 18.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.328 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 43.9 m-20 53.96 39.18 30.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.187 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 80.27 19.0 70.28 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.042 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.27 154.99 39.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.045 0.45 . . . . 0.0 111.096 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.497 HD13 ' HG ' ' A' ' 70' ' ' LEU . 51.6 mt -88.1 113.78 24.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.363 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -109.09 138.21 45.8 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.477 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.687 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -38.9 -71.74 0.12 Allowed Pre-proline 0 CA--C 1.426 -3.79 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 2.5 Cg_endo -107.92 129.29 0.05 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.234 0 C-N-CA 113.876 -3.616 . . . . 0.0 113.209 -176.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.697 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -165.2 -162.97 17.47 Favored Glycine 0 C--N 1.284 -2.324 0 CA-C-N 113.976 -1.466 . . . . 0.0 113.408 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -156.28 144.73 19.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.445 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.0 t 59.59 41.75 18.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.725 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 17.1 p90 -72.26 -37.57 69.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.45 -18.69 44.79 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.322 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 t -61.87 -20.67 63.97 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 110.63 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 m -144.46 24.34 1.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.699 0.285 . . . . 0.0 111.02 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.2 m -124.95 139.83 53.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.262 0.554 . . . . 0.0 111.467 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.91 177.12 6.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.041 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 61.75 39.78 13.72 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.284 0.365 . . . . 0.0 111.431 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 p -70.43 126.47 29.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.956 0.408 . . . . 0.0 111.92 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.56 150.34 29.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.866 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.812 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -105.62 113.52 27.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.95 0.405 . . . . 0.0 111.218 -179.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.453 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 4.7 t30 -84.21 123.64 30.33 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.645 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.607 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 18.2 t70 61.0 8.24 1.83 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.768 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.55 30.83 68.43 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.993 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.607 ' CD2' ' HB3' ' A' ' 66' ' ' ASP . 0.5 OUTLIER -150.7 -20.43 0.22 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.883 0.342 . . . . 0.0 111.453 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.458 ' O ' HD13 ' A' ' 64' ' ' LEU . 40.7 m -116.03 135.65 53.75 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.493 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.497 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.0 tp -97.6 129.78 44.69 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.66 129.85 53.07 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.62 173.11 17.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.067 0.46 . . . . 0.0 110.788 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.7 t -119.95 119.27 32.98 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.475 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 32.6 m -122.52 146.79 47.08 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.8 tmtt? -100.54 146.38 27.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.01 177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.0 -24.75 0.41 Allowed Glycine 0 C--O 1.227 -0.328 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.477 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -68.97 -34.34 75.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.623 0.712 . . . . 0.0 111.828 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -169.64 54.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.187 0.517 . . . . 0.0 110.542 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.53 -1.77 8.91 Favored Glycine 0 CA--C 1.518 0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.143 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.56 160.55 22.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.808 0.337 . . . . 0.0 110.825 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 49.3 p90 -97.63 168.63 10.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.395 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -155.72 148.67 24.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.823 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.19 132.87 45.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.121 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -152.35 161.1 43.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.558 0.694 . . . . 0.0 112.131 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.47 159.74 41.1 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.919 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.526 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 7.8 tpt -146.29 116.96 7.6 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.615 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.444 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 32.9 t0 -77.02 104.39 7.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.409 0.623 . . . . 0.0 110.342 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.784 ' HA ' HG22 ' A' ' 91' ' ' VAL . 12.5 mt -73.81 -8.32 55.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.403 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -47.19 -31.73 3.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.794 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 42.0 p90 -118.79 24.35 10.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.79 0.329 . . . . 0.0 111.602 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.784 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -130.39 -4.32 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.044 0.45 . . . . 0.0 110.996 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 9.1 p -153.03 144.29 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.341 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -139.18 -171.78 12.34 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.282 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.43 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.4 t30 -132.5 137.92 47.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.828 0.347 . . . . 0.0 110.849 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.627 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 4.0 t -144.57 116.72 8.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 60.2 41.45 16.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.499 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 58.37 31.32 66.12 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.899 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -136.51 149.27 48.06 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.449 ' O ' ' HG3' ' A' ' 99' ' ' MET . 19.7 ptt? -55.44 127.11 28.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.442 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.627 ' HG3' ' CB ' ' A' ' 95' ' ' SER . 6.7 mm-40 -142.12 77.78 17.77 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.296 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 43.0 Cg_endo -68.82 93.5 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.561 2.174 . . . . 0.0 113.103 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.7 p -111.23 116.53 31.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.28 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.726 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -91.34 147.07 23.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.769 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.23 34.93 2.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.37 0.605 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.454 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 74.8 m -154.95 -132.79 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 63.93 19.87 11.94 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.822 0.82 . . . . 0.0 110.466 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.08 156.67 38.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.129 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.43 93.82 4.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.276 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -162.31 176.57 10.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.27 83.05 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.529 0.68 . . . . 0.0 110.265 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.746 HD23 ' H ' ' A' ' 111' ' ' LEU . 2.4 pt? -90.99 73.21 6.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.698 0.761 . . . . 0.0 110.366 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -78.08 42.26 0.39 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.869 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.8 t 54.19 28.14 8.69 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.289 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.1 t -166.24 147.06 6.45 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.343 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.9 m -77.82 -16.73 58.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.386 0.612 . . . . 0.0 109.39 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 . . . . . 0 C--O 1.248 1.013 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.492 179.091 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 tpt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -83.05 151.56 25.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.856 0.36 . . . . 0.0 110.968 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.625 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 94.3 m -122.15 -76.03 0.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.277 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 62.56 83.9 0.15 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.528 ' CD1' HG13 ' A' ' 92' ' ' VAL . 3.3 p90 -64.46 -36.97 85.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.078 0.466 . . . . 0.0 111.167 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -63.12 -20.43 65.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.331 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -52.47 -32.83 41.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.122 0.487 . . . . 0.0 111.417 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.414 ' HB2' HD22 ' A' ' 94' ' ' ASN . 21.2 m -138.73 35.76 2.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.263 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -128.77 135.27 48.94 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.093 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.3 p -132.56 162.53 31.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.361 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 60.17 54.98 32.81 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.353 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 32.9 m -95.81 138.88 20.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.968 0.413 . . . . 0.0 111.263 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -134.99 140.67 45.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.888 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.775 HD22 HD23 ' A' ' 64' ' ' LEU . 20.1 tp -120.97 116.84 25.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.011 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.522 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.3 t80 -125.14 104.04 8.31 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.869 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.98 -68.45 2.83 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.553 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 39.6 p90 -163.81 19.54 0.07 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 122.445 0.298 . . . . 0.0 111.21 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.579 HG22 ' ND2' ' A' ' 36' ' ' ASN . 38.8 pt -114.4 126.69 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.712 0.291 . . . . 0.0 110.729 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.923 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.15 113.95 26.49 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.0 ttm180 -119.08 139.18 52.19 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.388 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.555 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -160.96 168.99 36.48 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.632 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 9.2 m-20 -97.3 105.79 18.0 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -104.16 131.73 51.15 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.8 mt -74.61 135.86 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.097 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -95.1 -179.96 5.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.632 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -50.4 -39.93 48.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.63 -24.42 65.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.64 1.38 46.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.41 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -101.99 139.67 20.51 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 57.8 Cg_endo -72.12 135.14 24.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.886 2.39 . . . . 0.0 112.188 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -125.21 126.11 44.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.154 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.13 122.74 18.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.987 0.423 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.8 t -136.94 158.86 43.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.809 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 p -138.95 143.01 38.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.623 0.249 . . . . 0.0 110.909 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.32 146.74 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.572 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.579 ' ND2' HG22 ' A' ' 18' ' ' ILE . 7.1 m120 -100.5 96.86 7.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.073 0.463 . . . . 0.0 110.244 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.923 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -60.43 -26.69 66.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.207 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.3 t-20 -53.93 -34.01 58.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.09 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -102.72 11.46 37.61 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.0 m-85 -127.37 -21.8 3.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.73 139.95 35.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.67 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.3 165.55 12.07 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.177 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -110.71 106.22 15.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.613 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -112.17 107.37 16.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.751 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.822 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 39.7 t30 60.8 39.43 17.16 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.93 17.74 79.46 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.559 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.47 144.4 50.11 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.834 0.35 . . . . 0.0 111.045 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.2 mp -72.69 123.76 23.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.883 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.484 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 10.3 tp10 -113.95 139.33 49.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.696 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -41.79 -69.42 0.22 Allowed Pre-proline 0 CA--C 1.426 -3.799 0 CA-C-O 118.311 -0.852 . . . . 0.0 112.867 -179.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.696 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 3.5 Cg_endo -110.3 131.36 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.323 0 C-N-CA 113.81 -3.66 . . . . 0.0 113.2 -177.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -162.45 -159.29 10.2 Favored Glycine 0 C--N 1.285 -2.27 0 CA-C-N 114.108 -1.406 . . . . 0.0 113.604 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -155.17 144.94 21.45 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 124.026 0.486 . . . . 0.0 110.869 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 m 51.41 43.92 29.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -73.03 -38.8 66.41 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.23 -18.6 49.75 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.515 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.3 m -64.71 -24.79 67.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.846 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 m -136.86 20.27 3.05 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.881 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.9 m -126.56 140.42 52.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.882 0.372 . . . . 0.0 110.805 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.522 HG23 ' HE2' ' A' ' 61' ' ' LYS . 27.8 m -131.27 176.45 8.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.146 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.522 ' HE2' HG23 ' A' ' 60' ' ' VAL . 2.4 mppt? 58.75 44.85 16.51 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 123.451 0.47 . . . . 0.0 111.248 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.6 p -71.41 123.19 21.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.611 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.3 163.09 38.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.305 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.775 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -121.24 112.65 18.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.018 0.437 . . . . 0.0 111.524 -178.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -77.07 119.27 20.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.294 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.842 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.6 t70 51.99 26.51 3.77 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 124.087 0.867 . . . . 0.0 110.956 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 6' ' ' ALA . . . 58.35 32.63 68.48 Favored Glycine 0 C--O 1.224 -0.472 0 CA-C-N 115.663 -0.698 . . . . 0.0 113.722 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.842 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 11.0 p80 -141.35 -29.82 0.63 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.708 0.754 . . . . 0.0 111.661 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 m -116.28 131.06 57.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.802 0.334 . . . . 0.0 111.359 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.589 ' HA ' HD22 ' A' ' 64' ' ' LEU . 16.1 tp -90.74 131.93 36.13 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -122.38 130.43 53.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.783 179.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -160.58 165.37 30.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.14 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.7 t -111.63 120.58 42.54 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 34.8 m -119.29 152.43 36.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 9.0 tmtt? -99.85 144.66 28.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.689 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.79 -27.85 0.66 Allowed Glycine 0 C--N 1.329 0.17 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.629 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.822 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.6 -40.3 75.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -174.33 54.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.349 0.595 . . . . 0.0 109.93 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 67.81 6.51 44.42 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.112 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 28.8 pt20 -126.01 169.91 12.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 45.7 p90 -98.78 171.55 8.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.822 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -160.21 145.2 14.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -76.41 132.87 39.94 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.21 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.9 p -152.1 166.22 32.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 111.369 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.5 OUTLIER -138.81 162.66 34.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.426 179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.62 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 16.9 tpp -147.92 117.87 7.2 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.5 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 37.8 t0 -74.44 107.65 6.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.202 0.525 . . . . 0.0 109.677 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.72 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.8 mt -76.04 -9.52 58.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.523 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.411 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 1.8 m120 -48.41 -29.43 4.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.602 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 47.2 p90 -119.23 21.67 12.15 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.698 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -127.7 -10.46 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.037 0.446 . . . . 0.0 110.693 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.802 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.1 p -150.78 141.62 16.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.356 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.625 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -133.86 -168.51 11.84 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.063 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.414 HD22 ' HB2' ' A' ' 8' ' ' SER . 15.6 t30 -132.54 127.68 35.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.281 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.592 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 68.5 m -139.1 112.2 8.0 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.76 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 57.49 40.45 27.13 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.512 0.507 . . . . 0.0 111.185 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.44 20.05 58.42 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.743 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -116.74 147.13 42.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.721 0.296 . . . . 0.0 110.279 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.502 ' O ' ' HG3' ' A' ' 99' ' ' MET . 20.1 ptt? -61.48 117.31 5.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.367 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 19.0 mm-40 -135.03 79.33 51.22 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.735 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.802 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 53.7 Cg_endo -71.33 82.98 1.04 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.799 2.332 . . . . 0.0 112.392 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.3 p -104.28 127.26 51.9 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.433 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.558 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -111.71 149.96 30.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.191 179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.38 39.92 1.36 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.136 0.493 . . . . 0.0 111.008 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.451 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 58.2 m -159.09 -127.07 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 70.23 -68.35 0.21 Allowed 'General case' 0 CA--C 1.511 -0.533 0 C-N-CA 123.706 0.802 . . . . 0.0 110.902 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -87.48 -25.2 23.83 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.474 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -90.78 47.76 1.45 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.749 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -166.09 157.53 13.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.165 0.507 . . . . 0.0 110.168 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.7 m -79.3 77.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.616 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.1 tp -112.58 33.02 5.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.908 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -80.44 117.71 21.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.689 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.8 p -79.14 62.3 3.5 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.198 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.2 m -147.22 115.6 6.65 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.109 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 p -64.59 -44.73 89.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.552 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.834 179.877 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.795 0.331 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.431 ' HB3' ' ND2' ' A' ' 4' ' ' ASN . 21.3 mp0 -89.81 149.3 22.74 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.522 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 78.4 m -74.97 -76.18 0.15 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.417 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.431 ' ND2' ' HB3' ' A' ' 2' ' ' GLN . 50.4 m-80 54.79 75.68 0.29 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 15.0 p90 -60.18 -36.83 78.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.181 0.515 . . . . 0.0 110.94 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -69.16 -22.72 63.91 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -60.06 -25.43 65.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.931 0.396 . . . . 0.0 111.319 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.457 ' HB2' HD22 ' A' ' 94' ' ' ASN . 16.3 m -132.04 29.97 4.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.664 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -131.23 140.11 49.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.831 0.348 . . . . 0.0 110.543 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -133.32 150.53 51.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.29 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.97 73.65 0.46 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.531 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.572 HG12 ' HA3' ' A' ' 21' ' ' GLY . 33.3 m -112.0 144.39 19.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.837 0.351 . . . . 0.0 111.249 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -128.45 155.67 44.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.215 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.719 HD22 HD23 ' A' ' 64' ' ' LEU . 23.1 tp -132.18 109.38 9.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.026 0.441 . . . . 0.0 110.59 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.477 ' O ' HG12 ' A' ' 18' ' ' ILE . 80.4 m-85 -114.37 100.43 8.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' HG21 ' A' ' 62' ' ' THR . . . 77.56 -63.64 3.36 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.919 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.733 ' HD1' HD21 ' A' ' 36' ' ' ASN . 8.7 p90 -166.04 23.45 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.618 0.247 . . . . 0.0 111.633 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 15' ' ' TYR . 42.2 pt -121.73 133.53 67.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.808 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -112.65 120.16 40.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.863 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -127.96 139.71 52.42 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.876 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.572 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.35 -175.51 37.38 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.335 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 3.6 m-20 -106.84 107.66 18.79 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.8 m -105.19 131.84 52.17 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 72.0 mt -72.46 137.43 23.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -100.82 -175.18 2.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.123 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.3 -27.5 62.22 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.024 0.44 . . . . 0.0 112.048 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.62 -26.36 68.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.64 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.44 2.78 55.55 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.926 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -112.18 142.11 26.27 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.722 0.296 . . . . 0.0 110.374 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 42.1 Cg_endo -68.7 136.64 36.5 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.981 2.454 . . . . 0.0 112.596 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -123.87 134.27 53.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.132 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.83 126.06 28.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.004 0.431 . . . . 0.0 111.241 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 t -141.09 160.31 40.36 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.579 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -139.45 145.45 38.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.978 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -131.58 145.29 35.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.81 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.733 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -102.66 95.44 6.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.808 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.99 -26.7 62.69 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.691 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.415 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.0 t-20 -55.25 -27.91 49.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.281 -178.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -104.7 7.94 34.95 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 30.9 m-85 -128.22 -21.94 3.5 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.2 mp -113.59 141.2 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.497 0.189 . . . . 0.0 110.722 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.658 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -118.61 170.07 13.66 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.371 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -109.56 110.89 22.1 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.963 0.411 . . . . 0.0 110.928 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -110.78 106.91 16.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.589 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 12.0 t30 52.12 41.55 30.08 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.909 0.484 . . . . 0.0 111.508 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.96 16.18 77.48 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.21 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.23 153.64 41.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.06 0.457 . . . . 0.0 110.92 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.578 HD13 ' HG ' ' A' ' 70' ' ' LEU . 37.1 mt -81.4 114.07 19.9 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.305 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.626 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.1 tt0 -107.31 132.75 52.78 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.772 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -32.49 -69.94 0.12 Allowed Pre-proline 0 CA--C 1.425 -3.837 0 O-C-N 124.762 1.289 . . . . 0.0 114.047 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.772 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -108.77 133.59 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.321 0 C-N-CA 113.939 -3.574 . . . . 0.0 112.655 -177.636 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.658 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -168.61 -162.94 21.73 Favored Glycine 0 C--N 1.283 -2.389 0 C-N-CA 119.559 -1.305 . . . . 0.0 113.65 -178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -154.29 146.3 23.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.352 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.1 m 53.43 41.9 32.05 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -71.93 -35.51 69.65 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.14 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.09 -18.64 57.96 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.259 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -63.32 -24.29 67.79 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.494 -0.353 . . . . 0.0 111.136 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.5 m -136.46 22.08 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.095 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.4 m -126.89 148.37 50.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.128 0.489 . . . . 0.0 111.476 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.413 HG23 ' HD3' ' A' ' 61' ' ' LYS . 30.5 m -138.11 173.75 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.532 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 73' ' ' SER . 0.1 OUTLIER 58.83 40.38 22.93 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.452 0.47 . . . . 0.0 111.648 -179.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 16' ' ' GLY . 6.4 p -65.97 118.46 9.79 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.085 0.469 . . . . 0.0 111.822 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.91 149.56 31.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.095 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.719 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -109.0 115.02 29.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.772 0.32 . . . . 0.0 110.761 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -88.8 124.77 34.48 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.751 0.31 . . . . 0.0 110.969 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.883 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 17.1 t70 58.1 19.74 6.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.603 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.436 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 58.43 31.31 66.31 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.929 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.883 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.5 p80 -139.36 -32.41 0.65 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.561 0.68 . . . . 0.0 111.142 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -116.01 131.9 56.81 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.268 0.556 . . . . 0.0 111.747 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.645 ' HA ' HD22 ' A' ' 64' ' ' LEU . 9.1 tp -90.1 130.84 36.22 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.613 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 129.22 53.88 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.0 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.85 164.36 31.38 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.999 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.446 ' HB2' ' HE3' ' A' ' 61' ' ' LYS . 7.7 t -111.76 124.37 52.2 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 21.9 m -126.47 150.09 48.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.325 0.583 . . . . 0.0 112.042 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.4 tmtt? -99.36 146.74 25.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.419 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.87 -30.69 0.66 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.209 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.589 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.09 -42.32 76.56 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -169.9 54.86 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.422 0.63 . . . . 0.0 110.293 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.449 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 67.54 3.43 26.49 Favored Glycine 0 C--N 1.328 0.108 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.454 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.7 160.78 25.15 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 12.2 p90 -101.98 169.88 8.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.851 0.358 . . . . 0.0 110.643 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -157.86 138.73 13.16 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.78 121.2 25.08 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.518 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.2 p -133.08 -179.81 5.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.148 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.48 164.51 28.52 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.044 0.449 . . . . 0.0 110.658 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.475 ' HB2' ' CB ' ' A' ' 48' ' ' LEU . 9.2 tpt -145.86 113.72 6.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.96 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.65 105.84 5.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.555 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.782 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.4 mt -75.78 -9.0 58.23 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.697 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -50.88 -26.04 5.33 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.591 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 51.4 p90 -119.41 22.21 11.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.325 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.782 HG22 ' HA ' ' A' ' 88' ' ' LEU . 2.2 m -127.62 -14.99 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.849 0.357 . . . . 0.0 110.569 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -139.22 145.42 27.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.924 177.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.522 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -134.18 179.96 17.01 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.89 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.457 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.5 t30 -131.85 127.79 37.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.684 0.278 . . . . 0.0 110.921 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.638 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 64.2 m -135.14 107.36 7.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.234 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 60.93 42.58 12.73 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.751 0.657 . . . . 0.0 110.622 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.26 22.47 63.16 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.692 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -118.24 147.18 43.67 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.484 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.439 ' O ' ' HG3' ' A' ' 99' ' ' MET . 20.3 ptt? -60.82 121.08 11.42 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.043 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.638 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 57.6 mm-40 -137.02 80.45 35.51 Favored Pre-proline 0 CA--C 1.516 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.346 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 44.5 Cg_endo -68.81 89.02 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.672 2.248 . . . . 0.0 112.962 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.7 p -114.66 123.55 49.58 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.215 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -99.94 149.81 23.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.386 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -100.33 23.51 10.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.939 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.446 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 68.9 m -145.67 -141.11 0.12 Allowed 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.631 ' HB2' ' HG3' ' A' ' 51' ' ' PRO . 29.0 t-20 64.05 104.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.592 0.757 . . . . 0.0 111.584 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.96 -28.19 19.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.389 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -133.12 133.16 42.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -78.15 -28.39 48.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.15 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.64 73.19 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 122.57 1.176 . . . . 0.0 110.339 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 111' ' ' LEU . 2.7 pt? -104.57 23.57 13.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.159 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -80.52 100.61 8.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.088 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.6 t -80.84 79.85 7.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.227 0.537 . . . . 0.0 109.663 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.9 m -155.31 -173.49 4.58 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.229 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.9 m -84.08 -53.14 5.74 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.623 -179.654 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 65.45 -171.83 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.98 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.463 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 35.0 m -122.85 -74.44 0.62 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.608 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.788 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 49.4 m-80 60.67 71.06 0.58 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.637 ' CD1' HG13 ' A' ' 92' ' ' VAL . 5.1 p90 -66.24 -37.5 85.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.025 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.56 -20.0 65.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.204 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.788 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 44.2 t-20 -51.57 -39.11 57.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.026 0.441 . . . . 0.0 110.769 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.474 ' HB2' HD22 ' A' ' 94' ' ' ASN . 19.2 m -132.01 27.71 4.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -118.53 139.99 50.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.012 0.434 . . . . 0.0 111.051 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.6 p -137.01 152.26 49.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.647 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.05 57.23 14.41 Favored Glycine 0 N--CA 1.455 -0.082 0 O-C-N 123.527 0.517 . . . . 0.0 112.764 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.563 HG12 ' HA3' ' A' ' 21' ' ' GLY . 15.9 m -101.17 134.03 42.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.065 0.459 . . . . 0.0 111.852 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -127.72 153.14 46.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.263 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.742 HD22 HD23 ' A' ' 64' ' ' LEU . 23.7 tp -128.33 120.55 27.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.97 0.414 . . . . 0.0 111.991 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.448 ' O ' HG12 ' A' ' 18' ' ' ILE . 73.0 t80 -126.66 108.55 11.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 62' ' ' THR . . . 78.5 -73.35 2.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.3 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' HD1' HD21 ' A' ' 36' ' ' ASN . 13.6 p90 -164.0 23.38 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.821 0.343 . . . . 0.0 111.377 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 15' ' ' TYR . 24.7 pt -121.13 127.84 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.702 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.857 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -109.29 114.59 28.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.176 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.06 139.74 51.22 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.014 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.563 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -165.93 -175.39 36.32 Favored Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.139 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 3.5 m-20 -107.89 108.05 19.04 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.572 0.225 . . . . 0.0 110.577 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 m -105.72 131.36 53.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 8' ' ' SER . 53.1 mt -69.65 140.78 18.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.982 0.42 . . . . 0.0 111.904 -178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -108.05 -172.8 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.331 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HB2' ' CD2' ' A' ' 96' ' ' TYR . 7.2 tp10 -49.85 -41.79 45.96 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.469 0.48 . . . . 0.0 112.153 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.87 -22.97 63.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.408 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.78 5.03 60.14 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.346 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -109.47 145.39 31.8 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.483 -0.359 . . . . 0.0 110.573 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 38.3 Cg_endo -66.74 131.53 26.12 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.98 2.453 . . . . 0.0 112.52 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -115.24 130.64 56.97 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.503 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.65 120.16 12.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.715 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -140.94 159.52 42.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.386 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.2 p -140.16 148.02 41.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.029 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 99' ' ' MET . 3.5 mp -126.94 147.61 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.373 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.4 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -105.53 85.9 2.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.857 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -54.39 -25.29 23.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.046 0.451 . . . . 0.0 111.383 -178.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 23.1 t-20 -53.47 -24.81 13.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.391 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -113.5 10.36 18.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -126.79 -8.2 6.13 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 120.869 0.366 . . . . 0.0 111.309 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.582 HD11 HD22 ' A' ' 88' ' ' LEU . 3.0 mp -127.41 134.55 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -117.04 -177.33 17.78 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 23.9 p-10 -127.96 101.66 6.41 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.648 0.737 . . . . 0.0 110.873 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -101.92 113.81 27.36 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.957 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.43 ' CG ' ' HA ' ' A' ' 77' ' ' ALA . 8.4 t-20 58.84 36.69 24.81 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.645 0.736 . . . . 0.0 110.129 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.6 19.75 78.95 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.992 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -122.45 146.1 47.69 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.654 0.264 . . . . 0.0 110.432 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.5 mp -72.04 120.78 18.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.401 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.523 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 6.1 pt-20 -108.16 138.73 43.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.426 0.632 . . . . 0.0 110.254 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -58.8 -24.15 1.44 Allowed Pre-proline 0 CA--C 1.447 -2.991 0 N-CA-C 118.125 2.639 . . . . 0.0 118.125 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.601 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 4.4 Cg_endo -129.5 12.16 0.0 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.771 1 C-N-CA 112.787 -4.342 . . . . 0.0 116.353 179.253 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.575 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -62.13 -176.23 2.52 Favored Glycine 0 C--N 1.259 -3.707 0 CA-C-N 111.266 -2.697 . . . . 0.0 115.547 -176.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -146.95 147.98 31.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m 58.48 45.41 16.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.046 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 9.5 p90 -74.11 -38.26 63.88 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.01 -23.74 47.65 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.444 -0.408 . . . . 0.0 112.317 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.0 m -62.02 -18.1 59.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.293 -0.453 . . . . 0.0 111.365 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 m -148.93 27.54 0.87 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.614 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.3 m -132.24 145.09 51.08 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.985 0.422 . . . . 0.0 111.052 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.41 HG23 ' HD3' ' A' ' 61' ' ' LYS . 22.2 m -136.39 176.85 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.253 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.41 ' HD3' HG23 ' A' ' 60' ' ' VAL . 2.2 mptm? 61.9 40.65 12.31 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.241 0.338 . . . . 0.0 111.659 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 16' ' ' GLY . 2.4 p -69.13 123.03 19.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.094 0.473 . . . . 0.0 112.05 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.41 161.97 41.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.718 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.742 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -123.17 113.79 19.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.872 0.368 . . . . 0.0 111.34 -178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -83.32 122.09 28.0 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.009 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.695 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 28.2 t70 52.5 25.24 3.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.776 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.49 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 56.62 39.62 86.02 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.624 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.695 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.9 p80 -149.24 -30.88 0.24 Allowed 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 117.249 0.524 . . . . 0.0 111.078 178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.428 ' O ' HD13 ' A' ' 64' ' ' LEU . 5.7 m -116.02 130.6 56.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.801 0.334 . . . . 0.0 111.282 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.691 ' HB2' HD11 ' A' ' 88' ' ' LEU . 14.0 tp -93.26 131.22 38.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.975 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.59 129.81 56.0 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.069 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.483 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -162.36 162.93 28.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 110.528 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 t -111.36 125.29 53.7 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 34.8 m -125.06 156.06 38.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.7 tmtt? -98.45 148.89 23.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.685 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.67 -28.37 0.84 Allowed Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.246 -0.978 . . . . 0.0 113.269 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 45' ' ' ASN . . . -55.53 -42.64 74.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.841 0.353 . . . . 0.0 111.564 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -172.98 56.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.765 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.92 2.39 38.02 Favored Glycine 0 C--O 1.229 -0.213 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.45 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -122.87 162.45 22.15 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 48.2 p90 -91.45 160.85 15.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.713 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -146.98 147.17 30.45 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -82.53 135.5 35.08 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 p -155.7 173.19 17.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.744 0.307 . . . . 0.0 111.259 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.84 164.28 30.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.843 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.68 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.3 tpt -149.99 119.64 7.01 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.553 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.425 ' OD2' ' HB3' ' A' ' 89' ' ' ASN . 25.2 t0 -73.28 108.9 6.42 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.7 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.0 mt -81.59 -9.12 59.75 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.327 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.425 ' HB3' ' OD2' ' A' ' 87' ' ' ASP . 25.4 t-20 -47.88 -29.48 3.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.648 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -117.11 15.82 15.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.557 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -120.24 -3.58 9.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.654 0.74 . . . . 0.0 110.294 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 1.069 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.3 p -155.46 131.18 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.017 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.463 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -126.12 179.67 16.16 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.128 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.474 HD22 ' HB2' ' A' ' 8' ' ' SER . 21.9 t30 -118.62 126.17 51.37 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.441 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.486 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 72.7 m -130.27 97.3 4.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.809 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.547 ' CD2' ' HB2' ' A' ' 26' ' ' GLU . 71.8 m-85 61.7 52.38 3.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.262 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.36 16.79 60.98 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.814 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -119.87 143.13 48.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.401 ' HB2' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -72.31 120.99 18.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.218 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 25.1 mm-40 -127.71 75.57 77.79 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.47 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 1.069 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.7 Cg_endo -72.4 103.89 1.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.964 2.443 . . . . 0.0 112.391 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.23 110.35 22.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.713 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.38 150.52 38.35 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.45 99.25 10.92 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.2 m 74.96 -66.12 0.31 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.155 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.601 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 17.0 t-20 60.48 100.06 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.274 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -154.87 132.39 11.26 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.336 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -78.68 -22.75 46.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.361 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -124.5 -60.44 1.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.816 0.341 . . . . 0.0 111.55 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.1 m -85.09 55.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.726 0.774 . . . . 0.0 112.165 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.1 tp -82.05 71.06 9.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.557 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -120.22 108.18 13.9 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.796 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 t -60.93 92.2 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.445 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.8 p -169.75 60.96 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.982 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 18.5 m -61.39 -43.08 99.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.698 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 119.083 -0.484 . . . . 0.0 110.793 -179.495 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 ttp . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.569 0.223 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -74.58 125.43 28.62 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.529 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 55.6 m -65.43 -67.96 0.4 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.292 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 2.6 m-20 46.25 73.31 0.18 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.649 ' CD1' HG13 ' A' ' 92' ' ' VAL . 2.3 p90 -59.24 -42.45 91.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.566 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.99 -21.38 44.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.67 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 10.6 t-20 -61.0 -28.68 69.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.502 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.52 ' HB2' HD22 ' A' ' 94' ' ' ASN . 50.4 m -139.44 23.9 2.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.871 0.367 . . . . 0.0 111.388 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.5 m -122.21 132.88 54.66 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.519 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -133.67 160.8 36.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.929 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.76 51.82 56.8 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.366 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.563 HG12 ' HA3' ' A' ' 21' ' ' GLY . 29.8 m -97.59 139.47 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.832 0.349 . . . . 0.0 111.231 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -136.02 151.8 50.26 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.583 HD22 HD23 ' A' ' 64' ' ' LEU . 13.1 tp -119.35 110.1 16.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.098 0.475 . . . . 0.0 111.661 -178.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' HG12 ' A' ' 18' ' ' ILE . 36.2 m-85 -106.1 98.58 8.24 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' O ' HG21 ' A' ' 62' ' ' THR . . . 71.27 -65.13 0.99 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.16 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.793 ' HD1' HD21 ' A' ' 36' ' ' ASN . 4.3 p90 -156.34 12.31 0.28 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.782 -0.246 . . . . 0.0 111.645 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 15' ' ' TYR . 44.9 pt -114.45 133.54 60.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 110.896 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.818 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.29 113.97 26.48 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.118 179.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.3 ttm105 -120.28 138.38 53.71 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.563 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -158.85 -177.44 31.94 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.825 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.3 m-20 -108.51 103.5 12.64 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.454 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 66.2 m -107.13 131.98 53.52 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.845 0.355 . . . . 0.0 110.288 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.8 mt -70.14 139.18 20.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.1 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 6.3 p30 -112.01 -168.62 1.34 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.509 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.29 -28.11 64.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.726 0.298 . . . . 0.0 111.788 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.96 -28.51 69.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.01 0.433 . . . . 0.0 111.345 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.8 -9.29 60.12 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.424 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -101.39 142.84 25.41 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.641 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 24.3 Cg_endo -64.16 121.74 9.5 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.791 2.327 . . . . 0.0 112.317 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -104.39 134.99 46.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.504 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.26 124.95 25.68 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.497 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.3 t -143.95 159.79 41.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.81 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.9 p -139.45 154.78 47.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.7 mp -140.67 145.5 25.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.793 HD21 ' HD1' ' A' ' 17' ' ' TYR . 2.9 t-20 -100.87 104.6 15.82 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -64.61 -22.16 66.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 25.4 t30 -63.97 -13.23 44.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -108.03 -1.3 20.63 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.364 -0.21 . . . . 0.0 110.977 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.413 ' HD1' ' NH2' ' A' ' 103' ' ' ARG . 52.3 m-85 -127.67 -9.43 5.6 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.538 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.6 mp -124.45 134.14 67.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.611 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -113.86 178.16 18.21 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.558 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -113.92 102.57 10.32 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.06 0.457 . . . . 0.0 110.452 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -102.42 103.92 14.36 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 47.48 45.42 17.32 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.535 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.3 14.69 76.0 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.769 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.13 147.39 47.98 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.041 0.42 . . . . 0.0 111.114 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.601 HD13 ' HG ' ' A' ' 70' ' ' LEU . 25.6 mt -72.35 121.64 19.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.014 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.601 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 6.7 tp10 -110.99 127.23 55.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.267 0.556 . . . . 0.0 110.792 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.575 ' HB3' ' SD ' ' A' ' 86' ' ' MET . 11.5 p90 -49.29 -29.13 1.72 Allowed Pre-proline 0 CA--C 1.453 -2.784 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.601 ' HD2' ' HG3' ' A' ' 49' ' ' GLU . 3.3 Cg_endo -129.57 17.63 0.0 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.764 1 C-N-CA 113.032 -4.179 . . . . 0.0 115.931 179.073 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.611 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -68.36 -174.86 9.13 Favored Glycine 1 C--N 1.254 -4.013 0 CA-C-N 111.16 -2.745 . . . . 0.0 115.508 -176.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -143.45 148.14 35.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.407 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m 57.83 60.47 2.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.915 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 12.5 p90 -90.1 -35.33 15.5 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.791 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.99 -19.03 43.03 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.607 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.1 m -62.19 -25.22 67.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.323 -0.439 . . . . 0.0 111.353 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.1 m -141.84 27.24 1.84 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.154 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 80.9 m -129.02 151.25 49.92 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.215 0.531 . . . . 0.0 111.732 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.517 HG23 ' HE2' ' A' ' 61' ' ' LYS . 15.7 m -146.81 175.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.25 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HE2' HG23 ' A' ' 60' ' ' VAL . 2.0 mppt? 63.14 41.94 7.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.873 0.368 . . . . 0.0 110.777 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.537 HG21 ' O ' ' A' ' 16' ' ' GLY . 12.5 p -72.1 125.21 26.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.987 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.79 156.68 40.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.802 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.583 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -117.11 112.01 20.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.899 0.38 . . . . 0.0 110.738 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.55 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 11.6 m120 -73.08 117.28 14.62 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.342 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.788 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 10.2 t70 51.95 21.17 1.41 Allowed 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.017 0.823 . . . . 0.0 111.056 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.38 37.61 95.1 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.441 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.788 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 8.5 p80 -144.96 -29.99 0.45 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 117.506 0.653 . . . . 0.0 111.296 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 16.9 m -116.6 135.15 54.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.639 0.257 . . . . 0.0 111.072 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.601 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.3 tp -95.91 131.72 41.96 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.62 132.29 54.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.171 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.41 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -164.05 163.5 23.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.375 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.6 t -110.96 125.07 53.32 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.8 m -125.46 148.02 49.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.306 0.574 . . . . 0.0 112.063 -178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.9 tmtt? -99.61 144.93 28.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.683 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.32 -21.64 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.827 -1.177 . . . . 0.0 113.834 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.65 -38.17 89.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.878 0.339 . . . . 0.0 111.385 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -173.8 55.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.353 0.597 . . . . 0.0 109.759 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.14 -3.74 20.92 Favored Glycine 0 CA--C 1.52 0.39 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.603 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -115.44 163.48 15.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.63 0.252 . . . . 0.0 110.604 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 29.4 p90 -103.69 166.99 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.194 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.07 127.49 5.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.419 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.01 123.1 18.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.498 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.2 p -136.79 175.91 9.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.198 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.07 162.27 35.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.902 0.382 . . . . 0.0 110.778 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.575 ' SD ' ' HB3' ' A' ' 50' ' ' TYR . 21.3 tpp -148.83 123.69 9.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.481 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.554 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 24.4 t0 -78.37 106.75 10.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.384 0.612 . . . . 0.0 109.762 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.737 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.6 mt -76.23 -9.52 58.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.733 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.471 ' HB3' ' OD2' ' A' ' 87' ' ' ASP . 27.9 t-20 -51.64 -26.72 9.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.041 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 43.9 p90 -116.86 19.25 14.5 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.782 0.325 . . . . 0.0 111.375 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.737 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -126.59 -9.25 4.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.108 0.48 . . . . 0.0 110.583 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.918 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 5.5 p -153.82 139.96 11.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.529 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.09 176.73 19.62 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.197 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.52 HD22 ' HB2' ' A' ' 8' ' ' SER . 28.7 t30 -118.57 123.44 45.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.012 0.434 . . . . 0.0 110.276 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.58 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 58.3 m -124.7 99.9 6.38 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.474 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.85 51.02 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.173 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 56.69 27.8 55.8 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.958 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -130.76 141.34 50.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.93 0.395 . . . . 0.0 110.469 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 22.6 ptm -55.21 116.68 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.349 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 9.9 mm-40 -141.43 75.63 22.32 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.111 178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.918 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 61.2 Cg_endo -75.66 112.54 3.54 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.741 2.294 . . . . 0.0 112.156 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p -128.41 130.0 47.0 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.417 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.557 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -113.36 149.68 33.71 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.546 179.082 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -104.84 49.96 0.8 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.261 0.553 . . . . 0.0 110.737 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 22.3 p -165.95 -122.83 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 25.8 t-20 67.77 -53.02 0.51 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.096 0.958 . . . . 0.0 113.526 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -113.67 -27.86 7.68 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.992 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 105' ' ' SER . 24.0 t70 -144.13 -172.34 3.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.457 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 77.6 t60 72.91 -67.41 0.27 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.65 0.78 . . . . 0.0 110.958 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.457 HG12 ' HD2' ' A' ' 109' ' ' HIS . 5.7 p -146.85 94.96 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.989 0.899 . . . . 0.0 110.498 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.7 tp -135.88 73.03 1.45 Allowed 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.664 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -120.38 101.8 8.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.742 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.3 m -70.56 115.98 10.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.893 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.5 p -115.71 82.48 1.77 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.131 0.491 . . . . 0.0 110.987 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.2 m -67.7 -53.88 23.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.747 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.933 179.589 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.711 0.291 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -88.91 117.21 27.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.91 0.386 . . . . 0.0 110.049 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.506 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 61.4 m -83.99 -74.02 0.39 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.164 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 89' ' ' ASN . 50.5 m-80 51.64 75.45 0.21 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.843 0.457 . . . . 0.0 111.896 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CD1' HG13 ' A' ' 92' ' ' VAL . 3.1 p90 -56.94 -39.8 75.21 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 110.943 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -56.89 -22.57 38.27 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -68.4 -21.65 64.67 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.69 0.281 . . . . 0.0 111.569 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.44 ' HB2' HD22 ' A' ' 94' ' ' ASN . 49.9 m -134.29 19.09 3.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.929 0.395 . . . . 0.0 110.903 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 81.4 m -124.8 132.98 53.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.244 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.6 p -126.77 155.14 43.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.262 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.79 63.78 4.79 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.381 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.8 m -98.38 133.93 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.252 0.549 . . . . 0.0 111.473 -179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.62 136.28 48.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.656 HD22 HD23 ' A' ' 64' ' ' LEU . 23.0 tp -121.64 124.84 45.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.086 0.469 . . . . 0.0 111.07 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -133.35 114.93 14.27 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.683 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.13 -71.46 1.98 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.007 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -167.81 24.07 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.314 0.646 . . . . 0.0 109.573 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.419 HG12 HD21 ' A' ' 36' ' ' ASN . 7.5 mt -120.08 113.27 40.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.549 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -99.81 114.82 28.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.994 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -116.94 140.03 49.95 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.21 176.6 40.14 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.265 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 41.6 m-20 -105.87 107.95 19.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 82.5 m -105.81 131.69 52.83 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.084 0.469 . . . . 0.0 110.043 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mt -70.02 138.96 20.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.516 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.445 HD21 ' CD2' ' A' ' 29' ' ' HIS . 4.7 p30 -105.61 -169.46 1.59 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.331 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.96 -29.03 66.85 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.452 ' OD2' ' HB3' ' A' ' 29' ' ' HIS . 24.9 t70 -68.76 -26.26 65.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.15 0.5 . . . . 0.0 111.751 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.34 57.29 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.132 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.452 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -107.78 138.95 20.17 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.604 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 24.6 Cg_endo -63.65 127.19 19.13 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.113 2.542 . . . . 0.0 112.808 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -109.79 133.17 53.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.184 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.39 118.73 16.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.903 0.383 . . . . 0.0 111.508 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.3 t -135.4 157.39 47.01 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.006 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.8 p -139.83 138.29 35.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.499 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mp -126.58 145.9 33.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.955 0.407 . . . . 0.0 111.258 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.492 HD22 ' HA ' ' A' ' 36' ' ' ASN . 3.4 m120 -103.57 99.16 8.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.049 0.452 . . . . 0.0 110.1 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -62.29 -23.67 66.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.895 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.98 -30.94 62.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.939 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -103.95 13.54 32.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -130.87 -25.85 2.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.538 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -109.08 141.95 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.664 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.94 -174.93 19.78 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.843 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -129.24 105.06 7.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.07 0.462 . . . . 0.0 111.292 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -103.27 111.17 23.44 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.544 ' HB2' ' HA ' ' A' ' 77' ' ' ALA . 5.4 p-10 42.18 47.08 3.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.675 1.19 . . . . 0.0 113.298 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.91 14.93 74.05 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.596 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.15 143.23 50.61 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.823 0.344 . . . . 0.0 111.23 -179.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.543 ' CD2' ' HG ' ' A' ' 70' ' ' LEU . 8.9 mp -71.49 119.34 15.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.814 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -109.9 139.13 45.33 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.832 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -41.14 -68.97 0.23 Allowed Pre-proline 0 CA--C 1.428 -3.746 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.832 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 7.8 Cg_endo -111.46 122.97 0.03 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.361 0 C-N-CA 113.943 -3.571 . . . . 0.0 113.544 -177.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.664 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -158.67 -160.82 10.58 Favored Glycine 0 C--N 1.277 -2.703 0 CA-C-N 113.758 -1.565 . . . . 0.0 113.282 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 34.5 mt-10 -156.31 144.39 19.67 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.942 0.436 . . . . 0.0 110.818 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 m 57.14 41.24 27.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.15 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -72.09 -40.2 68.39 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.049 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.01 -18.99 49.62 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.733 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.2 m -65.14 -24.34 67.38 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.514 0.326 . . . . 0.0 110.955 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.1 m -138.32 24.76 2.71 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.916 0.389 . . . . 0.0 110.635 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 83.0 m -131.29 141.48 49.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.314 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.443 HG23 ' HD3' ' A' ' 61' ' ' LYS . 30.2 m -133.92 172.81 15.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.376 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.8 mptt 64.1 43.3 5.13 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.715 0.635 . . . . 0.0 110.873 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 p -68.83 124.4 23.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.386 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.2 156.07 37.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.86 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.656 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -110.48 120.39 42.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.541 0.21 . . . . 0.0 110.61 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.486 ' C ' ' H ' ' A' ' 67' ' ' GLY . 19.3 t-20 -87.46 121.18 29.57 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.9 t70 68.33 -25.76 0.13 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.437 1.085 . . . . 0.0 112.356 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 65' ' ' ASN . . . 110.19 22.02 6.71 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -142.84 -20.47 0.66 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.452 ' O ' HD13 ' A' ' 64' ' ' LEU . 43.3 m -116.95 127.36 54.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.251 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.543 ' HG ' ' CD2' ' A' ' 48' ' ' LEU . 16.6 tp -90.61 129.28 36.75 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.79 130.29 54.86 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.487 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.501 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -162.55 165.32 26.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.833 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -110.08 125.55 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.466 ' SG ' HD12 ' A' ' 48' ' ' LEU . 60.9 m -123.23 147.73 46.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.351 0.596 . . . . 0.0 112.582 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.9 tmtt? -99.69 145.3 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.923 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.73 -16.27 0.94 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.822 -1.18 . . . . 0.0 113.332 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' A' ' 45' ' ' ASN . . . -59.67 -39.46 84.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.875 0.369 . . . . 0.0 110.759 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.3 t70 178.91 60.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.843 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.79 4.48 54.11 Favored Glycine 0 C--O 1.228 -0.223 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.544 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -124.92 165.34 18.26 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.6 p90 -112.53 166.27 11.47 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.282 0.364 . . . . 0.0 111.488 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -158.55 144.61 16.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -76.29 142.36 41.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.786 0.327 . . . . 0.0 110.158 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.9 p -153.6 174.58 14.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.419 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.82 156.54 46.12 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.082 0.468 . . . . 0.0 110.586 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.517 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 12.3 tpp -140.78 123.18 15.92 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.644 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -76.06 106.24 7.55 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.747 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.3 mt -73.34 -9.09 58.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.747 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.441 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 16.3 m120 -47.58 -31.15 4.17 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.79 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 26.7 p90 -119.74 23.58 11.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.411 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.747 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -128.49 -7.85 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.02 0.438 . . . . 0.0 110.52 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.8 p -156.82 141.79 8.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.023 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.506 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.91 -174.96 13.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.229 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.44 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.9 t30 -130.0 133.26 46.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.938 0.399 . . . . 0.0 110.991 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 m -142.35 112.25 6.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.398 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 60.17 40.51 18.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.397 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.67 24.6 66.44 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.457 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -128.17 138.86 52.66 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.445 ' O ' ' HG3' ' A' ' 99' ' ' MET . 13.5 ptt? -64.46 129.17 38.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.347 0.594 . . . . 0.0 112.5 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -140.09 77.35 25.77 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.79 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 33.3 Cg_endo -61.79 93.25 0.12 Allowed 'Trans proline' 0 C--N 1.333 -0.27 0 C-N-CA 123.422 2.748 . . . . 0.0 112.951 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 p -106.88 119.47 39.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.406 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.522 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -102.78 149.52 24.39 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.032 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -99.51 35.83 1.89 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.18 0.514 . . . . 0.0 111.237 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.48 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 21.6 t -161.49 -132.89 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.475 HD22 ' HB2' ' A' ' 51' ' ' PRO . 20.0 t-20 62.83 96.74 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 123.607 0.763 . . . . 0.0 110.432 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 73.29 -13.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.737 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 12.3 m-20 -129.61 168.12 16.92 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.662 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.522 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 63.4 t60 74.3 154.46 0.15 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.813 0.816 . . . . 0.0 110.856 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.09 91.67 2.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 122.242 1.02 . . . . 0.0 110.71 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.845 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.8 pt? -97.82 69.39 2.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.949 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.79 118.2 30.47 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.817 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.2 t -93.35 75.46 4.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.7 m -100.26 86.18 3.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.331 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.11 -54.04 48.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.187 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.607 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 tpp . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 120.987 0.423 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -120.44 101.85 8.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.522 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 28.5 m -75.55 -57.85 3.63 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.33 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' HB3' ' CG ' ' A' ' 7' ' ' ASN . 79.6 m-20 63.54 71.28 0.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 O-C-N 123.298 0.374 . . . . 0.0 110.891 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 9.8 p90 -54.43 -37.51 65.21 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.148 0.499 . . . . 0.0 111.361 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.86 -22.15 64.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.78 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.441 ' CG ' ' HB3' ' A' ' 4' ' ' ASN . 6.0 m-20 -69.79 -16.1 63.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.68 0.276 . . . . 0.0 111.301 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.6 m -127.03 4.44 6.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.2 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 0.8 OUTLIER -118.49 137.53 53.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.162 0.506 . . . . 0.0 112.079 -178.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 p -128.59 153.07 47.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.096 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 57.65 64.9 3.95 Favored Glycine 0 N--CA 1.453 -0.22 0 O-C-N 123.518 0.511 . . . . 0.0 112.442 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.602 HG12 ' HA3' ' A' ' 21' ' ' GLY . 32.4 m -100.64 147.04 8.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 111.278 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -138.18 148.91 45.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.127 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.628 HD22 HD23 ' A' ' 64' ' ' LEU . 8.5 tp -122.19 105.36 10.17 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.023 0.439 . . . . 0.0 110.72 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -134.62 112.4 10.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.34 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 75.24 38.33 39.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.282 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.427 ' HA ' HD11 ' A' ' 14' ' ' LEU . 10.2 m-85 64.55 24.06 12.98 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.15 0.58 . . . . 0.0 110.675 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 16' ' ' GLY . 16.2 mt -117.77 122.23 69.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.253 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.805 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -102.6 113.64 27.18 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.351 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 20.4 ttm180 -118.84 134.3 55.25 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.426 -0.509 . . . . 0.0 109.835 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.602 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -157.63 175.3 34.98 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.898 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 26.6 m-20 -101.15 107.29 18.66 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -106.02 131.8 52.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.5 mt -70.09 135.25 28.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.568 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.4 p30 -103.64 -175.12 2.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.125 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -54.09 -31.33 51.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.06 -27.5 69.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.451 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.34 -0.04 53.83 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.121 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -108.66 144.54 29.76 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 120.802 0.334 . . . . 0.0 110.385 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 35.6 Cg_endo -66.91 121.27 8.45 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.057 2.505 . . . . 0.0 112.655 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -107.09 129.24 54.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.306 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.53 119.19 13.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.011 0.434 . . . . 0.0 110.871 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -132.19 159.48 38.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.808 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.407 ' O ' ' HG2' ' A' ' 99' ' ' MET . 78.4 p -138.5 147.97 43.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.847 0.356 . . . . 0.0 111.502 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.74 142.55 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.9 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 36' ' ' ASN . 1.7 t-20 -101.96 92.71 4.91 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.805 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.69 -23.72 53.05 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.322 -178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 21.1 t-20 -54.8 -30.9 58.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.98 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -108.57 16.31 23.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.534 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.9 m-85 -126.97 -25.05 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -110.52 140.62 28.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.693 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -115.35 161.66 12.74 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.178 -1.01 . . . . 0.0 113.395 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -100.63 104.75 16.09 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.691 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -111.94 106.55 15.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.922 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.822 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 56.2 t30 58.41 36.98 25.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.121 0.486 . . . . 0.0 110.817 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.66 17.07 80.22 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.403 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.07 154.88 39.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.834 0.349 . . . . 0.0 110.825 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 31.5 mt -79.92 114.48 18.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.239 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -105.52 135.18 47.4 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.656 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.84 -72.45 0.11 Allowed Pre-proline 0 CA--C 1.426 -3.792 0 O-C-N 124.254 0.971 . . . . 0.0 113.333 -178.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.656 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 9.2 Cg_endo -108.36 126.14 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.319 0 C-N-CA 113.623 -3.784 . . . . 0.0 113.252 -177.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.693 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -156.65 -164.2 13.21 Favored Glycine 0 C--N 1.283 -2.398 0 CA-C-N 113.582 -1.645 . . . . 0.0 113.029 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -153.39 142.86 21.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.857 0.36 . . . . 0.0 111.013 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 m 53.4 42.37 32.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.226 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 10.5 p90 -68.47 -36.7 79.35 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.48 -18.12 28.69 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.377 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.7 t -64.54 -21.08 66.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.723 0.297 . . . . 0.0 110.487 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.5 m -140.8 23.38 2.26 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.099 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.5 m -128.97 142.61 50.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.954 0.407 . . . . 0.0 111.311 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 m -134.37 172.93 15.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.249 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? 63.25 37.74 10.91 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.501 0.5 . . . . 0.0 111.766 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.8 p -66.67 122.66 18.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.117 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.69 163.57 39.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.877 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.628 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -119.54 113.44 20.73 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.908 0.385 . . . . 0.0 111.471 -179.32 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.485 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 16.1 m120 -76.13 117.18 17.57 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.322 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.664 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 20.4 t70 58.9 9.53 1.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 O-C-N 123.907 0.755 . . . . 0.0 111.567 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.22 30.75 58.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.777 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.664 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 5.5 p80 -144.56 -26.06 0.51 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 117.547 0.674 . . . . 0.0 111.394 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 21.9 m -115.82 130.39 56.82 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.316 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.588 ' HA ' HD22 ' A' ' 64' ' ' LEU . 23.1 tp -91.02 130.67 36.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.71 129.82 55.48 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -162.59 159.84 25.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.231 0.538 . . . . 0.0 111.039 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.7 t -109.59 123.31 49.23 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 56.9 m -122.25 149.67 43.37 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.369 0.604 . . . . 0.0 112.534 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.7 tmtt? -99.74 139.56 35.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.024 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.91 -32.52 0.38 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.947 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.822 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -47.49 -43.33 24.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -171.69 49.77 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.85 5.56 65.05 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.608 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -122.83 165.72 16.17 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 33.4 p90 -101.2 162.55 12.82 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 123.292 0.37 . . . . 0.0 110.155 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.14 134.22 15.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -72.22 125.48 27.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.225 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.4 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 34.1 p -142.29 170.71 15.21 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.969 0.414 . . . . 0.0 110.719 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.37 164.95 26.59 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.692 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.4 tpt -145.74 120.02 9.57 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.067 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.27 105.01 5.25 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.778 ' HA ' HG22 ' A' ' 91' ' ' VAL . 17.5 mt -75.98 -8.44 56.95 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.528 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -47.15 -32.08 4.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.917 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 36.7 p90 -117.16 23.75 11.64 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.087 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.778 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -130.76 -5.71 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.989 0.423 . . . . 0.0 110.843 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.928 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.6 t -141.16 146.33 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.522 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -143.45 176.82 22.66 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.989 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -131.7 132.95 44.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.6 m -141.75 109.22 5.61 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.286 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 62.31 43.93 7.88 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.905 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.568 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 61.58 26.28 66.41 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.159 -0.543 . . . . 0.0 111.874 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -127.53 142.15 51.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 34' ' ' SER . 4.4 ppp? -67.68 134.14 50.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.115 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.07 71.09 7.07 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.039 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.928 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 12.3 Cg_endo -54.45 103.52 0.1 OUTLIER 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.408 2.739 . . . . 0.0 112.432 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.5 p -108.17 136.77 47.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.828 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -112.16 149.22 32.51 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.42 58.15 0.64 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.023 0.44 . . . . 0.0 111.06 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.1 t -176.48 -107.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.947 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 64.08 102.09 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.771 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.37 133.33 20.24 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.088 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.84 127.55 35.34 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.928 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 71.16 -52.05 0.69 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.642 0.777 . . . . 0.0 111.984 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.9 m -88.12 60.82 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 111.713 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.3 tp -128.48 43.66 3.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.017 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -124.74 27.32 6.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.991 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 86.8 p 46.62 -121.92 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.186 0.594 . . . . 0.0 110.786 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.6 t 74.03 102.66 0.07 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.522 0.677 . . . . 0.0 109.652 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.1 m -63.02 -43.15 99.53 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.649 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.016 179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 tpp . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 120.846 0.355 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.66 132.51 36.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.098 0.475 . . . . 0.0 109.85 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.575 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 1.1 m -108.93 -72.55 0.72 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.823 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 62.4 m-80 53.8 85.31 0.05 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.681 0.613 . . . . 0.0 112.56 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.583 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 6.0 p90 -62.51 -37.6 86.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.182 0.515 . . . . 0.0 110.165 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.91 -20.25 66.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.092 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 11.2 t-20 -52.11 -29.05 20.02 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.378 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.453 ' HB2' HD22 ' A' ' 94' ' ' ASN . 33.9 m -145.16 28.87 1.2 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.759 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -119.27 141.65 48.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.898 0.38 . . . . 0.0 110.97 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.9 p -137.97 157.44 46.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.065 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.5 34.3 89.53 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.211 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 21.3 m -69.76 138.95 21.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.003 0.43 . . . . 0.0 111.762 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -132.56 133.18 43.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.348 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.781 HD22 HD23 ' A' ' 64' ' ' LEU . 46.5 tp -119.8 123.33 43.42 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.934 0.397 . . . . 0.0 111.168 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -128.53 101.97 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.703 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.83 -60.8 2.96 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.944 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 1.6 p90 -166.91 18.03 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 26.3 pt -119.95 127.15 75.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.847 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.1 mt -116.05 114.92 25.21 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.197 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 27.2 ttm180 -111.83 139.03 47.65 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.88 165.15 33.03 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.2 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.589 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 1.7 m-20 -99.37 105.72 17.72 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.8 m -104.57 132.21 51.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.261 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.6 mt -69.86 139.57 20.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.318 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -108.9 -171.54 1.87 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.837 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -55.21 -31.35 61.38 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.35 -20.92 66.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.712 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.33 4.09 66.63 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.74 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -113.34 148.5 39.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.787 0.327 . . . . 0.0 110.29 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 51.3 Cg_endo -70.7 132.46 21.87 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.019 2.479 . . . . 0.0 113.027 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -118.39 132.45 56.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.269 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.94 127.29 31.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.169 0.509 . . . . 0.0 111.65 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -141.93 154.94 45.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.041 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 p -139.9 142.73 36.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.64 0.257 . . . . 0.0 111.155 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.55 143.8 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.485 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.51 90.49 3.88 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.847 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.35 -23.66 50.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.592 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.7 t-20 -52.74 -31.44 38.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.105 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -108.36 16.7 22.9 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.52 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 37.9 m-85 -129.69 -22.93 2.91 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.575 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -113.93 142.17 27.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.658 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -116.11 164.22 12.29 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.041 -1.076 . . . . 0.0 113.547 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -102.04 105.49 16.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.247 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -110.59 104.92 13.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.505 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.733 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 36.7 t30 52.96 43.64 31.43 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.199 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.13 16.55 80.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.948 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -123.68 157.48 33.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.862 0.363 . . . . 0.0 110.768 -179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.496 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 38.9 mt -83.97 113.4 20.96 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.472 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 26.1 tp10 -103.11 130.43 50.27 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.767 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.35 -71.79 0.11 Allowed Pre-proline 0 CA--C 1.424 -3.877 0 O-C-N 124.47 1.106 . . . . 0.0 113.063 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.767 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 3.1 Cg_endo -107.44 133.3 0.05 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.42 0 C-N-CA 113.704 -3.731 . . . . 0.0 112.179 -178.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.658 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -164.74 -163.64 18.3 Favored Glycine 0 C--N 1.285 -2.261 0 CA-C-N 114.379 -1.282 . . . . 0.0 113.665 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -151.37 143.59 24.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.283 -0.459 . . . . 0.0 110.921 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.4 m 52.07 45.0 29.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -74.27 -36.03 63.8 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.91 -19.37 50.07 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.281 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -62.27 -26.87 68.64 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.943 0.401 . . . . 0.0 110.816 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 m -134.16 15.15 3.84 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.268 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.1 m -121.64 140.33 52.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.001 0.429 . . . . 0.0 111.448 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 m -136.82 174.52 11.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.886 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 62.48 41.49 9.73 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.087 0.47 . . . . 0.0 110.725 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 16' ' ' GLY . 21.5 p -71.83 126.78 30.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.93 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.81 162.68 40.97 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.766 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.781 HD23 HD22 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -118.01 113.54 21.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.806 0.336 . . . . 0.0 111.566 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.487 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 3.9 m120 -73.51 116.13 13.71 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.403 178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 14.2 t70 58.95 5.21 0.49 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.114 0.884 . . . . 0.0 111.742 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.1 27.89 35.79 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.717 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.4 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 2.1 p-80 -145.21 -23.06 0.49 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 117.504 0.652 . . . . 0.0 112.23 179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 30.6 m -114.68 130.73 56.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.744 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.507 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.2 tp -91.88 127.79 37.47 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 129.69 55.46 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.84 171.11 20.05 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.805 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.3 t -118.58 121.21 39.67 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 32.8 m -121.4 149.84 42.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.181 0.515 . . . . 0.0 111.835 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.3 tmtt? -99.89 145.37 27.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.932 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.85 -28.1 0.74 Allowed Glycine 0 C--O 1.228 -0.256 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.251 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.733 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.14 -38.81 71.34 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.314 0.486 . . . . 0.0 112.314 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -172.02 50.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.385 0.612 . . . . 0.0 109.899 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.75 2.08 42.57 Favored Glycine 0 C--O 1.229 -0.174 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.112 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -125.25 167.29 15.08 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 42.8 p90 -104.99 169.64 8.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.459 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -161.78 147.01 13.29 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.95 130.24 42.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 111.139 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.42 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 45.0 t -144.66 161.13 39.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.225 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.03 160.25 37.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.496 ' HB2' ' CB ' ' A' ' 48' ' ' LEU . 9.7 tpt -144.25 112.83 6.58 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.156 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -72.08 105.11 3.81 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.752 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.4 mt -73.37 -9.18 58.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.534 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -48.82 -28.17 3.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.691 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.527 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 36.2 p90 -122.41 25.76 8.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.686 0.279 . . . . 0.0 111.441 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.752 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -129.78 -13.67 2.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.025 0.44 . . . . 0.0 110.708 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 1.082 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.7 p -155.36 136.56 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.539 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.575 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -131.85 -173.54 13.37 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.469 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.453 HD22 ' HB2' ' A' ' 8' ' ' SER . 18.1 t30 -123.81 133.31 53.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.428 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.572 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 72.6 m -137.42 104.72 5.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.208 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 60.34 45.86 10.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.912 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.94 20.27 70.51 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.276 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -127.4 145.18 50.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.055 0.427 . . . . 0.0 109.866 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.455 ' O ' ' HG3' ' A' ' 99' ' ' MET . 13.0 ptt? -64.11 130.71 45.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.977 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.572 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 5.6 mm-40 -140.77 77.93 21.24 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.613 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 1.082 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 38.7 Cg_endo -68.77 97.15 0.54 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.665 2.244 . . . . 0.0 112.714 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.0 p -116.68 133.48 55.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.458 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.572 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -90.99 138.0 31.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 90' ' ' TYR . . . -109.4 28.18 8.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.181 0.515 . . . . 0.0 110.714 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.3 m -152.99 -76.07 0.12 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.639 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.572 ' HB2' ' HG3' ' A' ' 103' ' ' ARG . 3.3 t-20 64.08 97.54 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.777 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.46 -58.44 3.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.835 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -71.06 130.29 41.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.79 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -78.34 -51.81 9.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.752 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.5 t -92.7 63.79 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.881 0.848 . . . . 0.0 110.257 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 35.2 tp -107.01 78.47 1.23 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.609 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -147.13 86.56 1.64 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -79.26 41.1 0.44 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.237 0.541 . . . . 0.0 110.675 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.6 m -113.03 71.31 0.74 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.777 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.5 m -78.09 -46.78 19.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.266 0.555 . . . . 0.0 109.647 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.683 179.513 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -79.07 133.0 36.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.836 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 65.5 m -73.83 -54.96 6.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.903 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 52.44 73.16 0.36 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 122.989 0.516 . . . . 0.0 112.054 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.531 ' HE1' ' HB2' ' A' ' 88' ' ' LEU . 9.3 p90 -57.43 -33.6 68.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.063 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.97 64.44 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -68.94 -20.36 64.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.898 0.38 . . . . 0.0 110.997 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 17.1 m -119.93 9.84 11.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -123.26 146.37 47.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.006 0.432 . . . . 0.0 111.432 -179.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.2 p -134.4 147.42 50.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.638 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.16 56.79 21.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.492 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.567 HG12 ' HA3' ' A' ' 21' ' ' GLY . 7.1 m -99.23 130.5 48.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.113 0.482 . . . . 0.0 111.433 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.98 152.81 47.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.601 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.648 HD22 HD23 ' A' ' 64' ' ' LEU . 11.5 tp -113.22 113.58 25.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.817 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.496 ' O ' HG12 ' A' ' 18' ' ' ILE . 26.3 m-85 -108.22 98.79 8.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.992 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.5 -65.5 1.36 Allowed Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.084 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 2.8 p90 -161.39 18.64 0.11 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.748 0.419 . . . . 0.0 111.128 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 15' ' ' TYR . 30.6 pt -122.16 133.1 69.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.824 0.345 . . . . 0.0 110.271 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.819 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -108.69 116.9 32.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.724 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 6.8 tmm_? -121.9 142.29 50.42 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.1 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.567 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -168.4 -174.71 37.4 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.414 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.569 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 35.8 m-20 -108.49 109.19 20.39 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -105.73 131.98 52.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.03 0.443 . . . . 0.0 110.005 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 58.2 mt -70.16 138.17 22.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.421 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -102.36 -174.31 2.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.89 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.71 -37.81 63.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.191 0.519 . . . . 0.0 111.946 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.64 -25.11 66.07 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.086 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.89 50.33 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.575 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -105.35 140.52 21.22 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-O 120.854 0.359 . . . . 0.0 110.388 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 39.4 Cg_endo -67.84 134.36 32.1 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 123.082 2.521 . . . . 0.0 112.955 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -119.91 133.65 55.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.596 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.75 126.09 27.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.281 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -143.13 156.03 44.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.2 p -136.72 151.3 49.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.937 0.399 . . . . 0.0 111.156 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -134.07 143.67 37.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.221 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.97 93.62 5.85 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.819 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -57.83 -29.25 64.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.317 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 22.2 t-20 -52.78 -29.13 25.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.935 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -108.53 12.76 25.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.6 m-85 -128.9 -20.14 3.53 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -113.57 142.11 27.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.67 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -113.72 166.07 12.11 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.256 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -109.92 111.13 22.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.141 -0.53 . . . . 0.0 110.82 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -110.78 105.46 14.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.669 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.737 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 29.9 t30 53.09 42.21 32.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.046 0.451 . . . . 0.0 111.401 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.456 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 78.11 17.63 77.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.121 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.62 154.71 40.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.966 0.412 . . . . 0.0 110.827 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD13 ' HG ' ' A' ' 70' ' ' LEU . 35.7 mt -82.1 122.99 28.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.051 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -112.71 138.49 49.44 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.694 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -40.88 -75.14 0.05 OUTLIER Pre-proline 0 CA--C 1.433 -3.556 0 CA-C-O 118.11 -0.947 . . . . 0.0 113.186 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.694 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 23.2 Cg_endo -111.32 129.0 0.03 OUTLIER 'Trans proline' 1 N--CA 1.342 -7.425 0 C-N-CA 114.009 -3.527 . . . . 0.0 113.042 -177.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.08 -158.02 8.6 Favored Glycine 0 C--N 1.28 -2.572 0 CA-C-N 113.529 -1.669 . . . . 0.0 113.143 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -155.2 138.45 15.71 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.897 0.41 . . . . 0.0 110.646 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.3 m 58.27 45.05 17.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 13.2 p90 -75.07 -37.61 61.56 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.73 -19.04 54.47 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.705 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -64.67 -22.49 66.99 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 120.83 0.348 . . . . 0.0 110.911 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.2 m -135.87 18.37 3.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.841 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 81.9 m -125.23 145.55 49.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.174 0.511 . . . . 0.0 111.44 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.4 HG23 ' HD3' ' A' ' 61' ' ' LYS . 12.0 m -138.07 176.91 6.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.16 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.5 mptt 61.85 35.0 16.75 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 123.145 0.278 . . . . 0.0 111.474 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 p -64.16 123.82 20.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.007 0.432 . . . . 0.0 111.187 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.95 148.87 27.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.836 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.648 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -107.18 113.45 26.89 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.453 0.168 . . . . 0.0 110.749 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.571 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 40.6 t-20 -79.63 126.1 30.47 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.518 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 33.1 t70 53.56 18.61 1.47 Allowed 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.354 1.034 . . . . 0.0 112.045 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.0 33.53 87.49 Favored Glycine 0 CA--C 1.521 0.445 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.935 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.571 ' HD2' ' O ' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -148.0 -25.55 0.35 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.525 0.663 . . . . 0.0 111.609 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.434 ' O ' HD13 ' A' ' 64' ' ' LEU . 44.4 m -116.71 131.13 57.03 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.207 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -90.97 134.21 34.67 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.787 0.327 . . . . 0.0 110.466 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.19 131.45 53.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.967 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -160.63 163.69 32.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.164 0.507 . . . . 0.0 111.544 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -110.8 118.21 35.53 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.456 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 37.4 m -119.17 147.48 44.16 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.4 tmtt? -100.1 142.92 30.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.473 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.72 -27.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.021 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.737 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -49.85 -41.07 44.42 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -179.34 51.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.449 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 77.22 -3.76 57.19 Favored Glycine 0 C--O 1.228 -0.254 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.234 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -113.23 161.01 17.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.975 -0.612 . . . . 0.0 109.781 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 41.0 p90 -103.71 168.37 9.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.522 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -158.03 137.93 12.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.354 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.13 127.27 32.11 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.8 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.7 p -142.62 177.81 8.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.597 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.425 ' HA ' HD12 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -138.78 162.22 35.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.979 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.532 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 11.8 tpp -145.67 120.99 10.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.113 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -77.63 106.09 9.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.33 0.586 . . . . 0.0 109.439 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.72 ' HA ' HG22 ' A' ' 91' ' ' VAL . 16.0 mt -73.1 -8.98 58.19 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.124 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -48.72 -33.04 9.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.815 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -116.15 24.49 11.38 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.062 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -128.69 -12.09 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.536 178.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 1.8 t -138.52 144.29 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -140.28 171.5 23.92 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.731 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.413 HD22 ' CB ' ' A' ' 8' ' ' SER . 24.6 t30 -121.96 141.19 51.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.045 0.45 . . . . 0.0 110.855 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.537 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 73.2 m -146.93 109.31 4.52 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 58.58 42.05 21.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.633 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 67.9 13.11 63.51 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.473 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -116.29 141.72 47.79 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.94 129.78 40.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.401 0.619 . . . . 0.0 111.645 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.537 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 36.3 mm-40 -139.02 78.81 28.45 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.179 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.797 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 32.1 Cg_endo -65.36 96.55 0.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.779 2.319 . . . . 0.0 112.442 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -102.67 131.82 49.2 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.952 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.67 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -102.31 146.43 28.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.916 0.388 . . . . 0.0 110.517 -179.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -99.5 19.24 16.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.04 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.475 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 68.8 m -156.01 -120.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 1.003 ' HA ' HD23 ' A' ' 111' ' ' LEU . 13.3 t-20 64.34 43.96 4.48 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.049 0.939 . . . . 0.0 110.402 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 54.93 -153.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.898 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.97 -32.89 57.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.231 0.538 . . . . 0.0 110.099 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -136.69 -75.86 0.42 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.234 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 112' ' ' LYS . 45.2 t -136.94 111.27 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.787 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 106' ' ' ASN . 4.2 pp -72.45 -11.02 60.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.281 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -77.83 76.27 4.36 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.88 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.9 m -62.94 118.27 7.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.375 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.4 t -165.45 136.88 3.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.326 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.7 m -72.76 -24.32 60.94 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 . . . . . 0 N--CA 1.441 -0.901 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.246 179.767 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -92.2 117.57 30.0 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.582 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 68.5 m -98.24 -72.29 0.66 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.143 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 12.5 m-20 55.46 78.77 0.18 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.919 0.488 . . . . 0.0 111.889 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.588 ' CD1' HG13 ' A' ' 92' ' ' VAL . 4.8 p90 -62.48 -46.18 89.64 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.719 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.46 -22.28 54.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.186 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 6.4 t-20 -57.91 -30.5 65.94 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.856 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.485 ' HB2' HD22 ' A' ' 94' ' ' ASN . 49.7 m -137.67 23.47 2.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.822 0.344 . . . . 0.0 111.353 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 92.3 m -120.96 132.83 55.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.985 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 p -132.19 152.99 51.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.531 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.78 42.88 94.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.622 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.601 HG12 ' HA3' ' A' ' 21' ' ' GLY . 26.8 m -89.33 141.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.794 0.331 . . . . 0.0 111.342 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.67 159.18 42.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.143 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.74 HD22 HD23 ' A' ' 64' ' ' LEU . 20.8 tp -127.08 126.89 43.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.978 0.418 . . . . 0.0 111.588 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.561 ' O ' HG12 ' A' ' 18' ' ' ILE . 68.4 t80 -130.83 104.79 7.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.808 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.411 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.92 -71.27 1.95 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.738 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' HD1' HD21 ' A' ' 36' ' ' ASN . 0.8 OUTLIER -163.01 23.16 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 122.605 0.362 . . . . 0.0 111.337 179.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.584 HG22 HD22 ' A' ' 36' ' ' ASN . 34.0 pt -117.24 131.11 70.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 110.544 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.827 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -112.41 114.66 27.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.688 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 13.2 ttm180 -121.56 140.44 52.22 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.601 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -164.69 179.31 39.47 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.449 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -104.44 105.42 15.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.416 ' HB3' ' ND2' ' A' ' 94' ' ' ASN . 69.3 m -106.16 132.18 52.53 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.213 0.53 . . . . 0.0 110.29 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.2 mt -71.68 141.4 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.31 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -105.83 -172.26 2.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.305 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -56.23 -30.52 62.46 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.76 -26.82 66.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.0 111.371 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.82 1.67 55.15 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.506 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.58 139.31 19.98 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 121.158 0.504 . . . . 0.0 111.037 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.38 127.96 20.3 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 124.117 3.211 . . . . 0.0 112.674 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -116.86 138.09 51.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.615 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.46 121.71 23.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.937 0.398 . . . . 0.0 111.171 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.4 t -140.54 156.6 46.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.928 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 p -140.4 138.92 35.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 mp -124.54 147.86 28.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.584 HD22 HG22 ' A' ' 18' ' ' ILE . 13.4 t-20 -103.75 107.55 18.47 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.827 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -66.1 -22.67 66.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.683 -178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 55' ' ' PHE . 32.2 t30 -66.72 -12.93 60.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.017 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -110.57 0.89 17.81 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.325 -0.234 . . . . 0.0 110.981 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 50.8 m-85 -128.31 -20.47 3.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.7 138.79 40.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.705 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -116.33 165.51 12.28 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 119.987 -1.102 . . . . 0.0 113.529 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -108.82 106.05 15.88 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.89 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -110.92 107.19 16.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.586 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 13.4 t30 56.78 40.42 29.08 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.173 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.63 16.18 80.96 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.81 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.419 ' HG3' ' OG ' ' A' ' 84' ' ' SER . 0.2 OUTLIER -124.14 152.61 42.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.836 0.351 . . . . 0.0 110.946 -179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 10.1 mp -80.52 123.49 28.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.895 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.592 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 9.3 tp10 -114.56 132.67 56.25 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.2 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.855 ' CD2' ' HD3' ' A' ' 51' ' ' PRO 0.251 0.1 OUTLIER -41.54 -63.11 0.89 Allowed Pre-proline 0 CA--C 1.423 -3.921 0 CA-C-O 117.87 -1.062 . . . . 0.0 113.522 -179.075 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.855 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 9.0 Cg_endo -112.28 123.36 0.02 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.471 0 C-N-CA 113.766 -3.689 . . . . 0.0 112.978 -179.039 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.705 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.52 -165.89 18.24 Favored Glycine 0 C--N 1.281 -2.519 0 CA-C-N 113.584 -1.644 . . . . 0.0 113.26 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -153.34 146.52 24.69 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 m 59.96 45.69 11.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 38' ' ' ASN . 10.8 p90 -79.35 -37.81 36.59 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.83 55.03 Favored Glycine 0 C--N 1.336 0.535 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.538 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 m -63.22 -29.16 70.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.223 -0.489 . . . . 0.0 110.943 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.8 m -133.49 19.58 3.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.304 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 55' ' ' PHE . 84.1 m -123.04 149.07 44.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.283 0.563 . . . . 0.0 111.724 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG23 ' HG2' ' A' ' 61' ' ' LYS . 23.4 m -141.58 176.8 3.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.943 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' HG2' HG23 ' A' ' 60' ' ' VAL . 74.1 mmtt 62.81 37.3 12.44 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.246 0.342 . . . . 0.0 111.001 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.0 OUTLIER -69.82 122.43 19.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.178 0.513 . . . . 0.0 111.75 -179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.73 149.23 28.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.438 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -106.34 113.29 26.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.741 0.305 . . . . 0.0 111.08 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -75.49 117.19 17.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.202 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.695 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 23.0 t70 55.05 23.32 5.09 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.084 0.865 . . . . 0.0 111.491 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.29 36.73 92.9 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.988 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.695 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 10.6 p80 -147.16 -29.94 0.35 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.692 0.746 . . . . 0.0 111.49 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 m -115.62 132.34 56.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.51 0.195 . . . . 0.0 111.115 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.55 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.3 tp -92.8 130.06 38.52 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.1 OUTLIER -120.97 129.75 53.55 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.093 179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -159.03 163.32 36.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.09 0.472 . . . . 0.0 111.116 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 16.4 t -110.51 120.17 41.55 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.3 m -121.75 148.75 44.24 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.6 tmtt? -100.35 145.58 28.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.542 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.03 -30.9 0.49 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.852 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.599 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.46 -41.58 66.31 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -172.93 52.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.225 0.536 . . . . 0.0 109.892 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.439 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 73.4 -1.11 44.95 Favored Glycine 0 C--N 1.329 0.175 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.335 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -119.12 158.53 25.72 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 21.0 p90 -100.6 171.12 7.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.467 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -163.3 151.15 13.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.9 132.34 41.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.419 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 40.1 t -148.35 158.51 44.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.851 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.404 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -135.1 159.99 39.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.287 0.565 . . . . 0.0 110.93 179.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.523 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 20.9 tpp -147.3 118.67 7.86 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.589 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.469 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 32.3 t0 -75.93 106.89 7.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.408 0.623 . . . . 0.0 109.773 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.724 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.9 mt -73.55 -9.58 58.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.709 -178.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -50.9 -27.33 7.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.197 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 46.1 p90 -117.82 19.28 13.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 111.583 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.4 m -126.18 -7.35 5.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.121 0.486 . . . . 0.0 110.603 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.5 p -157.69 145.08 9.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.321 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -135.82 -174.3 13.33 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.799 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.485 HD22 ' HB2' ' A' ' 8' ' ' SER . 23.4 t30 -126.01 131.24 52.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.93 0.395 . . . . 0.0 110.946 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.592 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 67.8 m -135.95 111.08 8.94 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.678 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 59.66 42.92 16.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.938 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 61.85 24.31 64.44 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.198 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -127.0 147.58 50.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.88 0.371 . . . . 0.0 110.165 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -60.02 128.85 38.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.145 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 36.4 mm-40 -140.38 78.16 22.92 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.004 178.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 44.0 Cg_endo -72.52 92.13 0.77 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.351 2.034 . . . . 0.0 111.859 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p -114.38 121.58 44.03 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.589 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.594 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -113.52 149.02 34.98 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.056 178.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -99.91 48.56 0.93 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.158 0.504 . . . . 0.0 110.368 179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.469 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 25.8 t -169.7 -133.82 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.656 HD22 ' HB2' ' A' ' 51' ' ' PRO . 28.6 t-20 72.71 107.65 0.07 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.343 1.057 . . . . 0.0 112.028 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' A' ' 111' ' ' LEU . . . -164.39 163.54 22.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.507 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -70.01 -70.33 0.3 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.178 0.513 . . . . 0.0 110.516 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -121.62 -41.39 2.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.732 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.6 p -82.31 78.79 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 122.266 1.031 . . . . 0.0 109.683 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.521 ' HA ' ' HB3' ' A' ' 107' ' ' ALA . 13.5 tp -71.25 82.62 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.553 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 18.4 ptmt -90.92 109.37 20.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.335 0.588 . . . . 0.0 111.36 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 37.7 m -88.77 64.46 7.29 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 45.3 m -149.85 137.98 20.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.405 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -72.36 -33.23 67.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.715 178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.297 179.502 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.691 0.281 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -142.14 146.91 35.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 75.7 m -130.99 -63.46 0.86 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.284 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 56.14 73.96 0.41 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.474 ' CD1' ' HB ' ' A' ' 92' ' ' VAL . 12.5 p90 -57.93 -34.5 69.93 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.138 0.494 . . . . 0.0 111.366 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.94 -22.08 63.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -62.43 -26.52 68.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 46.6 m -124.64 13.4 8.67 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.2 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -119.15 135.56 54.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.051 0.453 . . . . 0.0 111.212 -179.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 p -132.46 154.36 49.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.26 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.07 53.0 48.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.064 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.421 HG12 ' HA3' ' A' ' 21' ' ' GLY . 7.1 m -92.07 137.81 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.728 0.299 . . . . 0.0 110.874 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -135.21 149.85 49.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.178 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.564 HD22 HD23 ' A' ' 64' ' ' LEU . 11.9 tp -114.41 118.01 32.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.163 0.506 . . . . 0.0 111.485 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.507 ' O ' HG12 ' A' ' 18' ' ' ILE . 91.9 m-85 -115.51 99.75 7.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.82 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.82 -73.3 1.47 Allowed Glycine 0 C--O 1.224 -0.499 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.484 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.517 ' HD1' HD21 ' A' ' 36' ' ' ASN . 3.9 p90 -157.49 21.14 0.29 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.671 0.388 . . . . 0.0 110.848 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 15' ' ' TYR . 39.0 pt -121.4 132.77 69.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.054 0.454 . . . . 0.0 110.251 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.761 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -109.38 117.56 34.37 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.119 -179.136 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tmm_? -121.72 139.57 53.41 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.89 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.421 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -161.8 179.35 37.23 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.303 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 10.7 m-20 -100.98 106.14 17.43 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.0 OUTLIER -106.05 131.83 52.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.954 0.406 . . . . 0.0 109.944 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.7 mt -69.15 138.12 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.692 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.7 p30 -108.26 -170.28 1.65 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.29 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -56.48 -28.58 60.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.81 -26.69 66.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 0.0 111.55 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.64 -2.89 57.4 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.159 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -104.86 143.53 26.89 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.932 0.396 . . . . 0.0 110.3 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.641 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 29.3 Cg_endo -64.84 121.97 9.65 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.937 2.425 . . . . 0.0 113.015 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -108.32 130.72 55.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.171 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.84 119.65 15.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.057 0.456 . . . . 0.0 111.716 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.9 t -135.54 160.05 39.69 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.502 ' O ' ' HG2' ' A' ' 99' ' ' MET . 13.2 p -136.7 152.72 50.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.184 0.516 . . . . 0.0 111.551 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.22 145.78 33.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.799 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.517 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -104.58 94.56 5.38 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.9 -30.24 63.74 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.587 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.4 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.2 t-20 -54.53 -29.15 49.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -103.68 10.93 36.57 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.806 -0.357 . . . . 0.0 111.656 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 52.8 m-85 -129.67 -22.9 2.92 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.417 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.24 141.49 27.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.602 0.239 . . . . 0.0 110.83 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.572 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.54 -173.77 18.16 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.918 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -128.65 109.5 11.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.844 0.354 . . . . 0.0 111.128 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -113.11 109.62 19.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.66 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.647 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 22.1 t-20 56.08 45.48 23.48 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.72 0.772 . . . . 0.0 110.943 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.54 18.12 73.41 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.709 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.07 147.49 47.84 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.863 0.363 . . . . 0.0 110.364 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.4 mp -71.42 127.94 34.21 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.189 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -114.5 129.51 56.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.15 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.596 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.7 -70.53 0.14 Allowed Pre-proline 0 CA--C 1.425 -3.852 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.868 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.953 ' HB3' ' HG3' ' A' ' 103' ' ' ARG . 14.2 Cg_endo -110.36 124.36 0.03 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.444 0 C-N-CA 113.509 -3.861 . . . . 0.0 113.146 -178.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.572 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -159.08 -161.04 10.8 Favored Glycine 0 C--N 1.281 -2.527 0 CA-C-N 113.4 -1.727 . . . . 0.0 113.197 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -153.93 150.04 27.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.82 0.343 . . . . 0.0 110.341 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.2 p 47.79 44.97 18.37 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 20.4 p90 -69.84 -40.93 75.54 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.33 -26.9 38.41 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.675 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.6 t -56.93 -25.99 58.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.221 0.208 . . . . 0.0 111.286 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.2 m -137.17 28.0 2.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 0.0 110.705 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.1 m -131.61 145.92 51.94 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.346 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.42 HG23 ' HD3' ' A' ' 61' ' ' LYS . 18.4 m -136.62 174.82 11.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.811 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.42 ' HD3' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER 61.41 37.86 16.47 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.322 0.649 . . . . 0.0 112.265 -179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 p -63.11 123.0 17.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.895 0.379 . . . . 0.0 111.044 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.12 155.57 37.02 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -110.86 120.15 41.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.829 0.347 . . . . 0.0 110.838 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -82.57 119.1 23.82 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.7 t70 68.75 -59.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 124.623 1.202 . . . . 0.0 111.113 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.88 34.64 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.342 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.471 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 1.2 p-80 -155.81 -19.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m -116.55 128.0 55.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 120.618 0.247 . . . . 0.0 111.587 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.603 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.8 tp -91.09 130.74 36.95 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -120.16 129.87 54.33 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.724 179.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -160.28 164.12 32.87 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.148 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.6 t -110.95 123.98 51.22 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 39.2 m -125.45 153.74 43.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.92 0.391 . . . . 0.0 111.809 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.9 tmtt? -99.26 144.51 28.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.693 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.1 -26.82 0.62 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.224 -0.988 . . . . 0.0 113.0 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.647 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . . . -52.25 -42.5 63.69 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 122.551 0.341 . . . . 0.0 111.715 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -175.83 55.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.017 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.42 20.84 73.93 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.464 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -142.67 159.34 42.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 46.7 p90 -101.26 166.72 10.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.248 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -159.53 145.53 16.1 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -78.6 131.6 36.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.002 0.43 . . . . 0.0 110.772 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 p -143.51 176.03 9.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.271 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.6 OUTLIER -138.85 164.9 28.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.226 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.882 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.8 OUTLIER -145.87 121.72 10.6 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.533 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.6 105.11 6.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.739 ' HA ' HG22 ' A' ' 91' ' ' VAL . 19.8 mt -77.34 -8.26 57.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.659 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.471 ' OD1' ' HB2' ' A' ' 68' ' ' HIS . 11.5 m120 -47.15 -32.82 4.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.72 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -116.45 22.76 12.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.427 . . . . 0.0 111.324 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.739 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -127.94 -13.5 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.818 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.843 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -132.17 147.97 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.286 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -140.99 174.61 22.63 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.204 -0.522 . . . . 0.0 111.799 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.447 HD22 ' HB2' ' A' ' 8' ' ' SER . 20.6 t30 -135.31 133.54 38.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.684 0.278 . . . . 0.0 111.124 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.446 ' HB2' ' HG2' ' A' ' 100' ' ' GLU . 8.2 m -142.89 115.65 8.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.264 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 58.93 41.13 21.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.389 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 66.09 12.36 57.51 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.721 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -114.63 139.81 49.33 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 34' ' ' SER . 4.6 ppp? -66.01 133.54 51.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.032 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -152.87 69.31 7.0 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.759 178.13 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.843 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 15.7 Cg_endo -56.08 102.82 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 123.312 2.675 . . . . 0.0 112.548 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.83 110.09 21.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.637 0.732 . . . . 0.0 110.983 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.953 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -114.83 149.99 36.19 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.068 178.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -129.11 65.49 1.45 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.501 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.446 ' HB3' ' HD2' ' A' ' 50' ' ' TYR . 7.4 t -160.96 14.69 0.11 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.974 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.812 ' H ' HD22 ' A' ' 111' ' ' LEU . 2.9 t-20 -103.21 16.86 25.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.462 0.648 . . . . 0.0 110.386 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -161.83 141.45 10.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.034 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -85.94 -23.34 26.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.356 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -89.4 -79.77 0.32 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.728 0.299 . . . . 0.0 110.498 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.45 111.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.608 0.718 . . . . 0.0 110.847 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.812 HD22 ' H ' ' A' ' 106' ' ' ASN . 31.1 tp -92.18 62.04 4.05 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.468 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 114' ' ' SER . 86.9 tttt -94.32 122.94 37.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 18.3 m -76.12 35.27 0.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.308 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.534 ' HB3' ' HE2' ' A' ' 112' ' ' LYS . 11.4 t -159.79 83.01 0.73 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.6 m -59.13 -31.23 68.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.249 0.547 . . . . 0.0 110.493 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.272 179.278 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.834 0.35 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -73.96 140.74 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.336 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.602 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 71.2 m -75.98 -66.4 0.79 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.822 -0.627 . . . . 0.0 109.489 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 42.77 79.79 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.58 ' CD1' HG13 ' A' ' 92' ' ' VAL . 3.1 p90 -59.23 -34.54 72.31 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.226 0.536 . . . . 0.0 110.618 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.66 -21.76 66.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.529 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.73 -18.79 65.34 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 50.2 m -142.65 18.39 2.01 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.525 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -118.17 136.07 53.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.895 0.379 . . . . 0.0 110.822 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.5 p -133.8 154.19 51.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.572 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.26 61.8 6.9 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.291 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 35.6 m -93.3 144.59 9.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.293 0.568 . . . . 0.0 111.608 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -135.88 136.7 40.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.84 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.843 HD22 HD23 ' A' ' 64' ' ' LEU . 37.3 tp -122.63 119.77 31.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.976 0.417 . . . . 0.0 110.762 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.576 ' O ' HG12 ' A' ' 18' ' ' ILE . 28.8 t80 -127.93 109.39 11.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.019 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.449 ' O ' HG21 ' A' ' 62' ' ' THR . . . 72.98 -67.16 1.41 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.791 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.9 p90 -164.56 19.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.795 0.438 . . . . 0.0 110.653 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.591 HG22 ' ND2' ' A' ' 36' ' ' ASN . 43.5 pt -117.47 122.61 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.02 0.438 . . . . 0.0 110.569 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.852 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -109.21 114.67 28.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.788 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.2 ttt85 -115.71 140.92 48.75 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.82 176.74 41.81 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.142 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.7 m-20 -104.88 109.06 20.88 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.621 0.248 . . . . 0.0 110.417 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.8 OUTLIER -107.61 132.86 52.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.942 0.401 . . . . 0.0 110.403 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 57.9 mt -67.38 136.15 27.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.452 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -103.68 -174.03 2.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.197 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -54.62 -29.67 52.6 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -65.01 -25.82 68.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.819 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.52 -4.4 56.68 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.787 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -106.76 145.11 30.41 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 37.2 Cg_endo -66.37 134.02 34.59 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.904 2.403 . . . . 0.0 112.764 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -122.58 123.76 41.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.311 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.07 130.19 44.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.293 0.568 . . . . 0.0 111.761 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.0 t -144.05 164.96 29.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.478 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.3 p -140.47 138.33 34.57 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.283 -0.167 . . . . 0.0 110.65 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.419 HG13 ' HB3' ' A' ' 99' ' ' MET . 2.7 mp -122.02 145.48 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 120.838 0.351 . . . . 0.0 110.723 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.591 ' ND2' HG22 ' A' ' 18' ' ' ILE . 9.5 m120 -104.07 91.58 4.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.102 0.477 . . . . 0.0 110.015 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.852 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -57.75 -25.42 60.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.171 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.0 t-20 -55.29 -30.47 60.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.692 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -103.21 11.03 37.42 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.47 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.0 m-85 -126.71 -26.96 3.15 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.537 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.3 mp -110.64 140.89 27.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.672 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -112.6 171.5 14.04 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.481 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -113.86 108.25 16.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.608 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -111.92 105.94 14.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.635 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.831 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 52.6 t30 57.34 41.01 27.18 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.177 0.513 . . . . 0.0 110.78 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.62 15.75 81.3 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.132 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.03 145.74 48.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.832 0.349 . . . . 0.0 111.054 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 9.7 mp -75.09 119.31 19.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.268 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.535 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 49.0 tt0 -109.93 136.42 49.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.783 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.811 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.65 -68.01 0.26 Allowed Pre-proline 0 CA--C 1.426 -3.82 0 CA-C-O 118.029 -0.986 . . . . 0.0 113.347 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.811 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 2.4 Cg_endo -109.74 126.62 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.32 0 C-N-CA 113.69 -3.74 . . . . 0.0 113.328 -178.103 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.672 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -164.49 -161.53 13.71 Favored Glycine 0 C--N 1.283 -2.408 0 CA-C-N 113.693 -1.594 . . . . 0.0 113.372 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -153.24 147.76 26.07 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.777 0.339 . . . . 0.0 110.586 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.7 m 56.86 37.34 28.73 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 8.4 p90 -71.24 -35.7 71.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.4 0.619 . . . . 0.0 109.466 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.93 -18.38 70.59 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.165 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 m -72.47 -7.59 50.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.173 0.511 . . . . 0.0 110.894 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 56.3 m -146.3 23.01 1.33 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.16 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -128.25 154.79 45.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.435 0.636 . . . . 0.0 111.893 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.524 HG23 ' HD2' ' A' ' 61' ' ' LYS . 25.3 m -141.39 174.38 7.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.73 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HD2' HG23 ' A' ' 60' ' ' VAL . 0.1 OUTLIER 63.17 29.61 16.06 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.238 0.215 . . . . 0.0 111.245 -179.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.449 HG21 ' O ' ' A' ' 16' ' ' GLY . 4.0 p -60.98 117.72 5.82 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.201 0.524 . . . . 0.0 111.193 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.35 161.39 42.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.93 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.843 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -120.04 113.32 20.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.022 -178.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.572 ' O ' ' HD2' ' A' ' 68' ' ' HIS . 2.6 t-20 -84.9 128.52 34.66 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.612 ' HB3' ' CD2' ' A' ' 68' ' ' HIS . 7.3 t70 52.59 20.09 1.41 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.414 1.071 . . . . 0.0 112.014 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 59.99 35.11 86.15 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.324 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.612 ' CD2' ' HB3' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -148.49 -23.55 0.33 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.152 0.476 . . . . 0.0 111.549 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.419 ' O ' HD13 ' A' ' 64' ' ' LEU . 55.5 m -116.67 129.66 56.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.173 -179.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.587 ' HB2' HD11 ' A' ' 88' ' ' LEU . 13.8 tp -96.14 128.08 42.73 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.1 130.17 56.68 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.863 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -161.47 155.4 22.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.378 0.608 . . . . 0.0 111.303 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.584 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 7.9 t -105.93 108.28 19.71 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.801 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.0 m -105.1 149.27 26.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.448 0.642 . . . . 0.0 111.765 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 11.3 tmtt? -100.43 141.31 33.46 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.572 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.33 -30.9 0.48 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.485 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.831 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -49.34 -41.24 38.22 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -172.67 49.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.215 0.531 . . . . 0.0 110.144 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.52 1.9 62.43 Favored Glycine 0 C--O 1.23 -0.132 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.249 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -122.0 162.34 21.31 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 36.3 p90 -104.73 170.31 7.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.91 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' SER . 0.3 OUTLIER -157.17 133.76 9.95 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.25 112.42 7.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.009 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.6 p -125.82 175.04 7.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.978 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.99 163.83 29.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.9 0.381 . . . . 0.0 110.819 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.579 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.4 tpt -151.88 120.9 6.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.579 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 50.4 m-20 -74.89 106.78 6.58 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.752 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.4 mt -75.28 -9.43 58.55 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -47.99 -31.18 5.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.399 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 87' ' ' ASP . 4.0 p90 -117.3 21.35 13.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.661 0.267 . . . . 0.0 111.61 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.752 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -126.69 -11.64 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.064 0.459 . . . . 0.0 110.484 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.927 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.4 p -153.07 138.36 10.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.832 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.602 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.86 -169.45 11.93 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.013 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.451 HD22 ' HB2' ' A' ' 8' ' ' SER . 19.8 t30 -125.85 139.67 53.29 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.613 0.244 . . . . 0.0 110.451 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.582 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -150.14 109.64 4.01 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 62.54 43.27 7.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.49 25.02 62.47 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.529 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.17 148.72 52.04 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 120.919 0.39 . . . . 0.0 110.693 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.505 ' O ' ' HG3' ' A' ' 99' ' ' MET . 15.9 ptt? -57.44 118.49 5.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.925 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.582 ' HG3' ' CB ' ' A' ' 95' ' ' SER . 49.1 mm-40 -132.36 76.77 71.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.563 178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.927 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.7 Cg_endo -71.86 87.88 0.82 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.785 2.323 . . . . 0.0 112.681 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.8 p -110.79 130.87 55.46 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.019 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.505 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -112.44 149.63 32.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.454 179.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.31 61.12 0.62 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.025 0.441 . . . . 0.0 110.19 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.9 t -175.39 -113.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.495 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 66.3 105.16 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.849 0.718 . . . . 0.0 111.161 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 64.85 109.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.901 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 111' ' ' LEU . 18.5 t70 -138.21 156.51 47.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.861 -178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.425 ' CD2' HG13 ' A' ' 110' ' ' VAL . 86.2 t60 -52.4 -45.55 65.93 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.66 0.6 . . . . 0.0 111.134 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.425 HG13 ' CD2' ' A' ' 109' ' ' HIS . 6.5 m -128.51 57.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.698 0.761 . . . . 0.0 111.677 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 108' ' ' ASP . 1.1 tt -78.38 73.93 4.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.972 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -132.88 28.1 4.22 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.076 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.9 t 56.27 41.05 29.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.627 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.4 m -144.38 94.9 2.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.633 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.0 t -70.99 -29.3 65.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.354 -179.361 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.786 0.327 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -106.48 142.42 36.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.654 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.577 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 26.5 m -118.83 -55.32 2.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.74 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 55.08 79.39 0.15 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.956 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.491 ' HE1' ' HB2' ' A' ' 88' ' ' LEU . 14.5 p90 -56.76 -38.18 72.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.197 0.523 . . . . 0.0 111.158 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.03 -26.61 67.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.677 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -71.38 -6.51 40.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.673 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 15.3 m -137.67 8.04 2.8 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.765 0.316 . . . . 0.0 110.661 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -120.96 149.99 41.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.843 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.3 p -137.93 147.53 44.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.362 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 61.67 57.51 17.42 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.567 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 15.3 m -98.57 130.35 47.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.139 0.495 . . . . 0.0 111.817 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -127.4 137.5 52.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.511 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.632 HD22 HD23 ' A' ' 64' ' ' LEU . 18.3 tp -111.09 105.39 14.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.521 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -135.79 117.11 14.61 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.485 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 77.59 34.66 38.93 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.886 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' HD1' HG21 ' A' ' 62' ' ' THR . 19.8 m-85 65.27 23.07 12.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.053 0.541 . . . . 0.0 110.701 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 16' ' ' GLY . 9.2 mt -122.05 125.49 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.003 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.736 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.4 mt -108.07 114.22 27.95 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.007 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 4.6 ttm180 -116.86 140.23 49.69 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.593 -0.443 . . . . 0.0 109.989 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.516 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.08 177.99 41.48 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.265 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 11.5 m-20 -104.69 110.86 23.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.591 0.234 . . . . 0.0 110.565 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.9 OUTLIER -107.09 132.52 52.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.6 mt -69.9 134.31 30.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.027 0.441 . . . . 0.0 111.497 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -103.14 -173.11 2.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.842 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.93 -26.12 64.09 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.813 0.339 . . . . 0.0 111.909 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.75 -23.43 67.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.69 2.07 63.36 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.811 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -113.02 146.11 34.47 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.828 0.347 . . . . 0.0 110.443 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.639 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 33.0 Cg_endo -66.26 125.76 14.55 Favored 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.236 2.624 . . . . 0.0 112.705 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -109.59 127.46 54.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.255 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.81 126.63 30.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.973 0.416 . . . . 0.0 111.209 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -143.09 162.51 35.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.445 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.487 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 73.2 p -139.59 133.58 30.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.457 0.17 . . . . 0.0 110.709 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.416 HG13 ' CB ' ' A' ' 99' ' ' MET . 2.9 mp -115.23 143.01 25.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.253 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.08 92.82 5.17 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.736 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -58.56 -25.61 62.69 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.722 -178.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.556 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 22.8 t-20 -54.18 -31.7 53.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.376 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -107.61 16.4 23.77 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.0 m-85 -129.5 -22.32 3.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.54 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -112.66 141.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.634 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.0 174.26 15.48 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.363 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -112.82 108.32 17.26 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.9 0.381 . . . . 0.0 110.71 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -111.59 105.24 13.74 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.679 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.714 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 41.5 t30 56.75 42.59 26.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.146 0.498 . . . . 0.0 110.696 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 73.7 18.03 79.37 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.733 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.98 146.91 49.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 111.229 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 7.5 mp -72.38 114.32 10.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.616 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -108.79 132.04 54.37 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.879 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -31.21 -74.12 0.05 OUTLIER Pre-proline 0 CA--C 1.432 -3.568 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 -179.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.879 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 10.7 Cg_endo -108.89 129.43 0.04 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.242 0 C-N-CA 113.852 -3.632 . . . . 0.0 112.913 -177.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.634 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -161.44 -163.28 14.08 Favored Glycine 0 C--N 1.278 -2.683 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.016 -178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -153.38 143.22 22.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.013 0.435 . . . . 0.0 110.892 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.5 m 57.15 35.1 25.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.169 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 7.2 p90 -64.81 -34.16 77.7 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.03 -17.61 37.56 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.165 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.1 t -68.26 -30.82 69.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.739 0.304 . . . . 0.0 110.625 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 m -125.29 6.32 7.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.192 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 62.1 m -120.48 141.38 50.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.684 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.424 HG23 ' HD3' ' A' ' 61' ' ' LYS . 29.8 m -137.5 171.84 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.424 ' HD3' HG23 ' A' ' 60' ' ' VAL . 2.1 mptm? 63.61 43.35 5.8 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.774 0.671 . . . . 0.0 111.457 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.581 HG21 ' HD1' ' A' ' 17' ' ' TYR . 4.2 p -69.28 133.6 48.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.072 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.71 163.97 38.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.698 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.632 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -120.62 112.87 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.666 0.27 . . . . 0.0 111.647 -179.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.621 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 16.9 m120 -72.18 116.93 13.19 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.224 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.609 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 18.7 t70 54.08 15.17 0.83 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.955 0.784 . . . . 0.0 111.929 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.31 34.41 57.79 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.836 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.609 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.5 p80 -147.83 -26.1 0.36 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.7 0.75 . . . . 0.0 112.001 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 18.5 m -116.08 134.59 54.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.495 0.188 . . . . 0.0 111.058 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.539 ' HG ' ' CD2' ' A' ' 48' ' ' LEU . 24.3 tp -94.64 133.5 38.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.582 0.23 . . . . 0.0 110.613 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.71 130.57 52.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.855 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB3' HD11 ' A' ' 48' ' ' LEU . . . -163.19 163.31 25.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.8 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.421 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 23.0 t -109.68 126.82 54.08 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.454 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 17.5 m -124.85 150.36 46.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.22 0.533 . . . . 0.0 112.153 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 9.0 tmtt? -100.27 140.55 34.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.721 177.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.45 -30.49 0.52 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.145 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.714 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -53.19 -40.31 64.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -171.21 51.04 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.416 0.627 . . . . 0.0 110.053 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.43 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 70.71 5.21 56.11 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.782 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -129.34 162.14 28.67 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 47.9 p90 -90.14 160.11 16.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.309 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -153.87 133.04 12.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.48 124.75 24.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.702 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.8 p -138.45 171.0 15.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.766 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.17 159.41 41.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.965 0.412 . . . . 0.0 110.521 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.575 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 12.0 tpp -143.28 123.76 13.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.505 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.48 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 10.8 m-20 -73.1 105.74 4.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.247 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.736 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.1 mt -76.18 -8.61 57.41 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.909 0.385 . . . . 0.0 110.426 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -50.11 -28.73 7.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.943 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' A' ' 87' ' ' ASP . 44.1 p90 -120.16 22.77 11.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.982 0.42 . . . . 0.0 110.973 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.736 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.1 m -128.72 -9.93 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.594 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.927 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -138.93 140.6 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.235 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.577 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -139.01 176.47 20.91 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.305 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -121.66 123.31 41.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.632 0.253 . . . . 0.0 110.972 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.533 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 57.9 m -127.82 94.34 3.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.601 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 64.67 47.07 2.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.49 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.62 20.97 66.57 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.366 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -124.17 139.0 54.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' A' ' 99' ' ' MET . 12.9 ptt? -57.52 122.38 12.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.99 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.533 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 25.8 mm-40 -142.93 78.34 15.54 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.788 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.927 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.0 Cg_endo -71.78 96.38 0.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.884 2.389 . . . . 0.0 113.215 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 9.0 p -90.76 133.0 35.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.66 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.446 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -114.38 147.2 39.54 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.487 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -103.72 45.2 0.97 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.292 0.568 . . . . 0.0 110.489 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.5 t -165.89 -125.89 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.309 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.739 ' HA ' HD23 ' A' ' 111' ' ' LEU . 6.8 t-20 63.16 33.72 14.18 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 123.922 0.889 . . . . 0.0 110.583 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -154.4 -171.07 3.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.132 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.8 t70 66.99 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.733 0.813 . . . . 0.0 111.547 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -67.31 157.44 33.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.846 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.9 m -70.65 60.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.762 0.792 . . . . 0.0 112.689 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.739 HD23 ' HA ' ' A' ' 106' ' ' ASN . 39.7 tp -82.27 3.81 26.09 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.179 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 84.5 tttt -109.16 13.44 24.45 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.556 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.0 t 54.32 39.61 31.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.084 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 p -97.84 74.18 2.33 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.023 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.5 m -65.26 -46.03 82.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.696 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.197 179.815 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.643 0.258 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -131.73 -167.53 1.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.584 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 88.7 m -119.59 -72.45 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.94 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.495 ' CB ' ' HB2' ' A' ' 7' ' ' ASN . 58.4 m-80 52.17 82.73 0.06 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.598 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 14.4 p90 -60.77 -34.83 75.05 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.289 0.566 . . . . 0.0 110.507 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.85 -19.16 60.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.235 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.495 ' HB2' ' CB ' ' A' ' 4' ' ' ASN . 7.4 t-20 -51.22 -33.42 27.74 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.438 0.461 . . . . 0.0 111.532 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB2' HD22 ' A' ' 94' ' ' ASN . 19.8 m -136.5 27.14 3.1 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.941 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.598 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -120.41 132.81 55.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.088 0.471 . . . . 0.0 111.161 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.9 p -131.87 155.74 47.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.988 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.76 30.43 74.55 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.318 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.586 HG12 ' HA3' ' A' ' 21' ' ' GLY . 17.5 m -77.45 134.34 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.029 0.443 . . . . 0.0 111.669 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.73 151.88 49.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.697 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.663 HD22 HD23 ' A' ' 64' ' ' LEU . 8.8 tp -121.92 106.33 11.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.006 0.431 . . . . 0.0 111.176 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -134.21 114.73 13.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.789 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.469 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 73.76 38.45 49.97 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.738 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' CD1' HG21 ' A' ' 62' ' ' THR . 18.1 m-85 64.2 25.6 13.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.199 0.6 . . . . 0.0 110.886 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 16' ' ' GLY . 12.2 mt -121.56 124.81 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.133 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.785 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -102.74 113.76 27.44 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.442 ' HG3' ' HB3' ' A' ' 34' ' ' SER . 15.2 ttm180 -123.04 133.74 54.32 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.7 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -162.79 -173.38 31.43 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.13 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.63 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -106.55 109.53 21.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.626 0.25 . . . . 0.0 110.662 -179.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -104.82 132.08 51.5 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 8' ' ' SER . 54.1 mt -71.74 142.19 15.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.135 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.427 HD21 ' CD2' ' A' ' 29' ' ' HIS . 4.2 p30 -109.5 -171.12 1.78 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.399 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -54.91 -31.22 59.89 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.88 -9.68 58.8 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.16 5.23 85.87 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.845 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.427 ' CD2' HD21 ' A' ' 25' ' ' ASN . 0.0 OUTLIER -108.4 133.94 20.4 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.869 0.366 . . . . 0.0 110.168 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.63 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 18.5 Cg_endo -60.48 138.53 81.04 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 123.246 2.63 . . . . 0.0 112.741 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -123.41 135.87 54.34 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.32 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 112.39 5.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.214 0.53 . . . . 0.0 110.828 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -131.1 156.75 44.71 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.601 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.442 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 19.9 p -139.57 147.0 40.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.102 0.477 . . . . 0.0 111.603 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -129.74 143.96 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.563 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.06 89.77 3.38 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.785 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -54.29 -30.44 50.82 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.61 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.54 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.3 t-20 -54.33 -28.34 41.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.468 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -108.76 14.67 24.18 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.643 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 43.0 m-85 -128.05 -24.2 3.21 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.2 mp -111.4 143.03 22.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.661 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -112.61 170.58 13.54 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.374 -0.917 . . . . 0.0 113.56 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -113.84 111.35 21.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.294 -0.453 . . . . 0.0 111.35 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -110.63 104.35 13.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.76 178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.563 HD22 ' HA ' ' A' ' 77' ' ' ALA . 9.4 m120 48.08 47.04 19.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.126 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 74' ' ' CYS . . . 78.51 12.51 84.19 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.673 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.39 143.97 47.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.832 0.349 . . . . 0.0 110.667 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 8.6 mp -76.94 114.29 15.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.516 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -103.39 136.97 42.15 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.089 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.661 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.23 -76.19 0.05 OUTLIER Pre-proline 0 CA--C 1.436 -3.416 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.661 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 20.5 Cg_endo -109.95 125.64 0.04 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.324 0 C-N-CA 113.751 -3.699 . . . . 0.0 113.165 -177.342 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.661 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -155.67 -157.55 8.33 Favored Glycine 0 C--N 1.284 -2.36 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.664 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -151.56 143.31 23.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 111.052 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 m 49.82 44.9 25.13 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.54 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 11.5 p90 -68.97 -31.08 69.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 59' ' ' CYS . . . -62.22 -18.21 57.47 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.196 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -53.9 -30.66 47.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.315 0.246 . . . . 0.0 110.904 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 25.1 m -135.48 17.75 3.36 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.446 ' HB2' ' HA2' ' A' ' 56' ' ' GLY . 7.5 m -108.08 147.73 30.79 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.45 0.643 . . . . 0.0 112.238 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.74 173.3 8.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.995 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 59.94 35.91 21.68 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.427 0.291 . . . . 0.0 111.432 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.451 HG21 ' CD1' ' A' ' 17' ' ' TYR . 16.7 p -68.31 120.09 13.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.992 0.425 . . . . 0.0 111.488 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.85 152.49 30.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.728 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.663 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -108.34 112.75 25.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.525 0.202 . . . . 0.0 110.59 -179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -76.08 117.49 17.84 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.705 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 24.8 t70 58.48 18.04 5.36 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.081 0.863 . . . . 0.0 111.044 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.06 32.52 84.38 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.413 -0.812 . . . . 0.0 114.082 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.705 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 7.0 p80 -141.9 -27.26 0.65 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 117.811 0.805 . . . . 0.0 111.249 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.403 ' O ' HD13 ' A' ' 64' ' ' LEU . 27.9 m -116.01 126.24 53.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.56 ' HA ' HD22 ' A' ' 64' ' ' LEU . 16.8 tp -89.97 126.58 35.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.162 0.506 . . . . 0.0 109.783 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.6 OUTLIER -117.67 130.47 56.37 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.305 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.31 166.47 27.49 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.661 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 t -118.26 117.57 29.48 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.547 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -114.32 154.21 28.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.544 0.688 . . . . 0.0 111.828 -179.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.602 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 7.8 tmtt? -100.36 149.27 23.8 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.826 177.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.31 -15.53 1.87 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.829 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.563 ' HA ' HD22 ' A' ' 45' ' ' ASN . . . -58.78 -40.77 84.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.687 0.28 . . . . 0.0 110.744 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.9 t70 178.24 58.03 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.698 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.405 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 69.13 19.68 74.17 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -143.82 161.34 38.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 51.4 p90 -101.82 165.5 11.17 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.318 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.96 152.84 40.06 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.408 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -91.86 131.09 37.45 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.8 p -149.58 172.68 14.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.95 0.405 . . . . 0.0 111.286 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.6 OUTLIER -137.85 163.29 31.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.99 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.565 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . 4.6 tpt -146.67 113.05 5.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.01 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.4 106.49 4.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.792 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.4 mt -74.47 -7.62 53.6 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.762 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -46.83 -30.76 2.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.874 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -118.63 19.14 13.33 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.628 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.792 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -125.14 -10.01 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 121.313 0.578 . . . . 0.0 110.154 178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.827 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.1 t -141.79 139.5 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.525 178.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.584 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -129.92 176.42 18.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.519 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.441 HD22 ' HB2' ' A' ' 8' ' ' SER . 21.3 t30 -129.48 133.54 47.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.61 0.243 . . . . 0.0 110.454 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.408 ' CB ' ' HG3' ' A' ' 100' ' ' GLU . 5.4 t -142.38 111.49 6.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.88 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 57.65 43.55 22.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.401 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.56 7.56 65.01 Favored Glycine 0 C--N 1.33 0.218 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.455 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.9 145.16 41.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -68.91 131.22 44.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.224 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.408 ' HG3' ' CB ' ' A' ' 95' ' ' SER . 21.2 mm-40 -136.67 76.03 48.79 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.693 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.827 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 35.2 Cg_endo -66.27 119.36 6.38 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.438 2.092 . . . . 0.0 111.322 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 p -109.3 144.63 37.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.826 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.813 ' HG3' ' HB3' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -111.37 129.9 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.69 15.6 17.57 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.971 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.0 m -157.16 9.78 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.813 ' HB3' ' HG3' ' A' ' 103' ' ' ARG . 14.9 t-20 -111.13 74.79 0.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.589 0.709 . . . . 0.0 109.832 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -157.5 -47.01 0.07 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.527 -1.215 . . . . 0.0 108.93 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.37 177.27 7.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.833 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -115.71 -21.12 9.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.688 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.5 t -85.9 64.54 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.72 0.771 . . . . 0.0 110.369 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 tt -92.95 78.27 4.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.335 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -128.75 96.21 4.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.908 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.6 t -56.61 112.31 1.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.458 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 41.3 t -144.44 125.57 14.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.049 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.0 m -75.19 -43.13 53.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.066 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.649 -0.691 . . . . 0.0 109.359 179.445 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -82.27 137.94 34.71 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.601 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.402 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 82.0 m -75.81 -81.49 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.821 179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.944 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 24.4 m-80 51.76 69.09 0.7 Allowed 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.662 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 17.5 p90 -58.1 -41.66 83.98 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.25 0.547 . . . . 0.0 110.21 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.94 -21.62 65.09 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.821 -178.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 28.2 t-20 -54.71 -33.72 61.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.333 0.587 . . . . 0.0 110.802 -179.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.444 ' HB2' HD22 ' A' ' 94' ' ' ASN . 26.1 m -134.69 28.4 3.6 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.076 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.662 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -120.0 134.88 55.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.943 0.401 . . . . 0.0 110.584 179.267 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 p -128.25 152.19 48.39 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.985 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.84 57.91 12.68 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.756 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.598 HG12 ' HA3' ' A' ' 21' ' ' GLY . 15.5 m -104.83 132.12 52.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.962 0.41 . . . . 0.0 110.824 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -133.27 156.69 47.11 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.739 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.652 HD22 HD23 ' A' ' 64' ' ' LEU . 21.9 tp -121.33 127.73 51.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.542 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.448 ' O ' HG12 ' A' ' 18' ' ' ILE . 42.7 t80 -131.23 98.92 4.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.836 179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 62' ' ' THR . . . 78.41 -63.77 3.61 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.709 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.518 ' HD1' HD21 ' A' ' 36' ' ' ASN . 6.4 p90 -169.15 23.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.724 0.297 . . . . 0.0 111.47 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.7 pt -121.57 133.91 66.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.798 0.332 . . . . 0.0 110.659 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.791 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -115.72 114.28 24.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.828 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.46 140.55 51.23 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.598 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.22 -177.71 39.03 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.96 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 7.1 m-20 -109.63 108.3 18.67 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.439 0.162 . . . . 0.0 110.609 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 17.9 m -104.54 132.38 50.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.5 mt -69.58 133.43 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.56 -178.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -94.68 -176.59 3.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.917 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -54.72 -37.71 66.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.727 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.81 -30.02 67.3 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.938 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.03 -2.01 31.53 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.322 -179.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -104.49 139.69 20.35 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.372 . . . . 0.0 110.944 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 42.8 Cg_endo -69.91 125.99 12.7 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.921 2.414 . . . . 0.0 111.67 179.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -112.02 136.88 50.79 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.048 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.3 123.77 21.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.453 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -140.01 158.36 44.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.602 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.0 p -140.1 141.86 36.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.743 0.306 . . . . 0.0 111.192 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -124.86 145.4 32.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.588 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.518 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -103.74 95.82 6.29 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.75 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -58.54 -26.9 64.03 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.742 0.306 . . . . 0.0 111.337 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -55.41 -24.12 28.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.863 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -112.86 12.37 19.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.58 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -129.02 -12.03 4.7 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.529 HD13 ' HB3' ' A' ' 37' ' ' LEU . 3.0 mp -124.62 133.9 68.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.55 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -108.67 170.92 15.13 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.577 -179.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -110.88 102.49 10.99 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.299 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -110.57 105.64 14.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.889 179.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 14.3 t-20 52.6 47.37 24.83 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.708 0.766 . . . . 0.0 111.094 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.69 75.28 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.933 179.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -120.27 151.79 38.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.797 0.332 . . . . 0.0 110.672 -179.873 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.507 HD23 ' HG ' ' A' ' 70' ' ' LEU . 10.8 mp -85.5 117.01 24.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.892 -179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.673 ' HG3' ' CD ' ' A' ' 51' ' ' PRO . 12.8 tp10 -110.57 126.8 54.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.183 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.945 ' HB2' HG11 ' A' ' 91' ' ' VAL 0.252 53.5 p90 -61.13 -12.06 0.2 Allowed Pre-proline 0 CA--C 1.452 -2.811 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 -174.804 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.836 ' HB2' ' HB2' ' A' ' 106' ' ' ASN . 8.3 Cg_endo -128.62 9.22 0.0 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.601 1 C-N-CA 112.461 -4.56 . . . . 0.0 114.972 175.693 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.55 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -66.94 -167.72 3.05 Favored Glycine 0 C--N 1.27 -3.106 0 CA-C-N 110.849 -2.887 . . . . 0.0 115.69 -177.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -145.59 154.56 42.28 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.721 0.296 . . . . 0.0 110.928 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.8 m 55.76 45.28 24.72 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 10.4 p90 -79.61 -36.7 37.63 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.845 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.54 -18.38 69.83 Favored Glycine 0 CA--C 1.505 -0.533 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.83 -178.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 m -66.7 -13.21 61.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.049 -0.576 . . . . 0.0 110.779 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.4 m -149.02 26.84 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.617 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 55' ' ' PHE . 0.0 OUTLIER -124.55 155.36 39.17 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.162 0.506 . . . . 0.0 111.123 -179.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 61' ' ' LYS . 32.6 m -141.62 171.1 12.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.816 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.4 mptt 62.46 31.77 16.98 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.523 0.514 . . . . 0.0 111.345 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 16' ' ' GLY . 2.6 p -59.66 123.16 16.02 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.926 0.393 . . . . 0.0 111.489 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.45 162.88 40.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.315 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.652 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -121.98 112.62 18.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -85.33 124.8 32.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.858 0.361 . . . . 0.0 110.959 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' HB3' ' NE2' ' A' ' 68' ' ' HIS . 11.1 t70 56.36 21.36 5.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.048 179.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.94 36.06 92.28 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.807 -0.633 . . . . 0.0 114.33 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.429 ' NE2' ' HB3' ' A' ' 66' ' ' ASP . 0.9 OUTLIER -154.48 -23.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.571 0.686 . . . . 0.0 112.393 179.008 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.9 m -116.35 128.48 55.57 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.22 -0.3 . . . . 0.0 111.143 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.566 ' HA ' HD22 ' A' ' 64' ' ' LEU . 11.8 tp -91.3 129.73 37.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.297 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.402 ' N ' HD12 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -120.84 129.75 53.67 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.657 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.494 ' HB3' HD21 ' A' ' 48' ' ' LEU . . . -162.91 165.56 24.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.133 179.109 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.412 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 23.2 t -117.01 111.78 20.04 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 56.7 m -103.38 146.14 28.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.414 0.626 . . . . 0.0 110.742 -179.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 10.2 tmtt? -100.59 140.49 34.78 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.883 177.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.73 -24.46 0.3 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 119.909 -1.139 . . . . 0.0 112.992 179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.436 ' HA ' ' ND2' ' A' ' 45' ' ' ASN . . . -47.97 -45.85 31.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.0 111.135 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.2 t70 178.72 58.21 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.917 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.454 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 76.57 -0.16 65.71 Favored Glycine 0 C--O 1.229 -0.189 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.695 -179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -118.23 163.95 15.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.172 -179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.412 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 50.5 p90 -111.77 169.54 8.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.071 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -155.95 135.19 12.21 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -72.05 114.65 10.38 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.291 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.467 ' HB3' HD13 ' A' ' 48' ' ' LEU . 18.8 t -130.55 167.53 18.54 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.977 0.418 . . . . 0.0 110.418 -179.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.03 160.93 38.61 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.163 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.608 ' CE ' ' HA ' ' A' ' 86' ' ' MET . 0.6 OUTLIER -146.04 126.25 13.86 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.327 -179.611 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.565 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 45.9 t0 -78.28 108.78 11.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.144 0.497 . . . . 0.0 109.874 179.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.779 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.1 mt -82.26 -9.25 59.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.586 -179.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -52.21 -26.27 11.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.489 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 41.9 p90 -116.54 17.76 15.27 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.066 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.945 HG11 ' HB2' ' A' ' 50' ' ' TYR . 2.5 m -123.7 -10.57 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 CA-C-O 121.188 0.518 . . . . 0.0 110.476 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -133.73 124.16 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.402 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -114.98 159.03 13.95 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.44 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.444 HD22 ' HB2' ' A' ' 8' ' ' SER . 22.9 t30 -107.81 121.94 45.76 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.559 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 74.4 m -137.12 107.16 6.31 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.809 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 61.01 40.74 14.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.326 178.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.73 18.31 68.11 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.606 -0.725 . . . . 0.0 113.164 179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -124.75 147.97 48.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.504 ' O ' ' HG3' ' A' ' 99' ' ' MET . 8.2 ptt? -66.01 127.77 33.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.867 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.559 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 53.9 mm-40 -133.61 75.07 69.47 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.289 178.071 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 31.6 Cg_endo -62.19 135.48 54.71 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.734 2.289 . . . . 0.0 112.218 -179.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 5.7 p -123.45 111.6 16.52 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.578 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.459 ' HB2' ' CB ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -89.56 147.9 23.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.418 ' HB3' ' HE2' ' A' ' 50' ' ' TYR . . . -135.82 30.23 3.12 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.812 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.545 ' HB2' ' HG3' ' A' ' 51' ' ' PRO . 11.3 m -166.46 9.97 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.836 ' HB2' ' HB2' ' A' ' 51' ' ' PRO . 12.4 t-20 -99.86 -1.05 38.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.849 0.833 . . . . 0.0 109.661 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -86.75 -31.34 20.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.592 179.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.55 153.16 22.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.979 178.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -113.9 178.73 4.18 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.611 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 m 37.93 66.53 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 122.371 1.081 . . . . 0.0 112.023 -179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 111' ' ' LEU . 2.4 pt? -108.61 18.66 20.63 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.003 -178.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -65.86 115.89 6.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.123 179.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.7 p -77.48 68.9 3.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.404 0.621 . . . . 0.0 110.48 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 41.6 t -161.03 136.09 7.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.938 -179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 t -61.12 -33.66 73.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.525 178.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 C--O 1.25 1.079 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.327 -179.683 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 110.764 -0.087 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 58.96 102.17 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.896 0.855 . . . . 0.0 112.577 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.438 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 37.9 m -70.97 -77.38 0.09 Allowed 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.742 179.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 41.82 76.04 0.08 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 178.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.63 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 3.4 p90 -62.19 -32.68 73.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.006 0.431 . . . . 0.0 111.035 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.6 -22.31 65.36 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -63.05 -27.18 69.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.909 0.385 . . . . 0.0 111.106 -179.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HB2' HD22 ' A' ' 94' ' ' ASN . 71.0 m -129.87 28.7 5.06 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.733 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -129.75 144.81 51.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.927 0.394 . . . . 0.0 111.104 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.1 p -140.39 147.39 39.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.061 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.13 48.14 55.01 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.893 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.543 HG12 ' HA3' ' A' ' 21' ' ' GLY . 18.1 m -93.5 132.75 36.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.202 0.525 . . . . 0.0 111.083 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -126.6 154.86 43.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.672 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.732 HD22 HD23 ' A' ' 64' ' ' LEU . 16.2 tp -123.8 119.44 29.72 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.872 0.368 . . . . 0.0 111.41 -179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.546 ' O ' HG12 ' A' ' 18' ' ' ILE . 29.2 m-85 -118.01 99.21 6.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.158 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.478 ' O ' HG21 ' A' ' 62' ' ' THR . . . 73.44 -61.92 1.89 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.975 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 28.1 p90 -165.39 21.15 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.868 0.366 . . . . 0.0 111.211 179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.583 HG22 ' ND2' ' A' ' 36' ' ' ASN . 35.4 pt -118.82 127.54 75.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.922 0.391 . . . . 0.0 110.552 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.889 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -108.82 117.64 34.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.695 -179.594 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 20' ' ' ARG . 6.1 tmm_? -128.85 138.22 51.92 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.737 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.543 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -166.78 -168.54 29.12 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.937 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 5.1 m-20 -112.34 110.66 21.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.737 0.303 . . . . 0.0 111.078 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 m -106.38 132.98 51.78 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 54.7 mt -67.41 136.34 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.83 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.485 ' HB3' ' HA3' ' A' ' 97' ' ' GLY . 5.6 p30 -104.34 -174.46 2.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.355 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -52.79 -33.41 48.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.481 0.488 . . . . 0.0 112.098 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.68 -28.18 69.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.786 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.06 -4.04 48.64 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.514 -178.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -104.87 146.08 31.95 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.808 0.337 . . . . 0.0 110.524 179.231 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 37.1 Cg_endo -67.52 130.6 22.6 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.805 2.337 . . . . 0.0 112.137 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -118.96 132.38 56.07 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.743 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.82 126.25 27.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.41 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.5 t -143.03 158.7 43.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.649 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 p -138.98 151.17 46.64 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.542 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -136.25 147.24 28.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.316 -179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 18' ' ' ILE . 8.6 m120 -104.38 96.05 6.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.897 0.379 . . . . 0.0 110.785 179.299 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.889 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -60.39 -28.5 68.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.008 -179.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.471 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 24.4 t-20 -55.81 -26.56 46.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.289 -0.868 . . . . 0.0 112.2 -179.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.05 11.93 22.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.484 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.654 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 41.9 m-85 -128.71 -20.28 3.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -114.69 141.32 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.609 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.32 176.54 17.05 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.105 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -116.71 106.62 13.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.889 0.376 . . . . 0.0 110.695 -178.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -111.87 107.27 16.25 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.376 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.848 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 55.1 t30 56.02 40.79 30.27 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.037 0.446 . . . . 0.0 110.533 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.41 19.6 79.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.509 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -123.89 157.06 35.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.848 0.356 . . . . 0.0 110.568 -179.584 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.05 116.63 21.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.234 -178.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -104.18 128.77 51.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.596 179.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.706 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.83 -76.22 0.04 OUTLIER Pre-proline 0 CA--C 1.43 -3.639 0 CA-C-O 117.697 -1.144 . . . . 0.0 112.819 -179.825 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.751 ' HG2' ' HA ' ' A' ' 106' ' ' ASN . 6.0 Cg_endo -108.68 123.98 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.273 1 C-N-CA 113.199 -4.067 . . . . 0.0 113.083 -178.661 . . . . . . . . 4 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.609 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -152.35 -160.75 9.77 Favored Glycine 0 C--N 1.281 -2.509 0 CA-C-N 113.581 -1.645 . . . . 0.0 112.939 -177.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -154.87 142.76 20.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.693 0.282 . . . . 0.0 110.583 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.1 m 56.48 42.49 27.34 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.184 178.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 14.9 p90 -71.75 -35.61 70.17 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.07 -18.69 48.98 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.321 -178.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 m -64.4 -16.55 62.55 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.06 0.544 . . . . 0.0 111.01 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.9 m -148.22 23.77 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.884 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.7 m -129.99 138.67 50.94 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.26 0.552 . . . . 0.0 111.093 -179.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.416 HG23 ' HG2' ' A' ' 61' ' ' LYS . 25.1 m -133.06 178.09 6.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.295 179.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HG2' HG23 ' A' ' 60' ' ' VAL . 34.4 mmtp 62.81 37.09 12.6 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.415 0.447 . . . . 0.0 111.329 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.478 HG21 ' O ' ' A' ' 16' ' ' GLY . 12.6 p -67.84 123.2 19.91 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.86 149.73 27.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.92 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.732 HD23 HD22 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -106.34 115.01 29.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.853 0.359 . . . . 0.0 110.724 -179.639 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -85.94 120.37 27.27 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.195 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 58.69 23.36 10.98 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.924 0.765 . . . . 0.0 111.925 179.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 55.93 32.19 59.1 Favored Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.651 -0.704 . . . . 0.0 114.361 179.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -148.09 -25.15 0.35 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 117.376 0.588 . . . . 0.0 111.436 179.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.6 m -114.81 126.39 54.77 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.777 -179.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.535 ' HA ' HD22 ' A' ' 64' ' ' LEU . 15.0 tp -89.83 132.72 35.11 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.45 129.56 52.16 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.748 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.19 166.93 28.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 110.521 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 t -114.79 122.66 47.05 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 57.2 m -122.44 149.68 43.52 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.47 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.414 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 9.4 tmtt? -99.96 140.45 34.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.824 178.148 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.61 -32.07 0.3 Allowed Glycine 0 C--O 1.227 -0.297 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.18 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.848 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -52.95 -41.16 64.26 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -173.55 52.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.618 0.723 . . . . 0.0 109.811 -179.094 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.414 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 69.21 10.01 61.65 Favored Glycine 0 C--O 1.225 -0.418 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.096 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -131.78 158.67 40.62 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 17.4 p90 -100.72 166.3 10.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.093 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -158.53 149.12 20.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -69.59 139.33 53.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.931 0.396 . . . . 0.0 110.636 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.42 ' OG ' ' HG3' ' A' ' 47' ' ' ARG . 34.3 t -152.01 162.99 40.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.038 179.442 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.58 164.55 27.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.908 0.385 . . . . 0.0 110.021 179.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.813 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 2.6 tpt -148.7 121.38 8.63 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.689 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 19.2 m-20 -73.94 106.5 5.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.709 ' HA ' HG22 ' A' ' 91' ' ' VAL . 18.3 mt -75.76 -9.11 58.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.523 -178.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.38 -31.33 3.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.079 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.562 ' HE1' ' HD2' ' A' ' 50' ' ' TYR . 3.2 p90 -119.57 23.59 11.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 111.564 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -127.53 -14.35 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 121.102 0.477 . . . . 0.0 110.505 178.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.966 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 7.5 p -150.79 133.81 6.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.691 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -128.03 -179.82 16.08 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.523 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.449 HD22 ' HB2' ' A' ' 8' ' ' SER . 14.8 t30 -126.01 135.85 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.533 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 5.0 t -147.66 120.61 8.77 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 57.99 41.49 24.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 25' ' ' ASN . . . 60.58 28.98 68.59 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.764 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -136.29 151.44 49.64 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.835 0.35 . . . . 0.0 110.139 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.431 ' O ' ' HG3' ' A' ' 99' ' ' MET . 20.0 ptt? -61.9 127.89 33.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.071 -179.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 95' ' ' SER . 14.2 mm-40 -140.45 71.48 32.02 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.246 178.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.966 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 51.7 Cg_endo -70.91 100.73 0.99 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.77 2.314 . . . . 0.0 112.871 -179.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.17 116.31 32.39 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.031 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -91.75 149.66 21.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.48 -179.407 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.79 24.55 4.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -163.17 46.2 0.13 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.735 0.302 . . . . 0.0 111.446 -178.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.751 ' HA ' ' HG2' ' A' ' 51' ' ' PRO . 2.5 t-20 -88.86 20.4 3.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.836 0.35 . . . . 0.0 111.778 -178.389 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 111' ' ' LEU . . . -167.16 166.53 14.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.778 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.74 -57.88 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.235 0.541 . . . . 0.0 111.061 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -118.79 -41.45 2.79 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.921 -179.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.19 58.42 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 122.74 1.257 . . . . 0.0 110.026 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 107' ' ' ALA . 54.7 tp -81.84 89.21 6.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.355 -179.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.649 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 5.4 mmpt? -110.33 112.9 25.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.638 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.0 m -94.66 37.45 1.13 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.1 p -148.54 168.1 23.63 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.183 -1.372 . . . . 0.0 108.981 -178.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 m -70.67 -49.45 47.11 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 . . . . . 0 C--O 1.248 1.009 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.642 178.811 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtm . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 61.17 -161.53 0.29 Allowed 'General case' 0 C--N 1.332 -0.167 0 O-C-N 123.476 0.485 . . . . 0.0 110.789 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.582 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 83.3 m -116.67 -70.09 0.81 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.309 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 44.2 m-80 62.51 80.5 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 178.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.645 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 6.2 p90 -65.01 -35.87 82.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.066 178.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.9 64.96 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.871 -178.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 7.3 t-20 -52.18 -31.27 30.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.51 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.422 ' HB2' HD22 ' A' ' 94' ' ' ASN . 59.0 m -144.12 30.77 1.27 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.893 0.378 . . . . 0.0 110.721 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -119.48 142.17 48.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.024 179.156 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -141.44 157.53 45.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.395 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.79 61.03 7.66 Favored Glycine 0 C--N 1.329 0.157 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.723 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.584 HG12 ' HA3' ' A' ' 21' ' ' GLY . 30.9 m -100.71 139.02 23.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 120.91 0.386 . . . . 0.0 110.991 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 11.3 pt-20 -130.32 139.72 50.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.393 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.72 HD22 HD23 ' A' ' 64' ' ' LEU . 51.9 tp -124.62 123.74 40.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.484 ' O ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-85 -133.67 103.65 5.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.412 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' O ' HG21 ' A' ' 62' ' ' THR . . . 79.37 -65.2 3.67 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.161 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.6 p90 -167.6 21.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.813 0.339 . . . . 0.0 111.313 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 45.6 pt -117.02 129.05 74.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.47 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.917 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -119.79 114.45 22.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.609 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 21.2 ttm180 -114.0 136.0 53.38 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.584 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -154.93 168.32 32.89 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.399 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.657 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 17.8 m-20 -100.66 105.15 16.49 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.2 m -104.97 131.79 52.02 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 60.4 mt -70.71 136.2 26.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.646 -178.399 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -99.73 -176.5 3.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.404 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.37 -32.79 57.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -61.89 -29.04 69.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.022 0.439 . . . . 0.0 111.66 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.12 0.8 41.5 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.096 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -107.56 141.52 23.2 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 120.791 0.329 . . . . 0.0 110.656 179.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.657 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 36.5 Cg_endo -67.62 130.23 21.69 Favored 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 122.966 2.444 . . . . 0.0 112.532 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -114.72 132.61 56.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.95 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.38 124.27 23.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.171 0.51 . . . . 0.0 111.638 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.1 t -143.22 152.94 42.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.413 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 12.7 p -135.7 145.5 46.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.506 0.193 . . . . 0.0 111.117 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.84 151.81 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.788 -179.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.491 ' ND2' HG22 ' A' ' 18' ' ' ILE . 5.4 m120 -103.07 93.61 5.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.171 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.917 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -60.18 -24.48 64.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.797 -178.911 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.5 t-20 -55.09 -30.9 60.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.969 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -105.7 15.17 27.27 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.537 -178.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.1 m-85 -130.38 -24.62 2.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.3 mp -112.71 141.78 27.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.671 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -114.35 169.7 12.99 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.547 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -119.33 114.2 21.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.973 0.416 . . . . 0.0 110.933 -179.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -111.02 108.12 17.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.241 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 51.87 42.56 30.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.077 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 74' ' ' CYS . . . 80.07 18.05 73.03 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.539 179.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.67 150.17 46.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.047 0.451 . . . . 0.0 111.2 -179.83 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.468 HD13 ' HG ' ' A' ' 70' ' ' LEU . 43.4 mt -82.43 116.19 21.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.14 -179.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -112.49 132.04 55.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.583 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -33.17 -73.67 0.06 OUTLIER Pre-proline 0 CA--C 1.427 -3.765 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.598 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.583 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 4.9 Cg_endo -107.85 130.48 0.05 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.327 0 C-N-CA 113.563 -3.824 . . . . 0.0 113.212 -176.669 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.671 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -163.89 -160.46 11.8 Favored Glycine 0 C--N 1.286 -2.204 0 CA-C-N 114.074 -1.421 . . . . 0.0 113.322 -177.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -151.53 145.53 25.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 111.401 -179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.5 m 51.57 41.79 28.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.911 -1.041 . . . . 0.0 113.774 178.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -69.33 -39.37 78.23 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.523 178.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.03 -18.08 46.54 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.24 -179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 t -68.82 -20.44 64.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.002 0.43 . . . . 0.0 110.166 179.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.0 p -134.49 17.25 3.66 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.402 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.7 m -125.8 143.13 51.19 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.97 0.414 . . . . 0.0 111.17 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.31 172.81 15.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.454 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 62.0 37.54 14.85 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.597 0.56 . . . . 0.0 111.359 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 16' ' ' GLY . 18.0 p -63.94 127.43 31.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.972 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.55 160.28 43.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.231 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.72 HD23 HD22 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -118.54 112.92 20.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.805 0.336 . . . . 0.0 110.967 -179.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.593 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 15.9 m120 -70.28 114.61 8.58 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.316 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.57 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 27.7 t70 55.2 3.32 0.06 Allowed 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.145 0.903 . . . . 0.0 112.766 179.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 12' ' ' VAL . . . 86.84 47.78 4.66 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.475 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.57 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 2.2 p-80 -162.04 -30.06 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 111.684 178.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 23.9 m -115.89 134.15 55.28 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.692 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.605 ' HB2' HD11 ' A' ' 88' ' ' LEU . 12.3 tp -94.92 131.24 41.06 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.541 0.21 . . . . 0.0 110.482 179.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 128.99 53.81 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.77 162.57 37.1 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.165 0.507 . . . . 0.0 111.149 179.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -110.76 120.95 44.09 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.466 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 21.3 m -121.36 148.21 44.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.277 0.56 . . . . 0.0 112.303 -177.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 8.2 tmtt? -99.41 147.48 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.226 178.046 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.68 -18.55 0.87 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.005 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.79 -36.72 81.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.823 0.311 . . . . 0.0 110.815 179.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.7 t70 179.13 59.21 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.205 179.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.49 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 71.52 -3.75 16.22 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.635 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -116.19 161.51 18.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 44.3 p90 -106.11 166.58 10.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.299 -179.473 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -154.97 143.16 20.28 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.4 127.55 32.24 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.78 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 p -141.4 174.72 10.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.13 162.49 34.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 0.0 110.791 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.795 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.2 tpt -148.66 117.18 6.55 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.575 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 26.4 t70 -76.68 106.75 8.53 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.708 ' HA ' HG22 ' A' ' 91' ' ' VAL . 12.5 mt -78.85 -10.05 59.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.387 -177.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -58.44 -16.72 16.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.06 -179.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.563 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 48.2 p90 -119.45 19.43 12.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.174 0.512 . . . . 0.0 110.823 177.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 2.6 m -125.52 -6.63 5.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 121.479 0.657 . . . . 0.0 109.84 177.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 9.9 p -153.06 147.02 14.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.937 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -134.71 -177.09 14.71 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.793 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.422 HD22 ' HB2' ' A' ' 8' ' ' SER . 17.3 t30 -122.71 127.01 48.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.716 0.293 . . . . 0.0 110.65 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.6 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 58.2 m -127.68 92.9 3.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.77 178.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 60.99 54.29 3.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.996 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.25 27.37 62.8 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.965 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.88 142.83 51.16 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.898 0.38 . . . . 0.0 110.52 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 99' ' ' MET . 21.5 ptt? -62.22 121.21 12.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.547 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.6 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 12.7 mm-40 -138.43 80.93 25.94 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.199 178.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 42.3 Cg_endo -68.67 102.06 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.909 2.406 . . . . 0.0 112.064 179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.4 p -127.67 111.72 14.03 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.043 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.773 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 0.5 OUTLIER -81.33 149.1 29.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.143 -179.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -105.29 54.29 0.71 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.095 0.474 . . . . 0.0 110.849 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 37.7 t -179.76 -106.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.46 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.726 ' HB2' ' HG3' ' A' ' 103' ' ' ARG . 3.5 t-20 69.45 110.21 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.932 0.893 . . . . 0.0 112.008 179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.26 148.03 31.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.808 178.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.2 t70 60.4 28.78 18.43 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.614 0.721 . . . . 0.0 111.245 179.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB3' HD21 ' A' ' 106' ' ' ASN . 8.3 t60 -153.46 154.18 33.89 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.3 p -93.99 81.45 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 122.195 0.998 . . . . 0.0 111.038 -179.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.451 HD23 ' HB2' ' A' ' 51' ' ' PRO . 28.0 tp -144.64 39.19 1.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.37 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.469 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 39.8 ttpt -78.57 111.6 14.81 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.483 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.9 m -83.81 54.66 2.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.649 0.737 . . . . 0.0 110.016 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.7 m -153.16 132.96 13.17 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.222 -179.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.2 m -61.62 -35.54 78.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.162 -179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.969 -179.939 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 121.256 0.551 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -100.1 125.59 46.21 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.607 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 2.1 m -71.62 -62.76 1.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.723 -178.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 56.73 70.38 0.66 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.162 0.289 . . . . 0.0 110.863 179.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 6.8 p90 -58.35 -38.35 77.03 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.071 0.462 . . . . 0.0 111.582 -178.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.91 -22.6 65.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -69.37 -19.48 63.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.784 0.326 . . . . 0.0 111.312 -178.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.2 m -128.94 10.01 5.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.154 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -118.29 138.55 52.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.218 0.532 . . . . 0.0 111.475 -179.615 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.7 p -132.48 151.42 51.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.921 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.03 49.22 80.88 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.947 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.517 ' HB ' HD22 ' A' ' 19' ' ' LEU . 15.7 m -83.39 127.53 39.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.275 0.56 . . . . 0.0 111.493 -179.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -116.29 137.35 52.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.31 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.841 HD22 HD23 ' A' ' 64' ' ' LEU . 59.4 tp -119.08 129.05 54.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.793 0.33 . . . . 0.0 111.763 -178.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.506 ' O ' HG12 ' A' ' 18' ' ' ILE . 52.5 m-85 -133.91 103.49 5.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.624 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.34 -66.82 2.24 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.655 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.712 ' HD1' HD21 ' A' ' 36' ' ' ASN . 5.8 p90 -164.18 21.02 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.993 0.425 . . . . 0.0 111.089 179.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 15' ' ' TYR . 33.2 pt -121.42 127.28 75.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.176 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.853 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.5 mt -113.18 114.12 26.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.346 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG3' ' HB3' ' A' ' 34' ' ' SER . 10.8 ttm180 -116.49 132.39 56.69 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.577 178.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.42 -173.56 26.0 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.052 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.622 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.7 m-20 -109.04 109.65 20.72 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.719 0.295 . . . . 0.0 110.384 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 8' ' ' SER . 0.6 OUTLIER -106.79 132.54 52.64 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.267 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.9 mt -72.97 138.4 21.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.558 -178.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -102.94 -166.77 1.31 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.762 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.36 -28.41 69.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.907 0.384 . . . . 0.0 111.623 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.58 -26.89 68.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.649 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.83 -2.9 55.74 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.217 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -104.42 142.53 24.81 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.888 0.375 . . . . 0.0 110.707 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.622 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 31.5 Cg_endo -67.41 133.46 30.29 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.817 2.345 . . . . 0.0 112.158 178.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -115.74 139.0 50.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.528 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.24 119.83 16.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.012 0.435 . . . . 0.0 111.291 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -142.19 153.04 43.72 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.035 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.543 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 5.1 p -138.2 136.25 36.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.664 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.75 144.17 26.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.829 -179.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.712 HD21 ' HD1' ' A' ' 17' ' ' TYR . 1.8 t-20 -103.62 87.51 2.85 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.1 mm? -57.78 -18.16 20.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.034 -178.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' A' ' 54' ' ' SER . 0.2 OUTLIER -52.95 -32.33 45.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.69 -178.489 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -107.1 18.58 21.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.7 0.286 . . . . 0.0 111.307 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -125.66 -30.1 3.09 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.68 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.5 mp -111.08 143.13 21.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.717 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -116.88 166.92 12.46 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.013 -1.089 . . . . 0.0 113.645 -179.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -109.78 110.07 20.95 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.442 -179.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -110.15 105.19 14.19 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.468 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.739 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 22.2 t30 54.48 41.53 31.9 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.897 178.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.43 4.77 89.17 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.083 179.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.84 151.63 33.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.025 0.441 . . . . 0.0 111.131 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 84' ' ' SER . 10.8 mp -84.03 127.94 34.22 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.753 179.706 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -120.18 138.89 53.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.536 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.753 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -40.47 -69.31 0.21 Allowed Pre-proline 0 CA--C 1.429 -3.692 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.197 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.753 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 8.1 Cg_endo -109.73 124.9 0.03 OUTLIER 'Trans proline' 1 N--CA 1.341 -7.46 0 C-N-CA 114.054 -3.498 . . . . 0.0 113.551 -177.28 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.717 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -160.4 -161.79 11.8 Favored Glycine 0 C--N 1.281 -2.505 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.006 -177.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -153.04 143.75 22.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.758 0.328 . . . . 0.0 110.643 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.472 ' HA ' ' ND2' ' A' ' 38' ' ' ASN . 8.2 t 60.22 45.2 11.77 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.824 177.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.48 ' CE2' HD21 ' A' ' 70' ' ' LEU . 9.2 p90 -80.88 -37.43 29.8 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.732 -0.605 . . . . 0.0 110.069 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.74 -18.42 68.27 Favored Glycine 0 C--N 1.336 0.558 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.33 -178.085 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.3 m -68.9 -25.59 64.68 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.85 0.357 . . . . 0.0 110.929 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.7 p -123.76 0.6 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.375 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.5 m -107.77 151.78 25.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.058 0.456 . . . . 0.0 111.14 -179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.515 HG23 ' HD3' ' A' ' 61' ' ' LYS . 17.2 m -143.09 168.53 13.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.406 178.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.515 ' HD3' HG23 ' A' ' 60' ' ' VAL . 14.0 mptt 64.4 36.4 9.0 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.542 0.526 . . . . 0.0 110.751 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.4 p -63.97 132.03 49.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.087 -179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.17 162.17 41.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.801 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.841 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -123.04 112.91 18.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.773 0.321 . . . . 0.0 111.335 -179.401 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -82.35 123.27 28.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.266 179.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.763 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.6 t70 57.59 17.47 4.0 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.01 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.68 29.9 76.14 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.401 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.763 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 6.1 p80 -143.39 -30.41 0.5 Allowed 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 117.458 0.629 . . . . 0.0 111.391 179.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.8 m -105.43 125.37 50.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.099 0.476 . . . . 0.0 111.615 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.696 ' HB2' HD11 ' A' ' 88' ' ' LEU . 14.0 tp -90.54 129.29 36.71 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.0 OUTLIER -122.65 129.01 51.37 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.385 179.987 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -161.87 169.38 21.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.27 179.167 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.541 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 14.6 t -119.25 121.02 38.72 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.72 155.86 26.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.657 0.741 . . . . 0.0 111.856 -179.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.47 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 10.7 tmtt? -101.04 148.25 25.27 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.371 178.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.33 -32.66 0.54 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.433 178.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.739 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -55.0 -43.42 73.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -173.5 56.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.319 0.58 . . . . 0.0 110.661 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.47 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 71.55 -1.03 31.12 Favored Glycine 0 CA--C 1.516 0.147 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.783 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -119.01 168.54 10.71 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 42.8 p90 -110.27 161.38 15.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.119 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -153.01 135.17 14.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -61.87 134.4 56.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.966 -179.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.448 ' HB3' HD13 ' A' ' 48' ' ' LEU . 41.6 t -147.65 157.78 43.71 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.057 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.517 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.5 OUTLIER -131.63 162.13 31.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.363 . . . . 0.0 110.338 179.393 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.707 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 17.9 tpp -150.37 127.69 11.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.548 -179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.734 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 22.3 t0 -80.77 111.22 17.02 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.805 ' HA ' HG22 ' A' ' 91' ' ' VAL . 11.4 mt -81.33 -8.71 59.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.43 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -52.6 -26.09 12.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.888 179.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.734 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 25.5 p90 -116.66 19.05 14.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.772 0.32 . . . . 0.0 111.093 179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.805 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.3 m -129.55 -12.41 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.232 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.7 t -131.26 147.12 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.607 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -138.47 172.89 22.8 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.907 179.001 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.437 HD22 ' HB2' ' A' ' 8' ' ' SER . 17.3 t30 -130.31 123.58 30.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.574 -0.313 . . . . 0.0 110.439 -179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.627 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 75.6 m -124.82 98.63 5.79 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.219 179.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 62.59 48.36 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.352 179.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 64.01 21.55 65.85 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.176 -179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -121.81 139.24 53.86 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.607 0.241 . . . . 0.0 110.379 -179.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.468 ' O ' ' HG3' ' A' ' 99' ' ' MET . 22.2 ptt? -59.28 117.27 4.6 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.589 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.627 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 4.5 mm-40 -142.76 71.83 19.74 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 121.059 0.457 . . . . 0.0 110.654 179.04 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 51.8 Cg_endo -69.26 114.16 3.53 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.908 2.405 . . . . 0.0 112.772 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 12.9 p -118.34 137.71 52.91 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.444 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -108.17 145.13 34.64 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.23 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.49 16.79 16.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.199 0.523 . . . . 0.0 111.578 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.432 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 48.4 m -143.96 -139.4 0.11 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 59.88 21.82 10.78 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.451 0.644 . . . . 0.0 110.785 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.64 127.36 10.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.927 -179.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 109' ' ' HIS . 17.9 t70 67.25 155.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.762 0.664 . . . . 0.0 111.088 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 76.0 t60 73.38 155.89 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.73 0.776 . . . . 0.0 110.987 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 36.8 t -82.62 93.66 2.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.574 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.98 -23.01 67.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.743 179.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -74.06 100.47 3.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.736 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.0 m -81.63 73.21 8.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.299 0.571 . . . . 0.0 110.797 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.7 m -129.29 72.81 1.48 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.232 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.4 m -78.32 -24.01 46.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.653 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.943 -179.663 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -132.39 144.29 50.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.051 0.453 . . . . 0.0 110.39 -179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.48 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 74.1 m -60.6 -48.63 80.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.976 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 55.72 69.88 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 10.7 p90 -57.58 -39.51 76.93 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.324 0.583 . . . . 0.0 110.496 179.067 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.75 -22.34 61.95 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -177.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -72.01 -6.17 40.29 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.441 ' CB ' HD22 ' A' ' 94' ' ' ASN . 40.5 m -146.85 18.19 1.27 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.971 0.415 . . . . 0.0 110.399 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.5 m -127.31 133.39 50.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.786 -179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.9 p -136.13 154.59 50.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.11 57.38 10.76 Favored Glycine 0 CA--C 1.511 -0.163 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.649 179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 31.5 m -93.24 138.2 20.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.297 0.57 . . . . 0.0 112.3 -178.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 43.2 mt-10 -126.67 144.26 50.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.825 179.073 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.74 HD22 HD23 ' A' ' 64' ' ' LEU . 12.2 tp -127.97 110.59 12.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.388 179.099 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.454 ' O ' HG12 ' A' ' 18' ' ' ILE . 83.2 t80 -116.95 101.61 8.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.055 179.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.31 -65.7 2.69 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.97 179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 6.2 p90 -162.57 18.99 0.09 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.2 pt -118.79 131.52 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.817 0.342 . . . . 0.0 110.614 179.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.866 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -112.45 113.81 26.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.087 -179.522 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 7.8 ttm180 -113.67 139.38 49.1 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.158 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.21 165.0 34.15 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.449 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 6.0 m-20 -97.07 102.56 14.37 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.013 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 8' ' ' SER . 60.0 m -105.95 132.78 51.63 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mt -69.55 132.18 33.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.018 0.437 . . . . 0.0 111.184 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -103.57 -170.9 1.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.955 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.63 -28.92 61.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 111.712 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.24 -25.54 68.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.869 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.61 -1.02 63.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.629 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -110.03 142.88 26.83 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.632 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 25.9 Cg_endo -63.36 122.3 10.42 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.062 2.508 . . . . 0.0 112.326 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -107.63 132.53 53.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.816 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.24 117.25 15.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.142 0.496 . . . . 0.0 111.469 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -133.52 160.85 36.21 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.286 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 20' ' ' ARG . 64.5 p -136.43 147.49 47.27 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.22 142.7 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.94 88.5 3.56 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.357 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -54.36 -29.37 48.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.705 -178.342 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 24.5 t-20 -52.87 -35.8 58.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.82 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -100.9 12.47 37.56 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.792 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.636 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 46.7 m-85 -126.02 -23.55 3.91 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -114.26 141.56 30.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.643 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -114.5 169.14 12.76 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.402 -0.904 . . . . 0.0 113.153 -179.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -117.42 110.49 18.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 111.305 -179.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.57 108.82 18.46 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.725 179.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 47.75 48.34 17.48 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.256 1.022 . . . . 0.0 112.791 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.16 15.04 81.61 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.424 -0.807 . . . . 0.0 113.711 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.64 149.65 46.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.042 0.448 . . . . 0.0 111.591 -179.362 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' A' ' 86' ' ' MET . 10.0 mp -81.1 123.44 28.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.984 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 43.1 tp10 -114.99 131.97 56.75 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.713 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.35 -70.62 0.13 Allowed Pre-proline 0 CA--C 1.426 -3.816 0 CA-C-O 118.142 -0.932 . . . . 0.0 113.48 -179.213 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.713 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 10.2 Cg_endo -109.43 127.04 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.284 0 C-N-CA 113.724 -3.717 . . . . 0.0 113.399 -177.855 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.643 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -158.93 -160.64 10.5 Favored Glycine 0 C--N 1.281 -2.485 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.78 -177.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -153.42 138.82 17.62 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.831 0.371 . . . . 0.0 111.041 -179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 m 59.44 42.7 17.42 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 178.159 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -72.43 -36.18 68.51 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.56 -17.89 54.76 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.031 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -71.6 -12.94 61.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.295 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 p -144.73 13.59 1.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 111.149 179.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 63.4 m -125.87 149.51 48.62 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.019 -179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.433 HG23 ' HD3' ' A' ' 61' ' ' LYS . 18.0 m -140.79 174.3 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.176 179.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HD3' HG23 ' A' ' 60' ' ' VAL . 13.7 mptt 64.31 39.72 7.06 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.402 0.439 . . . . 0.0 111.32 179.602 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -68.32 120.81 15.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.391 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.43 162.33 39.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 178.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -118.68 112.86 20.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.681 -178.893 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.604 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 13.4 m120 -76.7 118.33 19.22 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.989 179.208 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.749 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.3 t70 54.66 19.64 2.57 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.869 0.731 . . . . 0.0 111.632 179.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.87 30.69 78.66 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.531 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.749 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 5.2 p80 -142.09 -26.04 0.66 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 117.538 0.669 . . . . 0.0 111.803 179.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 22.2 m -116.5 128.4 55.41 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.642 0.258 . . . . 0.0 111.489 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.53 ' HA ' HD22 ' A' ' 64' ' ' LEU . 14.7 tp -93.26 129.58 39.27 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.01 130.23 54.63 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.764 0.316 . . . . 0.0 110.512 179.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -158.58 156.75 30.68 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.515 178.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.566 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 9.5 t -106.34 125.55 51.14 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 22.9 m -122.7 150.99 41.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.231 0.539 . . . . 0.0 112.408 -178.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.443 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 11.0 tmtt? -100.14 148.92 24.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.138 177.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.47 -14.01 1.82 Allowed Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.098 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.12 -38.05 78.67 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.576 0.227 . . . . 0.0 110.986 179.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -175.81 54.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.255 0.55 . . . . 0.0 110.336 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.443 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 73.63 -7.38 13.68 Favored Glycine 0 CA--C 1.517 0.182 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.402 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -117.84 168.99 9.98 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.566 ' HD1' ' HG ' ' A' ' 73' ' ' SER . 53.4 p90 -111.03 162.34 14.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.831 -179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -148.89 149.32 31.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.08 141.98 47.57 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.406 ' HB3' HD13 ' A' ' 48' ' ' LEU . 41.8 t -151.08 157.07 42.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.013 0.435 . . . . 0.0 110.235 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.22 164.18 26.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.842 179.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.676 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 1.6 tpt -150.02 121.45 7.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.862 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -75.75 106.11 7.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.367 0.603 . . . . 0.0 109.405 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.747 ' HA ' HG22 ' A' ' 91' ' ' VAL . 19.6 mt -72.74 -8.36 55.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.01 -179.253 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -47.89 -31.39 5.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.549 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -116.85 23.31 12.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.738 0.304 . . . . 0.0 111.23 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.747 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -130.48 -12.22 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.143 178.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.846 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.2 t -136.83 142.83 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -137.88 162.64 25.58 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.441 HD22 ' CB ' ' A' ' 8' ' ' SER . 34.3 t30 -108.31 113.66 26.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.059 0.457 . . . . 0.0 110.489 179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.529 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 70.9 m -116.74 82.88 1.87 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.417 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 62.99 55.99 1.89 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.171 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.36 27.28 57.85 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.77 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.1 141.01 51.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.025 0.44 . . . . 0.0 110.674 -178.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.407 ' O ' ' HG3' ' A' ' 99' ' ' MET . 18.3 ptm -61.04 97.29 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.472 179.055 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 11.5 mm-40 -129.06 78.17 76.67 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.136 0.493 . . . . 0.0 111.007 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.846 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 61.0 Cg_endo -75.22 96.02 1.01 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.47 2.113 . . . . 0.0 112.26 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.4 p -101.23 134.27 44.52 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.927 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.467 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -111.76 150.0 30.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.913 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -108.27 33.42 4.15 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.096 0.474 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.8 m -155.74 -115.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.379 -179.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 51' ' ' PRO . 26.2 t-20 73.41 -66.5 0.3 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.156 0.982 . . . . 0.0 111.196 -179.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.68 -4.17 34.32 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.495 -1.229 . . . . 0.0 111.199 -179.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -65.45 -26.99 68.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.343 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.556 ' CD2' ' HB2' ' A' ' 111' ' ' LEU . 9.9 p-80 -130.41 176.53 8.07 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.9 m -72.69 62.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.691 0.758 . . . . 0.0 112.907 -178.428 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.556 ' HB2' ' CD2' ' A' ' 109' ' ' HIS . 33.9 tp -107.37 -29.61 9.17 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.483 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -54.9 134.05 48.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.636 -179.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.8 m -77.28 42.08 0.33 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.457 0.646 . . . . 0.0 110.671 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.0 p -150.7 149.97 30.49 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.389 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -79.59 -27.97 41.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.265 0.555 . . . . 0.0 109.867 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.064 -179.964 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 120.758 0.313 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -80.63 121.57 26.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.545 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 75.1 m -84.52 -50.73 7.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.395 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.54 ' HB3' ' CG ' ' A' ' 7' ' ' ASN . 16.4 m-20 53.26 66.56 1.19 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.539 0.524 . . . . 0.0 112.071 177.89 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 11.3 p90 -61.79 -39.3 91.24 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 111.053 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.66 -22.61 61.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.505 -178.15 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.54 ' CG ' ' HB3' ' A' ' 4' ' ' ASN . 4.1 m-20 -71.68 -7.07 45.7 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.969 0.414 . . . . 0.0 111.32 -178.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 31.2 m -138.49 15.44 2.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.178 179.249 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -127.2 140.65 52.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.147 -179.625 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 p -136.27 148.53 48.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.571 179.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.69 47.82 46.49 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.383 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.554 HG12 ' HA3' ' A' ' 21' ' ' GLY . 24.4 m -89.69 143.63 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.996 0.427 . . . . 0.0 111.252 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 6.3 tp10 -141.61 146.16 35.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.097 179.308 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.742 HD22 HD23 ' A' ' 64' ' ' LEU . 49.9 tp -126.76 123.32 37.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.372 . . . . 0.0 111.403 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' O ' HG12 ' A' ' 18' ' ' ILE . 66.0 t80 -132.82 112.74 12.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.714 178.394 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.88 -68.24 2.27 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.677 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 38' ' ' ASN . 43.0 p90 -166.0 18.7 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 122.594 0.357 . . . . 0.0 111.114 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.581 HG22 ' ND2' ' A' ' 36' ' ' ASN . 41.6 pt -119.65 125.12 74.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.051 0.453 . . . . 0.0 110.891 -178.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.845 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -111.06 115.15 28.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.704 179.627 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 9.6 ttm180 -116.24 136.47 52.98 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.554 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -161.46 169.73 37.04 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.92 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 2.4 m-20 -101.39 110.86 22.94 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.3 m -105.72 132.78 51.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 57.9 mt -68.65 136.53 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.438 -178.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -102.28 -175.18 2.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -55.42 -27.8 50.19 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -67.33 -23.44 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 0.0 111.768 -179.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.79 5.21 57.67 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.357 -179.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -111.65 142.52 26.76 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.286 -0.457 . . . . 0.0 109.87 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 56.1 Cg_endo -71.94 133.77 22.28 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.833 2.355 . . . . 0.0 112.536 179.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -119.97 131.55 55.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.695 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.82 126.35 28.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.145 0.498 . . . . 0.0 111.643 -179.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 t -140.43 156.59 46.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.645 179.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.7 p -130.54 148.75 52.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.47 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.81 146.75 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.818 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.581 ' ND2' HG22 ' A' ' 18' ' ' ILE . 8.3 m120 -105.43 96.17 6.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.23 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.845 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.2 mm? -63.07 -25.96 68.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.048 -178.216 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.539 ' HA ' ' CE1' ' A' ' 55' ' ' PHE . 26.0 t-20 -56.31 -27.51 55.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.03 -179.096 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -107.56 11.63 28.48 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.646 -178.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 47.2 m-85 -128.02 -23.21 3.36 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.528 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.0 mp -111.52 140.81 29.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.69 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -111.83 163.34 12.22 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.268 -179.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -112.43 106.62 15.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.183 -0.508 . . . . 0.0 110.176 -179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -111.51 107.17 16.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.373 -179.401 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 m120 57.86 42.13 23.67 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.306 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' C ' ' HB2' ' A' ' 74' ' ' CYS . . . 74.47 17.49 79.83 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.849 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -124.76 143.04 51.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.036 0.446 . . . . 0.0 111.385 -179.514 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.565 HD13 ' HG ' ' A' ' 70' ' ' LEU . 33.6 mt -73.16 124.02 24.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.618 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -117.21 137.15 52.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.798 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -36.1 -71.46 0.11 Allowed Pre-proline 0 CA--C 1.429 -3.687 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -179.875 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.798 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 11.6 Cg_endo -111.45 126.78 0.03 OUTLIER 'Trans proline' 1 N--CA 1.343 -7.366 0 C-N-CA 114.09 -3.473 . . . . 0.0 113.12 -177.573 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.69 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -159.89 -162.07 11.92 Favored Glycine 0 C--N 1.28 -2.547 0 CA-C-N 113.833 -1.531 . . . . 0.0 113.345 -177.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -152.76 142.16 21.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.531 -0.334 . . . . 0.0 111.015 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 m 55.32 43.16 29.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 177.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.539 ' CE1' ' HA ' ' A' ' 38' ' ' ASN . 17.7 p90 -70.24 -34.82 73.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.13 -18.38 27.29 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.545 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.1 t -52.7 -47.29 67.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.791 0.329 . . . . 0.0 110.544 179.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 74' ' ' CYS . 42.8 m -119.7 12.39 12.2 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 82.0 m -111.14 137.47 48.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 111.903 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.8 m -136.67 175.56 9.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.393 178.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 60.82 43.19 12.31 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.915 0.388 . . . . 0.0 111.038 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 p -67.77 130.09 41.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.208 179.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.65 163.33 39.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.434 179.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.742 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -122.56 113.02 18.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.948 0.404 . . . . 0.0 111.642 -179.55 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -83.68 122.08 28.14 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.618 179.195 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.786 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 30.2 t70 58.01 16.95 4.06 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.93 0.769 . . . . 0.0 111.347 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.62 29.32 74.89 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.464 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.786 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 5.9 p80 -143.51 -28.22 0.54 Allowed 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 117.243 0.521 . . . . 0.0 111.471 179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.3 m -110.51 129.65 55.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.802 0.334 . . . . 0.0 111.769 -179.077 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.565 ' HG ' HD13 ' A' ' 48' ' ' LEU . 14.4 tp -90.04 129.53 36.34 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.041 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.16 130.38 53.69 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.538 179.102 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.35 168.02 27.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.825 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.443 ' HG ' ' HD1' ' A' ' 81' ' ' TYR . 9.1 t -113.95 123.39 49.63 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.463 ' HB2' ' C ' ' A' ' 46' ' ' GLY . 14.2 m -126.13 147.61 49.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -177.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.0 tmtt? -99.96 144.65 28.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.471 177.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.95 -26.31 0.63 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.684 179.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.75 80.31 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -171.58 52.25 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.267 0.556 . . . . 0.0 110.146 -179.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.83 2.2 50.41 Favored Glycine 0 CA--C 1.519 0.293 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.431 -179.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -122.34 158.11 30.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.8 p90 -98.82 162.79 12.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.434 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -158.45 144.47 16.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -73.65 142.38 46.46 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.52 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.468 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 31.5 p -152.36 172.97 15.65 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.927 179.27 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -143.78 156.05 44.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.137 0.494 . . . . 0.0 111.016 -179.924 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.633 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 13.3 tpp -142.17 121.35 13.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.742 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.619 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 22.9 t0 -74.66 106.27 6.15 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.1 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.78 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.8 mt -78.82 -9.11 59.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.549 -178.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -52.26 -26.57 12.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.07 179.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.619 ' CE2' ' HB3' ' A' ' 87' ' ' ASP . 39.7 p90 -115.9 17.79 15.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.811 -0.355 . . . . 0.0 111.176 179.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.78 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -125.31 -11.69 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.985 0.422 . . . . 0.0 110.49 178.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.938 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.6 t -134.04 144.57 35.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.203 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.545 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -138.05 174.66 21.79 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.071 179.126 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.4 HD22 ' CB ' ' A' ' 8' ' ' SER . 27.3 t30 -122.98 134.54 54.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.834 0.35 . . . . 0.0 110.478 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.63 ' HB3' ' HG3' ' A' ' 100' ' ' GLU . 5.4 t -145.35 104.59 3.94 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 61.69 44.27 9.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.085 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 57.26 34.53 67.66 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.542 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -131.43 142.95 50.11 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.547 ' O ' ' HG3' ' A' ' 99' ' ' MET . 14.7 ptt? -59.34 114.9 2.89 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.764 179.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.63 ' HG3' ' HB3' ' A' ' 95' ' ' SER . 6.2 mm-40 -135.23 73.14 65.0 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.197 178.841 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.938 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 46.4 Cg_endo -70.38 96.06 0.63 Allowed 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.471 2.114 . . . . 0.0 112.56 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.1 p -104.67 125.22 50.57 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.055 179.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.537 ' H ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -111.59 149.53 31.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.724 179.325 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -102.87 33.44 3.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.096 0.474 . . . . 0.0 111.258 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.636 ' HB3' HD21 ' A' ' 111' ' ' LEU . 67.6 m -152.89 -130.13 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.578 -178.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 68.99 100.54 0.06 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.924 0.89 . . . . 0.0 111.676 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -167.39 -174.98 2.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.84 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -93.85 -68.81 0.78 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.054 0.454 . . . . 0.0 110.489 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -123.02 167.85 13.1 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.222 179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.401 HG22 ' HG2' ' A' ' 112' ' ' LYS . 8.7 p 39.37 73.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 122.44 1.114 . . . . 0.0 111.659 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.636 HD21 ' HB3' ' A' ' 105' ' ' SER . 40.7 tp -75.09 84.07 2.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.885 -179.006 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.401 ' HG2' HG22 ' A' ' 110' ' ' VAL . 10.5 mmmm -93.59 106.35 18.32 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.236 179.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.9 m -82.72 -7.35 59.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.317 0.58 . . . . 0.0 109.926 178.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.2 t -114.34 91.43 3.62 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.168 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.6 m -83.02 -35.37 25.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.493 -179.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 116' ' ' GLU . 7.7 pt-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.772 -179.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.77 ' HG3' ' H ' ' A' ' 3' ' ' CYS . 10.7 tp60 64.24 -158.65 0.3 Allowed 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.564 0.54 . . . . 0.0 110.019 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.77 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 59.5 m -131.37 -63.65 0.83 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.856 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 70.5 m-20 59.73 67.15 0.91 Allowed 'General case' 0 N--CA 1.462 0.148 0 O-C-N 123.145 0.278 . . . . 0.0 111.738 177.892 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.6 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 12.0 p90 -59.57 -42.75 93.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.296 0.569 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.74 -21.18 63.48 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.377 -178.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.856 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 65.9 t30 -60.33 -24.06 64.71 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.366 -178.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB2' HD22 ' A' ' 94' ' ' ASN . 41.0 m -136.92 25.5 3.04 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.459 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -125.64 134.88 51.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.823 179.634 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.1 p -131.41 158.71 40.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.739 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.89 61.37 7.26 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.588 179.054 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 27.8 m -95.65 149.96 4.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.081 0.467 . . . . 0.0 111.328 -179.213 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -138.67 140.16 38.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.031 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.922 HD22 HD23 ' A' ' 64' ' ' LEU . 40.2 tp -126.41 122.68 36.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.842 0.353 . . . . 0.0 110.993 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.552 ' O ' HG12 ' A' ' 18' ' ' ILE . 92.2 m-85 -130.09 106.3 8.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.334 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.74 -66.98 2.35 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.495 179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' HD1' HD21 ' A' ' 36' ' ' ASN . 2.2 p90 -165.58 22.65 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.621 0.369 . . . . 0.0 111.209 179.794 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 15' ' ' TYR . 34.0 pt -119.86 127.48 75.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.778 0.323 . . . . 0.0 110.263 179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.767 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.3 mt -112.78 119.87 39.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.415 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 1.4 ttt180 -120.32 138.01 53.94 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.36 175.16 40.45 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.517 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 23.4 m-20 -101.61 107.07 18.22 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.1 m -105.28 132.63 51.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mt -67.45 134.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.019 0.438 . . . . 0.0 111.511 -178.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -103.26 -171.44 1.94 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.45 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -51.32 -41.34 60.48 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.469 0.481 . . . . 0.0 111.846 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -59.79 -27.53 66.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.496 -179.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.75 -0.3 52.38 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.149 -1.024 . . . . 0.0 111.444 -178.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -105.51 138.44 19.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 121.554 0.693 . . . . 0.0 110.948 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 28.7 Cg_endo -60.76 121.25 9.41 Favored 'Trans proline' 0 C--N 1.329 -0.475 0 C-N-CA 124.207 3.271 . . . . 0.0 112.027 178.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -111.92 126.79 55.5 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.941 -179.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.32 126.94 29.77 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.008 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 t -142.93 160.16 40.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.373 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.1 p -133.35 148.17 51.85 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.765 0.316 . . . . 0.0 110.601 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.1 mp -133.69 143.95 37.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.616 HD21 ' HD1' ' A' ' 17' ' ' TYR . 2.1 t-20 -103.2 96.29 6.68 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.347 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.6 mm? -59.5 -22.17 61.22 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.919 -178.567 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -55.08 -31.53 61.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.768 -179.31 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -102.92 8.92 39.04 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.736 -179.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 43.8 m-85 -126.37 -22.63 3.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.576 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -114.1 139.13 41.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.122 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.633 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -112.32 170.06 13.36 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.718 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -115.33 107.44 15.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.901 0.381 . . . . 0.0 110.619 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.648 ' OD1' ' HA ' ' A' ' 112' ' ' LYS . 31.2 t70 -106.99 106.22 16.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.071 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 50.65 42.22 26.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.196 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 74' ' ' CYS . . . 82.47 15.13 74.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.512 178.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.93 145.79 48.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.226 0.536 . . . . 0.0 111.011 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.522 HD13 ' HG ' ' A' ' 70' ' ' LEU . 23.7 mt -74.98 116.32 15.59 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.47 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 51' ' ' PRO . 31.8 tt0 -107.53 132.31 53.39 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.868 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -39.0 -66.22 0.34 Allowed Pre-proline 0 CA--C 1.431 -3.634 0 CA-C-O 117.385 -1.293 . . . . 0.0 114.408 -179.195 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.868 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 5.6 Cg_endo -112.67 119.47 0.02 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.219 0 C-N-CA 113.552 -3.832 . . . . 0.0 113.361 -178.296 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.633 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -154.75 -163.9 12.44 Favored Glycine 0 C--N 1.275 -2.82 0 CA-C-N 113.754 -1.566 . . . . 0.0 113.745 -177.402 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -153.14 142.02 21.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.758 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.6 45.53 16.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.586 177.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -75.66 -38.96 58.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.916 0.389 . . . . 0.0 110.408 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.04 -18.55 41.41 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.747 -178.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.0 m -59.74 -19.57 50.98 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.814 0.446 . . . . 0.0 111.602 179.378 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.0 m -144.49 26.04 1.47 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.668 179.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.6 m -127.69 144.65 51.06 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.23 0.538 . . . . 0.0 111.624 -179.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 m -136.82 172.8 14.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.474 179.038 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mptt 62.83 37.88 11.95 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.377 0.423 . . . . 0.0 111.192 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 16' ' ' GLY . 1.2 p -68.81 122.26 18.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.152 0.501 . . . . 0.0 111.278 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -153.12 154.64 35.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.866 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.922 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -109.65 116.84 32.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.918 -179.344 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -84.05 118.86 24.34 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.701 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 33.2 t70 65.61 -1.92 0.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 124.199 0.937 . . . . 0.0 111.729 179.1 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.21 29.22 34.32 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.029 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.701 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 6.0 p80 -143.32 -29.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.056 0.428 . . . . 0.0 110.889 179.455 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.43 ' O ' HD13 ' A' ' 64' ' ' LEU . 15.9 m -113.39 130.28 56.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.354 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.547 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.9 tp -91.14 130.4 37.04 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.22 129.82 53.38 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.876 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.95 162.91 32.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.092 0.473 . . . . 0.0 110.868 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.444 ' HG ' ' HD2' ' A' ' 81' ' ' TYR . 12.7 t -111.02 122.57 48.23 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 33.7 m -122.77 149.0 44.7 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.532 0.682 . . . . 0.0 112.469 -177.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 80' ' ' GLN . 10.2 tmtt? -99.17 142.34 30.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.229 178.152 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.13 -24.46 0.39 Allowed Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.019 -1.086 . . . . 0.0 113.661 179.4 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.9 -38.59 88.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.872 0.368 . . . . 0.0 111.83 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -173.59 55.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.289 0.566 . . . . 0.0 109.5 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.4 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 69.32 -1.42 12.82 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.0 -179.097 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 24.9 pt20 -113.72 166.11 11.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.381 -178.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 52.4 p90 -106.2 168.84 8.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.239 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.88 133.19 5.28 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.51 123.17 23.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.93 0.395 . . . . 0.0 110.346 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 p -135.25 173.82 11.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.172 -179.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.28 155.29 46.9 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.405 0.621 . . . . 0.0 111.241 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.5 tpp -141.22 115.39 9.3 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.472 179.056 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -72.2 108.05 5.16 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.497 0.665 . . . . 0.0 109.449 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.804 ' HA ' HG22 ' A' ' 91' ' ' VAL . 13.1 mt -77.64 -8.83 58.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.957 -178.19 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -51.14 -26.48 6.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.083 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -116.72 13.83 15.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.18 179.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.804 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -122.37 -8.76 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.201 0.524 . . . . 0.0 111.109 179.175 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.4 t -133.53 137.45 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.612 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -126.59 161.61 20.87 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.281 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.441 HD22 ' HB2' ' A' ' 8' ' ' SER . 14.3 t30 -114.49 129.64 56.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.876 0.37 . . . . 0.0 110.432 179.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.602 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 73.2 m -143.83 113.11 6.87 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.939 178.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 56.32 36.89 28.25 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 123.39 0.431 . . . . 0.0 111.196 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.75 22.06 63.78 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.791 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -118.85 145.98 45.24 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.804 0.335 . . . . 0.0 110.323 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.438 ' O ' ' HG3' ' A' ' 99' ' ' MET . 16.0 ptm -58.59 110.83 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.794 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 8.7 mm-40 -135.15 74.79 61.52 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.042 0.448 . . . . 0.0 110.654 178.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 56.2 Cg_endo -70.95 150.44 60.95 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.729 2.286 . . . . 0.0 112.592 -179.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 27.3 p -136.41 144.42 44.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.83 -179.686 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.696 ' HB2' ' HB3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -111.36 147.46 35.12 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.152 179.649 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -97.59 7.55 46.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.345 0.593 . . . . 0.0 111.118 179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.411 ' H ' ' HG2' ' A' ' 103' ' ' ARG . 50.6 m -157.01 -115.3 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.085 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.666 ' HB3' ' HG3' ' A' ' 103' ' ' ARG . 8.5 t-20 48.76 37.91 10.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.059 0.944 . . . . 0.0 111.214 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.22 -0.02 11.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.728 -179.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -107.51 -176.2 3.0 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.689 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -84.09 -68.36 0.72 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.901 0.381 . . . . 0.0 110.271 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.49 95.67 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.554 0.692 . . . . 0.0 110.546 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.871 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.2 pt? -86.16 60.02 5.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.15 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.648 ' HA ' ' OD1' ' A' ' 44' ' ' ASP . 88.4 tttt -59.39 123.63 17.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.047 -179.195 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 20.1 m -91.19 64.69 5.31 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.097 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 m -143.78 113.42 7.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.115 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.8 m -64.1 -42.38 96.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.102 179.38 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.986 179.601 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.803 0.335 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -73.54 163.42 28.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.093 179.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 74.4 m -71.26 -72.0 0.24 Allowed 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.48 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 2.2 m-20 52.64 76.17 0.2 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.569 0.543 . . . . 0.0 111.525 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 68' ' ' HIS . 13.1 p90 -57.98 -44.28 87.05 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.149 0.499 . . . . 0.0 110.17 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.22 -21.34 65.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.587 -179.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.62 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 18.8 t-20 -57.72 -29.54 64.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.494 -178.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.488 ' HB2' HD22 ' A' ' 94' ' ' ASN . 13.5 m -132.94 17.46 4.18 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.62 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 80.9 m -117.96 133.49 55.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.777 0.322 . . . . 0.0 110.577 -179.255 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 p -130.59 149.28 52.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.749 -179.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 64.88 45.3 92.92 Favored Glycine 0 N--CA 1.452 -0.265 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.607 179.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.519 HG12 ' HA3' ' A' ' 21' ' ' GLY . 17.4 m -88.22 135.31 25.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.093 0.473 . . . . 0.0 111.353 -179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -129.45 156.41 44.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.169 -179.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.567 HD22 HD23 ' A' ' 64' ' ' LEU . 19.4 tp -130.03 125.01 34.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.976 0.417 . . . . 0.0 112.108 -178.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -126.32 99.18 5.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.12 178.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' HG21 ' A' ' 62' ' ' THR . . . 77.45 -62.43 3.46 Favored Glycine 0 C--O 1.226 -0.368 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.857 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.46 25.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.29 0.566 . . . . 0.0 110.141 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 12.8 mt -119.52 115.55 47.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.708 -179.169 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.832 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -103.8 113.62 27.28 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.201 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 4.5 ttm180 -122.73 142.83 50.27 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.732 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -170.19 179.54 42.35 Favored Glycine 0 N--CA 1.443 -0.9 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.165 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 11.7 m-20 -102.71 108.31 19.51 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 62.1 m -106.23 131.8 53.04 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.7 mt -75.37 136.29 25.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.33 0.586 . . . . 0.0 111.694 -177.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -102.97 -173.47 2.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.389 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -54.77 -36.55 64.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.932 0.396 . . . . 0.0 111.662 -179.829 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.42 ' OD2' ' HB3' ' A' ' 29' ' ' HIS . 28.3 t70 -59.21 -27.56 65.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.73 -179.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.04 1.33 57.13 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.845 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.42 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -106.19 140.1 20.94 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 121.302 0.572 . . . . 0.0 111.086 -179.994 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 30.2 Cg_endo -64.09 122.08 9.96 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 123.557 2.838 . . . . 0.0 112.454 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -105.3 130.02 53.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.51 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.65 115.69 12.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.985 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 t -136.73 156.88 47.93 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.063 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.428 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 35.3 p -140.06 142.75 36.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.732 -179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.12 144.91 35.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.864 0.364 . . . . 0.0 110.578 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -100.7 99.73 10.32 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -62.89 -22.23 66.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.76 -178.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -55.87 -32.81 64.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.09 -178.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -103.99 13.76 32.01 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.641 -178.291 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.644 ' HD1' HD12 ' A' ' 111' ' ' LEU . 46.7 m-85 -131.13 -17.27 3.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 37' ' ' LEU . 1.9 mp -118.6 142.05 35.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.564 0.221 . . . . 0.0 110.555 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.689 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -120.06 165.04 13.61 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.319 -179.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -117.69 112.01 19.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.57 0.7 . . . . 0.0 110.634 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -110.9 114.61 28.07 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.264 -179.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.802 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 44.0 t30 59.52 33.82 22.29 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.148 0.499 . . . . 0.0 110.976 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.82 9.58 86.15 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.678 -0.773 . . . . 0.0 113.013 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -115.42 154.88 28.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.66 0.267 . . . . 0.0 110.707 179.951 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' CB ' ' HB2' ' A' ' 86' ' ' MET . 30.9 mt -82.59 122.41 28.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.244 -179.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG3' ' HD2' ' A' ' 51' ' ' PRO . 4.1 tp10 -111.31 137.35 49.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.217 179.069 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.655 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -39.87 -70.15 0.18 Allowed Pre-proline 0 CA--C 1.424 -3.889 0 CA-C-O 118.441 -0.79 . . . . 0.0 113.027 -179.272 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.655 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 5.6 Cg_endo -110.45 131.21 0.04 OUTLIER 'Trans proline' 1 N--CA 1.34 -7.519 0 C-N-CA 113.911 -3.593 . . . . 0.0 112.973 -177.619 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.689 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -156.48 -159.16 9.25 Favored Glycine 0 C--N 1.283 -2.385 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.87 -177.687 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -152.43 137.16 16.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.261 -0.469 . . . . 0.0 111.311 -178.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.3 t 48.58 45.01 21.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.037 177.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -65.75 -36.54 83.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.161 0.505 . . . . 0.0 109.671 179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.76 -18.8 33.41 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.281 -179.143 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.8 t -62.68 -28.65 70.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.812 0.339 . . . . 0.0 110.34 179.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 50.2 m -136.32 28.83 3.06 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.868 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 76.2 m -133.73 139.69 46.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.842 0.353 . . . . 0.0 110.834 179.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.2 m -135.17 175.07 11.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.36 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 63.43 40.09 8.67 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.435 0.459 . . . . 0.0 111.648 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 16' ' ' GLY . 17.1 p -66.65 126.45 28.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.995 179.728 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.99 162.64 40.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.922 179.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.567 HD23 HD22 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -120.94 113.65 20.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.867 0.365 . . . . 0.0 111.06 -179.616 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 15.4 m120 -75.51 116.53 16.32 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.654 179.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.664 ' HB3' ' HD2' ' A' ' 68' ' ' HIS . 22.6 t70 55.29 15.35 1.32 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.901 0.75 . . . . 0.0 111.475 178.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.99 37.98 74.1 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.515 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.664 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 9.8 p80 -147.01 -30.73 0.34 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 117.396 0.598 . . . . 0.0 111.479 178.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 6.6 m -116.23 133.21 56.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.631 0.253 . . . . 0.0 111.403 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.564 ' HA ' HD22 ' A' ' 64' ' ' LEU . 13.7 tp -91.31 131.42 36.82 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 178.612 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.42 130.39 55.94 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 178.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.95 163.73 31.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.113 0.483 . . . . 0.0 110.817 179.277 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.465 ' HG ' ' HD2' ' A' ' 81' ' ' TYR . 20.1 t -112.94 123.67 50.85 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.1 m -123.51 154.94 38.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.15 0.5 . . . . 0.0 112.031 -178.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.462 ' HE3' ' HA2' ' A' ' 79' ' ' GLY . 9.2 tmtt? -99.81 150.08 22.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.072 178.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.13 -29.95 0.89 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.98 178.732 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.802 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -56.02 -38.56 70.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.456 ' HB3' HE21 ' A' ' 80' ' ' GLN . 21.0 t70 -175.22 52.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.252 0.549 . . . . 0.0 109.983 179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.462 ' HA2' ' HE3' ' A' ' 75' ' ' LYS . . . 68.92 6.36 51.71 Favored Glycine 0 C--N 1.329 0.146 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.65 -179.108 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.456 HE21 ' HB3' ' A' ' 78' ' ' ASP . 27.8 pt20 -123.97 170.52 10.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.465 ' HD2' ' HG ' ' A' ' 73' ' ' SER . 55.1 p90 -110.84 164.74 12.47 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 123.448 0.467 . . . . 0.0 110.815 -179.067 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -155.34 150.03 26.37 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.07 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -81.02 141.23 34.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.849 0.357 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.3 p -153.01 167.52 28.93 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.963 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.17 162.83 30.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.962 0.41 . . . . 0.0 110.445 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.765 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 3.4 tpt -145.99 112.98 6.09 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.97 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.431 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 32.6 t0 -71.78 106.86 4.3 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.75 ' HA ' HG22 ' A' ' 91' ' ' VAL . 15.1 mt -77.81 -8.62 58.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.265 -178.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -49.45 -29.62 6.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.244 179.469 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 43.9 p90 -116.68 20.26 14.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.49 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.75 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.5 m -125.94 -12.88 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.234 0.54 . . . . 0.0 110.031 177.9 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.831 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 2.8 t -134.5 147.39 29.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -139.23 171.9 23.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.005 -0.616 . . . . 0.0 111.678 179.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.488 HD22 ' HB2' ' A' ' 8' ' ' SER . 37.0 t30 -117.1 129.42 55.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.84 0.352 . . . . 0.0 110.849 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.564 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 70.7 m -134.42 100.31 4.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.436 178.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 61.0 44.46 10.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.558 179.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.57 29.73 70.33 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.167 -179.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -128.9 148.21 50.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.693 0.282 . . . . 0.0 110.302 -179.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.48 ' O ' ' HG3' ' A' ' 99' ' ' MET . 21.5 ptt? -62.63 119.61 9.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.167 -179.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 20.6 mm-40 -143.46 79.06 14.2 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.541 178.207 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.831 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 42.9 Cg_endo -69.95 93.34 0.54 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.766 2.31 . . . . 0.0 113.174 -179.31 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 2.1 p -105.52 126.68 52.41 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.501 178.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.566 ' HG3' ' HB2' ' A' ' 106' ' ' ASN . 0.0 OUTLIER -96.6 147.44 23.88 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.175 -179.173 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -109.3 28.88 8.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.086 0.47 . . . . 0.0 110.984 179.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.1 m -154.65 -95.87 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.372 -179.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.607 ' HA ' ' HG3' ' A' ' 51' ' ' PRO . 23.8 t-20 69.94 106.85 0.06 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.591 179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -93.57 -44.24 8.3 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.106 179.231 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -138.22 176.47 8.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.168 -179.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 65.78 149.1 0.04 OUTLIER 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.179 0.99 . . . . 0.0 113.259 -179.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.1 t -119.06 97.2 5.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.151 179.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.807 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.6 pt? -102.44 80.08 1.9 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.948 -179.138 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -116.16 106.5 13.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.71 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.1 m -72.06 -49.16 38.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.422 -179.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 t 64.61 80.07 0.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.6 m -56.15 -51.05 69.37 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.049 -178.522 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.277 179.761 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mmm . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -107.65 151.36 25.75 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.55 ' HB3' ' CA ' ' A' ' 93' ' ' GLY . 95.8 m -53.58 -82.02 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.089 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 53.68 78.18 0.16 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.562 ' O ' ' HB2' ' A' ' 9' ' ' CYS . 4.4 p90 -56.91 -36.63 70.41 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.987 0.422 . . . . 0.0 111.506 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -66.01 -21.77 66.41 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.292 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -61.6 -18.35 59.01 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.481 ' HB2' HD22 ' A' ' 94' ' ' ASN . 69.7 m -145.21 29.55 1.17 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.696 0.284 . . . . 0.0 110.699 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -128.78 133.01 47.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.023 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 p -129.51 158.21 39.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.373 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.81 58.48 14.35 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.747 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.585 HG12 ' HA3' ' A' ' 21' ' ' GLY . 19.7 m -101.07 139.61 21.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.992 0.425 . . . . 0.0 111.546 -179.317 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -137.03 155.64 49.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.263 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.623 HD22 HD23 ' A' ' 64' ' ' LEU . 27.0 tp -127.78 123.66 35.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.0 0.428 . . . . 0.0 111.706 -179.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.44 ' O ' HG12 ' A' ' 18' ' ' ILE . 97.6 m-85 -124.64 99.49 6.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.579 179.246 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 62' ' ' THR . . . 75.46 -63.18 2.63 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.167 -0.54 . . . . 0.0 113.077 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' HD1' HD21 ' A' ' 36' ' ' ASN . 3.9 p90 -165.27 21.93 0.05 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 15' ' ' TYR . 32.0 pt -121.76 126.94 75.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.569 179.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.832 ' HB2' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -107.82 114.64 28.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.652 -179.922 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 5.2 ttt180 -118.13 141.24 48.7 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.641 179.344 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.585 ' HA3' HG12 ' A' ' 12' ' ' VAL . . . -167.99 177.6 42.14 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.796 179.405 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 16.1 m-20 -101.62 107.98 19.4 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.651 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.2 m -106.09 132.84 51.68 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.533 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.7 mt -69.15 139.89 19.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.472 -178.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 96' ' ' TYR . 6.0 p30 -110.14 -173.1 2.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.632 179.534 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -55.85 -27.98 54.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -66.92 -20.35 65.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.497 -179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.77 4.5 69.7 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.913 -179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -112.72 144.62 31.35 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 120.791 0.329 . . . . 0.0 110.175 179.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.667 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 38.5 Cg_endo -68.21 123.68 10.86 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 123.021 2.48 . . . . 0.0 113.002 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -115.27 132.16 56.7 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.7 127.2 31.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.39 0.614 . . . . 0.0 112.142 -178.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 t -136.05 155.2 50.56 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.612 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 78.0 p -138.45 132.08 30.77 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.527 -179.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.85 143.96 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 O-C-N 123.517 0.511 . . . . 0.0 110.328 -179.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.5 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -99.37 92.19 5.29 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.933 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.832 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.53 -27.09 56.65 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.63 -178.376 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 26.2 t-20 -53.98 -30.66 48.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.967 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -103.15 10.39 37.89 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.613 -178.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.1 m-85 -129.35 -21.09 3.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.534 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.1 mp -113.84 141.34 30.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.642 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -113.58 170.91 13.54 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.629 -179.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -114.76 104.42 11.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.027 -0.587 . . . . 0.0 109.753 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -111.24 106.16 15.06 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.786 -179.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 24.6 t30 59.2 40.06 22.07 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.121 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.82 17.09 80.25 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.559 179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -124.58 149.82 46.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.886 0.374 . . . . 0.0 110.885 -179.511 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.422 HD13 ' HG ' ' A' ' 70' ' ' LEU . 28.9 mt -74.99 124.24 26.6 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.352 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -112.01 139.22 47.69 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.598 ' CD2' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -43.52 -75.51 0.05 OUTLIER Pre-proline 0 CA--C 1.433 -3.536 0 CA-C-O 117.782 -1.104 . . . . 0.0 112.497 179.949 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 2.5 Cg_endo -108.45 127.89 0.04 OUTLIER 'Trans proline' 1 N--CA 1.345 -7.242 1 C-N-CA 113.196 -4.069 . . . . 0.0 112.779 -178.662 . . . . . . . . 4 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.642 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -155.16 -159.42 9.29 Favored Glycine 0 C--N 1.281 -2.514 0 CA-C-N 113.74 -1.573 . . . . 0.0 113.417 -177.629 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -151.23 147.32 26.85 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.917 0.389 . . . . 0.0 111.068 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.6 p 46.42 44.95 13.42 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 177.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -71.79 -38.8 70.22 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.7 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.21 -18.52 55.36 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.288 -178.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -65.26 -19.28 65.89 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.736 0.414 . . . . 0.0 110.896 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.4 m -142.16 20.76 2.09 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.006 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 84.5 m -126.75 144.09 51.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.601 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG23 ' HD2' ' A' ' 61' ' ' LYS . 23.2 m -136.78 173.62 13.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.734 179.315 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HD2' HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER 63.68 41.15 7.29 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.486 0.491 . . . . 0.0 110.829 179.405 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.5 HG21 ' O ' ' A' ' 16' ' ' GLY . 11.5 p -69.22 130.49 42.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.612 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.65 162.85 40.69 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.807 179.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.623 HD23 HD22 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -121.61 112.55 18.59 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.596 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -85.47 122.04 29.04 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.216 -179.263 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.09 24.04 10.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.686 178.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.81 39.8 69.28 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.524 -0.762 . . . . 0.0 114.074 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.465 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 4.7 p80 -153.26 -28.53 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.272 0.536 . . . . 0.0 111.537 179.609 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.8 m -115.93 131.43 56.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.797 0.332 . . . . 0.0 111.461 -179.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.605 ' HA ' HD22 ' A' ' 64' ' ' LEU . 12.7 tp -90.2 134.53 34.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.728 178.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.65 130.76 53.15 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.614 178.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.05 160.85 22.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.098 0.475 . . . . 0.0 111.464 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 83' ' ' ASP . 13.1 t -106.62 125.06 50.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.891 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 48.5 m -125.5 149.16 48.52 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.5 tmtt? -99.25 143.3 29.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.585 178.139 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.58 -31.09 0.52 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.621 178.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.729 ' HA ' ' OD1' ' A' ' 45' ' ' ASN . . . -47.51 -45.42 26.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 179.128 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -171.89 49.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.466 0.65 . . . . 0.0 109.606 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.32 2.4 79.11 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.009 -179.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -121.91 160.35 24.97 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 75' ' ' LYS . 51.3 p90 -101.02 160.43 14.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.877 -179.192 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -153.79 141.25 19.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 36.4 t70 -82.1 132.98 35.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.89 0.376 . . . . 0.0 110.693 -179.056 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.419 ' OG ' ' HG ' ' A' ' 48' ' ' LEU . 26.0 p -143.34 179.51 7.04 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.432 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.28 161.43 37.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.814 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.597 ' SD ' ' HD1' ' A' ' 50' ' ' TYR . 14.2 tpp -145.02 125.39 13.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.782 -179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.564 ' OD2' ' HB2' ' A' ' 89' ' ' ASN . 28.2 t70 -79.35 106.59 11.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.732 ' HA ' HG22 ' A' ' 91' ' ' VAL . 17.0 mt -76.61 -10.02 59.08 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.323 -177.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.564 ' HB2' ' OD2' ' A' ' 87' ' ' ASP . 5.9 m120 -48.51 -33.83 10.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.99 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 87' ' ' ASP . 46.7 p90 -113.74 20.97 15.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.897 0.379 . . . . 0.0 111.326 -179.166 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.732 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.2 m -126.58 -8.66 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.549 178.575 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 1.019 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 8.9 p -153.22 138.35 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.097 0.475 . . . . 0.0 111.409 179.298 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.55 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . . . -131.16 172.22 20.78 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.877 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.481 HD22 ' HB2' ' A' ' 8' ' ' SER . 18.4 t30 -113.74 116.76 29.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.33 179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.547 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 58.7 m -111.65 78.53 1.13 Allowed 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.829 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 25' ' ' ASN . 43.1 m-85 66.28 60.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.581 178.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.78 23.0 60.54 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.774 -179.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -126.98 132.02 50.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.907 0.384 . . . . 0.0 110.593 -178.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 99' ' ' MET . 16.8 ptt? -64.28 117.36 7.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.742 179.415 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 4.6 mt-10 -142.26 81.59 13.89 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 121.314 0.578 . . . . 0.0 109.889 177.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 1.019 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 58.4 Cg_endo -71.47 125.83 11.62 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.864 2.376 . . . . 0.0 112.023 179.665 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 32.0 p -115.18 131.47 56.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.767 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -111.8 140.52 46.38 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.722 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -123.9 15.54 9.32 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.078 0.466 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.734 ' HA ' HD21 ' A' ' 111' ' ' LEU . 65.4 m -159.8 64.74 0.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.531 -178.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.695 ' H ' HD13 ' A' ' 111' ' ' LEU . 4.3 t-20 -114.09 79.61 1.28 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.234 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.71 116.11 5.4 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.752 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -160.19 -69.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.294 -179.562 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.438 ' ND1' HG23 ' A' ' 110' ' ' VAL . 16.3 t-80 -135.39 -74.39 0.45 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.591 -179.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.438 HG23 ' ND1' ' A' ' 109' ' ' HIS . 59.2 t -118.07 92.07 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.284 0.564 . . . . 0.0 110.291 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.734 HD21 ' HA ' ' A' ' 105' ' ' SER . 47.9 tp -90.78 89.26 7.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.036 179.189 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt 60.01 29.18 18.77 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.469 0.652 . . . . 0.0 110.56 179.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.7 t 58.28 21.98 8.8 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.918 -178.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.6 t -140.76 53.73 1.59 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.232 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 m -66.59 -32.36 73.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.334 -179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.973 179.405 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.052 0.453 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -123.05 107.44 11.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 0.0 109.757 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.477 ' HB3' ' HA3' ' A' ' 93' ' ' GLY . 72.1 m -71.48 -62.56 1.36 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.084 -179.272 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.855 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . 39.2 m-20 52.32 76.96 0.17 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.839 0.352 . . . . 0.0 111.747 179.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.556 ' CE1' ' HB2' ' A' ' 88' ' ' LEU . 15.4 p90 -60.31 -41.96 94.55 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.019 0.438 . . . . 0.0 110.873 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.94 -23.91 65.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.99 -178.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.855 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 62.7 t30 -60.46 -29.73 69.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.168 -179.123 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 8.3 m -123.36 16.4 9.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 -179.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -124.33 146.28 48.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.368 0.604 . . . . 0.0 112.029 -179.301 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.7 p -140.33 152.77 46.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.005 179.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.86 33.15 70.38 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.574 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 18.2 m -79.89 133.38 29.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.012 0.434 . . . . 0.0 111.655 -179.471 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' O ' HD23 ' A' ' 19' ' ' LEU . 10.7 pt-20 -132.19 150.16 52.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.007 179.021 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.785 HD22 HD23 ' A' ' 64' ' ' LEU . 32.7 tp -122.01 120.71 35.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.2 0.524 . . . . 0.0 110.777 -179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 18' ' ' ILE . 73.0 t80 -125.1 101.02 6.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.956 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.01 -68.44 3.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.811 179.248 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.769 ' HD1' HD21 ' A' ' 36' ' ' ASN . 24.3 p90 -162.26 17.79 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.654 0.264 . . . . 0.0 111.294 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 15' ' ' TYR . 29.9 pt -121.6 131.29 73.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.966 0.412 . . . . 0.0 110.51 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.723 ' HB2' HD21 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -113.78 114.72 26.71 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.115 -179.632 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 3.2 ttt180 -118.12 141.68 48.23 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.734 179.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.28 -176.44 38.12 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.878 179.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 30' ' ' PRO . 8.8 m-20 -108.8 111.11 22.67 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.673 0.273 . . . . 0.0 110.907 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 8' ' ' SER . 1.3 m -106.28 133.18 51.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.8 mt -68.83 134.3 30.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.828 0.347 . . . . 0.0 110.704 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -105.5 -172.68 2.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.02 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -57.24 -25.31 58.92 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.389 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -67.16 -20.65 65.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.068 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.43 1.69 74.46 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.88 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -112.19 144.48 30.88 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.633 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 29.1 Cg_endo -65.0 123.77 12.09 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.744 2.296 . . . . 0.0 112.445 179.699 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -109.17 130.19 55.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.671 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.24 122.89 21.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.972 0.415 . . . . 0.0 111.613 -179.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.6 t -142.57 164.03 31.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.446 ' HB3' ' HG3' ' A' ' 20' ' ' ARG . 12.2 p -138.69 149.67 45.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.024 0.44 . . . . 0.0 111.288 -179.222 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.87 142.65 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.723 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.769 HD21 ' HD1' ' A' ' 17' ' ' TYR . 0.2 OUTLIER -103.37 92.0 4.3 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.641 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.723 HD21 ' HB2' ' A' ' 19' ' ' LEU . 1.3 mm? -56.95 -29.41 63.15 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.669 -178.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -52.21 -33.88 43.12 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.875 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -102.05 16.32 26.39 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.839 -178.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 51' ' ' PRO . 44.4 m-85 -130.86 -26.47 2.19 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.48 HD13 ' HB3' ' A' ' 37' ' ' LEU . 2.5 mp -112.52 141.55 27.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.633 ' CA ' ' HA3' ' A' ' 52' ' ' GLY . . . -111.9 171.53 14.26 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.577 -0.82 . . . . 0.0 113.312 -179.518 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -113.37 109.05 18.08 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.24 -0.48 . . . . 0.0 110.996 -179.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -110.05 105.89 15.18 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 0.0 OUTLIER 49.32 39.12 15.32 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 122.662 1.22 . . . . 0.0 111.867 179.652 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 74' ' ' CYS . . . 88.65 3.66 77.25 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.415 178.538 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -110.06 154.4 23.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.988 0.423 . . . . 0.0 110.888 -179.869 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.5 mt -85.47 117.22 24.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.074 -179.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.952 ' HG3' HD11 ' A' ' 111' ' ' LEU . 31.3 tt0 -106.04 128.61 53.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.018 -179.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.653 ' HD1' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER -36.55 -66.8 0.25 Allowed Pre-proline 1 CA--C 1.42 -4.05 0 O-C-N 124.117 0.885 . . . . 0.0 112.754 -179.493 . . . . . . . . 4 4 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.594 ' HD3' ' CD2' ' A' ' 50' ' ' TYR . 3.0 Cg_endo -109.6 126.4 0.04 OUTLIER 'Trans proline' 1 N--CA 1.344 -7.313 0 C-N-CA 113.821 -3.652 . . . . 0.0 113.413 -177.708 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.633 ' HA3' ' CA ' ' A' ' 42' ' ' GLY . . . -165.05 -161.83 14.84 Favored Glycine 0 C--N 1.285 -2.257 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.684 -177.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -152.48 146.45 25.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.381 -0.41 . . . . 0.0 110.665 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.6 m 54.5 40.65 31.97 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 178.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.426 ' HD2' ' SG ' ' A' ' 59' ' ' CYS . 13.2 p90 -72.2 -34.16 68.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.49 -18.26 67.55 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.998 -179.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 m -68.89 -9.34 51.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.153 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.8 m -145.62 8.22 1.14 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.726 179.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.426 ' SG ' ' HD2' ' A' ' 55' ' ' PHE . 6.4 m -109.33 153.28 24.14 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.101 0.477 . . . . 0.0 111.462 -179.226 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.402 HG23 ' HD3' ' A' ' 61' ' ' LYS . 18.9 m -142.22 167.41 15.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.906 178.387 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HD3' HG23 ' A' ' 60' ' ' VAL . 5.1 mptp? 63.39 33.06 14.14 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.618 0.574 . . . . 0.0 111.293 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 p -59.68 122.09 13.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.324 179.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.94 161.39 42.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.869 -179.513 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.785 HD23 HD22 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -114.4 113.78 24.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.815 0.341 . . . . 0.0 111.803 -179.003 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 90.0 m-20 -73.09 116.35 13.52 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.526 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . 6.1 t70 54.47 20.01 2.6 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.104 0.878 . . . . 0.0 111.558 179.303 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.85 29.24 73.54 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.072 -0.513 . . . . 0.0 114.375 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.526 ' CE1' ' HB3' ' A' ' 66' ' ' ASP . 1.9 p-80 -142.57 -24.48 0.65 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.913 0.856 . . . . 0.0 112.036 179.276 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' A' ' 65' ' ' ASN . 20.3 m -116.24 132.53 56.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.774 0.321 . . . . 0.0 111.085 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.562 ' HB3' HD21 ' A' ' 88' ' ' LEU . 16.0 tp -90.77 129.63 36.83 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.422 HG23 ' HB3' ' A' ' 85' ' ' SER . 0.0 OUTLIER -120.2 129.29 54.03 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.312 179.857 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -163.86 163.94 23.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.067 0.46 . . . . 0.0 110.776 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.6 t -114.5 119.48 36.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.474 -0.784 . . . . 0.0 108.98 179.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -116.17 156.36 26.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.329 0.585 . . . . 0.0 111.831 -179.172 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' TYR . 10.9 tmtt? -99.5 143.34 29.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.304 178.471 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.72 -17.81 0.66 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.445 -1.359 . . . . 0.0 114.098 178.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 45' ' ' ASN . . . -63.37 -38.06 89.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.426 0.613 . . . . 0.0 110.484 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -177.25 59.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.754 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.84 16.72 66.47 Favored Glycine 0 C--N 1.329 0.179 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.086 -179.418 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -139.31 163.36 32.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 74' ' ' CYS . 40.8 p90 -97.6 171.62 8.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.143 -179.075 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.13 136.63 11.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.69 128.64 37.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.162 -179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -146.02 169.0 19.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.071 0.462 . . . . 0.0 111.264 -179.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.422 ' HB3' HG23 ' A' ' 71' ' ' THR . 0.9 OUTLIER -140.7 164.47 30.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.923 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.88 ' HA ' ' HE3' ' A' ' 86' ' ' MET . 0.5 OUTLIER -149.21 125.95 11.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.492 -179.235 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.476 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 9.0 m-20 -75.25 106.31 6.71 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.458 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.785 ' HA ' HG22 ' A' ' 91' ' ' VAL . 14.8 mt -79.11 -8.63 59.13 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.163 0.506 . . . . 0.0 109.687 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -49.61 -28.43 5.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.731 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 103' ' ' ARG . 10.4 p90 -119.11 21.52 12.29 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.65 0.262 . . . . 0.0 111.258 179.658 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.785 HG22 ' HA ' ' A' ' 88' ' ' LEU . 1.6 m -127.2 -16.25 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.943 0.402 . . . . 0.0 110.563 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 101' ' ' PRO . 3.1 t -132.94 148.74 31.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.205 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.477 ' HA3' ' HB3' ' A' ' 3' ' ' CYS . . . -147.72 164.26 28.81 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.89 179.533 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -107.93 135.06 49.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.899 0.38 . . . . 0.0 110.638 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.652 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 59.0 m -140.14 96.51 3.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.713 178.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 62.03 45.96 6.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.675 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 56.51 29.76 57.9 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.773 -179.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -127.08 147.11 50.17 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.844 0.354 . . . . 0.0 110.665 -178.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -59.0 103.11 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.475 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.652 ' HG3' ' HB2' ' A' ' 95' ' ' SER . 59.1 mm-40 -137.96 67.1 48.63 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.426 179.008 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 92' ' ' VAL . 28.3 Cg_endo -62.72 114.41 2.39 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 123.32 2.68 . . . . 0.0 112.838 -179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.03 129.22 54.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.042 179.197 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -112.29 147.38 36.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.092 179.767 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -107.59 56.14 0.64 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.139 0.495 . . . . 0.0 110.366 179.373 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.3 t -167.22 -124.48 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.494 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.465 ' C ' ' H ' ' A' ' 108' ' ' ASP . 28.9 t-20 63.63 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.861 0.865 . . . . 0.0 111.666 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 68.99 -32.7 0.23 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.826 0.85 . . . . 0.0 112.31 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 106' ' ' ASN . 28.1 t70 -62.92 -25.96 68.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.32 0.581 . . . . 0.0 110.756 179.321 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -136.57 155.41 49.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.821 179.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.429 HG12 ' HG2' ' A' ' 112' ' ' LYS . 25.0 t -112.16 96.3 4.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.788 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.952 HD11 ' HG3' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -82.2 74.85 9.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.617 0.722 . . . . 0.0 111.986 -178.466 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.802 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 7.4 mmpt? -101.45 95.08 6.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.985 179.02 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.3 p -82.92 61.94 6.22 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.667 -179.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.7 t -157.51 94.67 1.39 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.194 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -72.14 -53.14 13.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.167 0.508 . . . . 0.0 109.651 179.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 C--O 1.247 0.928 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.992 179.754 . . . . . . . . 0 0 . 1 stop_ save_